Citrus Sinensis ID: 041031
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 313 | 2.2.26 [Sep-21-2011] | |||||||
| F4IB81 | 651 | LysM domain receptor-like | yes | no | 0.968 | 0.465 | 0.545 | 7e-92 | |
| A8R7E6 | 617 | Chitin elicitor receptor | no | no | 0.923 | 0.468 | 0.496 | 1e-71 | |
| D7UPN3 | 605 | Chitin elicitor receptor | no | no | 0.891 | 0.461 | 0.481 | 2e-64 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.942 | 0.452 | 0.406 | 2e-54 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.884 | 0.386 | 0.406 | 2e-54 | |
| O22808 | 664 | Protein LYK5 OS=Arabidops | no | no | 0.920 | 0.433 | 0.391 | 3e-53 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.897 | 0.678 | 0.411 | 2e-52 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.913 | 0.676 | 0.396 | 2e-52 | |
| P43298 | 942 | Probable receptor protein | no | no | 0.913 | 0.303 | 0.415 | 2e-52 | |
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.862 | 0.290 | 0.416 | 6e-52 |
| >sp|F4IB81|LYK3_ARATH LysM domain receptor-like kinase 3 OS=Arabidopsis thaliana GN=LYK3 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 337 bits (864), Expect = 7e-92, Method: Compositional matrix adjust.
Identities = 168/308 (54%), Positives = 219/308 (71%), Gaps = 5/308 (1%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
+F+Y E+R AT FS S +G G+YGSVY G LR + A+K+M TK+KEF++E+K+LCK
Sbjct: 328 VFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFAAEMKVLCK 387
Query: 61 VH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
VH SNL+ELIGYAA D LF+VYEY + G L HLH P KG PL+W R QIALDAA+
Sbjct: 388 VHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDPQSKGNTPLSWIMRNQIALDAAR 447
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
GLEYIH++TK +YVHRD+KTSNILLD FRAKI+DFGL KL+E + E + +++VGT+G
Sbjct: 448 GLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVEKTGEGEISVTKVVGTYG 507
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
YLAPEY+ DG T+KSD+YAFGVVL E+I+G++A+ R G E R L MLAV
Sbjct: 508 YLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAVIRTEAIGTKN-PERRPLASIMLAVL 566
Query: 240 NDTKDF--MAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296
++ D M+ L E +DPN+ Y D + ++A L+K CVD++ RP+M I LS I
Sbjct: 567 KNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQCVDDDPILRPNMKQVVISLSQI 626
Query: 297 LISSKEWE 304
L+SS EWE
Sbjct: 627 LLSSIEWE 634
|
Putative Lysin motif (LysM) receptor kinase that may recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|A8R7E6|CERK1_ARATH Chitin elicitor receptor kinase 1 OS=Arabidopsis thaliana GN=CERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (690), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 152/306 (49%), Positives = 196/306 (64%), Gaps = 17/306 (5%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV 61
FS E+ AT NF+ S KIGQG +G+VY +LRG+ AAIK+M SK+F +ELK+L +V
Sbjct: 310 FSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASKQFLAELKVLTRV 369
Query: 62 HS-NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
H NL+ LIGY G SLFLVYEY +NG L HLH G++PL WT RVQIALD+A+G
Sbjct: 370 HHVNLVRLIGYCVEG-SLFLVYEYVENGNLGQHLHG---SGREPLPWTKRVQIALDSARG 425
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR-IVGTFG 179
LEYIH++T P YVHRD+K++NIL+D FRAK+ADFGL KL E+ +A+R +GTFG
Sbjct: 426 LEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLT----EVGGSATRGAMGTFG 481
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
Y+APE V G V+ K DVYAFGVVL ELI+ + A+ + E R LV F
Sbjct: 482 YMAPETVY-GEVSAKVDVYAFGVVLYELISAKGAVVKM----TEAVGEFRGLVGVFEESF 536
Query: 240 NDTKDFMAKLTECLDPNLT-RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298
+T D L + +DP L Y DS+ +MA L K C EN + RP M + LS +
Sbjct: 537 KET-DKEEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLRPSMRYIVVALSTLFS 595
Query: 299 SSKEWE 304
S+ W+
Sbjct: 596 STGNWD 601
|
Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity toward both biotic and abiotic stresses (e.g. tolerance to salinity, heavy-metal stresses, and Botrytis cinerea infection). Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to pathogenic fungi Alternaria brassicicola and Erysiphe cichoracearum, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Target of the bacterial type III effector E3-ligase protein hopAB2/avrPtoB of Pseudomonas syringae pv. tomato DC3000 that mediates ubiquitination and subsequent proteolysis, thus blocking all defense responses by suppressing PAMP-triggered immunity (PTI). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|D7UPN3|CERK1_ORYSJ Chitin elicitor receptor kinase 1 OS=Oryza sativa subsp. japonica GN=CERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 246 bits (627), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 143/297 (48%), Positives = 189/297 (63%), Gaps = 18/297 (6%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV 61
FSY E+ +AT FS KIGQG +GSVY +LRG+ AIK+M ++EF +ELK+L V
Sbjct: 305 FSYEEIFNATQGFSMEHKIGQGGFGSVYYAELRGEKTAIKKMGMQATQEFLAELKVLTHV 364
Query: 62 HS-NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
H NL+ LIGY + LFLVYE+ NG LS HL G PL+W TRVQIALD+A+G
Sbjct: 365 HHLNLVRLIGYCVE-NCLFLVYEFIDNGNLSQHLQR---TGYAPLSWATRVQIALDSARG 420
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
LEY+H++ P YVHRD+K++NILLD +FRAKIADFGL KL E + ++R+ GTFGY
Sbjct: 421 LEYLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLAKLTEVGSMSQSLSTRVAGTFGY 480
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLV---DYMLA 237
+ PE R G V+ K DVYAFGVVL EL++ +QA+ R + +E + LV + L+
Sbjct: 481 MPPE-ARYGEVSPKVDVYAFGVVLYELLSAKQAIVRSS----ESVSESKGLVFLFEEALS 535
Query: 238 VFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293
N T+ L E +DP+L Y DS L++A L+K C E RP M + + L
Sbjct: 536 APNPTE----ALDELIDPSLQGDYPVDSALKIASLAKSCTHEEPGMRPTMRSVVVAL 588
|
Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands (By similarity). Lysin motif (LysM) receptor kinase required as a cell surface receptor for chitin elicitor (chitooligosaccharides) signaling leading to innate immunity in response to both biotic and abiotic stresses. Involved in the resistance to pathogenic fungi, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 129/317 (40%), Positives = 183/317 (57%), Gaps = 22/317 (6%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKL-RGKNAAIKQMK---NTKSKEFSSELKI 57
F+Y E+ AT+ FS + +GQG +G V+ G L GK A+KQ+K +EF +E++I
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 58 LCKVH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALD 116
+ +VH +L+ LIGY G LVYE+ N L HLH KG+ + W+TR++IAL
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG---KGRPTMEWSTRLKIALG 384
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
+AKGL Y+H+ P +HRD+K SNIL+D F AK+ADFGL K+ S ++R++G
Sbjct: 385 SAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIA--SDTNTHVSTRVMG 442
Query: 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236
TFGYLAPEY G +T KSDV++FGVVL+ELITG++ + DA NN Y + SLVD+
Sbjct: 443 TFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPV--DA---NNVYVDD-SLVDWAR 496
Query: 237 AVFN---DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293
+ N + DF + Y ++ M +M + CV + +RRP MS L
Sbjct: 497 PLLNRASEEGDFEGLADSKMG---NEYDREEMARMVACAAACVRHSARRRPRMSQIVRAL 553
Query: 294 SHILISSKEWEKMECCH 310
+ S E M H
Sbjct: 554 EGNVSLSDLNEGMRPGH 570
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 120/295 (40%), Positives = 175/295 (59%), Gaps = 18/295 (6%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKS---KEFSSELKI 57
F+Y E+ AT+ FS + +GQG +G V+ G LR GK A+KQ+K S +EF +E+ I
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 58 LCKVH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALD 116
+ +VH +L+ L+GY LVYE+ N L HLH KG+ + W++R++IA+
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHG---KGRPTMEWSSRLKIAVG 458
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
+AKGL Y+H+ P +HRD+K SNIL+D F AK+ADFGL K+ S ++R++G
Sbjct: 459 SAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIA--SDTNTHVSTRVMG 516
Query: 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236
TFGYLAPEY G +T KSDV++FGVVL+ELITG++ + NN + ++ SLVD+
Sbjct: 517 TFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDV-----NNVHADN-SLVDWAR 570
Query: 237 AVFNDTKDFMAKLTECLDPNL-TRYHKDSMLQMALLSKDCVDENWKRRPDMSNAA 290
+ N + + +D L Y K+ M +M + CV RRP M A
Sbjct: 571 PLLNQVSE-LGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVA 624
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22808|LYK5_ARATH Protein LYK5 OS=Arabidopsis thaliana GN=LYK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (531), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 121/309 (39%), Positives = 189/309 (61%), Gaps = 21/309 (6%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
++ +N+++ ATSNFS +I GSVY + G +AA+K +K S SSE+ +L K
Sbjct: 359 LYRFNDLQSATSNFSDENRIK----GSVYRATINGDDAAVKVIKGDVS---SSEINLLKK 411
Query: 61 V-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
+ HSN+I L G+ + +LV+EY++NG++SD LH GKK L W RV+IA D A+
Sbjct: 412 LNHSNIIRLSGFCIREGTSYLVFEYSENGSISDWLH---SSGKKSLTWKQRVEIARDVAE 468
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
L+Y+H Y P ++H++++++NILLDSNFRAKIA+FG+ ++L+ + GT G
Sbjct: 469 ALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVARILDEGDLDLQLTRHVEGTQG 528
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
YLAPEYV +G +T+K DV+AFGV ++EL++G++A++ ++ E V+ + V
Sbjct: 529 YLAPEYVENGVITSKLDVFAFGVAVLELLSGREAVTI------HKKKEGEEEVEMLCKVI 582
Query: 240 NDT---KDFMAKLTECLDPNL-TRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295
N ++ KL E +DP+L Y + MA L+K CV + RP ++ LS
Sbjct: 583 NSVLGGENVREKLKEFMDPSLGNEYPLELAYTMAQLAKSCVATDLNSRPSVTQVLTTLSM 642
Query: 296 ILISSKEWE 304
I+ SS +WE
Sbjct: 643 IVSSSIDWE 651
|
May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 125/304 (41%), Positives = 173/304 (56%), Gaps = 23/304 (7%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELK 56
FS+ E+ AT NF IG+G +G VY GKL G A+KQ+ +KEF E+
Sbjct: 67 FSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEVL 126
Query: 57 ILCKVH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL 115
+L +H +L+ LIGY A GD LVYEY G+L DHL + PL W TR++IAL
Sbjct: 127 MLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHL-LDLTPDQIPLDWDTRIRIAL 185
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP--EIAAAASR 173
AA GLEY+H P ++RD+K +NILLD F AK++DFGL KL P + +SR
Sbjct: 186 GAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKL---GPVGDKQHVSSR 242
Query: 174 IVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233
++GT+GY APEY R G +TTKSDVY+FGVVL+ELITG++ + + + ++LV
Sbjct: 243 VMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVID------TTRPKDEQNLVT 296
Query: 234 YMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMAL-LSKDCVDENWKRRPDMSNAAIR 292
+ VF + F E DP+L + L A+ ++ C+ E RP MS+
Sbjct: 297 WAQPVFKEPSRF----PELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTA 352
Query: 293 LSHI 296
L +
Sbjct: 353 LGFL 356
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (523), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 122/308 (39%), Positives = 184/308 (59%), Gaps = 22/308 (7%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS---KEFSSELK 56
F++ E+ +AT NF + +G+G +G V+ G + + AIKQ+ +EF E+
Sbjct: 91 FTFQELAEATGNFRSDCFLGEGGFGKVFKGTIEKLDQVVAIKQLDRNGVQGIREFVVEVL 150
Query: 57 ILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLH-WPSVKGKKPLAWTTRVQIA 114
L H NL++LIG+ A GD LVYEY G+L DHLH PS GKKPL W TR++IA
Sbjct: 151 TLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLPS--GKKPLDWNTRMKIA 208
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI 174
AA+GLEY+H P ++RD+K SNILL +++ K++DFGL K + S + ++R+
Sbjct: 209 AGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAK-VGPSGDKTHVSTRV 267
Query: 175 VGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234
+GT+GY AP+Y G +T KSD+Y+FGVVL+ELITG++A+ N + + ++LV +
Sbjct: 268 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID------NTKTRKDQNLVGW 321
Query: 235 MLAVFNDTKDFMAKLTECLDPNLT-RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293
+F D ++F + +DP L +Y + Q +S CV E RP +S+ + L
Sbjct: 322 ARPLFKDRRNF----PKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLAL 377
Query: 294 SHILISSK 301
+ L SSK
Sbjct: 378 -NFLASSK 384
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (523), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 127/306 (41%), Positives = 176/306 (57%), Gaps = 20/306 (6%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKN-----TKSKEFSSE 54
+ S +R T+NFS+ +G G +G VY G+L G A+K+M+N EF SE
Sbjct: 575 LISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRMENGVIAGKGFAEFKSE 634
Query: 55 LKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQI 113
+ +L KV H +L+ L+GY G+ LVYEY G LS HL S +G KPL W R+ +
Sbjct: 635 IAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWSEEGLKPLLWKQRLTL 694
Query: 114 ALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE-IAAAAS 172
ALD A+G+EY+H ++HRD+K SNILL + RAK+ADFGLV+L +PE + +
Sbjct: 695 ALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL---APEGKGSIET 751
Query: 173 RIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLV 232
RI GTFGYLAPEY G VTTK DVY+FGV+LMELITG+++L +Q E LV
Sbjct: 752 RIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDE------SQPEESIHLV 805
Query: 233 DYMLAVF-NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291
+ ++ N F + +D L S+ +A L+ C +RPDM +A
Sbjct: 806 SWFKRMYINKEASFKKAIDTTID--LDEETLASVHTVAELAGHCCAREPYQRPDMGHAVN 863
Query: 292 RLSHIL 297
LS ++
Sbjct: 864 ILSSLV 869
|
Probable receptor. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (519), Expect = 6e-52, Method: Compositional matrix adjust.
Identities = 122/293 (41%), Positives = 172/293 (58%), Gaps = 23/293 (7%)
Query: 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKS---KEFSSELKILCKVH 62
+ +AT NFS K+G+GS+GSVY G+++ GK A+K + S ++F +E+ +L ++H
Sbjct: 601 LEEATDNFSK--KVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIH 658
Query: 63 -SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGL 121
NL+ LIGY D LVYEY NG+L DHLH S KPL W TR+QIA DAAKGL
Sbjct: 659 HRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSS--DYKPLDWLTRLQIAQDAAKGL 716
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
EY+H P +HRDVK+SNILLD N RAK++DFGL + E ++ +S GT GYL
Sbjct: 717 EYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEE--DLTHVSSVAKGTVGYL 774
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMELITGQQALS-RDANPGNNQYTEHRSLVDYMLAVFN 240
PEY +T KSDVY+FGVVL EL++G++ +S D P N RSL+
Sbjct: 775 DPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLI-------- 826
Query: 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293
D + C+ N+ +S+ ++A ++ CV++ RP M + +
Sbjct: 827 RKGDVCGIIDPCIASNV---KIESVWRVAEVANQCVEQRGHNRPRMQEVIVAI 876
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 313 | ||||||
| 225430257 | 593 | PREDICTED: probable LRR receptor-like se | 0.990 | 0.522 | 0.770 | 1e-141 | |
| 224092452 | 329 | predicted protein [Populus trichocarpa] | 0.977 | 0.930 | 0.726 | 1e-131 | |
| 296082024 | 262 | unnamed protein product [Vitis vinifera] | 0.750 | 0.896 | 0.830 | 1e-110 | |
| 115439853 | 420 | Os01g0741200 [Oryza sativa Japonica Grou | 0.971 | 0.723 | 0.545 | 9e-93 | |
| 222619228 | 687 | hypothetical protein OsJ_03403 [Oryza sa | 0.971 | 0.442 | 0.545 | 3e-92 | |
| 218189030 | 687 | hypothetical protein OsI_03683 [Oryza sa | 0.971 | 0.442 | 0.545 | 5e-92 | |
| 414880580 | 417 | TPA: putative lysM-domain protein kinase | 0.980 | 0.736 | 0.553 | 2e-91 | |
| 359482890 | 666 | PREDICTED: proline-rich receptor-like pr | 0.952 | 0.447 | 0.549 | 2e-90 | |
| 297743186 | 508 | unnamed protein product [Vitis vinifera] | 0.952 | 0.586 | 0.549 | 2e-90 | |
| 224059146 | 664 | predicted protein [Populus trichocarpa] | 0.968 | 0.456 | 0.551 | 4e-90 |
| >gi|225430257|ref|XP_002282620.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g51810-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1308), Expect = e-141, Method: Compositional matrix adjust.
Identities = 242/314 (77%), Positives = 272/314 (86%), Gaps = 4/314 (1%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
+FSY EV DAT NFS SLKIGQGSYGSVYLGKLRG + AIKQMK TKSKEF SEL IL +
Sbjct: 283 VFSYIEVCDATCNFSMSLKIGQGSYGSVYLGKLRGIDVAIKQMKETKSKEFFSELHILSR 342
Query: 61 VH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
VH +NLI+LIGYA GGDSLFLVYE+AQNGALS HLH P+ +G KPL WTTR+QIALDAA+
Sbjct: 343 VHHTNLIKLIGYAGGGDSLFLVYEFAQNGALSHHLHRPTARGYKPLEWTTRLQIALDAAR 402
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
GLEYIH++TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL EHSP AAAASRIVGTFG
Sbjct: 403 GLEYIHEHTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLFEHSPNSAAAASRIVGTFG 462
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
YLAPEY+RDGCVTTKSDVYA+GVVLMEL+TGQ ALSRDANPGN+QY EHRSLV+Y+L+
Sbjct: 463 YLAPEYIRDGCVTTKSDVYAYGVVLMELLTGQPALSRDANPGNDQYIEHRSLVEYLLSAL 522
Query: 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299
ND+ D L +C+DPNL YH DS+ QMALLSKDCVD++W +RPDMS+ IRL H+L
Sbjct: 523 NDSHD---SLMQCIDPNLIHYHADSVFQMALLSKDCVDDDWNQRPDMSSIVIRLLHLLAR 579
Query: 300 SKEWEKMECCHQMS 313
S+EWEK+EC H MS
Sbjct: 580 SREWEKLECSHPMS 593
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224092452|ref|XP_002309617.1| predicted protein [Populus trichocarpa] gi|222855593|gb|EEE93140.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 475 bits (1222), Expect = e-131, Method: Compositional matrix adjust.
Identities = 231/318 (72%), Positives = 266/318 (83%), Gaps = 12/318 (3%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
+ YNE+R+ATSNFS SL IGQGSYG VYLGKLRG + AIKQMK+T SKEF SEL ILCK
Sbjct: 12 VLPYNEIREATSNFSRSLIIGQGSYGLVYLGKLRGTDVAIKQMKDTNSKEFLSELNILCK 71
Query: 61 VHS-NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
VH NLIELIGYAAGG+SLFLVYE+AQNGALS+HLH P+++G KPL WTTRVQIALDAAK
Sbjct: 72 VHHINLIELIGYAAGGESLFLVYEFAQNGALSNHLHNPALRGHKPLPWTTRVQIALDAAK 131
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAK----------IADFGLVKLLEHSPEIA- 168
GLEYIH++TKPYYVHRD+K SNILLDSNF AK IADFGLVKL E SP+
Sbjct: 132 GLEYIHEHTKPYYVHRDIKPSNILLDSNFHAKPFNVQFLSPQIADFGLVKLSEQSPDAGG 191
Query: 169 AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEH 228
AAASRIVGTFGYLAPEYVRDG VT KSDVY+FGVVLMEL+TGQ ALS+DA+P N + +EH
Sbjct: 192 AAASRIVGTFGYLAPEYVRDGHVTAKSDVYSFGVVLMELLTGQPALSKDASPENEKLSEH 251
Query: 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSN 288
RS+V YML+ ND++D +L +C+DPNLT Y KDS+ +MALLSKDCVD+NWKRRPDMS
Sbjct: 252 RSVVQYMLSALNDSQDSFDELAKCIDPNLTSYDKDSLYEMALLSKDCVDDNWKRRPDMSR 311
Query: 289 AAIRLSHILISSKEWEKM 306
+RLSHIL SS+EWE++
Sbjct: 312 VVLRLSHILSSSREWEEL 329
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296082024|emb|CBI21029.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 405 bits (1041), Expect = e-110, Method: Compositional matrix adjust.
Identities = 196/236 (83%), Positives = 214/236 (90%), Gaps = 1/236 (0%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
+FSY EV DAT NFS SLKIGQGSYGSVYLGKLRG + AIKQMK TKSKEF SEL IL +
Sbjct: 12 VFSYIEVCDATCNFSMSLKIGQGSYGSVYLGKLRGIDVAIKQMKETKSKEFFSELHILSR 71
Query: 61 VH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
VH +NLI+LIGYA GGDSLFLVYE+AQNGALS HLH P+ +G KPL WTTR+QIALDAA+
Sbjct: 72 VHHTNLIKLIGYAGGGDSLFLVYEFAQNGALSHHLHRPTARGYKPLEWTTRLQIALDAAR 131
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
GLEYIH++TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL EHSP AAAASRIVGTFG
Sbjct: 132 GLEYIHEHTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLFEHSPNSAAAASRIVGTFG 191
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235
YLAPEY+RDGCVTTKSDVYA+GVVLMEL+TGQ ALSRDANPGN+QY EHRSLV+Y+
Sbjct: 192 YLAPEYIRDGCVTTKSDVYAYGVVLMELLTGQPALSRDANPGNDQYIEHRSLVEYV 247
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|115439853|ref|NP_001044206.1| Os01g0741200 [Oryza sativa Japonica Group] gi|57899494|dbj|BAD86955.1| putative Nod-factor receptor 1b [Oryza sativa Japonica Group] gi|113533737|dbj|BAF06120.1| Os01g0741200 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 346 bits (887), Expect = 9e-93, Method: Compositional matrix adjust.
Identities = 168/308 (54%), Positives = 226/308 (73%), Gaps = 4/308 (1%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
+F+Y E+ +T +FS + +G G+YGSVY G LR + AIK+M TK+KEF E+K+LCK
Sbjct: 96 VFTYQEILASTDSFSDANLLGHGTYGSVYYGVLRDQEVAIKRMTATKTKEFIVEMKVLCK 155
Query: 61 VH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
VH ++L+ELIGYAA D L+L+YEY+Q G+L +HLH P KG L+W RVQIALDAA+
Sbjct: 156 VHHASLVELIGYAASKDELYLIYEYSQKGSLKNHLHDPQSKGYTSLSWIYRVQIALDAAR 215
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
GLEYIH++TK +YVHRD+K+SNILLD +FRAKI+DFGL KL+ S + A+ +++VGTFG
Sbjct: 216 GLEYIHEHTKDHYVHRDIKSSNILLDESFRAKISDFGLAKLVVKSTDAEASVTKVVGTFG 275
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
YLAPEY+RDG TTK+DVYAFGVVL ELI+G++A++R +E RSL ML+
Sbjct: 276 YLAPEYLRDGLATTKNDVYAFGVVLFELISGKEAITRTDGLNEGSNSERRSLASVMLSAL 335
Query: 240 NDTKD--FMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296
+ ++ +M L +C+DPNL Y D + +MA+L+K CV+E+ RPDM A I LS I
Sbjct: 336 KNCRNSMYMGSLKDCIDPNLMDLYPHDCVYKMAMLAKQCVEEDPVLRPDMKQAVITLSQI 395
Query: 297 LISSKEWE 304
L+SS EWE
Sbjct: 396 LLSSIEWE 403
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|222619228|gb|EEE55360.1| hypothetical protein OsJ_03403 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 344 bits (882), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 168/308 (54%), Positives = 226/308 (73%), Gaps = 4/308 (1%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
+F+Y E+ +T +FS + +G G+YGSVY G LR + AIK+M TK+KEF E+K+LCK
Sbjct: 363 VFTYQEILASTDSFSDANLLGHGTYGSVYYGVLRDQEVAIKRMTATKTKEFIVEMKVLCK 422
Query: 61 VH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
VH ++L+ELIGYAA D L+L+YEY+Q G+L +HLH P KG L+W RVQIALDAA+
Sbjct: 423 VHHASLVELIGYAASKDELYLIYEYSQKGSLKNHLHDPQSKGYTSLSWIYRVQIALDAAR 482
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
GLEYIH++TK +YVHRD+K+SNILLD +FRAKI+DFGL KL+ S + A+ +++VGTFG
Sbjct: 483 GLEYIHEHTKDHYVHRDIKSSNILLDESFRAKISDFGLAKLVVKSTDAEASVTKVVGTFG 542
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
YLAPEY+RDG TTK+DVYAFGVVL ELI+G++A++R +E RSL ML+
Sbjct: 543 YLAPEYLRDGLATTKNDVYAFGVVLFELISGKEAITRTDGLNEGSNSERRSLASVMLSAL 602
Query: 240 NDTKD--FMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296
+ ++ +M L +C+DPNL Y D + +MA+L+K CV+E+ RPDM A I LS I
Sbjct: 603 KNCRNSMYMGSLKDCIDPNLMDLYPHDCVYKMAMLAKQCVEEDPVLRPDMKQAVITLSQI 662
Query: 297 LISSKEWE 304
L+SS EWE
Sbjct: 663 LLSSIEWE 670
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|218189030|gb|EEC71457.1| hypothetical protein OsI_03683 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 343 bits (880), Expect = 5e-92, Method: Compositional matrix adjust.
Identities = 168/308 (54%), Positives = 225/308 (73%), Gaps = 4/308 (1%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
+F+Y E+ +T +FS + +G G+YGSVY G LR + AIK+M TK+KEF E+K+LCK
Sbjct: 363 VFTYQEILASTDSFSDANLLGHGTYGSVYYGVLRDQEVAIKRMTATKTKEFIVEMKVLCK 422
Query: 61 VH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
VH ++L+ELIGYAA D L+L+YEY+Q G+L +HLH P KG L+W RVQIALDAA+
Sbjct: 423 VHHASLVELIGYAASKDELYLIYEYSQKGSLKNHLHDPQSKGYTSLSWIYRVQIALDAAR 482
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
GLEYIH++TK +YVHRD+K+SNILLD +FRAKI+DFGL KL+ S + A+ +++VGTFG
Sbjct: 483 GLEYIHEHTKDHYVHRDIKSSNILLDESFRAKISDFGLAKLVVKSTDAEASVTKVVGTFG 542
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
YLAPEY+RDG TTK+DVYAFGVVL ELI+G++A++R +E RSL ML+
Sbjct: 543 YLAPEYLRDGLATTKNDVYAFGVVLFELISGKEAITRTDGLNEGSNSERRSLASVMLSAL 602
Query: 240 NDTKD--FMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296
+ ++ +M L C+DPNL Y D + +MA+L+K CV+E+ RPDM A I LS I
Sbjct: 603 KNCRNSMYMGSLKACIDPNLMDLYPHDCVYKMAMLAKQCVEEDPVLRPDMKQAVITLSQI 662
Query: 297 LISSKEWE 304
L+SS EWE
Sbjct: 663 LLSSIEWE 670
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|414880580|tpg|DAA57711.1| TPA: putative lysM-domain protein kinase family protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 342 bits (876), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 172/311 (55%), Positives = 225/311 (72%), Gaps = 4/311 (1%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
+F++ E+ +T +FS + +G G+YGSVY G LR + AIK+M TK+KEF E+K+LCK
Sbjct: 93 VFTHEEILISTDSFSDANLLGHGTYGSVYYGVLREQEVAIKRMMATKTKEFIVEMKVLCK 152
Query: 61 VH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
VH ++L+ELIGYAAG D LFLVYEY+QNG+L +HLH P KG L+W RVQIALDAA+
Sbjct: 153 VHHASLVELIGYAAGKDELFLVYEYSQNGSLKNHLHDPERKGCSSLSWIFRVQIALDAAR 212
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
GLEYIH++TK +YVHRD+K+SNILLD +FRAKI+DFGL KL+ S + A+ +++VGTFG
Sbjct: 213 GLEYIHEHTKDHYVHRDIKSSNILLDGSFRAKISDFGLAKLVVKSNDAEASVTKVVGTFG 272
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
YLAPEY+RDG TTKSDVYAFGVVL ELI+G++A++R G + +E SL MLA
Sbjct: 273 YLAPEYLRDGLATTKSDVYAFGVVLFELISGKEAITRAEGMGASSNSERCSLASVMLAAV 332
Query: 240 NDTKD--FMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296
+ +M L +C+D NL Y D +MA+L+K CVDE+ RPDM I LS I
Sbjct: 333 RKCPNSTYMGNLKDCIDHNLRDLYPYDCAYKMAMLAKQCVDEDPVLRPDMKQVVITLSQI 392
Query: 297 LISSKEWEKME 307
L+SS EWE +
Sbjct: 393 LLSSIEWEATQ 403
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482890|ref|XP_002283628.2| PREDICTED: proline-rich receptor-like protein kinase PERK10-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 338 bits (867), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 172/313 (54%), Positives = 222/313 (70%), Gaps = 15/313 (4%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
+F+Y E+ +T FS S +G G+YGSVY G L + AIK+M TK++EF SE+K+LCK
Sbjct: 343 VFTYEEILSSTDGFSDSNLLGHGTYGSVYYGVLHDQEVAIKKMTATKTREFMSEMKVLCK 402
Query: 61 VH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
VH +NL+ELIGYAA D LFL+YEYAQ G+L HLH P KG L+W RVQIALDAA+
Sbjct: 403 VHHTNLVELIGYAASDDELFLIYEYAQKGSLKSHLHDPQNKGHTSLSWIMRVQIALDAAR 462
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
G+EYIH++TK +YVHRD+KTSNILLD FRAKI+DFGL KL+ + E A+A+R+VGTFG
Sbjct: 463 GIEYIHEHTKTHYVHRDIKTSNILLDGAFRAKISDFGLAKLVGKTGEGEASATRVVGTFG 522
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDA-----NPGNNQYTEHRSLVDY 234
YLAPEY+ DG TTKSDVYAFG+VL E+I+G++A++R NP E RSL
Sbjct: 523 YLAPEYLSDGLATTKSDVYAFGIVLFEIISGKEAVTRTEGMVMKNP------ERRSLASI 576
Query: 235 MLAVFNDTKDFMAKLT--ECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291
MLA ++ + M+ + +C+DPNL Y D + +MA+L+K CVD + RPDM I
Sbjct: 577 MLAALRNSPNSMSMSSMKDCIDPNLMDLYPHDCLYKMAMLAKQCVDHDPILRPDMKQVVI 636
Query: 292 RLSHILISSKEWE 304
LS IL+SS EWE
Sbjct: 637 SLSQILLSSVEWE 649
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297743186|emb|CBI36053.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 338 bits (867), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 172/313 (54%), Positives = 222/313 (70%), Gaps = 15/313 (4%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
+F+Y E+ +T FS S +G G+YGSVY G L + AIK+M TK++EF SE+K+LCK
Sbjct: 185 VFTYEEILSSTDGFSDSNLLGHGTYGSVYYGVLHDQEVAIKKMTATKTREFMSEMKVLCK 244
Query: 61 VH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
VH +NL+ELIGYAA D LFL+YEYAQ G+L HLH P KG L+W RVQIALDAA+
Sbjct: 245 VHHTNLVELIGYAASDDELFLIYEYAQKGSLKSHLHDPQNKGHTSLSWIMRVQIALDAAR 304
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
G+EYIH++TK +YVHRD+KTSNILLD FRAKI+DFGL KL+ + E A+A+R+VGTFG
Sbjct: 305 GIEYIHEHTKTHYVHRDIKTSNILLDGAFRAKISDFGLAKLVGKTGEGEASATRVVGTFG 364
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDA-----NPGNNQYTEHRSLVDY 234
YLAPEY+ DG TTKSDVYAFG+VL E+I+G++A++R NP E RSL
Sbjct: 365 YLAPEYLSDGLATTKSDVYAFGIVLFEIISGKEAVTRTEGMVMKNP------ERRSLASI 418
Query: 235 MLAVFNDTKDFMAKLT--ECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291
MLA ++ + M+ + +C+DPNL Y D + +MA+L+K CVD + RPDM I
Sbjct: 419 MLAALRNSPNSMSMSSMKDCIDPNLMDLYPHDCLYKMAMLAKQCVDHDPILRPDMKQVVI 478
Query: 292 RLSHILISSKEWE 304
LS IL+SS EWE
Sbjct: 479 SLSQILLSSVEWE 491
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224059146|ref|XP_002299738.1| predicted protein [Populus trichocarpa] gi|222846996|gb|EEE84543.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 337 bits (864), Expect = 4e-90, Method: Compositional matrix adjust.
Identities = 170/308 (55%), Positives = 219/308 (71%), Gaps = 5/308 (1%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
+F+Y E+ AT F S +G G+YGSVY G L + AIK+M TK+KEF +E+KILCK
Sbjct: 341 VFTYEEILFATDEFLDSSLLGHGTYGSVYYGHLHDQEVAIKRMTATKTKEFMAEMKILCK 400
Query: 61 VH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
VH +NL+ELIGYAA LF++YEYAQ G+L HLH P KG PL+W RVQIALDAA+
Sbjct: 401 VHHTNLVELIGYAASDAELFVIYEYAQKGSLRSHLHDPQNKGHTPLSWIMRVQIALDAAR 460
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
GLEYIH++TK +YVHRD+KTSNILLD +FRAKI+DFGL KL+ + E A A+++VGT+G
Sbjct: 461 GLEYIHEHTKTHYVHRDIKTSNILLDGSFRAKISDFGLAKLVGKTGEGEATATKVVGTYG 520
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
YLAPEY+ DG TTKSDVYAFGVVL E+I+G++A+ R + E RSL MLA
Sbjct: 521 YLAPEYLSDGLATTKSDVYAFGVVLFEIISGKEAIIRTEG-AVTKNPERRSLASTMLAAL 579
Query: 240 NDTKD--FMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296
+T D M+ L + +DPN+ Y D + ++A+L+K CVDE+ RPDM I LS I
Sbjct: 580 RNTPDSMSMSSLKDLIDPNMMDLYPHDCVFKLAMLAKQCVDEDPILRPDMKQVVISLSQI 639
Query: 297 LISSKEWE 304
++SS EWE
Sbjct: 640 VLSSIEWE 647
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 313 | ||||||
| TAIR|locus:2195814 | 651 | LYK3 "LysM-containing receptor | 0.968 | 0.465 | 0.545 | 7.2e-84 | |
| TAIR|locus:2089860 | 617 | CERK1 "chitin elicitor recepto | 0.923 | 0.468 | 0.496 | 2.2e-66 | |
| UNIPROTKB|D7UPN3 | 605 | CERK1 "Chitin elicitor recepto | 0.891 | 0.461 | 0.481 | 2.1e-61 | |
| TAIR|locus:2075517 | 558 | AT3G02810 [Arabidopsis thalian | 0.929 | 0.521 | 0.403 | 2.6e-54 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.875 | 0.420 | 0.421 | 1.3e-52 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.875 | 0.423 | 0.414 | 2.1e-52 | |
| TAIR|locus:2050987 | 664 | LYK5 "LysM-containing receptor | 0.929 | 0.438 | 0.392 | 2.7e-52 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.916 | 0.759 | 0.413 | 9.2e-52 | |
| TAIR|locus:2199857 | 375 | AT1G24030 [Arabidopsis thalian | 0.916 | 0.765 | 0.409 | 1.2e-51 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.916 | 0.676 | 0.403 | 1.5e-51 |
| TAIR|locus:2195814 LYK3 "LysM-containing receptor-like kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 840 (300.8 bits), Expect = 7.2e-84, P = 7.2e-84
Identities = 168/308 (54%), Positives = 219/308 (71%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
+F+Y E+R AT FS S +G G+YGSVY G LR + A+K+M TK+KEF++E+K+LCK
Sbjct: 328 VFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATKTKEFAAEMKVLCK 387
Query: 61 VH-SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
VH SNL+ELIGYAA D LF+VYEY + G L HLH P KG PL+W R QIALDAA+
Sbjct: 388 VHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDPQSKGNTPLSWIMRNQIALDAAR 447
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
GLEYIH++TK +YVHRD+KTSNILLD FRAKI+DFGL KL+E + E + +++VGT+G
Sbjct: 448 GLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVEKTGEGEISVTKVVGTYG 507
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
YLAPEY+ DG T+KSD+YAFGVVL E+I+G++A+ R G E R L MLAV
Sbjct: 508 YLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAVIRTEAIGTKN-PERRPLASIMLAVL 566
Query: 240 NDTKDFM--AKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296
++ D M + L E +DPN+ Y D + ++A L+K CVD++ RP+M I LS I
Sbjct: 567 KNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQCVDDDPILRPNMKQVVISLSQI 626
Query: 297 LISSKEWE 304
L+SS EWE
Sbjct: 627 LLSSIEWE 634
|
|
| TAIR|locus:2089860 CERK1 "chitin elicitor receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 2.2e-66, P = 2.2e-66
Identities = 152/306 (49%), Positives = 196/306 (64%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV 61
FS E+ AT NF+ S KIGQG +G+VY +LRG+ AAIK+M SK+F +ELK+L +V
Sbjct: 310 FSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASKQFLAELKVLTRV 369
Query: 62 HS-NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
H NL+ LIGY G SLFLVYEY +NG L HLH G++PL WT RVQIALD+A+G
Sbjct: 370 HHVNLVRLIGYCVEG-SLFLVYEYVENGNLGQHLHG---SGREPLPWTKRVQIALDSARG 425
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR-IVGTFG 179
LEYIH++T P YVHRD+K++NIL+D FRAK+ADFGL KL E + +A+R +GTFG
Sbjct: 426 LEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLTE----VGGSATRGAMGTFG 481
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
Y+APE V G V+ K DVYAFGVVL ELI+ + A+ + E R LV F
Sbjct: 482 YMAPETVY-GEVSAKVDVYAFGVVLYELISAKGAVVKMTEAVG----EFRGLVGVFEESF 536
Query: 240 NDTKDFMAKLTECLDPNL-TRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298
+T D L + +DP L Y DS+ +MA L K C EN + RP M + LS +
Sbjct: 537 KET-DKEEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLRPSMRYIVVALSTLFS 595
Query: 299 SSKEWE 304
S+ W+
Sbjct: 596 STGNWD 601
|
|
| UNIPROTKB|D7UPN3 CERK1 "Chitin elicitor receptor kinase 1" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 628 (226.1 bits), Expect = 2.1e-61, P = 2.1e-61
Identities = 143/297 (48%), Positives = 189/297 (63%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV 61
FSY E+ +AT FS KIGQG +GSVY +LRG+ AIK+M ++EF +ELK+L V
Sbjct: 305 FSYEEIFNATQGFSMEHKIGQGGFGSVYYAELRGEKTAIKKMGMQATQEFLAELKVLTHV 364
Query: 62 HS-NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
H NL+ LIGY + LFLVYE+ NG LS HL G PL+W TRVQIALD+A+G
Sbjct: 365 HHLNLVRLIGYCVE-NCLFLVYEFIDNGNLSQHLQRT---GYAPLSWATRVQIALDSARG 420
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
LEY+H++ P YVHRD+K++NILLD +FRAKIADFGL KL E + ++R+ GTFGY
Sbjct: 421 LEYLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLAKLTEVGSMSQSLSTRVAGTFGY 480
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLV---DYMLA 237
+ PE R G V+ K DVYAFGVVL EL++ +QA+ R + +E + LV + L+
Sbjct: 481 MPPE-ARYGEVSPKVDVYAFGVVLYELLSAKQAIVRSSE----SVSESKGLVFLFEEALS 535
Query: 238 VFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293
N T+ L E +DP+L Y DS L++A L+K C E RP M + + L
Sbjct: 536 APNPTE----ALDELIDPSLQGDYPVDSALKIASLAKSCTHEEPGMRPTMRSVVVAL 588
|
|
| TAIR|locus:2075517 AT3G02810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 561 (202.5 bits), Expect = 2.6e-54, P = 2.6e-54
Identities = 125/310 (40%), Positives = 188/310 (60%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSEL 55
+F++ E+ AT NF +G+G +G VY G L+ G+ A+KQ+ +KEF +E+
Sbjct: 51 IFTFRELATATKNFRQECLLGEGGFGRVYKGTLKSTGQVVAVKQLDKHGLHGNKEFQAEV 110
Query: 56 KILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA 114
L ++ H NL++LIGY A GD LVY+Y G+L DHLH P P+ WTTR+QIA
Sbjct: 111 LSLGQLDHPNLVKLIGYCADGDQRLLVYDYISGGSLQDHLHEPKADSD-PMDWTTRMQIA 169
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE-IAAAASR 173
AA+GL+Y+H P ++RD+K SNILLD +F K++DFGL KL + + + A +SR
Sbjct: 170 YAAAQGLDYLHDKANPPVIYRDLKASNILLDDDFSPKLSDFGLHKLGPGTGDKMMALSSR 229
Query: 174 IVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233
++GT+GY APEY R G +T KSDVY+FGVVL+ELITG++AL P + Q +LV
Sbjct: 230 VMGTYGYSAPEYTRGGNLTLKSDVYSFGVVLLELITGRRALDT-TRPNDEQ-----NLVS 283
Query: 234 YMLAVFNDTKDFMAKLTECLDPNL-TRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292
+ +F D K + + DP L ++ + + Q ++ CV E RP +S+ +
Sbjct: 284 WAQPIFRDPKRY----PDMADPVLENKFSERGLNQAVAIASMCVQEEASARPLISDVMVA 339
Query: 293 LSHILISSKE 302
LS + + +++
Sbjct: 340 LSFLSMPTED 349
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 545 (196.9 bits), Expect = 1.3e-52, P = 1.3e-52
Identities = 123/292 (42%), Positives = 176/292 (60%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKL-RGKNAAIKQMK---NTKSKEFSSELKI 57
F+Y E+ AT+ FS + +GQG +G V+ G L GK A+KQ+K +EF +E++I
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 58 LCKVHS-NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALD 116
+ +VH +L+ LIGY G LVYE+ N L HLH KG+ + W+TR++IAL
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG---KGRPTMEWSTRLKIALG 384
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
+AKGL Y+H+ P +HRD+K SNIL+D F AK+ADFGL K+ S ++R++G
Sbjct: 385 SAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIA--SDTNTHVSTRVMG 442
Query: 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236
TFGYLAPEY G +T KSDV++FGVVL+ELITG++ + DAN N Y + SLVD+
Sbjct: 443 TFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPV--DAN---NVYVDD-SLVDWAR 496
Query: 237 AVFNDTKDFMAKLTECLDPNL-TRYHKDSMLQMALLSKDCVDENWKRRPDMS 287
+ N + D + Y ++ M +M + CV + +RRP MS
Sbjct: 497 PLLNRASE-EGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMS 547
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 2.1e-52, P = 2.1e-52
Identities = 121/292 (41%), Positives = 176/292 (60%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKL-RGKNAAIKQMK---NTKSKEFSSELKI 57
F+Y E+ AT+ FS + +GQG +G V+ G L GK A+KQ+K +EF +E++I
Sbjct: 263 FTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQAEVEI 322
Query: 58 LCKVHS-NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALD 116
+ +VH +L+ L+GY G LVYE+ N L HLH +G+ + W+TR++IAL
Sbjct: 323 ISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHG---EGRPTMEWSTRLKIALG 379
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
+AKGL Y+H+ P +HRD+K SNIL+D F AK+ADFGL K+ S ++R++G
Sbjct: 380 SAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIA--SDTNTHVSTRVMG 437
Query: 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236
TFGYLAPEY G +T KSDV++FGVVL+ELITG++ + DAN N Y + SLVD+
Sbjct: 438 TFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPV--DAN---NVYVDD-SLVDWAR 491
Query: 237 AVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMS 287
+ N + D + Y ++ M +M + CV + +RRP MS
Sbjct: 492 PLLNRASE-QGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMS 542
|
|
| TAIR|locus:2050987 LYK5 "LysM-containing receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 2.7e-52, P = 2.7e-52
Identities = 120/306 (39%), Positives = 187/306 (61%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK 60
++ +N+++ ATSNFS +I GSVY + G +AA+K +K S SSE+ +L K
Sbjct: 359 LYRFNDLQSATSNFSDENRIK----GSVYRATINGDDAAVKVIKGDVS---SSEINLLKK 411
Query: 61 V-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
+ HSN+I L G+ + +LV+EY++NG++SD LH GKK L W RV+IA D A+
Sbjct: 412 LNHSNIIRLSGFCIREGTSYLVFEYSENGSISDWLH---SSGKKSLTWKQRVEIARDVAE 468
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
L+Y+H Y P ++H++++++NILLDSNFRAKIA+FG+ ++L+ + GT G
Sbjct: 469 ALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVARILDEGDLDLQLTRHVEGTQG 528
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
YLAPEYV +G +T+K DV+AFGV ++EL++G++A++ + E L + +V
Sbjct: 529 YLAPEYVENGVITSKLDVFAFGVAVLELLSGREAVTIHKKKEGEEEVE--MLCKVINSVL 586
Query: 240 NDTKDFMAKLTECLDPNL-TRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298
++ KL E +DP+L Y + MA L+K CV + RP ++ LS I+
Sbjct: 587 GG-ENVREKLKEFMDPSLGNEYPLELAYTMAQLAKSCVATDLNSRPSVTQVLTTLSMIVS 645
Query: 299 SSKEWE 304
SS +WE
Sbjct: 646 SSIDWE 651
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 537 (194.1 bits), Expect = 9.2e-52, P = 9.2e-52
Identities = 127/307 (41%), Positives = 184/307 (59%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRG--KNAAIKQMKNTK---SKEFSSELK 56
F+++E+ AT NF IG+G +G VY G L + AAIKQ+ + ++EF E+
Sbjct: 61 FTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFLVEVL 120
Query: 57 ILCKVHS-NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL 115
+L +H NL+ LIGY A GD LVYEY G+L DHLH S GK+PL W TR++IA
Sbjct: 121 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDIS-PGKQPLDWNTRMKIAA 179
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIV 175
AAKGLEY+H T P ++RD+K SNILLD ++ K++DFGL KL + + ++R++
Sbjct: 180 GAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDK-SHVSTRVM 238
Query: 176 GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235
GT+GY APEY G +T KSDVY+FGVVL+E+ITG++A+ + G ++LV +
Sbjct: 239 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGE------QNLVAWA 292
Query: 236 LAVFNDTKDFMAKLTECLDPNLT-RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294
+F D + F ++ DP L +Y + Q ++ CV E RP +++ LS
Sbjct: 293 RPLFKDRRKF----SQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTALS 348
Query: 295 HILISSK 301
+ L S K
Sbjct: 349 Y-LASQK 354
|
|
| TAIR|locus:2199857 AT1G24030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 1.2e-51, P = 1.2e-51
Identities = 129/315 (40%), Positives = 189/315 (60%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQM------KNTKSKEFSS 53
+++ E+ +ATS+FS +G+G +G VY G L+ G+ AIK+M K +EF
Sbjct: 63 VYTLKEMEEATSSFSDENLLGKGGFGRVYQGTLKTGEVVAIKKMDLPTFKKADGEREFRV 122
Query: 54 ELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQ 112
E+ IL ++ H NL+ LIGY A G FLVYEY QNG L DHL+ +K K ++W R++
Sbjct: 123 EVDILSRLDHPNLVSLIGYCADGKHRFLVYEYMQNGNLQDHLN--GIKEAK-ISWPIRLR 179
Query: 113 IALDAAKGLEYIHQYTK---PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAA 169
IAL AAKGL Y+H + P VHRD K++N+LLDSN+ AKI+DFGL KL+ +
Sbjct: 180 IALGAAKGLAYLHSSSSVGIPI-VHRDFKSTNVLLDSNYNAKISDFGLAKLMPEGKDTCV 238
Query: 170 AASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHR 229
A R++GTFGY PEY G +T +SD+YAFGVVL+EL+TG++A+ D G N+ +
Sbjct: 239 TA-RVLGTFGYFDPEYTSTGKLTLQSDIYAFGVVLLELLTGRRAV--DLTQGPNE----Q 291
Query: 230 SLVDYMLAVFNDTKDFMAKLTECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMS 287
+LV + + ND K KL + +D L R Y +++ A L+ C+ K RP +
Sbjct: 292 NLVLQVRNILNDRK----KLRKVIDVELPRNSYSMEAITMFADLASRCIRIESKERPSVM 347
Query: 288 NAAIRLSHILISSKE 302
+ L I+ ++ +
Sbjct: 348 DCVKELQLIIYTNSK 362
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 535 (193.4 bits), Expect = 1.5e-51, P = 1.5e-51
Identities = 124/307 (40%), Positives = 181/307 (58%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKN--AAIKQMKNTKS---KEFSSELK 56
F++ E+ +T NF + +G+G +G VY G + N AIKQ+ + +EF E+
Sbjct: 86 FTFEELSVSTGNFKSDCFLGEGGFGKVYKGFIEKINQVVAIKQLDRNGAQGIREFVVEVL 145
Query: 57 ILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLH-WPSVKGKKPLAWTTRVQIA 114
L H NL++LIG+ A G LVYEY G+L +HLH PS GK PLAW TR++IA
Sbjct: 146 TLSLADHPNLVKLIGFCAEGVQRLLVYEYMPLGSLDNHLHDLPS--GKNPLAWNTRMKIA 203
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI 174
AA+GLEY+H KP ++RD+K SNIL+D + AK++DFGL K+ E ++R+
Sbjct: 204 AGAARGLEYLHDTMKPPVIYRDLKCSNILIDEGYHAKLSDFGLAKVGPRGSE-THVSTRV 262
Query: 175 VGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234
+GT+GY AP+Y G +T KSDVY+FGVVL+ELITG++A N + H+SLV++
Sbjct: 263 MGTYGYCAPDYALTGQLTFKSDVYSFGVVLLELITGRKAYD------NTRTRNHQSLVEW 316
Query: 235 MLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294
+F D K+F + L+ + Y + Q ++ CV E RP +++ + L
Sbjct: 317 ANPLFKDRKNFKKMVDPLLEGD---YPVRGLYQALAIAAMCVQEQPSMRPVIADVVMALD 373
Query: 295 HILISSK 301
H L SSK
Sbjct: 374 H-LASSK 379
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00032634001 | SubName- Full=Chromosome chr4 scaffold_6, whole genome shotgun sequence; (322 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 313 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-33 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-28 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-26 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-24 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-23 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-19 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-14 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.004 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-53
Identities = 69/206 (33%), Positives = 113/206 (54%), Gaps = 20/206 (9%)
Query: 19 KIGQGSYGSVYLGKLRGKNA------AIKQMKNTKS----KEFSSELKILCKV-HSNLIE 67
K+G+G++G VY G L+GK A+K +K S +EF E +I+ K+ H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L+G + L +V EY G L D+L K L+ + + AL A+G+EY+
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLR---KNRPKELSLSDLLSFALQIARGMEYLES- 121
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
K + +HRD+ N L+ N KI+DFGL + L ++ ++APE ++
Sbjct: 122 -KNF-IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLK 177
Query: 188 DGCVTTKSDVYAFGVVLMELIT-GQQ 212
+G T+KSDV++FGV+L E+ T G++
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE 203
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 7e-53
Identities = 70/206 (33%), Positives = 116/206 (56%), Gaps = 21/206 (10%)
Query: 19 KIGQGSYGSVYLGKLRGKNA------AIKQMKNTKS----KEFSSELKILCKV-HSNLIE 67
K+G+G++G VY GKL+GK A+K +K S +EF E +I+ K+ H N+++
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L+G + L++V EY + G L +L K + L+ + + AL A+G+EY+
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLR----KNRPKLSLSDLLSFALQIARGMEYLES- 120
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
K + +HRD+ N L+ N KI+DFGL + L ++ ++APE ++
Sbjct: 121 -KNF-IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLK 176
Query: 188 DGCVTTKSDVYAFGVVLMELIT-GQQ 212
+G T+KSDV++FGV+L E+ T G+Q
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQ 202
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 4e-49
Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 20/206 (9%)
Query: 19 KIGQGSYGSVYLGKLRGKNA------AIKQMKNTKS----KEFSSELKILCKV-HSNLIE 67
K+G+G++G VY G L+G A+K +K S +EF E I+ K+ H N++
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L+G G+ L++V EY G L D L K + L +Q+AL AKG+EY+
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR----KHGEKLTLKDLLQMALQIAKGMEYLES- 120
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
K + VHRD+ N L+ N KI+DFGL + + + ++APE ++
Sbjct: 121 -KNF-VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK-WMAPESLK 177
Query: 188 DGCVTTKSDVYAFGVVLMELIT-GQQ 212
DG T+KSDV++FGV+L E+ T G+Q
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQ 203
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 5e-49
Identities = 74/197 (37%), Positives = 113/197 (57%), Gaps = 19/197 (9%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMK----NTKSKEFSSELKILCKV-HSNLIELIGYA 72
+G+G +G+VYL + + GK AIK +K ++ +E E++IL K+ H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
+ L+LV EY + G+L D L + + L+ ++I L +GLEY+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK----ENEGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 133 VHRDVKTSNILLDS-NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC- 190
+HRD+K NILLDS N + K+ADFGL KLL + IVGT Y+APE +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL---LKTIVGTPAYMAPEVLLGKGY 170
Query: 191 VTTKSDVYAFGVVLMEL 207
+ KSD+++ GV+L EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 1e-46
Identities = 71/209 (33%), Positives = 113/209 (54%), Gaps = 19/209 (9%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
K+G+G++G VY GKL+GK+ A+K +K S K+F E +++ K+ H N++ L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHL--HWPSVK--GKKPLAWTTRVQIALDAAKGLEYI 124
+G + L+LV EY + G L D+L P K L+ + A+ AKG+EY+
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
K + VHRD+ N L+ + KI+DFGL + + + ++APE
Sbjct: 122 AS--KKF-VHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177
Query: 185 YVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
++DG T+KSDV++FGV+L E+ T G
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 5e-46
Identities = 86/253 (33%), Positives = 121/253 (47%), Gaps = 29/253 (11%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-----FSSELKILCKV-HSNLIELIG 70
K+G GS+G+VY K + GK A+K +K K E++IL ++ H N++ LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
D L+LV EY + G L D+L PL+ +IAL +GLEY+H
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLS-----RGGPLSEDEAKKIALQILRGLEYLHSNG-- 118
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
+HRD+K NILLD N KIADFGL K L S + VGT Y+APE + G
Sbjct: 119 -IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS---LTTFVGTPWYMAPEVLLGGN 174
Query: 191 -VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQ------YTEHRSLVDYMLAVFNDTK 243
K DV++ GV+L EL+TG+ S + Q + + K
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 244 DFMAKLTECLDPN 256
D + K CL+ +
Sbjct: 235 DLIKK---CLNKD 244
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 77/248 (31%), Positives = 112/248 (45%), Gaps = 25/248 (10%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFS----SELKILCKV-HSNLIELIGY 71
K+G+GS+G VYL + + GK AIK +K K K+ E+KIL K+ H N++ L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPY 131
D L+LV EY + G L D L K + L+ LEY+H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLL-----KKRGRLSEDEARFYLRQILSALEYLHSKG--- 117
Query: 132 YVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV 191
VHRD+K NILLD + K+ADFGL + L+ + + VGT Y+APE +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK----LTTFVGTPEYMAPEVLLGKGY 173
Query: 192 TTKSDVYAFGVVLMELITGQQALSRDANPG---NNQYTEHRSLVDYMLAVFNDTKDFMAK 248
D+++ GV+L EL+TG+ D + + KD + K
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233
Query: 249 LTECLDPN 256
L +
Sbjct: 234 ---LLVKD 238
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 1e-40
Identities = 72/255 (28%), Positives = 117/255 (45%), Gaps = 32/255 (12%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMK-----NTKSKEFSSELKILCKV-HSNLIELIG 70
+G+GS+GSVYL + G+ A+K ++ + + E++IL + H N++ G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 71 --YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
++L + EY G+LS L K L + +GL Y+H
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLL-----KKFGKLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
VHRD+K +NIL+DS+ K+ADFG K L E + GT ++APE +R
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRL-GDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 189 GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQY-----TEHRSLVDYMLAVFNDTK 243
+D+++ G ++E+ TG+ S NP Y E + +++ + K
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSE---EAK 234
Query: 244 DFMAKLTECL--DPN 256
DF+ K CL DP
Sbjct: 235 DFLRK---CLRRDPK 246
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 6e-38
Identities = 81/245 (33%), Positives = 119/245 (48%), Gaps = 39/245 (15%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMK----NTKSKEFS-SELKILCKV-HSNLIELIG 70
+IG+GS+G VYL K GK +K++ + K +E + +E+KIL K+ H N+I+
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKP-----LAWTTRVQIALDAAKGLEYIH 125
L +V EYA G LS + +GK L W VQ+ L L+Y+H
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQLCL----ALKYLH 120
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
+HRD+K NI L SN K+ DFG+ K+L + A +VGT YL+PE
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST---VDLAKTVVGTPYYLSPEL 174
Query: 186 VRDGCVTTKSDVYAFGVVLMELITGQQA-------------LSRDANPGNNQY-TEHRSL 231
++ KSD+++ G VL EL T + L P +QY +E R+L
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL 234
Query: 232 VDYML 236
V +L
Sbjct: 235 VSSLL 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-36
Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 23/207 (11%)
Query: 14 FSTSLKIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSS---ELKILCKV-HSNLIE 67
F KIG+G +G VY K GK AIK +K ++ E++IL K H N+++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA---LDAAKGLEYI 124
G D L++V E+ G+L D L + L T QIA + KGLEY+
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLK----STNQTL---TESQIAYVCKELLKGLEYL 114
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
H +HRD+K +NILL S+ K+ DFGL L + A + +VGT ++APE
Sbjct: 115 HSNGI---IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK----ARNTMVGTPYWMAPE 167
Query: 185 YVRDGCVTTKSDVYAFGVVLMELITGQ 211
+ K+D+++ G+ +EL G+
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 64/193 (33%), Positives = 111/193 (57%), Gaps = 19/193 (9%)
Query: 20 IGQGSYGSVYLGKLRGKNAAIKQMKN--TKSKEFSSELKILCKV-HSNLIELIGYAAGGD 76
IG+G +G V LG RG+ A+K +K+ T ++ F +E ++ + H NL++L+G G+
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73
Query: 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRD 136
L++V EY G+L D+L +G+ + ++ ALD +G+EY+ + +VHRD
Sbjct: 74 PLYIVTEYMAKGSLVDYLR---SRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRD 127
Query: 137 VKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTF--GYLAPEYVRDGCVTTK 194
+ N+L+ + AK++DFGL K A+ + G + APE +R+ +TK
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK--------EASQGQDSGKLPVKWTAPEALREKKFSTK 179
Query: 195 SDVYAFGVVLMEL 207
SDV++FG++L E+
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 35/219 (15%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQ------MKNTKSKEFSSELKILCKV--HSNLIELI 69
IG+GS+ +V L K + K AIK +K K K E ++L ++ H +I+L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
++L+ V EYA NG L ++ G T A + LEY+H
Sbjct: 69 YTFQDEENLYFVLEYAPNGELLQYIR---KYGSLDEKCT--RFYAAEILLALEYLHSKG- 122
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA-----------------AS 172
+HRD+K NILLD + KI DFG K+L+ + + +
Sbjct: 123 --IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 173 RIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
VGT Y++PE + + SD++A G ++ +++TG+
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 68/195 (34%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 19 KIGQGSYGSVYLGKLRGK-NAAIKQMK-NTKSKE-FSSELKILCKV-HSNLIELIGYAAG 74
K+G G +G V++G G A+K +K T S E F E +I+ K+ H L++L +
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
+ +++V EY G+L D L GKK L V +A A+G+ Y+ Y+H
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGE--GKK-LRLPQLVDMAAQIAEGMAYLESRN---YIH 126
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTK 194
RD+ NIL+ N KIADFGL +L+E A ++ + APE G T K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIK 184
Query: 195 SDVYAFGVVLMELIT 209
SDV++FG++L E++T
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-31
Identities = 67/208 (32%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 13 NFSTSLKIGQGSYGSVY--LGKLRGKNAAIKQMKNTKSKE-----FSSELKILCKV-HSN 64
N+ IG+G++G VY L G AIKQ+ K KE E+ +L + H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYI 124
+++ IG DSL+++ EYA+NG+L + + L Q+ +GL Y+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVYVYQVL----QGLAYL 115
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL-VKLLEHSPEIAAAASRIVGTFGYLAP 183
H+ +HRD+K +NIL + K+ADFG+ KL + S + A+ +VGT ++AP
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS----VVGTPYWMAP 168
Query: 184 EYVRDGCVTTKSDVYAFGVVLMELITGQ 211
E + +T SD+++ G ++EL+TG
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 19 KIGQGSYGSVYLGKL------RGKNAAIKQMK----NTKSKEFSSELKILCKV-HSNLIE 67
++G+G +G V L + G+ A+K + +F E++IL + H N+++
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 68 LIG--YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
G GG SL L+ EY +G+L D+L + + + + + KG++Y+
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ----RHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS-RIVGTFGYLAPE 184
Y+HRD+ NIL++S KI+DFGL K+L + F Y APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 185 YVRDGCVTTKSDVYAFGVVLMELIT 209
+R ++ SDV++FGV L EL T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 29/205 (14%)
Query: 19 KIGQGSYGSVYLGKLRGKN--AAIKQMKNTKSKEFS--SELKIL--CKVHSNLIELIGYA 72
KIG+G+ G VY R AIK+M+ K + +E+ I+ CK H N+++
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCK-HPNIVDYYDSY 84
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA---LDAAKGLEYIHQYTK 129
GD L++V EY G+L+D + V+ +P QIA + +GLEY+H
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIITQNFVRMNEP-------QIAYVCREVLQGLEYLHSQNV 137
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR---IVGTFGYLAPEYV 186
+HRD+K+ NILL + K+ADFG + ++ S+ +VGT ++APE +
Sbjct: 138 ---IHRDIKSDNILLSKDGSVKLADFG------FAAQLTKEKSKRNSVVGTPYWMAPEVI 188
Query: 187 RDGCVTTKSDVYAFGVVLMELITGQ 211
+ K D+++ G++ +E+ G+
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-30
Identities = 71/208 (34%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKE------FSSELKILCKV--HSNLIELIG 70
K+G+GS+G VYL + R K A+K + + F E++IL + N+++L
Sbjct: 7 KLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+ SL+LV EY G+L D L KG + + I LEY+H
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEA--LFILAQILSALEYLHS---K 120
Query: 131 YYVHRDVKTSNILLDSN-FRAKIADFGLVKLLEH---SPEIAAAASRIVGTFGYLAPEYV 186
+HRD+K NILLD + K+ DFGL KLL + I A S VGT GY+APE +
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 187 RDGC---VTTKSDVYAFGVVLMELITGQ 211
++ SD+++ G+ L EL+TG
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQ----MKNTKSKEFSSELKILCKV-HSNLIELIG- 70
+GQGS G VY K GK A+K+ K+ ELK L +++ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV--QIALDAAKGLEYIHQYT 128
+ G + +V EY G+L+D L KK V IA KGL+Y+H
Sbjct: 68 FYKEG-EISIVLEYMDGGSLADLL-------KKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
+HRD+K SN+L++S KIADFG+ K+LE++ + VGT Y++PE ++
Sbjct: 120 H--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF---VGTVTYMSPERIQG 174
Query: 189 GCVTTKSDVYAFGVVLMELITGQ 211
+ +D+++ G+ L+E G+
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-28
Identities = 88/290 (30%), Positives = 129/290 (44%), Gaps = 52/290 (17%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS---ELKIL--CKVHSNLIELIGY 71
+IG G+YG VY + G+ AIK +K +F E+ +L C+ H N++ G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR-HPNIVAYFGS 68
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL---DAAKGLEYIHQYT 128
D L++V EY G+L D + PL + +QIA + KGL Y+H+
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQ----VTRGPL---SELQIAYVCRETLKGLAYLHETG 121
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV-- 186
K +HRD+K +NILL + K+ADFG+ L + IA S I GT ++APE
Sbjct: 122 K---IHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IAKRKSFI-GTPYWMAPEVAAV 175
Query: 187 -RDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245
R G K D++A G+ +EL Q + D +P M A+F +K
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPMF-DLHP--------------MRALFLISKSN 220
Query: 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295
P L K S K C+ ++ K+RP A L H
Sbjct: 221 FPP------PKLKDKEKWS-PVFHDFIKKCLTKDPKKRPT---ATKLLQH 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 72/208 (34%), Positives = 112/208 (53%), Gaps = 31/208 (14%)
Query: 20 IGQGSYGSV----Y--LGKLRGKNAAIKQMKNTKSKE---FSSELKILCKVHSNLI---E 67
+G+G++GSV Y L G+ A+K+++++ ++ F E++IL + + I +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHL--HWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
+ Y+AG +L LV EY G+L D+L H + +K L + +++ KG+EY+
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------CKGMEYL- 124
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI----AAAASRIVGTFGYL 181
YVHRD+ T NIL++S R KI DFGL K+L E S I F Y
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI---FWY- 178
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMELIT 209
APE + + + SDV++FGVVL EL T
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 61/191 (31%), Positives = 106/191 (55%), Gaps = 15/191 (7%)
Query: 20 IGQGSYGSVYLGKLRGKNAAIKQMKN-TKSKEFSSELKILCKV-HSNLIELIGY-AAGGD 76
IG+G +G V LG RG A+K +KN ++ F +E ++ ++ HSNL++L+G
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73
Query: 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRD 136
L++V EY G+L D+L +G+ L ++ +LD + +EY+ +VHRD
Sbjct: 74 GLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127
Query: 137 VKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSD 196
+ N+L+ + AK++DFGL K + + + + APE +R+ +TKSD
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSD 181
Query: 197 VYAFGVVLMEL 207
V++FG++L E+
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 28/205 (13%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFS--------SELKILCKV-HSNLIEL 68
+G+GS+G V L + + GK A+K +K K K +E IL ++ H +++L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK--KKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTR--VQIALDAAKGLEYIHQ 126
+ L+LV EYA G L HL S +G+ +I L LEY+H
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAEIVL----ALEYLHS 111
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
++RD+K NILLD++ K+ DFGL K L + + GT YLAPE +
Sbjct: 112 LG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE---GSRTNTFCGTPEYLAPEVL 165
Query: 187 RDGCVTTKSDVYAFGVVLMELITGQ 211
D ++ GV+L E++TG+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-25
Identities = 73/211 (34%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 13 NFSTSLKIGQGSYGSVY--LGKLRGKNAAIKQMK----NTKSKEFS-SELKILCKV-HSN 64
+F KIG+GS+G V+ + K + A+KQ+ N + +E + E ++L K+ S
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLA----WTTRVQIALDAAKG 120
+I L +V EYA+NG L L ++ +PL W +QI L G
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLK---MQRGRPLPEDQVWRFFIQILL----G 113
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
L ++H +HRD+K+ N+ LD+ KI D G+ KLL + A IVGT Y
Sbjct: 114 LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT---IVGTPYY 167
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
L+PE D KSDV+A GVVL E TG+
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 69/228 (30%), Positives = 107/228 (46%), Gaps = 52/228 (22%)
Query: 20 IGQGSYGSVYLGKLR---GKNA----AIKQMKNTKS----KEFSSELKILCKV-HSNLIE 67
+G+G++G V+LG+ +N A+K +K T S K+F E ++L H N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHL--HWPSVK-------GKKPLAWTTRVQIALDAA 118
G GD +V+EY ++G L+ L H P L + +QIA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 119 KGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTF 178
G+ Y+ ++VHRD+ T N L+ + KI DFG+ SR V T
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGM--------------SRDVYTT 175
Query: 179 GY-------------LAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
Y + PE + TT+SDV++FGVVL E+ T G+Q
Sbjct: 176 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 20 IGQGSYGSVYLG--KLRGKN---AAIKQMKNTKSK----EFSSELKILCKV-HSNLIELI 69
IG G +G V G KL GK AIK +K S +F +E I+ + H N+I L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
G + ++ EY +NG+L L + V + A G++Y+ ++
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLR----ENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS-PEIAAAASRIVGTFGYLAPEYVRD 188
YVHRD+ NIL++SN K++DFGL + LE S +I + APE +
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAY 182
Query: 189 GCVTTKSDVYAFGVVLMELIT 209
T+ SDV++FG+V+ E+++
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 66/196 (33%), Positives = 109/196 (55%), Gaps = 15/196 (7%)
Query: 19 KIGQGSYGSVYLGKLRG-KNAAIKQMKN-TKSKE-FSSELKILCKV-HSNLIELIGYAA- 73
K+G G +G V++G G AIK +K + S E F +E ++ ++ H L+ L YA
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL--YAVV 70
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
+ ++++ EY +NG+L D L P G K L + +A A+G+ +I + Y+
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPE--GIK-LTINKLIDMAAQIAEGMAFIERKN---YI 124
Query: 134 HRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTT 193
HRD++ +NIL+ KIADFGL +L+E + A ++ + APE + G T
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTI 182
Query: 194 KSDVYAFGVVLMELIT 209
KSDV++FG++L E++T
Sbjct: 183 KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-25
Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 19 KIGQGSYGSVYLGKLRGK-NAAIKQMKNTKSKE----FSSELKILCKV-HSNLIELIGYA 72
KIG+G++G VY G L+G A+K ++T + F E +IL + H N+++LIG
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
+++V E G+L L K K L +Q++LDAA G+EY+
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLR----KKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 133 VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVT 192
+HRD+ N L+ N KI+DFG+ + E + + APE + G T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 193 TKSDVYAFGVVLMELITG 210
++SDV+++G++L E +
Sbjct: 174 SESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 39/212 (18%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-FS----SELKILCKV-HSNLIELIG 70
+IG+G+YG VY + + G+ A+K+++ KE F E+K+L K+ H N++ L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 71 --YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQI---ALDAAKGLEYIH 125
+ G S+++V+EY + L+ L P VK T QI +GL+Y+H
Sbjct: 66 IVTSKGKGSIYMVFEYMDHD-LTGLLDSPEVK-------FTESQIKCYMKQLLEGLQYLH 117
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE- 184
+HRD+K SNIL++++ K+ADFGL + A +R++ T Y PE
Sbjct: 118 SNG---ILHRDIKGSNILINNDGVLKLADFGLARPYT-KRNSADYTNRVI-TLWYRPPEL 172
Query: 185 ------YVRDGCVTTKSDVYAFGVVLMELITG 210
Y + D+++ G +L EL G
Sbjct: 173 LLGATRY------GPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 1e-24
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIKQMK--NTKSKEFSSELK----ILCKVHSNLIELIGY 71
I +G+YG V+L K G AIK +K + K ++ IL + S + + Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 72 AAGGDS-LFLVYEYAQNGALSDHLH----WPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
+ G L+LV EY G L+ L + +A +I L LEY+H
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-----EIVL----ALEYLHS 111
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGL-----VKLLEHSPEIAAAASRIVGTFGYL 181
+HRD+K NIL+DSN K+ DFGL V+ + + RIVGT Y+
Sbjct: 112 NG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMELITG 210
APE + + D ++ G +L E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 4e-24
Identities = 72/199 (36%), Positives = 109/199 (54%), Gaps = 19/199 (9%)
Query: 18 LKIGQGSYGSVYLGKLRGKN-AAIKQMK-NTKSKE-FSSELKILCKV-HSNLIELIGYAA 73
+K+GQG +G V++G G AIK +K T S E F E +++ K+ H L++L YA
Sbjct: 12 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 69
Query: 74 -GGDSLFLVYEYAQNGALSDHLHWPSVKGK--KPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+ +++V EY G+L D L KG+ K L V +A A G+ Y+ +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 122
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
YVHRD++ +NIL+ N K+ADFGL +L+E + A ++ + APE G
Sbjct: 123 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGR 179
Query: 191 VTTKSDVYAFGVVLMELIT 209
T KSDV++FG++L EL T
Sbjct: 180 FTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 7e-24
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 18/200 (9%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQM----KNTKSKEFSSELKILCKVHS-NLIELIGY 71
++G G+ G V R GK A+K + K+ EL IL K +S ++ G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPY 131
+ + EY G+L L V+G+ P ++ +A+ KGL Y+H+ K
Sbjct: 68 FYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAV--LKGLTYLHEKHK-- 121
Query: 132 YVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV 191
+HRDVK SNIL++S + K+ DFG+ L + + A VGT Y+APE ++
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQL-----VNSLAKTFVGTSSYMAPERIQGNDY 176
Query: 192 TTKSDVYAFGVVLMELITGQ 211
+ KSD+++ G+ L+EL TG+
Sbjct: 177 SVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 8e-24
Identities = 73/211 (34%), Positives = 111/211 (52%), Gaps = 21/211 (9%)
Query: 19 KIGQGSYGSVYLGKLRGKN-AAIKQMK-NTKSKE-FSSELKILCKV-HSNLIELIGYAA- 73
K+G G +G V++G G A+K +K T S E F E +I+ K+ H L++L YA
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVV 70
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGK-KPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
+ +++V EY G+L D L G+ + L V +A A G+ YI + Y
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLK----DGEGRALKLPNLVDMAAQVAAGMAYIERMN---Y 123
Query: 133 VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVT 192
+HRD++++NIL+ KIADFGL +L+E + A ++ + APE G T
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFT 181
Query: 193 TKSDVYAFGVVLMELITGQQALSRDANPGNN 223
KSDV++FG++L EL+T R PG N
Sbjct: 182 IKSDVWSFGILLTELVTK----GRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-23
Identities = 69/211 (32%), Positives = 110/211 (52%), Gaps = 28/211 (13%)
Query: 20 IGQGSYGSVYLGKLRGK----NAAIKQMKNTKSKE----FSSELKILCKV--HSNLIELI 69
IG+G++G V +++ +AAIK+MK SK+ F+ EL++LCK+ H N+I L+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKP-----------LAWTTRVQIALDAA 118
G L+L EYA +G L D L V P L+ + A D A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 119 KGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTF 178
+G++Y+ Q ++HRD+ NIL+ N+ AKIADFGL + E+ +
Sbjct: 135 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLPV 187
Query: 179 GYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
++A E + TT SDV+++GV+L E+++
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-23
Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 22/200 (11%)
Query: 19 KIGQGSYGSVY--LGKLRGKNAAIKQMK-NTKSKEFSSELKIL--CKVHSNLIELIGYAA 73
K+G+GSYGSVY + K G+ AIK + +E E+ IL C +++ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCD-SPYIVKYYGSYF 68
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL---DAAKGLEYIHQYTKP 130
L++V EY G++SD + + K L T +IA KGLEY+H K
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITN----KTL---TEEEIAAILYQTLKGLEYLHSNKK- 120
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
+HRD+K NILL+ +AK+ADFG+ L + A + ++GT ++APE +++
Sbjct: 121 --IHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---MAKRNTVIGTPFWMAPEVIQEIG 175
Query: 191 VTTKSDVYAFGVVLMELITG 210
K+D+++ G+ +E+ G
Sbjct: 176 YNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-23
Identities = 69/197 (35%), Positives = 106/197 (53%), Gaps = 15/197 (7%)
Query: 18 LKIGQGSYGSVYLGKLRGKN-AAIKQMK-NTKSKE-FSSELKILCKV-HSNLIELIGYAA 73
+K+GQG +G V++G G AIK +K T E F E +I+ K+ H L+ L +
Sbjct: 12 VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGK-KPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
+ +++V E+ G+L D L +G K L V +A A G+ YI + Y
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLK----EGDGKYLKLPQLVDMAAQIADGMAYIERMN---Y 123
Query: 133 VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVT 192
+HRD++ +NIL+ N KIADFGL +L+E + A ++ + APE G T
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFT 181
Query: 193 TKSDVYAFGVVLMELIT 209
KSDV++FG++L EL+T
Sbjct: 182 IKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-23
Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 16 TSLK-IGQGSYGSVYLGKLRGK-NAAIKQMKNTKSKE--FSSELKILCKV-HSNLIELIG 70
T LK +G G +G V+LGK RGK + AIK ++ E F E K++ K+ H NL++L G
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+F+V EY NG L ++L KGK W + + D + +EY+
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLR--ERKGKLGTEWL--LDMCSDVCEAMEYLESNG-- 120
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
++HRD+ N L+ + K++DFGL + + ++ ++ + PE
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPEVFDYSR 177
Query: 191 VTTKSDVYAFGVVLMELITG 210
++KSDV++FGV++ E+ +
Sbjct: 178 FSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-23
Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 28/211 (13%)
Query: 20 IGQGSYGSVYLGKLRGK----NAAIKQMKNTKS----KEFSSELKILCKV--HSNLIELI 69
IG+G++G V ++ NAAIK +K S ++F+ EL++LCK+ H N+I L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKP-----------LAWTTRVQIALDAA 118
G L++ EYA G L D L V P L +Q A D A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 119 KGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTF 178
G++Y+ ++ ++HRD+ N+L+ N +KIADFGL + E+ +
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGRLPV 182
Query: 179 GYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
++A E + TTKSDV++FGV+L E+++
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 3e-23
Identities = 58/196 (29%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMK--NTKSKEFSSELKILCKV-HSNLIELIGYAA 73
K+G G YG VY G K A+K +K + +EF E ++ ++ H NL++L+G
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
+++ E+ G L D+L ++ + + +A + +EY+ K ++
Sbjct: 73 REPPFYIITEFMTYGNLLDYLR---ECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 126
Query: 134 HRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTT 193
HRD+ N L+ N K+ADFGL +L+ A A ++ + APE + +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSI 184
Query: 194 KSDVYAFGVVLMELIT 209
KSDV+AFGV+L E+ T
Sbjct: 185 KSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 4e-23
Identities = 54/195 (27%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-AIKQMK--NTKSKEFSSELKILCKV-HSNLIELIGYAAG 74
K+G G +G V+ G A+K +K K+F +E +I+ K+ H LI+L
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
+ +++V E + G+L ++L + L + +A A G+ Y+ Y+H
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQ---GGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTK 194
RD+ N+L+ N K+ADFGL ++++ A ++ + APE + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIK 184
Query: 195 SDVYAFGVVLMELIT 209
SDV++FG++L E++T
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 5e-23
Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 28/211 (13%)
Query: 20 IGQGSYGSVYLGKLRGK----NAAIKQMKNTKS----KEFSSELKILCKV--HSNLIELI 69
IG+G++G V +++ +AAIK+MK S ++F+ EL++LCK+ H N+I L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKP-----------LAWTTRVQIALDAA 118
G L+L EYA +G L D L V P L+ + A D A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 119 KGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTF 178
+G++Y+ ++ ++HRD+ NIL+ N+ AKIADFGL + E+ +
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLPV 175
Query: 179 GYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
++A E + TT SDV+++GV+L E+++
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 9e-23
Identities = 68/210 (32%), Positives = 110/210 (52%), Gaps = 25/210 (11%)
Query: 13 NFSTSLKIGQGSYGSVYLGKLRGKNA--AIKQMK----NTKSKEFS-SELKILCKV-HSN 64
+F K+G+GSYGSVY K N A+K++ + K +E + +E++IL V H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLA----WTTRVQIALDAAKG 120
+I G+ L +V EYA G LS + K +K + W +Q+ +G
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAIS-KRKKKRKLIPEQEIWRIFIQLL----RG 115
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
L+ +H+ +HRD+K++NILL +N KI D G+ K+L+ + A +GT Y
Sbjct: 116 LQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-----MAKTQIGTPHY 167
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
+APE + + KSD+++ G +L E+ T
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-22
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 40/212 (18%)
Query: 19 KIGQGSYGSVYLGKLRGKN--AAIKQMKNTKSKEFSS--------ELKILCKV--HSNLI 66
++G G++GSVYL + + AIK+MK K+F S E+K L K+ H N++
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNEHPNIV 61
Query: 67 ---ELIGYAAGGDSLFLVYEYAQN---GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
E+ D L+ V+EY + + D KP + + I +G
Sbjct: 62 KLKEVFREN---DELYFVFEYMEGNLYQLMKDR-------KGKPFSESVIRSIIYQILQG 111
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
L +IH K + HRD+K N+L+ KIADFGL + + P V T Y
Sbjct: 112 LAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD----YVSTRWY 164
Query: 181 LAPEYV-RDGCVTTKSDVYAFGVVLMELITGQ 211
APE + R ++ D++A G ++ EL T +
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 57/193 (29%), Positives = 106/193 (54%), Gaps = 15/193 (7%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMK-NTKSKEFSSELKILCKV-HSNLIELIGYAAGGD 76
IG+G +G+V G+ G+ A+K +K + ++ F E ++ K+ H NL+ L+G +
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-N 71
Query: 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRD 136
L++V E G L + L +G+ ++ +Q +LD A+G+EY+ VHRD
Sbjct: 72 GLYIVMELMSKGNLVNFLR---TRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRD 125
Query: 137 VKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSD 196
+ NIL+ + AK++DFGL ++ + S++ + APE ++ ++KSD
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKL--PVKWTAPEALKHKKFSSKSD 179
Query: 197 VYAFGVVLMELIT 209
V+++GV+L E+ +
Sbjct: 180 VWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 2e-22
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 46/215 (21%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKE-FSS----ELKILCKV-HSNLIELIG 70
K+G+G+YG VY K G+ A+K+++ +E S E+ +L ++ H N+++L+
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV--QIALDAAKGLEYIHQYT 128
L+LV+EY L +L K+P + + I +GL Y H +
Sbjct: 66 VIHTERKLYLVFEYCDMD-LKKYLD------KRPGPLSPNLIKSIMYQLLRGLAYCHSH- 117
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGL-----VKLLEHSPEIAAAASRIVGTFGYLAP 183
+HRD+K NIL++ + K+ADFGL + L ++ E+ T Y AP
Sbjct: 118 --RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--------TLWYRAP 167
Query: 184 E-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
E Y +T D+++ G + E+ITG+
Sbjct: 168 EILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-22
Identities = 69/218 (31%), Positives = 108/218 (49%), Gaps = 36/218 (16%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE---FSS--ELKILCKV-HS 63
+ F +IG+G+YG VY + G+ A+K+++ ++ SS E+ +L + H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 64 NLIELIGYAAGG--DSLFLVYEYAQN--GALSDHLHWP----SVKGKKPLAWTTRVQIAL 115
N++EL G DS+FLV EY + +L D++ P VK + L
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC-----------LML 115
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIV 175
+GL+Y+H+ + +HRD+K SN+LL KIADFGL + A + V
Sbjct: 116 QLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL---PAKPMTPKV 169
Query: 176 GTFGYLAPEYVRDGCV--TTKSDVYAFGVVLMELITGQ 211
T Y APE + GC TT D++A G +L EL+ +
Sbjct: 170 VTLWYRAPELLL-GCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-21
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIKQMK----NTKSKEFSSEL----KILCKV-HSNLIEL 68
+G GS+GSVY G G A+K++ +E +L +L K+ H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL---DAAKGLEYIH 125
+G D+L++ E G+L+ L K I L GLEY+H
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL--------KKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 126 -QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
+ T VHRD+K +NIL+D+N K+ADFG+ K E + A S G+ ++APE
Sbjct: 120 DRNT----VHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKS-FKGSPYWMAPE 171
Query: 185 YV-RDGCVTTKSDVYAFGVVLMELITGQ 211
+ + G +D+++ G ++E+ TG+
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-21
Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 14/203 (6%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLRGK-NAAIKQMKN---TKSKEFSSELKILCKV-HSNLI 66
F+ K+G G +G V+ G + + AIK +K+ K ++F E++ L ++ H +LI
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
L + G+ ++++ E + G+L L P + L + + +A A+G+ Y+ +
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEE 122
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
+HRD+ NIL+ + K+ADFGL +L++ ++ +I + + APE
Sbjct: 123 QN---SIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKI--PYKWTAPEAA 176
Query: 187 RDGCVTTKSDVYAFGVVLMELIT 209
G +TKSDV++FG++L E+ T
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 70/209 (33%), Positives = 104/209 (49%), Gaps = 24/209 (11%)
Query: 13 NFSTSLKIGQGSYGSVYL--GKLRGKNAAIKQMKNT----KSKEFS-SELKILCKV-HSN 64
+ KIG+GS+G +YL K ++ IK++ T K KE S E+ +L K+ H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHL---HWPSVKGKKPLAWTTRVQIALDAAKGL 121
++ LF+V EY G L + + L+W VQI+L GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISL----GL 114
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFR-AKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
++IH +HRD+K+ NI L N AK+ DFG+ + L S E+A VGT Y
Sbjct: 115 KHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC---VGTPYY 168
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
L+PE ++ K+D+++ G VL EL T
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 54/202 (26%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 12 SNFSTSLKIGQGSYGSVYLGK-LRGKNAAIKQMKN--TKSKEFSSELKILCKV-HSNLIE 67
S + +IG G +G V+LG L + AIK ++ ++F E +++ K+ H L++
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQ 63
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L G + LV+E+ ++G LSD+L + +GK + T + + LD +G+ Y+
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLR--AQRGK--FSQETLLGMCLDVCEGMAYLESS 119
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
+HRD+ N L+ N K++DFG+ + + ++ ++ + +PE
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKWSSPEVFS 174
Query: 188 DGCVTTKSDVYAFGVVLMELIT 209
++KSDV++FGV++ E+ +
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 68/232 (29%), Positives = 103/232 (44%), Gaps = 38/232 (16%)
Query: 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS--KEFSSELKILCKV-- 61
D T F IG+G+YG VY + + G+ AIK M + +E E IL K
Sbjct: 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSN 61
Query: 62 HSNLIELIG------YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV-QIA 114
H N+ G D L+LV E G+++D VKG + + IA
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-----LVKGLRKKGKRLKEEWIA 116
Query: 115 L---DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAA 171
+ +GL Y+H+ +HRD+K NILL N K+ DFG+ S ++ +
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV------SAQLDSTL 167
Query: 172 SR---IVGTFGYLAPEYV-----RDGCVTTKSDVYAFGVVLMELITGQQALS 215
R +GT ++APE + D +SDV++ G+ +EL G+ L
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 59/195 (30%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 19 KIGQGSYGSVYLGKLRGKN-AAIKQMK-NTKSKEFSSELKILCKV--HSNLIELIGYAAG 74
K+G G +G V++G A+K +K T S + E L K H L+ L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
+ ++++ EY G+L D L S +G K + + + A+G+ YI + Y+H
Sbjct: 73 EEPIYIITEYMAKGSLLDFLK--SDEGGK-VLLPKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTK 194
RD++ +N+L+ + KIADFGL +++E + A ++ + APE + G T K
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIK 184
Query: 195 SDVYAFGVVLMELIT 209
SDV++FG++L E++T
Sbjct: 185 SDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-21
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTKSK----EFSSELKILCK 60
SN +G+G +G V+L K +G +K ++ TK + EF EL + K
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 61 V-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKK----PLAWTTRVQIAL 115
+ H N++ L+G + +++ EY G L L K +K PL+ +V +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIV 175
A G++++ + +VHRD+ N L+ S K++ L K + ++ E + ++
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDV-YNSEYYKLRNALI 180
Query: 176 GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
+LAPE V++ +TKSDV++FGV++ E+ T
Sbjct: 181 -PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-21
Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 20 IGQGSYGSVYLGKLRGKNA-------AIKQMKNTKS----KEFSSELKILCKV-HSNLIE 67
+G+G++G VY G+L G N AIK +K +EF E +++ + H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHL--HWP---------SVKGKKPLAWTTRVQIALD 116
L+G +++EY +G L + L + P K L + + IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
A G+EY+ + ++VHRD+ N L+ KI+DFGL + + +S + S+ +
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDI-YSADYYRVQSKSLL 188
Query: 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMEL 207
++ PE + G TT+SD+++FGVVL E+
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 4e-21
Identities = 72/293 (24%), Positives = 113/293 (38%), Gaps = 54/293 (18%)
Query: 20 IGQGSYGSVYLGKLRGKNA-----AIKQMKNTKS----KEFSSELKILCKV-HSNLIELI 69
+G G++GSV G K+ A+K +K KEF E ++ ++ H ++ LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHL-HWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
G G + L LV E A G L +L + +V A G+ Y+
Sbjct: 63 GVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES-- 113
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
++VHRD+ N+LL + +AKI+DFG+ + L + A + + APE +
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 189 GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAK 248
G ++KSDV+++GV L E A S A P Y E + + +A
Sbjct: 173 GKFSSKSDVWSYGVTLWE------AFSYGAKP----YGEMKG------------AEVIAM 210
Query: 249 LTECL----DPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297
L + ML C + RP S
Sbjct: 211 LESGERLPRPEECPQEIYSIMLS-------CWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 5e-21
Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 20 IGQGSYGSVYLGKLR--GKN---AAIKQMK----NTKSKEFSSELKILCKV-HSNLIELI 69
IG G +G V G+L+ GK AIK +K + ++F SE I+ + H N+I L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA---LDAAKGLEYIHQ 126
G + +V EY +NG+L L +K T +Q+ A G++Y+
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL-------RKHDGQFTVIQLVGMLRGIASGMKYLSD 124
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
YVHRD+ NIL++SN K++DFGL ++LE PE A + APE +
Sbjct: 125 MG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 187 RDGCVTTKSDVYAFGVVLMELIT 209
T+ SDV+++G+V+ E+++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 6e-21
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 19 KIGQGSYGSVYLGKLR----GKNAAIKQ-----MKNTKSKEFSSELKILCKV-HSNLIEL 68
IG+GS+G+V K+R GK K+ M + ++ SE+ IL ++ H N++
Sbjct: 7 TIGKGSFGTVR--KVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 69 IGYAAGGDS--LFLVYEYAQNGALSDHLHWPSVKGKKPLA----WTTRVQIALDAAKGLE 122
+ L++V EY + G L+ + K +K + W Q+ L L
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQ-KCKKERKYIEEEFIWRILTQLLL----ALY 119
Query: 123 YIH--QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
H +HRD+K +NI LD+N K+ DFGL K+L H ++ A VGT Y
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD---SSFAKTYVGTPYY 176
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
++PE + KSD+++ G ++ EL
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 6e-21
Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 29/203 (14%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKNTK---SKEFS---SELKILCKV-HSNLIELIG 70
+G GS+G V L + +G A+K + K K+ +E +IL + H L+ L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV---QIALDAAKGLEYIHQY 127
+L+LV EY G L HL K + R Q+ L LEY+H
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHL----RKSGRFPEPVARFYAAQVVL----ALEYLHSL 120
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
V+RD+K N+LLDS+ KI DFG K ++ + GT YLAPE +
Sbjct: 121 D---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TYTLCGTPEYLAPEIIL 171
Query: 188 DGCVTTKSDVYAFGVVLMELITG 210
D +A G+++ E++ G
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 6e-21
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 19 KIGQGSYGSVYLG-KLR-GKNAAIKQMKNTKS-----KEFSSELKILCKV-HSNLIELIG 70
KIG G++G VY L G+ A+K+++ + KE + E+K+L + H NL++ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+ +++ EY G L + L + L +GL Y+H +
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQL--LEGLAYLHSHG-- 119
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGL-VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
VHRD+K +NI LD N K+ DFG VKL ++ + + GT Y+APE + G
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 190 CVTTK---SDVYAFGVVLMELITG 210
+D+++ G V++E+ TG
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 7e-21
Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 33/219 (15%)
Query: 20 IGQGSYGSVY----LGKLRGKN---AAIKQMKNTKS----KEFSSELKILCKV-HSNLIE 67
IGQG++G V+ G L + A+K +K S +F E ++ + H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVK-----------------GKKPLAWTTR 110
L+G A G + L++EY G L++ L S + PL+ T +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 111 VQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA 170
+ IA A G+ Y+ ++ +VHRD+ T N L+ N KIADFGL + + +S + A
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI-YSADYYKA 188
Query: 171 ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
+ ++ PE + TT+SDV+A+GVVL E+ +
Sbjct: 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 8e-21
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 20 IGQGSYGSVYLG--KLRGKN---AAIKQMK----NTKSKEFSSELKILCKV-HSNLIELI 69
IG G +G V+ G K+ G+ AIK +K + ++F SE I+ + H N+I L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
G ++ EY +NGAL +L + V + A G++Y+
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLR----DHDGEFSSYQLVGMLRGIAAGMKYLSDMN- 127
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
YVHRD+ NIL++SN K++DFGL ++LE PE S + APE +
Sbjct: 128 --YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 190 CVTTKSDVYAFGVVLMELIT 209
T+ SDV++FG+V+ E+++
Sbjct: 186 KFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 9e-21
Identities = 68/208 (32%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 14 FSTSLKIGQGSYGSVYLG--KLRGKNAAIKQM------KNTKSKEFSSELKILCKV-HSN 64
F+ +IG GS+G+VY + AIK+M N K ++ E++ L ++ H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHL--HWPSVKGKKPLAWTTRVQIALDAAKGLE 122
IE G + +LV EY G+ SD L H KKPL I A +GL
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL-GSASDILEVH------KKPLQEVEIAAICHGALQGLA 129
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
Y+H + + +HRD+K NILL K+ADFG S + + A+ VGT ++A
Sbjct: 130 YLHSHER---IHRDIKAGNILLTEPGTVKLADFG-------SASLVSPANSFVGTPYWMA 179
Query: 183 PEYV---RDGCVTTKSDVYAFGVVLMEL 207
PE + +G K DV++ G+ +EL
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 9e-21
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 20 IGQGSYGSVYLGKLRG-------KNAAIKQMKNTKS----KEFSSELKILCKVHSNLI-E 67
+GQGS+G VY G +G AIK + S EF +E ++ + + + +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHL--HWPSVKGKKPLAWTTRVQI---ALDAAKGLE 122
L+G + G +V E G L +L P + L T + A + A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
Y+ K +VHRD+ N ++ + KI DFG+ + + + ++ ++A
Sbjct: 134 YLAA-KK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMA 189
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
PE ++DG TTKSDV++FGVVL E+ T +Q
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMATLAEQ 220
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-20
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 26/204 (12%)
Query: 20 IGQGSYGSVYLG--KLRGKNA----AIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
+G G++G+VY G G+ AIK ++ S KE E ++ V H +++ L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHL--HWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
+G + L+ + G L D++ H ++ + L W VQIA KG+ Y+ +
Sbjct: 75 LGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIA----KGMSYLEE 127
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE-HSPEIAAAASRIVGTFGYLAPEY 185
VHRD+ N+L+ + KI DFGL KLL+ E A ++ ++A E
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV--PIKWMALES 182
Query: 186 VRDGCVTTKSDVYAFGVVLMELIT 209
+ T KSDV+++GV + EL+T
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 19 KIGQGSYGSVYLGKLR---GK--NAAIKQMKNTK----SKEFSSELKILCKV-HSNLIEL 68
K+G GS+G V G+ GK A+K +K+ K +F E I+ + H NLI L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
G L +V E A G+L D L +T A+ A G+ Y+
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKD---ALGHFLISTLCDYAVQIANGMRYLES-- 115
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
++HRD+ NILL S+ + KI DFGL++ L + + + F + APE +R
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 189 GCVTTKSDVYAFGVVLMELIT-GQQ 212
+ SDV+ FGV L E+ T G++
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEE 199
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 32/219 (14%)
Query: 19 KIGQGSYGSVYLGKLRGKN----------------AAIKQMK----NTKSKEFSSELKIL 58
K+G+G +G V+L + G A+K ++ T +F E+KI+
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 59 CKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK-------KPLAWTTR 110
++ + N+I L+G D L ++ EY +NG L+ L ++ ++
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 111 VQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA 170
+ +A+ A G++Y+ +VHRD+ T N L+ +++ KIADFG+ + L +S +
Sbjct: 132 LYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNL-YSGDYYRI 187
Query: 171 ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
R V ++A E + G TT SDV+AFGV L E+ T
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-20
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 49/215 (22%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKE------FSS--ELKILCKV-HSNLIE 67
K+G+G+Y VY K G+ AIK++K + KE F++ E+K+L ++ H N+I
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 68 LIGYAAGGDSLFLVYEYAQ--------NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
L+ ++ LV+E+ + + ++ L +K L +
Sbjct: 67 LLDVFGHKSNINLVFEFMETDLEKVIKDKSIV--LTPADIK-----------SYMLMTLR 113
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI----V 175
GLEY+H + +HRD+K +N+L+ S+ K+ADFGL + + +R V
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR-------SFGSPNRKMTHQV 163
Query: 176 GTFGYLAPEYVRDGC--VTTKSDVYAFGVVLMELI 208
T Y APE + G D+++ G + EL+
Sbjct: 164 VTRWYRAPELLF-GARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-20
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 20 IGQGSYGSVYLGKLR--GKN---AAIKQMK----NTKSKEFSSELKILCKV-HSNLIELI 69
IG G +G V G+L+ GK AIK +K + ++F SE I+ + H N+I L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
G + ++ E+ +NGAL L + V + A G++Y+ +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLR----QNDGQFTVIQLVGMLRGIAAGMKYLSEMN- 126
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG--YLAPEYVR 187
YVHRD+ NIL++SN K++DFGL + LE S + G + APE +
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 188 DGCVTTKSDVYAFGVVLMELIT 209
T+ SDV+++G+V+ E+++
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-20
Identities = 63/221 (28%), Positives = 110/221 (49%), Gaps = 18/221 (8%)
Query: 16 TSLK-IGQGSYGSVYLGKLRGK-NAAIKQMK--NTKSKEFSSELKILCKV-HSNLIELIG 70
T LK +G G +G V GK RG+ + AIK +K + EF E K++ K+ H L++L G
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+++V EY NG L ++L + K + +++ D +G+ Y+
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLR----EHGKRFQPSQLLEMCKDVCEGMAYLESKQ-- 120
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
++HRD+ N L+D K++DFGL + + ++ S+ + PE +
Sbjct: 121 -FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLLYSK 177
Query: 191 VTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRS 230
++KSDV+AFGV++ E+ + G+ R N++ E S
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYER---FNNSETVEKVS 215
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-20
Identities = 75/256 (29%), Positives = 124/256 (48%), Gaps = 46/256 (17%)
Query: 9 DATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKE---FSSELKILCKV-H 62
D S +KIG+GS G V + K G+ A+K+M K + +E+ I+ H
Sbjct: 16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH 75
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV---QIA---LD 116
N++E+ GD L++V E+ + GAL+D + TR+ QIA L
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTD------------IVTHTRMNEEQIATVCLA 123
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
K L ++H +HRD+K+ +ILL S+ R K++DFG + S E+ S +VG
Sbjct: 124 VLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQV--SKEVPRRKS-LVG 177
Query: 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ---------QALS--RDANPGNNQY 225
T ++APE + T+ D+++ G++++E++ G+ QA+ RD P +
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKN 237
Query: 226 T-----EHRSLVDYML 236
RS +D ML
Sbjct: 238 LHKVSPRLRSFLDRML 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 7e-20
Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 19 KIGQGSYGSVYLGKLRGKNA--AIKQMKNTKSKE----FSSELKILCKVHS-NLIELIGY 71
IG+GS+G VY + N AIK + ++++ E++ L + S + + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPY 131
G L+++ EY G+ D L P + +A+ R + GLEY+H+ K
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLK-PGKLDETYIAFILR-----EVLLGLEYLHEEGK-- 119
Query: 132 YVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR---IVGTFGYLAPEYVRD 188
+HRD+K +NILL K+ADFG+ S ++ + S+ VGT ++APE ++
Sbjct: 120 -IHRDIKAANILLSEEGDVKLADFGV------SGQLTSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 189 GCVTTKSDVYAFGVVLMELITGQQALS 215
K+D+++ G+ +EL G+ LS
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLS 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-20
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 20 IGQGSYGSVYLGKLRGKNA-------AIKQMKNTKSKE----FSSELKILCK-VHSNLIE 67
+G G++G VY G RG++ A+K + + S++ F E I+ K H N++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHW--PSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
LIG + F++ E G L L P + L + A D AKG +Y+
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 126 QYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
+ +++HRD+ N LL AKIADFG+ + + + R + ++
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA-SYYRKGGRAMLPIKWMP 189
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMEL 207
PE DG T+K+DV++FGV+L E+
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 61/217 (28%), Positives = 110/217 (50%), Gaps = 27/217 (12%)
Query: 19 KIGQGSYGSVYLGKLRGKN-------AAIKQMKN---TKSKEFSSELKILCKV-HSNLIE 67
++G+G++G V+L + + A+K +K+ K+F E ++L + H ++++
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHL--HWPSV---------KGKKPLAWTTRVQIALD 116
G GD L +V+EY ++G L+ L H P + K L + + IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
A G+ Y+ ++VHRD+ T N L+ +N KI DFG+ + + +S + +
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-YSTDYYRVGGHTML 187
Query: 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
++ PE + TT+SDV++FGV+L E+ T G+Q
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 67/224 (29%), Positives = 106/224 (47%), Gaps = 41/224 (18%)
Query: 19 KIGQGSYGSVYLGKLRGKNA------------------AIKQMKNTKSK----EFSSELK 56
K+G+G +G V+L + G A+K ++ S +F E+K
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 57 ILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHL--HWP----SVKGKKPLAWTT 109
IL ++ N+ L+G L ++ EY +NG L+ L H K L+++T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 110 RVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAA 169
+ +A A G+ Y+ +VHRD+ T N L+ N+ KIADFG+ + L ++
Sbjct: 132 LLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNL-----YSS 183
Query: 170 AASRIVGT----FGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
R+ G ++A E V G TTKSDV+AFGV L E++T
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-19
Identities = 68/213 (31%), Positives = 109/213 (51%), Gaps = 28/213 (13%)
Query: 8 RDATSNFSTSLKIGQGSYGSVYLGK--LRGKNAAIKQMKNTKSKEFS---SELKIL--CK 60
R+ +F +IG G+YG VY + G+ AAIK +K ++F+ E+ ++ CK
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64
Query: 61 VHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
HSN++ G D L++ E+ G+L D H V G PL+ + ++ + +G
Sbjct: 65 -HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH---VTG--PLSESQIAYVSRETLQG 118
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR---IVGT 177
L Y+H K +HRD+K +NILL N K+ADFG+ S +I A ++ +GT
Sbjct: 119 LYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGV------SAQITATIAKRKSFIGT 169
Query: 178 FGYLAPEYV---RDGCVTTKSDVYAFGVVLMEL 207
++APE R G D++A G+ +EL
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 67/292 (22%), Positives = 118/292 (40%), Gaps = 51/292 (17%)
Query: 19 KIGQGSYGSVYLGK--LRGKNAAIKQMK-----NTKSKEFSSELKILCKV-HSNLIELIG 70
KIG+G+YG VY + L G+ AIK++K K E+K+L ++ H N+I+L+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKG-KKPLAWTTRVQIALDAAKGLEYIHQYTK 129
L+LV+E+ +D +K ++ L + +GL + H +
Sbjct: 66 VFRHKGDLYLVFEFM----DTDLYKL--IKDRQRGLPESLIKSYLYQLLQGLAFCHSHG- 118
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE-YVRD 188
+HRD+K N+L+++ K+ADFGL + + V T Y APE + D
Sbjct: 119 --ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR---PYTHYVVTRWYRAPELLLGD 173
Query: 189 GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF----NDTKD 244
+T D+++ G + EL++ + PG +S +D + +F +
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLF-----PG-------KSEIDQLFKIFRTLGTPDPE 221
Query: 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRR-PDMSNAAIRLSH 295
K T + + P+ S A+ L
Sbjct: 222 VWPKFTSLARNYKFSF------------PKKAGMPLPKLFPNASPQALDLLS 261
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 20 IGQGSYGSVYLGKLRG-------KNAAIKQMK-NTKSKEFS---SELKILCKV--HSNLI 66
+G+G++G V + G A+K +K + K+ S SE++++ + H N+I
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHL--HWP---------SVKGKKPLAWTTRVQIAL 115
L+G L++V EYA +G L D L P ++ L V A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIV 175
A+G+E++ +HRD+ N+L+ + KIADFGL + + H + +
Sbjct: 140 QVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDI-HHIDYYRKTTNGR 195
Query: 176 GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
++APE + D T +SDV++FGV+L E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 25/201 (12%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKVHS--NLIELI 69
I +G++GSVYL K R G AIK +K + + +E I+ + +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
D L+LV EY G + + G P W Q + G+E +HQ
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDLHQRG- 117
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
+HRD+K N+L+D K+ DFGL + + + VGT YLAPE +
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-------KFVGTPDYLAPETILGV 168
Query: 190 CVTTKSDVYAFGVVLMELITG 210
SD ++ G V+ E + G
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-19
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 20 IGQGSYGSVYLGKLRGKNA--------AIKQMK----NTKSKEFSSELKILCKV-HSNLI 66
+G G++G VY G A+K ++ + + KEF E ++ H N++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKP--LAWTTRVQIALDAAKGLEYI 124
+L+G + +++ E + G L +L V+ P L + I LD AKG Y+
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 125 HQYTKPYYVHRDVKTSNILL-----DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
Q +++HRD+ N L+ D++ KI DFGL + + S ++
Sbjct: 123 EQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL-PVR 178
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
++APE + DG TT+SDV++FGV++ E++T GQQ
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-19
Identities = 66/216 (30%), Positives = 114/216 (52%), Gaps = 33/216 (15%)
Query: 8 RDATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQM---KNTKSKEFSSELKILCKVH 62
R+ +F +KIG+GS G V + K GK A+K+M K + + +E+ I+ H
Sbjct: 21 REYLDSF---IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77
Query: 63 -SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV---QIA---L 115
N++++ GD L++V E+ + GAL+D + TR+ QIA L
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTD------------IVTHTRMNEEQIATVCL 125
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIV 175
+ L Y+H +HRD+K+ +ILL S+ R K++DFG + S E+ S +V
Sbjct: 126 SVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKS-LV 179
Query: 176 GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
GT ++APE + T+ D+++ G++++E+I G+
Sbjct: 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-19
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 20 IGQGSYGSVYLGKLRGKNAA---------IKQMKNTKSKEFSSELKILCKV-HSNLIELI 69
+G+G++G V+L R K ++QM + +E ++L + H N+IE
Sbjct: 8 VGRGAFGIVHL--CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
+L +V EYA G L++++ + L T + + L ++H
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQ---KRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 130 PYYVHRDVKTSNILLDSN-FRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
+HRD+KT NILLD + KI DFG+ K+L + A +VGT Y++PE
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK----SKAYTVVGTPCYISPELCEG 175
Query: 189 GCVTTKSDVYAFGVVLMELITGQQA 213
KSD++A G VL EL + ++A
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-19
Identities = 56/195 (28%), Positives = 106/195 (54%), Gaps = 13/195 (6%)
Query: 19 KIGQGSYGSVYLGKL-RGKNAAIKQMK--NTKSKEFSSELKILCKVHSNLIELIGYAAGG 75
K+G G +G V++ + A+K MK + + F +E ++ + + + +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 76 DSLFLVYEYAQNGALSDHLHWPSVKG-KKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
+ ++++ E+ G+L D L S +G K+PL + + A+G+ +I Q Y+H
Sbjct: 73 EPIYIITEFMAKGSLLDFLK--SDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 125
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTK 194
RD++ +NIL+ ++ KIADFGL +++E + A ++ + APE + G T K
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIK 183
Query: 195 SDVYAFGVVLMELIT 209
SDV++FG++LME++T
Sbjct: 184 SDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-19
Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 10 ATSNFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTKSK----EFSSELKIL 58
A + S ++GQGS+G VY G +G AIK + S EF +E ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 59 CKVHSN-LIELIGYAAGGDSLFLVYEYAQNGALSDHLH-----WPSVKGKKPLAWTTRVQ 112
+ + + ++ L+G + G ++ E G L +L + + P + +Q
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
+A + A G+ Y++ +VHRD+ N ++ +F KI DFG+ + + +
Sbjct: 124 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 173 RIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
++ +++PE ++DG TT SDV++FGVVL E+ T
Sbjct: 181 GLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-19
Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 26/216 (12%)
Query: 19 KIGQGSYGSVYLG----------KLRGKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIE 67
++G+G++G V+L K+ A+K+ + ++F E ++L + H +++
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHL--HWPSVK----GKK----PLAWTTRVQIALDA 117
G G L +V+EY ++G L+ L H P K G+ L + IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
A G+ Y+ ++VHRD+ T N L+ KI DFG+ + + +S + R +
Sbjct: 132 ASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRTMLP 187
Query: 178 FGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
++ PE + TT+SD+++FGVVL E+ T G+Q
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 9e-19
Identities = 72/211 (34%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 9 DATSNFSTSLKIGQGSYGSVYLGKLRGKN--AAIKQMK------NTKSKEFSSELKILCK 60
D F+ +IG GS+G+VY + N AIK+M N K ++ E+K L +
Sbjct: 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR 81
Query: 61 V-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
+ H N IE G + +LV EY G+ SD L KKPL I A +
Sbjct: 82 IKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE----VHKKPLQEVEIAAITHGALQ 136
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
GL Y+H + +HRD+K NILL + K+ADFG S IA+ A+ VGT
Sbjct: 137 GLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG-------SASIASPANSFVGTPY 186
Query: 180 YLAPEYV---RDGCVTTKSDVYAFGVVLMEL 207
++APE + +G K DV++ G+ +EL
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 9e-19
Identities = 76/245 (31%), Positives = 116/245 (47%), Gaps = 42/245 (17%)
Query: 19 KIGQGSYGSVYLGKLRGKN--AAIKQMK------NTKSKEFSSELKILCKV-HSNLIELI 69
+IG GS+G+VY N A+K+M N K ++ E+K L ++ H N IE
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
G + +LV EY G+ SD L KKPL I A +GL Y+H +
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV--- 186
+HRD+K NILL + K+ADFG S ++ A+ VGT ++APE +
Sbjct: 143 ---IHRDIKAGNILLTEPGQVKLADFG-------SASKSSPANSFVGTPYWMAPEVILAM 192
Query: 187 RDGCVTTKSDVYAFGVVLMELITGQQAL------------SRDANPG--NNQYTEH-RSL 231
+G K DV++ G+ +EL + L +++ +P +N++T+ R
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252
Query: 232 VDYML 236
VDY L
Sbjct: 253 VDYCL 257
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQ-----MKNTKSKEFSSELKILCKV-HSNLIELIG 70
KIG+GS+G L K + GK IK+ M + +E E+ +L + H N+++
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTR------VQIALDAAKGLEYI 124
+L++V +Y + G L + + ++ + + VQI L L+++
Sbjct: 67 SFEENGNLYIVMDYCEGGDL-----YKKINAQRGVLFPEDQILDWFVQICL----ALKHV 117
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
H +HRD+K+ NI L + K+ DFG+ ++L + E+A +GT YL+PE
Sbjct: 118 HDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC---IGTPYYLSPE 171
Query: 185 YVRDGCVTTKSDVYAFGVVLMELITGQQAL 214
+ KSD++A G VL E+ T + A
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-18
Identities = 63/227 (27%), Positives = 111/227 (48%), Gaps = 24/227 (10%)
Query: 13 NFSTSLKIGQGSYGSVYLG----------KLRGKNAAIKQMKNTKSKEFSSELKILCKV- 61
N ++G+G++G V+L K+ +K + K+F E ++L +
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 62 HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHL--HWPSV----KGKKP--LAWTTRVQI 113
H ++++ G GD L +V+EY ++G L+ L H P +G +P L + + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 114 ALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR 173
A A G+ Y+ ++VHRD+ T N L+ N KI DFG+ + + +S +
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV-YSTDYYRVGGH 181
Query: 174 IVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDAN 219
+ ++ PE + TT+SDV++ GVVL E+ T G+Q + +N
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 74/251 (29%), Positives = 109/251 (43%), Gaps = 27/251 (10%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQM--KNTKSKEFSS----ELKILCKVHSNLIELIGY 71
+G+G +G V +++ GK A K++ K K ++ E KIL KV S I + Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHWPSVKG-KKPLAWTTRVQIALDAAKGLEYIHQYTK 129
A D L LV G L H++ G + A QI GLE++HQ
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIIC----GLEHLHQR-- 114
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGL-VKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
V+RD+K N+LLD + +I+D GL V+L A GT GY+APE ++
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA-----GTPGYMAPEVLQG 168
Query: 189 GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL---VDYMLAVFNDTKDF 245
D +A G L E+I G+ + + + R+L V+Y + KD
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDL 228
Query: 246 MAKLTECLDPN 256
L DP
Sbjct: 229 CEALL-QKDPE 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-18
Identities = 63/210 (30%), Positives = 110/210 (52%), Gaps = 28/210 (13%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIKQM-------KNTKSKE-----FSSELKILCKV-HSN 64
IG GS+GSVYLG G+ A+KQ+ + K + E+ +L ++ H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHL-HWPSVKGKKPLAWTTRVQIALDAAKGLEY 123
+++ +G + D L + EY G+++ L ++ + + + L QI KGL Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE--ETLVRNFVRQIL----KGLNY 121
Query: 124 IHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAA---AASRIVGTFGY 180
+H +HRD+K +NIL+D+ KI+DFG+ K LE + A + G+ +
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
+APE V+ T K+D+++ G +++E++TG
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 70/211 (33%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 9 DATSNFSTSLKIGQGSYGSVYLGKLRGKN--AAIKQMK------NTKSKEFSSELKILCK 60
D FS +IG GS+G+VY + + AIK+M N K ++ E++ L K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 61 V-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
+ H N I+ G + +LV EY G+ SD L KKPL + A +
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE----VHKKPLQEVEIAAVTHGALQ 126
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
GL Y+H + +HRDVK NILL K+ DFG S I A A+ VGT
Sbjct: 127 GLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFG-------SASIMAPANXFVGTPY 176
Query: 180 YLAPEYV---RDGCVTTKSDVYAFGVVLMEL 207
++APE + +G K DV++ G+ +EL
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-18
Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 17/196 (8%)
Query: 19 KIGQGSYGSVYLGKLRGKNA--AIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIG 70
+IG+G++G V+ G+LR N A+K + T K+K F E +IL + H N++ LIG
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIG 60
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+++V E Q G D L + +G + L +Q+ +AA G+EY+
Sbjct: 61 VCTQKQPIYIVMELVQGG---DFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLES---K 113
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
+ +HRD+ N L+ KI+DFG+ + E + + + + APE + G
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI-PVKWTAPEALNYGR 172
Query: 191 VTTKSDVYAFGVVLME 206
+++SDV++FG++L E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 37/211 (17%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-----FSSELKILCKV-HSNLIELIG 70
+IG+G++G V+ K R G+ A+K++ + + E+K L H +++L+
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQI---ALDAAKGLEYIHQY 127
G LV EY + LS+ L ++PL Q+ KG+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSD-LSEVLR----DEERPL---PEAQVKSYMRMLLKGVAYMH-- 116
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE--- 184
+HRD+K +N+L+ ++ KIADFGL +L S E S V T Y APE
Sbjct: 117 -ANGIMHRDLKPANLLISADGVLKIADFGLARLF--SEEEPRLYSHQVATRWYRAPELLY 173
Query: 185 ----YVRDGCVTTKSDVYAFGVVLMELITGQ 211
Y D V D++A G + EL+ G
Sbjct: 174 GARKY--DPGV----DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-18
Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 41/227 (18%)
Query: 19 KIGQGSYGSVYLGKL----------------RGKN--AAIKQMKNTKSK----EFSSELK 56
K+G+G +G V+L ++ +G+ A+K ++ +K +F E+K
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 57 ILCKVHS-NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHW--------PSVKGKKP--- 104
IL ++ N+I L+G D L ++ EY +NG L+ L P
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 105 ---LAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161
+++++ + +AL A G++Y+ +VHRD+ T N L+ N KIADFG+ + L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELI 208
++ + R V ++A E + G TT SDV+AFGV L E++
Sbjct: 189 -YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-18
Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 33/220 (15%)
Query: 19 KIGQGSYGSVYLGKLRGKN------------------AAIKQMKNTKSK----EFSSELK 56
K+G+G +G V+L + G A+K ++ +K +F E+K
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 57 ILCKVHS-NLIELIGYAAGGDSLFLVYEYAQNGALSDHL--HWPSVKGKKP----LAWTT 109
I+ ++ N+I L+ D L ++ EY +NG L+ L H P +K ++++T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 110 RVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAA 169
+ +A A G++Y+ +VHRD+ T N L+ N+ KIADFG+ + L +S +
Sbjct: 132 LIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNL-YSGDYYR 187
Query: 170 AASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
R V +++ E + G TT SDV+AFGV L E++T
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-18
Identities = 68/201 (33%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFS------SELKILCKVHSNLIELIGY 71
+G+G +G V ++R GK A K+++ + K+ +E +IL KV+S + + Y
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
A D+L LV G L H++ G+ V A + GLE +HQ
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYH---MGEAGFEEGRAVFYAAEICCGLEDLHQ---E 121
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
V+RD+K NILLD + +I+D GL H PE R VGT GY+APE V++
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGR-VGTVGYMAPEVVKNER 177
Query: 191 VTTKSDVYAFGVVLMELITGQ 211
T D +A G +L E+I GQ
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 6e-18
Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 20 IGQGSYGSVYLGKLRGKNAAIKQ------MKNTKSKEFSSELKILCKVHSN-LIELIGYA 72
+G G+ GSV K + + K++ K+ EL+I+ + S ++ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
+++ + E+ G+L D ++ K P+ +IA+ +GL Y+ Y
Sbjct: 73 LNENNICMCMEFMDCGSL-DRIY----KKGGPIPVEILGKIAVAVVEGLTYL--YNVHRI 125
Query: 133 VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVT 192
+HRD+K SNIL++S + K+ DFG+ L I + A VGT Y++PE ++ G T
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGEL-----INSIADTFVGTSTYMSPERIQGGKYT 180
Query: 193 TKSDVYAFGVVLMELITGQ 211
KSDV++ G+ ++EL G+
Sbjct: 181 VKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 7e-18
Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 37/222 (16%)
Query: 20 IGQGSYGSVYLG---KLRGK----NAAIKQMK-NTKSKEFS---SELKILCKV-HSNLIE 67
+G+G +G V +L+G+ A+K +K N S E SE +L +V H ++I+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLH-------------------WPSVKGKKPLAWT 108
L G + L L+ EYA+ G+L L + ++ L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 109 TRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK-LLEHSPEI 167
+ A ++G++Y+ + VHRD+ N+L+ + KI+DFGL + + E +
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
+ RI ++A E + D TT+SDV++FGV+L E++T
Sbjct: 185 KRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMK--------NTKSKEFSSELKILCKVHSNLIELI 69
+G+GS+G V L +L+G N AIK +K + + + L H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
+ LF V EY G L H+ G+ A A + GL+++H K
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQ---SSGRFDEARARFY--AAEIICGLQFLH---K 114
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
++RD+K N+LLD + KIADFG+ K + AS GT Y+APE ++
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE---NMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 190 CVTTKSDVYAFGVVLMELITGQ 211
D ++FGV+L E++ GQ
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 19 KIGQGSYGSVYLGKLRGKNA----AIKQMKNTKSKEFSS-----ELKILCKV-HSNLIEL 68
+G+G+YG V K R K AIK+ K ++ E E+K+L ++ H N++ L
Sbjct: 8 VVGEGAYGVVL--KCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
L+LV+EY + L P G P A R + + Y H +
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELLEASP--GGLPPDA--VR-SYIWQLLQAIAYCHSHN 120
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE-YVR 187
+HRD+K NIL+ + K+ DFG + L P A+ + V T Y APE V
Sbjct: 121 ---IIHRDIKPENILVSESGVLKLCDFGFARALRARP--ASPLTDYVATRWYRAPELLVG 175
Query: 188 DGCVTTKSDVYAFGVVLMELITGQ 211
D DV+A G ++ EL+ G+
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 33/208 (15%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKNTKSKEF----------SSELKILCKV--HSNL 65
+G+GS+G V L +L+G + A+K +K K+ +E ++L H L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLK----KDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
+L D LF V EY G L H+ S + +P A +I L GL+++H
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRARFYAAEIVL----GLQFLH 113
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK--LLEHSPEIAAAASRIVGTFGYLAP 183
+ ++RD+K N+LLDS KIADFG+ K +L S GT Y+AP
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-----GVTTSTFCGTPDYIAP 165
Query: 184 EYVRDGCVTTKSDVYAFGVVLMELITGQ 211
E + D +A GV+L E++ GQ
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 39/217 (17%)
Query: 20 IGQGSYGSVYLGKLRGKNA-----AIKQM--------KNTKSKEFS-----SELKILCK- 60
+G G++G VY K+R KN A+K++ K+ + ++ S SE+ I+ +
Sbjct: 8 LGSGAFGCVY--KVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 61 -VHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKK-----PLAWTTRVQIA 114
H N++ D L++V + + L +H + S+K KK W VQ+
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFN--SLKEKKQRFTEERIWNIFVQMV 123
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI 174
L L Y+H+ + VHRD+ +NI+L + + I DFGL K + PE + + +
Sbjct: 124 L----ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPE--SKLTSV 173
Query: 175 VGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
VGT Y PE V++ K+DV+AFG +L ++ T Q
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 2e-17
Identities = 57/211 (27%), Positives = 107/211 (50%), Gaps = 18/211 (8%)
Query: 7 VRDATSNFSTSLKIGQGSYGSVYLGK--LRGKNAAIKQM---KNTKSKEFSSELKILCKV 61
+ D ++ KIGQG+ G+V+ G+ AIKQ+ K K + +E+ ++ ++
Sbjct: 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL 73
Query: 62 HS-NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
+ N++ + GD LF+V EY G+L+D V + + + + +
Sbjct: 74 KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD------VVTETCMDEAQIAAVCRECLQA 127
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
LE++H +HRD+K+ N+LL + K+ DFG + +PE + S +VGT +
Sbjct: 128 LEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI--TPE-QSKRSTMVGTPYW 181
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
+APE V K D+++ G++ +E++ G+
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-17
Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 58/297 (19%)
Query: 20 IGQGSYGSVYLGKL-----RGKNAAIKQM-KNTKSKEFSSELK--ILCK--VHSNLIELI 69
IG+G +G VY G L + + A+K + + T +E LK I+ K H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 70 GYAAGGDSLFLV-YEYAQNGALSDHL----HWPSVKGKKPLAWTTRVQIALDAAKGLEYI 124
G + LV Y ++G L + + H P+VK + L AKG+EY+
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK--------DLIGFGLQVAKGMEYL 114
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK-LLE---HSPEIAAAASRIVGTFGY 180
+VHRD+ N +LD +F K+ADFGL + + + +S A V +
Sbjct: 115 ASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV---KW 168
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240
+A E ++ TTKSDV++FGV+L EL+T D +
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-------------------F 209
Query: 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297
D ++ + L P Y D + ++ L C + RP S R+ I
Sbjct: 210 DITVYLLQGRRLLQP---EYCPDPLYEVML---SCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-17
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 20 IGQGSYGSVYL------GKLRGKNAAIKQMKNTKSKEFSSELK----ILCKV-HSNLIEL 68
+G+G +G V L G G+ A+K +K ++LK IL + H N+++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 69 IGYAA--GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
G GG+ + L+ E+ +G+L ++L P K K L +++ A+ KG++Y+
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINL--KQQLKYAVQICKGMDYLGS 127
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
YVHRD+ N+L++S + KI DFGL K +E E + + APE +
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 187 RDGCVTTKSDVYAFGVVLMELIT 209
SDV++FGV L EL+T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-17
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMK----NTKSKEFSSELKILCKV-HSNLIELIGY 71
IG G+ VY + AIK++ T E E++ + + H N+++
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL---DAAKGLEYIHQYT 128
GD L+LV Y G+L D +K P IA + KGLEY+H
Sbjct: 68 FVVGDELWLVMPYLSGGSLLD-----IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR--IVGTFGYLAPEYV 186
+ +HRD+K NILL + KIADFG+ L R VGT ++APE +
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLA-DGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 187 -RDGCVTTKSDVYAFGVVLMELITG 210
+ K+D+++FG+ +EL TG
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-17
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 34/206 (16%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMK--NTKS-----KEFSSELKILCKVHS-NLIELIG 70
++G+G+ GSV +L+ I +K T K+ EL+I S +++ G
Sbjct: 8 RLGEGAGGSVTKCRLKN-TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 71 --YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV------QIALDAAKGLE 122
S+ + EY + G+L D + KK R+ +IA KGL
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSL-DSI------YKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE-IAAAASRIVGTFGYL 181
Y+H +HRD+K SNILL + K+ DFG+ S E + + A GT Y+
Sbjct: 120 YLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGV------SGELVNSLAGTFTGTSFYM 170
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMEL 207
APE ++ + SDV++ G+ L+E+
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-17
Identities = 57/209 (27%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 9 DATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQM---KNTKSKEFSSELKILCKV-H 62
D S +KIG+GS G V + K G+ A+K M K + + +E+ I+ H
Sbjct: 18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 77
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLE 122
N++E+ G+ L+++ E+ Q GAL+D + + L + + L
Sbjct: 78 QNVVEMYKSYLVGEELWVLMEFLQGGALTD------IVSQTRLNEEQIATVCESVLQALC 131
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
Y+H +HRD+K+ +ILL + R K++DFG + S ++ S +VGT ++A
Sbjct: 132 YLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKS-LVGTPYWMA 185
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
PE + T+ D+++ G++++E++ G+
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 20 IGQGSYGSVYLGKLRGKNA-AIKQMKNTKSKE----FSSELKILCKV-HSNLIELIGYAA 73
+G+G++G V+ G L+ K A+K K +E F SE +IL + H N+++LIG
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
+++V E G L K K L V+ ALDAA G+ Y+ +
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR----KKKDELKTKQLVKFALDAAAGMAYLESKN---CI 115
Query: 134 HRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTT 193
HRD+ N L+ N KI+DFG+ + + ++ +I + APE + G ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSS 173
Query: 194 KSDVYAFGVVLMEL----------ITGQQA 213
+SDV+++G++L E +T QQA
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQA 203
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-17
Identities = 58/209 (27%), Positives = 109/209 (52%), Gaps = 18/209 (8%)
Query: 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQM---KNTKSKEFSSELKILCKV-H 62
D + +KIG+GS G V + ++ GK A+K+M K + + +E+ I+ H
Sbjct: 17 DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLE 122
N++E+ GD L++V E+ + GAL+D + + ++ A + L K L
Sbjct: 77 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLKALS 130
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
+H +HRD+K+ +ILL + R K++DFG + S E+ S +VGT ++A
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKS-LVGTPYWMA 184
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
PE + + D+++ G++++E++ G+
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 7e-17
Identities = 59/211 (27%), Positives = 108/211 (51%), Gaps = 18/211 (8%)
Query: 7 VRDATSNFSTSLKIGQGSYGSVY--LGKLRGKNAAIKQM---KNTKSKEFSSELKILCK- 60
V D ++ KIGQG+ G+VY + G+ AI+QM + K + +E+ ++ +
Sbjct: 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN 74
Query: 61 VHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
+ N++ + GD L++V EY G+L+D + + + A + + +
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQA 128
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
LE++H +HRD+K+ NILL + K+ DFG + +PE + S +VGT +
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPE-QSKRSTMVGTPYW 182
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
+APE V K D+++ G++ +E+I G+
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-17
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 8 RDATSNFSTSLKIGQGSYGSVYLGK--LRGKNAAIKQMKNTKSKEFS---SELKIL--CK 60
R+ ++ ++G G+YG VY + G+ AA+K +K +FS E+ ++ CK
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK 64
Query: 61 VHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
H N++ G + L++ EY G+L D H V G PL+ + + +G
Sbjct: 65 -HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH---VTG--PLSELQIAYVCRETLQG 118
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
L Y+H K +HRD+K +NILL N K+ADFG+ + + IA S +GT +
Sbjct: 119 LAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKI--TATIAKRKS-FIGTPYW 172
Query: 181 LAPEYV---RDGCVTTKSDVYAFGVVLMEL 207
+APE ++G D++A G+ +EL
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-17
Identities = 63/208 (30%), Positives = 109/208 (52%), Gaps = 25/208 (12%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQMK-NTKSKEFSS---ELKILCKVH----SNLIELI 69
IG+G+YG+VY GK G+ A+K + +T + S E+ +L ++ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTR-VQIALDAAKGLEYIHQYT 128
G G L+++ EYA+ G++ L +K ++ R V +AL +YIH
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVAL------KYIH--- 118
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
K +HRD+K +NIL+ + K+ DFG+ LL + ++ S VGT ++APE + +
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN---SSKRSTFVGTPYWMAPEVITE 175
Query: 189 G-CVTTKSDVYAFGVVLMELITGQQALS 215
G TK+D+++ G+ + E+ TG S
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYS 203
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-16
Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 18/211 (8%)
Query: 7 VRDATSNFSTSLKIGQGSYGSVY--LGKLRGKNAAIKQM---KNTKSKEFSSELKILCK- 60
V D ++ KIGQG+ G+VY + G+ AIKQM + K + +E+ ++ +
Sbjct: 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN 73
Query: 61 VHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
+ N++ + GD L++V EY G+L+D + + + A + + +
Sbjct: 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQA 127
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
L+++H +HRD+K+ NILL + K+ DFG + +PE + S +VGT +
Sbjct: 128 LDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPE-QSKRSTMVGTPYW 181
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
+APE V K D+++ G++ +E++ G+
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-16
Identities = 55/195 (28%), Positives = 103/195 (52%), Gaps = 13/195 (6%)
Query: 19 KIGQGSYGSVYLGKLRGK-NAAIKQMKNTKSKE--FSSELKILCKV-HSNLIELIGYAAG 74
++G G +G V+LGK R + AIK + E F E K++ K+ H L++L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
L++V E+ +NG L ++L +GK L+ + + D +G+EY+ + + ++H
Sbjct: 71 QKPLYIVTEFMENGCLLNYLR--QRQGK--LSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTK 194
RD+ N L+ S K++DFG+ + + +++ ++ + PE ++K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF--PVKWSPPEVFNFSKYSSK 181
Query: 195 SDVYAFGVVLMELIT 209
SDV++FGV++ E+ T
Sbjct: 182 SDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-16
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 20 IGQGSYGSVYL--GKLRGKNAAIKQMK-NTKSKEFSSELKIL-CKV-------HSNLIEL 68
+GQG++G VYL G+ A+KQ+ + S E E+ L C++ H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
G ++L + EY G++ D L K L T + +G+EY+H
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL-----KAYGALTETVTRKYTRQILEGVEYLHSN- 123
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
VHRD+K +NIL DS K+ DFG K L+ + GT +++PE +
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 189 GCVTTKSDVYAFGVVLMELIT 209
K+DV++ G ++E++T
Sbjct: 182 EGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-16
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 20 IGQGSYGSVYLGKLRG-------KNAAIKQMKNT----KSKEFSSELKILCKV--HSNLI 66
+G G++G V G A+K +K T + + SELKI+ + H N++
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
L+G G + ++ EY G L + L K + L + + AKG+ ++
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLR---RKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH-SPEIAAAASRIVGTFGYLAPEY 185
+HRD+ N+LL KI DFGL + + + S + +R+ ++APE
Sbjct: 160 KN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPES 214
Query: 186 VRDGCVTTKSDVYAFGVVLMELIT 209
+ + T +SDV+++G++L E+ +
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 34/292 (11%)
Query: 9 DATSNFSTSLKIGQGSYGSVYLG-KLRGKNA-AIK----QMKNTKSKEFSSELKILCKVH 62
D F+ +IG+GS+G VY G R K AIK + + ++ E+ +L +
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 63 SNLI-ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGL 121
S I G G L+++ EY G+ D L PL T I + KGL
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK------PGPLEETYIATILREILKGL 114
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
+Y+H K +HRD+K +N+LL K+ADFG+ L + + VGT ++
Sbjct: 115 DYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT---DTQIKRNTFVGTPFWM 168
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMELITGQQALSR-----------DANPGNNQYTEHRS 230
APE ++ K+D+++ G+ +EL G+ S +P + +
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKP 228
Query: 231 LVDYMLAVFNDTKDFMAKLTECLDPN-LTRYHKDSMLQMALLSKDCVDENWK 281
+++ A N F E L +TRY K + L+ + + WK
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDR---YKRWK 277
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-16
Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQM---KNTKSKEFSSELKILCKV-HSNLIELIGYA 72
KIGQG+ G+VY G+ AIKQM + K + +E+ ++ + H N++ +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
GD L++V EY G+L+D V + + + + + LE++H
Sbjct: 86 LVGDELWVVMEYLAGGSLTD------VVTETCMDEGQIAAVCRECLQALEFLHSN---QV 136
Query: 133 VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVT 192
+HRD+K+ NILL + K+ DFG + +PE + S +VGT ++APE V
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPE-QSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 193 TKSDVYAFGVVLMELITGQ 211
K D+++ G++ +E++ G+
Sbjct: 194 PKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 9 DATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIK----QMKNTKSKEFSSELKILCKVH 62
D F+ KIG+GS+G V+ G K AIK + + ++ E+ +L +
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 63 SNLI-ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGL 121
S + + G L+++ EY G+ D L PL T I + KGL
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE------PGPLDETQIATILREILKGL 114
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
+Y+H K +HRD+K +N+LL + K+ADFG+ L + + VGT ++
Sbjct: 115 DYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNTFVGTPFWM 168
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
APE ++ +K+D+++ G+ +EL G+
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 29/215 (13%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQM--KNTKSKEFSS---ELKILCKV-HSNLIELIGY 71
+G+GSYG V L + R GK IK++ +N +E + E ++L ++ H N++
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 72 AAGGDS-LFLVYEYAQNGALSDHLHWPSVKGK-----KPLAWTTRVQIALDAAKGLEYIH 125
G D L++V + + G L L KGK + + W VQIA+ L+Y+H
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLK--EQKGKLLPENQVVEWF--VQIAM----ALQYLH 119
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
+ + +HRD+KT N+ L K+ D G+ ++LE+ ++ AS ++GT Y++PE
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM---ASTLIGTPYYMSPEL 173
Query: 186 VRDGCVTTKSDVYAFGVVLMELITGQQAL-SRDAN 219
+ KSDV+A G + E+ T + A ++D N
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 27/231 (11%)
Query: 7 VRDATSNFSTSLKIGQGSYGSVYLGK--LRGKNAAIKQMKNT--KSKEFSSELKILCKV- 61
+RD F +G G+YG VY G+ G+ AAIK M T + +E E+ +L K
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 62 -HSNLIELIGY------AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA 114
H N+ G D L+LV E+ G+++D + + KG L I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNT-LKEEWIAYIC 117
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI 174
+ +GL ++HQ+ +HRD+K N+LL N K+ DFG+ L+ + +
Sbjct: 118 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT---VGRRNTF 171
Query: 175 VGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANP 220
+GT ++APE + D KSD+++ G+ +E+ G L D +P
Sbjct: 172 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC-DMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 11 TSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIK-----QMKNTKSKEFS-SELKILCKV- 61
NF KIG+G + VY L G+ A+K +M + K+++ E+ +L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 62 HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPL----AWTTRVQIALDA 117
H N+I+ + + L +V E A G LS + K K+ + W VQ+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLS-RMIKHFKKQKRLIPERTIWKYFVQLC--- 116
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
LE++H +HRD+K +N+ + + K+ D GL + S + AA S +VGT
Sbjct: 117 -SALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHS-LVGT 169
Query: 178 FGYLAPEYVRDGCVTTKSDVYAFGVVLMEL 207
Y++PE + + KSD+++ G +L E+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 31/204 (15%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE----FSSELKIL--CKVHSNLIELIGY 71
+G G++G VY + + G AA K + +S+E F E+ IL CK H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAK-IIQIESEEELEDFMVEIDILSECK-HPNIVGLYEA 70
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL---DAAKGLEYIHQYT 128
+ L+++ E+ GAL + ++ ++ L T QI + L ++H +
Sbjct: 71 YFYENKLWILIEFCDGGALDSIM----LELERGL---TEPQIRYVCRQMLEALNFLHSH- 122
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV-- 186
+HRD+K NILL + K+ADFG+ + + + +GT ++APE V
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ---KRDTFIGTPYWMAPEVVAC 177
Query: 187 ---RDGCVTTKSDVYAFGVVLMEL 207
+D K+D+++ G+ L+EL
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 70/290 (24%), Positives = 132/290 (45%), Gaps = 41/290 (14%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMK--NTKSKEFSSELKILCKVHSNLIELIGYAAGG 75
I +G G+ Y GK G +K++ N+ +++ L H N+++LIG
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKL--QHPNIVKLIGLCRSE 755
Query: 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHR 135
+L++EY + LS+ L + L+W R +IA+ AK L ++H P V
Sbjct: 756 KGAYLIHEYIEGKNLSEVL--------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 136 DVKTSNILLDSNFRAKIADFGLVKLL--EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTT 193
++ I++D + L LL + I++A Y+APE +T
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA---------YVAPETRETKDITE 857
Query: 194 KSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECL 253
KSD+Y FG++L+EL+TG+ +P + ++ H S+V++ ++D L +
Sbjct: 858 KSDIYGFGLILIELLTGK-------SPADAEFGVHGSIVEWARYCYSD-----CHLDMWI 905
Query: 254 DPNLTRY---HKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300
DP++ +++ ++++ L+ C + RP ++ L SS
Sbjct: 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-16
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 20 IGQGSYGSVYLGKL------RGKNAAIKQMKNTKSKEFSS----ELKILCKV-HSNLIEL 68
+G+G +G V L G+ A+K +K ++ +S E+ IL + H N+++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 69 IGYAA--GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
G + GG L L+ EY G+L D+L K L + A +G+ Y+H
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
+Y+HRD+ N+LLD++ KI DFGL K + E + A E +
Sbjct: 126 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 187 RDGCVTTKSDVYAFGVVLMELIT 209
++ + SDV++FGV L EL+T
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 32/217 (14%)
Query: 20 IGQGSYGSVYLGKLRGKN---------AAIKQMKNTKSKEFSSEL-------KILCKVHS 63
+G+G +G V + + G + A+K +K+ +++ S+L K++ K H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK-HK 84
Query: 64 NLIELIGYAAGGDSLFLVYEYAQNGALSDHL-----------HWPSVKGKKPLAWTTRVQ 112
N+I L+G L+++ EYA G L ++L + P+ ++ L++ V
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
A A+G+EY+ +HRD+ N+L+ + KIADFGL + + H +
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 173 RIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
+ ++APE + D T +SDV++FGV+L E+ T
Sbjct: 202 GRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-16
Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIKQMK-------NTKSKEFS------SELKILCKV-HS 63
IG+G+YG VYL G+ A+KQ++ S++ SE++ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 64 NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEY 123
N+++ +G+ + L + EY G++ L + ++ L Q+ +GL Y
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVL----EGLAY 123
Query: 124 IHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAA--AASRIVGTFGYL 181
+H +HRD+K N+L+D++ KI+DFG+ K S +I + G+ ++
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMSMQGSVFWM 177
Query: 182 APEYV---RDGCVTTKSDVYAFGVVLMELITGQQALSRD 217
APE + G + K D+++ G V++E+ G++ S +
Sbjct: 178 APEVIHSYSQG-YSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-16
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 19 KIGQGSYGSVYLGKLRGK-----NAAIKQMKN----TKSKEFSSELKILCKV-HSNLIEL 68
IG+G +G VY G A+K KN + ++F E I+ + H ++++L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
IG + +++V E A G L +L K L + + + + L Y+
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQ----VNKYSLDLASLILYSYQLSTALAYLESKR 127
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
+VHRD+ N+L+ S K+ DFGL + LE A+ ++ ++APE +
Sbjct: 128 ---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINF 182
Query: 189 GCVTTKSDVYAFGVVLMELI 208
T+ SDV+ FGV + E++
Sbjct: 183 RRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-16
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 20 IGQGSYGSVYLGKLRGKN---------AAIKQMK-NTKSKEFS---SELKILCKV--HSN 64
+G+G +G V + + G + A+K +K + K+ S SE++++ + H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKG-----------KKPLAWTTRVQI 113
+I L+G L+++ EYA G L ++L G + + + V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 114 ALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR 173
A+G+EY+ +HRD+ N+L+ N KIADFGL + + ++ + +
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKKTTN 198
Query: 174 IVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
++APE + D T +SDV++FGV++ E+ T
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 7e-16
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSS-----ELKILCKV-HSNLIELI-- 69
IG G+YG V K G+ AIK++ N + E+K+L + H N+I L+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 70 ---GYAAGGDSLFLVYEYAQNGALSDHLHWPSV-KGKKPLAWTTRVQ-IALDAAKGLEYI 124
+ +++V E + +D LH V K +PL +Q +GL+Y+
Sbjct: 68 LRPPSPEDFNDVYIVTELME----TD-LH--KVIKSPQPLT-DDHIQYFLYQILRGLKYL 119
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
H +HRD+K SNIL++SN KI DFGL + ++ + + V T Y APE
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 185 YVRDGCVTTKS-DVYAFGVVLMELITG 210
+ TK+ D+++ G + EL+T
Sbjct: 177 LLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 8e-16
Identities = 71/246 (28%), Positives = 110/246 (44%), Gaps = 30/246 (12%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMK------NTKSKEFSSELKILCKVHSN--LIELI 69
+G+GS+G V L +L+GK A+K +K + + E ++L N L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
+ LF V E+ G L H+ KG+ L T A + GL+++H
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQ---DKGRFDLYRATFY--AAEIVCGLQFLHS--- 114
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
++RD+K N++LD + KIADFG+ K + AS GT Y+APE ++
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 190 CVTTKSDVYAFGVVLMELITGQQALSRDAN----PGNNQYTEHRSLVDYMLAVFNDTKDF 245
T D ++FGV+L E++ GQ D T H Y + ++KD
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPH-----YPRWITKESKDI 226
Query: 246 MAKLTE 251
+ KL E
Sbjct: 227 LEKLFE 232
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 9e-16
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 33/226 (14%)
Query: 10 ATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKE-FS----SELKILCKV- 61
++ K+G+G++G VY G+ A+K++ K+ F E+KIL K+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 62 HSNLIELIG--YAAGGD------SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQI 113
H N++ LI S+++V Y + LS L PSVK + +Q+
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPY-MDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 114 ALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP-------- 165
L+ G+ Y+H+ + +HRD+K +NIL+D+ KIADFGL + + P
Sbjct: 125 -LE---GINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 166 EIAAAASRIVGTFGYLAPEYVRDGC-VTTKSDVYAFGVVLMELITG 210
+ +V T Y PE + TT D++ G V E+ T
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 20 IGQGSYGSVYLGKLRGKNAAI--KQ--MKNTKSKEFS---SELKILCKV-HSNLIELIGY 71
+G+G++G L + ++ + K+ + KE +E+ IL + H N+I +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPY 131
++L + EYA G L D + + + + + YIH+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--- 121
Query: 132 YVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV 191
+HRD+KT NI L K+ DFG+ K+L E + A + +VGT Y++PE +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAET-VVGTPYYMSPELCQGVKY 178
Query: 192 TTKSDVYAFGVVLMELIT 209
KSD++A G VL EL+T
Sbjct: 179 NFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKE---FSS--ELKILCKV-HSNLIEL-- 68
+I +G+YG VY K G+ A+K++K K KE +S E+ IL K+ H N++ +
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 69 IGYAAGGDSLFLVYEYAQN---GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
+ + D +++V EY ++ + K+P + + L G+ ++H
Sbjct: 72 VVVGSNLDKIYMVMEYVEHDLKSLMETM--------KQPFLQSEVKCLMLQLLSGVAHLH 123
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
+ +HRD+KTSN+LL++ KI DFGL + + +++V T Y APE
Sbjct: 124 DN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK---PYTQLVVTLWYRAPEL 177
Query: 186 VRD-GCVTTKSDVYAFGVVLMELITGQQ 212
+ +T D+++ G + EL+T +
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 7 VRDATSNFSTSLKIGQGSYGSVYLGK--LRGKNAAIKQMKNTKSKE--FSSELKILCKV- 61
+RD F +G G+YG VY G+ G+ AAIK M T+ +E E+ +L K
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS 70
Query: 62 -HSNLIELIGY------AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA 114
H N+ G D L+LV E+ G+++D + + KG L I
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVK--NTKGNA-LKEDWIAYIC 127
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI 174
+ +GL ++H + +HRD+K N+LL N K+ DFG+ L+ + +
Sbjct: 128 REILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT---VGRRNTF 181
Query: 175 VGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANP 220
+GT ++APE + D +SD+++ G+ +E+ G L D +P
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC-DMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 19 KIGQGSYGSVYLGKLRGKNA----AIKQMKNTKS-----KEFSSELKILCKV-HSNLIEL 68
KIG+GSYG V+ K R + AIK+ ++ K E+++L ++ H NL+ L
Sbjct: 8 KIGEGSYGVVF--KCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 69 IGYAAGGDSLFLVYEYAQNGALSD---HLH-WPSVKGKKPLAWTTRVQIALDAAKGLEYI 124
I L LV+EY + L++ + P KK + W T + + +
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK-IIWQT--------LQAVNFC 116
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
H++ +HRDVK NIL+ + K+ DFG ++L + V T Y APE
Sbjct: 117 HKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG---DDYTDYVATRWYRAPE 170
Query: 185 Y-VRDGCVTTKSDVYAFGVVLMELITGQ 211
V D DV+A G V EL+TGQ
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 53/214 (24%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 19 KIGQGSYGSVYLGKL------RGKNAAIKQMKNTKSK----EFSSELKILCKVH-SNLIE 67
++G+ ++G +Y G L + AIK +K+ + EF E ++ ++H N++
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKG------------KKPLAWTTRVQIAL 115
L+G + +++EY G L + L S K L + IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIV 175
A G+EY+ + ++VH+D+ NIL+ KI+D GL + + +S + + +
Sbjct: 132 QIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREI-YSADYYRVQPKSL 187
Query: 176 GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
++ PE + G ++ SD+++FGVVL E+ +
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-15
Identities = 70/245 (28%), Positives = 113/245 (46%), Gaps = 35/245 (14%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFS------SELKILCKVHSNLIELIGY 71
+G+G +G V ++R GK A K+++ + K+ +E +IL KV+S + + Y
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHW---PSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
A D+L LV G L H++ P + ++ L + A + GLE +H+
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY------AAEILCGLEDLHRE 121
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGL-VKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
V+RD+K NILLD +I+D GL VK+ PE + R VGT GY+APE +
Sbjct: 122 N---TVYRDLKPENILLDDYGHIRISDLGLAVKI----PEGESIRGR-VGTVGYMAPEVL 173
Query: 187 RDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246
+ T D + G ++ E+I GQ + + R V + +
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR--------VLETEEVYS 225
Query: 247 AKLTE 251
AK +E
Sbjct: 226 AKFSE 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-15
Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 19 KIGQGSYGSVYLGK----LRGK---NAAIKQMKNTKSK----EFSSELKILCKVHS--NL 65
++GQGS+G VY G ++G+ A+K + + S EF +E ++ K + ++
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM-KGFTCHHV 71
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLHW--PSVK---GKKPLAWTTRVQIALDAAKG 120
+ L+G + G +V E +G L +L P + G+ P +Q+A + A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
+ Y++ +VHRD+ N ++ +F KI DFG+ + + + ++ +
Sbjct: 132 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRW 187
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
+APE ++DG TT SD+++FGVVL E+ +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-15
Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 13 NFSTSLKIGQGSYGSVYL-----GKLRGKNAAIKQMKNT------KSKEFS-SELKILCK 60
NF +G G+YG V+L G GK A+K +K K+ E + +E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 61 VHSN--LIELIGYAAGGDS-LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDA 117
V L+ L YA D+ L L+ +Y G L HL + + RV IA +
Sbjct: 61 VRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHL---YQREHFTES-EVRVYIA-EI 114
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
L+++HQ ++RD+K NILLDS + DFGL K E A GT
Sbjct: 115 VLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF--LAEEEERAYSFCGT 169
Query: 178 FGYLAPEYVRDGCVTTKS--DVYAFGVVLMELITG 210
Y+APE +R G D ++ GV+ EL+TG
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 20 IGQGSYGSVYLGKLRG---------KNAAIKQMKNTKS-KEFS---SELKILCKV--HSN 64
+G+G +G V + + G A+K +K+ + K+ S SE++++ + H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKG-----------KKPLAWTTRVQI 113
+I L+G L+++ EYA G L ++L G ++ L + V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 114 ALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR 173
A A+G+EY+ +HRD+ N+L+ + KIADFGL + + H+ + +
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTTN 195
Query: 174 IVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
++APE + D T +SDV++FGV+L E+ T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-15
Identities = 66/258 (25%), Positives = 107/258 (41%), Gaps = 47/258 (18%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS------ELKILCKVHSNLIELIGY 71
+G+G +G V ++R GK A K++ + K+ E +IL KVHS I + Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 72 A--------------AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDA 117
A GGD + +Y + P + +T ++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN--------PGFPEPRACFYTAQI------ 106
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL-VKLLEHSPEIAAAASRIVG 176
GLE++HQ ++RD+K N+LLD++ +I+D GL V+L + + A G
Sbjct: 107 ISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA----G 159
Query: 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL---VD 233
T G++APE ++ D +A GV L E+I + N+ + R L V
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT 219
Query: 234 YMLAVFNDTKDFMAKLTE 251
Y +K F L
Sbjct: 220 YPDKFSPASKSFCEALLA 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 66/241 (27%), Positives = 107/241 (44%), Gaps = 27/241 (11%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFS------SELKILCKVHSNLIELIGY 71
+G+G +G V ++R GK A K+++ + K+ +E +IL KV+S + + Y
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
A D+L LV G L H++ G + A + GLE + +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIY---NMGNPGFDEQRAIFYAAELCCGLEDLQ---RE 121
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
V+RD+K NILLD +I+D GL + PE R VGT GY+APE + +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQI---PEGETVRGR-VGTVGYMAPEVINNEK 177
Query: 191 VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLT 250
T D + G ++ E+I GQ + + + R V D +++ K +
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR--------VKEDQEEYSEKFS 229
Query: 251 E 251
E
Sbjct: 230 E 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 41/284 (14%)
Query: 9 DATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKE-------FSSELKILCKV 61
D F+ +IG+GS+G V+ G + + + +K +E E+ +L +
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 62 HSNLI-ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
S + + G G L+++ EY G+ D L P + + KG
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR------AGPFDEFQIATMLKEILKG 113
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
L+Y+H K +HRD+K +N+LL K+ADFG+ L + + VGT +
Sbjct: 114 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT---DTQIKRNTFVGTPFW 167
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240
+APE ++ +K+D+++ G+ +EL G+ P N+ R L +++ N
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGE--------PPNSDMHPMRVL--FLIPKNN 217
Query: 241 D-------TKDFMAKLTECL--DPNLTRYHKDSMLQMALLSKDC 275
+K F + CL DP+ K+ +L+ + K+
Sbjct: 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKE-LLKHKFIVKNA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 6e-15
Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMK--------NTKSKEFSSELKILCKVHSNLIELI 69
+G+GS+G V+L +L+G N AIK +K + + + L H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
++LF V EY G L H+ K P A +I GL+++H
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQ-SCHKFDLPRATFYAAEIIC----GLQFLHSKG- 116
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
V+RD+K NILLD++ KIADFG+ K + A GT Y+APE +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLGQ 171
Query: 190 CVTTKSDVYAFGVVLMELITGQ 211
T D ++FGV+L E++ GQ
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 6e-15
Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 32/217 (14%)
Query: 20 IGQGSYGSVYLGKLRGKN---------AAIKQMK-NTKSKEFS---SELKILCKV---HS 63
+G+G +G V + G + A+K +K N K+ + SE++++ K+ H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM-KLIGKHK 78
Query: 64 NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKG-----------KKPLAWTTRVQ 112
N+I L+G L+++ EYA G L + L G ++ L++ V
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
A A+G+EY+ +HRD+ N+L+ + KIADFGL + + H + S
Sbjct: 139 CAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGV-HDIDYYKKTS 194
Query: 173 RIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
++APE + D T +SDV++FG+++ E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 7e-15
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 33/208 (15%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQM----KNTKSKEFSSELKILCKV-HSNLIELIGY 71
+IG G+ G+VY R G+ A+K + ++T ++ E++IL V H N+++
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPY 131
+ ++ E+ G+L ++ LA R QI G+ Y+H + +
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIA----DEQFLADVAR-QIL----SGIAYLH---RRH 188
Query: 132 YVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR---- 187
VHRD+K SN+L++S KIADFG+ ++L + + ++ VGT Y++PE +
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLN 245
Query: 188 ----DGCVTTKSDVYAFGVVLMELITGQ 211
DG D+++ GV ++E G+
Sbjct: 246 HGAYDGYA---GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 7e-15
Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQMK---NTKS------KEFSSELKILCKV-HSNLIE 67
+G G++ S Y + G A+KQ+ NT S + E++++ ++ H ++I
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 68 LIGYAAGGDSLFLVY-EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
++G A DS F ++ E+ G++S L + +GL Y+H+
Sbjct: 68 MLG-ATCEDSHFNLFVEWMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 127 YTKPYYVHRDVKTSNILLDSN-FRAKIADFGLVKLLEHSPEIAAAA---SRIVGTFGYLA 182
+HRDVK +N+L+DS R +IADFG L + + A +++GT ++A
Sbjct: 122 NQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL--AAKGTGAGEFQGQLLGTIAFMA 176
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
PE +R DV++ G V++E+ T +
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-15
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 20 IGQGSYGSVYLGKLRGKNA-----AIKQMK-----NTKSKEFSSELKILCKV-HSNLIEL 68
+G+G +GSV G+L + A+K MK ++ +EF SE + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 69 IGYAAGGDSL------FLVYEYAQNGALSDHLHWPSVKGK-KPLAWTTRVQIALDAAKGL 121
IG SL ++ + ++G L L + + G + L T ++ +D A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
EY+ + ++HRD+ N +L + +ADFGL K + +S + ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI-YSGDYYRQGRIAKMPVKWI 182
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMELIT-GQ 211
A E + D T+KSDV+AFGV + E+ T GQ
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-15
Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 29/226 (12%)
Query: 1 MFSYNEVRDATS---NFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK------SKEF 51
N+++ S + TS+ I + S+Y G K I+ K
Sbjct: 6 RSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDIT 65
Query: 52 SSELKILCKVHS-NLIELIGY----AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLA 106
+E+K L ++ S N++++ G+ L L+ EY G L + L +K L+
Sbjct: 66 ENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-----DKEKDLS 120
Query: 107 WTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166
+ T++ +A+D KGL +++YT Y + + + + L+ N++ KI GL K+L P
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKPYKN--LTSVSFLVTENYKLKIICHGLEKILSSPP- 177
Query: 167 IAAAASRIVGTFGYLAPEYVRD--GCVTTKSDVYAFGVVLMELITG 210
+ V Y + + + D T K D+Y+ GVVL E+ TG
Sbjct: 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 8e-15
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 43/218 (19%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKVHS 63
+F ++GQG YG V+L K + G+ A+K+MK + + + +E IL S
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 64 NLIELIGYA-AGGDSLFLVYEY----------AQNGALSDHLHWPSVKGKKPLAWTTRVQ 112
+ + YA + L+L EY G LS+ R
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED--------------HARFY 106
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
+ A+ E + + Y+HRD+K N L+D++ K+ DFGL S I A+
Sbjct: 107 M----AEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGL------SKGIVTYAN 156
Query: 173 RIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
+VG+ Y+APE +R D ++ G +L E + G
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 8e-15
Identities = 62/237 (26%), Positives = 98/237 (41%), Gaps = 46/237 (19%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSS-----------------ELKILCK 60
+G+G+YG V L GK AIK++K + + ELKI+ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 61 V-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
+ H N++ L+ GD + LV + L V K L + I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDI-MASDLKK-----VVDRKIRLTESQVKCILLQILN 130
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI----- 174
GL +H++ Y++HRD+ +NI ++S KIADFGL + + P +
Sbjct: 131 GLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 175 ------VGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQ 224
V T Y APE + D+++ G + EL+TG+ PG N+
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF-----PGENE 239
|
Length = 335 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 16/161 (9%)
Query: 62 HSNLIELIGYA-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
H N++ L+ A LF V+EY L + L L ++ L
Sbjct: 37 HPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL-----AADGALPAGETGRLMLQVLDA 91
Query: 121 LEYIHQYTKPYYVHRDVKTSNILL---DSNFRAKIADFGLVKLLEHSPEIAAA----ASR 173
L H VHRD+K NI++ AK+ DFG+ LL + A +
Sbjct: 92 LACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTE 148
Query: 174 IVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQAL 214
++GT Y APE +R VT SD+YA+G++ +E +TGQ+ +
Sbjct: 149 VLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQ------MKNTKSKEFSSELKILCKVHSNLIELIGY 71
IG+G++G V L + + A+K +K + S F E I+ +S I + Y
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 72 AAGGDS-LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
A D L++V EY G L + + + K +T V +ALDA IH
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDA------IHSMG-- 162
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR--- 187
++HRDVK N+LLD + K+ADFG ++ + + VGT Y++PE ++
Sbjct: 163 -FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV--RCDTAVGTPDYISPEVLKSQG 219
Query: 188 -DGCVTTKSDVYAFGVVLMELITG 210
DG + D ++ GV L E++ G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 68/235 (28%), Positives = 113/235 (48%), Gaps = 33/235 (14%)
Query: 20 IGQGSYGSVYLGKLRGKNA----AIKQMK-----NTKSKEFSSELKILCKV-HSNLIELI 69
+G+G +GSV G+L ++ A+K MK ++ ++F SE + + H N++ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 70 GY------AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTR--VQIALDAAKGL 121
G + G S ++ + ++G L L + S G P T+ V+ D A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLY-SRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT-FGY 180
EY+ + ++HRD+ N +L+ N +ADFGL K + + RI +
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG--RIAKMPVKW 180
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235
+A E + D TTKSDV++FGV + E+ T Q PG E+ + DY+
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQT----PYPG----VENSEIYDYL 227
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-14
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 26/202 (12%)
Query: 20 IGQGSYGSVYL--GKLRGKNAAIKQMKNTKS----KEFSSELKILCKV-HSNLIELIGYA 72
+G+GS+G L + A+K+++ KS ++ E +L K+ H N++
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGK-----KPLAWTTRVQIALDAAKGLEYIHQY 127
L++V EY G L + +GK L W VQ+ L G+++IH
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIK--LQRGKLFPEDTILQWF--VQMCL----GVQHIH-- 117
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
+ +HRD+K+ NI L N + K+ DFG +LL A A VGT Y+ PE
Sbjct: 118 -EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYVGTPYYVPPEIWE 173
Query: 188 DGCVTTKSDVYAFGVVLMELIT 209
+ KSD+++ G +L EL T
Sbjct: 174 NMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 27/230 (11%)
Query: 5 NEVRD---ATSNFSTSLKIGQGSYGSVYL--GKLRGKNAAIK------QMKNTKSKEFSS 53
N++RD ++ IG+G++G V L K K A+K +K + S F
Sbjct: 33 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 54 ELKILCKVHSNLIELIGYAAGGDS-LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQ 112
E I+ +S + + YA D L++V EY G L + + V K +T V
Sbjct: 93 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV 152
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
+ALDA + +IH RDVK N+LLD + K+ADFG ++ + E
Sbjct: 153 LALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFG--TCMKMNKEGMVRCD 201
Query: 173 RIVGTFGYLAPEYVR----DGCVTTKSDVYAFGVVLMELITGQQALSRDA 218
VGT Y++PE ++ DG + D ++ GV L E++ G D+
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 20 IGQGSYGSVYLGK-LRGK-NAAIKQMKNTKSKE---FSSELKI---LCKVHSNLIELIGY 71
+G+G+YG VY + L + AIK++ S+ E+ + L H N+++ +G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK--HRNIVQYLGS 73
Query: 72 AAGGDSLFLVYEYAQNGALSDHLH--WPSVKGKKP-LAWTTRVQIALDAAKGLEYIHQYT 128
+ + E G+LS L W +K + + + T+ QI +GL+Y+H
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QIL----EGLKYLHDNQ 128
Query: 129 KPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
VHRD+K N+L+++ + KI+DFG K L I GT Y+APE +
Sbjct: 129 ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL---AGINPCTETFTGTLQYMAPEVID 182
Query: 188 DGC--VTTKSDVYAFGVVLMELITGQ 211
G +D+++ G ++E+ TG+
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 74/236 (31%), Positives = 109/236 (46%), Gaps = 28/236 (11%)
Query: 13 NFSTSLKIGQGSYGSVYL-----GKLRGKNAAIKQMKNT------KSKEFS-SELKILCK 60
NF +G G+YG V+L G GK A+K +K K+ E + +E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 61 V-HSNLIELIGYAAGGDS-LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL-DA 117
+ S + + YA D+ L L+ +Y G L HL ++ VQI +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL------SQRERFKEQEVQIYSGEI 114
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
LE++H K ++RD+K NILLDSN + DFGL K H E+ A S GT
Sbjct: 115 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYS-FCGT 169
Query: 178 FGYLAPEYVR--DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL 231
Y+AP+ VR DG D ++ GV++ EL+TG + D + R L
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 67/215 (31%), Positives = 91/215 (42%), Gaps = 30/215 (13%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIKQM------KNTKSKEFSSELKILCK--VHSNLIELI 69
IG+GS+G V L K GK A+K + K + K +E +L K H L+ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHL----HWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
D L+ V +Y G L HL +P + + A + A L Y+H
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF---------YAAEIASALGYLH 113
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
++RD+K NILLDS + DFGL K E + S GT YLAPE
Sbjct: 114 SLN---IIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEV 167
Query: 186 VRDGCVTTKSDVYAFGVVLMELITGQQAL-SRDAN 219
+R D + G VL E++ G SRD
Sbjct: 168 LRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 48/222 (21%)
Query: 19 KIGQGSYGSVYLGKL----RGKNAAIKQMKNTKSKE--FS----------SELKILCKVH 62
IG+G+YG VY K GK AIK+ K K + S ELK H
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-----H 61
Query: 63 SNLIELIG--YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK--------KPLAWTTRVQ 112
N++ L+ S++L+++YA++ L + + + K L W Q
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHD-LWQIIKFHRQAKRVSIPPSMVKSLLW----Q 116
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF----RAKIADFGLVKLLEHSPEIA 168
I L+ G+ Y+H + +HRD+K +NIL+ KI D GL +L +
Sbjct: 117 I-LN---GVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 169 AAASRIVGTFGYLAPEYVRDGCVTTKS-DVYAFGVVLMELIT 209
A +V T Y APE + TK+ D++A G + EL+T
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 26/204 (12%)
Query: 20 IGQGSYGSVYL-GKLRGKNA----AIKQMKNTKSK-----EFSSELKILCKVHSNLIELI 69
+GQGS+G V+L K+ G +A A+K +K K E IL +V+ I +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 70 GYAAGGD-SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTR-VQIAL-DAAKGLEYIHQ 126
YA + L+L+ ++ + G L L K + +T V+ L + A L+++H
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRL-------SKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
++RD+K NILLD K+ DFGL K + A GT Y+APE V
Sbjct: 117 LG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEVV 170
Query: 187 RDGCVTTKSDVYAFGVVLMELITG 210
T +D ++FGV++ E++TG
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS----ELKILCKVHS--NLIELIGY 71
IG G+ G VY + + G A+KQM+ T +KE + +L ++ K H +++ GY
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPY 131
+F+ E D L + + P+ ++ + K L Y+ + K
Sbjct: 83 FITDSDVFICMELM--STCLDKL---LKRIQGPIPEDILGKMTVAIVKALHYLKE--KHG 135
Query: 132 YVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV 191
+HRDVK SNILLD++ K+ DFG+ L S A +R G Y+APE +
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS----KAKTRSAGCAAYMAPERIDPPDP 191
Query: 192 TTK----SDVYAFGVVLMELITGQ 211
K +DV++ G+ L+EL TGQ
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 65/236 (27%), Positives = 112/236 (47%), Gaps = 30/236 (12%)
Query: 4 YNEVRDATSNFSTSLKIGQGSYGSVY--LGKLRGKNAAIKQMK--NTKSKEFSSELKILC 59
++ D + + IG+G+YG V+ L K G AA+K + + +E +E IL
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK 69
Query: 60 KV--HSNLIELIGY-----AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQ 112
+ H N+++ G GD L+LV E G+++D + +G++ +
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-MEEPIIAY 128
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
I +A GL+++H +HRDVK +NILL + K+ DFG+ S ++ +
Sbjct: 129 ILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGV------SAQLTSTRL 179
Query: 173 R---IVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANP 220
R VGT ++APE + D + DV++ G+ +EL G L+ D +P
Sbjct: 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA-DLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 24/204 (11%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMK------NTKSKEFSSELKIL----CKVHSNLIE 67
+G+G +G V L + + AIK +K + + E +I + H L+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L D + V EYA G L H+H + + + V + GL+Y+H+
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL------GLQYLHEN 120
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
V+RD+K N+LLD+ KIADFGL K S GT +LAPE +
Sbjct: 121 K---IVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAPEVLT 174
Query: 188 DGCVTTKSDVYAFGVVLMELITGQ 211
+ T D + GV++ E++ G+
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-14
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSEL------KILCKVHSNLIELIGY 71
+G+G +G V ++R GK A K+++ + K+ E +IL KV+S + + Y
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLH---WPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
A D+L LV G L H++ P ++ + + + GLE +H
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC------GLEDLH-- 119
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
+ V+RD+K NILLD +I+D GL PE R VGT GY+APE V+
Sbjct: 120 -RERIVYRDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGR-VGTVGYMAPEVVK 174
Query: 188 DGCVTTKSDVYAFGVVLMELITGQ 211
+ T D + G ++ E+I G+
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 13 NFSTSLKIGQGSYGSVYLGKLRGKNA--AIKQMKNTKSKEFSSELKILCKVHSNLIELIG 70
NF L G+GS+G V L + +G + AIK +K K + V ++E
Sbjct: 3 NFLMVL--GKGSFGKVMLAERKGTDELYAIKILK--KDVIIQDD-----DVECTMVEKRV 53
Query: 71 YAAGG---------------DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL 115
A G D L+ V EY G L H+ K K+P A V A
Sbjct: 54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHA----VFYAA 108
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIV 175
+ A GL ++H ++RD+K N++LD+ KIADFG+ K E+
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFG-GKTTRTFC 162
Query: 176 GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
GT Y+APE + D +AFGV+L E++ GQ
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-14
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 19 KIGQGSYGSVYLGKLRG----KNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIEL--IG 70
K+G+G+YG VY K + ++ A+KQ++ T S E+ +L ++ H N+I L +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 71 YAAGGDSLFLVYEYAQNGALSD-HLHWPSVKGKKPLAWTTRVQIALDAAKGLEY-----I 124
+ ++L+++YA++ H S KKP VQ+ K L Y I
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP------VQLPRGMVKSLLYQILDGI 121
Query: 125 HQYTKPYYVHRDVKTSNILL----DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
H + +HRD+K +NIL+ R KIAD G +L + A +V TF Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 181 LAPEYVRDGCVTTKS-DVYAFGVVLMELITGQ 211
APE + TK+ D++A G + EL+T +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 33/221 (14%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKS------KEFSSELKILCK-VHSNLIELI 69
IG+G G VYL + + A+K+++ S K F E KI +H ++ +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLH--WPSVKGKKPLAWTTRV----QIALDAAKGLEY 123
+ GD ++ Y + L L W K LA T V I +EY
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 124 IHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS----------- 172
+H +HRD+K NILL I D+G + E
Sbjct: 129 VHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 173 ----RIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
+IVGT Y+APE + + +D+YA GV+L +++T
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 60/266 (22%), Positives = 103/266 (38%), Gaps = 35/266 (13%)
Query: 33 LRGKNAAIKQMKNTKSKEFSSELKILCKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSD 92
LR K +N +++ + K K L ++ S + ++ + +
Sbjct: 103 LRSKRECFSPYRNKSTRKREMKQKEGKKQ-----RLDSVSSSQSSASSGFIEDKSLSDVE 157
Query: 93 HLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKI 152
K+PL + + A+G+E++ +HRD+ NILL N KI
Sbjct: 158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKI 214
Query: 153 ADFGLVKLLEHSPE-IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
DFGL + + P+ + +R+ ++APE + D TT+SDV++FGV+L E+ +
Sbjct: 215 CDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-- 270
Query: 212 QALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALL 271
L PG ++F +L E Y + + L
Sbjct: 271 --LGASPYPG-----------------VQIDEEFCRRLKEGTRMRAPEYATPEIYSIML- 310
Query: 272 SKDCVDENWKRRPDMSNAAIRLSHIL 297
DC N + RP S L +L
Sbjct: 311 --DCWHNNPEDRPTFSELVEILGDLL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 20 IGQGSYGSVYL--GKLRGKNAAIKQMK-NTKSKEFSSELKIL-CKV-------HSNLIEL 68
+GQG++G VYL G+ A KQ++ + +S E S E+ L C++ H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 69 IG--YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
G +L + EY G++ D L K L + + +G+ Y+H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL-----KAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
VHRD+K +NIL DS K+ DFG K L+ + GT +++PE +
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 187 RDGCVTTKSDVYAFGVVLMELIT 209
K+DV++ G ++E++T
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 61/205 (29%), Positives = 88/205 (42%), Gaps = 29/205 (14%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQMKNT------KSKEFSSELKILCK--VHSNLIELI 69
IG+GS+G V L K L GK A+K ++ + K +E +L K H L+ L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLH----WPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
+ L+ V ++ G L HL +P + + A + A L Y+H
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA---------EIASALGYLH 113
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
V+RD+K NILLDS + DFGL K + + GT YLAPE
Sbjct: 114 SIN---IVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEV 167
Query: 186 VRDGCVTTKSDVYAFGVVLMELITG 210
+R D + G VL E++ G
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 19 KIGQGSYGSVYLGKLRGKNA----AIKQ-MKNTKSKEFSS----ELKILCKV-HSNLIEL 68
+G+GSYG V K + K AIK+ +++ K E+++L ++ H NL+ L
Sbjct: 8 LVGEGSYGMVM--KCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
I L+LV+E+ + L D +P+ L + + +G+E+ H +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHN 120
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY-VR 187
+HRD+K NIL+ + K+ DFG + L E+ + V T Y APE V
Sbjct: 121 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV---YTDYVATRWYRAPELLVG 174
Query: 188 DGCVTTKSDVYAFGVVLMELITGQ 211
D D++A G ++ E++TG+
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 63/220 (28%), Positives = 111/220 (50%), Gaps = 28/220 (12%)
Query: 14 FSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMK-----NTKSKEFSSELKILCKV-H 62
F+ +G+G +GSV +L+ + A+K +K ++ +EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 63 SNLIELIGYAAGGDSL------FLVYEYAQNGALSDHLHWPSVKGKKP--LAWTTRVQIA 114
N+I+LIG + + ++ + ++G L L + G++P L T V+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI-GEEPFTLPLQTLVRFM 119
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI--AAAAS 172
+D A G+EY+ + ++HRD+ N +L+ N +ADFGL K + +S + AS
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI-YSGDYYRQGCAS 175
Query: 173 RIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQ 212
++ +LA E + D TT SDV+AFGV + E++T Q
Sbjct: 176 KL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 21/216 (9%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS------ELKILCKVHSNLIELIGY 71
IG+G++G V + + R K A+K M K E S E +IL +++ + + Y
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+ ++++LV + G L HL + K + I + LEY+H
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLS----QKVKFSEEQVKFWIC-EIVLALEYLHSKG-- 120
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
+HRD+K NILLD I DF + + + GT GY+APE +
Sbjct: 121 -IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS----TSGTPGYMAPEVLCRQG 175
Query: 191 VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYT 226
+ D ++ GV E + G++ + +Q
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMK------NTKSKEFSSELKILCKV-HSNLIELIG 70
+G G +G V L K++ KN A+K +K + + SE +IL + H +++L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 71 YAAGGDS--LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
Y D ++++ EY G L L +G +T R IA EY+H
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILR---DRGLFD-EYTARFYIAC-VVLAFEYLHNRG 113
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
++RD+K N+LLDSN K+ DFG K L+ GT Y+APE + +
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS----GQKTWTFCGTPEYVAPEIILN 166
Query: 189 GCVTTKSDVYAFGVVLMELITGQQALSRDA 218
D ++ G++L EL+TG+ D
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 24/199 (12%)
Query: 20 IGQGSYGSVY--LGKLRGKNAAIK----QMKNTKSKEFSSELKILCKVHSN-LIELIGYA 72
+G G+ G+VY L + A+K + K+ SEL+IL K S +I G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
+ + + E+ G+L V K P R+ +A+ KGL Y+
Sbjct: 69 FVENRISICTEFMDGGSLD-------VYRKIPEHVLGRIAVAV--VKGLTYLWSLK---I 116
Query: 133 VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVT 192
+HRDVK SN+L+++ + K+ DFG+ L +S A VGT Y+APE +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-----IAKTYVGTNAYMAPERISGEQYG 171
Query: 193 TKSDVYAFGVVLMELITGQ 211
SDV++ G+ MEL G+
Sbjct: 172 IHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 68/239 (28%), Positives = 109/239 (45%), Gaps = 30/239 (12%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVY--LGKLRGKNAAIKQMKNTKS--KEFSSELK 56
M + D T + IG+G+YG VY K G AA+K + +E +E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYN 70
Query: 57 ILCKV--HSNLIELIG--YAAG---GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTT 109
IL + H N+++ G Y A G L+LV E G++++ + + G++ L
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAM 129
Query: 110 RVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAA 169
I A GL+++H +HRDVK +NILL + K+ DFG+ S ++ +
Sbjct: 130 ISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGV------SAQLTS 180
Query: 170 AASR---IVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANP 220
R VGT ++APE + D + DV++ G+ +EL G L D +P
Sbjct: 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF-DMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-H 62
+ +G G++G V+L + R A+K M + + +E ++L +V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 63 SNLIELIGYAAGGDS--LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
+I L + D L+++ EY G L +L + + +T + A +
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL-----RNSGRFSNSTGLFYASEIVCA 113
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
LEY+H V+RD+K NILLD K+ DFG K ++ + GT Y
Sbjct: 114 LEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEY 164
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANP 220
LAPE ++ D +A G+++ E++ G D NP
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF-FDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 12 SNFSTSLKIGQGSYGSVYL--GKLRGKNAAIKQMK-NTKSKEFSSELKIL-CKV------ 61
+N+ +GQG++G VYL G+ A+KQ++ + +S E S E+ L C++
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 62 -HSNLIELIGYAAGG--DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAA 118
H +++ G +L + E+ G++ D L K L +
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTENVTRKYTRQIL 116
Query: 119 KGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTF 178
+G+ Y+H VHRD+K +NIL DS K+ DFG K L+ + GT
Sbjct: 117 EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173
Query: 179 GYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
+++PE + K+D+++ G ++E++T
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-13
Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 20 IGQGSYGSVYLGKL--RGKN----AAIKQMKNTKSKEFSSE-----LKILCKVHSNLIEL 68
+G G +G+V+ G G + AIK +++ ++ E L + H+ ++ L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHL--HWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
+G G SL LV + + G+L DH+ H S+ ++ L W VQIA KG+ Y+ +
Sbjct: 75 LGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIA----KGMYYLEE 127
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
+ VHR++ NILL S+ +IADFG+ LL + + S ++A E +
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLL-YPDDKKYFYSEHKTPIKWMALESI 183
Query: 187 RDGCVTTKSDVYAFGVVLMELIT 209
G T +SDV+++GV + E+++
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 47/220 (21%)
Query: 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMK-NTKSKEFSS----ELKILCKV-HSN 64
NF KIG+G+YG VY + + G+ A+K+++ +T+++ S E+ +L ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK----- 119
+++L+ + L+LV+E+ L L KK + + I L K
Sbjct: 61 IVKLLDVIHTENKLYLVFEF-----LHQDL-------KKFMDASPLSGIPLPLIKSYLFQ 108
Query: 120 ---GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL-----VKLLEHSPEIAAAA 171
GL + H + +HRD+K N+L+++ K+ADFGL V + ++ E
Sbjct: 109 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE----- 160
Query: 172 SRIVGTFGYLAPEYVRDGC--VTTKSDVYAFGVVLMELIT 209
V T Y APE + GC +T D+++ G + E++T
Sbjct: 161 ---VVTLWYRAPEILL-GCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 26/220 (11%)
Query: 12 SNFSTSLKIGQGSYGSVYLGK--LRGKNAAIK-----QMKNTKSKE-FSSELKILCKV-H 62
+NF KIG+G + VY L K A+K +M + K+++ E+ +L ++ H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPL-----AWTTRVQIALDA 117
N+I+ + + L +V E A G LS + + K +K L W VQ+
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKY--FKKQKRLIPERTVWKYFVQLC--- 116
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
+E++H +HRD+K +N+ + + K+ D GL + S + AA S +VGT
Sbjct: 117 -SAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHS-LVGT 169
Query: 178 FGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRD 217
Y++PE + + KSD+++ G +L E+ Q D
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 19 KIGQGSYGSVYLGKLRG----------KNAAIKQMKNTKSKEFSSELKILCKV-HSNLIE 67
++G+GS+G+VYL K + K + ++ ++ + + E ++L K+ H +++
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
D+ ++ EY + L L GK L+ + + G+ Y+HQ
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT-LSENQVCEWFIQLLLGVHYMHQR 125
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
+HRD+K NI L +N KI DFG+ +LL S ++A + GT Y++PE ++
Sbjct: 126 R---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---TTFTGTPYYMSPEALK 178
Query: 188 DGCVTTKSDVYAFGVVLMEL 207
+KSD+++ G +L E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-13
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 19 KIGQGSYGSVYLGKLRG----KNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIEL--IG 70
K+G+G+YG VY K + K A+KQ++ T S E+ +L ++ H N+I L +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 71 YAAGGDSLFLVYEYAQNGALSD-HLHWPSVKGKKPLAWTTRVQIALDAAKGLEY-----I 124
+ ++L+++YA++ H S KKP+ Q+ K L Y I
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPM------QLPRSMVKSLLYQILDGI 121
Query: 125 HQYTKPYYVHRDVKTSNILL----DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
H + +HRD+K +NIL+ R KIAD G +L + A +V TF Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 181 LAPEYVRDGCVTTKS-DVYAFGVVLMELITGQ 211
APE + TK+ D++A G + EL+T +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-13
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 19 KIGQGSYGSVYLGKL-RGKNAA---IKQMKNTKSKEFSSELKILCKV-------HSNLIE 67
+IG G +G V LG+ RG + A +K+++ + + + +L L +V H N+++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPD--EQLLFLQEVQPYRELNHPNVLQ 59
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQ--IALDAAKGLEYIH 125
+G LV E+ G L ++L S +G V +A + A GL ++H
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLR--SNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE-IAAAASRIVGTFGYLAPE 184
Q ++H D+ N L ++ KI D+GL LE PE +LAPE
Sbjct: 118 QA---DFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLRWLAPE 172
Query: 185 YVRD-------GCVTTKSDVYAFGVVLMELIT 209
V T KS++++ GV + EL T
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-13
Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 44/286 (15%)
Query: 18 LKIGQGSYGSVYLG--KLRGK--NAAIKQMKNTKSK----EFSSELKILCKVHSNLI-EL 68
+++G G++G V G K+R K + AIK +KN K E E +I+ ++ + I +
Sbjct: 1 VELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
IG ++L LV E A G L+ L K + + V++ + G++Y+
Sbjct: 61 IGVCEA-EALMLVMEMASGGPLNKFL----SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
+VHRD+ N+LL + AKI+DFGL K L A S + APE +
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 189 GCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247
+++SDV+++G+ + E + GQ+ + P + E +
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR--------------LD 218
Query: 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293
EC +M L KDC W+ RP+ + R+
Sbjct: 219 CPAECPP------------EMYALMKDCWIYKWEDRPNFAKVEERM 252
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 35/216 (16%)
Query: 13 NFSTSLKIGQGSYGSVYLGKLRGKNA--AIKQMKN-------------TKSKEFSSELK- 56
+F+ + +G+GS+G V L + +G + AIK +K + + + + K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 57 -ILCKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL 115
L ++HS + D L+ V EY G L H+ K K+P A V A
Sbjct: 61 PFLTQLHSCFQTV-------DRLYFVMEYVNGGDLMYHIQQVG-KFKEPQA----VFYAA 108
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIV 175
+ + GL ++H + ++RD+K N++LDS KIADFG+ K EH +
Sbjct: 109 EISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVD-GVTTRTFC 162
Query: 176 GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
GT Y+APE + D +A+GV+L E++ GQ
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-13
Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 20 IGQGSYGSVYLGKL-RGKNAAIKQM------KNTKSKEFS---SELKILCKV-HSNLIEL 68
+G+G+YG+VY G +G+ A+KQ+ KE+ E+ +L + H N+++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
+G +++ + E+ G++S L PL + G+ Y+H
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL-------EHSPEIAAAASRIVGTFGYL 181
VHRD+K +N++L N K+ DFG + L HS + + + GT ++
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS----MHGTPYWM 175
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMELITGQQALS 215
APE + + KSD+++ G + E+ TG+ L+
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLA 209
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 35/216 (16%)
Query: 13 NFSTSLKIGQGSYGSVYLGKLRGKNA--AIKQMKN---------------TKSKEFSSEL 55
+F+ + +G+GS+G V L + +G + AIK +K + S +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 56 KILCKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL 115
L ++HS + D L+ V EY G L + + K+P A V A
Sbjct: 61 PFLTQLHSCFQTM-------DRLYFVMEYVNGGDLMYQIQQVG-RFKEPHA----VFYAA 108
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIV 175
+ A GL ++H ++RD+K N++LDS KIADFG+ K E+ +
Sbjct: 109 EIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWD-GVTTKTFC 162
Query: 176 GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
GT Y+APE + D +AFGV+L E++ GQ
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 8e-13
Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 44/274 (16%)
Query: 19 KIGQGSYGSVY--LGKLRGKNAAIKQMK----NTKSKEFSSELKILCKVHS-NLIELIGY 71
++G+G+YGSVY L + G A+K+++ +K + EL IL K S +++ G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYI---HQYT 128
++++ EY G+L P R I KGL+++ H
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEEHNI- 124
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
+HRDVK +N+L++ N + K+ DFG+ L A+ A +G Y+APE ++
Sbjct: 125 ----IHRDVKPTNVLVNGNGQVKLCDFGVSGNLV-----ASLAKTNIGCQSYMAPERIKS 175
Query: 189 G------CVTTKSDVYAFGVVLMELITGQQALSRDANP---GNNQYTEHRSLVD----YM 235
G T +SDV++ G+ ++E+ AL R P N + + ++VD +
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEM-----ALGRYPYPPETYANIFAQLSAIVDGDPPTL 230
Query: 236 LAVFNDT-KDFMAKLTECLDPNLTRYHKDSMLQM 268
+ ++D +DF+AK CL+ R + L
Sbjct: 231 PSGYSDDAQDFVAK---CLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 45/288 (15%)
Query: 12 SNFSTSLKIGQGSYGSVYLGK--LRGKNAAIKQ------MKNTKSKEFSSELKILCKV-H 62
+NF KIG+G + VY L G A+K+ M + E+ +L ++ H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHL-HWPSVKGKKP--LAWTTRVQIALDAAK 119
N+I+ + L +V E A G LS + H+ K P W VQ+
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----S 117
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
LE++H +HRD+K +N+ + + K+ D GL + AA +VGT
Sbjct: 118 ALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK---TTAAHSLVGTPY 171
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
Y++PE + + KSD+++ G +L E+ Q D N Y+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYS------------- 215
Query: 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS 287
K+ +C P L H L+ L C++ + ++RPD++
Sbjct: 216 -----LCKKIEQCDYPPLPSDHYSEELRQ--LVNMCINPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLRGKN--AAIKQMKNT---KSKE---FSSELKILCKV-H 62
S+F +G GS+G V + K +G AIK +K K K+ + E IL ++ H
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKP--LAWTTRVQIALDAAKG 120
++ ++ + ++ + E+ G L HL G+ P +A ++ L
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR---KAGRFPNDVAKFYHAELVL----A 130
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
EY+H ++RD+K N+LLD+ K+ DFG K ++ + GT Y
Sbjct: 131 FEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTFTLCGTPEY 181
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
LAPE ++ D + GV+L E I G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNT---KSKE---FSSELKILCKVHSN---LIEL 68
IG+G++G V+L + + G+ A+K ++ + K + +E IL ++ +++L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL--ADADSPWIVKL 66
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA-LDAAKGLEYIHQY 127
+ L+LV EY G D ++ K P R IA L A L+ +H+
Sbjct: 67 YYSFQDEEHLYLVMEYMPGG---DLMNLLIRKDVFPEETA-RFYIAELVLA--LDSVHKL 120
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGL------------VKLLEHSPEIAAA----- 170
++HRD+K NIL+D++ K+ADFGL H+
Sbjct: 121 ---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 171 ---------ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
A+ VGT Y+APE +R + D ++ GV+L E++ G
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMK--------NTKSKEFSSELKILCKVHSNLIELI 69
+G+GS+G V L +L+G + AIK +K + + L H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
D LF V EY G L + + +K +R A + L ++H++
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQ----RSRKFDEPRSRFYAA-EVTLALMFLHRHG- 116
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
++RD+K NILLD+ K+ADFG+ K + GT Y+APE +++
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 190 CVTTKSDVYAFGVVLMELITGQQALSRD 217
D +A GV++ E++ GQ D
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 20 IGQGSYGSVYLGKLRGKNAAI--------KQMKNTKSKEFSSELKILCKVHSNLIELIGY 71
IG+G++G V + KL+ + + +K ++ F E +L + I + Y
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 72 AAGGDS-LFLVYEYAQNGALSDHLHWPSVKGKKPLA--WTTRVQIALDAAKGLEYIHQYT 128
A ++ L+LV +Y G L L + + +A + + IA+D+ +HQ
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS------VHQL- 121
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFG-LVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
+YVHRD+K NIL+D N ++ADFG +KL+E +S VGT Y++PE ++
Sbjct: 122 --HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---TVQSSVAVGTPDYISPEILQ 176
Query: 188 -----DGCVTTKSDVYAFGVVLMELITGQ 211
G + D ++ GV + E++ G+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 42/102 (41%), Positives = 56/102 (54%), Gaps = 11/102 (10%)
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
IA+ K L Y+ + K +HRDVK SNILLD N K+ DFG+ L S A +
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS----IAKT 165
Query: 173 RIVGTFGYLAPEYV----RDGCVTTKSDVYAFGVVLMELITG 210
R G Y+APE + RDG +SDV++ G+ L E+ TG
Sbjct: 166 RDAGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 38/110 (34%), Positives = 63/110 (57%), Gaps = 9/110 (8%)
Query: 101 GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160
G+ P ++ IA+ +GL Y+ + K +HRDVK SNIL++S K+ DFG+
Sbjct: 94 GRIPENILGKISIAV--LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149
Query: 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
L I + A+ VGT Y++PE ++ T +SD+++ G+ L+E+ G
Sbjct: 150 L-----IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 69/244 (28%), Positives = 108/244 (44%), Gaps = 33/244 (13%)
Query: 9 DATSNFSTSLKIGQGSYGSV--YLGKLRGKNAAIKQMKN-----TKSKEFSSELKILCKV 61
D S + IG G+YG V + GK AIK++ + T +K ELKIL
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61
Query: 62 -HSNLIE----LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL- 115
H N+I L A +++V + ++ LH + +PL ++ L
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLMES-----DLH-HIIHSDQPLT-EEHIRYFLY 114
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP-EIAAAASRI 174
+GL+YIH +HRD+K SN+L++ + +I DFG+ + L SP E +
Sbjct: 115 QLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 175 VGTFGYLAPE--YVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLV 232
V T Y APE TT D+++ G + E++ +Q PG N Y L+
Sbjct: 172 VATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGRRQLF-----PGKN-YVHQLKLI 224
Query: 233 DYML 236
+L
Sbjct: 225 LSVL 228
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 60/201 (29%), Positives = 86/201 (42%), Gaps = 21/201 (10%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQM------KNTKSKEFSSELKILCK--VHSNLIELI 69
IG+GS+G V L K + + A+K + K + +E +L K H L+ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
+ L+ V +Y G L HL + + L R A + A + Y+H
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQ----RERCFLEPRARFYAA-EVASAIGYLHSLN- 116
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
++RD+K NILLDS + DFGL K E S GT YLAPE +R
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 190 CVTTKSDVYAFGVVLMELITG 210
D + G VL E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 62/202 (30%), Positives = 87/202 (43%), Gaps = 23/202 (11%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQM------KNTKSKEFSSELKILCK--VHSNLIELI 69
IG+GS+G V L + + + A+K + K + K SE +L K H L+ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQI-ALDAAKGLEYIHQYT 128
D L+ V +Y G L HL ++ R + A + A L Y+H
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQ------RERCFLEPRARFYAAEIASALGYLHSLN 116
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
V+RD+K NILLDS + DFGL K + E S GT YLAPE +
Sbjct: 117 ---IVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHK 170
Query: 189 GCVTTKSDVYAFGVVLMELITG 210
D + G VL E++ G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 35/208 (16%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQMK--NTKS-------KEFSSELKILCKV-HSNLIE 67
IG+G+YG+VY + G+ A+K+++ ++ +E + LK L H N++
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL-LKQLESFEHPNIVR 65
Query: 68 LIGYAAGGD-----SLFLVYEYA-QNGALSDHL--HWPSVKGKKPLAWTTRVQIALDAAK 119
L+ G L LV+E+ Q+ L+ +L + + R Q+ +
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQD--LATYLSKCPKPGLPPETIKDLMR-QLL----R 118
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
G++++H + VHRD+K NIL+ S+ + KIADFGL ++ A + +V T
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY----SFEMALTSVVVTLW 171
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMEL 207
Y APE + T D+++ G + EL
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 52/218 (23%), Positives = 97/218 (44%), Gaps = 42/218 (19%)
Query: 22 QGSYGSVYLGKLRG------KNAAIKQMKNTKSKE----FSSELKILCKV-HSNLIELIG 70
+G++G ++ G L + +K +K+ S+ E +L + H N++ ++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 71 YAA-GGDSLFLVYEYAQNGALSDHLHWPS-VKGKKPLAWTTR--VQIALDAAKGLEYIHQ 126
G+ F++Y Y G L L + P A +T+ V +A+ A G+ Y+H+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL-----------EHSPEIAAAASRIV 175
+H+D+ N ++D + KI D L + L E+ P
Sbjct: 136 RG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP---------- 182
Query: 176 GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
++A E + + ++ SDV++FGV+L EL+T GQ
Sbjct: 183 --VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQT 218
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-12
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 26/204 (12%)
Query: 20 IGQGSYGSVYLGKL--RGKNA----AIKQMKNTKSK----EFSSELKILCKV-HSNLIEL 68
+G G++G+VY G G+ AIK + T EF E I+ + H +L+ L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 69 IGYAAGGDSLFLVYEYAQNGALSD--HLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
+G ++ LV + +G L D H H ++ + L W ++ AKG+ Y+ +
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE-HSPEIAAAASRIVGTFGYLAPEY 185
VHRD+ N+L+ S KI DFGL +LLE E A ++ ++A E
Sbjct: 128 RR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--PIKWMALEC 182
Query: 186 VRDGCVTTKSDVYAFGVVLMELIT 209
+ T +SDV+++GV + EL+T
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-12
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMK--------NTKSKEFS--SELKILCK 60
NF K+G+G+Y +VY G+ R G+ A+K++ +T +E S ELK
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK---- 56
Query: 61 VHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
H N++ L + L LV+EY L ++ V+G L KG
Sbjct: 57 -HENIVRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQL--LKG 112
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
+ + H+ +HRD+K N+L++ K+ADFGL + + ++ +V T Y
Sbjct: 113 IAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAF--GIPVNTFSNEVV-TLWY 166
Query: 181 LAPEYVRDGCVT--TKSDVYAFGVVLMELITG 210
AP+ V G T T D+++ G ++ E+ITG
Sbjct: 167 RAPD-VLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-12
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 26/204 (12%)
Query: 20 IGQGSYGSVYLGKL--RGKN----AAIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
+G G++G+VY G G+ AIK+++ S KE E ++ V + ++ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHL--HWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
+G ++ L+ + G L D++ H ++ + L W VQIA KG+ Y+ +
Sbjct: 75 LGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIA----KGMNYLEE 127
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL-EHSPEIAAAASRIVGTFGYLAPEY 185
VHRD+ N+L+ + KI DFGL KLL E A ++ ++A E
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMALES 182
Query: 186 VRDGCVTTKSDVYAFGVVLMELIT 209
+ T +SDV+++GV + EL+T
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-12
Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 25/229 (10%)
Query: 20 IGQGSYGSVYLGKLRGKN--------AAIKQMKNTKSKEFSSELKILCKVHSN-LIELIG 70
IG+G++G V L + + + + +K + S F E I+ +S +++L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
L++V EY G L + + V K +T V +ALDA + IH
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH----- 165
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR--- 187
RDVK N+LLD + K+ADFG ++ + + + VGT Y++PE ++
Sbjct: 166 ----RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQG 219
Query: 188 -DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGN-NQYTEHRSLVDY 234
DG + D ++ GV L E++ G D+ G ++ +H++ +++
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF 268
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-12
Identities = 39/111 (35%), Positives = 64/111 (57%), Gaps = 9/111 (8%)
Query: 101 GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160
G+ P +V IA+ KGL Y+ + K +HRDVK SNIL++S K+ DFG+
Sbjct: 98 GRIPEQILGKVSIAV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153
Query: 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
L I + A+ VGT Y++PE ++ + +SD+++ G+ L+E+ G+
Sbjct: 154 L-----IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-12
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 37/213 (17%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQM------KNTKSKEFSSELKILCKVHSNLIELIGY 71
IG+G++G V + K++ G+ A+K + K ++ F E +L I + Y
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68
Query: 72 AAGGDS-LFLVYEYAQNGAL-------SDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEY 123
A ++ L+LV +Y G L D L P + LA + +A+D+
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRL--PEDMARFYLA---EMVLAIDS------ 117
Query: 124 IHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAP 183
+HQ YVHRD+K N+LLD N ++ADFG L + ++ VGT Y++P
Sbjct: 118 VHQL---GYVHRDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISP 172
Query: 184 EYVR-----DGCVTTKSDVYAFGVVLMELITGQ 211
E ++ G + D ++ GV + E++ G+
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQMKN-----TKSKEFSSELKILCKV-HSNLIELIGY 71
IG G++G V+ GK A+K+M N K ELK+LC H N++ +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 72 AAGGD-----SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL-DAAKGLEYIH 125
+++V E Q SD LH V +PL+ + V++ L +GL+Y+H
Sbjct: 68 LQPPHIDPFEEIYVVTELMQ----SD-LHKIIVS-PQPLS-SDHVKVFLYQILRGLKYLH 120
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
+HRD+K N+L++SN KI DFGL ++ E P+ + ++ V T Y APE
Sbjct: 121 S---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE--PDESKHMTQEVVTQYYRAPE- 174
Query: 186 VRDGC--VTTKSDVYAFGVVLMELITGQ 211
+ G T+ D+++ G + EL+ +
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 35/218 (16%)
Query: 14 FSTSLKIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKE-FS----SELKILCKV-HSNL 65
F +IG+G+YG VY K G+ A+K+++ KE F E+KIL ++ H N+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 66 IEL----------IGYAAGGDSLFLVYEYAQN---GALSDHLHWPSVKGKKPLAWTTRVQ 112
+ L + + + +LV+EY + G L L S K ++
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-----MK 123
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
L+ GL Y H K ++HRD+K SNILL++ + K+ADFGL +L +S E +
Sbjct: 124 QLLE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLY-NSEESRPYTN 176
Query: 173 RIVGTFGYLAPEYVR-DGCVTTKSDVYAFGVVLMELIT 209
+++ T Y PE + + DV++ G +L EL T
Sbjct: 177 KVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 19 KIGQGSYGSVYLG---KLRGKNAAIKQMKNTKSKE---FSS--ELKILCKV----HSNLI 66
+IG+G+YG V+ K G+ A+K+++ +E S+ E+ +L + H N++
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 67 ELIGYAAGGDS-----LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGL 121
L + L LV+E+ L+ +L G T + +GL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPT---ETIKDMMFQLLRGL 123
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
+++H + VHRD+K NIL+ S+ + K+ADFGL ++ A + +V T Y
Sbjct: 124 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMALTSVVVTLWYR 176
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMEL 207
APE + T D+++ G + E+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 34/100 (34%), Positives = 60/100 (60%), Gaps = 7/100 (7%)
Query: 112 QIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAA 171
++++ +GL Y+ + K +HRDVK SNIL++S K+ DFG+ L I + A
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMA 159
Query: 172 SRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
+ VGT Y++PE ++ + +SD+++ G+ L+EL G+
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 56/219 (25%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMK---------NTKSKEFS--SELKILCKVHSNL 65
KIG+G+YG VY G+ + G+ A+K+++ +T +E S EL+ H N+
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-----HPNI 61
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
+ L L+L++E+ LS L KK L + +DA Y++
Sbjct: 62 VCLQDVLMQESRLYLIFEF-----LSMDL-------KKYLD-SLPKGQYMDAELVKSYLY 108
Query: 126 QYTKPYY-------VHRDVKTSNILLDSNFRAKIADFGL-------VKLLEHSPEIAAAA 171
Q + +HRD+K N+L+D+ K+ADFGL V++ H
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHE------- 161
Query: 172 SRIVGTFGYLAPEYVRDGC-VTTKSDVYAFGVVLMELIT 209
V T Y APE + +T D+++ G + E+ T
Sbjct: 162 ---VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 20 IGQGSYGSVYLG--KLRGKN---AAIKQMKNTKSKE----FSSELKILCKV-HSNLIELI 69
+G G +G + G KL K AI ++ S + F +E L + HSN++ L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
G G+++ +V EY NGAL L K + L + + A G++Y+ ++
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLR----KHEGQLVAGQLMGMLPGLASGMKYL---SE 125
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
YVH+ + +L++S+ KI+ F +L E E + APE ++
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 190 CVTTKSDVYAFGVVLMELIT 209
++ SDV++FG+V+ E+++
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 19 KIGQGSYGSVYLGKLR----GKNAAIKQMKNTKSKE-FSSELKILCKVHSNL-----IEL 68
++G G++G+V G + K A+K +KN + EL V L + +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
IG +S LV E A+ G L+ L + K + ++ + G++Y+ +
Sbjct: 62 IGICEA-ESWMLVMELAELGPLNKFL-----QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
+VHRD+ N+LL + AKI+DFGL K L A + + APE +
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 189 GCVTTKSDVYAFGVVLME 206
++KSDV++FGV++ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQ--MKNTKSKEFS----SELKILCKV-HSNLIELI 69
KIGQG++G V+ + + + A+K+ M+N K + F E+KIL + H N++ LI
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLI 77
Query: 70 --------GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGL 121
Y S +LV+E+ ++ L+ L +VK + GL
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEHD-LAGLLSNKNVKFTLSEIKKVMKMLL----NGL 132
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA---ASRIVGTF 178
YIH+ +HRD+K +NIL+ + K+ADFGL + + + +R+V T
Sbjct: 133 YYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAF-SLSKNSKPNRYTNRVV-TL 187
Query: 179 GYLAPEYV---RDGCVTTKSDVYAFGVVLMELIT 209
Y PE + RD D++ G ++ E+ T
Sbjct: 188 WYRPPELLLGERD--YGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 20 IGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEF----------SSELKILCKVHSN--LIE 67
IG+GSY V L +L+ KN I MK K KE +E + + SN L+
Sbjct: 3 IGRGSYAKVLLVRLK-KNDQIYAMKVVK-KELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L LFLV EY G L H+ + ++ L A + L ++H+
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHM-----QRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
++RD+K N+LLD++ K+ D+G+ K S GT Y+APE +R
Sbjct: 116 G---IIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEILR 169
Query: 188 DGCVTTKSDVYAFGVVLMELITGQ 211
D +A GV++ E++ G+
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 26/204 (12%)
Query: 20 IGQGSYGSVYLGKL--RGKN----AAIKQMKNTKS----KEFSSELKILCKVHSNLI-EL 68
+G G++G+VY G G+N AIK ++ S KE E ++ V S + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHL--HWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
+G ++ LV + G L D++ + + + L W VQIA KG+ Y+ +
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIA----KGMSYLEE 127
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE-HSPEIAAAASRIVGTFGYLAPEY 185
VHRD+ N+L+ S KI DFGL +LL+ E A ++ ++A E
Sbjct: 128 VR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALES 182
Query: 186 VRDGCVTTKSDVYAFGVVLMELIT 209
+ T +SDV+++GV + EL+T
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 36/109 (33%), Positives = 60/109 (55%), Gaps = 6/109 (5%)
Query: 102 KKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161
K PL + + A+G+E++ +HRD+ NILL N KI DFGL + +
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 162 EHSPE-IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
P+ + ++R+ ++APE + D TT+SDV++FGV+L E+ +
Sbjct: 225 YKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 53/200 (26%), Positives = 83/200 (41%), Gaps = 30/200 (15%)
Query: 102 KKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161
KK L + + AKG+E++ +HRD+ NILL N KI DFGL + +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 162 EHSPE-IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANP 220
P+ + +R+ ++APE + D T +SDV++FGV+L E+ + L P
Sbjct: 230 YKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYP 283
Query: 221 GNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENW 280
G ++F +L E Y M Q L DC
Sbjct: 284 G-----------------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML---DCWHGEP 323
Query: 281 KRRPDMSNAAIRLSHILISS 300
+RP S L ++L ++
Sbjct: 324 SQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 26/203 (12%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNT-KSKE---FSSELKILCKV--HSNLIELIG 70
KIG+G++ V + R GK AIK MK KS E E++ L ++ H N++ LI
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 71 --YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKK-PLAWTTRVQIALDAAKGLEYIHQY 127
+ L LV+E L D + +KG+K PL K L+++H+
Sbjct: 66 VLFDRKTGRLALVFE------LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE-YV 186
HRD+K NIL+ + K+ADFG + + P S T Y APE +
Sbjct: 120 G---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS----TRWYRAPECLL 171
Query: 187 RDGCVTTKSDVYAFGVVLMELIT 209
DG K D++A G V E+++
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 58/231 (25%), Positives = 103/231 (44%), Gaps = 37/231 (16%)
Query: 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTKS----KEFSSE 54
E+ +T F L G+ +G VY G L G + AIK +K+ +EF E
Sbjct: 1 EINLSTVRFMEEL--GEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 55 LKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKG-----------K 102
+ ++ H N++ L+G L +++ Y + L + L S K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 103 KPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162
L V I A G+E++ + + VH+D+ T N+L+ KI+D GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREV- 174
Query: 163 HSPEIAAAASRIVGT----FGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
AA +++G +++PE + G + SD++++GVVL E+ +
Sbjct: 175 ----YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 41/113 (36%), Positives = 61/113 (53%), Gaps = 15/113 (13%)
Query: 124 IHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG-TFG--- 179
+H + +HRD+K++NILL SN K+ DFG K+ AA S VG TF
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY------AATVSDDVGRTFCGTP 209
Query: 180 -YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL 231
Y+APE R + K+D+++ GV+L EL+T L R + N + H++L
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLT----LKRPFDGENMEEVMHKTL 258
|
Length = 496 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 62/201 (30%), Positives = 86/201 (42%), Gaps = 20/201 (9%)
Query: 20 IGQGSYGSVYL--GKLRGKNAAIKQMKN---TKSKEFS---SELKILCKV-HSNLIELIG 70
+G+G++G V L K GK A+K +K E + +E ++L H L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
D L V EYA G L HL V + R A + L Y+H
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSED----RARFYGA-EIVSALGYLHSCD-- 115
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
V+RD+K N++LD + KI DFGL K A GT YLAPE + D
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 191 VTTKSDVYAFGVVLMELITGQ 211
D + GVV+ E++ G+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 38/220 (17%)
Query: 20 IGQGSYGSVYLGKLRGKN--AAIKQMKN--TKSKE----FSSELKILCKVHSNLIELIGY 71
+G+G +G V + + + A+K MK ++E F E IL +S I + Y
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDA-------AKGLEY 123
A D+L+LV EY G L L+ R + D A+ +
Sbjct: 69 AFQDKDNLYLVMEYQPGGDL--------------LSLLNRYEDQFDEDMAQFYLAELVLA 114
Query: 124 IHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAP 183
IH + YVHRD+K N+L+D K+ADFG L + + + VGT Y+AP
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP--VGTPDYIAP 172
Query: 184 EYVR------DGCVTTKSDVYAFGVVLMELITGQQALSRD 217
E + G + D ++ GV+ E+I G+
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 7 VRDATSNFSTSLKIGQGSYGSVYLGK--LRGKNAAIKQMKN-----TKSKEFSSELKILC 59
V + T+ + +G G++G V + L G+N AIK++ +K ELK+L
Sbjct: 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK 64
Query: 60 KV-HSNLIELIG-YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDA 117
+ H N+I L + + + ++ V E L LH + +PL
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTEL-----LGTDLH--RLLTSRPLEKQFIQYFLYQI 117
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
+GL+Y+H VHRD+K SNIL++ N KI DFGL ++ + + V T
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ------MTGYVST 168
Query: 178 FGYLAPEYVRDGCVT-----TKSDVYAFGVVLMELITGQ 211
Y APE + +T + D+++ G + E++ G+
Sbjct: 169 RYYRAPEIM----LTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 20 IGQGSYGSVYL--GKLRGKNAAIKQMK-NTKSKEFSSELKIL-CKV-------HSNLIEL 68
+G+G++G VYL G+ A+KQ+ + S+E S E+ L C++ H +++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 69 IGYAAGGDS--LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
G + L + EY G++ D L + TR QI +G+ Y+H
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-QIL----QGVSYLHS 124
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
VHRD+K +NIL DS K+ DFG K ++ + GT +++PE +
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 187 RDGCVTTKSDVYAFGVVLMELIT 209
K+DV++ ++E++T
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 33/234 (14%)
Query: 20 IGQGSYGSVY------LGKLRG-KNAAIKQMKNTKSKEFSSELKILCKVHSN----LIEL 68
IG+G +G VY GK+ K K++K + + + +I+ + S I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 69 IGYA-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
+ YA D L + + G L HL V +K + + A + GLE++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLEHMHNR 116
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
+ V+RD+K +NILLD + +I+D GL + S + A+ VGT GY+APE ++
Sbjct: 117 ---FVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEVLQ 168
Query: 188 DGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240
G + +D ++ G +L +L+ G +P T+ + +D M N
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGH-------SPFRQHKTKDKHEIDRMTLTVN 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-11
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMK------NTKSKEFSSELKILCKVHSN--LIELI 69
+G+GS+G V L +L+ G+ A+K +K + + +E +IL ++ L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
D LF V E+ G L H+ S + + A +I L ++H
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEIT----SALMFLHDKG- 116
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
++RD+K N+LLD K+ADFG+ K + S GT Y+APE +++
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN---GKTTSTFCGTPDYIAPEILQEM 171
Query: 190 CVTTKSDVYAFGVVLMELITGQ 211
D +A GV+L E++ G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGH 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 60/201 (29%), Positives = 88/201 (43%), Gaps = 20/201 (9%)
Query: 20 IGQGSYGSVYL--GKLRGKNAAIKQMKNT------KSKEFSSELKILCKVHSNLIELIGY 71
+G+G++G V L K GK A+K +K + +E ++L + + Y
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+ D L V EY G L HL V + TR A + L+Y+H
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSED----RTRFYGA-EIVSALDYLHSGK-- 115
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
V+RD+K N++LD + KI DFGL K AA GT YLAPE + D
Sbjct: 116 -IVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDND 171
Query: 191 VTTKSDVYAFGVVLMELITGQ 211
D + GVV+ E++ G+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 8e-11
Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 41/221 (18%)
Query: 13 NFSTSLKIGQGSYGSVYL-----GKLRGKNAAIKQMKN------TKSKEFS-SELKILCK 60
NF +G G+YG V+L G GK A+K ++ K+ E + +E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 61 V-HSNLIELIGYAAGGDS-LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAA 118
V S + + YA ++ L L+ +Y G + HL+ R + D
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-------------QRDNFSEDEV 107
Query: 119 K--------GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA 170
+ LE++H K V+RD+K NILLDS + DFGL K E E
Sbjct: 108 RFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSK--EFLSEEKER 162
Query: 171 ASRIVGTFGYLAPEYVRDGCVTTKS-DVYAFGVVLMELITG 210
GT Y+APE +R K+ D ++ G+++ EL+TG
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 65/231 (28%), Positives = 96/231 (41%), Gaps = 29/231 (12%)
Query: 20 IGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKI-----------LCKVHSNLIEL 68
IG+GSY V L +L+ K I MK K + + + I H L+ L
Sbjct: 3 IGRGSYAKVLLVRLK-KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
LF V EY G L H+ K + A +I+L L Y+H+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISL----ALNYLHERG 116
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
++RD+K N+LLDS K+ D+G+ K S GT Y+APE +R
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 189 GCVTTKSDVYAFGVVLMELITGQQALSRDANPGN-NQYTEHRSLVDYMLAV 238
D +A GV++ E++ G+ + N +Q TE DY+ V
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE-----DYLFQV 216
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 20 IGQGSYGSVYL--GKLRGKNAAIKQMKNT------KSKEFSSELKILCKVHSNLIELIGY 71
+G+G++G V L K G+ A+K ++ + +E ++L + + Y
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQI-ALDAAKGLEYIHQYTK 129
A D L V EYA G L HL V ++ R + + LEY+H
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEE------RARFYGAEIVSALEYLHSRD- 115
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
V+RD+K N++LD + KI DFGL K A GT YLAPE + D
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 190 CVTTKSDVYAFGVVLMELITGQ 211
D + GVV+ E++ G+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 10/103 (9%)
Query: 112 QIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAA 171
+IA+ K LEY+H +K +HRDVK SN+L++ N + K+ DFG+ L S A
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS----VAK 160
Query: 172 SRIVGTFGYLAPEYV----RDGCVTTKSDVYAFGVVLMELITG 210
+ G Y+APE + KSDV++ G+ ++EL TG
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 60/214 (28%), Positives = 89/214 (41%), Gaps = 42/214 (19%)
Query: 20 IGQGSYGSVYL-----GKLRGKNAAIKQMKNTK-------SKEFSSELKILCKV-HSNLI 66
+G+G YG V+ G GK A+K +K + +E IL V H ++
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL-DAAK------ 119
+LI G L+L+ EY G L HL R I + D A
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLE--------------REGIFMEDTACFYLSEI 109
Query: 120 --GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
LE++HQ ++RD+K NILLD+ K+ DFGL K S GT
Sbjct: 110 SLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK---ESIHEGTVTHTFCGT 163
Query: 178 FGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
Y+APE + D ++ G ++ +++TG
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSEL------KILCKVHSNLIELIGY 71
+G+G +G V +++ GK A K++ + K+ S E +IL KV+S I + Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 72 AAGGDS-LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
A + L LV G L H++ G++ L + + G+ ++H
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIY---NVGERGLEMERVIHYSAQITCGILHLHSMD-- 115
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
V+RD+K N+LLD +++D GL L+ I A GT GY+APE +++
Sbjct: 116 -IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA----GTNGYMAPEILKEEP 170
Query: 191 VTTKSDVYAFGVVLMELITGQ 211
+ D +A G + E++ G+
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 31/210 (14%)
Query: 19 KIGQGSYGSVYLGK--LRGKNAAIK--QMKNTKSKEFSS--ELKILCKV-HSNLIELIGY 71
K+G+GSY +VY GK + GK A+K +++ + F++ E +L + H+N++ L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 72 AAGGDSLFLVYEYAQNGA---LSDH---LHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
++L LV+EY + H LH +VK +GL YIH
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVK-----------LFLFQLLRGLSYIH 120
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
Q Y +HRD+K N+L+ K+ADFGL + + P + S V T Y P+
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVP--SHTYSNEVVTLWYRPPDV 174
Query: 186 VRDGC-VTTKSDVYAFGVVLMELITGQQAL 214
+ +T D++ G + +E+I G A
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKN---TKSKEFS---SELKILCKVHSNLIELIGY 71
+G+G++G V L K + G+ A+K +K E + +E ++L + + Y
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+ D L V EYA G L HL V + + + L+Y+H ++
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-----YGAEIVSALDYLH--SEK 115
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
V+RD+K N++LD + KI DFGL K + A GT YLAPE + D
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 191 VTTKSDVYAFGVVLMELITGQ 211
D + GVV+ E++ G+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 66/270 (24%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAI---KQMKNTKSKE----FSSELKILCKV-HSNLIELIG 70
++G G++G VY K + K + ++ +TKS+E + E+ IL H N+++L+
Sbjct: 12 ELGDGAFGKVY--KAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
++L+++ E+ GA+ + ++ ++PL T QI + + LE ++ +
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVM----LELERPL---TEPQIRVVCKQTLEALNYLHEN 122
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV---- 186
+HRD+K NIL + K+ADFG+ +++ I S +GT ++APE V
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDS-FIGTPYWMAPEVVMCET 179
Query: 187 -RDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245
+D K+DV++ G+ L+E+ + + NP +S + + +F
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPP-HHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238
Query: 246 MAKLTECLDPNL-TRYHKDSMLQMALLSKD 274
L +CL+ N+ R+ +LQ ++ +
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 32/208 (15%)
Query: 20 IGQGSYGSVYLGKLRGKNAA-IKQMKNTKSKEFSS---------ELKIL-CKVHSNLIEL 68
IG+G++G VY +R K+ I MK KE + E IL + +
Sbjct: 1 IGKGTFGQVYQ--VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFI 58
Query: 69 IG--YAAGGDS-LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
+G ++ DS L+LV +Y G L HL +G+ + IA + LE++H
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQ---KEGRFS-EDRAKFYIA-ELVLALEHLH 113
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAA--SRIVGTFGYLAP 183
+Y V+RD+K NILLD+ + DFGL K + + GT YLAP
Sbjct: 114 KYD---IVYRDLKPENILLDATGHIALCDFGLSK-----ANLTDNKTTNTFCGTTEYLAP 165
Query: 184 EYVRDGCVTTKS-DVYAFGVVLMELITG 210
E + D TK D ++ GV++ E+ G
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIK------QMKNTKSKEFSSELKILCKVHSNLIELIGY 71
IG+G++G V + K++ A+K +K ++ F E +L I + Y
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 72 AAGGDS-LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
A ++ L+LV +Y G L L + + +A ++ L + IHQ
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL----AIHSIHQL--- 121
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-- 188
+YVHRD+K N+LLD N ++ADFG L+ + + +S VGT Y++PE ++
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 189 ---GCVTTKSDVYAFGVVLMELITGQ 211
G + D ++ GV + E++ G+
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 20 IGQGSYGSVYLGKLRGKNA----AIKQMKNTKSKEFSSE-----LKILCKV-HSNLIELI 69
+G+G+YG V K R K AIK+ K+++ E E LK+L + N++EL
Sbjct: 9 VGEGAYGVVL--KCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
L+LV+EY + L P+ G P + + + A IH K
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPN--GVPPEKVRSYIYQLIKA------IHWCHK 118
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
VHRD+K N+L+ N K+ DFG + L A + V T Y +PE +
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRWYRSPELLLGA 176
Query: 190 CVTTKSDVYAFGVVLMELITGQ 211
D+++ G +L EL GQ
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 20 IGQGSYGSVY------LGKLRG-KNAAIKQMKNTKSKEFSSELKILCKVHSN----LIEL 68
IG+G +G VY GK+ K K++K + + + +I+ + S I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 69 IGYA-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
+ YA D L + + G L HL V + + + A + GLE++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-----YAAEIILGLEHMHNR 116
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
+ V+RD+K +NILLD + +I+D GL + S + A+ VGT GY+APE ++
Sbjct: 117 ---FVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEVLQ 168
Query: 188 DGCVTTKS-DVYAFGVVLMELITG----QQALSRDAN 219
G S D ++ G +L +L+ G +Q ++D +
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 29/204 (14%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-AIKQMKNTKSKE----FSSELKILCKV-HSNLIELIGYA 72
++G G++G VY K + A A ++ TKS+E + E++IL H +++L+G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
L+++ E+ GA+ D + +G T QI + + LE +
Sbjct: 79 YWDGKLWIMIEFCPGGAV-DAIMLELDRG------LTEPQIQVICRQMLEALQYLHSMKI 131
Query: 133 VHRDVKTSNILLDSNFRAKIADFGL----VKLLEHSPEIAAAASRIVGTFGYLAPEYV-- 186
+HRD+K N+LL + K+ADFG+ VK L+ +GT ++APE V
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR-------DSFIGTPYWMAPEVVMC 184
Query: 187 ---RDGCVTTKSDVYAFGVVLMEL 207
+D K+D+++ G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 41/212 (19%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS---------ELKIL-CKVHSNLIE 67
+G G+YG V G+ AIK++ S+ F S EL++L H N+I
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKL----SRPFQSAIHAKRTYRELRLLKHMDHENVIG 78
Query: 68 LIGYAAGGDSL------FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQ-IALDAAKG 120
L+ SL +LV +D L+ ++ + L+ +Q + +G
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMG----AD-LN--NIVKCQKLS-DDHIQFLVYQILRG 130
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
L+YIH +HRD+K SNI ++ + KI DFGL + + + V T Y
Sbjct: 131 LKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE------MTGYVATRWY 181
Query: 181 LAPEYVRDGCVTTKS-DVYAFGVVLMELITGQ 211
APE + + ++ D+++ G ++ EL+TG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-10
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 19 KIGQGSYGSVYLGKL-RGKNAA---IKQMKNTKS----KEFSSELKILCKV-HSNLIELI 69
+IG G +G V LG++ G A +K+++ + S +F E + + HSNL++ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
G LV E+ G L +L TT ++A + A GL ++H+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD- 188
++H D+ N LL ++ KI D+GL ++ + ++ ++APE V +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 189 -GCV-----TTKSDVYAFGVVLMEL 207
G + T +S+V++ GV + EL
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 7/107 (6%)
Query: 119 KGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTF 178
+GL Y+H +HRDVKT NI ++ + I D G + P +A A + GT
Sbjct: 168 EGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF----PVVAPAFLGLAGTV 220
Query: 179 GYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQY 225
APE + +K+D+++ G+VL E++ + D +Y
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEY 267
|
Length = 357 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 29/231 (12%)
Query: 20 IGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKI--------LCKVHSNLIELIGY 71
IG+GSY V L +L+ K I MK K + + + I + + SN L+G
Sbjct: 3 IGRGSYAKVLLVELK-KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 72 AAGGDS---LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
+ + LF V E+ G L H+ K + A +I+L L ++H+
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQ-RQRKLPEEHARFYSAEISL----ALNFLHERG 116
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
++RD+K N+LLD+ K+ D+G+ K S GT Y+APE +R
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 189 GCVTTKSDVYAFGVVLMELITGQQALS-RDANPGNNQYTEHRSLVDYMLAV 238
D +A GV++ E++ G+ + +Q TE DY+ V
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTE-----DYLFQV 216
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 36/96 (37%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 119 KGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIA--AAASRIVG 176
K L+YIH +HRD+K SNILL+S+ R K+ADFGL + L E + V
Sbjct: 118 KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 177 TFGYLAPE-YVRDGCVTTKSDVYAFGVVLMELITGQ 211
T Y APE + T D+++ G +L E++ G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 47 KSKEFSSE-LKILCKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDH----LHWPSVKG 101
KS E+S E L I+ N++ L Y DS+FLV ++A+ G L H L+ P
Sbjct: 28 KSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECV 87
Query: 102 KKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161
K+ W + +ALDA +H+ V RD+ +NILLD ++ F +
Sbjct: 88 KR---WAAEMVVALDA------LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEV 135
Query: 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPG 221
E S + A + Y APE T D ++ G +L EL+TG + L G
Sbjct: 136 EDSCD-GEAVENM-----YCAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
Query: 222 NNQYT----------EHRSLVDYMLAVFNDTK 243
N +T E RSL+ +L FN T+
Sbjct: 189 INTHTTLNIPEWVSEEARSLLQQLLQ-FNPTE 219
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 6 EVRDATSNFS--TSLKIGQGSYGSVYLGKLRG--KNAAIKQMKNTKSKEFSS-ELKI--L 58
E+ N LK+ G +G V + K + K K +K K F++ E + L
Sbjct: 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKA---KNFNAIEPMVHQL 64
Query: 59 CKVHSNLIELIGYAAGG--DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALD 116
K + N I+L Y + L+ +Y ++G L D +K + L+ +I
Sbjct: 65 MKDNPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFD-----LLKKEGKLSEAEVKKIIRQ 117
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLD-SNFRAKIADFGLVKLLEHSPEIAAAASRIV 175
+ L +H++ +H D+K N+L D + R + D+GL K+ +P S
Sbjct: 118 LVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGTP------SCYD 167
Query: 176 GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
GT Y +PE ++ D +A GV+ EL+TG+
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 41/218 (18%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMK---------NTKSKEFS-----SE----LKIL 58
KIG+G+YG VY + + GK A+K+ + T +E S SE +++L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 59 CKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKK---PLAWTTRVQIAL 115
H G SL+LV+EY SD + G+ PL T
Sbjct: 68 DVEHVE------EKNGKPSLYLVFEYLD----SDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLD-SNFRAKIADFGLVKLLEHSPEIAAAASRI 174
KG+ + H++ +HRD+K N+L+D KIAD GL + S + + I
Sbjct: 118 QLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF--SIPVKSYTHEI 172
Query: 175 VGTFGYLAPEYVRDGC-VTTKSDVYAFGVVLMELITGQ 211
V T Y APE + +T D+++ G + E+ Q
Sbjct: 173 V-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 19 KIGQGSYGSV----YLGKLRGKNAAIKQMKNTKSKEFSS-----ELKIL--CKVHSNLIE 67
++GQG+YG V + AIK++ N SK+ + ELK+L + H N+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 68 L----IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEY 123
L I + + L+L YE L ++ +PL GL+Y
Sbjct: 67 LYDMDIVFPGNFNELYL-YEELMEADLHQ-----IIRSGQPLTDAHFQSFIYQILCGLKY 120
Query: 124 IHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP-EIAAAASRIVGTFGYLA 182
IH +HRD+K N+L++++ KI DFGL + +P E A + V T Y A
Sbjct: 121 IHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 183 PEYVRDGCVTTKS-DVYAFGVVLMELITGQ 211
PE + TK+ DV++ G +L EL+ +
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMK---NTKSKEFSS--ELKILCKV----HSNLIE 67
+IG G+YG+VY + G A+K ++ N S+ E+ +L ++ H N++
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 68 LIGYAAGGDS-----LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLE 122
L+ A + + LV+E+ L +L G L T + +GL+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPG---LPAETIKDLMRQFLRGLD 122
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
++H VHRD+K NIL+ S + K+ADFGL ++ A + +V T Y A
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ----MALTPVVVTLWYRA 175
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMEL 207
PE + T D+++ G + E+
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 30/208 (14%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKN-----TKSKEFSSELKILCKV-HSNLIEL--I 69
IG+G+YG V K + AIK++ N +K E+K+L + H N+I + I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 70 GYAAGGDS---LFLVYEYAQNGALSD-HLHWPSVKGKKPLAWTTRVQIAL-DAAKGLEYI 124
++ +++VYE L D LH ++ + L+ Q L +GL+YI
Sbjct: 73 MPPPHREAFNDVYIVYE------LMDTDLH-QIIRSSQTLS-DDHCQYFLYQLLRGLKYI 124
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
H +HRD+K SN+LL++N KI DFGL + + E + V T Y APE
Sbjct: 125 HSAN---VLHRDLKPSNLLLNANCDLKICDFGLART---TSEKGDFMTEYVVTRWYRAPE 178
Query: 185 YVRDGCVTTKS-DVYAFGVVLMELITGQ 211
+ + T + DV++ G + EL+ +
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 45/226 (19%)
Query: 9 DATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQM----KNTKSKEFSSELKILCKV- 61
D + IG+G+YG V K G AIK++ T + E+KIL +
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK 61
Query: 62 HSNLIEL--IGYAAGGDSL---FLVYEY----------AQNGALS-DHLHWPSVKGKKPL 105
H N+I + I +S ++V E Q+ LS DH+ +
Sbjct: 62 HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH--LSNDHIQY--------- 110
Query: 106 AWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165
QI +GL+YIH +HRD+K SN+LL++N KI DFGL ++ +
Sbjct: 111 ---FLYQIL----RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160
Query: 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKS-DVYAFGVVLMELITG 210
+ + V T Y APE + + TK+ D+++ G +L E+++
Sbjct: 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 59/230 (25%), Positives = 90/230 (39%), Gaps = 47/230 (20%)
Query: 19 KIGQGSYGSVYLGKLRGKNA--AIKQM------KNTKSKEFSSELKILCKV-HSNLIELI 69
+G+G G V+L +L+G A+K + K K K +E +IL + H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK---GLEYIHQ 126
L LV +Y G L L ++P + AA+ LEY+H
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQ------RQPGKCLSEEVARFYAAEVLLALEYLHL 121
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP--------------------- 165
V+RD+K NILL + ++DF L K + P
Sbjct: 122 LG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 166 ----EIAAAASR-IVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
E + S VGT Y+APE + + D + G++L E++ G
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 24/202 (11%)
Query: 20 IGQGSYGSVYLGKLRGKNA----AIKQMKNTKSKEFS------SELKILCKVHSNLIELI 69
IG+GS+G V ++R ++ A+K ++ S +E +L +V+ I +
Sbjct: 1 IGKGSFGKVM--QVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 70 GYA-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
++ + L+LV + G L HL + + R A + LE +H++
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQ----REGRFDLSRARFYTA-ELLCALENLHKFN 113
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
++RD+K NILLD + DFGL KL + + GT YLAPE +
Sbjct: 114 ---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLG 167
Query: 189 GCVTTKSDVYAFGVVLMELITG 210
T D + GV+L E++TG
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 46/214 (21%)
Query: 19 KIGQGSYGSVYLGKLRGKNA--AIKQMK---------NTKSKEFS--SELKILCKVHSNL 65
KIG+G+YG VY + R N A+K+++ +T +E S E++ H N+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-----HGNI 63
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKP-LAWTTRVQIALDAAKGLEYI 124
+ L L+LV+EY + L H+ K P L T QI +G+ Y
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQI----LRGIAYC 118
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRA-KIADFGL-------VKLLEHSPEIAAAASRIVG 176
H + +HRD+K N+L+D A K+ADFGL V+ H V
Sbjct: 119 HSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE----------VV 165
Query: 177 TFGYLAPEYVRDGC-VTTKSDVYAFGVVLMELIT 209
T Y APE + +T D+++ G + E++
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
A+G+E++ VHRD+ N+LL KI DFGL + + H + S +
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL-P 302
Query: 178 FGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
++APE + D TT SDV+++G++L E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 58/246 (23%)
Query: 12 SNFSTSLKIGQGSYGSVYL--GKLRGKNAAIKQMKNTKSKEFS--------SELKILCKV 61
+F + IG+G++G V L K G A+K+++ KS+ +E IL +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEA 58
Query: 62 HSNLIELIGYAAGGDS-LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
+ + + Y+ ++ L+L+ EY G + L +K TR IA +
Sbjct: 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL----MKKDTFTEEETRFYIA-ETILA 113
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE--HSPEIA---------- 168
++ IH+ Y+HRD+K N+LLD+ K++DFGL L+ H E
Sbjct: 114 IDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 169 -----------------------AAASRIVGTFGYLAPE-YVRDGCVTTKSDVYAFGVVL 204
A A VGT Y+APE +++ G + D ++ GV++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIM 229
Query: 205 MELITG 210
E++ G
Sbjct: 230 YEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 10 ATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIK--QMKNTKSKEFSS--ELKILCKV-H 62
A +++ K+G+GSY +VY G ++ G+ A+K MK + F++ E +L + H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLE 122
+N++ L ++L V+EY + P G P + R+ +GL
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG--GLHP--YNVRL-FMFQLLRGLA 117
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
YIH + +HRD+K N+L+ K+ADFGL + S +S +V T Y
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVV-TLWYRP 171
Query: 183 PEYVRDGC-VTTKSDVYAFGVVLMELITGQQALSRDAN 219
P+ + ++ D++ G + +E++ GQ A ++
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEF--SSELKILCKV----HSNLIELIG 70
KIG+G+YG+V+ K R + A+K+++ E SS L+ +C + H N++ L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
L LV+EY L + S G + KGL + H +
Sbjct: 67 VLHSDKKLTLVFEYCDQD-LKKYFD--SCNGD--IDPEIVKSFMFQLLKGLAFCHSH--- 118
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGL-----VKLLEHSPEIAAAASRIVGTFGYLAPEY 185
+HRD+K N+L++ N K+ADFGL + + +S E V T Y P+
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE--------VVTLWYRPPDV 170
Query: 186 VRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNN 223
+ + +T D+++ G + EL + L PGN+
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLF----PGND 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 45/140 (32%), Positives = 67/140 (47%), Gaps = 17/140 (12%)
Query: 76 DSLFLVYEYAQNGALSDHL------HWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
D L L+ EY G L+ + H P + + L + QI L L+ +H
Sbjct: 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLF---YQIVL----ALDEVHSRK- 189
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
+HRD+K++NI L K+ DFG K S + A+S GT YLAPE
Sbjct: 190 --MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS-FCGTPYYLAPELWERK 246
Query: 190 CVTTKSDVYAFGVVLMELIT 209
+ K+D+++ GV+L EL+T
Sbjct: 247 RYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 19 KIGQGSYGSVYLGKL----RGKNAAIKQMK-NTKSKEFSSELK------ILCKVHSNLIE 67
+IG G +G V L ++ +K++K N SKE + L+ IL H N+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL--QHPNILQ 59
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQ-IALDAAKGLEYIHQ 126
+G LV+EY + G L +L + + + +Q +A + A G+ ++H
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLS--QEQWHRRNSQLLLLQRMACEIAAGVTHMH- 116
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
K ++H D+ N L S+ K+ D+G + + + +LAPE V
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYG-IGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 187 ---RDGCVTTK----SDVYAFGVVLMEL 207
G +T + S+V+A GV L EL
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLRG--KNAAIKQM-------KNTKSKEFSSELKILCKVH 62
+F T I G+YG+VYL + + + A+K++ +N + F E IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAE 59
Query: 63 SN-LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPL-AWTTRVQIALDAAKG 120
+ ++ + L +V EY + G + L K L R+ A +
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL-----KNIGALPVDMARMYFA-ETVLA 113
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK---------LLEHSPEIAAAA 171
LEY+H Y VHRD+K N+L+ S K+ DFGL K L E E
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 172 ---SRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
++ GT Y+APE + D +A G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMK--------NTKSKEFSSELKILCKVHSNLIEL 68
K+G+GSY +VY G KL G+ A+K+++ T +E +S LK L H+N++ L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE-ASLLKDL--KHANIVTL 68
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHW-PSVKGKKPLAWTTRVQIAL-DAAKGLEYIHQ 126
+L LV+EY L ++ G V++ L +GL Y HQ
Sbjct: 69 HDIIHTKKTLTLVFEYLDTD-LKQYMDDCGG--GLSM----HNVRLFLFQLLRGLAYCHQ 121
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
+HRD+K N+L+ K+ADFGL + S ++ +V T Y P+ V
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLAR--AKSVPSKTYSNEVV-TLWYRPPD-V 174
Query: 187 RDG--CVTTKSDVYAFGVVLMELITGQ 211
G +T D++ G + E+ TG+
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 43/214 (20%)
Query: 19 KIGQGSYGSVY--LGKLRGKNAAIKQMK---------NTKSKEFS--SELKILCKVHSNL 65
KIG+G+YG VY KL G+ A+K+++ +T +E S EL H N+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-----HPNI 60
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHL-HWPSVKGKKPLAWTTRVQIALDAAKGLEYI 124
+ L+ + L+LV+E+ + L ++ P PL + Q+ +G+ Y
Sbjct: 61 VRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQL----LQGIAYC 115
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL-----VKLLEHSPEIAAAASRIVGTFG 179
H + +HRD+K N+L+D K+ADFGL V + ++ E+ T
Sbjct: 116 HSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--------TLW 164
Query: 180 YLAPEYVRDGCVT--TKSDVYAFGVVLMELITGQ 211
Y APE + G T D+++ G + E++ +
Sbjct: 165 YRAPE-ILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 9/97 (9%)
Query: 119 KGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTF 178
+ L+YIH T + HRD+K NIL +++ + KI DFGL ++ + A + V T
Sbjct: 114 RALKYIH--TANVF-HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 179 GYLAPEYVRDGCVTTKS----DVYAFGVVLMELITGQ 211
Y APE G +K D+++ G + E++TG+
Sbjct: 171 WYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 31/105 (29%), Positives = 53/105 (50%), Gaps = 4/105 (3%)
Query: 105 LAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164
L++ V + A G+E++ VHRD+ N+L+ KI DFGL + +
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
+ S + ++APE + + TT SDV++FG++L E+ T
Sbjct: 293 SNYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 41/216 (18%)
Query: 16 TSLK-IGQGSYGSV--YLGKLRGKNAAIKQMKNTKSKEFSSE---------LKILCKV-H 62
TSLK +G G+YGSV + K G+ AIK++ S+ F SE L +L + H
Sbjct: 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL----SRPFQSEIFAKRAYRELTLLKHMQH 73
Query: 63 SNLIELIGYAAGGDSL------FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALD 116
N+I L+ S +LV Y Q H S + L +
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM------- 126
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
GL+YIH +HRD+K N+ ++ + KI DFGL + + A + V
Sbjct: 127 -LCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD------AEMTGYVV 176
Query: 177 TFGYLAPEYVRDGCVTTKS-DVYAFGVVLMELITGQ 211
T Y APE + + ++ D+++ G ++ E++TG+
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 21/219 (9%)
Query: 23 GSYGSVYLGKLRGKNAAIKQMKN--TKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79
GS G V++ G K + T K E+ IL + H +I LI ++
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVC 162
Query: 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKT 139
+V + + V PL + I + L Y+H +HRDVKT
Sbjct: 163 MVMPKYK------CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKT 213
Query: 140 SNILLDSNFRAKIADFGLV-KLLEH--SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSD 196
NI LD A + DFG KL H +P+ GT +PE + K+D
Sbjct: 214 ENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW----SGTLETNSPELLALDPYCAKTD 269
Query: 197 VYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235
+++ G+VL E+ L ++ ++ RS++ M
Sbjct: 270 IWSAGLVLFEMSVKNVTLFGKQVKSSS--SQLRSIIRCM 306
|
Length = 392 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 5 NEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKN---AAIKQMKNTK---SKEFS---SEL 55
N+++ NF +L G GS+G V L + ++ AIK+ + +K K+ SE
Sbjct: 25 NKMKYEDFNFIRTL--GTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 56 KILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA 114
KIL + H + L G L+LV E+ G L + + + QI
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR-RNKRFPNDVGCFYAAQIV 141
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI 174
L EY+ V+RD+K N+LLD + K+ DFG K+++ +
Sbjct: 142 LI----FEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTYTL 188
Query: 175 VGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
GT Y+APE + + +D + G+ + E++ G
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMK--------NTKSKEFSSELKILCKVHSNLIEL 68
K+G+G+Y +V+ G KL A+K+++ T +E S LK L H+N++ L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSL-LKNL--KHANIVTL 68
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL-DAAKGLEYIHQY 127
L LV+EY SD + G L V+I + +GL Y H
Sbjct: 69 HDIIHTERCLTLVFEYLD----SDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCH-- 120
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
K +HRD+K N+L++ K+ADFGL + S ++ +V T Y P+ +
Sbjct: 121 -KRKILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVV-TLWYRPPDVLL 176
Query: 188 DGC-VTTKSDVYAFGVVLMELITGQ 211
+T D++ G +L E+ TG+
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 34/119 (28%), Positives = 62/119 (52%), Gaps = 10/119 (8%)
Query: 104 PLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK-LLE 162
PL ++ + A+G++++ +HRDV N+LL AKI DFGL + ++
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPG 221
S + +R+ ++APE + D T +SDV+++G++L E+ + L + PG
Sbjct: 265 DSNYVVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 68/262 (25%), Positives = 122/262 (46%), Gaps = 48/262 (18%)
Query: 6 EVRDATSNFSTSLKIGQGSYGSV--YLGKLRGKNAAIKQM-KNTKSKEFSS----ELKIL 58
EV D + ++G G+YG+V L + G AIK++ + +S+ F+ EL++L
Sbjct: 12 EVPDRYRDL---KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 59 CKV-HSNLIELIGYAAGGDSL------FLVYEYAQN--GALSDHLHWPSVKGKKPLAWTT 109
+ H N+I L+ SL +LV + G L H + L+
Sbjct: 69 KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---------EKLS-ED 118
Query: 110 RVQ-IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIA 168
R+Q + KGL+YIH +HRD+K N+ ++ + KI DFGL + +
Sbjct: 119 RIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR------QTD 169
Query: 169 AAASRIVGTFGYLAPEYVRDGCVTTKS-DVYAFGVVLMELITGQQALSRDANPGNNQYTE 227
+ + V T Y APE + + T++ D+++ G ++ E++TG+ G++ +
Sbjct: 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK-----GHDHLDQ 224
Query: 228 HRSLVDYMLAVFNDTKDFMAKL 249
L++ M +K+F+ KL
Sbjct: 225 ---LMEIMKVTGTPSKEFVQKL 243
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 6e-07
Identities = 59/249 (23%), Positives = 99/249 (39%), Gaps = 38/249 (15%)
Query: 4 YNEVRDATSNFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTKSKEFSSELK 56
Y++ + + KIG G +G V+L K + K + + +K + + E+
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 57 ILCKV-HSNLIELIG--YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQI 113
++ ++ H N++ I L+++ E+ G LS ++ K + V I
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ-KCYKMFGKIEEHAIVDI 123
Query: 114 ALDAAKGLEYIHQYTK----PYYVHRDVKTSNILLDSNFR-----------------AKI 152
L Y H +HRD+K NI L + R AKI
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV--RDGCVTTKSDVYAFGVVLMELITG 210
DFGL K + I + A VGT Y +PE + KSD++A G ++ EL +G
Sbjct: 184 GDFGLSKNIG----IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 211 QQALSRDAN 219
+ + N
Sbjct: 240 KTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 72/309 (23%), Positives = 124/309 (40%), Gaps = 48/309 (15%)
Query: 27 SVYLGKLRGKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLI---ELIGYAAGGDSLFL 80
S GK + + K++K + + +E+ L ++ H N++ E++ A +
Sbjct: 184 STNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQ 243
Query: 81 VYEYAQNGALSDH-LHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKT 139
Y++ + D W +PL TR I +EYIH +HRD+K
Sbjct: 244 KYDFDLYSFMYDEAFDWKD----RPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKL 295
Query: 140 SNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV-RDG-CVTTKSDV 197
NI L+ + + + DFG E E A VGT +PE + DG C T D+
Sbjct: 296 ENIFLNCDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDGYCEIT--DI 351
Query: 198 YAFGVVLMELITGQQALSRDANP----GNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECL 253
++ G++L+++ LS D P G + ++D + + D KL + +
Sbjct: 352 WSCGLILLDM------LSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYI 405
Query: 254 D------------PNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301
D P + + + L+ D W RP AA L+ L S++
Sbjct: 406 DSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD--WHLRP---GAAELLALPLFSAE 460
Query: 302 EWEKMECCH 310
E E++ H
Sbjct: 461 EEEEILFIH 469
|
Length = 501 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 39/149 (26%), Positives = 61/149 (40%), Gaps = 22/149 (14%)
Query: 75 GDSLFLVYEYAQNGALSDHL--HWPSVKGKKPLAWTTRVQIAL---DAAKGLEYIHQYTK 129
L++V G+ D L H+P G LA IA D L+YIH
Sbjct: 71 DSELYVVSPLMAYGSCEDLLKTHFPE--GLPELA------IAFILKDVLNALDYIH---S 119
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADF-GLVKLLEHSPEIAAAAS---RIVGTFGYLAPEY 185
++HR VK S+ILL + + ++ V +++H V +L+PE
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 186 VRDGC--VTTKSDVYAFGVVLMELITGQQ 212
++ KSD+Y+ G+ EL G
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHV 208
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 61/252 (24%), Positives = 97/252 (38%), Gaps = 63/252 (25%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEF---------SSELKILCKVH 62
S F IG G++G V L + + A+ MK + + +E IL +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVR-KVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD 59
Query: 63 SNLIELIGYA-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKP--LAWTTRVQIALDAAK 119
+ + + Y+ D+L+ V +Y G + L G LA R IA +
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRLGIFEEDLA---RFYIA-ELTC 112
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL--------------------VK 159
+E +H K ++HRD+K NIL+D + K+ DFGL
Sbjct: 113 AIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 160 LLEHSPEIAAAASR--------------------IVGTFGYLAPEYVRDGCVTTKSDVYA 199
+E S E + +VGT Y+APE + T D ++
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229
Query: 200 FGVVLMELITGQ 211
GV+L E++ GQ
Sbjct: 230 VGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 21/152 (13%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIKQMKNTK------SKEFSSELKILCKVHSNLIELIGY 71
I +G++G VYLG K K A+K +K + +E L S I + Y
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHWPSVKG--KKPLAWTTRVQIALDAAKGLEYIHQYT 128
+ ++++LV EY G + LH + G + +A V+ + A L+Y+H++
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLH---IYGYFDEEMA----VKYISEVALALDYLHRHG 124
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160
+HRD+K N+L+ + K+ DFGL K+
Sbjct: 125 ---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 47/215 (21%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMK--------NTKSKEFS--SELKILCKVHSNLI 66
K+G+G+Y +VY G KL A+K+++ T +E S +LK H+N++
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-----HANIV 67
Query: 67 ELIGYAAGGDSLFLVYEYAQNGA---LSD-----HLHWPSVKGKKPLAWTTRVQIAL-DA 117
L SL LV+EY L D ++H V++ L
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMH--------------NVKLFLFQL 113
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
+GL Y H+ +HRD+K N+L++ K+ADFGL + S ++ +V T
Sbjct: 114 LRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVV-T 167
Query: 178 FGYLAPEYVRDGC-VTTKSDVYAFGVVLMELITGQ 211
Y P+ + +T+ D++ G + E+ TG+
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 32/220 (14%)
Query: 6 EVRDATSNFSTSLKIGQGSYGSV--YLGKLRGKNAAIKQMKN-----TKSKEFSSELKIL 58
EV + N S +G G+YGSV G A+K++ +K EL++L
Sbjct: 14 EVPERYQNLS---PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 59 CKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPS----VKGKKPLAWTTRVQI 113
+ H N+I L+ SL E + L HL VK +K VQ
Sbjct: 71 KHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQF 124
Query: 114 AL-DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
+ +GL+YIH +HRD+K SN+ ++ + KI DFGL + H+ + +
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---HTDD---EMT 175
Query: 173 RIVGTFGYLAPEYVRDGCVTTKS-DVYAFGVVLMELITGQ 211
V T Y APE + + ++ D+++ G ++ EL+TG+
Sbjct: 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 35/209 (16%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMK--------NTKSKEFS--SELKILCKVHSNLI 66
K+G+G+Y +V+ G KL A+K+++ T +E S +LK H+N++
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-----HANIV 67
Query: 67 ELIGYAAGGDSLFLVYEYAQNGA---LSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEY 123
L SL LV+EY + D + S+ K + QI +GL Y
Sbjct: 68 TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLY----QIL----RGLAY 119
Query: 124 IHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAP 183
H + +HRD+K N+L++ K+ADFGL + S ++ +V T Y P
Sbjct: 120 CH---RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVV-TLWYRPP 173
Query: 184 EYVRDGC-VTTKSDVYAFGVVLMELITGQ 211
+ + +T+ D++ G + E+ +G+
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH-SPEIAAAASRIVG 176
AKG+ ++ +HRD+ NILL KI DFGL + + + S + +R+
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL-- 278
Query: 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
++APE + + T +SDV+++G++L E+ +
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 65/250 (26%), Positives = 116/250 (46%), Gaps = 47/250 (18%)
Query: 20 IGQGSYGSV---YLGKLRGKNAAIKQMKNTKSKEFSS---------ELKILCKV-HSNLI 66
+G G+YGSV Y +LR K A+K++ S+ F S EL++L + H N+I
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK-VAVKKL----SRPFQSLIHARRTYRELRLLKHMKHENVI 77
Query: 67 ELIGY---AAGGDSLFLVYEYAQ-NGALSDHLHWPSVKGKKPLAWTTRVQIAL-DAAKGL 121
L+ A ++ VY GA +++ VK +K VQ + +GL
Sbjct: 78 GLLDVFTPATSIENFNEVYLVTNLMGADLNNI----VKCQK--LSDEHVQFLIYQLLRGL 131
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
+YIH +HRD+K SN+ ++ + +I DFGL + + + V T Y
Sbjct: 132 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE------MTGYVATRWYR 182
Query: 182 APEYVRDGCVTTKS-DVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240
APE + + ++ D+++ G ++ EL+ G+ PGN+ + + + M V
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF-----PGNDYIDQLKRI---MEVVGT 234
Query: 241 DTKDFMAKLT 250
+ + + K++
Sbjct: 235 PSPEVLKKIS 244
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 61/236 (25%), Positives = 96/236 (40%), Gaps = 50/236 (21%)
Query: 17 SLK-IGQGSYGSVYL--GKLRGKNAAIKQMKNTKSKE------FSSELKILCKVHSNLIE 67
SLK IG+G++G V L K G A+K ++ E +E IL + S +
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVV 64
Query: 68 LIGYAAGGD-SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
+ Y+ +L+L+ E+ G + L +K T+ IA + ++ IHQ
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMTLL----MKKDTLTEEETQFYIA-ETVLAIDSIHQ 119
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE--HSPEI----------------- 167
++HRD+K N+LLDS K++DFGL L+ H E
Sbjct: 120 LG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 168 -------------AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
A VGT Y+APE D ++ GV++ E++ G
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 44/212 (20%), Positives = 83/212 (39%), Gaps = 34/212 (16%)
Query: 20 IGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKVHSN--------------- 64
+GQG++ ++ G R + + + LK+L K H N
Sbjct: 3 LGQGTFTKIFKGIRR------EVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL 56
Query: 65 ----LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
L+ G GD +V EY + G+L +L K ++W ++++A A
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLK--KNKNLINISW--KLEVAKQLAWA 112
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI-VGTFG 179
L ++ H +V N+LL K + +KL + I I +
Sbjct: 113 LHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP 169
Query: 180 YLAPEYVRDG-CVTTKSDVYAFGVVLMELITG 210
++ PE + + ++ +D ++FG L E+ +G
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 28/95 (29%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 119 KGLEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
+GL+YIH +HRD+K +N+ +++ + KI DFGL ++++ S + T
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 178 FGYLAPEYVRDGCVTTKS-DVYAFGVVLMELITGQ 211
Y +P + TK+ D++A G + E++TG+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 52/237 (21%)
Query: 17 SLK-IGQGSYGSVYL--GKLRGKNAAIKQMKNTKSKE------FSSELKILCKVHSNLIE 67
SLK IG+G++G V L K G A+K ++ E +E IL + +
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 68 LIGYA-AGGDSLFLVYEYAQNGALSDHL-HWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
+ Y+ +L+L+ E+ G + L ++ + + +A+DA IH
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA------IH 118
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV------------KLLEHSPEIAAA--- 170
Q ++HRD+K N+LLD+ K++DFGL + L H+P +
Sbjct: 119 QLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 171 -----------------ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
A VGT Y+APE D ++ GV++ E++ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 25/113 (22%)
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL--LEHSPEIA-- 168
I A +GL Y+HQ Y+HR++K S+IL I+ GLV L L H +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRN 154
Query: 169 AAASRIVGTFG--------YLAPEYVRDGC--VTTKSDVYAFGVVLMELITGQ 211
+++V F +L+PE +R KSD+Y+ G+ EL TG+
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 58/246 (23%), Positives = 94/246 (38%), Gaps = 63/246 (25%)
Query: 20 IGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEF---------SSELKILCKVHSNLIELIG 70
+G G++G V L + A+ MK + K+ +E IL + + + +
Sbjct: 9 LGIGAFGEVCLAC-KVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY 67
Query: 71 YA-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
Y+ D+L+ V +Y G + L V + R IA + +E +H K
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV----LARFYIA-ELTLAIESVH---K 119
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGL-------------------------------- 157
++HRD+K NIL+D + K+ DFGL
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 158 ---------VKLLEHSPEIA---AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLM 205
+K LE A +VGT Y+APE + T D ++ GV+L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 206 ELITGQ 211
E++ GQ
Sbjct: 240 EMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 29/205 (14%)
Query: 20 IGQGSYGSV--YLGKLRGKNAAIKQM-----KNTKSKEFSSELKIL-CKVHSNLIELIGY 71
IG G+ G V + G N A+K++ T +K EL +L C H N+I L+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 72 AAGGDSL------FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
SL +LV E + L +H L + G++++H
Sbjct: 89 FTPQKSLEEFQDVYLVMEL-MDANLCQVIH-------MELDHERMSYLLYQMLCGIKHLH 140
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
+HRD+K SNI++ S+ KI DFGL + + + V T Y APE
Sbjct: 141 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----TACTNFMMTPYVVTRYYRAPEV 193
Query: 186 VRDGCVTTKSDVYAFGVVLMELITG 210
+ D+++ G ++ EL+ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 47/157 (29%), Positives = 75/157 (47%), Gaps = 23/157 (14%)
Query: 13 NFSTSLKIGQGSYGSVYL--GKLRGKNAAIKQMKNTKSKEFS--------SELKILCKVH 62
+F T IG+G++G V L K GK A+K + KS+ F +E +L +
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL--KSEMFKKDQLAHVKAERDVLAESD 59
Query: 63 SNLIELIGYAAGGDS--LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
S + + Y + D+ L+L+ E+ G L L +K TR +A +
Sbjct: 60 SPWVVSL-YYSFQDAQYLYLIMEFLPGGDLMTML----IKYDTFSEDVTRFYMA-ECVLA 113
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157
+E +H K ++HRD+K NIL+D K++DFGL
Sbjct: 114 IEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 59/246 (23%), Positives = 97/246 (39%), Gaps = 63/246 (25%)
Query: 20 IGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEF---------SSELKILCKVHSNLIELIG 70
+G G++G V L + + A+ MK + K+ +E IL + + + +
Sbjct: 9 LGIGAFGEVCLAR-KVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLY 67
Query: 71 YA-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
Y+ D+L+ V +Y G + L + + LA R IA + +E +H K
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIF-PEDLA---RFYIA-ELTCAVESVH---K 119
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGL-------------------------------- 157
++HRD+K NIL+D + K+ DFGL
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 158 ---------VKLLEHSP---EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLM 205
+K LE A +VGT Y+APE + T D ++ GV+L
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 206 ELITGQ 211
E++ GQ
Sbjct: 240 EMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 13/89 (14%)
Query: 20 IGQGSYGSVYLGKLRGKN-------AAIKQMKNT----KSKEFSSELKILCKV--HSNLI 66
+G G++G V G + A+K +K+T + + SELKI+ + H N++
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLH 95
L+G G ++++ EY + G L D+LH
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 13/101 (12%)
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV-------KLLEHSP 165
I D LEYIH++ H D+K NI++D N R I D+G+ K +E+S
Sbjct: 131 IMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK 187
Query: 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLME 206
E GT Y + CVT + D+ + G +++
Sbjct: 188 E---QKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 11/95 (11%)
Query: 119 KGLEYIHQYTKPYYVHRDVKTSNILLDSNFRA-KIADFGLVK-LLEHSPEIAAAASRIVG 176
+ L YIH + HRD+K N+L+D N K+ DFG K LL ++ SR
Sbjct: 181 RALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-- 235
Query: 177 TFGYLAPEYVRDGC-VTTKSDVYAFGVVLMELITG 210
Y APE + TT D+++ G ++ E+I G
Sbjct: 236 ---YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 57/220 (25%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIKQMKN-----TKSKEFSSELKIL-CKVHSNLIELIGY 71
IG G+ G V + G+N AIK++ T +K EL ++ H N+I L+
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83
Query: 72 AAGGDSL------FLVYEYAQNGALSDH-LHWPSVKGKKPLAWTTRVQIALDAAK----- 119
SL +LV E L D L +Q+ LD +
Sbjct: 84 FTPQKSLEEFQDVYLVME------LMDANLC-------------QVIQMDLDHERMSYLL 124
Query: 120 -----GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAA--- 171
G++++H +HRD+K SNI++ S+ KI DFGL + A +
Sbjct: 125 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMM 174
Query: 172 SRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
+ V T Y APE + D+++ G ++ E+I G
Sbjct: 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 29/125 (23%), Positives = 55/125 (44%), Gaps = 12/125 (9%)
Query: 102 KKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161
K+ +A + I + ++Y+H+ +HRD+K NI ++ + DFG
Sbjct: 176 KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF- 231
Query: 162 EHSPEIAAAASRIVGTFGYLA---PEYVRDGCVTTKSDVYAFGVVLMELITGQQAL-SRD 217
+ A++ G G +A PE + D+++ G+VL E+ T +L +D
Sbjct: 232 ----PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287
Query: 218 ANPGN 222
G+
Sbjct: 288 GLDGD 292
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 15/96 (15%)
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS----PEIAAAASRIV 175
G++++H +HRD+K SNI++ S+ KI DFGL + S P +
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV------- 187
Query: 176 GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
T Y APE + D+++ G ++ E+I G
Sbjct: 188 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 45/215 (20%)
Query: 20 IGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKIL------------------CKV 61
+GQG++ ++Y G LR ++ +E S LK+L
Sbjct: 3 LGQGTFTNIYKGVLRVQS---DLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS 59
Query: 62 HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGL 121
H +L++L G D +V EY + G L LH K L W ++ +A A L
Sbjct: 60 HKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLH--REKNNVSLHW--KLDVAKQLASAL 114
Query: 122 EYIHQYTKPYYVHRDVKTSNILL---DSNFR----AKIADFGLVKLLEHSPEIAAAASRI 174
Y+ VH +V NIL+ N K++D G+ P +
Sbjct: 115 HYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI-------PITVLSREER 164
Query: 175 VGTFGYLAPEYVRDGCV--TTKSDVYAFGVVLMEL 207
V ++APE +R+G T +D ++FG L+E+
Sbjct: 165 VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 6 EVRDAT----SNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQM-----KNTKSKEFSSE 54
EV D+T + IG G+ G V + +N AIK++ T +K E
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 55 LKIL-CKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQI 113
L ++ C H N+I L+ SL E Q+ L L ++ +Q+
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKSL----EEFQDVYLVMELMDANL--------CQVIQM 114
Query: 114 ALDAAK----------GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163
LD + G++++H +HRD+K SNI++ S+ KI DFGL +
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---- 167
Query: 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELI 208
+ + + V T Y APE + D+++ G ++ E++
Sbjct: 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 19/110 (17%)
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF-GLVKLLEHSPEIAAAA 171
I K L+YIH YVHR VK S+IL+ + + ++ + ++ H +
Sbjct: 106 ILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL---- 158
Query: 172 SRIVGTF--------GYLAPEYVRDGC--VTTKSDVYAFGVVLMELITGQ 211
R+V F +L+PE ++ KSD+Y+ G+ EL G
Sbjct: 159 -RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 10/107 (9%)
Query: 103 KPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG---LVK 159
+PL +A ++YIH +HRD+KT N+L++ + DFG +
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLME 206
+P I GT APE + T D+++ G+V+ E
Sbjct: 312 GSWSTP----FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 313 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.43 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.41 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.4 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.11 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.06 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.98 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.94 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.85 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.82 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.81 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.76 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.67 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.63 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.62 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.3 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.29 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.26 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.24 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.24 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.21 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.21 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.18 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.15 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.11 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.01 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.97 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.89 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.86 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.82 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.78 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.77 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.7 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.63 | |
| PLN02236 | 344 | choline kinase | 97.37 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.32 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.1 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.03 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.96 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.95 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.91 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.8 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.76 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.7 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.61 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.47 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.47 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.46 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.44 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.26 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.26 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.04 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.48 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=337.98 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=215.1
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEecccc----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCe-EEEEEe
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT----KSKEFSSELKILCKV-HSNLIELIGYAAGGDS-LFLVYE 83 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~-~~lv~e 83 (313)
++.+.++.||+|..|+||++.++ ++-+|+|.+... ...++.+|+++++.. ||+||++++.|.+... +.++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 46778899999999999999998 788999999533 355688999999999 9999999999999995 999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||++|+|++++. ..+.+++..+..++.+++++|.|||. .+ |+||||||+|+|++..|.|||+|||.+....
T Consensus 159 YMDgGSLd~~~k-----~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 159 YMDGGSLDDILK-----RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred hcCCCCHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 999999999983 45779999999999999999999995 77 9999999999999999999999999988665
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
++ .+..+.||..|||||.+.+..|+.++||||||++++|+.+|+.||...... .
T Consensus 231 nS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~---------------------~ 284 (364)
T KOG0581|consen 231 NS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP---------------------Y 284 (364)
T ss_pred hh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC---------------------C
Confidence 43 455678999999999999999999999999999999999999999875211 1
Q ss_pred HHHHHHhhhhcCCCCCCCCH-HHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHK-DSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
.+....+...++........ .++.+++.++..||+.||.+|||++|+++.=.-
T Consensus 285 ~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 285 LDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred CCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence 13455555556544444444 488899999999999999999999999976443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-50 Score=352.91 Aligned_cols=262 Identities=20% Similarity=0.360 Sum_probs=219.2
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccc------cccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKN------TKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~------~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
..|...+.||+|||+.||.+++. |+.||+|++.+ ...+.+.+|++|.+++ |||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 45999999999999999999984 99999999865 3366789999999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|+|..++|..+++ ..+.+++.+++.++.||+.||.|||+.+ |+|||||..|+|++++.+|||+|||+|....
T Consensus 98 ELC~~~sL~el~K-----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHH-----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeec
Confidence 9999999999994 5678999999999999999999999999 9999999999999999999999999999887
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ......+|||.|.|||++....++..+||||+||++|-|+.|++||....-
T Consensus 170 ~~~---Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v----------------------- 223 (592)
T KOG0575|consen 170 YDG---ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV----------------------- 223 (592)
T ss_pred Ccc---cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-----------------------
Confidence 543 345567899999999999999999999999999999999999999964322
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccccccccccc
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEWEKMECCHQ 311 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~ 311 (313)
...+.......+ ..+...+....+||.++|+.||.+|||+.+|+..=.--..-.+.-....||++
T Consensus 224 ---kety~~Ik~~~Y-~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~~l~~ 288 (592)
T KOG0575|consen 224 ---KETYNKIKLNEY-SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSSCLTM 288 (592)
T ss_pred ---HHHHHHHHhcCc-ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCcccccc
Confidence 222222111111 13446667788999999999999999999999654332333344444455543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=334.27 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=205.4
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----------cHHHHHHHHHHHhc-CCCceeeeeEEEeC
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----------SKEFSSELKILCKV-HSNLIELIGYAAGG 75 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~ 75 (313)
...+.|.+.+.||+|+||.|-+|..+ ++.||||+++... ...+.+|+++|+++ |||||+++++|+..
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 35677899999999999999999887 8999999997432 23367999999999 99999999999999
Q ss_pred CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC---CcEEE
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN---FRAKI 152 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~---~~~~l 152 (313)
+..|+||||++||.|.+++ ..++.+.+..-+.++.|++.|+.|||++| |+||||||+|||++.+ -.+|+
T Consensus 249 ds~YmVlE~v~GGeLfd~v-----v~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKV-----VANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred CceEEEEEEecCccHHHHH-----HhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEe
Confidence 9999999999999999998 56677888888999999999999999999 9999999999999765 67899
Q ss_pred eeccccccccCChhhhhhcccccccccccCCccccCCCC---CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccch
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV---TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 229 (313)
.|||+|...... .....++|||.|.|||++.+... ..+.|+|||||++|-+++|.+||.......
T Consensus 321 tDFGlAK~~g~~----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------- 388 (475)
T KOG0615|consen 321 TDFGLAKVSGEG----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------- 388 (475)
T ss_pred cccchhhccccc----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--------
Confidence 999999987632 23345689999999999986553 347799999999999999999997654421
Q ss_pred hHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 230 SLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.....+...-...-.......+....+||.+||..||++|||+.|+|+.
T Consensus 389 --------------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 389 --------------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --------------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1122222211111112344556778889999999999999999999853
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=336.94 Aligned_cols=281 Identities=46% Similarity=0.785 Sum_probs=237.0
Q ss_pred CcChHHHHHHhcCccccceeccCCeEEEEEeEECC-cceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeC
Q 041031 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRG-KNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGG 75 (313)
Q Consensus 1 ~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~ 75 (313)
.||+++++.++++|...+.||+|+||.||+|...+ ..||||.+.... ..++..|+.++.++ |||+++++|+|.+.
T Consensus 64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEG 143 (361)
T ss_pred eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence 39999999999999999999999999999999984 889999888755 45799999999999 99999999999999
Q ss_pred C-eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 76 D-SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 76 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
+ ..+||+||++.|+|.+.|...... .+++....+|+.++|.||+|||....++|+|+||||+|||+|++...|++|
T Consensus 144 ~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 144 GEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred CceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 8 599999999999999999643321 889999999999999999999998877899999999999999999999999
Q ss_pred ccccccccCChhhhhhcccc-cccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 155 FGLVKLLEHSPEIAAAASRI-VGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
||++...... . ...... .||.+|++||+...+..+.++||||+|+++.|++||+.|.....+. ....+.+
T Consensus 221 FGLa~~~~~~-~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~------~~~~l~~ 291 (361)
T KOG1187|consen 221 FGLAKLGPEG-D--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR------GELSLVE 291 (361)
T ss_pred ccCcccCCcc-c--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc------ccccHHH
Confidence 9999654431 1 111111 6899999999999999999999999999999999999887654421 1223666
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCC-C-CCH-HHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLT-R-YHK-DSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~-~-~~~-~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
|........ .+.+++|+.+. . ... .....+..+...|++.+|.+||++.+|+++|+.+..
T Consensus 292 w~~~~~~~~-----~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 292 WAKPLLEEG-----KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHHHCc-----chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 664443332 67788899876 3 332 577889999999999999999999999999965543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-48 Score=325.37 Aligned_cols=199 Identities=31% Similarity=0.560 Sum_probs=180.2
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
....+|...+.||+|+||+||+|+++ +..||||.+.... .+-+..|+.+|+.+ |||||.+++++..++.++|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 35689999999999999999999988 7889999997663 44577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC------CcEEEee
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN------FRAKIAD 154 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~------~~~~l~d 154 (313)
|||||+||+|.+++ ...+.+++..++.++.|++.|+++||+++ |+|+||||.|||++.+ ..+||+|
T Consensus 87 VMEyC~gGDLs~yi-----~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYI-----RRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred EEEeCCCCCHHHHH-----HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecc
Confidence 99999999999999 45568999999999999999999999999 9999999999999764 5689999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCC
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDAN 219 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~ 219 (313)
||+++...... .....+|++-|||||++..++|+.++|+||+|+++|+|++|..||.....
T Consensus 159 FGfAR~L~~~~----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 159 FGFARFLQPGS----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred cchhhhCCchh----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 99999988653 34456799999999999999999999999999999999999999986544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=319.16 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=209.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeee-EEEeCCe-EE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIG-YAAGGDS-LF 79 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~-~~~~~~~-~~ 79 (313)
...+|+++++||+|+||.||++... |..+|.|.++-+ ..+.+..|+.+|++| |||||++++ .+..++. +.
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 4567999999999999999999876 889999988733 245578999999999 999999999 4544444 89
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC-CCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY-TKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
+|||++.+|+|.+.++.-. .....+++..+|.++.|++.||.++|.+ .+..|.|+||||.||+++.+|.+||+|||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 9999999999999985433 4567899999999999999999999993 2234999999999999999999999999999
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
..+..... ......|||.|++||.+.+.+|+.+|||||+||++|||+.-++||.+..-.
T Consensus 176 r~l~s~~t---fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~------------------ 234 (375)
T KOG0591|consen 176 RFLSSKTT---FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL------------------ 234 (375)
T ss_pred hHhcchhH---HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH------------------
Confidence 98876533 334468999999999999999999999999999999999999999876432
Q ss_pred hcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
++.+++..+ .+.. ...-++..|..||..|+..||..||+...++..
T Consensus 235 -----~L~~KI~qg---d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 235 -----SLCKKIEQG---DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred -----HHHHHHHcC---CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 445555554 3333 235677889999999999999999985444433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=337.11 Aligned_cols=260 Identities=28% Similarity=0.461 Sum_probs=219.3
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEECCc-ceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLRGK-NAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~-~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.+...+.+..++.||+|.||.||.|.+.+. .||+|.++... .+.+.+|+++|++| |++||++++++.....++|||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 344556678899999999999999999965 99999998753 56788999999999 999999999999988999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||++.|+|.++|.. .....+...+.+.++.|||++++||++++ +|||||.++||||+++..+||+|||++....
T Consensus 281 E~m~~GsLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EecccCcHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999953 24677899999999999999999999999 9999999999999999999999999999544
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
++.. .......-+.-|+|||++....++.+|||||||++||||+| |+.||.+....
T Consensus 355 d~~Y--~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------------------- 411 (468)
T KOG0197|consen 355 DDEY--TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------------------- 411 (468)
T ss_pred CCce--eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------------------
Confidence 3322 12222234678999999999999999999999999999999 88998877653
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+.+.-.- ..+..++..+++++..||+.+|++|||++.+...|+++....
T Consensus 412 --ev~~~le~GyRl---p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 412 --EVLELLERGYRL---PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred --HHHHHHhccCcC---CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 333333332221 145567888999999999999999999999999999887653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=330.95 Aligned_cols=255 Identities=35% Similarity=0.549 Sum_probs=214.7
Q ss_pred hcCccccceeccCCeEEEEEeEECCcc-eEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC-eEEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKN-AAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGD-SLFLVY 82 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~-~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~-~~~lv~ 82 (313)
.++....+.+|.|+||+||+|.|.|.. ||||.+.... .+.+.+|+.+|..+ |||||+++|++.+.. ..++||
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 445566777999999999999999888 9999998654 44789999999999 999999999999888 799999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC-cEEEeeccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF-RAKIADFGLVKLL 161 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~~~ 161 (313)
||+++|+|.+++... ....++...+..++.+++.|+.|||+++. |+|+||||+|+|++.++ ++||+|||++...
T Consensus 120 Ey~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceee
Confidence 999999999999532 36789999999999999999999999985 79999999999999997 9999999999876
Q ss_pred cCChhhhhhcccccccccccCCcccc--CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVR--DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
.... .......||+.|+|||++. ...++.++||||||+++|||+||..||......
T Consensus 195 ~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------------------- 252 (362)
T KOG0192|consen 195 VISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------------------- 252 (362)
T ss_pred cccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-------------------
Confidence 5432 1222257899999999999 568999999999999999999999999765531
Q ss_pred cCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 240 NDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
...........+. ....++..+..|+..||..||.+||++.+++..|+.+...
T Consensus 253 -------~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 253 -------QVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred -------HHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 1122222222222 3344778899999999999999999999999999988774
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=322.73 Aligned_cols=239 Identities=26% Similarity=0.366 Sum_probs=205.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|++++.||+|+||.||.++.+ ++-+|+|++++.. .+....|..+|..+ ||.||+++..|++...+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4789999999999999999999877 7889999987543 55578899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
|+||+.||.|...| ++.+.+++..+.-++..|+.||.|||+++ |+|||+||+|||++++|+++|.|||++..
T Consensus 103 Vld~~~GGeLf~hL-----~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL-----QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEeccCCccHHHHH-----HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence 99999999999999 56788999999999999999999999999 99999999999999999999999999986
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
....+ .....++||+.|+|||++.+..|+..+|.||||+++|+|++|.+||.+.+..
T Consensus 175 ~~~~~---~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-------------------- 231 (357)
T KOG0598|consen 175 DLKDG---DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-------------------- 231 (357)
T ss_pred cccCC---CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH--------------------
Confidence 54332 2334478999999999999999999999999999999999999999876542
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD 285 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 285 (313)
......+..++.......+...++++++.|+.||++|..
T Consensus 232 ------~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 232 ------KMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ------HHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 222222333333334445667888999999999999963
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-48 Score=313.91 Aligned_cols=269 Identities=24% Similarity=0.334 Sum_probs=206.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccccc-----HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS-----KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~-----~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++.|+.+.++|+|++|+|++++++ |+-||||.+..... +...+|+++|+++ |+|+|.++++|.-...++|||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 467999999999999999999988 88999999976653 2367899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||++. ++.+-+. .....++.+.+..++.|++.|+.|+|+++ ++|+||||+|||++.+|.+||||||.|+...
T Consensus 81 E~~dh-TvL~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 81 EYCDH-TVLHELE----RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred eecch-HHHHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhc
Confidence 99976 4444443 44567899999999999999999999999 9999999999999999999999999999877
Q ss_pred CChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchh---HHHHHHHH
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS---LVDYMLAV 238 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~ 238 (313)
..+.. . .....|.+|+|||.+.+ .+|+.+.||||+||++.||++|.+.|++..+.+..- ..... +......+
T Consensus 153 ~pgd~--Y-TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy-~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 153 APGDN--Y-TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY-LIRKTLGNLIPRHQSI 228 (396)
T ss_pred CCcch--h-hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH-HHHHHHcccCHHHHHH
Confidence 53321 1 22367999999999988 789999999999999999999999999887643111 01111 11111122
Q ss_pred hcCcHHHHHHhhh-hcCC-CCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 239 FNDTKDFMAKLTE-CLDP-NLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 239 ~~~~~~~~~~l~~-~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+...+-|...... .-++ .+.......+..+.+|++.||+.||.+|++-++++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 2221111111100 0011 111134445567889999999999999999999873
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=325.93 Aligned_cols=268 Identities=26% Similarity=0.371 Sum_probs=218.3
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc--ccHH--HHHHHHHHHhc--CCCceeeeeEEEeCC-eE
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT--KSKE--FSSELKILCKV--HSNLIELIGYAAGGD-SL 78 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~--~~~~--~~~e~~~l~~l--h~~i~~~~~~~~~~~-~~ 78 (313)
....++|.++++||.|.||.||+|..+ ++.||||.++.. ..++ -.+|+..|+++ ||||+++.+++.+.+ .+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 456789999999999999999999877 889999998754 2333 45899999999 999999999998888 99
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++||||+ ..+|.++++ .+...+++..++.|+.||+++|+|+|.+| +.|||+||+|||+..+..+||+|||+|
T Consensus 86 ~fVfE~M-d~NLYqLmK----~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMK----DRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred eeeHHhh-hhhHHHHHh----hcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccc
Confidence 9999999 559999997 33678999999999999999999999999 999999999999998889999999999
Q ss_pred ccccCChhhhhhcccccccccccCCcccc-CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVR-DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+...+.+... ....|.+|+|||++. ...|+.+.|||++||+++|+.+-++.|.+....+ +-..+.+.+..
T Consensus 158 Rev~SkpPYT----eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-----qi~KIc~VLGt 228 (538)
T KOG0661|consen 158 REVRSKPPYT----EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-----QIYKICEVLGT 228 (538)
T ss_pred cccccCCCcc----hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-----HHHHHHHHhCC
Confidence 9877654322 235799999999986 4678999999999999999999999998876642 33333444444
Q ss_pred HhcCcHHHHHHhhhhcCCCCCC--------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTR--------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...+.+.....+...+.-.+.. .-.+.+.+..+||.+|+++||.+||||+++++.
T Consensus 229 P~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 229 PDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 4444444444454444433332 233366788899999999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=297.15 Aligned_cols=258 Identities=30% Similarity=0.389 Sum_probs=211.2
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccccH-----HHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK-----EFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~-----~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
++|...+++|+|.||.||+|++. |+.||||.++..... ...+|+..|+.+ |+||+.++++|.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 57999999999999999999998 899999999866533 477999999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|++ .+|+..++ .....++...+..++.+++.+++|||++. |+|+|+||.|+|++++|.+|++|||+++.+.+
T Consensus 82 fm~-tdLe~vIk----d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIK----DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhc----ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 994 59999995 55678999999999999999999999999 99999999999999999999999999998775
Q ss_pred ChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCC-------------CCCccccch
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANP-------------GNNQYTEHR 229 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~-------------~~~~~~~~~ 229 (313)
.... ......|.+|+|||.+.| ..|+...||||.||++.||+-|.+.|.+..+. ...+|.+..
T Consensus 154 p~~~---~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 154 PNRI---QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred CCcc---cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 4321 112267999999999986 56999999999999999999999999887762 223333333
Q ss_pred hHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 230 SLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+.++..-. ..-.+.+......++.++.+|+.+||.+||.+|+|+.|++++
T Consensus 231 ~lpdY~~~~------------~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQ------------QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHh------------cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 332221111 111122222344556677999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=322.42 Aligned_cols=248 Identities=29% Similarity=0.427 Sum_probs=210.1
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccc------cccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKN------TKSKEFSSELKILCKV--HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~------~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~ 79 (313)
-..+|...+.||.|+|++|++|+.+ ++.||||++.+ .....+..|-++|.+| ||+|++++..|+|...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3568999999999999999999887 88999998754 3455678899999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+|+||+++|.|.++| .+.+.+++...+.++.+|+.||.|||++| |+||||||+|||++++|+++|.|||.+.
T Consensus 151 FvLe~A~nGdll~~i-----~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLI-----KKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEecCCCcHHHHH-----HHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999 56788999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCChhh------h----hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccch
Q 041031 160 LLEHSPEI------A----AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 160 ~~~~~~~~------~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 229 (313)
.+.+.... . ..+..+.||-.|.+||++.....+..+|+|+|||++|+|+.|.+||.+.+..
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--------- 293 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--------- 293 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---------
Confidence 77654332 1 1123478999999999999999999999999999999999999999876542
Q ss_pred hHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 230 SLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
-...++.. ++.. +....+....+|+++.|..||.+|+|+++|.+.
T Consensus 294 --------------liFqkI~~-l~y~---fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 --------------LIFQKIQA-LDYE---FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --------------HHHHHHHH-hccc---CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11112211 1222 233444678889999999999999999887653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=315.58 Aligned_cols=256 Identities=28% Similarity=0.434 Sum_probs=207.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCC--eEEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGD--SLFLVY 82 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~--~~~lv~ 82 (313)
..+|...+.||+|+||+||++.+. +...|||...... .+.+.+|+.+|+++ |||||++++...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 467899999999999999999988 6899999988765 45589999999999 999999999854444 699999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-CCcEEEeeccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLL 161 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~ 161 (313)
||+.+|+|.+++. ..++.+++..+..+.+|++++|+|||+++ ++|+||||+|||++. ++.+||+|||.+...
T Consensus 96 Ey~~~GsL~~~~~----~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 96 EYAPGGSLSDLIK----RYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eccCCCcHHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 9999999999994 22227999999999999999999999999 999999999999999 799999999998876
Q ss_pred cCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
..............||+.|+|||++.. .....++|||||||++.||+||..||.....
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~--------------------- 227 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE--------------------- 227 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc---------------------
Confidence 642222233444679999999999995 3344599999999999999999999965310
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
.....+........+......+....+++.+|++.+|++||||.++|+.-.-..
T Consensus 228 ---~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 228 ---EAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred ---hHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 001112222222223345567778899999999999999999999998766443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=310.06 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=209.3
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
...+.|++...||.|..++||+|+.. ++.||||++.-+. .+.+.+|+..++.+ ||||++++..|..++.+++|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 35688999999999999999999887 8999999998554 46689999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|+++.+||+.+++.... ...+.+..+..+++++++||.|||++| .+|||||+.|||++++|.|+|+|||.+...
T Consensus 103 mpfMa~GS~ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYY---PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ehhhcCCcHHHHHHHHc---cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999996433 345999999999999999999999999 999999999999999999999999987665
Q ss_pred cCChhhhhhc-ccccccccccCCccccC--CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 162 EHSPEIAAAA-SRIVGTFGYLAPEYVRD--GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 162 ~~~~~~~~~~-~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
...+...... ..+.++++|+|||++.. ..|+.++||||||++..|+.+|+.||....+.
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------------------ 238 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------------------ 238 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------------------
Confidence 5544333333 55689999999999754 56999999999999999999999999766542
Q ss_pred hcCcHHHHHHhhhhcCCCCC--------C-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLT--------R-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~--------~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+.+...+..... . .....+..+.+++..||..||.+|||++++++
T Consensus 239 --------kvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 239 --------KVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred --------HHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 222111111111 0 22334457888999999999999999999984
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=296.14 Aligned_cols=233 Identities=27% Similarity=0.414 Sum_probs=204.8
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|+.++.||.|+||+|.+++.+ +..+|+|++.... .+...+|.++|+.+ ||.++++++.+.+.+.+++
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 3578999999999999999999988 7889999998654 44567899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||.+||.|.+++ .+.+.+++..++-++.+++.|+.|||+++ |++||+||+|||+|.+|.+|+.|||.+..
T Consensus 122 vmeyv~GGElFS~L-----rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~ 193 (355)
T KOG0616|consen 122 VMEYVPGGELFSYL-----RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKR 193 (355)
T ss_pred EEeccCCccHHHHH-----HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEE
Confidence 99999999999999 56778999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
... .+...+|||.|+|||++....++.++|.||||+++|||+.|.+||.....
T Consensus 194 v~~------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------------------- 246 (355)
T KOG0616|consen 194 VSG------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------------------- 246 (355)
T ss_pred ecC------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---------------------
Confidence 664 35567899999999999999999999999999999999999999987654
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCC
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRR 283 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 283 (313)
.......+..++. ++...+..+.+|++..|+.|-.+|
T Consensus 247 -----~~iY~KI~~~~v~-fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 247 -----IQIYEKILEGKVK-FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -----HHHHHHHHhCccc-CCcccCHHHHHHHHHHHhhhhHhh
Confidence 2222333333332 355666788899999999999999
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=318.06 Aligned_cols=268 Identities=28% Similarity=0.351 Sum_probs=210.7
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeC--CeEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGG--DSLF 79 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~--~~~~ 79 (313)
-.+.|+.+++||+|.||.||+|++. |+.||+|.+.-+. .....+|+.||+++ ||||+++.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 4577999999999999999999987 8889999987554 44578999999999 99999999998776 6899
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
|||||++. +|.-++. ...-.+++.++..+++|++.+|.|||.++ |+|+|||.+||||+.+|.+||+|||+|.
T Consensus 195 lVFeYMdh-DL~GLl~----~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLS----SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEecccc-hhhhhhc----CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccccee
Confidence 99999965 7877774 34557999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
++....... -.....|.+|+|||.+.| ..|+...|+||.||+|.||++|++.|.+.... .+...++..+-..
T Consensus 267 ~y~~~~~~~--~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-----eQl~kIfklcGSP 339 (560)
T KOG0600|consen 267 FYTPSGSAP--YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-----EQLHKIFKLCGSP 339 (560)
T ss_pred eccCCCCcc--cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-----HHHHHHHHHhCCC
Confidence 877654422 233467999999999987 56999999999999999999999999876652 2222333333333
Q ss_pred hcCcHHHHHHhh-hhcCC------CCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 239 FNDTKDFMAKLT-ECLDP------NLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 239 ~~~~~~~~~~l~-~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
..+.+...+... ....+ .+.+.....+....+|+..+|..||.+|.|+.++|+.
T Consensus 340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 340 TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 333332111111 01111 1111233445667889999999999999999999853
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=315.08 Aligned_cols=246 Identities=25% Similarity=0.364 Sum_probs=205.5
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc--------ccHHHHHHHHHHHhc--CCCceeeeeEEEeCC
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT--------KSKEFSSELKILCKV--HSNLIELIGYAAGGD 76 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~--------~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~ 76 (313)
.....|.+.+.||+|+||.|+.|.+. +..||+|++... ..+.+.+|+.+++.+ ||||+++++++...+
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45679999999999999999999887 899999987653 234567899999999 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC-CcEEEeec
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN-FRAKIADF 155 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~~l~df 155 (313)
.+++||||+.||.|.+++. ..+.+.+..+..+++|++.|++|||++| |+||||||+|++++.+ +++||+||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~-----~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV-----NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred eEEEEEEecCCccHHHHHH-----HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 9999999999999999994 4678999999999999999999999999 9999999999999999 99999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccCCC-CC-CccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC-VT-TKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
|++...... ........|++.|+|||++.+.. |+ .++||||+|++||.|++|..||......
T Consensus 166 G~s~~~~~~---~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------------- 229 (370)
T KOG0583|consen 166 GLSAISPGE---DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------------- 229 (370)
T ss_pred ccccccCCC---CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-------------
Confidence 999877311 13445568999999999999877 75 7899999999999999999999763321
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCCCCHHH-HHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTRYHKDS-MLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
..........+ ...... +..+..|+++||..||.+|+|+.+|++.
T Consensus 230 -------------~l~~ki~~~~~-~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 230 -------------NLYRKIRKGEF-KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred -------------HHHHHHhcCCc-cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 11111111111 112222 6778899999999999999999999943
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=314.68 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=202.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeC-C
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGG-D 76 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~-~ 76 (313)
.++|++.++||+|+||.||+|.+. ++.||+|.+.... ...+.+|+.++..+ ||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 468999999999999999999752 4679999987543 34577899999998 99999999988754 4
Q ss_pred eEEEEEeecCCCChhhhhcCCCCC--------------------------------------------------------
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVK-------------------------------------------------------- 100 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------- 100 (313)
.++++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 588999999999999998542210
Q ss_pred -CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhccccccccc
Q 041031 101 -GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179 (313)
Q Consensus 101 -~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 179 (313)
....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++......... .......++..
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~~ 241 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLPLK 241 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCCcc
Confidence 0134778889999999999999999999 999999999999999999999999998765432221 11122345678
Q ss_pred ccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCC
Q 041031 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLT 258 (313)
Q Consensus 180 ~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 258 (313)
|+|||++.+..++.++||||||+++|+|++ |..||....... .+...+.. ....
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----------------------~~~~~~~~---~~~~ 296 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----------------------EFCQRLKD---GTRM 296 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----------------------HHHHHHhc---CCCC
Confidence 999999998899999999999999999997 999997543210 11111111 1111
Q ss_pred CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 259 RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 259 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
......+..+.+++.+||+.||.+|||+.++++.|+.+..+
T Consensus 297 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11223456788999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=320.01 Aligned_cols=242 Identities=26% Similarity=0.388 Sum_probs=208.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHH-----HHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-----FSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~-----~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
+++|.+.+.||+|+||+||+|+.+ .+.||+|.+.+....+ +.+|++|++.+ ||||+.++++|+...++++|+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 368999999999999999999887 6789999997654333 88999999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+.| +|..++ ...+.++++.+..++.+++.||.|||+++ |.|+|+||.||++..+|.+|++|||++....
T Consensus 81 e~a~g-~L~~il-----~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 81 EYAVG-DLFTIL-----EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred hhhhh-hHHHHH-----HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc
Confidence 99966 999999 56788999999999999999999999999 9999999999999999999999999998766
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.+. .......|||.|+|||.+.++.|+..+|+|||||++||+++|++||.....
T Consensus 152 ~~t---~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si----------------------- 205 (808)
T KOG0597|consen 152 TNT---SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI----------------------- 205 (808)
T ss_pred cCc---eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-----------------------
Confidence 532 233446799999999999999999999999999999999999999975322
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...+...+.... ......+.....++...|..||.+|.|..+++.
T Consensus 206 ---~~Lv~~I~~d~v-~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 206 ---TQLVKSILKDPV-KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---HHHHHHHhcCCC-CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 222222222111 234466677888999999999999999999884
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=319.69 Aligned_cols=250 Identities=27% Similarity=0.348 Sum_probs=214.4
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
...-|...+.||.|+.|.|-+|++. |+.+|||++.... ...+.+|+-||+.+ |||++.+++++++..++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 4566899999999999999999987 9999999997652 55689999999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
|.||+++|.|.+++ ...+++.+.++..++.||+.|+.|||..+ |+|+|+||+|+|++..++|||+|||+|..
T Consensus 90 vlEyv~gGELFdyl-----v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 90 VLEYVPGGELFDYL-----VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred EEEecCCchhHHHH-----HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeec
Confidence 99999999999999 56788999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
-..+.-+. ..+|.++|++||++.|..| +.++||||.|++||.++||+.||..++.
T Consensus 162 e~~gklLe----TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------------------- 217 (786)
T KOG0588|consen 162 EVPGKLLE----TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------------------- 217 (786)
T ss_pred ccCCcccc----ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--------------------
Confidence 66554333 3479999999999999887 6799999999999999999999984332
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
+.+...+....-.+....+.+..+|+++|+..||++|.|++||++.-.-...
T Consensus 218 -------r~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 218 -------RVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred -------HHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 2222222222233445566678899999999999999999999987654443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=313.71 Aligned_cols=246 Identities=27% Similarity=0.407 Sum_probs=212.2
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
+....|...+.||+|.||.||+|.+. ++.||+|++..+ ..+++++|+.++.++ ++||.+.++.+..+..++++
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 34567889999999999999999988 888999999754 466799999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+.||++.+.+. .+..+.+..+.-+++++..|+.|||..+ .+|+|||+.||+++.+|.+|++|||.+...
T Consensus 90 Mey~~gGsv~~lL~-----~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLK-----SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQL 161 (467)
T ss_pred HHHhcCcchhhhhc-----cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeee
Confidence 99999999999983 4445588888889999999999999999 999999999999999999999999999887
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
..... ....+.||+.|||||++.+..|+.++||||||++.+||.+|.+|+....+.
T Consensus 162 ~~~~~---rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------------------- 217 (467)
T KOG0201|consen 162 TNTVK---RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------------------- 217 (467)
T ss_pred echhh---ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------------------
Confidence 76543 336678999999999999999999999999999999999999999766552
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+.+.-.-....+.....++..+.+|+..||+.||+.||||.++++
T Consensus 218 -----rvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 218 -----RVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred -----eEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 222222222233344477788999999999999999999999985
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=304.47 Aligned_cols=241 Identities=24% Similarity=0.420 Sum_probs=197.7
Q ss_pred cceeccCCeEEEEEeEECCcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEe----CCeEEEEEeec
Q 041031 17 SLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAG----GDSLFLVYEYA 85 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~----~~~~~lv~e~~ 85 (313)
...+|+|++|.||+|.+.++.||||.++... .+.+.+|+.+++++ ||||+++++++.+ ....+++|||+
T Consensus 25 ~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred CeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3789999999999999999999999987543 24466899999999 9999999999876 45689999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC-CCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY-TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
++|+|.+++. ....+++.....++.+++.++.+||+. + ++|+||+|+||++++++.+|++|||++......
T Consensus 105 ~~g~L~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 105 TRGYLREVLD-----KEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCcHHHHHh-----hCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 9999999994 345688889999999999999999985 7 889999999999999999999999998754432
Q ss_pred hhhhhhcccccccccccCCccccC--CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRD--GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
. ....++..|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 177 ~------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---------------------- 228 (283)
T PHA02988 177 P------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---------------------- 228 (283)
T ss_pred c------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----------------------
Confidence 1 12357889999999976 67899999999999999999999999754321
Q ss_pred HHHHHHhh-hhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 243 KDFMAKLT-ECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 243 ~~~~~~l~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
+....+. ...... .....+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 229 -~~~~~i~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 229 -EIYDLIINKNNSLK---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -HHHHHHHhcCCCCC---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1111111 111111 22245667999999999999999999999999999875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=305.86 Aligned_cols=256 Identities=28% Similarity=0.382 Sum_probs=206.4
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----------------cHHHHHHHHHHHhc-CCCceee
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----------------SKEFSSELKILCKV-HSNLIEL 68 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----------------~~~~~~e~~~l~~l-h~~i~~~ 68 (313)
....+|++.+.||+|.||.|-+|++. ++.||||++.+.. .+.+.+|+.+|+++ |||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34679999999999999999999998 8889999986432 34688999999999 9999999
Q ss_pred eeEEEe--CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC
Q 041031 69 IGYAAG--GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS 146 (313)
Q Consensus 69 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~ 146 (313)
+++..+ .+.+|||+||+..|.+...= .....+++.+++.++++++.+|.|||.+| |+||||||+|+|+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 999875 46799999999988887653 22233999999999999999999999999 999999999999999
Q ss_pred CCcEEEeeccccccccCC--hhhhhhcccccccccccCCccccCCC----CCCccchhhHHHHHHHHHhCCCCccCCCCC
Q 041031 147 NFRAKIADFGLVKLLEHS--PEIAAAASRIVGTFGYLAPEYVRDGC----VTTKSDVYAFGVVLMELITGQQALSRDANP 220 (313)
Q Consensus 147 ~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~~l~~~~tg~~p~~~~~~~ 220 (313)
+|++||+|||.+...... ...........|||.|+|||...++. -+.+.||||+|++||.|+.|+.||.+....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 999999999998866322 11222333468999999999997643 367889999999999999999999765431
Q ss_pred CCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 221 GNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
......+...+.. ...+....+.+||+++|..||++|.++.+|....+.-..
T Consensus 326 --------------------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 326 --------------------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred --------------------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1112222222222 233456678999999999999999999999988876555
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=309.05 Aligned_cols=244 Identities=24% Similarity=0.354 Sum_probs=202.7
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
-.++|.++..||+|+||.||+|+.+ |..+|+|++++.. .+.+..|-.+|... +|.||+++..|++...+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3578999999999999999999876 8999999998654 44567788888888 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||++||++..+| .+.+.+++..+..++.+++.|+..+|+.| ++|+||||+|+|||..|++||.|||++..
T Consensus 219 iMEylPGGD~mTLL-----~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL-----MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEecCCccHHHHH-----HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999 57788999999999999999999999999 99999999999999999999999999753
Q ss_pred ccCC---------------------hhhh-----------------------hhcccccccccccCCccccCCCCCCccc
Q 041031 161 LEHS---------------------PEIA-----------------------AAASRIVGTFGYLAPEYVRDGCVTTKSD 196 (313)
Q Consensus 161 ~~~~---------------------~~~~-----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~D 196 (313)
.... .... .......|||.|+|||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 2110 0000 0011247999999999999999999999
Q ss_pred hhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhcc
Q 041031 197 VYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCV 276 (313)
Q Consensus 197 iwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl 276 (313)
.|||||++|||+.|.+||.+..+. +...++..+............+....+||.+|+
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~-----------------------~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQ-----------------------ETYRKIVNWRETLKFPEEVDLSDEAKDLITRLL 427 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHH-----------------------HHHHHHHHHhhhccCCCcCcccHHHHHHHHHHh
Confidence 999999999999999999887763 334444444322222223344467888999999
Q ss_pred ccCcCCCCC
Q 041031 277 DENWKRRPD 285 (313)
Q Consensus 277 ~~~p~~Rps 285 (313)
. ||.+|.-
T Consensus 428 ~-d~~~RLG 435 (550)
T KOG0605|consen 428 C-DPENRLG 435 (550)
T ss_pred c-CHHHhcC
Confidence 9 9999986
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=302.61 Aligned_cols=247 Identities=24% Similarity=0.336 Sum_probs=197.8
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.|+..+.||+|+||.||+|.+. ++.+|+|.+.... ...+.+|+.+++.+ |++++++++++.+.+..+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4788999999999999999886 8899999886432 22466899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++|+|.+.+... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999998877421 2346889999999999999999999999 99999999999999999999999999876533
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
.. ......++..|+|||++.+..++.++|||||||++|+|++|+.||....... .
T Consensus 155 ~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--------~------------- 209 (285)
T cd05631 155 GE----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--------K------------- 209 (285)
T ss_pred CC----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--------h-------------
Confidence 21 1123467999999999999999999999999999999999999997654321 0
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-----MSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~ll~~ 292 (313)
...+...+...........+..+.+|+++||+.||.+||+ ++++++.
T Consensus 210 --~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 210 --REEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --HHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0011111111111122334567889999999999999997 7787763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=307.40 Aligned_cols=241 Identities=26% Similarity=0.366 Sum_probs=198.9
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|++.+.||+|+||.||+|.+. ++.+|+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999987 7889999986432 34577899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++. ....+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLR-----NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 9999999999983 4456889999999999999999999999 9999999999999999999999999987654
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.. .....+++.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 153 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---------------------- 204 (291)
T cd05612 153 DR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---------------------- 204 (291)
T ss_pred CC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------------
Confidence 32 12235789999999999988999999999999999999999999654321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-----MSNAAIRL 293 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~ll~~l 293 (313)
+....+.. ... ......+..+.+|+++||+.||.+||+ ++++++.-
T Consensus 205 -~~~~~i~~---~~~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 205 -GIYEKILA---GKL-EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred -HHHHHHHh---CCc-CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 11111111 110 112223456889999999999999995 88887653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=312.41 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=213.4
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
+-...|....++|+|..|.||.|... +..||||.+.... .+-+.+|+.+|+.. |+|||++++.|...+.++.||
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 34567999999999999999999887 7789999986543 44588999999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||++||+|-+.+. ...+++.++..+.+.++.||+|||.++ |+|+|||.+||+++.+|.+||+|||++....
T Consensus 350 Eym~ggsLTDvVt------~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 350 EYMEGGSLTDVVT------KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred eecCCCchhhhhh------cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 9999999999873 455999999999999999999999999 9999999999999999999999999988777
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.... ......|||.|+|||++....|+.+.||||||++..||+.|.+||-...+.
T Consensus 421 ~~~~---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl---------------------- 475 (550)
T KOG0578|consen 421 EEQS---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---------------------- 475 (550)
T ss_pred cccC---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH----------------------
Confidence 5433 444568999999999999999999999999999999999999999754432
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...-.+...-.+.+.. ....+..+.+|+.+||..||.+||++.|||+.
T Consensus 476 -rAlyLIa~ng~P~lk~-~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 476 -RALYLIATNGTPKLKN-PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -HHHHHHhhcCCCCcCC-ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2234444444444433 45566789999999999999999999999964
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=312.07 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=217.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe-EEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDS-LFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~-~~l 80 (313)
..++|..++.+|+|+||.++.++++ ++.+++|.+.... .....+|+.++.++ |||||.+.+.|..++. +++
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 3578999999999999999999888 7789999987443 33578899999999 9999999999999988 999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||+|++||++.+.+..++ +..++++.+..|+.|++.|+.|||+++ |+|+|||+.|||++.++.|+|+|||++..
T Consensus 82 vm~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKI 155 (426)
T ss_pred EEeecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhh
Confidence 999999999999996443 578999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
..... .......||+.|++||++.+.+|+.++|||||||++|||++-+++|.+.+.
T Consensus 156 l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------------------- 211 (426)
T KOG0589|consen 156 LNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------------------- 211 (426)
T ss_pred cCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---------------------
Confidence 77643 234456899999999999999999999999999999999999999987654
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...+...........+..++..+..|++.||+.+|+.||++.+++.+
T Consensus 212 -----~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 212 -----SELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----HHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33333344444555677888899999999999999999999999987
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=310.28 Aligned_cols=244 Identities=24% Similarity=0.372 Sum_probs=201.1
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|++.+.||+|+||.||+|++. ++.||||++.... ...+..|+.++..+ ||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999987 7889999987532 34467899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~g~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLN-----NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 9999999999983 4456889999999999999999999999 9999999999999999999999999987544
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
. ......+++.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 153 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---------------------- 204 (333)
T cd05600 153 T------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---------------------- 204 (333)
T ss_pred c------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH----------------------
Confidence 3 222346899999999999999999999999999999999999999754321
Q ss_pred HHHHHHhhhhc----CCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 KDFMAKLTECL----DPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 ~~~~~~l~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+.... .+.........+..+.+++.+||..+|.+||++.++++.
T Consensus 205 -~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 205 -ETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -HHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1111111110 111111112345678899999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=326.51 Aligned_cols=262 Identities=30% Similarity=0.490 Sum_probs=222.2
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
-.++.+..+.||+|.||.||+|+.. ...||||.++..+ ..++++|++++..+ |||||+++|++..++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 4567778899999999999999866 2458999998765 34699999999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCC---------CCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKG---------KKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF 148 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~---------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~ 148 (313)
+++|+||+..|+|.+||....... ..+++..+.+.++.|||.++.||-+++ +||+||-.+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 999999999999999994332111 234899999999999999999999999 99999999999999999
Q ss_pred cEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCcccc
Q 041031 149 RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTE 227 (313)
Q Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~ 227 (313)
.|||+|||+++...+... ........-+.+|||||.+..++++.+|||||+|++|||+++ |..||.+..+.
T Consensus 641 ~VKIsDfGLsRdiYssDY-Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------- 712 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDY-YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------- 712 (774)
T ss_pred EEEecccccchhhhhhhh-hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-------
Confidence 999999999987665433 222224466889999999999999999999999999999999 89999877663
Q ss_pred chhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 228 HRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
+ .+...-+.++.....+++..++.|+..||+.+|.+||+++||-.+|+....+++
T Consensus 713 ----------------E---VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 713 ----------------E---VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ----------------H---HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 2 222223344555678889999999999999999999999999999998877654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=310.05 Aligned_cols=241 Identities=24% Similarity=0.375 Sum_probs=198.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|++.+.||+|+||.||+|+++ ++.+|+|++.... .+.+.+|+.+++.+ ||||+++++++.+.+..+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 578999999999999999999987 7889999986532 34577899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+.+++|.+.+. ....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 97 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 97 LEFVVGGELFTHLR-----KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EcCCCCChHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 99999999999984 3456888999999999999999999999 999999999999999999999999998765
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.... ....+++.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 169 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------------------- 221 (329)
T PTZ00263 169 PDRT------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------------------- 221 (329)
T ss_pred CCCc------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---------------------
Confidence 4321 1246889999999999999999999999999999999999999653321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-----MSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~ll~~ 292 (313)
+....+. ...+. .....+..+.+|+++||+.||.+||+ +++++..
T Consensus 222 --~~~~~i~---~~~~~-~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 222 --RIYEKIL---AGRLK-FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --HHHHHHh---cCCcC-CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111111 11111 11223456788999999999999997 6777644
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=300.78 Aligned_cols=246 Identities=25% Similarity=0.399 Sum_probs=209.5
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccH------HHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK------EFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~------~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.+.-+|++.+.||+|.+|.|-+|... |+.||||.++++..+ .+.+|++||..+ ||||+.++.+|++.+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 45668999999999999999999875 999999999876533 378999999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+||||..+|.|.+++ ...+.+++.+++.+++||+.|+.|||.++ ++|+|+|.+|||++.++++||+|||++-
T Consensus 130 ivMEYaS~GeLYDYi-----Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 130 IVMEYASGGELYDYI-----SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred EEEEecCCccHHHHH-----HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhh
Confidence 999999999999999 56678999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
.+....- ...++|++-|.+||+++|..| ++..|.||||++||-+..|..||.+.+..
T Consensus 202 ly~~~kf----LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------------------ 259 (668)
T KOG0611|consen 202 LYADKKF----LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------------------ 259 (668)
T ss_pred hhccccH----HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------------------
Confidence 8776433 334689999999999999887 68899999999999999999999876542
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.+...+. ...+.. ..-+....-||++||-.||..|.|+.+|+..-+
T Consensus 260 -----~lvrQIs---~GaYrE--P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 260 -----RLVRQIS---RGAYRE--PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -----HHHHHhh---cccccC--CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1122222 121111 112233456999999999999999999998776
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=296.86 Aligned_cols=251 Identities=23% Similarity=0.381 Sum_probs=201.6
Q ss_pred hcCccccceeccCCeEEEEEeEEC-----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..+|++.+.||+|+||.||+|.++ +..+|+|.++... ...+.+|+.+++.+ ||||+++++.+...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 467999999999999999999764 4578999987653 23467899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+++++|.+++. .....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++++|||.+..
T Consensus 84 v~e~~~~~~L~~~l~----~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 84 VTEYMSNGALDSFLR----KHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEeCCCCcHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999984 22356889999999999999999999999 99999999999999999999999998665
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...... .......++..|+|||.+.+..++.++|||||||++|++++ |..||......
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------------------- 215 (266)
T cd05064 157 DKSEAI--YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------------------- 215 (266)
T ss_pred ccccch--hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------------------
Confidence 432211 11111234578999999999999999999999999999875 99999654321
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
+....+.... ........+..+.+++.+||+.+|.+|||+.+|++.|.++
T Consensus 216 ----~~~~~~~~~~---~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 216 ----DVIKAVEDGF---RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----HHHHHHHCCC---CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111111111 1112334566789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=299.94 Aligned_cols=262 Identities=23% Similarity=0.273 Sum_probs=198.5
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
++|++.+.||+|+||.||+|+++ ++.+|+|.+.... .+.+.+|+.+++.+ ||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999997 6789999886432 34567899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|++++++..+. .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLE-----EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99887776554 23356889999999999999999999999 99999999999999999999999999876543
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
... .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||....... .+........+...
T Consensus 153 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~ 222 (287)
T cd07848 153 GSN--ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID--------QLFTIQKVLGPLPA 222 (287)
T ss_pred ccc--ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHhhCCCCH
Confidence 221 11123457899999999998889999999999999999999999997643311 11111100000000
Q ss_pred HHHHHhhhh------cCCCCCC-------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 244 DFMAKLTEC------LDPNLTR-------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 244 ~~~~~l~~~------~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+........ ..+.... .....+..+.+|+++||+.||++|||++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 223 EQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111100000 0000000 01123567899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=303.58 Aligned_cols=271 Identities=21% Similarity=0.277 Sum_probs=203.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++|++.+.||+|+||.||++.+. +..+|+|.+.... ...+.+|+++++.+ ||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999987 7789999887542 34578899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC-CCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY-TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|+++++|.+++. ....+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 84 HMDGGSLDQVLK-----EAKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred cCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999984 345688999999999999999999985 6 9999999999999999999999999987553
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcc------------ccchh
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQY------------TEHRS 230 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~------------~~~~~ 230 (313)
.. ......+++.|+|||++.+..++.++|||||||++|+|++|+.||........... .....
T Consensus 156 ~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 156 DS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred cc-----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 32 12234588999999999998999999999999999999999999965432100000 00000
Q ss_pred --------HHHHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 231 --------LVDYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 231 --------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
............................. .....+..+.+|+++||+.||++|||+.+|++.-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 00000000000000011111111111111 12234567899999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=299.25 Aligned_cols=262 Identities=21% Similarity=0.284 Sum_probs=196.6
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++|++.++||.|+||.||+|.+. +..||+|.+.... ...+.+|+.+++.+ ||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 468999999999999999999887 7889999886432 34577899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|++ ++|.+++. .....+++..+..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++.....
T Consensus 84 ~~~-~~l~~~l~----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 84 YLD-SDLKQYLD----NCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCC-cCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 996 48988874 23345788999999999999999999999 99999999999999999999999999875432
Q ss_pred ChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.. .......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.... ..+...........
T Consensus 156 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~ 224 (288)
T cd07871 156 PT---KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--------EELHLIFRLLGTPT 224 (288)
T ss_pred CC---ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCCCC
Confidence 21 11222357899999999875 56899999999999999999999999765431 01111100000000
Q ss_pred HHHHHH------hhhhcCCCCCC-----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDFMAK------LTECLDPNLTR-----YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~~~~------l~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+.... ......+.... .....+..+.+|+++||..||.+|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 225 EETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 00000111000 11123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.70 Aligned_cols=236 Identities=26% Similarity=0.350 Sum_probs=192.3
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (313)
+.||+|+||.||+|.++ ++.+|+|++.... ...+.+|+.+++.+ ||||+++++.+...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999886 7889999987532 23466789999999 999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhh
Q 041031 89 ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIA 168 (313)
Q Consensus 89 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (313)
+|.+.+. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--- 149 (323)
T cd05571 81 ELFFHLS-----RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--- 149 (323)
T ss_pred cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---
Confidence 9999883 4467899999999999999999999999 9999999999999999999999999886532211
Q ss_pred hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHH
Q 041031 169 AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAK 248 (313)
Q Consensus 169 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
.......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----------------------~~~~~ 206 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------------KLFEL 206 (323)
T ss_pred CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----------------------HHHHH
Confidence 1222346899999999999999999999999999999999999999653221 00111
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 041031 249 LTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAI 291 (313)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~ 291 (313)
+. ... .......+..+.+|+++||+.||++|| ++.++++
T Consensus 207 ~~---~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 207 IL---MEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HH---cCC-CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 10 000 011223456788999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=297.24 Aligned_cols=255 Identities=29% Similarity=0.490 Sum_probs=204.6
Q ss_pred hcCccccceeccCCeEEEEEeEECC-------cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
.++|++.+.||+|+||.||+|.+.+ ..+++|.+.... ...+.+|+.++..+ |||++++++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 4689999999999999999998763 458999987543 23467899999999 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCC-----------CCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKG-----------KKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN 147 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~-----------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~ 147 (313)
+++|||+++++|.+++....... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 99999999999999985432111 156888999999999999999999999 9999999999999999
Q ss_pred CcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccc
Q 041031 148 FRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYT 226 (313)
Q Consensus 148 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~ 226 (313)
+.++|+|||++........ ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------ 233 (283)
T cd05048 161 LTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------ 233 (283)
T ss_pred CcEEECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 9999999999875433211 112223345788999999988889999999999999999998 99998654321
Q ss_pred cchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 227 EHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
+....+.. ..........+..+.+|+.+||+.||.+||++.+|+++|+.
T Consensus 234 -----------------~~~~~i~~---~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 -----------------EVIEMIRS---RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -----------------HHHHHHHc---CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 11112234566789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=292.30 Aligned_cols=249 Identities=24% Similarity=0.439 Sum_probs=200.6
Q ss_pred hcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.++|++.+.||+|+||.||++.++ +..+++|.+.... ...+.+|+.+++.+ |||++++++++...+..+++|||++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 467999999999999999999987 5589999887543 45688899999999 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||.+........
T Consensus 83 ~~~L~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 83 NGCLLNYLR----QRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCcHHHHHH----hCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999984 22345889999999999999999999999 99999999999999999999999998875433211
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
. ......++..|+|||++.+..++.++|+||+|+++|+|++ |+.||...... +.
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-----------------------~~ 210 (256)
T cd05114 156 T--SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-----------------------EV 210 (256)
T ss_pred e--ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-----------------------HH
Confidence 1 1112234568999999998889999999999999999999 89998654321 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
...+...... ......+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 211 ~~~i~~~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 211 VEMISRGFRL---YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHHHCCCCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111111111 111223457889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=319.99 Aligned_cols=263 Identities=21% Similarity=0.299 Sum_probs=216.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc--CCCceeeeeEE-E---e---CC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV--HSNLIELIGYA-A---G---GD 76 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l--h~~i~~~~~~~-~---~---~~ 76 (313)
.-++++.+.|.+|||+.||.|.+. +..||+|.+-..+ ...+.+|+++|+.| |+|||.+++.. . . .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 346789999999999999999998 4899999886554 44578999999999 99999999942 1 1 13
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
.++|.||||.||.|-+++..+- ...|++.++++|+.++++|+++||... ++++|||||-+|||++.+|..||||||
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 5789999999999999995332 334999999999999999999999997 459999999999999999999999999
Q ss_pred ccccccCChhhh------hhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcccc
Q 041031 157 LVKLLEHSPEIA------AAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE 227 (313)
Q Consensus 157 ~~~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~ 227 (313)
.+.......... ........|+.|++||++. +..+++++|||+|||+||-||....||...+..
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 987544333111 1112246799999999884 778999999999999999999999999765432
Q ss_pred chhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccccccc
Q 041031 228 HRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEWEKM 306 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 306 (313)
++++.++.. ....++..|.+||+.||+.||.+||++-+++..+.++.....-..++
T Consensus 265 -----------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~ 321 (738)
T KOG1989|consen 265 -----------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDI 321 (738)
T ss_pred -----------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcccc
Confidence 244455444 34678889999999999999999999999999999999887766666
Q ss_pred c
Q 041031 307 E 307 (313)
Q Consensus 307 ~ 307 (313)
+
T Consensus 322 ~ 322 (738)
T KOG1989|consen 322 Y 322 (738)
T ss_pred c
Confidence 6
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=299.91 Aligned_cols=261 Identities=26% Similarity=0.406 Sum_probs=198.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC------------------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCcee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR------------------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIE 67 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~------------------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~ 67 (313)
..+|.+.++||+|+||.||+|.+. +..||+|.+.... ...+.+|+.++..+ ||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 468999999999999999999753 2358999987643 33577899999999 999999
Q ss_pred eeeEEEeCCeEEEEEeecCCCChhhhhcCCCC--------------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceE
Q 041031 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSV--------------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133 (313)
Q Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~ 133 (313)
+++++.+.+..+++|||+.+++|.+++..... .....+++..++.++.|++.||+|||+.+ ++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999998853321 11235678889999999999999999999 99
Q ss_pred EeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh--CC
Q 041031 134 HRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT--GQ 211 (313)
Q Consensus 134 h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t--g~ 211 (313)
|+||||+||++++++.++|+|||++........ ........++..|+|||++.+..++.++||||||+++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999875543211 111122345778999999998889999999999999999987 55
Q ss_pred CCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 212 QALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 212 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.||...... ...... ...+...............+..+.+++.+||+.||.+|||+.+|.+
T Consensus 240 ~p~~~~~~~---------~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 240 QPYGELTDE---------QVIENA----------GEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCcCCHH---------HHHHHH----------HHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 677643321 000000 0000000000001112234567899999999999999999999998
Q ss_pred HHH
Q 041031 292 RLS 294 (313)
Q Consensus 292 ~l~ 294 (313)
.|+
T Consensus 301 ~l~ 303 (304)
T cd05096 301 FLT 303 (304)
T ss_pred HHh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=308.10 Aligned_cols=257 Identities=23% Similarity=0.370 Sum_probs=201.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGDS 77 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~ 77 (313)
.++|++.+.||+|+||.||+|.+. +..||||+++... .+.+.+|+.++..+ ||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 457999999999999999999742 4579999987543 33577899999998 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCC---------------------------------------------------------
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVK--------------------------------------------------------- 100 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------------------- 100 (313)
.++||||+++|+|.+++......
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999988532210
Q ss_pred -------------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 101 -------------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 101 -------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1124778889999999999999999999 999999999999999999999999998765433211
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
. ......++..|+|||++.+..++.++||||||+++|+|++ |..||...... . .+.
T Consensus 271 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--------~--------------~~~ 327 (375)
T cd05104 271 V-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--------S--------------KFY 327 (375)
T ss_pred c-ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--------H--------------HHH
Confidence 1 1112234567999999999999999999999999999998 88888654321 0 111
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
..+....... .....+..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus 328 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 328 KMIKEGYRML---SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHhCccCC---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111111111 1112345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=292.46 Aligned_cols=251 Identities=25% Similarity=0.463 Sum_probs=203.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.++|++.++||+|++|.||+|.+. +..+++|.+.... .+.+.+|+.+++.+ |+|++++++.+.+.+..+++||+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 578999999999999999999877 6679999887543 45678899999999 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++... ....++...++.++.|++.||+|||+.+ ++|+||+|+||++++++.++++|||++........
T Consensus 85 ~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 85 KGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999998522 2356788899999999999999999999 99999999999999999999999999876543221
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
. ......++..|+|||++.+..++.++|+||||+++|+|+| |..||...... +.
T Consensus 159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----------------------~~ 213 (261)
T cd05072 159 T--AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-----------------------DV 213 (261)
T ss_pred e--ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-----------------------HH
Confidence 1 1112235678999999998889999999999999999998 99999654321 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
...+...... ......+..+.+++.+||..+|++|||++++.+.|++
T Consensus 214 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 214 MSALQRGYRM---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHcCCCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111111111 1122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=290.99 Aligned_cols=264 Identities=25% Similarity=0.332 Sum_probs=204.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHH-----HHHHHHHHHhc-CCCceeeeeEEEe--CCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-----FSSELKILCKV-HSNLIELIGYAAG--GDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~-----~~~e~~~l~~l-h~~i~~~~~~~~~--~~~~~l 80 (313)
.++|++++.|++|.||.||+|+++ ++.||+|.++.+...+ ..+|+.+|.+. |||||.+..+... -+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 468999999999999999999998 7889999998776333 67899999999 9999999998764 457999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||++. +|..+++ ...+++...++..++.|++.|++|||.+. |+|+|+||+|+|++..|.+|++|||+|..
T Consensus 155 VMe~~Eh-DLksl~d----~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLME----TMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eHHHHHh-hHHHHHH----hccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhh
Confidence 9999965 8999986 44578999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
+.+.. ..-.....|.+|+|||.+.+ ..|+.+.|+||+||++.||+++.+.|.+....+ +...++..+....
T Consensus 227 ygsp~---k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-----Ql~~If~llGtPt 298 (419)
T KOG0663|consen 227 YGSPL---KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-----QLDKIFKLLGTPS 298 (419)
T ss_pred hcCCc---ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-----HHHHHHHHhCCCc
Confidence 77542 22334568999999999987 469999999999999999999999998876632 1111111111111
Q ss_pred cCcHHHHHHh------------hhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 240 NDTKDFMAKL------------TECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 240 ~~~~~~~~~l------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...+.-...+ ...+..+.... ..+..-++|+..+|.+||.+|.|+.|.|+.
T Consensus 299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~--~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGAL--SLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccCCCccccchhhccccCCCCchhhhhhcccc--ccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111001111 11111111111 134567789999999999999999998864
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=309.95 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=201.7
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|.+.+.||+|+||.||+|++. ++.||||++... ....+..|+.++..+ ||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999988 889999998743 234577899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLI-----RKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 9999999999984 3367899999999999999999999999 9999999999999999999999999987654
Q ss_pred CChh--------------------------hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccC
Q 041031 163 HSPE--------------------------IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSR 216 (313)
Q Consensus 163 ~~~~--------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~ 216 (313)
.... .........+++.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 3320 00122234689999999999999999999999999999999999999975
Q ss_pred CCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-HHHHHHH
Q 041031 217 DANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-MSNAAIR 292 (313)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~ll~~ 292 (313)
.... +....+...............+..+.+|+.+||. ||.+||+ +.++++.
T Consensus 233 ~~~~-----------------------~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 233 DTLQ-----------------------ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCHH-----------------------HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 5421 1111111111110011111245678899999998 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=279.91 Aligned_cols=262 Identities=21% Similarity=0.285 Sum_probs=206.1
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEe-----CCe
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAG-----GDS 77 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~-----~~~ 77 (313)
..-++|++.++||.|||+.||+++.- ++.+|+|.+...+ .+...+|++..+++ |||+++++++... ...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 34578999999999999999999855 7889999987554 55578999999999 9999999988643 345
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.|++++|+..|||.+.+.... .++..+++.+++.++.++++||.+||+...+ +.|+||||.||++++.+.+++.|||.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k-~kg~~~sE~~iL~if~gic~gL~~lH~~~~~-yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLK-IKGNFVSEAQILWIFLGICRGLEALHEKEPP-YAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEEeehhccccHHHHHHHHh-hcCCccCHHHHHHHHHHHHHHHHHHhccCCc-ccccCCCcceeEecCCCceEEEeccC
Confidence 899999999999999986443 3456899999999999999999999999854 79999999999999999999999998
Q ss_pred cccccCChhhh------hhcccccccccccCCccccC---CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccc
Q 041031 158 VKLLEHSPEIA------AAASRIVGTFGYLAPEYVRD---GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 158 ~~~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~ 228 (313)
+....-..... ........|..|+|||.+.- ...++++|||||||+||.|+.|..||...-..
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-------- 247 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-------- 247 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------
Confidence 87543211111 11112357899999999974 45789999999999999999999999533221
Q ss_pred hhHHHHHHHHhcCcHHHHHHhh-hhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 229 RSLVDYMLAVFNDTKDFMAKLT-ECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
...+. +...+.... -....+..|.++++.||+.||.+||++.+++..++.+.
T Consensus 248 -----------------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 -----------------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----------------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111 111112111 12226778999999999999999999999999998764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=308.50 Aligned_cols=260 Identities=28% Similarity=0.478 Sum_probs=213.6
Q ss_pred HHhcCccccceeccCCeEEEEEeEECCcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
...++..+...||+|.||+||+|+|.| .||||.++.+. .+.+.+|+..+++- |.||+-+.|++..... .+|+
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 345677889999999999999999996 59999997654 44578999999999 9999999999998877 9999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
-|++|.+|..++. .....+.+...+.|++|+++|+.|||.++ |+|+|+|..|||+.+++.|||+|||++..-.
T Consensus 467 qwCeGsSLY~hlH----v~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 467 QWCEGSSLYTHLH----VQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred hhccCchhhhhcc----chhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeee
Confidence 9999999999997 33467999999999999999999999999 9999999999999999999999999987533
Q ss_pred CChhhhhhcccccccccccCCccccC---CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD---GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
.- ..........+...|+|||++.. ..|+..+||||||+++|||+||..||. ..+.+..-+...
T Consensus 540 ~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVG----------- 606 (678)
T KOG0193|consen 540 RW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVG----------- 606 (678)
T ss_pred ee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEec-----------
Confidence 21 11122223457789999999963 468999999999999999999999998 444321111111
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
...+.+.+.....++.+++.+|+..||++++++||++.+|+.+|+.+....
T Consensus 607 ----------rG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 607 ----------RGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ----------ccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 112334444456778889999999999999999999999999999988854
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=298.21 Aligned_cols=263 Identities=25% Similarity=0.324 Sum_probs=195.0
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++|.+.+.||.|+||.||+|+++ ++.+|+|++.... .....+|+.+++.+ ||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999986 7889999987432 33567899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+. ++|.+++. .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 84 ~~~-~~l~~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 84 YVH-TDLCQYMD----KHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred CCC-cCHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 995 67877774 33456888999999999999999999999 99999999999999999999999998865432
Q ss_pred ChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.. .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ..+...........
T Consensus 156 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~ 225 (303)
T cd07869 156 PS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-------DQLERIFLVLGTPN 225 (303)
T ss_pred CC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-------HHHHHHHHHhCCCC
Confidence 21 11122457899999999875 457889999999999999999999997643210 01111100000000
Q ss_pred HHHHH---Hhhhhc--------CCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDFMA---KLTECL--------DPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~~~---~l~~~~--------~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+... ...... ...+.. ........+.+|+.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 000000 000000 00012245778999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=309.50 Aligned_cols=238 Identities=26% Similarity=0.415 Sum_probs=203.7
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~ 79 (313)
..++|..+++||+|+||.|++++.+ ++.+|||.++++ +.+....|.+|+... ||.++++++.|+..+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4678999999999999999999988 778999998765 356678899999988 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+||||+.||++..+. +...+++..+.-+++.++.||.|||+++ |+|||||.+|||+|.+|.+||+|||++.
T Consensus 446 fvmey~~Ggdm~~~~------~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI------HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEecCCCcEEEEE------ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 999999999955543 4577999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
..-.. ...++.+.|||.|+|||++.+..|+.+.|.||||+++|+|+.|..||.+++..
T Consensus 517 e~m~~---g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------------------- 574 (694)
T KOG0694|consen 517 EGMGQ---GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------------------- 574 (694)
T ss_pred ccCCC---CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------------------
Confidence 64422 24666789999999999999999999999999999999999999999987763
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM 286 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 286 (313)
+.-+.+.. .++. .+...+.+...+++++|..+|++|...
T Consensus 575 ----e~FdsI~~-d~~~---yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 ----EVFDSIVN-DEVR---YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----HHHHHHhc-CCCC---CCCcccHHHHHHHHHHhccCcccccCC
Confidence 22222211 1222 344566677889999999999999865
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=309.59 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=197.0
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|++.+.||+|+||.||+|++. ++.||||++.... ...+.+|+.++..+ ||||+++++.+.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999987 7889999987532 23467899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+.+|+|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 E~~~~g~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLM-----KKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 9999999999984 3456899999999999999999999999 9999999999999999999999999886543
Q ss_pred CChhhh-----------------------------------hhcccccccccccCCccccCCCCCCccchhhHHHHHHHH
Q 041031 163 HSPEIA-----------------------------------AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMEL 207 (313)
Q Consensus 163 ~~~~~~-----------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~ 207 (313)
...... .......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 211000 000123589999999999999999999999999999999
Q ss_pred HhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCC-
Q 041031 208 ITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPD- 285 (313)
Q Consensus 208 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps- 285 (313)
++|..||...... +....+..+. ..+.. .....+..+.+|+.+|+. +|.+|++
T Consensus 233 ~~G~~Pf~~~~~~-----------------------~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~ 287 (364)
T cd05599 233 LVGYPPFCSDNPQ-----------------------ETYRKIINWK-ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN 287 (364)
T ss_pred hcCCCCCCCCCHH-----------------------HHHHHHHcCC-CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC
Confidence 9999999754321 1111111111 00110 111234567889999997 9999998
Q ss_pred --HHHHHHH
Q 041031 286 --MSNAAIR 292 (313)
Q Consensus 286 --~~~ll~~ 292 (313)
+.++++.
T Consensus 288 ~~~~~ll~h 296 (364)
T cd05599 288 NGVNEIKSH 296 (364)
T ss_pred CCHHHHhcC
Confidence 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=290.65 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=204.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..+|.+.+.||+|++|.||+|.+. ++.+++|.+..+. ...+.+|+++++.+ |||++++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457899999999999999999886 7889999987654 34678899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++++|.+++... ....+++..++.++.|++.+|+|||+++ ++|+||+|+||++++++.++++|||.+.......
T Consensus 85 ~~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 85 TYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999998422 2346888899999999999999999999 9999999999999999999999999987654321
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. ........+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.... +
T Consensus 159 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----------------------~ 213 (263)
T cd05052 159 Y--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------------Q 213 (263)
T ss_pred e--eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------------H
Confidence 1 11111234568999999998899999999999999999998 88998654321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
....+....... .....+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 214 ~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 214 VYELLEKGYRME---RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHCCCCCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111111111111 2233456788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=305.78 Aligned_cols=262 Identities=22% Similarity=0.336 Sum_probs=194.8
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeC-----CeEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGG-----DSLF 79 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~-----~~~~ 79 (313)
+|++.++||+|+||.||+|.+. +..||||.+... ....+.+|+.+++.+ ||||+++++++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5899999999999999999986 788999988642 233577899999999 99999999987543 3589
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+||||+ +++|.+++. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~-~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELM-ESDLHQVIK-----ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecC-CCCHHHHHH-----hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccc
Confidence 999999 568998883 3456899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccC--CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRD--GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
................+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..... ....+..
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---------~~~~~~~ 222 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---------QLDLITD 222 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---------HHHHHHH
Confidence 54332221122233468899999999876 678999999999999999999999997543210 0011110
Q ss_pred HhcC-cHHH---------HHHhhhhcCCC---CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 238 VFND-TKDF---------MAKLTECLDPN---LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~-~~~~---------~~~l~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.... ..+. ...+....... ........+..+.+++.+||+.||++|||+.++++.
T Consensus 223 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 0000 00011111000 000111234567899999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=304.21 Aligned_cols=241 Identities=24% Similarity=0.340 Sum_probs=197.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC---CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR---GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
.++|.+.+.||+|+||.||+|.+. +..+|+|.+... ..+.+.+|+.+++.+ ||||+++++++.+.+.+++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 468999999999999999999875 257999988543 234577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+.+|+|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 109 v~Ey~~~g~L~~~i~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 109 VLEFVIGGEFFTFLR-----RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 999999999999984 4456889999999999999999999999 99999999999999999999999999876
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
.... .....+|+.|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 181 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------------------- 234 (340)
T PTZ00426 181 VDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------------------- 234 (340)
T ss_pred cCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------------------
Confidence 5422 12346899999999999888999999999999999999999999754321
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
.....+.. ... ......+..+.+++++||+.||.+|+ +++++++.
T Consensus 235 ---~~~~~i~~---~~~-~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 235 ---LIYQKILE---GII-YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---HHHHHHhc---CCC-CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11111111 110 11222345678899999999999995 88888764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=306.55 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=202.2
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCC
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGD 76 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~ 76 (313)
..++|++.+.||+|+||.||+|.+. +..||+|.+.... ...+.+|+.+++.+ |+||+++++++....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3467999999999999999999864 2469999987543 33467899999988 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCC---------------------------------------------------------
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSV--------------------------------------------------------- 99 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 99 (313)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998743210
Q ss_pred --------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhc
Q 041031 100 --------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAA 171 (313)
Q Consensus 100 --------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 171 (313)
.....+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++......... ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~~~ 271 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-VVK 271 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-eec
Confidence 01235788889999999999999999999 999999999999999999999999998754332111 111
Q ss_pred ccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhh
Q 041031 172 SRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLT 250 (313)
Q Consensus 172 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
....++..|+|||++.+..++.++|||||||++|+|++ |..||....... .....+.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----------------------~~~~~~~ 329 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----------------------KFYKMVK 329 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----------------------HHHHHHH
Confidence 12234568999999998889999999999999999997 999996543210 1111111
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 251 ECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
....... ....+..+.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 330 ~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 330 RGYQMSR---PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cccCccC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1111111 1123467889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=289.56 Aligned_cols=252 Identities=28% Similarity=0.456 Sum_probs=202.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC-----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
.++|++.+.||+|+||.||+|.+. ...+++|.+.... ...+.+|+.+++.+ ||||+++++.+...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 467999999999999999999886 2468999887543 23467799999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
+||++++++|.+++. .....++...++.++.|++.|++|||+++ ++|+||+|+||++++++.++++|||++..
T Consensus 83 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 83 ITEYMENGSLDKFLR----ENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEcCCCCCHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhc
Confidence 999999999999985 23347889999999999999999999999 99999999999999999999999999887
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
....... ........+..|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------------------- 215 (266)
T cd05033 156 LEDSEAT-YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------------------- 215 (266)
T ss_pred ccccccc-eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-------------------
Confidence 6421111 11112234578999999998889999999999999999998 99998543221
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
+....+.... ........+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 216 ----~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 216 ----DVIKAVEDGY---RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----HHHHHHHcCC---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111111110 0011223456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=303.16 Aligned_cols=247 Identities=24% Similarity=0.348 Sum_probs=195.1
Q ss_pred CccccceeccCCeEEEEEeEEC-----CcceEEEeccccc-------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK-------SKEFSSELKILCKV--HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~-------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~ 78 (313)
+|++.+.||+|+||.||+++.. ++.+|+|++.... .+....|+.+++.+ ||+|+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998763 6789999986432 23467799999998 89999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++||||+.+++|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLY-----QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 99999999999999983 3456899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
........ .......+++.|+|||++.+. .++.++|||||||++|+|++|..||....... ...
T Consensus 153 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------~~~----- 217 (332)
T cd05614 153 KEFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN--------TQS----- 217 (332)
T ss_pred ccccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC--------CHH-----
Confidence 76433221 112234689999999999865 47889999999999999999999996543321 000
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
.+...+.. .++. .....+..+.+++.+||+.||++|| +++++++.
T Consensus 218 ------~~~~~~~~-~~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 218 ------EVSRRILK-CDPP---FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ------HHHHHHhc-CCCC---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11111111 1111 1223445688899999999999999 67777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=303.80 Aligned_cols=267 Identities=18% Similarity=0.204 Sum_probs=198.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
..+|+++++||+|+||.||+|.+. ++.||+|.... ..+.+|+++++.+ ||||+++++++......++++|++.
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~- 166 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK- 166 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence 357999999999999999999987 78899997543 3567899999999 9999999999999999999999994
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|..++. ....+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++........
T Consensus 167 ~~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 167 TDLYCYLA-----AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 68888873 3456889999999999999999999999 99999999999999999999999999865332211
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc-------
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN------- 240 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 240 (313)
.......+|+.|+|||++.+..++.++|||||||++|+|++|..||............ ...+...+...-.
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~-~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDS-DRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred -cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCch-hHHHHHHHHHhcCChhhcCc
Confidence 1222346899999999999999999999999999999999999887654332111100 1111111111100
Q ss_pred CcHHHHH-Hh---hhhc--CCCCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 241 DTKDFMA-KL---TECL--DPNLTR---YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 241 ~~~~~~~-~l---~~~~--~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
....... .. .... .+.... .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 00 0000 010000 011335678899999999999999999999963
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=292.90 Aligned_cols=263 Identities=25% Similarity=0.416 Sum_probs=207.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
..+|.+.+.||.|+||.||++... +..+++|.+.... ...+.+|+.+++.+ |||++++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 468999999999999999999752 3458899887543 34578899999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCC--------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEE
Q 041031 80 LVYEYAQNGALSDHLHWPSV--------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAK 151 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~--------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~ 151 (313)
++|||+++++|.+++..... .....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 99999999999999853221 12245899999999999999999999999 99999999999999999999
Q ss_pred EeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchh
Q 041031 152 IADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~ 230 (313)
|+|||.+........ ........+++.|+|||++.+..++.++|+||||+++|+|++ |..||......
T Consensus 161 l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---------- 229 (288)
T cd05093 161 IGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---------- 229 (288)
T ss_pred eccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----------
Confidence 999999875433211 111122334678999999998899999999999999999998 89998654321
Q ss_pred HHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccc
Q 041031 231 LVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW 303 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 303 (313)
+....+. ...........+..+.+++.+||+.||.+|||+.++++.|+++...+..+
T Consensus 230 -------------~~~~~i~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~ 286 (288)
T cd05093 230 -------------EVIECIT---QGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVY 286 (288)
T ss_pred -------------HHHHHHH---cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcccc
Confidence 1111111 11111112234457899999999999999999999999999998766544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=288.77 Aligned_cols=269 Identities=21% Similarity=0.301 Sum_probs=203.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCC-ceeeeeEEEeCC-----
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSN-LIELIGYAAGGD----- 76 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~-i~~~~~~~~~~~----- 76 (313)
...|..+++||+|.+|+||+|+.+ |+.||+|.++-+. +....+|+.+++.+ |+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 667899999999999999999988 8899999997553 44578999999999 998 999999998877
Q ss_pred -eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 77 -SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 77 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
.+++|||+. ..+|..+++...... ..++...+..++.|++.||+|||+++ |+||||||.||+++++|.+||+||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeecc
Confidence 899999999 569999996443211 45777899999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
|++....-.. ..-....+|.+|+|||++.+. .|+...||||+||+++||++++..|.+..+. .+...+++.
T Consensus 165 GlAra~~ip~---~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-----~ql~~If~~ 236 (323)
T KOG0594|consen 165 GLARAFSIPM---RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-----DQLFRIFRL 236 (323)
T ss_pred chHHHhcCCc---ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-----HHHHHHHHH
Confidence 9998544211 122334789999999999886 7999999999999999999999999887662 111111111
Q ss_pred HHHHhcCcHHHHHHhhhhcCC--C---CCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 235 MLAVFNDTKDFMAKLTECLDP--N---LTR---YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~~~~--~---~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
....-...+.....+....-+ . ... ..........+++.+||+++|.+|.|++.++++
T Consensus 237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111111111111111111000 0 000 011111367789999999999999999999976
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=289.62 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=205.8
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|++.+.||+|+||.||+|++. ++.++||.+.... ...+.+|+.+++.+ |||++++++.+.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999886 7899999775321 23467899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++.... .....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 9999999998874322 12356788999999999999999999999 9999999999999999999999999887655
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... ..
T Consensus 158 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----------~~---------- 214 (267)
T cd08228 158 SKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------LF---------- 214 (267)
T ss_pred chhH---HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----------HH----------
Confidence 3322 112235788999999999888999999999999999999999998654321 00
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
+....+.....+. ......+..+.+++.+||+.+|++||++.++++.++++.
T Consensus 215 -~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 215 -SLCQKIEQCDYPP--LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -HHHHHHhcCCCCC--CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1111111111111 122344567899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=292.92 Aligned_cols=254 Identities=26% Similarity=0.449 Sum_probs=203.6
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
.++|.+.+.||+|+||.||+|.+. +..+|+|.+.... ...+.+|+++++.+ |+|++++++.+......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 467999999999999999999864 3679999987653 34578899999999 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCC---------CCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc
Q 041031 79 FLVYEYAQNGALSDHLHWPS---------VKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR 149 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~ 149 (313)
+++|||+++++|.+++.... ......+++..+..++.|++.++++||+++ ++|+||+|+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999985332 122345788899999999999999999999 999999999999999999
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccc
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~ 228 (313)
++|+|||.+......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 161 ~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------- 231 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------- 231 (280)
T ss_pred EEECCcccceecccCcce-ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------
Confidence 999999998754322110 11112235678999999999999999999999999999998 99998654331
Q ss_pred hhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+. ...........+..+.+++.+||+.||.+||++.|++++|+
T Consensus 232 ---------------~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 ---------------EVIECIT---QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---------------HHHHHHH---cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111 11122223345567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=289.42 Aligned_cols=249 Identities=25% Similarity=0.434 Sum_probs=200.5
Q ss_pred hcCccccceeccCCeEEEEEeEECC-cceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRG-KNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~-~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.++|.+.+.||+|++|.||.|.+.+ ..+|+|.+.... .+.+.+|+.+++.+ ||||+++++++......+++|||+.
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4678999999999999999998874 469999887543 45688899999999 9999999999999889999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++. .....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++++|||.+........
T Consensus 83 ~~~l~~~i~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 83 NGCLLNYLR----EHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCcHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999984 22346899999999999999999999999 99999999999999999999999998875543221
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +.
T Consensus 156 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----------------------~~ 210 (256)
T cd05113 156 --TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----------------------ET 210 (256)
T ss_pred --eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----------------------HH
Confidence 11112235678999999998889999999999999999998 99998643321 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
...+...... ......+..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 211 ~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 211 VEKVSQGLRL---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1111111111 111223567889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=303.06 Aligned_cols=245 Identities=22% Similarity=0.366 Sum_probs=193.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
..++|+..++||+|+||.||+|.+. ++.||||++.... ...+.+|+++++.+ |+||+++++++...+.+++||
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 4577889999999999999999987 7899999986543 34577899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+.+++|.+.. ...+..+..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++....
T Consensus 152 e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 152 EFMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred ecCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 999999886542 2456778889999999999999999 9999999999999999999999999987654
Q ss_pred CChhhhhhcccccccccccCCccccC-----CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD-----GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
... .......++..|+|||++.. ...+.++|||||||++|+|++|+.||......
T Consensus 220 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~----------------- 279 (353)
T PLN00034 220 QTM---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG----------------- 279 (353)
T ss_pred ccc---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----------------
Confidence 321 11223468999999998853 23456899999999999999999999733221
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....................+..+.+|+.+||+.||++|||+.|+++.
T Consensus 280 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 280 ------DWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------cHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111111111111223455678999999999999999999999975
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=299.06 Aligned_cols=271 Identities=21% Similarity=0.296 Sum_probs=201.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++|++.++||.|+||.||++.+. +..+|+|.+.... ...+.+|+++++.+ ||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 578999999999999999999987 7788999876542 34578899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC-CCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY-TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|+.+++|.+++. ....+++..+..++.|++.|+.|||+. + ++|+||||+||++++++.++|+|||++....
T Consensus 84 ~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999984 345688899999999999999999975 7 9999999999999999999999999986543
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcc---------------cc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQY---------------TE 227 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~---------------~~ 227 (313)
.. ......++..|+|||++.+..++.++|+|||||++|+|++|..||........... ..
T Consensus 156 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 156 DS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hh-----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 21 11223578999999999988899999999999999999999999975432110000 00
Q ss_pred chhHHHHHHHHhcCc---HHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 228 HRSLVDYMLAVFNDT---KDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~---~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
............+.. ..........+...... .....+..+.+|+.+||+.||++|||+.|+++.-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000000000000000 00001111111111111 11123456889999999999999999999986543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=306.36 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=194.8
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
+.|+.++.||+|+||.||+|++. ++.+|+|++.... ...+.+|+.+++.+ ||||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 46899999999999999999987 7789999986532 33467899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 81 E~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 81 DYIPGGDMMSLLI-----RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred ecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 9999999999984 3456889999999999999999999999 9999999999999999999999999875331
Q ss_pred CChhh--------------------------------------------hhhcccccccccccCCccccCCCCCCccchh
Q 041031 163 HSPEI--------------------------------------------AAAASRIVGTFGYLAPEYVRDGCVTTKSDVY 198 (313)
Q Consensus 163 ~~~~~--------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw 198 (313)
..... ........||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 10000 0001124689999999999988899999999
Q ss_pred hHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhc-CCCCCCCCHHHHHHHHHHHhh--c
Q 041031 199 AFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECL-DPNLTRYHKDSMLQMALLSKD--C 275 (313)
Q Consensus 199 slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~l~~li~~--c 275 (313)
||||++|+|++|..||...... +....+.... ..... .....+..+.+|+.+ |
T Consensus 233 SlG~il~elltG~~Pf~~~~~~-----------------------~~~~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~ 288 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTPT-----------------------ETQLKVINWENTLHIP-PQVKLSPEAVDLITKLCC 288 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCHH-----------------------HHHHHHHccccccCCC-CCCCCCHHHHHHHHHHcc
Confidence 9999999999999999764431 1111111100 00010 111234567788888 5
Q ss_pred cccCcCCCCCHHHHHHH
Q 041031 276 VDENWKRRPDMSNAAIR 292 (313)
Q Consensus 276 l~~~p~~Rps~~~ll~~ 292 (313)
+..+|..||++.++++.
T Consensus 289 ~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 289 SAEERLGRNGADDIKAH 305 (381)
T ss_pred CcccccCCCCHHHHhcC
Confidence 56666679999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=300.50 Aligned_cols=236 Identities=26% Similarity=0.372 Sum_probs=191.6
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (313)
+.||+|+||.||++++. +..||+|++... ....+.+|+.+++.+ ||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999986 788999998753 233456799999999 999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhh
Q 041031 89 ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIA 168 (313)
Q Consensus 89 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (313)
+|...+. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--- 149 (323)
T cd05595 81 ELFFHLS-----RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--- 149 (323)
T ss_pred cHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC---
Confidence 9998883 4457899999999999999999999999 9999999999999999999999999876532211
Q ss_pred hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHH
Q 041031 169 AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAK 248 (313)
Q Consensus 169 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
.......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----------------------~~~~~ 206 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------------RLFEL 206 (323)
T ss_pred CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----------------------HHHHH
Confidence 1122346899999999999999999999999999999999999999654321 00111
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 041031 249 LTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAI 291 (313)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~ 291 (313)
+ ..... ......+..+.+++.+||+.||.+|| ++.++++
T Consensus 207 ~---~~~~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 207 I---LMEEI-RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred H---hcCCC-CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1 00110 11223456788999999999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.90 Aligned_cols=237 Identities=25% Similarity=0.344 Sum_probs=192.5
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (313)
+.||+|+||.||++++. ++.+|+|++... ....+.+|+.+++.+ ||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999986 788999998753 233467789999999 999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhh
Q 041031 89 ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIA 168 (313)
Q Consensus 89 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (313)
+|.+.+. ....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--- 149 (328)
T cd05593 81 ELFFHLS-----RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--- 149 (328)
T ss_pred CHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc---
Confidence 9998883 4457899999999999999999999999 9999999999999999999999999986532211
Q ss_pred hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHH
Q 041031 169 AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAK 248 (313)
Q Consensus 169 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
.......+++.|+|||++.+..++.++|||||||++|+|++|..||...+.. +....
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----------------------~~~~~ 206 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------------KLFEL 206 (328)
T ss_pred cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----------------------HHHHH
Confidence 1122346899999999999889999999999999999999999999654321 11111
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 249 LTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
+.. .... .....+..+.+|+++||+.||.+|| ++.++++.
T Consensus 207 ~~~-~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 207 ILM-EDIK---FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred hcc-CCcc---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 100 0111 1223455788899999999999997 88988864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=287.82 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=203.7
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..++|++.+.||+|++|.||+|.+. ++.+++|.++... ...+.+|+.+++.+ |||++++++++...+..+++||++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 3567999999999999999999876 6679999987653 45688899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++++|.+++... ....+++..+..++.|++.|+.+||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 84 KYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999998422 1346889999999999999999999999 9999999999999999999999999987665321
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. ........+..|+|||++.+..++.++|+||||+++|+|++ |+.||.+.... .
T Consensus 158 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------------~ 212 (261)
T cd05068 158 Y--EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----------------------E 212 (261)
T ss_pred c--cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------------------H
Confidence 1 11111223468999999998889999999999999999999 99999654321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
....+...... ......+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 213 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 213 VLQQVDQGYRM---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHcCCCC---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11111111110 1122345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=299.17 Aligned_cols=234 Identities=25% Similarity=0.343 Sum_probs=188.9
Q ss_pred eccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCCh
Q 041031 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 20 lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (313)
||+|+||.||+|.+. ++.+|+|.+... ....+.+|+.+++.+ ||||+++++.+.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999987 678999988643 233466899999999 99999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhh
Q 041031 91 SDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA 170 (313)
Q Consensus 91 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 170 (313)
.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~ 149 (312)
T cd05585 81 FHHLQ-----REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---DK 149 (312)
T ss_pred HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC---Cc
Confidence 99984 3456899999999999999999999999 9999999999999999999999999987533221 12
Q ss_pred cccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhh
Q 041031 171 ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLT 250 (313)
Q Consensus 171 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
.....+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------------~~~~~------------- 204 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------------EMYRK------------- 204 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------------HHHHH-------------
Confidence 22346899999999999999999999999999999999999999643221 11111
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC---HHHHHH
Q 041031 251 ECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD---MSNAAI 291 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~ll~ 291 (313)
...... ......+..+.+++.+||+.||.+||+ +.+++.
T Consensus 205 -~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 205 -ILQEPL-RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -HHcCCC-CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 111111 112234567889999999999999986 455553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=304.57 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=197.7
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|.+.+.||+|+||.||++++. ++.+|+|.++... ...+.+|+.+++.+ ||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999987 7889999987542 33467889999998 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++. .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~----~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLN----RYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 9999999999985 22357899999999999999999999999 9999999999999999999999999987654
Q ss_pred CChhhhhhcccccccccccCCcccc------CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVR------DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
.... .......+++.|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 154 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---------------- 215 (330)
T cd05601 154 ANKM--VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---------------- 215 (330)
T ss_pred CCCc--eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH----------------
Confidence 3322 1222346889999999986 456788999999999999999999999654321
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.....+...............+..+.+|+.+||. +|.+|||+.++++.
T Consensus 216 -------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 216 -------KTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0011111110000000112345678889999998 99999999998853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=306.87 Aligned_cols=249 Identities=23% Similarity=0.323 Sum_probs=198.6
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
...++|++.++||+|+||.||++++. ++.+|+|.+... ....+.+|+.+++.+ ||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999987 788999998642 223466899999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+||||+++|+|.+++. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 120 lv~Ey~~gg~L~~~l~------~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 120 MVMEYMPGGDLVNLMS------NYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecccee
Confidence 9999999999999984 235788889999999999999999999 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCC----CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDG----CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
....... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 191 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------------- 253 (370)
T cd05596 191 KMDANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------------- 253 (370)
T ss_pred eccCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---------------
Confidence 6543221 122234689999999998653 3788999999999999999999999754321
Q ss_pred HHHhcCcHHHHHHhhhhcCCCCC-CCCHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 041031 236 LAVFNDTKDFMAKLTECLDPNLT-RYHKDSMLQMALLSKDCVDENWKR--RPDMSNAAIR 292 (313)
Q Consensus 236 ~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~ll~~ 292 (313)
.....+..... .+. ......+..+.+|+.+||..+|.+ |||+.++++.
T Consensus 254 --------~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 254 --------GTYSKIMDHKN-SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --------HHHHHHHcCCC-cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111111000 011 112234567888999999999987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=307.14 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=194.3
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|+++++||+|+||.||++.+. ++.||||.+.... ...+.+|+++++.+ ||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999886 7889999886432 34567899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++|+|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLI-----KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999999999983 3456889999999999999999999999 9999999999999999999999999986322
Q ss_pred CChhh-----------hh---------------------------------hcccccccccccCCccccCCCCCCccchh
Q 041031 163 HSPEI-----------AA---------------------------------AASRIVGTFGYLAPEYVRDGCVTTKSDVY 198 (313)
Q Consensus 163 ~~~~~-----------~~---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Diw 198 (313)
..... .. ......||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 10000 00 00013589999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhcccc
Q 041031 199 AFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDE 278 (313)
Q Consensus 199 slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 278 (313)
||||++|+|++|..||...... +....+...............+..+.+|+.+||.
T Consensus 233 SlGvil~elltG~~Pf~~~~~~-----------------------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~- 288 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSH-----------------------ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT- 288 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHH-----------------------HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-
Confidence 9999999999999999654321 1111111110000000111234568889999998
Q ss_pred CcCCC---CCHHHHHHH
Q 041031 279 NWKRR---PDMSNAAIR 292 (313)
Q Consensus 279 ~p~~R---ps~~~ll~~ 292 (313)
+|.+| +|+.+++..
T Consensus 289 ~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 289 NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CHhhcCCCCCHHHHhcC
Confidence 77765 599998865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=289.91 Aligned_cols=252 Identities=26% Similarity=0.467 Sum_probs=205.8
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
+...+|++.++||.|+||.||+|.+. +..+++|.+.... ...+.+|+.+++.+ |||++++++++.+.+..+++||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 44678999999999999999999987 6889999987654 35678899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++++|.+++... ....++...++.++.|++.|++|||+++ ++|+||+|+||++++++.++++|||.+.....
T Consensus 83 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 83 LMEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ecccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999532 2356889999999999999999999999 99999999999999999999999999876543
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ......++..|+|||++.+..++.++|+||||+++|+|++ |..||......
T Consensus 157 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---------------------- 211 (261)
T cd05148 157 DVY---LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---------------------- 211 (261)
T ss_pred ccc---cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----------------------
Confidence 211 1112235678999999988889999999999999999998 89999654321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
+....+...... ......+..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 212 -~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 212 -EVYDQITAGYRM---PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -HHHHHHHhCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111111111111 1223445678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=307.56 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=195.2
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|++++.||+|+||.||+|++. ++.+|||++... ....+.+|+.+++.+ ||||+++++.+.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999987 788999998643 234577899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++|+|.+++. ....+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||++....
T Consensus 81 E~~~~g~L~~~i~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLI-----RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 9999999999983 3456888999999999999999999999 9999999999999999999999999875321
Q ss_pred CChh----------------------------------------hhhhcccccccccccCCccccCCCCCCccchhhHHH
Q 041031 163 HSPE----------------------------------------IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGV 202 (313)
Q Consensus 163 ~~~~----------------------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ 202 (313)
.... .........||+.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 0000 000011236899999999999999999999999999
Q ss_pred HHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcC
Q 041031 203 VLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWK 281 (313)
Q Consensus 203 ~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~ 281 (313)
++|+|++|..||...... +....+..+. ..+.. .....+..+.+++.+|+ .+|.
T Consensus 233 ilyell~G~~Pf~~~~~~-----------------------~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~l~-~~p~ 287 (376)
T cd05598 233 ILYEMLVGQPPFLADTPA-----------------------ETQLKVINWE-TTLHIPSQAKLSREASDLILRLC-CGAE 287 (376)
T ss_pred eeeehhhCCCCCCCCCHH-----------------------HHHHHHhccC-ccccCCCCCCCCHHHHHHHHHHh-cCHh
Confidence 999999999999765431 1111111100 00000 11234456777888876 4999
Q ss_pred CCC---CHHHHHHH
Q 041031 282 RRP---DMSNAAIR 292 (313)
Q Consensus 282 ~Rp---s~~~ll~~ 292 (313)
+|+ |+.++++.
T Consensus 288 ~R~~~~t~~ell~h 301 (376)
T cd05598 288 DRLGKNGADEIKAH 301 (376)
T ss_pred hcCCCCCHHHHhCC
Confidence 999 88998865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=287.79 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=199.5
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
++|.+.+.||.|++|.||.|.+. ++.+++|.+.... ...+.+|+++++.+ ||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999875 7899999876432 23467899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
++|++++++|.+.+. ....+++..+..++.|++.|+++||+.+ ++|+||+|+||++++++.++|+|||.+..
T Consensus 82 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLK-----AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 999999999999984 3456888999999999999999999999 99999999999999999999999999875
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
...............++..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------------------- 213 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------------------- 213 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--------------------
Confidence 433211111112235678999999999988999999999999999999999999643221
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...... .............+..+.+++++||..+|.+|||+.++++.
T Consensus 214 ---~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 214 ---AAIFKI--ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---HHHHHH--hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000000 00111111233455678899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=293.44 Aligned_cols=246 Identities=34% Similarity=0.575 Sum_probs=192.9
Q ss_pred cccceeccCCeEEEEEeEEC------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 15 STSLKIGQGSYGSVYLGKLR------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 15 ~~~~~lg~g~~g~v~~~~~~------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.+.+.||.|.||.||+|.+. +..|+||.++... .+.+.+|++.++++ ||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 45789999999999999988 5679999996543 45688899999999 9999999999998888999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++|+|.+++... ....++...++.++.|++.||+|||+++ ++|+||+++||++++++.+||+|||++.....
T Consensus 82 ~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp --TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 99999999999522 2467899999999999999999999999 99999999999999999999999999887632
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.... ...........|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---------------------- 212 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---------------------- 212 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH----------------------
T ss_pred cccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------------
Confidence 2111 22222356788999999998889999999999999999999 67887544321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
+....+... ........++..+.+++.+||+.+|.+|||+.+|+++|
T Consensus 213 -~~~~~~~~~---~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 213 -EIIEKLKQG---QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -HHHHHHHTT---EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ccccccccc---ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 222222211 11122334566788999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=311.94 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=199.6
Q ss_pred cCccccceeccCCeEEEEEeEEC---CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR---GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~---~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
..|.+.+.||+|++|.||+|... +..+++|.+.... ...+..|+.+++.+ ||||+++++.+...+.+++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34999999999999999999875 4568888775443 23466799999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++|+|.+.+.... ....++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 147 ~~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 147 GSGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999998874321 23456889999999999999999999999 999999999999999999999999998865432
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||...... +
T Consensus 223 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----------------------~ 278 (478)
T PTZ00267 223 VSL-DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----------------------E 278 (478)
T ss_pred ccc-ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----------------------H
Confidence 211 1223346899999999999999999999999999999999999999643321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
....+. ...........+..+.+++.+||..||++|||+.+++.
T Consensus 279 ~~~~~~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 279 IMQQVL---YGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHH---hCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111111 11111122234567889999999999999999999875
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=306.39 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=192.8
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
+.|+++++||+|+||.||+|++. ++.+|+|.+.... ...+.+|+.+++.+ ||||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36899999999999999999986 7789999987542 34577899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++|+|.+++. ....+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||++....
T Consensus 81 E~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 81 DYIPGGDMMSLLI-----RMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred eCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 9999999999984 3456889999999999999999999999 9999999999999999999999999875321
Q ss_pred CChhh--------------------------------------------hhhcccccccccccCCccccCCCCCCccchh
Q 041031 163 HSPEI--------------------------------------------AAAASRIVGTFGYLAPEYVRDGCVTTKSDVY 198 (313)
Q Consensus 163 ~~~~~--------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw 198 (313)
..... ........||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 10000 0001123588999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhcccc
Q 041031 199 AFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDE 278 (313)
Q Consensus 199 slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 278 (313)
||||++|+|++|..||...... +....+...............+....+++.+|+ .
T Consensus 233 SlGvil~elltG~~Pf~~~~~~-----------------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~ 288 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTPL-----------------------ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-R 288 (382)
T ss_pred echHHHHHHHhCCCCCCCCCHH-----------------------HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-c
Confidence 9999999999999999754331 111111111100000011223456677787766 4
Q ss_pred CcCCCCC---HHHHHH
Q 041031 279 NWKRRPD---MSNAAI 291 (313)
Q Consensus 279 ~p~~Rps---~~~ll~ 291 (313)
+|.+|++ +.++++
T Consensus 289 ~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 289 GPEDRLGKNGADEIKA 304 (382)
T ss_pred CHhHcCCCCCHHHHhc
Confidence 9999997 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=303.25 Aligned_cols=199 Identities=26% Similarity=0.421 Sum_probs=171.7
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|++.+.||+|+||.||+|.+. ++.+|+|++.... ...+..|..++..+ |++|+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999887 7889999986532 23467899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++|+|.+++. ....+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++....
T Consensus 81 E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLM-----KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 9999999999984 4467899999999999999999999999 9999999999999999999999999987543
Q ss_pred CChhh--------------------------------hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhC
Q 041031 163 HSPEI--------------------------------AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210 (313)
Q Consensus 163 ~~~~~--------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg 210 (313)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 21100 0001124689999999999999999999999999999999999
Q ss_pred CCCccCCC
Q 041031 211 QQALSRDA 218 (313)
Q Consensus 211 ~~p~~~~~ 218 (313)
..||.+..
T Consensus 233 ~~Pf~~~~ 240 (363)
T cd05628 233 YPPFCSET 240 (363)
T ss_pred CCCCCCCC
Confidence 99997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=291.89 Aligned_cols=247 Identities=24% Similarity=0.331 Sum_probs=197.9
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.|++.++||+|+||.||++.+. ++.||+|.+.... ...+.+|+.+++.+ ||||+++++.+...+..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4889999999999999999986 7889999986542 22356799999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+.+++|.+.+.. .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||++.....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYN---MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHh---cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999988742 12346899999999999999999999999 99999999999999999999999999876543
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
... .....++..|+|||++.+..++.++||||+|+++|+|++|..||.+..... .
T Consensus 155 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--------~------------- 209 (285)
T cd05605 155 GET----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--------K------------- 209 (285)
T ss_pred CCc----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--------H-------------
Confidence 211 122357899999999998889999999999999999999999997543310 0
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
...+...+...........+..+.+|+.+||..||.+|| ++.++++.
T Consensus 210 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 210 --REEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --HHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 001111111111112233556788999999999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=307.89 Aligned_cols=197 Identities=26% Similarity=0.369 Sum_probs=172.8
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc--C-----CCceeeeeEEEeCCeE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV--H-----SNLIELIGYAAGGDSL 78 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l--h-----~~i~~~~~~~~~~~~~ 78 (313)
+..+|.+.+.||+|.||.|.+|.+. ++.||||+++... ..+...|+.+|+.+ | -|+|+++++|...++.
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 3457899999999999999999987 7889999998765 44566789999998 3 2799999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC--CcEEEeecc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN--FRAKIADFG 156 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~--~~~~l~dfg 156 (313)
|||+|.+ ..+|.++++.. +...++...++.++.|++.||.+||..+ |+|+||||+|||+.+- ..||++|||
T Consensus 264 ciVfELL-~~NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeehhh-hhhHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecc
Confidence 9999999 67999999633 3456999999999999999999999999 9999999999999753 469999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCC
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDAN 219 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~ 219 (313)
+++......- .-..+..|+|||++.|..|+.+.|||||||+++||++|.+.|.+.+.
T Consensus 337 SSc~~~q~vy------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 337 SSCFESQRVY------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cccccCCcce------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 9997664322 33678899999999999999999999999999999999999988776
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=291.75 Aligned_cols=261 Identities=22% Similarity=0.339 Sum_probs=193.1
Q ss_pred cCccccceeccCCeEEEEEeEEC---CcceEEEeccccc-----cHHHHHHHHHHHhc----CCCceeeeeEEE-----e
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR---GKNAAIKQMKNTK-----SKEFSSELKILCKV----HSNLIELIGYAA-----G 74 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~---~~~~aiK~~~~~~-----~~~~~~e~~~l~~l----h~~i~~~~~~~~-----~ 74 (313)
.+|++.+.||+|+||.||+|++. +..+|+|.+.... .....+|+.+++.+ ||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999874 5679999886432 23455677777765 999999999885 3
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
...++++||+++ ++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcc
Confidence 456899999995 6898888422 2345889999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
||++...... .......+++.|+|||++.+..++.++|||||||++|+|++|.+||.+..... .+...
T Consensus 154 fg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--------~~~~i 221 (290)
T cd07862 154 FGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--------QLGKI 221 (290)
T ss_pred ccceEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--------HHHHH
Confidence 9998765432 12223467899999999998889999999999999999999999997654321 11111
Q ss_pred HHHHh-cCcHHHHH---HhhhhcCCCCCC----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 235 MLAVF-NDTKDFMA---KLTECLDPNLTR----YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 235 ~~~~~-~~~~~~~~---~l~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
..... +...++.. .......+.... .....+..+.+|+.+||+.||++|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 11000 00000000 000111111110 11234456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=286.47 Aligned_cols=272 Identities=25% Similarity=0.361 Sum_probs=210.5
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccc-----cccHHHHHHHHHHHhc-CCCceeeeeEEEe-----
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKN-----TKSKEFSSELKILCKV-HSNLIELIGYAAG----- 74 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~-----~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~----- 74 (313)
..+...|..++.||.|.+|.|+.|.++ |+.||||.+.. ....+..+|+.+|+.+ |+||+.+++.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 345667778899999999999999988 88999999872 2356678999999999 9999999999864
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
-+.+|+|+|++ +.+|.+.+ ..+..++...+..++.|++.||+|+|+.+ ++|+|+||+|++++.+..+|++|
T Consensus 98 f~DvYiV~elM-etDL~~ii-----k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQII-----KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred cceeEEehhHH-hhHHHHHH-----HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecc
Confidence 46799999999 66899998 34555999999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhhhhhcccccccccccCCcccc-CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR-DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
||+|+..... ........-..|.+|+|||++. ...|+...||||+||++.||++|++.|.+.+... ...
T Consensus 169 FGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~---------Ql~ 238 (359)
T KOG0660|consen 169 FGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH---------QLQ 238 (359)
T ss_pred ccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH---------HHH
Confidence 9999987643 2122223446899999999886 4679999999999999999999999998876532 111
Q ss_pred HHHHHh-cCcHHHHHHhh-----hhcC-----CC--CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 234 YMLAVF-NDTKDFMAKLT-----ECLD-----PN--LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 234 ~~~~~~-~~~~~~~~~l~-----~~~~-----~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
.+.... .-..+....+. ..+. +. .............+|+.+||..||.+|+|++|+|+.=---..
T Consensus 239 lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 239 LILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 122211 11222222221 0111 11 111334556678899999999999999999999976543333
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=302.92 Aligned_cols=260 Identities=24% Similarity=0.398 Sum_probs=204.4
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCC
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGD 76 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~ 76 (313)
..++|++.++||.|+||.||+|.+. +..||||.+.... .+.+.+|+.+++.+ ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3578899999999999999999874 2358999997543 34577899999999 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCC---------------------------------------------------------
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSV--------------------------------------------------------- 99 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 99 (313)
..++||||+++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999988753210
Q ss_pred ----------------------------------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC
Q 041031 100 ----------------------------------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD 145 (313)
Q Consensus 100 ----------------------------------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~ 145 (313)
.....+++..+..++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 01134778888999999999999999999 99999999999999
Q ss_pred CCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCc
Q 041031 146 SNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQ 224 (313)
Q Consensus 146 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~ 224 (313)
+++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--- 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--- 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---
Confidence 9999999999998765432211 11222345678999999998889999999999999999997 889986542210
Q ss_pred cccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 225 YTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
.+...+...... ......+..+.+++.+||+.+|++|||+.+|.++|+++..
T Consensus 348 -------------------~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 -------------------TFYNKIKSGYRM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -------------------HHHHHHhcCCCC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111111111111 1223445678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=297.20 Aligned_cols=240 Identities=28% Similarity=0.409 Sum_probs=191.5
Q ss_pred ccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHH---hc-CCCceeeeeEEEeCCeEEEE
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILC---KV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~---~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
|.+.+.||+|+||.||+|.+. ++.||||.++... .+.+..|.+++. .+ ||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678999999999999999987 7889999987432 334566666654 44 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++++|...+. ...+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+||+|||++...
T Consensus 81 ~E~~~~~~L~~~~~------~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999998873 346899999999999999999999999 999999999999999999999999987643
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.... .......+++.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 152 ~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------------------- 207 (324)
T cd05589 152 MGFG---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------------------- 207 (324)
T ss_pred CCCC---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---------------------
Confidence 2211 1222346889999999999999999999999999999999999999754321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
+....+... ... .....+..+.+++.+||..||.+|| ++.++++.
T Consensus 208 --~~~~~i~~~-~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 208 --EVFDSIVND-EVR---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --HHHHHHHhC-CCC---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 111111110 011 1223456788899999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=274.93 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=208.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|.+.+.||+|.||.||.|+.+ +.-||+|++.+.. ..++.+|+++-..| ||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4578999999999999999999987 5668999987654 44577889998889 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
++||...|++...|.. .....+++...+.++.|++.|+.|+|.++ |+|+||||+|+|++..+.+|++|||.+..
T Consensus 100 ilEya~~gel~k~L~~---~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQE---GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEecCCchHHHHHHh---cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceee
Confidence 9999999999999842 24567899999999999999999999999 99999999999999999999999999887
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
... ......+||..|+|||...+..++...|+|++|++.||++.|.+||......
T Consensus 174 ~p~-----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-------------------- 228 (281)
T KOG0580|consen 174 APS-----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-------------------- 228 (281)
T ss_pred cCC-----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--------------------
Confidence 542 3455678999999999999999999999999999999999999999754421
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+..+.+...- +. .....+....+||.+|+..+|.+|.+..|+++.=+
T Consensus 229 ---etYkrI~k~~---~~-~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 229 ---ETYKRIRKVD---LK-FPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred ---HHHHHHHHcc---cc-CCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 2233332211 11 12445567888999999999999999999987543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.71 Aligned_cols=231 Identities=26% Similarity=0.385 Sum_probs=187.1
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|+||.||+|+++ ++.||+|++... .......|..++..+ ||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999987 778999998643 233456788888776 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~L~~~i~-----~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-- 150 (320)
T cd05590 81 GDLMFHIQ-----KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-- 150 (320)
T ss_pred chHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--
Confidence 99999883 4456899999999999999999999999 9999999999999999999999999877533221
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.......+++.|+|||++.+..++.++|||||||++|+|++|+.||...... +...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----------------------~~~~ 206 (320)
T cd05590 151 -KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----------------------DLFE 206 (320)
T ss_pred -CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----------------------HHHH
Confidence 1222346899999999999999999999999999999999999999754321 1111
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM 286 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 286 (313)
.+. .... ......+..+.+++++||+.||.+||++
T Consensus 207 ~i~---~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 207 AIL---NDEV-VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHh---cCCC-CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 111 1110 1122344578889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=297.36 Aligned_cols=236 Identities=27% Similarity=0.388 Sum_probs=190.2
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-C-CCceeeeeEEEeCCeEEEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-H-SNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h-~~i~~~~~~~~~~~~~~lv~ 82 (313)
+|++.+.||+|+||.||+|.+. ++.||+|++... ..+.+..|..++..+ | ++++++++++.+.+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999987 568999998643 234466788888888 4 56889999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 E~~~~g~L~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQ-----QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 9999999999883 3456889999999999999999999999 9999999999999999999999999876432
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... .......+++.|+|||++.+..++.++||||+||++|+|++|+.||.+....
T Consensus 153 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---------------------- 207 (324)
T cd05587 153 FGG---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---------------------- 207 (324)
T ss_pred CCC---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------------------
Confidence 211 1222346899999999999999999999999999999999999999754321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM 286 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 286 (313)
+....+.. .. .......+..+.+++++||..||.+|++.
T Consensus 208 -~~~~~i~~---~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 208 -ELFQSIME---HN-VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -HHHHHHHc---CC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11111111 11 01122345578899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=284.76 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=206.0
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|++.+.||+|++|.||+|.+. ++.+++|.++.. ..+.+.+|+++++.+ |+|++++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999987 888999987532 144577899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++.... .....++...++.++.+++.++++||+.+ ++|+||+|+||+++.++.++++|||.+....
T Consensus 82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 9999999999885322 23456889999999999999999999999 9999999999999999999999999887544
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ..+
T Consensus 158 ~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~~--------- 215 (267)
T cd08224 158 SKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------LYS--------- 215 (267)
T ss_pred CCCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----------HHH---------
Confidence 3211 112235788899999999888999999999999999999999998644321 101
Q ss_pred HHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
....+.. ..... .....+..+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 216 --~~~~~~~---~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 216 --LCKKIEK---CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --HHhhhhc---CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111111 11111 12245567889999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=290.15 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=203.5
Q ss_pred CccccceeccCCeEEEEEeEECC-------cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~~-------~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
+|++.+.||+|+||.||+|.+.. ..+++|.+.... ...+.+|+.+++.+ ||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998752 458888886543 33577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCC-------------------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCC
Q 041031 81 VYEYAQNGALSDHLHWPSV-------------------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSN 141 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~-------------------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~n 141 (313)
++||+.+++|.+++..... .....++...++.++.|++.||.|||+.+ ++|+||+|+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999998753221 11235788999999999999999999999 9999999999
Q ss_pred eeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCC
Q 041031 142 ILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANP 220 (313)
Q Consensus 142 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~ 220 (313)
|++++++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999998765432221 11222345678999999988889999999999999999998 99999654321
Q ss_pred CCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 221 GNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
+....+....... .....+..+.+++.+||+.+|.+||++.++++.|+++...
T Consensus 237 -----------------------~~~~~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 -----------------------RLFNLLKTGYRME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -----------------------HHHHHHhCCCCCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1111111111111 1223446788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=290.04 Aligned_cols=261 Identities=24% Similarity=0.414 Sum_probs=207.6
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEecccccc---HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTKS---KEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~~---~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
..+|.+.+.||+|+||.||+|++. +..+++|.+..... ..+.+|+++++.+ |+|++++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 356899999999999999999753 34588888876543 4578899999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCC-----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC
Q 041031 80 LVYEYAQNGALSDHLHWPSV-----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF 148 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~ 148 (313)
+||||+++++|.+++..... .....+++..++.++.|++.|++|||+++ ++|+||+|+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 99999999999999853221 12345889999999999999999999999 99999999999999999
Q ss_pred cEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCcccc
Q 041031 149 RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTE 227 (313)
Q Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~ 227 (313)
.++|+|||++........ ........++..|+|||++.+..++.++||||||+++|+|+| |..||......
T Consensus 161 ~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------- 232 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------- 232 (291)
T ss_pred cEEECCCCcccccCCCce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------
Confidence 999999999875543221 111222345788999999999999999999999999999999 99998654331
Q ss_pred chhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 228 HRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
+....+ ............+..+.+++.+||+.+|.+|||+.+|+++|.++....+
T Consensus 233 ----------------~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 233 ----------------EVIECI---TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred ----------------HHHHHH---hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 111111 1111111222345678899999999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=295.71 Aligned_cols=236 Identities=25% Similarity=0.382 Sum_probs=187.7
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|+||.||+|++. ++.||+|.++... .+....|..++... ||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999987 6779999987532 23345566666655 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~L~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-- 150 (316)
T cd05592 81 GDLMFHIQ-----SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-- 150 (316)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--
Confidence 99999883 3456899999999999999999999999 9999999999999999999999999987543221
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. +...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----------------------~~~~ 206 (316)
T cd05592 151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----------------------ELFD 206 (316)
T ss_pred -CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----------------------HHHH
Confidence 1222346899999999999988999999999999999999999999754321 1111
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHH-HHHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS-NAAI 291 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~ll~ 291 (313)
.+.. ..+. .....+..+.+++.+||+.||.+||++. ++++
T Consensus 207 ~i~~-~~~~---~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 207 SILN-DRPH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHc-CCCC---CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1111 0111 1223445678899999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=285.84 Aligned_cols=248 Identities=25% Similarity=0.434 Sum_probs=199.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
..+|++.+.||+|+||.||+|.+. +..+++|.+.... ...+.+|+++++.+ |||++++++++...+..+++||+++
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 356899999999999999999887 5579999987543 45677899999999 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++. .....+++..++.++.|++.|+++||+.+ ++|+||+|+||++++++.++++|||.+........
T Consensus 83 ~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 83 NGCLLNYLR----ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999984 22346889999999999999999999999 99999999999999999999999998875442211
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
........+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... +.
T Consensus 156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------------~~ 210 (256)
T cd05059 156 --TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----------------------EV 210 (256)
T ss_pred --cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----------------------HH
Confidence 11111223467999999998889999999999999999999 78998654321 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
...+...... ......+..+.+++.+||+.+|++|||+.++++.|
T Consensus 211 ~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 211 VESVSAGYRL---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHcCCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1111111111 11223456789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=288.56 Aligned_cols=244 Identities=21% Similarity=0.307 Sum_probs=192.0
Q ss_pred eccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCCh
Q 041031 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 20 lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (313)
||+|+||.||+++.+ ++.+|+|.+.... ......|+++++.+ ||||+++++.+.+....+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999887 8899999886432 22345689999999 99999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhh
Q 041031 91 SDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA 170 (313)
Q Consensus 91 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 170 (313)
.+.+.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~ 150 (277)
T cd05607 81 KYHIYN---VGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----T 150 (277)
T ss_pred HHHHHh---ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----e
Confidence 988742 12345888899999999999999999999 9999999999999999999999999987654321 1
Q ss_pred cccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhh
Q 041031 171 ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLT 250 (313)
Q Consensus 171 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
.....++..|+|||++.+..++.++|+||+||++|+|++|..||....... .. .....
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--------~~--------------~~~~~ 208 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--------AK--------------EELKR 208 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--------hH--------------HHHHH
Confidence 123457899999999998889999999999999999999999996543210 00 00111
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 251 ECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
..+...........+..+.+|+.+||+.||.+||++.|+++.+..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 209 RTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred HhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 111111111122345678899999999999999999777654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=286.51 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=205.6
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|++.+.||.|++|.||+|.+. ++.++||.+.... ...+.+|+.+++.+ |||++++++.+...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 68999999999999999999975 8899999775421 34577899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|++++++|.+++.... .....+++..++.++.|++.+++|||+++ ++|+||+|+||+++.++.++++|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999999885322 23456889999999999999999999999 9999999999999999999999999877654
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ..
T Consensus 158 ~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~---------- 214 (267)
T cd08229 158 SKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------LY---------- 214 (267)
T ss_pred cCCc---ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----------HH----------
Confidence 3221 112235788999999999888999999999999999999999999654321 00
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
.....+.....+.. .....+..+.+++.+||+.+|.+|||+.+|++.+.++-
T Consensus 215 -~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 215 -SLCKKIEQCDYPPL--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -HHhhhhhcCCCCCC--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11111111111111 12345567899999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=298.87 Aligned_cols=263 Identities=23% Similarity=0.284 Sum_probs=197.2
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCC----
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGGD---- 76 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~---- 76 (313)
...++|++.+.||+|+||.||++.+. +..+|+|.+... ....+.+|+.+++.+ ||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 56789999999999999999999886 788999998643 244567899999999 999999999986443
Q ss_pred --eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 77 --SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 77 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
.++++|||+++ +|.+.+. ..++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEec
Confidence 57999999965 6666652 24788889999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
||++....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+... .+...
T Consensus 167 fg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~--------~~~~~ 234 (359)
T cd07876 167 FGLARTACTNF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID--------QWNKV 234 (359)
T ss_pred CCCccccccCc----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHH
Confidence 99987543221 1122357899999999999999999999999999999999999997654311 11111
Q ss_pred HHHHhcCcHHHHHHhh----hh-------------------cCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 235 MLAVFNDTKDFMAKLT----EC-------------------LDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~----~~-------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.........++...+. .. ..+............+.+|+.+||..||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 235 IEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111111111110 00 000000011122456889999999999999999999998
Q ss_pred HHH
Q 041031 292 RLS 294 (313)
Q Consensus 292 ~l~ 294 (313)
.-+
T Consensus 315 hp~ 317 (359)
T cd07876 315 HPY 317 (359)
T ss_pred Cch
Confidence 644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=289.35 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=199.2
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
..++|++.+.||+|++|.||+|.+. +..+|+|.+.... ...+.+|+.+++.+ ||||+++++.+.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999999865 3569999886432 23467899999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCC-----CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEE
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVK-----GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKI 152 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l 152 (313)
.+++|||+++++|.+++...... ....++...+..++.|++.||.|||+.+ ++|+||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998532211 1234577888999999999999999999 999999999999999999999
Q ss_pred eeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhH
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~ 231 (313)
+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 161 ~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~----------- 228 (277)
T cd05062 161 GDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----------- 228 (277)
T ss_pred CCCCCccccCCccee-ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------
Confidence 999988754332111 11112234678999999998889999999999999999999 68888644321
Q ss_pred HHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 232 VDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+. ...........+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 229 ------------~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 229 ------------QVLRFVM---EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ------------HHHHHHH---cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111111 11111122234457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=302.88 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=197.4
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
+....++|++.+.||+|+||.||++++. ++.+|+|.+... ....+.+|..+++.+ ||||+++++.+.+.+.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445678999999999999999999987 778999998642 233467889999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
+++||||+++|+|.+++. ...+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~------~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999984 234788899999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCC----CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG----CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
+........ .......+|+.|+|||++.+. .++.++|+||+||++|+|++|..||......
T Consensus 189 a~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------------- 253 (370)
T cd05621 189 CMKMDETGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------------- 253 (370)
T ss_pred ceecccCCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------------
Confidence 876543221 122345689999999999754 3788999999999999999999999754321
Q ss_pred HHHHHhcCcHHHHHHhhhhc-CCCCCCCCHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 041031 234 YMLAVFNDTKDFMAKLTECL-DPNLTRYHKDSMLQMALLSKDCVDENWKR--RPDMSNAAIR 292 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~ll~~ 292 (313)
.....+.... ..... .....+..+.+++..||..++.. |+|+.++++.
T Consensus 254 ----------~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 254 ----------GTYSKIMDHKNSLNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----------HHHHHHHhCCcccCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0011111100 01111 11234566788999999865543 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=296.64 Aligned_cols=238 Identities=27% Similarity=0.377 Sum_probs=191.6
Q ss_pred cceeccCCeEEEEEeEEC-----CcceEEEeccccc-------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 17 SLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK-------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~-------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
++.||+|+||.||+++.. ++.+|+|++.... ...+..|+.+++.+ ||||+++++.+..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 468999999999999863 6789999986432 23456899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++++|.+.+. ....+.+..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 81 YLSGGELFMHLE-----REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCCchHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 999999999983 4456788889999999999999999999 99999999999999999999999999864332
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
.. .......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 153 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~----------------------- 206 (323)
T cd05584 153 EG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK----------------------- 206 (323)
T ss_pred CC---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----------------------
Confidence 21 1122346899999999999888999999999999999999999999754321
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
.....+ ..... ......+..+.+++++||+.+|++|| ++.++++.
T Consensus 207 ~~~~~~---~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 207 KTIDKI---LKGKL-NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHHH---HcCCC-CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111111 11111 11223445788999999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=312.31 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=202.9
Q ss_pred HHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC-
Q 041031 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGD- 76 (313)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~- 76 (313)
.++....+|.+.+.||+|+||.||+|++. ++.||||.+.... ...+.+|+.++..+ |+|++++...+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 44556789999999999999999999876 8899999986532 33467788889888 999999988775332
Q ss_pred -------eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc
Q 041031 77 -------SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR 149 (313)
Q Consensus 77 -------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~ 149 (313)
.+++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 3689999999999999985432 23457899999999999999999999999 999999999999999999
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccch
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 229 (313)
++|+|||++........ ........+++.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 182 vkL~DFGls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--------- 251 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--------- 251 (496)
T ss_pred EEEEecccCeecccccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---------
Confidence 99999999876543211 11222346899999999999999999999999999999999999999653321
Q ss_pred hHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 230 SLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+ +...........+..+.+++.+||+.||.+||++.++++.
T Consensus 252 --------------~~~~~~---~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 --------------EVMHKT---LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --------------HHHHHH---hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111 1111111233455678899999999999999999999864
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.15 Aligned_cols=237 Identities=25% Similarity=0.342 Sum_probs=191.0
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (313)
+.||+|+||.||++.+. ++.+|+|++.... ......|+++++.+ ||||+++.+++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999886 7889999987532 33456788889888 999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 89 ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 89 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
+|.+++. ....+++..+..++.|++.||+|||+ .+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 151 (325)
T cd05594 81 ELFFHLS-----RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA- 151 (325)
T ss_pred cHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-
Confidence 9998883 44578999999999999999999997 78 99999999999999999999999999865332211
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
......+++.|+|||++.+..++.++|||||||++|+|++|..||...... +...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----------------------~~~~ 206 (325)
T cd05594 152 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------------KLFE 206 (325)
T ss_pred --ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----------------------HHHH
Confidence 122346899999999999989999999999999999999999999654321 0111
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
.+.. .... .....+..+.+++.+||+.||.+|+ ++.++++.
T Consensus 207 ~i~~-~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 207 LILM-EEIR---FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHhc-CCCC---CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1100 0111 1223445788899999999999997 89998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=283.98 Aligned_cols=244 Identities=26% Similarity=0.435 Sum_probs=193.1
Q ss_pred ceeccCCeEEEEEeEEC--C---cceEEEecccccc----HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--G---KNAAIKQMKNTKS----KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~---~~~aiK~~~~~~~----~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
++||+|+||.||+|.+. + ..+++|.+..... +.+.+|+.+++.+ |||++++++++.. +..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 47999999999999875 2 5799999876543 3577899999999 9999999998764 467999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++. ....+++..++.++.|++.++++||..+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLK-----KRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 99999994 3347899999999999999999999999 999999999999999999999999998765433221
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-----------------------~~~ 208 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-----------------------EVI 208 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-----------------------HHH
Confidence 111111123467999999998899999999999999999998 99999654321 111
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
..+..... .......+..+.+++.+||+.+|.+||++.++++.|..+
T Consensus 209 ~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 209 AMLESGER---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHcCCc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11111100 012223446788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=296.95 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=191.0
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|+||.||+|++. ++.||+|+++... ...+..|..+++.+ ||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999987 7789999987532 23467889999888 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~L~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 150 (329)
T cd05588 81 GDLMFHMQ-----RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-- 150 (329)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--
Confidence 99998883 4467999999999999999999999999 9999999999999999999999999886422111
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.......+++.|+|||++.+..++.++|+|||||++|+|++|..||............. .++. ..
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~----------~~ 215 (329)
T cd05588 151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT----EDYL----------FQ 215 (329)
T ss_pred -CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccc----hHHH----------HH
Confidence 12223468999999999999999999999999999999999999996433221000000 0110 00
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC------HHHHHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD------MSNAAI 291 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps------~~~ll~ 291 (313)
.+ ..... ......+..+.+++++||+.||.+||+ +.++++
T Consensus 216 ~~---~~~~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 216 VI---LEKQI-RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HH---HcCCC-CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11 11111 112234456888999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=283.82 Aligned_cols=243 Identities=26% Similarity=0.414 Sum_probs=193.1
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCCh
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (313)
+.||+|+||.||+|.+. ++.+++|.+.... ...+.+|+++++.+ ||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999886 7889999876432 34578899999999 99999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhh
Q 041031 91 SDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA 170 (313)
Q Consensus 91 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 170 (313)
.+++. .....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+........ ...
T Consensus 81 ~~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 152 (252)
T cd05084 81 LTFLR----TEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-AST 152 (252)
T ss_pred HHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc-ccc
Confidence 99984 23346889999999999999999999999 99999999999999999999999999875432111 011
Q ss_pred cccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHh
Q 041031 171 ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKL 249 (313)
Q Consensus 171 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (313)
......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... +....+
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----------------------~~~~~~ 209 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----------------------QTREAI 209 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----------------------HHHHHH
Confidence 111123467999999998889999999999999999998 88888543211 111111
Q ss_pred hhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 250 TECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
...... ......+..+.+++.+||+.+|++|||+.+++++|.
T Consensus 210 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 210 EQGVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111111 122234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=285.82 Aligned_cols=254 Identities=30% Similarity=0.478 Sum_probs=202.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--Cc---ceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GK---NAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~---~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..+|+..+.||+|++|.||+|... +. .+++|.+.... ...+..|+++++.+ |||++++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457889999999999999999876 22 68999887542 34577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
+||++++++|.+++. .....+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++++|||++..
T Consensus 84 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLR----DHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999984 23356889999999999999999999999 99999999999999999999999999876
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
................+..|+|||++.+..++.++|+||||+++|+|++ |..||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------------------- 217 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------------------- 217 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-------------------
Confidence 5433221111111223457999999998889999999999999999997 99998543221
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
+....+.... ........+..+.+++.+||+.+|.+||++.+|++.|.+++
T Consensus 218 ----~~~~~i~~~~---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 218 ----EVMKAINDGF---RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred ----HHHHHHhcCC---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1122221111 11112234567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=284.62 Aligned_cols=244 Identities=26% Similarity=0.408 Sum_probs=192.9
Q ss_pred ceeccCCeEEEEEeEEC----CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR----GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
++||+|+||.||+|.++ +..+|+|+++... .+.+..|+.+++.+ ||||+++++++.. ...+++||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 36899999999999763 6789999986543 34577889999999 9999999998764 467899999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++. ....+++..+..++.|++.|+.+||+++ ++|+||+|+||++++++.++++|||.+.........
T Consensus 80 ~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 80 GPLNKFLQ-----KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 99999983 3456889999999999999999999999 999999999999999999999999998765433221
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...... +..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------------~~~ 208 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----------------------EVT 208 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------------HHH
Confidence 111111233578999999988889999999999999999998 99999654321 112
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
..+.....+ ......+..+.+++.+||+.||++||++.+|.++|...
T Consensus 209 ~~i~~~~~~---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 209 QMIESGERM---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHCCCCC---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 222211111 12223456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=283.66 Aligned_cols=244 Identities=27% Similarity=0.474 Sum_probs=193.5
Q ss_pred eeccCCeEEEEEeEEC----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCC
Q 041031 19 KIGQGSYGSVYLGKLR----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGA 89 (313)
Q Consensus 19 ~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (313)
.||+|+||.||+|.+. +..+|+|.+.... .+.+.+|+.+++++ ||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999775 3458999987653 24477899999999 9999999998864 46899999999999
Q ss_pred hhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhh
Q 041031 90 LSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAA 169 (313)
Q Consensus 90 L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 169 (313)
|.+++. .....+++..++.++.|++.|++|||+++ ++|+||+|+||+++.++.++++|||++...........
T Consensus 81 L~~~l~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLS----GKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 999984 23456899999999999999999999999 99999999999999999999999999875543322111
Q ss_pred hcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHH
Q 041031 170 AASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAK 248 (313)
Q Consensus 170 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
......++..|+|||.+.+..++.++||||||+++|++++ |..||...... +....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------------~~~~~ 210 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----------------------EVMSF 210 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----------------------HHHHH
Confidence 1111223578999999998889999999999999999996 99999654321 11222
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 249 LTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
+...... ......+.++.+++.+||..+|++||++.+|++.|..+
T Consensus 211 ~~~~~~~---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 211 IEQGKRL---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHCCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2111111 12334567888999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=284.28 Aligned_cols=245 Identities=24% Similarity=0.388 Sum_probs=199.0
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccc----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
+|++.+.||.|+||.||++.+. +..+++|.++.. ..+.+.+|+.+++.+ |+|++++++.+.+.+.++++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5889999999999999999887 788999987533 244577899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++++|.+++... ....+++..++.++.|++.|+.+||+++ ++|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 81 DGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 999999987422 2345789999999999999999999999 9999999999999999999999999987654322
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
. ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...... ..
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----------------------~~ 208 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----------------------NL 208 (255)
T ss_pred c---ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----------------------HH
Confidence 1 122345788999999999888999999999999999999999999643221 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...+. ...........+..+.+++.+||+.||.+|||+.+++.+
T Consensus 209 ~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 209 ILKVC---QGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHh---cCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11111 111111222345568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=292.98 Aligned_cols=256 Identities=24% Similarity=0.387 Sum_probs=201.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--Cc----ceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GK----NAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~----~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
..+|++.+.||+|+||.||+|.+. +. .+|+|.+.... ...+.+|+.+++.+ ||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 467999999999999999999874 33 38999986543 34577889999999 99999999998765 467
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
++++++.+|+|.+++. .....++...++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 85 ~v~e~~~~g~l~~~l~----~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 85 LITQLMPFGCLLDYVR----EHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeecCCCCCHHHHHH----hccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence 8999999999999985 33456888899999999999999999999 9999999999999999999999999998
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
........ ........+..|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------------------ 218 (316)
T cd05108 158 LLGADEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------------------ 218 (316)
T ss_pred cccCCCcc-eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------------------
Confidence 65532211 11111234668999999999999999999999999999998 99998643221
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
+....+..... . .....+...+.+++.+||+.+|.+|||+.+++..+.++..+..
T Consensus 219 -----~~~~~~~~~~~--~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 219 -----EISSILEKGER--L-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred -----HHHHHHhCCCC--C-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 11111111100 0 1122334568889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=289.65 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=202.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEecccccc----HHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTKS----KEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~~----~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
.++|++.++||.|+||.||+|.+. +..+|+|.++.... +.+.+|..++..+ ||||+++++.+......
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 456899999999999999999874 35799999975542 3467889999999 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCC-----------CCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC
Q 041031 79 FLVYEYAQNGALSDHLHWPS-----------VKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN 147 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~ 147 (313)
++++||+.+++|.+++.... ......++...++.++.|++.||.|+|+.+ ++|+||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence 99999999999999984221 111245788889999999999999999999 9999999999999999
Q ss_pred CcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccc
Q 041031 148 FRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYT 226 (313)
Q Consensus 148 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~ 226 (313)
+.++|+|||++........ ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------ 233 (283)
T cd05091 161 LNVKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------ 233 (283)
T ss_pred CceEecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 9999999998776543221 111222345678999999988889999999999999999998 88888654321
Q ss_pred cchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 227 EHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
+....+ .+........+++..+.+++.+||+.+|.+||++.+|+++|+.
T Consensus 234 -----------------~~~~~i---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 -----------------DVIEMI---RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----------------HHHHHH---HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111 1222222334566678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=288.42 Aligned_cols=243 Identities=22% Similarity=0.307 Sum_probs=191.8
Q ss_pred eccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCCh
Q 041031 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 20 lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (313)
||+|+||.||++.+. ++.+|+|.+.... .+.+..|+.+++.+ |+|++++.+++...+..+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999887 7889999986532 23456799999999 99999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhh
Q 041031 91 SDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA 170 (313)
Q Consensus 91 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 170 (313)
.+.+.... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~---~ 153 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---K 153 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---c
Confidence 88774221 23456899999999999999999999999 99999999999999999999999999876543221 1
Q ss_pred cccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhh
Q 041031 171 ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLT 250 (313)
Q Consensus 171 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
.....+++.|+|||++.+..++.++|+||+|+++|+|++|+.||....... .. .....
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--------~~--------------~~~~~ 211 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--------EN--------------KELKQ 211 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--------hH--------------HHHHH
Confidence 223467899999999999999999999999999999999999997544321 00 00000
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 251 ECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
...... .......+..+.+++.+||+.||++|| +++++++.
T Consensus 212 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 212 RILNDS-VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred hhcccC-CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 111111 112233556788999999999999999 66777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=287.64 Aligned_cols=254 Identities=26% Similarity=0.463 Sum_probs=200.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|++.+.||+|+||.||+|.+. +..+++|.+.... ...+.+|+.+++.+ |||++++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 367999999999999999999852 5679999987533 24577899999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCC------------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC
Q 041031 80 LVYEYAQNGALSDHLHWPSV------------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN 147 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~ 147 (313)
++|||+++++|.+++..... .....+++..+..++.|++.||+|||+++ ++|+||+|+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence 99999999999998842210 11235788889999999999999999999 9999999999999999
Q ss_pred CcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccc
Q 041031 148 FRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYT 226 (313)
Q Consensus 148 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~ 226 (313)
+.++++|||++......... .......++..|+|||++.+..++.++|+||||+++|+|++ |..||.+....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~------ 233 (283)
T cd05090 161 LHVKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ------ 233 (283)
T ss_pred CcEEeccccccccccCCcce-ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 99999999998765432211 11122334678999999998889999999999999999998 88898654321
Q ss_pred cchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 227 EHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+.. ..........+..+.+++.+||+.||.+||++.+|+++|.
T Consensus 234 -----------------~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 234 -----------------EVIEMVRK---RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred -----------------HHHHHHHc---CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 11111111 1111122344567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=296.11 Aligned_cols=237 Identities=26% Similarity=0.358 Sum_probs=190.4
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
++||+|+||.||+|++. ++.+|+|++.... ......|.+++..+ ||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999987 6789999987532 23356788888876 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|...+. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 150 (321)
T cd05591 81 GDLMFQIQ-----RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-- 150 (321)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--
Confidence 99998883 4456889999999999999999999999 9999999999999999999999999887533221
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.......+++.|+|||++.+..++.++|||||||++|+|++|+.||...... +...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----------------------~~~~ 206 (321)
T cd05591 151 -VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----------------------DLFE 206 (321)
T ss_pred -ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----------------------HHHH
Confidence 1122346899999999999989999999999999999999999999754321 1111
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-------CHHHHHHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-------DMSNAAIR 292 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-------s~~~ll~~ 292 (313)
.+. .... ......+..+.+++.+||..||.+|| +++++++.
T Consensus 207 ~i~---~~~~-~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 207 SIL---HDDV-LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHH---cCCC-CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111 1110 01122345788899999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=283.51 Aligned_cols=248 Identities=29% Similarity=0.488 Sum_probs=200.2
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEeccccc-cHHHHHHHHHHHhc-CCCceeeeeEE-EeCCeEEEEEeecCC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIELIGYA-AGGDSLFLVYEYAQN 87 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h~~i~~~~~~~-~~~~~~~lv~e~~~~ 87 (313)
.++|++.+.||+|+||.||++...+..+++|.++... .+.+.+|+.+++.+ |+|++++++.+ ...+..++++||+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 4689999999999999999999999999999987654 34578899999999 99999999975 455678999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++... ....+++..++.++.|++.||+|||+++ ++|+||+|+||++++++.++++|||++.......
T Consensus 85 ~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 85 GSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999998522 2235788999999999999999999999 9999999999999999999999999877543221
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
.....+..|+|||++.+..++.++|||||||++|+|++ |..||...... +..
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~-----------------------~~~ 209 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------------DVV 209 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----------------------HHH
Confidence 11234568999999998889999999999999999998 99998643221 111
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
..+.....+. .....+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 210 ~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 210 PRVEKGYKMD---APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHhcCCCCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1111111111 1223456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=290.73 Aligned_cols=260 Identities=30% Similarity=0.488 Sum_probs=203.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC--Cc--ceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GK--NAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~--~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~l 80 (313)
.++|++.+.||+|+||.||+|.++ +. .+++|.+.... ...+.+|+.++.++ |||++++++++..++.+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 468999999999999999999876 33 35777765432 33567899999998 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCC-----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc
Q 041031 81 VYEYAQNGALSDHLHWPSV-----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR 149 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~ 149 (313)
+|||+++++|.+++..... .....+++..++.++.|++.|++|||+++ ++|+||+|+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999853321 11236789999999999999999999999 999999999999999999
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccc
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~ 228 (313)
++|+|||++...... ........+..|+|||++.+..++.++||||||+++|+|+| |..||......
T Consensus 163 ~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------- 230 (303)
T cd05088 163 AKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------- 230 (303)
T ss_pred EEeCccccCcccchh----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--------
Confidence 999999987632211 11111234567999999988889999999999999999998 99998644321
Q ss_pred hhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccc
Q 041031 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW 303 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 303 (313)
+....+...... ......+..+.+|+.+||+.+|.+||++.++++.|.++......+
T Consensus 231 ---------------~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 231 ---------------ELYEKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred ---------------HHHHHHhcCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 111111111100 111223456889999999999999999999999999988776544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=286.62 Aligned_cols=266 Identities=25% Similarity=0.382 Sum_probs=199.2
Q ss_pred cCc-cccceeccCCeEEEEEeEEC------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeC--Ce
Q 041031 12 SNF-STSLKIGQGSYGSVYLGKLR------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGG--DS 77 (313)
Q Consensus 12 ~~y-~~~~~lg~g~~g~v~~~~~~------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~--~~ 77 (313)
++| ++.+.||+|+||.||++... +..+|+|.+.... ...+.+|+++++.+ |||++++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 88999999999999886532 6679999987543 34567899999999 99999999987653 46
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.+++|||+++++|.+++. ...+++..++.++.|++.|+.|||+++ ++|+||||+||++++++.++|+|||+
T Consensus 83 ~~lv~e~~~~~~l~~~~~------~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~ 153 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLP------KHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGL 153 (283)
T ss_pred EEEEecCCCCCCHHHHHH------HcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccc
Confidence 889999999999999983 235899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+.................++..|+|||.+.+..++.++||||||+++|+|++|..||............... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~-------~ 226 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ-------G 226 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccc-------c
Confidence 876553322111112223566799999998888999999999999999999999998654321000000000 0
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
. .........+..... .......+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus 227 ~-~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 227 Q-MTVVRLIELLERGMR---LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred c-cchhhhhhhhhcCCC---CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0 000000111111111 1123345568999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=295.05 Aligned_cols=237 Identities=27% Similarity=0.391 Sum_probs=191.0
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|+||.||+|++. +..+|+|+++.. ....+..|..++..+ ||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999987 678999998753 233456788888877 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+.+. ....+++..+..++.|++.||+|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~L~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 150 (318)
T cd05570 81 GDLMFHIQ-----RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-- 150 (318)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--
Confidence 99998883 4457899999999999999999999999 9999999999999999999999999886432211
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.......+++.|+|||++.+..++.++|+|||||++|+|++|..||...... +...
T Consensus 151 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----------------------~~~~ 206 (318)
T cd05570 151 -VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----------------------ELFQ 206 (318)
T ss_pred -CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----------------------HHHH
Confidence 1122345789999999999999999999999999999999999999654321 1111
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH-----HHHHHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM-----SNAAIR 292 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~ll~~ 292 (313)
.+. .... ......+..+.+|+.+||..||.+|||+ .++++.
T Consensus 207 ~i~---~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 207 SIL---EDEV-RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHH---cCCC-CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 111 1111 1122345678899999999999999999 777643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=295.50 Aligned_cols=236 Identities=26% Similarity=0.381 Sum_probs=190.4
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~ 82 (313)
+|.+.+.||+|+||.||+|++. ++.+|+|++.... ......|..++..+ |++++++++.+...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999987 6789999987532 22355677777776 889999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++|+|.+.+. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 81 E~~~~g~L~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQ-----QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999999883 3456889999999999999999999999 9999999999999999999999999987533
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... .......+++.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 153 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---------------------- 207 (323)
T cd05616 153 WDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---------------------- 207 (323)
T ss_pred CCC---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----------------------
Confidence 211 1122346899999999999999999999999999999999999999754321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM 286 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 286 (313)
+....+. .... ......+..+.+++.+||+.||.+|++.
T Consensus 208 -~~~~~i~---~~~~-~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 208 -ELFQSIM---EHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -HHHHHHH---hCCC-CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111111 1111 1122345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.22 Aligned_cols=260 Identities=28% Similarity=0.446 Sum_probs=202.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEe-CC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAG-GD 76 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~-~~ 76 (313)
.++|++.+.||+|+||.||+|.+. ++.||+|++.... ...+.+|++++..+ |+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 458999999999999999999754 3679999987543 23466799999998 8999999998764 45
Q ss_pred eEEEEEeecCCCChhhhhcCCCCC--------------------------------------------------------
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVK-------------------------------------------------------- 100 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------- 100 (313)
.+++++||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 788999999999999988432110
Q ss_pred CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccc
Q 041031 101 GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180 (313)
Q Consensus 101 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 180 (313)
....+++..+..++.|++.||+|||+++ ++|+||||+||++++++.++|+|||++......... .......++..|
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~y 241 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLKW 241 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCccc
Confidence 0136788999999999999999999999 999999999999999999999999998865432211 112223456789
Q ss_pred cCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC
Q 041031 181 LAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR 259 (313)
Q Consensus 181 ~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 259 (313)
+|||++.+..++.++|||||||++|+|++ |..||.+..... .+...+.......
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----------------------~~~~~~~~~~~~~--- 296 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----------------------EFCRRLKEGTRMR--- 296 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----------------------HHHHHHhccCCCC---
Confidence 99999999999999999999999999998 999996533210 1111111111111
Q ss_pred CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 260 YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 260 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
........+.+++.+||+.+|++||++.++++.|.++..+
T Consensus 297 ~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1123345788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=283.55 Aligned_cols=252 Identities=28% Similarity=0.467 Sum_probs=200.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
..+|++.++||+|++|.||+|.+. +..+++|.+.... .+.+.+|+++++.+ |||++++++.+.. ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 467999999999999999999887 4579999987533 45678899999999 9999999998754 55789999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++... ....+++..+..++.|++.||+++|+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 84 KGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999998522 2345788999999999999999999999 99999999999999999999999999876543221
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
.......++..|+|||+..+..++.++|+||||+++|+|++ |..||...... +.
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----------------------~~ 212 (262)
T cd05071 158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----------------------EV 212 (262)
T ss_pred --ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----------------------HH
Confidence 11122345678999999988889999999999999999999 88888654321 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
...+.... ........+..+.+++.+||+.+|++||++.++++.|+...
T Consensus 213 ~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 213 LDQVERGY---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHhcCC---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 11111100 01122345567889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.25 Aligned_cols=260 Identities=26% Similarity=0.432 Sum_probs=205.6
Q ss_pred HHHhcCccccceeccCCeEEEEEeEECC-------cceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEe
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAG 74 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~ 74 (313)
+...++|++.+.||+|++|.||++.+.+ ..+++|.+.... ...+.+|+++++.+ |+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3455789999999999999999998752 568999887543 23467899999998 9999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCC-----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCee
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSV-----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNIL 143 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil 143 (313)
.+.++++|||+++++|.+++..... .....+++..++.++.|++.||+|||+.+ ++|+||+|+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 9999999999999999999853210 23456889999999999999999999999 999999999999
Q ss_pred eCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCC
Q 041031 144 LDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGN 222 (313)
Q Consensus 144 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~ 222 (313)
+++++.++|+|||.+........ ........++..|+|||++.+..++.++|||||||++|++++ |..||......
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 241 (293)
T ss_pred EcCCCeEEeCccccccccccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence 99999999999999876543211 111112234578999999998899999999999999999998 88998654321
Q ss_pred CccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 223 NQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
+....+.... ........+..+.+|+.+||+.+|.+|||+.++++.|+.+.
T Consensus 242 ---------------------~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ---------------------ELFKLLKEGY---RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---------------------HHHHHHHcCC---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111111 11122344567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=295.46 Aligned_cols=240 Identities=26% Similarity=0.390 Sum_probs=187.4
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|+||.||+|++. ++.+|+|++.... ...+..|..++..+ ||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999987 6789999987532 23466788888777 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|..++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~L~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-- 150 (329)
T cd05618 81 GDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-- 150 (329)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--
Confidence 99998873 4467899999999999999999999999 9999999999999999999999999986532211
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.......+++.|+|||++.+..++.++|+|||||++|+|++|..||............. ..+. ..
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~----~~~~----------~~ 215 (329)
T cd05618 151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT----EDYL----------FQ 215 (329)
T ss_pred -CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccccc----HHHH----------HH
Confidence 12223468999999999999999999999999999999999999996432211100000 0000 00
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM 286 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 286 (313)
.+ .... .......+..+.+++++||+.||.+||++
T Consensus 216 ~i---~~~~-~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 216 VI---LEKQ-IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HH---hcCC-CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 01 1111 11223345568889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=293.74 Aligned_cols=235 Identities=26% Similarity=0.387 Sum_probs=188.2
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|+||.||+|+++ ++.+|+|.++.. .......|..++... |||++++++++.+.+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999987 778999998753 233456677777765 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++. ....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~L~~~i~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 150 (316)
T cd05620 81 GDLMFHIQ-----DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-- 150 (316)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--
Confidence 99999883 3456889999999999999999999999 9999999999999999999999999876432111
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.......+++.|+|||++.+..++.++|||||||++|+|++|..||...... +...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-----------------------~~~~ 206 (316)
T cd05620 151 -NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-----------------------ELFE 206 (316)
T ss_pred -CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----------------------HHHH
Confidence 1222346899999999999999999999999999999999999999654321 1111
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHH-HHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS-NAA 290 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~ll 290 (313)
.+.. ..+.. ....+..+.+++.+||+.||.+||++. +++
T Consensus 207 ~~~~-~~~~~---~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 207 SIRV-DTPHY---PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHh-CCCCC---CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1110 01111 123445788899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=287.58 Aligned_cols=267 Identities=23% Similarity=0.365 Sum_probs=200.2
Q ss_pred cCccccceeccCCeEEEEEeEEC------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeC--CeE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGG--DSL 78 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~--~~~ 78 (313)
.-|++++.||+|+||.||++++. +..+++|.++... ...+.+|+.+++.+ |||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 35789999999999999999742 6789999987543 34577899999999 99999999998775 568
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
+++|||+++++|.+++. .....+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLP----RNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccc
Confidence 99999999999999984 22346889999999999999999999999 999999999999999999999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
.................++..|+|||++.+..++.++||||||+++|+|+++..|+............ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~-----------~ 225 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIG-----------P 225 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcc-----------c
Confidence 86543322111122345667899999998888999999999999999999987765332111000000 0
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
..........................+..+.+|+.+||+.+|.+|||+.++++.|+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 226 THGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000001111111111112233556899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=284.85 Aligned_cols=253 Identities=29% Similarity=0.477 Sum_probs=201.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC-----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..+|++.+.||+|+||.||+|.+. +..+++|.+.... ...+.+|+.+++.+ ||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 467899999999999999999874 2368999887543 34577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
+||++++++|.+++. .....++...+..++.|++.|+++||+++ ++|+||+|+||+++.++.++++|||.+..
T Consensus 83 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 83 VTEYMENGSLDAFLR----KHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEcCCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 999999999999985 23356888999999999999999999999 99999999999999999999999999876
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
................+..|+|||.+.+..++.++|+||||+++|++++ |..||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~------------------- 216 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ------------------- 216 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-------------------
Confidence 5543221111111223568999999998889999999999999999887 99998654321
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
+....+...... ......+..+.+++.+||+.+|.+|||+.++++.|.++
T Consensus 217 ----~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 217 ----DVIKAIEEGYRL---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----HHHHHHhCCCcC---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111111111110 11223455788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=283.00 Aligned_cols=251 Identities=28% Similarity=0.486 Sum_probs=200.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-CcceEEEecccc--ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNT--KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~--~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..++|++.++||+|++|.||+|.+. +..+++|.+... ..+.+.+|+.+++.+ |+|++++++.+. ....+++|||+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 3568999999999999999999877 667999988754 345688999999999 999999999875 45678999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++++|.+++... ....+++..++.++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 83 SKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999998522 2345889999999999999999999999 9999999999999999999999999987654322
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... +
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----------------------~ 211 (260)
T cd05070 157 YT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-----------------------E 211 (260)
T ss_pred cc--cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----------------------H
Confidence 11 1111234568999999988889999999999999999999 88898653321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
....+...... ......+..+.+++.+||..+|.+|||+.++.+.|++
T Consensus 212 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 212 VLEQVERGYRM---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHcCCCC---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111111111 1223445678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=282.87 Aligned_cols=248 Identities=29% Similarity=0.534 Sum_probs=204.0
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
..+|++.+.||.|++|.||+|...++.+++|.+.... ...+.+|+.+++.+ |+|++++++.+.+.+..+++||++++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4689999999999999999999999999999998664 35678899999999 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 85 ~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 85 GSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999998422 2236899999999999999999999999 99999999999999999999999999876532211
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
....+..|+|||++.+..++.++|+||||+++|++++ |..||...... +..
T Consensus 158 -----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------------~~~ 209 (256)
T cd05039 158 -----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------------DVV 209 (256)
T ss_pred -----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----------------------HHH
Confidence 1234567999999988889999999999999999997 99998644321 111
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
..+...... ......+..+.+++.+||..+|++|||+.+++++|+.+
T Consensus 210 ~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 210 PHVEKGYRM---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHhcCCCC---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 111111111 11223456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.38 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=204.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC---------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR---------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGG 75 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~ 75 (313)
.++|.+.+.||+|+||.||+|++. ...+|+|.+.... ...+..|+++++.+ ||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 478999999999999999999864 2459999997543 23467799999988 99999999999999
Q ss_pred CeEEEEEeecCCCChhhhhcCCCCC-----------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSVK-----------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL 144 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 144 (313)
+..+++|||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 9999999999999999999643211 1235888999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCC
Q 041031 145 DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNN 223 (313)
Q Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~ 223 (313)
++++.++|+|||.+......... ........++.|+|||++.+..++.++|+||||+++|+|++ |..||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---
Confidence 99999999999998754322111 11111123468999999998889999999999999999998 88888543211
Q ss_pred ccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 224 QYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+.... ........+..+.+++.+||..+|.+|||+.++++.|.++....
T Consensus 250 --------------------~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 --------------------ELFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred --------------------HHHHHHHcCC---CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111111 11122344567889999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=293.32 Aligned_cols=236 Identities=27% Similarity=0.385 Sum_probs=188.4
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|+||.||+|.+. ++.||+|.++.. .......|..++... ||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999987 678999998753 233455677777765 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
|+|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 150 (316)
T cd05619 81 GDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-- 150 (316)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--
Confidence 99999984 3456888999999999999999999999 9999999999999999999999999886432211
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.......+++.|+|||++.+..++.++||||+||++|+|++|..||...... +...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----------------------~~~~ 206 (316)
T cd05619 151 -AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-----------------------ELFQ 206 (316)
T ss_pred -CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-----------------------HHHH
Confidence 1122346889999999999989999999999999999999999999754321 1111
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHH-HHHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS-NAAI 291 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~ll~ 291 (313)
.+.. ..+. ........+.+++.+||+.||.+||++. ++++
T Consensus 207 ~i~~-~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 207 SIRM-DNPC---YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHh-CCCC---CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1111 1111 1123445688899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=300.70 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=198.5
Q ss_pred HHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeC
Q 041031 5 NEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGG 75 (313)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~ 75 (313)
..++...++|++.+.||+|+||.||+++++ ++.+|+|++.... ...+.+|..+++.+ ||||+++++.+.+.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344555689999999999999999999987 7789999986421 23466788999999 99999999999999
Q ss_pred CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
+..++||||+++++|.+++. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999984 234788889999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccCC----CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG----CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~ 231 (313)
|++........ .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 187 G~a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----------- 253 (371)
T cd05622 187 GTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----------- 253 (371)
T ss_pred CceeEcCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-----------
Confidence 99876543221 122334689999999999754 3788999999999999999999999754321
Q ss_pred HHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCC--CCCHHHHHHHH
Q 041031 232 VDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKR--RPDMSNAAIRL 293 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~ll~~l 293 (313)
.....+...............+..+.+++..||..++.+ |+++.++++..
T Consensus 254 ------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 254 ------------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ------------HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111111100000012234567888999999844433 77999988764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=289.86 Aligned_cols=271 Identities=24% Similarity=0.349 Sum_probs=190.2
Q ss_pred cceeccCCeEEEEEeEEC----CcceEEEeccccc-cHHHHHHHHHHHhc-CCCceeeeeEEEe--CCeEEEEEeecCCC
Q 041031 17 SLKIGQGSYGSVYLGKLR----GKNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIELIGYAAG--GDSLFLVYEYAQNG 88 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 88 (313)
.++||+|+||.||+|.++ ++.+|+|.+.... ...+.+|+.+++.+ ||||+++++.+.. ....+++|||+. +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 468999999999999865 4679999987553 44578899999999 9999999999854 456899999984 5
Q ss_pred ChhhhhcCCCC----CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee----CCCCcEEEeecccccc
Q 041031 89 ALSDHLHWPSV----KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL----DSNFRAKIADFGLVKL 160 (313)
Q Consensus 89 ~L~~~l~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~----~~~~~~~l~dfg~~~~ 160 (313)
+|.+++..... .....+++..++.++.|++.||.|||+++ ++|+||||+||++ +.++.+||+|||++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 88887643221 12235889999999999999999999999 9999999999999 4567899999999976
Q ss_pred ccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...............+|+.|+|||++.+ ..++.++||||+||++|+|++|++||....................+....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 5433221122233467899999999976 458999999999999999999999997654432221111111111111111
Q ss_pred cCc--------------HHHHHHhhhhcCCCC------CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 240 NDT--------------KDFMAKLTECLDPNL------TRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 240 ~~~--------------~~~~~~l~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
... ............... ..........+.+|+.+||+.||.+|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000000000000000 0000111245778999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=288.72 Aligned_cols=247 Identities=29% Similarity=0.504 Sum_probs=197.1
Q ss_pred ccccceeccCCeEEEEEeEEC--CcceEEEeccccccHH-----HHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-----FSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~-----~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
|++++.||+|+||+||++.+. ++.+|+|.+....... ..+|+.+++.+ ||||+++++++.+.+..+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 788999999999999999998 5579999998776433 23488999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++++|.+++. ....++...+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~- 151 (260)
T PF00069_consen 81 PGGSLQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN- 151 (260)
T ss_dssp TTEBHHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST-
T ss_pred cccccccccc-----cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-
Confidence 9999999984 4567899999999999999999999999 999999999999999999999999998764211
Q ss_pred hhhhhcccccccccccCCcccc-CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVR-DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
........++..|+|||++. +..++.++|+||||+++|+|++|..||..... .............
T Consensus 152 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---------~~~~~~~~~~~~~--- 217 (260)
T PF00069_consen 152 --NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---------DDQLEIIEKILKR--- 217 (260)
T ss_dssp --TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---------HHHHHHHHHHHHT---
T ss_pred --ccccccccccccccccccccccccccccccccccccccccccccccccccccc---------hhhhhhhhhcccc---
Confidence 12333446789999999998 88899999999999999999999999975511 0111111111000
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+..... ........+.+++.+||+.||++|||+.++++
T Consensus 218 ---~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 218 ---PLPSSSQ-----QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---HHHHHTT-----SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---ccccccc-----ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 00011267999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=284.28 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=199.2
Q ss_pred ccccceeccCCeEEEEEeEEC-----CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe-----
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDS----- 77 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~----- 77 (313)
|.+.+.||+|+||.||+|... +..+|+|.++... ...+.+|+.+++.+ |||++++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678899999999999999875 2569999987542 23577899999999 9999999998765443
Q ss_pred -EEEEEeecCCCChhhhhcCCCC-CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 78 -LFLVYEYAQNGALSDHLHWPSV-KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 78 -~~lv~e~~~~~~L~~~l~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
.++++||+++++|..++...+. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 7999999999999998854332 12346889999999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
|++......... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus 158 g~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-------------- 222 (273)
T cd05035 158 GLSKKIYSGDYY-RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-------------- 222 (273)
T ss_pred cceeeccccccc-cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------------
Confidence 998765433211 11122234678999999988889999999999999999999 88888654321
Q ss_pred HHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 235 MLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
+....+.. ..........+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 223 ---------~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 223 ---------EIYDYLRH---GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------HHHHHHHc---CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111111 111112334556789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=301.34 Aligned_cols=247 Identities=28% Similarity=0.461 Sum_probs=207.8
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGA 89 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (313)
++...-++-||.|..|.||+|+.+++.||||.++.-+. .++..|++| ||||+.+.++|.....+|||||||..|.
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elkE----TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELKE----TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred HHHhhhhhhhccCcccceeeeeccCceehhHHHhhhhh----hhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 34455677899999999999999999999998876543 346778899 9999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhh
Q 041031 90 LSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAA 169 (313)
Q Consensus 90 L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 169 (313)
|.+.| +....++..-...|..+|+.++.|||.++ |+|+|||.-||||+.+..|||+|||-+...... .
T Consensus 199 L~~VL-----ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~----S 266 (904)
T KOG4721|consen 199 LYEVL-----KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK----S 266 (904)
T ss_pred HHHHH-----hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh----h
Confidence 99999 45567888889999999999999999999 999999999999999999999999988765543 2
Q ss_pred hcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHh
Q 041031 170 AASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKL 249 (313)
Q Consensus 170 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (313)
....+.||-.|||||++.++..+++.||||||++||||+||..||...+.. ..+
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--------------------------AII 320 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--------------------------AII 320 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh--------------------------eeE
Confidence 333468999999999999999999999999999999999999999754431 111
Q ss_pred hhhcCCCCC-CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 250 TECLDPNLT-RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 250 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
-..-...+. .....++..+.-|+++||+..|..||++.+|+..|+-..++
T Consensus 321 wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 321 WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 111111111 14667777888899999999999999999999999876664
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=285.07 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=203.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC--Cc----ceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GK----NAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~----~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|++.++||+|+||.||+|.+. ++ .||+|.+.... ...+.+|..+++.+ |||++++++.+... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 468999999999999999999875 33 47999886543 33467788888888 99999999998754 467
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
++++++++|+|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||++++++.++|+|||++.
T Consensus 85 l~~~~~~~g~l~~~l~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVR----ENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCcee
Confidence 8999999999999984 23456899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
........ ........+..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------------------ 218 (279)
T cd05109 158 LLDIDETE-YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR------------------ 218 (279)
T ss_pred ecccccce-eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------------------
Confidence 65432211 11111234678999999998889999999999999999998 88998643221
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccccc
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEWEK 305 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 305 (313)
+....+...... ......+..+.+++.+||+.||++||++.++++.|..+.-+...+..
T Consensus 219 -----~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~~~ 277 (279)
T cd05109 219 -----EIPDLLEKGERL---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFVV 277 (279)
T ss_pred -----HHHHHHHCCCcC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCeEe
Confidence 111111111111 11233456788999999999999999999999999988776655544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=282.82 Aligned_cols=251 Identities=27% Similarity=0.496 Sum_probs=201.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..++|++.++||+|+||.||+|... ++.+|+|.+.... ...+.+|+.+++.+ |+|++++++++.. +..+++||++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYM 82 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEEEEEcC
Confidence 3578999999999999999999886 7889999987644 45688999999999 9999999998754 5689999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
.+++|.+++... ....++...+..++.|++.||+|||+.+ ++|+||+|+||++++++.++++|||.+.......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 83 ENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999988422 2356888999999999999999999999 9999999999999999999999999987654221
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. .......++..|+|||++.+..++.++|+||||+++|++++ |..||.+.... +
T Consensus 157 ~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------------~ 211 (260)
T cd05067 157 Y--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-----------------------E 211 (260)
T ss_pred c--ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-----------------------H
Confidence 1 11112235678999999998889999999999999999999 99999754321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
....+...... ......+..+.+++.+||+.+|++|||++++++.|+.
T Consensus 212 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 212 VIQNLERGYRM---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHcCCCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11112111111 1122344578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=290.88 Aligned_cols=264 Identities=20% Similarity=0.321 Sum_probs=197.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++|.+.++||+|+||.||+|.++ ++.+|+|.+.... .....+|+.+++.+ ||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 468999999999999999999887 6789999886432 33567899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++ +|.+++. .....++...+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~~~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 85 YLDK-DLKQYMD----DCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCCC-CHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 9964 8888774 23345788999999999999999999999 99999999999999999999999999875432
Q ss_pred ChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC-
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND- 241 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 241 (313)
... ......+++.|+|||++.+ ..++.++||||||+++|+|+||+.||.+..... .+ ..+......
T Consensus 157 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--------~~-~~~~~~~~~~ 224 (309)
T cd07872 157 PTK---TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED--------EL-HLIFRLLGTP 224 (309)
T ss_pred Ccc---ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------HH-HHHHHHhCCC
Confidence 211 1122356889999999865 458899999999999999999999997654321 00 001000000
Q ss_pred cHHHHHHh------hhhcCCCCC-----CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 242 TKDFMAKL------TECLDPNLT-----RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 242 ~~~~~~~l------~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
..+....+ .....+... ......+..+.+|+.+||+.||.+|||+.|+++.-.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 225 TEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred CHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 00000000 000000000 011223456789999999999999999999997433
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=284.96 Aligned_cols=258 Identities=23% Similarity=0.359 Sum_probs=201.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--Cc----ceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GK----NAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~----~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|++.+.||+|+||.||+|.+. +. .+++|.+.... ..++..|+.++..+ ||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 368899999999999999999985 33 47888876443 23456677788888 9999999998764 4577
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+++|++++|+|.+++. .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++++|||.+.
T Consensus 85 ~i~e~~~~gsL~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 85 LVTQLSPLGSLLDHVR----QHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEEeCCCCcHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence 8999999999999985 23456899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
....... ........++..|+|||.+.+..++.++||||||+++|++++ |..||.+....
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------------------ 218 (279)
T cd05111 158 LLYPDDK-KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH------------------ 218 (279)
T ss_pred eccCCCc-ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------------------
Confidence 6543221 111223346678999999998889999999999999999998 99999654321
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccc
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW 303 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 303 (313)
...+.+....... ....+...+.+++.+||..||++|||+.++++.|..+..+.+.+
T Consensus 219 -----~~~~~~~~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~ 275 (279)
T cd05111 219 -----EVPDLLEKGERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY 275 (279)
T ss_pred -----HHHHHHHCCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence 1111111111111 11123456788999999999999999999999999988766544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=287.39 Aligned_cols=256 Identities=30% Similarity=0.481 Sum_probs=200.8
Q ss_pred cCccccceeccCCeEEEEEeEEC--Cc--ceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GK--NAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~--~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv 81 (313)
++|++.+.||+|+||.||+|.++ +. .+++|.++... .+.+.+|+.++.++ |||++++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 68999999999999999999876 22 46888876432 23577899999888 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCC-----------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcE
Q 041031 82 YEYAQNGALSDHLHWPSVK-----------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRA 150 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~ 150 (313)
+||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 9999999999998532210 1235888999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccch
Q 041031 151 KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~ 229 (313)
+|+|||++...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 159 kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--------- 225 (297)
T cd05089 159 KIADFGLSRGEEVY----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--------- 225 (297)
T ss_pred EECCcCCCccccce----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---------
Confidence 99999987632211 01111123567999999998889999999999999999997 99999644321
Q ss_pred hHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 230 SLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+....... .....+..+.+++.+||+.+|.+|||+.+++++|..+....
T Consensus 226 --------------~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 226 --------------ELYEKLPQGYRME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred --------------HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111111111111 12234567889999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=292.89 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=211.2
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccccc------HHHHHHHHHHHhc--CCCceeeeeEEEeCCeE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS------KEFSSELKILCKV--HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~------~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~ 78 (313)
...+.|.+.+.||.|.||.||++..+ |+.+|+|.+.+... +.+.+|+.+|+++ |||++.+.+++++.+.+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 45568999999999999999999988 88899999976542 5789999999999 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC----CCcEEEee
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS----NFRAKIAD 154 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~----~~~~~l~d 154 (313)
++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.| ++|+|+||+|+++.. ++.++++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999998522 3999999999999999999999999 999999999999953 35799999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
||++...... .......||+.|+|||++....|+..+||||+|+++|.|++|..||.+.....
T Consensus 183 FGla~~~~~~----~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~------------- 245 (382)
T KOG0032|consen 183 FGLAKFIKPG----ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE------------- 245 (382)
T ss_pred CCCceEccCC----ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-------------
Confidence 9999987652 34556789999999999999999999999999999999999999997665421
Q ss_pred HHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 235 MLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.+...+.... .-........+..+.++++.|+..||.+|+|+.++|+.-+
T Consensus 246 ---------~~~~i~~~~~-~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 246 ---------IFLAILRGDF-DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ---------HHHHHHcCCC-CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 1111111111 1111245566788999999999999999999999999643
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=285.91 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=197.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.++|++.+.||+|+||.||+|.+. ++.+++|++.... ...+.+|+.+++.+ |||++++++.+......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 467999999999999999999986 7789999986543 34577899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++. ....+++..+..++.|++.|+.|||+.+ ++|+|++|+||++++++.++++|||++......
T Consensus 88 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 88 CGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 99999999883 3456889999999999999999999999 999999999999999999999999998765422
Q ss_pred hhhhhhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.. ......+++.|+|||.+. ...++.++|+||+|+++|+|++|..||.........
T Consensus 160 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------------------ 218 (267)
T cd06646 160 IA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------------------ 218 (267)
T ss_pred cc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh------------------
Confidence 11 112235788999999885 345788999999999999999999998544321000
Q ss_pred cHHHHHHhhhhcC-CCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 242 TKDFMAKLTECLD-PNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 242 ~~~~~~~l~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
......... +... .....+..+.+++++||..+|++|||++++++.+
T Consensus 219 ----~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 219 ----FLMSKSNFQPPKLK-DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ----eeeecCCCCCCCCc-cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000000000 0010 1123446788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=281.54 Aligned_cols=252 Identities=28% Similarity=0.469 Sum_probs=203.4
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..++|++.+.||.|++|.||+|.+. +..++||.+.... ...+.+|+.+++.+ |+|++++++.+......+++||++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4578999999999999999999887 5678999887543 45688999999999 999999999999989999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++++|.+++... ....++...+..++.+++.|+.|||+++ ++|+||+|+||++++++.++++|||.+.......
T Consensus 84 ~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 84 SKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred CCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999998522 2346889999999999999999999999 9999999999999999999999999987654321
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. ........+..|+|||.+.+..++.++|+||+|+++|++++ |+.||.+.... .
T Consensus 158 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----------------------~ 212 (261)
T cd05034 158 Y--TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-----------------------E 212 (261)
T ss_pred h--hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------------H
Confidence 1 11112234568999999998889999999999999999998 99998644321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
....+....... .....+..+.+++.+||+.+|.+||+++++.+.|+.
T Consensus 213 ~~~~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 213 VLEQVERGYRMP---RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111111111111 112235578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=285.92 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=202.7
Q ss_pred HhcCccccceeccCCeEEEEEeEECC-------cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
..++|++.+.||+|+||.||+|.+++ ..+++|.+.... ...+.+|+.+++.+ |||++++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 35789999999999999999998762 569999987553 23467899999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCC-----CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEE
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVK-----GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKI 152 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l 152 (313)
.+++|||+++++|.+++...... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 99999999999999998533211 1235788899999999999999999999 999999999999999999999
Q ss_pred eeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhH
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~ 231 (313)
+|||++......... .......++..|+|||.+.+..++.++||||||+++|++++ |..||......
T Consensus 161 ~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----------- 228 (277)
T cd05032 161 GDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE----------- 228 (277)
T ss_pred CCcccchhhccCccc-ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-----------
Confidence 999998755432211 11122345778999999988889999999999999999998 88998643321
Q ss_pred HHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 232 VDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+. ...........+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 229 ------------~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 229 ------------EVLKFVI---DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ------------HHHHHHh---cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111111 11111122234667899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=287.75 Aligned_cols=264 Identities=23% Similarity=0.402 Sum_probs=207.6
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC---------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeE
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR---------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGY 71 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~ 71 (313)
.....++|.+.+.||+|+||.||+|++. +..+++|...... ...+.+|+.+++.+ ||||+++++.
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3455788999999999999999999752 2368999886532 34578899999998 9999999999
Q ss_pred EEeCCeEEEEEeecCCCChhhhhcCCCCC-----------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCC
Q 041031 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVK-----------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTS 140 (313)
Q Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~ 140 (313)
+......+++|||+.+++|.+++...... ....++...+..++.|++.||+|||+++ ++|+||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence 99999999999999999999998643211 1245788889999999999999999999 999999999
Q ss_pred CeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCC
Q 041031 141 NILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDAN 219 (313)
Q Consensus 141 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~ 219 (313)
||++++++.++|+|||.+......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred eEEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999998765432211 11112234678999999998889999999999999999998 7788854322
Q ss_pred CCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 220 PGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
. +....+..... .......+..+.+++.+||+.+|.+|||+.++++.|.++..-
T Consensus 246 ~-----------------------~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 E-----------------------ELFKLLKEGHR---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred H-----------------------HHHHHHHcCCc---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1 11111211111 112234556788999999999999999999999999998765
Q ss_pred c
Q 041031 300 S 300 (313)
Q Consensus 300 ~ 300 (313)
.
T Consensus 300 ~ 300 (304)
T cd05101 300 T 300 (304)
T ss_pred h
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=280.17 Aligned_cols=245 Identities=31% Similarity=0.455 Sum_probs=200.6
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+|.+.+.||+|++|.||+|.+. ++.+++|.+... ....+.+|+++++.+ |||++++++.+...+..+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5888999999999999999886 788999987643 244577899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++... ....++...++.++.+++.||.|||+.+ ++|+||+|+||++++++.++++|||.+......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999998532 2356889999999999999999999999 999999999999999999999999988765543
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
.. ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...... +
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------------------~ 208 (256)
T cd08529 155 TN---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----------------------A 208 (256)
T ss_pred cc---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----------------------H
Confidence 22 112235788999999999888999999999999999999999999654321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
....+ ............+..+.+++.+||+.+|++||++.++++.
T Consensus 209 ~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 209 LILKI---IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHH---HcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11111 1111122222455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=315.75 Aligned_cols=265 Identities=23% Similarity=0.326 Sum_probs=206.7
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.+|++.++||+|+||.||+|.+. ++.||+|.+.... ...+.+|+++++.+ ||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999987 7889999987532 23577899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCC------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 83 EYAQNGALSDHLHWPSVK------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
||++|++|.+++...... .....+...++.++.|++.||+|||+++ ++|+||||+||+++.++.++++|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988532211 1234566778899999999999999999 9999999999999999999999999
Q ss_pred ccccccCChh---------------hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCC
Q 041031 157 LVKLLEHSPE---------------IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPG 221 (313)
Q Consensus 157 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~ 221 (313)
++........ .........||+.|+|||++.+..++.++|||||||++|+|+||..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9876521110 0011122468999999999999999999999999999999999999996533210
Q ss_pred CCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHHHhcc
Q 041031 222 NNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-DMSNAAIRLSHILISS 300 (313)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~ll~~l~~~~~~~ 300 (313)
. .. .. ....+.........+..+.+++.+||+.||++|| +++++++.|+......
T Consensus 239 ---------i---~~---------~~---~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 ---------I---SY---------RD---VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred ---------h---hh---------hh---hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0 00 00 0000100001123445688899999999999996 6788888899887776
Q ss_pred ccc
Q 041031 301 KEW 303 (313)
Q Consensus 301 ~~~ 303 (313)
++|
T Consensus 295 p~w 297 (932)
T PRK13184 295 PEW 297 (932)
T ss_pred ccc
Confidence 665
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=285.41 Aligned_cols=265 Identities=30% Similarity=0.454 Sum_probs=198.1
Q ss_pred cCccccceeccCCeEEEEEeEEC------CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEe--CCeEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR------GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAG--GDSLF 79 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~------~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~--~~~~~ 79 (313)
..|++.+.||+|+||.||++... +..+++|.+.... ...+.+|+++++.+ |||++++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57899999999999999998742 6789999987654 33577899999999 9999999998643 45689
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+++||+++++|.+++. .....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 84 lv~e~~~~~~L~~~l~----~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 84 LVMEYLPYGSLRDYLQ----KHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEecCCCCHHHHHH----hcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 9999999999999984 22345889999999999999999999999 9999999999999999999999999988
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
................++..|+|||++.+..++.++|+||||+++|+|++|..|+......- .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-------------~~~~~ 223 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-------------MRMMG 223 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-------------hhhcc
Confidence 65432221111111223456999999998889999999999999999999887764332110 00000
Q ss_pred cCc--HHHHHHhhhhcCCC-CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 240 NDT--KDFMAKLTECLDPN-LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 240 ~~~--~~~~~~l~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
... ......+...+... ........+..+.+|+.+||+.+|++|||+.+|+++|+.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 224 NDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000 00001111111111 1111233456788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=299.41 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=193.7
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|++++.||+|+||.||++.++ ++.+|+|++... ....+.+|..++..+ ||+++++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999886 788999998643 234567899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLM-----KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 9999999999983 4466899999999999999999999999 9999999999999999999999999876442
Q ss_pred CChhh--------------------------------hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhC
Q 041031 163 HSPEI--------------------------------AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210 (313)
Q Consensus 163 ~~~~~--------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg 210 (313)
..... ........||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 21000 0001123689999999999999999999999999999999999
Q ss_pred CCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC---HH
Q 041031 211 QQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD---MS 287 (313)
Q Consensus 211 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~ 287 (313)
..||...... +....+........-......+..+.+|+.+++. ||.+|++ +.
T Consensus 233 ~~Pf~~~~~~-----------------------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ 288 (360)
T cd05627 233 YPPFCSETPQ-----------------------ETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVE 288 (360)
T ss_pred CCCCCCCCHH-----------------------HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHH
Confidence 9999754431 1111111110000000111234567778888764 9999996 55
Q ss_pred HHHHH
Q 041031 288 NAAIR 292 (313)
Q Consensus 288 ~ll~~ 292 (313)
++++.
T Consensus 289 ei~~h 293 (360)
T cd05627 289 EIKSH 293 (360)
T ss_pred HHhcC
Confidence 65543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=287.49 Aligned_cols=270 Identities=22% Similarity=0.293 Sum_probs=206.0
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
++|++.+.||+|+||.||++.+. +..+++|.+.... ...+.+|+++++.+ ||||+++++.+.+++.++++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999887 6778999886542 23477899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
+++++|.+++. ....+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 81 MDGGSLDQVLK-----KAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred cCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 99999999984 34668899999999999999999997 58 99999999999999999999999998765432
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc---
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN--- 240 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 240 (313)
. ......++..|+|||++.+..++.++|+||||+++|+|++|..||....... ..........
T Consensus 153 ~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~~ 218 (308)
T cd06615 153 S-----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---------LEAMFGRPVSEGE 218 (308)
T ss_pred c-----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---------HHHhhcCcccccc
Confidence 2 1122457889999999988889999999999999999999999986543211 0000000000
Q ss_pred ----------------CcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccc
Q 041031 241 ----------------DTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW 303 (313)
Q Consensus 241 ----------------~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 303 (313)
................... .....+..+.+++.+||..+|++|||+.++++.-.-...+.+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~ 298 (308)
T cd06615 219 AKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEV 298 (308)
T ss_pred ccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccccc
Confidence 0000001111111111011 11124556889999999999999999999999877666655554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=284.52 Aligned_cols=255 Identities=27% Similarity=0.419 Sum_probs=199.2
Q ss_pred HhcCccccceeccCCeEEEEEeEECC-------cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
..++|.+.+.||+|++|.||+|.+.+ ..+++|.+.... ...+.+|+.+++.+ |+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35789999999999999999998853 568899876443 23477899999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCC--CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC---cEEE
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVK--GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF---RAKI 152 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~---~~~l 152 (313)
.+++|||+++++|.+++...... ....+++..++.++.|++.+++|||+++ ++|+||+|+||+++.++ .+++
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 99999999999999998543211 2235889999999999999999999999 99999999999998654 5899
Q ss_pred eeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhH
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~ 231 (313)
+|||++......... ........+..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----------- 228 (277)
T cd05036 161 ADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----------- 228 (277)
T ss_pred ccCccccccCCccce-ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------
Confidence 999998765322111 11112233568999999998889999999999999999997 99998654321
Q ss_pred HHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 232 VDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+...... ......+..+.+++.+||+.+|.+|||+.+|++.|.
T Consensus 229 ------------~~~~~~~~~~~~---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 ------------EVMEFVTGGGRL---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ------------HHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111111111 112234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=288.00 Aligned_cols=259 Identities=24% Similarity=0.410 Sum_probs=204.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC---------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR---------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGG 75 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~ 75 (313)
.++|.+.++||+|+||.||+|.+. ...+|+|.+.... ...+.+|+++++.+ ||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 468999999999999999999753 3468999887543 23467899999998 99999999999999
Q ss_pred CeEEEEEeecCCCChhhhhcCCCC-----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSV-----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL 144 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 144 (313)
+.++++|||+++++|.+++..... .....+++..+..++.|++.||.|||+++ ++|+||+|+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999854321 12345888999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCC
Q 041031 145 DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNN 223 (313)
Q Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~ 223 (313)
++++.++|+|||.+......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--- 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--- 243 (314)
T ss_pred cCCCcEEEccccccccccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999998765432111 11111223467999999998889999999999999999999 88888644321
Q ss_pred ccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 224 QYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
+....+..... .......+..+.+++.+||+.+|.+|||+.++++.|.++...
T Consensus 244 --------------------~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 --------------------ELFKLLREGHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred --------------------HHHHHHHcCCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11111111111 112233455788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=317.83 Aligned_cols=264 Identities=26% Similarity=0.410 Sum_probs=217.0
Q ss_pred HhcCccccceeccCCeEEEEEeEEC---Cc----ceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR---GK----NAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~---~~----~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
..++.+..+.||+|.||.||.|... +. .||||.+++.. ..++.+|..+|+.+ ||||++++|++-+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3556778899999999999999876 33 38999887653 45688999999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCC--CCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKG--KKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
.++++|||.+|+|..+|...+... ...++..+.+.++.++|.+..||++++ +||+||..+|+|+++...+|++||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence 999999999999999996554322 457899999999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
|+|+............ .-.-+..|+|||.+..+.++.++||||||+++||++| |..||....+.
T Consensus 847 GlArDiy~~~yyr~~~-~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-------------- 911 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHG-EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-------------- 911 (1025)
T ss_pred chhHhhhhchheeccC-ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--------------
Confidence 9999554432211111 1234568999999999999999999999999999999 89999877653
Q ss_pred HHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccc
Q 041031 235 MLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW 303 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 303 (313)
+....+ ..... ......++..+++++.+||+.+|++||++..|++++..+.......
T Consensus 912 ---------~v~~~~--~~ggR-L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 912 ---------EVLLDV--LEGGR-LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred ---------HHHHHH--HhCCc-cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 212211 11122 2246678889999999999999999999999999999998865443
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=282.53 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=195.2
Q ss_pred ccccceeccCCeEEEEEeEEC--Cc--ceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEe------CCe
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR--GK--NAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAG------GDS 77 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~--~~--~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~------~~~ 77 (313)
|.+.++||+|+||.||+|.+. +. .+|+|.++.. ..+.+.+|+.+++.+ ||||+++++.+.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 457889999999999999886 22 5899987643 244577899999999 9999999998643 235
Q ss_pred EEEEEeecCCCChhhhhcCCCC-CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSV-KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
.++++||+.+++|.+++...+. .....+++..+..++.|++.||+|||+++ ++|+||||+||++++++.++++|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 7899999999999988743221 22345889999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
++......... ........++.|++||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 158 ~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------------- 221 (272)
T cd05075 158 LSKKIYNGDYY-RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--------------- 221 (272)
T ss_pred cccccCcccce-ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---------------
Confidence 98865432211 11122345678999999999999999999999999999999 78888653221
Q ss_pred HHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 236 LAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 236 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
+....+.. ..........+..+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 222 --------~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 222 --------EIYDYLRQ---GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------HHHHHHHc---CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111111 111111223455688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=294.33 Aligned_cols=232 Identities=28% Similarity=0.420 Sum_probs=185.0
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHH-HHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELK-ILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~-~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|+||.||+|.+. ++.||+|++.... ...+..|.. +++.+ ||||+++++.+.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999986 7889999987532 223344444 45667 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (323)
T cd05575 81 GELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-- 150 (323)
T ss_pred CCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--
Confidence 99999883 4467889999999999999999999999 9999999999999999999999999886432211
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.......+++.|+|||++.+..++.++|||||||++|+|++|..||...... +...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----------------------~~~~ 206 (323)
T cd05575 151 -KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----------------------EMYD 206 (323)
T ss_pred -CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----------------------HHHH
Confidence 1222346899999999999999999999999999999999999999654321 1111
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS 287 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 287 (313)
.+ ..... ......+..+.+++.+||+.||.+||++.
T Consensus 207 ~i---~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 207 NI---LNKPL-RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HH---HcCCC-CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11 11111 11223356788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=300.49 Aligned_cols=260 Identities=24% Similarity=0.357 Sum_probs=195.4
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCC-----eEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGGD-----SLF 79 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~-----~~~ 79 (313)
+|++.+.||+|+||.||+|.+. ++.||||.+... ....+.+|+.+++.+ ||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999999976 889999988643 234577899999999 999999999998776 789
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+|+||+. ++|.+.+. ....++...++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIV-----SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecccccee
Confidence 9999995 57888773 3457899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
....... .......+++.|+|||++.+. .++.++||||+||++|+|++|+.||.+..... ....+...
T Consensus 152 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------~~~~i~~~ 220 (372)
T cd07853 152 VEEPDES--KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---------QLDLITDL 220 (372)
T ss_pred ecccCcc--ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH---------HHHHHHHH
Confidence 6443211 111223568899999999874 47899999999999999999999997654321 01111110
Q ss_pred hcC-c--------HHHHHHhhhh-cCCC----CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 239 FND-T--------KDFMAKLTEC-LDPN----LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 239 ~~~-~--------~~~~~~l~~~-~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
... . ......+... ..+. +.......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 221 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 221 LGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred cCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 0 0001111100 0000 001112235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=294.64 Aligned_cols=262 Identities=22% Similarity=0.268 Sum_probs=196.7
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeC----
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGG---- 75 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~---- 75 (313)
....++|++.+.||+|+||.||++.+. ++.+|||.+.... ...+.+|+.+++.+ ||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 356789999999999999999999876 7889999886432 34566899999999 99999999988643
Q ss_pred --CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEe
Q 041031 76 --DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIA 153 (313)
Q Consensus 76 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~ 153 (313)
...+++|||+++ +|.+.+. ..++...+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEe
Confidence 357999999965 6777662 24788889999999999999999999 9999999999999999999999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.... .....
T Consensus 162 Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~ 229 (355)
T cd07874 162 DFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--------DQWNK 229 (355)
T ss_pred eCcccccCCCcc----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 999987543321 112246789999999999999999999999999999999999999765421 11111
Q ss_pred HHHHHhcCcHHHHHHhh----hhcC--CC-----------------CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 041031 234 YMLAVFNDTKDFMAKLT----ECLD--PN-----------------LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAA 290 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~----~~~~--~~-----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll 290 (313)
.+.......+++...+. ...+ +. ...........+.+|+.+||+.||++|||+.|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell 309 (355)
T cd07874 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309 (355)
T ss_pred HHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence 11111111111111110 0000 00 0001112345678999999999999999999999
Q ss_pred HH
Q 041031 291 IR 292 (313)
Q Consensus 291 ~~ 292 (313)
+.
T Consensus 310 ~h 311 (355)
T cd07874 310 QH 311 (355)
T ss_pred cC
Confidence 86
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=275.77 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=202.7
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecc-----ccccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMK-----NTKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~-----~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
..++|++.+.||+|.|+.|+++.+. |+.+|+|++. ....+++.+|++|.+.+ ||||+++.+.+....-.++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4578999999999999999998776 8888888775 34577899999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcEEEeecccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLV 158 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~~ 158 (313)
+|++.|+.|..-+. ....+++..+-.+++||++||.|+|.++ |+|+|+||+|+++.. ..-+||+|||++
T Consensus 89 Fe~m~G~dl~~eIV-----~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV-----AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence 99999999987763 2256788899999999999999999999 999999999999953 345899999999
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
...++. .....+.|||.|+|||++....|+-++|||+-|++||-++.|.+||.+.+.. +....+
T Consensus 161 i~l~~g----~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~------------rlye~I 224 (355)
T KOG0033|consen 161 IEVNDG----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------------RLYEQI 224 (355)
T ss_pred EEeCCc----cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH------------HHHHHH
Confidence 987732 2334468999999999999999999999999999999999999999764332 111111
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
... ..+..- ...........+|+++||..||.+|.|+.|.|..
T Consensus 225 ~~g----------~yd~~~-~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 225 KAG----------AYDYPS-PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred hcc----------ccCCCC-cccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 111 111111 1233445567889999999999999999998854
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=286.43 Aligned_cols=257 Identities=28% Similarity=0.427 Sum_probs=200.2
Q ss_pred hcCccccceeccCCeEEEEEeEECC------------------cceEEEeccccc----cHHHHHHHHHHHhc-CCCcee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRG------------------KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIE 67 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~------------------~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~ 67 (313)
.++|++++.||+|+||.||+|.+.. ..+++|.+.... .+.+.+|+++++.+ |||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 5689999999999999999998752 347999987653 34577899999999 999999
Q ss_pred eeeEEEeCCeEEEEEeecCCCChhhhhcCCCCC------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCC
Q 041031 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVK------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSN 141 (313)
Q Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~n 141 (313)
+++++..+...++++|++.+++|.+++...... ....+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 999999999999999999999999998533211 1236899999999999999999999999 9999999999
Q ss_pred eeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh--CCCCccCCCC
Q 041031 142 ILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT--GQQALSRDAN 219 (313)
Q Consensus 142 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t--g~~p~~~~~~ 219 (313)
|+++.++.++++|||.+......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999998754332111 11222345678999999988889999999999999999998 6677754332
Q ss_pred CCCCccccchhHHHHHHHHhcCcHHHHHHhhhhc----CCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 220 PGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECL----DPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
. +......... ...........+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 240 ~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 Q-----------------------QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H-----------------------HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 0011111110 00001112234467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=281.63 Aligned_cols=253 Identities=28% Similarity=0.469 Sum_probs=200.0
Q ss_pred hcCccccceeccCCeEEEEEeEEC--C---cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--G---KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~---~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
...|++.+.||+|+||.||+|.+. + ..++||.+.... ...+..|+.+++.+ |||++++++.+.+....++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 356899999999999999999876 3 259999987542 34577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
+|||+++++|.+++. .....++...++.++.|++.|++|||+++ ++|+||+|+||+++.++.++++|||.+..
T Consensus 83 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 83 ITEFMENGALDSFLR----QNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEecCCCCcHHHHHh----hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccc
Confidence 999999999999985 23356889999999999999999999999 99999999999999999999999998876
Q ss_pred ccCChhhhhhccccc--ccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 161 LEHSPEIAAAASRIV--GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~--~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
............... .+..|+|||.+.+..++.++||||+|+++|++++ |..||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----------------- 218 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----------------- 218 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----------------
Confidence 543322111111111 2457999999998889999999999999999886 99998644321
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
+....+...... ....+.+..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus 219 ------~~~~~i~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 219 ------DVINAIEQDYRL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------HHHHHHHcCCcC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111111000 11223455688899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=279.77 Aligned_cols=247 Identities=30% Similarity=0.493 Sum_probs=200.3
Q ss_pred ceeccCCeEEEEEeEEC-----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|+||.||+|.+. +..+++|.+.... ...+.+|+.+++.+ |+|++++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 47999999999999887 6689999998654 35678899999999 99999999999999999999999999
Q ss_pred CChhhhhcCCCCC----CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 88 GALSDHLHWPSVK----GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 88 ~~L~~~l~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
++|.+++...... ....+++..++.++.|++.||.+||+++ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998533110 1377899999999999999999999999 99999999999999999999999999887654
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 158 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---------------------- 214 (262)
T cd00192 158 DDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---------------------- 214 (262)
T ss_pred ccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH----------------------
Confidence 322 112223456789999999998889999999999999999999 68999755321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+.. ..........+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 215 -~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 215 -EVLEYLRK---GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -HHHHHHHc---CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11122221 1111123344678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=281.70 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=201.9
Q ss_pred hcCccccceeccCCeEEEEEeEECC-----cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRG-----KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..+|.+.++||+|+||.||+|.+.+ ..++||...... .+.+.+|+.+++.+ |||++++++++.+. ..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEE
Confidence 4678999999999999999998752 368999887543 33577899999999 99999999988764 5689
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
+|||+++++|.+++. .....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++++|||++..
T Consensus 84 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 84 VMELAPLGELRSYLQ----VNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEcCCCCcHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence 999999999999985 22345899999999999999999999999 99999999999999999999999999876
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...... .......++..|+|||.+.+..++.++||||||+++|++++ |..||......
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------------------- 215 (270)
T cd05056 157 LEDESY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN------------------- 215 (270)
T ss_pred cccccc--eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-------------------
Confidence 543321 11112234568999999988889999999999999999986 99999655431
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+...... ......+..+.+++.+|+..+|.+|||+.++++.|..+..+.
T Consensus 216 ----~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 216 ----DVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred ----HHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 111111111111 112234567889999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=285.64 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=201.4
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
..++|++.+.||+|+||.||+|.+. +..+++|.+.... ...+.+|+.+++.+ |||++++++++.+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4578999999999999999999863 4678999987543 34577899999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCC-----------------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCC
Q 041031 78 LFLVYEYAQNGALSDHLHWPSV-----------------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTS 140 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~ 140 (313)
.++++||+++++|.+++..... .....+++..++.++.|++.||.|||+++ ++|+||+|+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 9999999999999999853211 11235788889999999999999999999 999999999
Q ss_pred CeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCC
Q 041031 141 NILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDAN 219 (313)
Q Consensus 141 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~ 219 (313)
||++++++.++++|||.+......... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred heEecCCCceEECccccceecccCccc-cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999987754322111 11112234567999999998899999999999999999998 8888854322
Q ss_pred CCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 220 PGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
. +....+ .+..........+..+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 239 ~-----------------------~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 E-----------------------EVIYYV---RDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H-----------------------HHHHHH---hcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 111111 1111111223445679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=294.97 Aligned_cols=262 Identities=23% Similarity=0.289 Sum_probs=196.9
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeC----
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGG---- 75 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~---- 75 (313)
....++|++.+.||+|+||.||++.+. ++.+|||.+... ....+.+|+.+++.+ ||||+++++++...
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 356789999999999999999999986 788999998643 234567899999999 99999999987543
Q ss_pred --CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEe
Q 041031 76 --DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIA 153 (313)
Q Consensus 76 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~ 153 (313)
..+++||||++ ++|.+.+. ..++...+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~ 168 (364)
T cd07875 100 EFQDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 168 (364)
T ss_pred ccCeEEEEEeCCC-CCHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEE
Confidence 35799999995 47777762 24778889999999999999999999 9999999999999999999999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. .....
T Consensus 169 DfG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--------~~~~~ 236 (364)
T cd07875 169 DFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--------DQWNK 236 (364)
T ss_pred eCCCccccCCCC----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 999987544321 112346789999999999999999999999999999999999999765431 11111
Q ss_pred HHHHHhcCcHHHHHHhhhh----cC--CCC-----------------CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 041031 234 YMLAVFNDTKDFMAKLTEC----LD--PNL-----------------TRYHKDSMLQMALLSKDCVDENWKRRPDMSNAA 290 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~----~~--~~~-----------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll 290 (313)
.+.......+++...+... .. +.. ..........+.+|+.+||..||.+|||+.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L 316 (364)
T cd07875 237 VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316 (364)
T ss_pred HHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 1111111111111111100 00 000 001111235678999999999999999999998
Q ss_pred HH
Q 041031 291 IR 292 (313)
Q Consensus 291 ~~ 292 (313)
+.
T Consensus 317 ~h 318 (364)
T cd07875 317 QH 318 (364)
T ss_pred cC
Confidence 75
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=280.87 Aligned_cols=250 Identities=26% Similarity=0.321 Sum_probs=207.0
Q ss_pred HhcCccccceeccCCeEEEEEeEECC--cceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRG--KNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~--~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
-.+.|+.++.||.|..|+||+++..+ ..+|+|++.+.. ..+++.|-+||..+ ||.+..+++.|+.++-.|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 35678899999999999999999985 678999997654 44577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
+||||+||+|..++..+ .+..+++..++-++..++-||.|||..| ||+|||||+||||.++|+|-|.||.++..
T Consensus 155 ~meyCpGGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEecCCCccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999998633 4577999999999999999999999999 99999999999999999999999987543
Q ss_pred ccCChh--------------------------------hh---------------------hhcccccccccccCCcccc
Q 041031 161 LEHSPE--------------------------------IA---------------------AAASRIVGTFGYLAPEYVR 187 (313)
Q Consensus 161 ~~~~~~--------------------------------~~---------------------~~~~~~~~~~~~~aPE~~~ 187 (313)
..-.+. .. .....+.||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 211000 00 1112257899999999999
Q ss_pred CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHH
Q 041031 188 DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSML 266 (313)
Q Consensus 188 ~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~ 266 (313)
|..++.+.|.|+||+++|||+.|..||.+.+.. ..+...+...+.- .....+.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~--------------------------~Tl~NIv~~~l~Fp~~~~vs~ 362 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK--------------------------ETLRNIVGQPLKFPEEPEVSS 362 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch--------------------------hhHHHHhcCCCcCCCCCcchh
Confidence 999999999999999999999999999988764 2222333333222 2335667
Q ss_pred HHHHHHhhccccCcCCCCC----HHHHHH
Q 041031 267 QMALLSKDCVDENWKRRPD----MSNAAI 291 (313)
Q Consensus 267 ~l~~li~~cl~~~p~~Rps----~~~ll~ 291 (313)
.+++||++.|-.||++|.. +.||.+
T Consensus 363 ~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 363 AAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHHHHHHhccChhhhhccccchHHhhc
Confidence 8999999999999999998 777654
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=279.41 Aligned_cols=250 Identities=29% Similarity=0.479 Sum_probs=198.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.++|.+.++||.|++|.||+|.+. +..+++|.+.... .+.+.+|+++++.+ |+|++++++++.. +..+++|||+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 467999999999999999999987 4579999887543 34577899999999 9999999988754 56789999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 84 KGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999998522 2345788999999999999999999999 99999999999999999999999999876543221
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
.......++..|+|||...+..++.++|+||||+++|+|++ |..||.+.... +.
T Consensus 158 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------------~~ 212 (260)
T cd05069 158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-----------------------EV 212 (260)
T ss_pred --cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------------HH
Confidence 11112235678999999988889999999999999999999 88998654321 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
...+...... ......+..+.+++.+||+.||.+||+++++++.|+.
T Consensus 213 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 213 LEQVERGYRM---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHcCCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111111111 1123445678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=284.06 Aligned_cols=254 Identities=24% Similarity=0.429 Sum_probs=199.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|+..++||+|+||.||++... +..+++|.+.... ...+.+|+++++.+ |+||+++++++.+....+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 468899999999999999999642 4578888876543 34578899999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCC----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc
Q 041031 80 LVYEYAQNGALSDHLHWPSV----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR 149 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~ 149 (313)
++|||+++++|.+++..... .....+++..++.++.|++.|++|||+.+ ++|+||+|+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999853321 11235788999999999999999999999 999999999999999999
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccc
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~ 228 (313)
++|+|||++........ ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------- 231 (280)
T cd05092 161 VKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------- 231 (280)
T ss_pred EEECCCCceeEcCCCce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--------
Confidence 99999999875432211 111122234678999999999899999999999999999998 89998643321
Q ss_pred hhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+...... ......+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 232 ---------------~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 ---------------EAIECITQGREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---------------HHHHHHHcCccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111111111 112234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=284.82 Aligned_cols=247 Identities=27% Similarity=0.346 Sum_probs=195.9
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.|+..+.||+|+||.||++.+. ++.+|+|.+.... ...+.+|+.+++.+ |++++.+++.+.+.+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4788899999999999999987 7789999886532 23356799999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||++.....
T Consensus 81 ~~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999988421 2345889999999999999999999999 99999999999999999999999998875443
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
... .....++..|+|||++.+..++.++|+||+|+++|+|++|..||....... ..... ..
T Consensus 155 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~--------~~~~~-~~------ 215 (285)
T cd05630 155 GQT----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--------KREEV-ER------ 215 (285)
T ss_pred Ccc----ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc--------hHHHH-Hh------
Confidence 211 112367899999999998889999999999999999999999997543210 00000 00
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-----MSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~ll~~ 292 (313)
...... . ......+..+.+|+.+||+.||++||| +.++++.
T Consensus 216 -~~~~~~----~---~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 216 -LVKEVQ----E---EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred -hhhhhh----h---hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 000000 0 011223456888999999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=279.10 Aligned_cols=249 Identities=24% Similarity=0.448 Sum_probs=200.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.++|++.+.||.|++|.||+|.+. +..+++|.+.... ...+.+|+++++++ |||++++++++......++++||+.
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 468899999999999999999887 7889999887543 45688899999999 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++. .....++++.++.++.+++.++++||+.+ ++|+||+|+||+++.++.++++|||.+........
T Consensus 83 ~~~L~~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 83 HGCLSDYLR----AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCcHHHHHH----hCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999984 23346788999999999999999999999 99999999999999999999999998875433211
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
........+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... +.
T Consensus 156 --~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----------------------~~ 210 (256)
T cd05112 156 --TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----------------------EV 210 (256)
T ss_pred --cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----------------------HH
Confidence 11112234578999999998889999999999999999998 89998643321 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
...+........ ....+..+.+++.+||+.+|.+|||+.+++++|.
T Consensus 211 ~~~~~~~~~~~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 211 VETINAGFRLYK---PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHhCCCCCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 111111111111 1123467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=280.76 Aligned_cols=247 Identities=31% Similarity=0.509 Sum_probs=193.0
Q ss_pred ceeccCCeEEEEEeEEC--Cc--ceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GK--NAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~--~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|+||.||+|.++ +. .+++|.++... .+.+.+|++++..+ |||++++++.+...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999986 22 46888877432 34577899999988 99999999999999999999999999
Q ss_pred CChhhhhcCCCC-----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 88 GALSDHLHWPSV-----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 88 ~~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
++|.+++..... .....+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999854321 11235789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
++...... ........+..|+|||++.+..++.++|+||||+++|+|++ |..||......
T Consensus 158 l~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------------- 218 (270)
T cd05047 158 LSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------------- 218 (270)
T ss_pred Cccccchh----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---------------
Confidence 87532211 11111234567999999988889999999999999999997 99999643221
Q ss_pred HHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 236 LAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 236 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
+....+...... ......+..+.+++.+||+.+|.+|||+.+++++|.++.
T Consensus 219 --------~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 --------ELYEKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------HHHHHHhCCCCC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111111111101 112234457889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=280.02 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=197.1
Q ss_pred CccccceeccCCeEEEEEeEEC-CcceEEEeccccc---------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK---------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~---------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
+|++.+.||.|+||.||+|... ++.+|+|.+.... ...+.+|+++++.+ |+|++++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 5889999999999999999875 7889999886432 23477899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
+||+++++|.+++. ....+++..+..++.|++.++++||+.+ ++|+||+|+||++++++.++++|||.+...
T Consensus 81 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILN-----RFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 99999999999984 3356789999999999999999999999 999999999999999999999999988754
Q ss_pred cCChh---hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 162 EHSPE---IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 162 ~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
..... .........++..|+|||++.+..++.++|+||||+++|+|++|..||.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------------- 215 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----------------- 215 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----------------
Confidence 32111 1111122357889999999999889999999999999999999999996433210
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
. ...+.. ............+..+.+++++||+.+|.+||++.++++
T Consensus 216 -----~-~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 216 -----A-MFYIGA-HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----H-HHHhhh-ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 000000 000111122334567889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=283.86 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=201.4
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
..++|++.+.||+|+||.||+|..+ +..+|+|.+.... ...+.+|+.+++.+ |||++++++.+.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999998754 3478999876443 22466788999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCC-----CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEE
Q 041031 78 LFLVYEYAQNGALSDHLHWPSV-----KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKI 152 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l 152 (313)
.+++|||+++|+|.+++..... ......+...+..++.|++.||+|||+++ ++|+||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999853211 11234567788999999999999999999 999999999999999999999
Q ss_pred eeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhH
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~ 231 (313)
+|||++......... .......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+....
T Consensus 161 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~----------- 228 (288)
T cd05061 161 GDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE----------- 228 (288)
T ss_pred CcCCccccccccccc-cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------
Confidence 999988754332211 11122234678999999998889999999999999999998 78888643221
Q ss_pred HHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 232 VDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
+..+.+ .+..........+..+.+++.+||+.+|.+|||+.++++.|...+.
T Consensus 229 ------------~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 229 ------------QVLKFV---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred ------------HHHHHH---HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 111111 1111111122334678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=295.25 Aligned_cols=259 Identities=25% Similarity=0.442 Sum_probs=202.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCC
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGD 76 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~ 76 (313)
..++|.+.++||+|+||.||+|.+. +..||+|.++... ...+.+|+.++..+ ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3467889999999999999999864 3579999997543 23577899999998 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCC---------------------------------------------------------
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSV--------------------------------------------------------- 99 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------- 99 (313)
..++|+||+.+|+|.+++.....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999853211
Q ss_pred ------------------------------------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCee
Q 041031 100 ------------------------------------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNIL 143 (313)
Q Consensus 100 ------------------------------------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil 143 (313)
.....+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 01124567788899999999999999999 999999999999
Q ss_pred eCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCC
Q 041031 144 LDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGN 222 (313)
Q Consensus 144 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~ 222 (313)
+++++.++++|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~- 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE- 349 (401)
T ss_pred EeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence 999999999999998764322211 11112345788999999998889999999999999999998 888986543210
Q ss_pred CccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 223 NQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
.....+...... ......+..+.+++.+||..+|.+||++.+|++.|++++
T Consensus 350 ---------------------~~~~~~~~~~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 ---------------------QFYNAIKRGYRM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---------------------HHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 011111111111 112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=297.87 Aligned_cols=254 Identities=30% Similarity=0.476 Sum_probs=207.2
Q ss_pred cCccccceeccCCeEEEEEeEEC-C----cc-eEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR-G----KN-AAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~-~----~~-~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
++....++||+|.||.||+|..+ + .. ||||..+.. ...++.+|+++|+++ ||||++++|+......+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34456689999999999999877 1 23 899998852 245588999999999 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++|||++.||+|.++|. .....++..+...++.+.+.||+|||+++ ++||||-.+|+|++.++.+|++|||++
T Consensus 237 ~ivmEl~~gGsL~~~L~----k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLK----KNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EEEEEecCCCcHHHHHH----hCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999994 33346999999999999999999999999 999999999999999999999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
.....-. ........+..|+|||.+....++.++||||+|+++||+++ |..||.+....
T Consensus 310 ~~~~~~~---~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----------------- 369 (474)
T KOG0194|consen 310 RAGSQYV---MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----------------- 369 (474)
T ss_pred cCCccee---eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----------------
Confidence 7644111 11111235789999999999999999999999999999999 88899876653
Q ss_pred HhcCcHHHHHHh-hhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 238 VFNDTKDFMAKL-TECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 238 ~~~~~~~~~~~l-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
+....+ ....... .+...+..+..++.+||..+|++|||+.++.+.|+.+.....
T Consensus 370 ------~v~~kI~~~~~r~~---~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 370 ------EVKAKIVKNGYRMP---IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ------HHHHHHHhcCccCC---CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 222222 1111111 233556678889999999999999999999999998877544
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=290.42 Aligned_cols=236 Identities=26% Similarity=0.388 Sum_probs=190.0
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~ 82 (313)
+|...+.||+|+||.||+|+++ ++.||+|++.... ......|..++..+ |++++++++++...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999987 7889999987432 23456788888877 678889999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++....
T Consensus 81 Ey~~~g~L~~~i~-----~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQ-----QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999999883 4456899999999999999999999999 9999999999999999999999999887533
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... .......+++.|+|||++.+..++.++|+||+||++|+|++|..||.+....
T Consensus 153 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---------------------- 207 (323)
T cd05615 153 VDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---------------------- 207 (323)
T ss_pred CCC---ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----------------------
Confidence 221 1122345899999999999988999999999999999999999999754321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM 286 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 286 (313)
+....+.. ... ......+..+.+++.+||+.+|.+|++.
T Consensus 208 -~~~~~i~~---~~~-~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 208 -ELFQSIME---HNV-SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -HHHHHHHh---CCC-CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11111111 110 1122334567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=294.31 Aligned_cols=234 Identities=26% Similarity=0.342 Sum_probs=189.2
Q ss_pred cceeccCCeEEEEEeEEC-----CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 17 SLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
++.||+|+||.||++++. ++.+|+|++.... ......|+++++++ ||||+++++++.+.+..++||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 368999999999998762 6789999987532 23456789999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
.+++|.+.+. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 81 RGGDLFTRLS-----KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 9999999983 3456899999999999999999999999 9999999999999999999999999987543321
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
.......+++.|+|||++.+..++.++|||||||++|+|++|+.||...... +.
T Consensus 153 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----------------------~~ 206 (318)
T cd05582 153 ---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----------------------ET 206 (318)
T ss_pred ---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----------------------HH
Confidence 1222346889999999999888999999999999999999999999654321 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSN 288 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 288 (313)
...+. .... ......+..+.+|+++||+.||.+||++.+
T Consensus 207 ~~~i~---~~~~-~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 207 MTMIL---KAKL-GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHH---cCCC-CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11111 1111 112234457888999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=282.26 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=196.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.++|.+.+.||+|+||.||+|.+. ++.+++|.++... ...+.+|+.+++.+ |||++++++.+...+..++++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 468999999999999999999886 7889999987543 23467899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++. ..+.+++..++.++.|++.++.|||+.+ ++|+||+|+||+++.++.++++|||.+......
T Consensus 88 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 88 CGGGSLQDIYH-----VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred cCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 99999999983 3457899999999999999999999999 999999999999999999999999998755432
Q ss_pred hhhhhhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
. .......++..|+|||++. ...++.++|+|||||++|+|++|..||.......
T Consensus 160 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-------------------- 216 (267)
T cd06645 160 I---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-------------------- 216 (267)
T ss_pred c---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--------------------
Confidence 1 1222346789999999874 4558889999999999999999999986443210
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...........+.........+..+.+++.+||+.+|++|||+.+|++
T Consensus 217 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 217 --ALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --hHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000000000001000011123456888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=278.48 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=200.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.++|++.+.||.|++|.||+|.+. ++.+++|.+.... ...+.+|+.+++.+ |||++++++.+.+.+.++++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 468999999999999999999986 6789999987543 45578899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++. .....+++..++.++.|++.|++|||+.+ ++|+||+|+||++++++.++++|||.+......
T Consensus 82 ~~~~~l~~~~~----~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 82 CGGGSLQDIYQ----VTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCcHHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999884 22356889999999999999999999999 999999999999999999999999998765432
Q ss_pred hhhhhhcccccccccccCCccccCC---CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDG---CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
. .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... ...
T Consensus 155 ~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--------~~~---------- 213 (262)
T cd06613 155 I---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--------RAL---------- 213 (262)
T ss_pred h---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------HHH----------
Confidence 1 112234578889999999776 7889999999999999999999999654321 000
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.........+.........+..+.+++.+||..+|.+|||+.+|+.
T Consensus 214 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 214 ----FLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ----HHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000011111112334567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=280.12 Aligned_cols=245 Identities=27% Similarity=0.455 Sum_probs=197.2
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccccc------------HHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS------------KEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~------------~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
+|.+...||.|++|.||+|.+. ++.+++|.+..... +.+.+|+.+++.+ ||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788999999999999999876 68899998864321 3467899999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.++++||+++++|.+++. ....++...+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||.
T Consensus 81 ~~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN-----NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHH-----hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCC
Confidence 999999999999999984 3456888899999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhh---hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 158 VKLLEHSPEIA---AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 158 ~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
+.......... .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------------- 218 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------------- 218 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------------
Confidence 87665321110 1111234778999999999888999999999999999999999999653221
Q ss_pred HHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 235 MLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.....+.....+ ......+..+.+++.+||+.||.+||++.++++
T Consensus 219 ---------~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 219 ---------QAIFKIGENASP---EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---------HHHHHHhccCCC---cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000111111111 122345567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=283.81 Aligned_cols=268 Identities=24% Similarity=0.384 Sum_probs=203.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC------CcceEEEecccccc----HHHHHHHHHHHhc-CCCceeeeeEEEe--CCe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR------GKNAAIKQMKNTKS----KEFSSELKILCKV-HSNLIELIGYAAG--GDS 77 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~------~~~~aiK~~~~~~~----~~~~~e~~~l~~l-h~~i~~~~~~~~~--~~~ 77 (313)
.+.|++.+.||+|+||.||+|.+. +..+|||.+..... ..+.+|+++++.+ |||++++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 357888999999999999999864 56899999986643 4688999999999 9999999999877 567
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.+++|||+++++|.+++. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||.
T Consensus 83 ~~lv~e~~~~~~l~~~l~----~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQ----RHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred eEEEEecCCCCCHHHHHH----hCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccc
Confidence 899999999999999985 22336899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+..................+..|+|||.+.+..++.++|+||||+++|+|++|..|+................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~------- 228 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG------- 228 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccc-------
Confidence 8876532221111112234567999999988889999999999999999999999886543211000000000
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
..........+..... .......+..+.+++.+||+.+|.+|||+.+|+++|+.+
T Consensus 229 -~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 229 -QMIVTRLLELLKEGER---LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -cccHHHHHHHHHcCCc---CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000011111111111 111223446788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=278.63 Aligned_cols=251 Identities=25% Similarity=0.458 Sum_probs=201.0
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..++|.+.++||+|+||.||++.+. +..+++|.+.... .+.+.+|+++++.+ |+|++++.+.+.. ...+++|||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4678999999999999999999876 6679999887654 35678899999999 9999999999887 7789999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++++|.+++... ....++...+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++++|||.+.......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 83 AKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999998532 2345788889999999999999999999 9999999999999999999999999887654321
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. .......++..|+|||++.+..++.++|+||||+++|++++ |..||...... +
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----------------------~ 211 (260)
T cd05073 157 Y--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----------------------E 211 (260)
T ss_pred c--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----------------------H
Confidence 1 11112234677999999998889999999999999999999 89999654321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
....+...... ......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 212 ~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 212 VIRALERGYRM---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHhCCCCC---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111111000 1122344578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=276.41 Aligned_cols=242 Identities=26% Similarity=0.416 Sum_probs=193.2
Q ss_pred ceeccCCeEEEEEeEEC-CcceEEEecccccc----HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCChh
Q 041031 18 LKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKS----KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALS 91 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~~----~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (313)
++||+|+||.||+|... +..+++|.+..... ..+.+|+++++.+ |||++++++.+...+..+++|||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47899999999999876 67899999876542 3467899999999 999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhc
Q 041031 92 DHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAA 171 (313)
Q Consensus 92 ~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 171 (313)
+++. .....+++..++.++.+++.++.|+|+.+ ++|+||+|+||++++++.++++|||++........ ...
T Consensus 81 ~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~ 151 (250)
T cd05085 81 SFLR----KKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY--SSS 151 (250)
T ss_pred HHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc--ccC
Confidence 9884 22345789999999999999999999999 99999999999999999999999998865432211 111
Q ss_pred ccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhh
Q 041031 172 SRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLT 250 (313)
Q Consensus 172 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
.....+..|+|||++.+..++.++|+||||+++|++++ |..||...... +....+.
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----------------------~~~~~~~ 208 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----------------------QAREQVE 208 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----------------------HHHHHHH
Confidence 11234567999999998889999999999999999998 99999654321 1111111
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 251 ECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
..... ......+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 209 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 209 KGYRM---SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred cCCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11111 112234567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=282.52 Aligned_cols=262 Identities=26% Similarity=0.353 Sum_probs=199.6
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEeCC-----eEEEEEe
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAGGD-----SLFLVYE 83 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~-----~~~lv~e 83 (313)
=.|...+++|.|+||.||+|... ++.+|||..-.+.. .-.+|+++|+.+ |||||+++-+|.... ...+|||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 35788999999999999999887 68999999877643 445799999999 999999999885332 3458999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-CCcEEEeecccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLLE 162 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~ 162 (313)
|++ .+|.+.+..- ...+..++...++-+..|+++|++|||..+ |+||||||.|+|+|. .|.+||+|||.|....
T Consensus 103 ymP-~tL~~~~r~~-~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 103 YMP-ETLYRVIRHY-TRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred hch-HHHHHHHHHH-hhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 995 5999988531 123567888888999999999999999999 999999999999995 4999999999999876
Q ss_pred CChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.+.. ...-..+..|+|||.+.+ ..|+.+.||||.||++.||+-|++.|.+.+..+ .+...+.-.-..
T Consensus 178 ~~ep----niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--------QL~eIik~lG~P 245 (364)
T KOG0658|consen 178 KGEP----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--------QLVEIIKVLGTP 245 (364)
T ss_pred cCCC----ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--------HHHHHHHHhCCC
Confidence 5422 122356889999998886 579999999999999999999999999866531 222222222211
Q ss_pred cH-HHHHHhhhhcCCCCCC---------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 242 TK-DFMAKLTECLDPNLTR---------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 242 ~~-~~~~~l~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.. +....-....+.+.+. .......++.+|+.++|.++|.+|.++.|++.
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11 2111111111111111 23445678999999999999999999999984
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=284.45 Aligned_cols=260 Identities=23% Similarity=0.323 Sum_probs=191.3
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc----CCCceeeeeEEEe-----CC
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV----HSNLIELIGYAAG-----GD 76 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l----h~~i~~~~~~~~~-----~~ 76 (313)
+|++.+.||+|+||.||+|++. ++.+|+|.+.... .....+|+.+++.+ ||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999987 7789999886432 23456677777665 9999999998764 34
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
..+++||++. ++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccC
Confidence 5899999996 5888887422 2245899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
++....... ......++..|+|||++.+..++.++||||+||++|+|++|.+||.+.... ..+.....
T Consensus 154 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~--------~~~~~~~~ 221 (288)
T cd07863 154 LARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--------DQLGKIFD 221 (288)
T ss_pred ccccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH--------HHHHHHHH
Confidence 987654321 112235688999999999888999999999999999999999999654331 01111111
Q ss_pred HHh-cCcHHHHHHh---hhhcCCCC----CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 237 AVF-NDTKDFMAKL---TECLDPNL----TRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 237 ~~~-~~~~~~~~~l---~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
... +....+.... .....+.. ..........+.+++.+||+.||.+|||+.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 222 LIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0000000000 00000000 0112234566889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=280.59 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=205.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC--Cc----ceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GK----NAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~----~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|++.+.||+|+||.||+|.++ ++ .+++|...... ...+.+|+.+++.+ |||++++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 468999999999999999999875 32 58999887654 34577899999999 9999999999887 6889
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+++|++++++|.+++. .....+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||.+.
T Consensus 85 ~v~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVR----NHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence 9999999999999985 33445899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
........ ........+..|+|||.+....++.++|+||||+++|++++ |..||......
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------------ 218 (279)
T cd05057 158 LLDVDEKE-YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------------------ 218 (279)
T ss_pred cccCcccc-eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------------------
Confidence 65532211 11111223567999999988889999999999999999998 99999654321
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccccc
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEWE 304 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 304 (313)
++...+.... ........+..+.+++.+||..+|.+|||+.++++.|.++..+.....
T Consensus 219 -----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~~ 276 (279)
T cd05057 219 -----EIPDLLEKGE---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRYL 276 (279)
T ss_pred -----HHHHHHhCCC---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcceE
Confidence 1111221110 011122244578889999999999999999999999999877655443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.67 Aligned_cols=239 Identities=26% Similarity=0.371 Sum_probs=187.3
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHH-HHHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSEL-KILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~-~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|+||.||+|++. ++.+|+|++.... ...+..|. .+++.+ ||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999987 6779999986532 12233343 345666 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++. ....+.+..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-- 150 (325)
T cd05602 81 GELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-- 150 (325)
T ss_pred CcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--
Confidence 99999983 3456788889999999999999999999 9999999999999999999999999986532211
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.......+++.|+|||++.+..++.++|||||||++|+|++|..||...... +...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------------~~~~ 206 (325)
T cd05602 151 -GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----------------------EMYD 206 (325)
T ss_pred -CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----------------------HHHH
Confidence 1222346899999999999999999999999999999999999999754321 1111
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.+.. ... ......+..+.+++.+||+.||.+||++.+.+..+.
T Consensus 207 ~i~~---~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 207 NILN---KPL-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred HHHh---CCc-CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 1111 000 112234557889999999999999999875544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=285.10 Aligned_cols=261 Identities=26% Similarity=0.389 Sum_probs=197.7
Q ss_pred hcCccccceeccCCeEEEEEeEECC----------------cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRG----------------KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELI 69 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~----------------~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~ 69 (313)
..+|++.+.||+|+||.||++.+.+ ..+|+|.++... ...+.+|+++++.+ |+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3689999999999999999987642 248999987643 33577899999999 99999999
Q ss_pred eEEEeCCeEEEEEeecCCCChhhhhcCCCCC-------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCe
Q 041031 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVK-------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNI 142 (313)
Q Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~ni 142 (313)
+++...+..+++|||+.+++|.+++...... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 9999999999999999999999998532211 1124678889999999999999999999 99999999999
Q ss_pred eeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh--CCCCccCCCCC
Q 041031 143 LLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT--GQQALSRDANP 220 (313)
Q Consensus 143 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t--g~~p~~~~~~~ 220 (313)
++++++.++++|||++........ ........++..|+|||++.+..++.++|+||||+++|+|++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999999875433211 111122234678999999998889999999999999999998 56677543321
Q ss_pred CCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 221 GNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+.+... ...................+..+.+|+.+||+.+|.+|||+.+|++.|.
T Consensus 240 ------------~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 ------------QVIENT-------GEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ------------HHHHHH-------HHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 000000 0000000000001112233467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=284.28 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=199.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC------------------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCcee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR------------------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIE 67 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~------------------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~ 67 (313)
.++|++.++||+|+||.||++++. ...+|+|.+.... ...+.+|+.+++.+ |+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457999999999999999998653 2358999987543 34577899999999 999999
Q ss_pred eeeEEEeCCeEEEEEeecCCCChhhhhcCCCC------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCC
Q 041031 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSV------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSN 141 (313)
Q Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~n 141 (313)
+++++...+..+++|||+++++|.+++..... .....+++..++.++.|++.|++|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999854321 11235778899999999999999999999 9999999999
Q ss_pred eeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh--CCCCccCCCC
Q 041031 142 ILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT--GQQALSRDAN 219 (313)
Q Consensus 142 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t--g~~p~~~~~~ 219 (313)
|++++++.++++|||++......... ........+..|++||+..+..++.++|+|||||++|+|++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999998755432211 11112234678999999888889999999999999999998 6788864432
Q ss_pred CCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 220 PGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
. +..... ..................++..+.+|+.+||+.||.+|||+.+|++.|++
T Consensus 240 ~------------~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 E------------QVIENT-------GEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H------------HHHHHH-------HHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 000000 00000000000011122344678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=291.77 Aligned_cols=232 Identities=26% Similarity=0.376 Sum_probs=184.0
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHH-HHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELK-ILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~-~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
++||+|+||.||+|++. ++.+|+|++.... ...+..|.. +++.+ ||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999987 7789999986432 223444443 56667 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|...+. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (321)
T cd05603 81 GELFFHLQ-----RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-- 150 (321)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--
Confidence 99998873 4456888999999999999999999999 9999999999999999999999999876532211
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.......+++.|+|||++.+..++.++|||||||++|+|++|..||...+.. .. ..
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~-----------~~ 206 (321)
T cd05603 151 -ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------------QM-----------YD 206 (321)
T ss_pred -CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------------HH-----------HH
Confidence 1222346889999999999888999999999999999999999999654321 11 11
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS 287 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 287 (313)
. ...... .........+.+++.+||+.||.+||++.
T Consensus 207 ~---i~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 207 N---ILHKPL-QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred H---HhcCCC-CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1 111111 12223455788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.38 Aligned_cols=249 Identities=25% Similarity=0.331 Sum_probs=196.5
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
++|++.++||+|+||.||+|.+. +..+|+|.+.... ...+.+|+++++++ |||++++++.+...+..+++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 47889999999999999999876 7889999886542 23577899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|..+. .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 81 MDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred CCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 9999886542 3678888999999999999999999 999999999999999999999999998754322
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
......++..|+|||++.+..++.++|+||||+++|+|++|..||............ . .
T Consensus 149 -----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~--~--------------~ 207 (279)
T cd06619 149 -----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP--L--------------Q 207 (279)
T ss_pred -----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch--H--------------H
Confidence 122346788999999999888999999999999999999999999653322100000 0 0
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
....+.....+.+ .....+..+.+++.+||+.+|.+||++.++++.-.-
T Consensus 208 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 208 LLQCIVDEDPPVL--PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred HHHHHhccCCCCC--CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 0111111111111 122234568899999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=290.35 Aligned_cols=239 Identities=24% Similarity=0.356 Sum_probs=188.1
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|+||.||+|++. ++.+|+|++.... ...+.+|..++..+ ||+|+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999987 6789999997532 23467888888888 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+.+. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~L~~~~~-----~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 150 (327)
T cd05617 81 GDLMFHMQ-----RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-- 150 (327)
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--
Confidence 99998883 3456899999999999999999999999 9999999999999999999999999886432211
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.......+++.|+|||++.+..++.++|||||||++|+|++|..||......... ...... ..
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~------~~~~~~----------~~ 213 (327)
T cd05617 151 -DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM------NTEDYL----------FQ 213 (327)
T ss_pred -CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc------ccHHHH----------HH
Confidence 1222346899999999999999999999999999999999999999654321100 000000 11
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS 287 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 287 (313)
.+. ... .......+..+.+++.+||+.||.+|+++.
T Consensus 214 ~~~---~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 214 VIL---EKP-IRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHH---hCC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 111 111 111223445678899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=301.80 Aligned_cols=264 Identities=23% Similarity=0.312 Sum_probs=191.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEeC--------CeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAGG--------DSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~--------~~~~ 79 (313)
..+|.+.++||+|+||.||+|.+. ++.||||.+.... ....+|+.+++.+ ||||+++++++... ..++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 457999999999999999999886 7889999886543 3455799999999 99999999886432 2467
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC-cEEEeecccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF-RAKIADFGLV 158 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~ 158 (313)
+||||++ ++|.+++.... .....+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++ .+||+|||++
T Consensus 144 lvmE~~~-~~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 144 VVMEFIP-QTVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEecCC-ccHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccc
Confidence 8999996 47777663221 23467899999999999999999999999 99999999999998654 6999999999
Q ss_pred ccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.... ..+...+..
T Consensus 219 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--------~~~~~i~~~ 286 (440)
T PTZ00036 219 KNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--------DQLVRIIQV 286 (440)
T ss_pred hhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHH
Confidence 7654321 1122357899999999875 46899999999999999999999999765432 111111111
Q ss_pred HhcCcHHHHHHhh-hhcC---CCCC-----C-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 238 VFNDTKDFMAKLT-ECLD---PNLT-----R-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~~~~l~-~~~~---~~~~-----~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
......+...... ...+ +... . .....+..+.+|+.+||.+||.+|||+.|+++.
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 1000000000000 0000 0000 0 111234578899999999999999999999854
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=291.58 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=197.2
Q ss_pred HHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeC--
Q 041031 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGG-- 75 (313)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~-- 75 (313)
.+-.+.++|++.+.||.|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++...
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 44567889999999999999999999876 6789999987532 33466899999999 99999999987543
Q ss_pred ----CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEE
Q 041031 76 ----DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAK 151 (313)
Q Consensus 76 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~ 151 (313)
...+++++++ +++|.+++. ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~k 158 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVK------CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELR 158 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEE
Confidence 4578999988 779988873 346899999999999999999999999 99999999999999999999
Q ss_pred EeeccccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchh
Q 041031 152 IADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~ 230 (313)
|+|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..
T Consensus 159 l~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~ 224 (343)
T cd07878 159 ILDFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--------DQ 224 (343)
T ss_pred EcCCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--------HH
Confidence 9999998765432 122357899999999976 56899999999999999999999999654321 11
Q ss_pred HHHHHHHHhcCcHHHHHHhh--------hhc----CCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 231 LVDYMLAVFNDTKDFMAKLT--------ECL----DPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~l~--------~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+............+....+. ..+ ...+..........+.+|+.+||..||.+|||+.++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 225 LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111111111111111110 000 000000111223457889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=282.10 Aligned_cols=247 Identities=25% Similarity=0.321 Sum_probs=195.5
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.|+..+.||+|+||.||+|.+. ++.+|+|.+.... ...+.+|+++++.+ |++++.+.+.+..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4778899999999999999987 7889999986532 23366799999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+.+++|.+.+.. .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 81 IMNGGDLKFHIYN---MGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred eccCccHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 9999999988742 12346899999999999999999999999 99999999999999999999999998865432
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
.. ......++..|+|||++.+..++.++|+||+|+++|+|++|..||...... ..
T Consensus 155 ~~----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~--------~~------------- 209 (285)
T cd05632 155 GE----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK--------VK------------- 209 (285)
T ss_pred CC----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH--------HH-------------
Confidence 21 112236789999999999888999999999999999999999999754321 00
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-----MSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~ll~~ 292 (313)
...+...+...........+..+.+|+..||+.||++||+ +.+++..
T Consensus 210 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 210 --REEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --HHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0011111111001112234456788999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=284.57 Aligned_cols=254 Identities=23% Similarity=0.391 Sum_probs=201.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGDS 77 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~ 77 (313)
.++|.+.+.||+|+||.||+|.+. +..+|+|.++... .+.+.+|+.+++++ ||||+++++.+...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 457999999999999999999752 3468999887543 34577899999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.+++|||+.+++|.+++... ....+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++++|||+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999998422 2234899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
+......... .......++..|+|||++.+..++.++||||+|+++|+|++ |..||.......
T Consensus 188 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------------- 251 (302)
T cd05055 188 ARDIMNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------------- 251 (302)
T ss_pred cccccCCCce-eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---------------
Confidence 8755432211 11112345678999999998889999999999999999998 999986543210
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
.+...+....... .....+..+.+++.+||..+|++|||+.++++.|.++
T Consensus 252 -------~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 -------KFYKLIKEGYRMA---QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -------HHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111111111111 1122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=283.13 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=204.0
Q ss_pred CcChHHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc--CCCceeeeeEEEe
Q 041031 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV--HSNLIELIGYAAG 74 (313)
Q Consensus 1 ~~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l--h~~i~~~~~~~~~ 74 (313)
||+++++..+.++|.+.+.||+|+||.||++... ++.+++|.+.... ...+.+|+.+++.+ |||++++++++..
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 4667888889999999999999999999999986 7789999987543 45677899999988 9999999999864
Q ss_pred C-----CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc
Q 041031 75 G-----DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR 149 (313)
Q Consensus 75 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~ 149 (313)
. ...++|+||+++++|.+++.... .....+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 3 36899999999999999875322 23456889999999999999999999999 999999999999999999
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCccccCC-----CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCc
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-----CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQ 224 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~ 224 (313)
++++|||.+........ ......++..|+|||++... .++.++|+||||+++|+|++|+.||......
T Consensus 167 ~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---- 239 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---- 239 (291)
T ss_pred EEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH----
Confidence 99999998876543211 11223578899999998643 3688999999999999999999999654321
Q ss_pred cccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 225 YTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
..+ ..+.....+... ........+.+++.+||+.+|++||++.++++.
T Consensus 240 ----~~~---------------~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 ----KTL---------------FKIPRNPPPTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ----HHH---------------HHHhcCCCCCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000 001100011111 112234568899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=289.94 Aligned_cols=249 Identities=23% Similarity=0.321 Sum_probs=193.1
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|++.+.||+|+||.||++++. ++.+|+|++... ....+.+|..++..+ |+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999987 788999998642 233467788899888 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+.+++|.+++. .....+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLS----KFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 9999999999984 22456889999999999999999999999 9999999999999999999999999987554
Q ss_pred CChhhhhhcccccccccccCCccccC-----CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD-----GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
.... .......+++.|+|||++.. ..++.++||||+||++|+|++|+.||...... +.
T Consensus 154 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------------~~--- 216 (331)
T cd05597 154 ADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------------ET--- 216 (331)
T ss_pred CCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------------HH---
Confidence 3221 11122358999999999863 45788999999999999999999999654321 01
Q ss_pred HhcCcHHHHHHhhhhc-CCCCCCCCHHHHHHHHHHHhhccccCcC--CCCCHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECL-DPNLTRYHKDSMLQMALLSKDCVDENWK--RRPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~--~Rps~~~ll~~ 292 (313)
...+.... ...........+..+.+++++||..++. .||++.++++.
T Consensus 217 --------~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 217 --------YGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred --------HHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11111000 0011111122455678889988765443 37899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=277.84 Aligned_cols=245 Identities=29% Similarity=0.452 Sum_probs=194.9
Q ss_pred ceeccCCeEEEEEeEEC---Cc--ceEEEecccccc----HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR---GK--NAAIKQMKNTKS----KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~---~~--~~aiK~~~~~~~----~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|++|.||+|.+. ++ .+|||.+..... ..+.+|+.+++++ |||++++++.+.+ ...++++|++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 47899999999999875 22 589999987654 3577899999999 9999999999988 889999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+.+.... ...+++..++.++.|++.||++||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999985322 146899999999999999999999999 999999999999999999999999998876542221
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...... +..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------------~~~ 210 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----------------------QIL 210 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----------------------HHH
Confidence 112222346778999999998899999999999999999999 99998543221 111
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
..+.... ... ......+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 211 ~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 211 KKIDKEG-ERL-ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHhcC-CcC-CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1111100 001 112234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=281.19 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=195.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccccc---HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS---KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~---~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
-+.|+++++||.|+||.||+|++. +..+++|.+..... ..+.+|+.+++.+ |||++++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367999999999999999999987 78899999876543 3466799999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|..++. .....+++..++.++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 91 ~~~~~l~~~~~----~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 91 CPGGAVDAIML----ELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred CCCCcHHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999988874 23456899999999999999999999999 999999999999999999999999987653322
Q ss_pred hhhhhhcccccccccccCCcccc-----CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
. .......+++.|+|||++. ...++.++|+|||||++|+|++|..||......
T Consensus 164 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------------------- 221 (292)
T cd06644 164 L---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------------------- 221 (292)
T ss_pred c---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------------------
Confidence 1 1122345788999999985 344678899999999999999999998643321
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...........+.. ......+..+.+++.+||..+|++||++.++++
T Consensus 222 ----~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 222 ----RVLLKIAKSEPPTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----HHHHHHhcCCCccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00111111111111 012234456888999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=284.68 Aligned_cols=262 Identities=21% Similarity=0.344 Sum_probs=197.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++|++.++||.|+||.||+|.+. ++.||+|.+.... ...+.+|+.+++.+ ||||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 468999999999999999999887 7789999886432 34567899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|++ ++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||++.....
T Consensus 85 ~~~-~~l~~~l~----~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 85 YLD-KDLKQYLD----DCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred ccc-cCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 996 58888874 23456889999999999999999999999 99999999999999999999999998875432
Q ss_pred ChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+.. .....+.......
T Consensus 157 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---------~~~~~~~~~~~~~ 224 (301)
T cd07873 157 PTK---TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---------EQLHFIFRILGTP 224 (301)
T ss_pred CCC---cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHHHcCCC
Confidence 211 1122346889999999875 45788999999999999999999999755431 1111111111000
Q ss_pred -HH-HHHHhh--hhcC---CCC-----CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 -KD-FMAKLT--ECLD---PNL-----TRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 -~~-~~~~l~--~~~~---~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+ +...+. .... +.. .......+..+.+|+.+||..||.+|||++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 225 TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 000000 0000 000 01122345578899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=279.80 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=186.3
Q ss_pred ceeccCCeEEEEEeEEC----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCC
Q 041031 18 LKIGQGSYGSVYLGKLR----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (313)
+.||+|+||.||+|... ...+++|.+.... ...+.+|+.+++.+ ||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 36899999999999754 3468888776443 23467899999999 999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhh
Q 041031 89 ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIA 168 (313)
Q Consensus 89 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (313)
+|.+++...........++..+..++.|++.|++|||+++ ++|+||||+||++++++.++++|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 156 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY- 156 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe-
Confidence 9999986443322344567788899999999999999999 999999999999999999999999987653322111
Q ss_pred hhcccccccccccCCccccC-------CCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 169 AAASRIVGTFGYLAPEYVRD-------GCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 169 ~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
.......++..|+|||++.. ..++.++|||||||++|+|++ |..||......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------------------- 216 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------------------- 216 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--------------------
Confidence 11122345678999998743 356889999999999999999 77888644321
Q ss_pred CcHHHHHHhhhhcCCCCC--CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLT--RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+............+. ......+..+.+++..|+ .||.+|||+++|++.|.
T Consensus 217 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 217 ---QVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ---HHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111111111111 122344556777888998 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=271.57 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=206.6
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----------cHHHHHHHHHHHhc--CCCceeeeeEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----------SKEFSSELKILCKV--HSNLIELIGYAA 73 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----------~~~~~~e~~~l~~l--h~~i~~~~~~~~ 73 (313)
.-..+|...+.||.|..++|-++.++ +..+|+|++.... .+...+|+.||+++ ||+|+++.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34567888999999999999999877 7889999885321 22345799999999 999999999999
Q ss_pred eCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEe
Q 041031 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIA 153 (313)
Q Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~ 153 (313)
.+.-+|+|+|.++.|.|.+++ ...-.++++..+.+++|+.+++.|||.++ |||+|+||+|||++++.+++|.
T Consensus 94 s~sF~FlVFdl~prGELFDyL-----ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYL-----TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred CcchhhhhhhhcccchHHHHh-----hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence 999999999999999999999 44567999999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccC------CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcccc
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD------GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE 227 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~ 227 (313)
|||.++........ ...+|||+|+|||.+.. +.|+...|+|+.|+++|-++.|.+||-...-
T Consensus 166 DFGFa~~l~~GekL----relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------- 233 (411)
T KOG0599|consen 166 DFGFACQLEPGEKL----RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------- 233 (411)
T ss_pred ccceeeccCCchhH----HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------
Confidence 99999988876443 34579999999999863 5688899999999999999999999953221
Q ss_pred chhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 228 HRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
. -....+.+..-.--+.-..+.+....+||.+||+.||.+|.|++|+|+.=.-+
T Consensus 234 ----m-----------lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 234 ----M-----------LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred ----H-----------HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 0 01111111111111123455667788999999999999999999999764443
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=282.47 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=199.2
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
...+|++.+.||+|++|.||+|.+. +..+++|.+.... .+.+.+|+.+++.+ |+|++++++.+......++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 4568999999999999999999875 7889999886543 34577899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++++|.+++. ...++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+.....
T Consensus 98 ~~~~~~L~~~~~------~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 98 YLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ccCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999999983 234788899999999999999999999 99999999999999999999999998775433
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
... ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||....... .+
T Consensus 169 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----------~~--------- 225 (296)
T cd06654 169 EQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----------AL--------- 225 (296)
T ss_pred ccc---ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----------hH---------
Confidence 211 1122357889999999998889999999999999999999999996543210 00
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.... ....+.. .........+.+++.+||..+|.+|||+.++++.
T Consensus 226 --~~~~-~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 226 --YLIA-TNGTPEL-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --HHHh-cCCCCCC-CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0000 0000111 1122344668889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=294.69 Aligned_cols=265 Identities=22% Similarity=0.292 Sum_probs=200.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC----CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR----GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..+|.+++.||.|+||.||++... +..+++|.+... ....+|+++++.+ ||||+++++.+......+++||++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY 168 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence 457999999999999999999764 467899988654 3456899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
. ++|.+++ .....+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.......
T Consensus 169 ~-~~l~~~l-----~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 169 K-CDLFTYV-----DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred C-CCHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 5 6888887 34467899999999999999999999999 9999999999999999999999999987654332
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh------
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF------ 239 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 239 (313)
.. .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... ....+.......-
T Consensus 240 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 240 DT-PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-----SSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred cc-ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-----cHHHHHHHHHHhccCcccc
Confidence 21 12223468999999999999999999999999999999999999997765432 1111111111100
Q ss_pred --cCcHHHHHHhhhh---cCCCCCC----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 240 --NDTKDFMAKLTEC---LDPNLTR----YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 240 --~~~~~~~~~l~~~---~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
............. ..+.... ........+.++|++||..||.+|||+.+++..
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000111111111 1111100 011234567889999999999999999999875
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=315.43 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=198.2
Q ss_pred hHHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEe-
Q 041031 4 YNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAG- 74 (313)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~- 74 (313)
+++-.....+|.++++||.|+||.||+|.+. +..+++|.+.... ...+..|+.+++.+ ||||++++++|.+
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 4455567789999999999999999999987 6778999886432 34577899999999 9999999999854
Q ss_pred -CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCC----CceEEeccCCCCeeeCC---
Q 041031 75 -GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK----PYYVHRDVKTSNILLDS--- 146 (313)
Q Consensus 75 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~----~~i~h~di~p~nil~~~--- 146 (313)
...+++||||+++++|.++|.... .....+++..++.++.||+.||.|||+.+. .+|+|+||||+|||++.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 456899999999999999985322 123578999999999999999999998431 12999999999999964
Q ss_pred --------------CCcEEEeeccccccccCChhhhhhcccccccccccCCccccC--CCCCCccchhhHHHHHHHHHhC
Q 041031 147 --------------NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD--GCVTTKSDVYAFGVVLMELITG 210 (313)
Q Consensus 147 --------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~tg 210 (313)
.+.++|+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 2348999999987654321 1223468999999999864 4588999999999999999999
Q ss_pred CCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 041031 211 QQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAA 290 (313)
Q Consensus 211 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll 290 (313)
..||...... . .+...+... +.+ .....+..+.+||..||..+|.+||++.+++
T Consensus 240 k~PF~~~~~~-----------~-----------qli~~lk~~--p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 240 KTPFHKANNF-----------S-----------QLISELKRG--PDL--PIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CCCCCcCCcH-----------H-----------HHHHHHhcC--CCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 9999643321 0 111111111 111 1122346788999999999999999999998
Q ss_pred H
Q 041031 291 I 291 (313)
Q Consensus 291 ~ 291 (313)
.
T Consensus 294 ~ 294 (1021)
T PTZ00266 294 G 294 (1021)
T ss_pred c
Confidence 4
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=281.39 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=196.8
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc--CCCceeeeeEEEeC------
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV--HSNLIELIGYAAGG------ 75 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l--h~~i~~~~~~~~~~------ 75 (313)
+++.+.|++.+.||+|+||.||+|.+. ++.+|+|.+.... ...+..|+.+++.+ |+|++++++.+...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 456788999999999999999999886 7789999986543 44678899999888 99999999998653
Q ss_pred CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
...+++|||+++++|.+++... ....+++..+..++.|++.|++|||+++ ++|+||+|+||++++++.++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence 4689999999999999998522 2346889999999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCcccc-----CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchh
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~ 230 (313)
|++....... .......+++.|+|||++. +..++.++|+||+||++|+|++|..||...... .
T Consensus 156 g~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~--------~- 223 (272)
T cd06637 156 GVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--------R- 223 (272)
T ss_pred CCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH--------H-
Confidence 9987543221 1222346788999999986 345788999999999999999999999543221 0
Q ss_pred HHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 231 LVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
. ...+.. ...........+..+.+|+.+||..+|.+|||+.++++
T Consensus 224 --~------------~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 224 --A------------LFLIPR--NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --H------------HHHHhc--CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 000000 11111112234457889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.30 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=199.9
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
++|++++.||+|+||.||++.+. +..+|+|.+.... ...+.+|+.+++++ |||++++++.+...+..+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47999999999999999999987 8889999876432 34577899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
+++++|.+++... .....+++..+..++.|++.|+.|||+ .+ ++|+||+|+||+++.++.++++|||.+.....
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 81 MDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred cCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 9999999988532 123478999999999999999999996 58 99999999999999999999999998865432
Q ss_pred ChhhhhhcccccccccccCCccccCCC------CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGC------VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
. ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||......
T Consensus 156 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----------------- 213 (286)
T cd06622 156 S-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA----------------- 213 (286)
T ss_pred C-----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----------------
Confidence 2 112234678899999986543 478999999999999999999999643221
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.....+...............+..+.+++.+||..+|.+||++.+++..-.
T Consensus 214 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 214 ------NIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred ------hHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 111222222222222333446678889999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=286.78 Aligned_cols=263 Identities=24% Similarity=0.412 Sum_probs=205.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC---------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR---------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAG 74 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~ 74 (313)
...+|++.+.||+|+||.||+|.+. +..+++|.+.... ...+.+|+++++++ ||||+++++.+..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3457999999999999999999763 1258999887532 34577899999998 9999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCC-----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCee
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSV-----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNIL 143 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil 143 (313)
.+..++++||+++++|.+++..... .....++...+..++.|++.||+|||+++ ++|+||+|+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 9999999999999999999854321 12235788889999999999999999999 999999999999
Q ss_pred eCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCC
Q 041031 144 LDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGN 222 (313)
Q Consensus 144 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~ 222 (313)
+++++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 243 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 243 (334)
T ss_pred EcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 999999999999998755432111 11111233567999999999999999999999999999998 88888643221
Q ss_pred CccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccc
Q 041031 223 NQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKE 302 (313)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 302 (313)
+....+... .........+..+.+++.+||+.+|.+|||+.++++.|.++...+.+
T Consensus 244 ---------------------~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 244 ---------------------ELFKLLKEG---HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred ---------------------HHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 111112111 11112234456788999999999999999999999999999965543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.06 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=195.6
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+|++.+.||.|++|.||+|.+. +..+++|.+.... ...+.+|+.+++.+ |||++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5889999999999999999986 7889999886432 34578899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+. ++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 96 68888874321 2356899999999999999999999999 999999999999999999999999998754322
Q ss_pred hhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH-----
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV----- 238 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 238 (313)
. .......+++.|+|||++.+ ..++.++|+||||+++|+|+||+.||.+..... .........
T Consensus 155 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--------~~~~~~~~~~~~~~ 223 (285)
T cd07861 155 V---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--------QLFRIFRILGTPTE 223 (285)
T ss_pred c---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHHHhCCCCh
Confidence 1 11112245788999998865 457889999999999999999999997543210 000000000
Q ss_pred --hcC---cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 239 --FND---TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 239 --~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
++. ..+....................+..+.+++++||..||.+|||+.+|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 00111111111111111112234567789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=277.23 Aligned_cols=245 Identities=26% Similarity=0.453 Sum_probs=198.2
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEeccccc-cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (313)
.++|++.+.||+|+||.||++...++.+++|..+... ...+.+|+.+++.+ |||++++++++... ..+++|||+.++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~ 83 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG 83 (254)
T ss_pred HHHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence 3679999999999999999999889999999987653 45678899999999 99999999998765 478999999999
Q ss_pred ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhh
Q 041031 89 ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIA 168 (313)
Q Consensus 89 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (313)
+|.+++... ....+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 84 NLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999998522 2345788899999999999999999999 9999999999999999999999999887543211
Q ss_pred hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 169 AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 169 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... +...
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----------------------~~~~ 208 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----------------------EVKE 208 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----------------------HHHH
Confidence 11234578999999988889999999999999999998 99998654321 1111
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.+....... .....+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 209 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 209 CVEKGYRME---PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHhCCCCCC---CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 111111111 12234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=291.39 Aligned_cols=236 Identities=27% Similarity=0.395 Sum_probs=186.1
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHH-HHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELK-ILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~-~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||+|+||.||+|.+. ++.+|+|++.... ...+..|.. +++.+ ||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999987 7889999986432 223444544 45556 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|...+. ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-- 150 (325)
T cd05604 81 GELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-- 150 (325)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--
Confidence 99998883 4567899999999999999999999999 9999999999999999999999999986432211
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.......+++.|+|||++.+..++.++|||||||++|+|++|..||...... +...
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----------------------~~~~ 206 (325)
T cd05604 151 -DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----------------------EMYD 206 (325)
T ss_pred -CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----------------------HHHH
Confidence 1222346899999999999999999999999999999999999999754321 1111
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+ ....+ ......+..+.+++++||..+|.+||++.+.++
T Consensus 207 ~~---~~~~~-~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 207 NI---LHKPL-VLRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred HH---HcCCc-cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 11 11111 111234456788999999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=302.71 Aligned_cols=195 Identities=25% Similarity=0.382 Sum_probs=161.1
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc-C------CCceeeeeEEEeC-C
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV-H------SNLIELIGYAAGG-D 76 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h------~~i~~~~~~~~~~-~ 76 (313)
....+|++.++||+|+||.||+|.+. ++.||||+++... ......|+.+++.+ | .+++++++++... .
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 34578999999999999999999886 7789999986432 33456677777777 3 4588888888754 5
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCCCC-------
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDSNF------- 148 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~------- 148 (313)
.+++||+++ +++|.+++. ....+++..+..++.|++.||.|||+ .+ |+|+||||+||+++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIM-----KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred eEEEEEecc-CCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 788999988 778888873 34578999999999999999999998 58 99999999999998665
Q ss_pred ---------cEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCC
Q 041031 149 ---------RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDA 218 (313)
Q Consensus 149 ---------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~ 218 (313)
.+||+|||.+..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998754221 1223468999999999999999999999999999999999999997654
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=276.46 Aligned_cols=247 Identities=27% Similarity=0.419 Sum_probs=202.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.++|++.+.||.|++|.||+|.+. +..+++|.+.... .+.+.+|+++++.+ |||++++++.+.+....++++|+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 468999999999999999999987 6789999987654 56788999999999 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++. .....+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~L~~~l~----~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 82 AGSVSDIMK----ITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCcHHHHHH----hCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999984 23467899999999999999999999999 99999999999999999999999999886554321
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
......++..|+|||++.+..++.++||||+|+++|+|++|..||....... ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-----------------------~~ 208 (256)
T cd06612 155 ---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-----------------------AI 208 (256)
T ss_pred ---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-----------------------hh
Confidence 1223346889999999998889999999999999999999999996543210 00
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
..+........ .........+.+++.+||+.+|.+|||+.++++
T Consensus 209 ~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 209 FMIPNKPPPTL-SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhccCCCCCC-CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00000000100 112234457889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=279.99 Aligned_cols=259 Identities=21% Similarity=0.319 Sum_probs=203.4
Q ss_pred HhcCccccceeccCCeEEEEEeEECC------cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEe-CCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRG------KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAG-GDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~------~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~-~~~ 77 (313)
..++|++.+.||+|+||.||+|.+.. ..+++|.+.... ...+.+|+.+++.+ |||++++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46789999999999999999998763 678999886542 34467899999999 9999999998765 567
Q ss_pred EEEEEeecCCCChhhhhcCCCCC---CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVK---GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
.++++++.++++|.+++...... ....++...++.++.|++.||.|||+.+ ++|+||+|+||++++++.++++|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998543211 1256889999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHH
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
||++......... .......++..|+|||++.+..++.++||||||+++|++++ |..||......
T Consensus 161 ~g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------- 226 (280)
T cd05043 161 NALSRDLFPMDYH-CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF------------- 226 (280)
T ss_pred CCCcccccCCceE-EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-------------
Confidence 9998755332111 11112235678999999998889999999999999999999 99999654321
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
+....+....... ....++..+.+++.+||..+|++|||+.++++.|+.+..
T Consensus 227 ----------~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 227 ----------EMAAYLKDGYRLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ----------HHHHHHHcCCCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111111111111 122345578899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=278.80 Aligned_cols=244 Identities=26% Similarity=0.390 Sum_probs=199.8
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
++|++.+.||.|++|.||+|.+. ++.+++|.+.... ...+.+|+++++.+ |+|++++.+.+.+....++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47899999999999999999986 7889999986543 34577899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++.. ..+++..++.++.|++.|+.+||+.+ ++|+||+|+||++++++.++++|||.+......
T Consensus 81 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999841 27899999999999999999999999 999999999999999999999999998776543
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... .
T Consensus 152 ~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----------------------~ 205 (274)
T cd06609 152 M---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----------------------R 205 (274)
T ss_pred c---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----------------------H
Confidence 2 1222345778899999999888999999999999999999999999654321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
....+.....+.+.. ...+..+.+++.+||..+|++|||++++++.
T Consensus 206 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 206 VLFLIPKNNPPSLEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHhhhcCCCCCcc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111111111111111 1145678899999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=287.60 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=199.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEe-CC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAG-GD 76 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~-~~ 76 (313)
.++|++.+.||+|+||.||+|.+. ++.||||.++... ...+.+|+.++..+ ||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 468999999999999999999742 5689999987543 23477899999999 7999999998764 45
Q ss_pred eEEEEEeecCCCChhhhhcCCCCC--------------------------------------------------------
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVK-------------------------------------------------------- 100 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------- 100 (313)
..+++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999988532110
Q ss_pred ------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhcccc
Q 041031 101 ------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI 174 (313)
Q Consensus 101 ------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 174 (313)
....++...+..++.|++.||+|||+++ ++|+||||+||++++++.++++|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~ 241 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDA 241 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcCCC
Confidence 0123677888899999999999999999 999999999999999999999999998765332211 111223
Q ss_pred cccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhc
Q 041031 175 VGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECL 253 (313)
Q Consensus 175 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 253 (313)
.++..|+|||++.+..++.++||||||+++|+|++ |..||...... . ++...+....
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~--------------~~~~~~~~~~ 299 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------E--------------EFCRRLKEGT 299 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--------H--------------HHHHHHhccC
Confidence 35678999999998889999999999999999997 88998653321 0 1111111111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 254 DPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 254 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
.... ....+..+.+++.+||+.+|.+|||+.+|++.|+.++..
T Consensus 300 ~~~~---~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 300 RMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111 112335688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=276.54 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=188.6
Q ss_pred ceeccCCeEEEEEeEEC-----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEE-eCCeEEEEEeecC
Q 041031 18 LKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAA-GGDSLFLVYEYAQ 86 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~-~~~~~~lv~e~~~ 86 (313)
+.||+|+||.||+|.+. +..+|+|.+.... .+.+.+|+.+++.+ |||++++++.+. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 47899999999999864 3468999885432 34567889999999 999999999765 4556889999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++. ......+...+..++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||++........
T Consensus 81 ~~~L~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIR----SETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999985 22344677788899999999999999999 99999999999999999999999999875433211
Q ss_pred hh-hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhC-CCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 167 IA-AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG-QQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 167 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
.. .......++..|+|||.+.+..++.++||||||+++|+|++| .+||...... +
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-----------------------~ 210 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-----------------------D 210 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------------H
Confidence 00 111122356789999999888899999999999999999995 5556432210 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
....+. ...........+..+.+++.+||+.+|++||++.+++++|+++..
T Consensus 211 ~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 211 ITVYLL---QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHh---cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 111111 111111112234578899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=277.42 Aligned_cols=248 Identities=23% Similarity=0.332 Sum_probs=194.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--------cHHHHHHHHHHHhc-CCCceeeeeEEEe--CCe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--------SKEFSSELKILCKV-HSNLIELIGYAAG--GDS 77 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--------~~~~~~e~~~l~~l-h~~i~~~~~~~~~--~~~ 77 (313)
+++|++.+.||+|+||.||.|.+. ++.+++|.+.... ...+.+|+.+++.+ ||||+++++.+.+ ...
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 368999999999999999999876 7889999875321 23567899999999 9999999998876 356
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
++++|||+++++|.+++. ....+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~ 152 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLK-----SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGA 152 (265)
T ss_pred EEEEEEecCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcc
Confidence 889999999999999984 3345788889999999999999999999 99999999999999999999999998
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+.................++..|+|||++.+..++.++|+||||+++|+|++|+.||......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----------------- 215 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----------------- 215 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----------------
Confidence 875442211111122235788999999998888999999999999999999999999643211
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.........+............+.+++++|+. +|++||+++++++.
T Consensus 216 --------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 216 --------AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred --------HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00000011111111334455678889999995 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=279.09 Aligned_cols=253 Identities=27% Similarity=0.445 Sum_probs=199.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEecccccc----HHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTKS----KEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~~----~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
.++|++.+.||.|+||.||+|+.+ ...+++|....... ..+.+|+++++.+ |+|++++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 478999999999999999999864 35689998875443 3578899999999 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCC----CCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKG----KKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
+++|||+++++|.+++....... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999985332111 126899999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHH
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 161 ~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------------- 225 (275)
T cd05046 161 LSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------------- 225 (275)
T ss_pred cccccccCcccc--cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-------------
Confidence 998764432211 11122345678999999988888999999999999999999 78888543221
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
........ ..... .....+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 226 ----------~~~~~~~~---~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 226 ----------EVLNRLQA---GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----------HHHHHHHc---CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111110 01000 12234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=277.62 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=187.6
Q ss_pred ceeccCCeEEEEEeEEC----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCC
Q 041031 18 LKIGQGSYGSVYLGKLR----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (313)
+.||+|+||.||+|.+. +..+++|.++... ...+.+|+.+++.+ |||++++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999865 3468999887543 23577899999999 999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhh
Q 041031 89 ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIA 168 (313)
Q Consensus 89 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (313)
+|.+++...........+...+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||.+........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-~ 156 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-Y 156 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce-e
Confidence 9999985433223345667788889999999999999999 99999999999999999999999998865332211 1
Q ss_pred hhcccccccccccCCccccCC-------CCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 169 AAASRIVGTFGYLAPEYVRDG-------CVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 169 ~~~~~~~~~~~~~aPE~~~~~-------~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
.......++..|+|||++.+. .++.++|+||||+++|+|++ |..||...... ...... .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---------~~~~~~--~-- 223 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---------QVLTYT--V-- 223 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---------HHHHHH--h--
Confidence 112223567889999998642 35789999999999999996 99999644321 000000 0
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.........+. ........+.+++..|+ .+|.+|||+.+|...|+
T Consensus 224 -----~~~~~~~~~~~---~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 224 -----REQQLKLPKPR---LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -----hcccCCCCCCc---cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000011111 11223456778999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=275.25 Aligned_cols=245 Identities=26% Similarity=0.415 Sum_probs=196.7
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEe-CCeEEEEEe
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAG-GDSLFLVYE 83 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~-~~~~~lv~e 83 (313)
+|++.+.||.|++|.||++.++ ++.+++|.+.... .+.+.+|+++++.+ |+|++++.+.+.. +..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999887 6789999986432 33467889999999 9999999998764 446899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
++++++|.+++... ....+++..++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999998521 2346899999999999999999999999 99999999999999999999999999876543
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
... ......+++.|+|||++.+..++.++|+||+|+++|+|++|+.||...+.. ..
T Consensus 155 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------------~~--------- 210 (257)
T cd08223 155 QCD---MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------------SL--------- 210 (257)
T ss_pred cCC---ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------------HH---------
Confidence 211 222345788999999999988999999999999999999999998643221 00
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
... .....+.......+..+.+++.+||+.+|.+|||+.++++.
T Consensus 211 --~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 211 --VYR---IIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --HHH---HHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111 11111112233455678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=282.39 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=201.9
Q ss_pred ChHHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc--CCCceeeeeEEE---
Q 041031 3 SYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV--HSNLIELIGYAA--- 73 (313)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l--h~~i~~~~~~~~--- 73 (313)
+++.+....++|++.+.||+|+||.||++.+. ++.+++|...... ...+..|+.+++.+ |||++++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 35667778899999999999999999999886 7889999886533 35677899999998 999999999873
Q ss_pred --eCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEE
Q 041031 74 --GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAK 151 (313)
Q Consensus 74 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~ 151 (313)
..+..+++|||+++++|.+++.... .....+++..++.++.|++.|+.|||+.+ ++|+||+|+||++++++.++
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 4457899999999999999874322 23456888999999999999999999999 99999999999999999999
Q ss_pred EeeccccccccCChhhhhhcccccccccccCCccccC-----CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccc
Q 041031 152 IADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-----GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYT 226 (313)
Q Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~ 226 (313)
++|||.+........ ......+++.|+|||++.. ..++.++|+||+||++|+|++|..||.......
T Consensus 165 l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----- 236 (286)
T cd06638 165 LVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----- 236 (286)
T ss_pred EccCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----
Confidence 999999876543211 1222357899999999853 447889999999999999999999996543210
Q ss_pred cchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 227 EHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
. .........+... ........+.+++.+||+.||.+|||+.++++..
T Consensus 237 -----------------~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 -----------------A-LFKIPRNPPPTLH-QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred -----------------H-HhhccccCCCccc-CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 0000000000000 1112234688899999999999999999999754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=288.87 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=193.3
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|++.++||+|+||.||+++++ ++.+|+|++.... ...+.+|..++..+ |++|+++++.+.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999987 6779999986421 23366788888888 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+.+|+|.+++. .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 ey~~~g~L~~~l~----~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLS----KFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999999999995 22456889999999999999999999999 9999999999999999999999999986543
Q ss_pred CChhhhhhcccccccccccCCcccc-----CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
.... .......+++.|+|||++. ...++.++|||||||++|+|++|+.||......
T Consensus 154 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~----------------- 214 (332)
T cd05623 154 EDGT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----------------- 214 (332)
T ss_pred cCCc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-----------------
Confidence 2221 1122346899999999986 345788999999999999999999999654321
Q ss_pred HhcCcHHHHHHhhh-hcCCCCCCCCHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 041031 238 VFNDTKDFMAKLTE-CLDPNLTRYHKDSMLQMALLSKDCVDENWKR--RPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~ll~~ 292 (313)
+....+.. .............+..+.+|+++|+..++.. |+++.++++.
T Consensus 215 ------~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 215 ------ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111111 0001111112234567888999988654444 6889998866
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=282.35 Aligned_cols=198 Identities=29% Similarity=0.468 Sum_probs=159.6
Q ss_pred ceeccCCeEEEEEeEEC----CcceEEEeccccc-cHHHHHHHHHHHhc-CCCceeeeeEEE--eCCeEEEEEeecCCCC
Q 041031 18 LKIGQGSYGSVYLGKLR----GKNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIELIGYAA--GGDSLFLVYEYAQNGA 89 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h~~i~~~~~~~~--~~~~~~lv~e~~~~~~ 89 (313)
.+||+|+||.||+|+.. +..+|+|.+.... ...+.+|+.+++.+ ||||+++++++. .....++++||+. ++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HD 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-Cc
Confidence 58999999999999875 4679999887654 34577899999999 999999999885 4567899999985 57
Q ss_pred hhhhhcCCCC----CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee----CCCCcEEEeeccccccc
Q 041031 90 LSDHLHWPSV----KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL----DSNFRAKIADFGLVKLL 161 (313)
Q Consensus 90 L~~~l~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~----~~~~~~~l~dfg~~~~~ 161 (313)
|.+++..... .....+++..++.++.|++.||.|||+.+ ++|+||||+||++ ++++.++|+|||++...
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 8777642211 12335788999999999999999999999 9999999999999 45678999999999865
Q ss_pred cCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDAN 219 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~ 219 (313)
..............+++.|+|||++.+ ..++.++|||||||++|+|+||.+||.....
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~ 221 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccc
Confidence 433221122223467899999999976 4578999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=277.51 Aligned_cols=246 Identities=23% Similarity=0.386 Sum_probs=200.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
...|+..+.||.|+||.||+|.+. +..+|+|.+.... ...+.+|+.+++.+ |||++++++.+.+.+..++|||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 457889999999999999999886 7889999886443 34577899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++++|.+++. ..++++..+..++.|++.|+++||+.+ ++|+||+|+||++++++.++++|||.+.....
T Consensus 83 ~~~~~~L~~~i~------~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 83 YLGGGSALDLLR------AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 999999999884 245788889999999999999999999 99999999999999999999999999876543
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
... ......++..|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 154 ~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----------------------- 207 (277)
T cd06640 154 TQI---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM----------------------- 207 (277)
T ss_pred Ccc---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----------------------
Confidence 221 122235678899999998888999999999999999999999998654321
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.....+.. ..........+..+.+++.+||+.+|.+||++.+++..-.
T Consensus 208 ~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 208 RVLFLIPK---NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred hHhhhhhc---CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 00011100 1111234456677889999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=276.39 Aligned_cols=246 Identities=23% Similarity=0.374 Sum_probs=192.4
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--------cHHHHHHHHHHHhc-CCCceeeeeEEEe--CCeE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--------SKEFSSELKILCKV-HSNLIELIGYAAG--GDSL 78 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--------~~~~~~e~~~l~~l-h~~i~~~~~~~~~--~~~~ 78 (313)
-+|+..+.||+|+||.||+|.+. +..+++|.+.... ...+.+|+.+++.+ ||||+++++.+.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 37999999999999999999876 7889999875321 23477899999999 9999999998865 3678
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++++|++++++|.+++. ....++...++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK-----AYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 89999999999999984 3345888999999999999999999999 999999999999999999999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
.................++..|+|||.+.+..++.++|+||+||++|+|++|+.||...... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~--------- 216 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------A--------- 216 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------H---------
Confidence 75432111111112235788999999999888999999999999999999999999644221 0
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...........+ .........+..++ +||..+|++||+++||++
T Consensus 217 -----~~~~~~~~~~~~---~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 217 -----AIFKIATQPTNP---QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -----HHHHHhcCCCCC---CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111111111111 12233445677777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=274.32 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=200.3
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+|+.++.||.|+||.||.++.. +..+++|.+.... ...+.+|+.+++++ |+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5889999999999999988876 7889999875432 34577899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++... ....++...+..++.|++.++.|||+.+ ++|+||+|+||++++++.++++|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999998522 1356889999999999999999999999 999999999999999999999999998765433
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... +
T Consensus 155 ~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----------------------~ 208 (256)
T cd08221 155 YS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----------------------N 208 (256)
T ss_pred cc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----------------------H
Confidence 21 222345789999999998888899999999999999999999998643221 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
....+ ............+..+.+++.+||..+|.+|||+.++++.+
T Consensus 209 ~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 209 LVVKI---VQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHH---HcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11111 11122222234456788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=285.91 Aligned_cols=246 Identities=21% Similarity=0.351 Sum_probs=210.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccccc-----HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS-----KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~-----~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
..-|...+.||+|.|.+|-+|++- |+.||||++.+... ..+.+|++.|+.. |||||++|++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 445888999999999999999876 99999999987653 4478999999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC-CCCcEEEeeccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD-SNFRAKIADFGLVKLL 161 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~~l~dfg~~~~~ 161 (313)
|.-++|+|.+++. +....+.+.-..+++.||+.|+.|||+.+ +||+|+||+|+.+. +.|.|||.|||++-.+
T Consensus 97 ELGD~GDl~DyIm----KHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 97 ELGDGGDLFDYIM----KHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EecCCchHHHHHH----hhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999999986 56678999999999999999999999999 99999999999876 5799999999999887
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCC-CccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVT-TKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
...... ...+|+..|-|||++.|..|+ ++.||||||++||.+.+|+.||..-++.
T Consensus 170 ~PG~kL----~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-------------------- 225 (864)
T KOG4717|consen 170 QPGKKL----TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-------------------- 225 (864)
T ss_pred CCcchh----hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--------------------
Confidence 765443 345789999999999999986 5679999999999999999999766553
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+..+... .+.-.+.+.++||..||..||.+|.|+++|...-|
T Consensus 226 ---ETLTmImDCKYt----vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 226 ---ETLTMIMDCKYT----VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred ---hhhhhhhccccc----CchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 333333332221 34566778889999999999999999999986543
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=278.34 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=195.7
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
+-|++.+.||.|+||.||+|.+. +..+++|.+.... ...+.+|+++++.+ |||++++++.+...+..++++||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34789999999999999999987 6678888886543 34467899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++++|..++. .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~~~~l~~~~~----~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 85 AGGAVDAVML----ELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred CCCcHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 9999998874 23456899999999999999999999999 9999999999999999999999999986543221
Q ss_pred hhhhhcccccccccccCCcccc-----CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 166 EIAAAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
.......++..|+|||++. +..++.++|+||+||++|+|++|..||......
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------------------- 214 (282)
T cd06643 158 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------------------- 214 (282)
T ss_pred ---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--------------------
Confidence 1122345788999999984 345778999999999999999999998643321
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
+..........+... .....+..+.+++.+||+.+|.+||++.++++.-
T Consensus 215 ---~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 215 ---RVLLKIAKSEPPTLA-QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ---HHHHHHhhcCCCCCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 001111111111111 1223456788999999999999999999988643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=289.02 Aligned_cols=249 Identities=23% Similarity=0.316 Sum_probs=193.5
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|.+.+.||+|+||.||++++. ++.+|+|.+.... ...+.+|..++..+ |++|+++++.+.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999987 6789999986421 23366788888888 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+.+|+|.+++. .....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 Ey~~gg~L~~~l~----~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLS----KFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999985 22356889999999999999999999999 9999999999999999999999999987654
Q ss_pred CChhhhhhcccccccccccCCccccC-----CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD-----GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
.... .......+++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||......
T Consensus 154 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----------------- 214 (331)
T cd05624 154 QDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----------------- 214 (331)
T ss_pred CCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-----------------
Confidence 3221 11223468999999999875 46788999999999999999999999654321
Q ss_pred HhcCcHHHHHHhhh-hcCCCCCCCCHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 041031 238 VFNDTKDFMAKLTE-CLDPNLTRYHKDSMLQMALLSKDCVDENWKR--RPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~~~~l~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~ll~~ 292 (313)
+....+.. .....+.....+.+..+.+++.+||..++.. |++++++++.
T Consensus 215 ------~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 215 ------ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ------HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11111111 0001111112234567888999999866544 4678887754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=280.57 Aligned_cols=258 Identities=25% Similarity=0.364 Sum_probs=203.6
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++|++.++||+|++|.||++.+. +..+++|++.... ...+.+|+++++.+ ||||+++++.+...+.+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 468999999999999999999987 7889999876443 34577899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|+++++|.+++. ..+.++...+..++.+++.++.|||+ .+ ++|+||+|+||++++++.++++|||++....
T Consensus 84 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 84 FMDCGSLDRIYK-----KGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred cCCCCCHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 999999999883 34568999999999999999999997 57 9999999999999999999999999876442
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.. ......++..|+|||++.+..++.++|+||+||++|++++|..||.......... .....+
T Consensus 156 ~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~-~~~~~~----------- 218 (284)
T cd06620 156 NS-----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ-DDPMGI----------- 218 (284)
T ss_pred hh-----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh-hhhhHH-----------
Confidence 21 1123457899999999988889999999999999999999999997654321100 001111
Q ss_pred HHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
...+.......... .....+..+.+|+.+||+.||.+|||+.|+++...-+
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 219 ---LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred ---HHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 11111111111111 1122456788999999999999999999999875433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=276.30 Aligned_cols=249 Identities=21% Similarity=0.398 Sum_probs=198.0
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc---------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
+|+..+.||+|++|.||+|.+. ++.+++|.+.... ...+.+|+.+++.+ |+|++++++.+.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5889999999999999999875 7889999986432 34577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC-cEEEeeccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF-RAKIADFGLVK 159 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~ 159 (313)
|+||+++++|.+++. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++ .++|+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 999999999999984 3456889999999999999999999999 99999999999998775 58999999987
Q ss_pred cccCChhh-hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEI-AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
........ ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ....+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~- 222 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---------HLALIFK- 222 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---------hHHHHHH-
Confidence 65532111 111122457889999999988889999999999999999999999996433210 0000000
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
. ................+.+++.+||..+|.+|||+.++++
T Consensus 223 ----------~--~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 ----------I--ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----------H--hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0 0001111123345567889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=280.12 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=200.3
Q ss_pred ChHHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc--CCCceeeeeEEE---
Q 041031 3 SYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV--HSNLIELIGYAA--- 73 (313)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l--h~~i~~~~~~~~--- 73 (313)
++.++....+.|++.+.||.|+||.||+|.+. ++.+++|...... ...+..|+.+++.+ |+|++++++.+.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 45667778899999999999999999999986 7889999886543 34577888988888 999999999985
Q ss_pred ---eCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcE
Q 041031 74 ---GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRA 150 (313)
Q Consensus 74 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~ 150 (313)
..+..+++|||+++++|.+++... ....+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.+
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 346789999999999999998532 2345788889999999999999999999 9999999999999999999
Q ss_pred EEeeccccccccCChhhhhhcccccccccccCCcccc-----CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcc
Q 041031 151 KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQY 225 (313)
Q Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~ 225 (313)
+|+|||.+....... .......++..|+|||++. +..++.++|+||||+++|+|++|..||.......
T Consensus 161 ~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~---- 233 (282)
T cd06636 161 KLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR---- 233 (282)
T ss_pred EEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh----
Confidence 999999877543221 1122345788999999886 3457889999999999999999999996433210
Q ss_pred ccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 226 TEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
. ...+.....+. ......+..+.+++++||+.||.+|||+.+|++
T Consensus 234 ----~---------------~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 234 ----A---------------LFLIPRNPPPK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----h---------------hhhHhhCCCCC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00011111111 112234567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=280.31 Aligned_cols=245 Identities=24% Similarity=0.394 Sum_probs=199.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.+.|+..+.||+|+||.||+|.+. +..+|+|.+.... .+.+.+|+.+++.+ |||++++++.+...+..++|+|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 456888999999999999999876 6789999887443 33577899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++++|.+++. ...+++..+..++.|++.|+.|||+++ ++|+||+|+||++++++.++++|||++.....
T Consensus 83 ~~~~~~L~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 83 YLGGGSALDLLK------PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred ccCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 999999999873 246888999999999999999999999 99999999999999999999999999876543
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
... ......++..|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 154 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----------------------- 207 (277)
T cd06642 154 TQI---KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM----------------------- 207 (277)
T ss_pred cch---hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----------------------
Confidence 221 112235788999999999888999999999999999999999998643321
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
.....+.... ........+..+.+++.+||+.+|.+|||+.++++.-
T Consensus 208 ~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 208 RVLFLIPKNS---PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred hHHhhhhcCC---CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 0000011111 1112223456788999999999999999999999853
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=274.37 Aligned_cols=245 Identities=24% Similarity=0.393 Sum_probs=199.3
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+|++.++||+|+||.+|.+... ++.+++|.+... ....+.+|+.+++.+ |||++++++.+...+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5899999999999999999886 788999987632 234578899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+.+++|.+.+... ....+++..++.++.|++.++.+||+++ ++|+||+|+||+++.++.++++|||.+......
T Consensus 81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999988421 2345788999999999999999999999 999999999999999999999999998765443
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
.. ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...... +
T Consensus 155 ~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----------------------~ 208 (256)
T cd08218 155 VE---LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-----------------------N 208 (256)
T ss_pred hh---hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-----------------------H
Confidence 21 122235788899999999888999999999999999999999998643221 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+...+...........+..+.+++.+||+.+|.+||++.++++.
T Consensus 209 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 209 ---LVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---HHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111111111112233445678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=272.35 Aligned_cols=243 Identities=28% Similarity=0.434 Sum_probs=194.3
Q ss_pred ceeccCCeEEEEEeEEC-CcceEEEecccccc----HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCChh
Q 041031 18 LKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKS----KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALS 91 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~~----~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (313)
++||+|++|.||++.+. ++.+++|.+..... ..+.+|+++++++ |+||+++++++.+....++++|++.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999987 88999999876543 3577899999999 999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhc
Q 041031 92 DHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAA 171 (313)
Q Consensus 92 ~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 171 (313)
+++. .....++...+..++.+++.++.+||+++ ++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 81 ~~l~----~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~ 152 (251)
T cd05041 81 TFLR----KKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-TVSD 152 (251)
T ss_pred HHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc-eecc
Confidence 9984 22346788999999999999999999999 99999999999999999999999999875442111 0111
Q ss_pred ccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhh
Q 041031 172 SRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLT 250 (313)
Q Consensus 172 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
.....+..|+|||.+.+..++.++|+||||+++|+|+| |..||...... .....+.
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-----------------------~~~~~~~ 209 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-----------------------QTRERIE 209 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-----------------------HHHHHHh
Confidence 11223567999999998889999999999999999999 78888654321 1111111
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 251 ECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
...... .....+..+.+++.+||..+|.+|||+.++++.|.
T Consensus 210 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 210 SGYRMP---APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCCCC---CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 110010 12234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=286.38 Aligned_cols=266 Identities=21% Similarity=0.306 Sum_probs=192.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
..+|.+++.||+|+||.||+|.+. ++.+|+|+.... ....|+.+++.+ ||||+++++++......++|+|++.
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 347999999999999999999987 568999985543 335689999999 9999999999999999999999994
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 141 ~~l~~~l~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 141 SDLYTYLT----KRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred CcHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 58888874 34467899999999999999999999999 9999999999999999999999999987533221
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcc--ccchhHHHHHHHHhcCcHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQY--TEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 245 (313)
......+++.|+|||++.+..++.++|||||||++|+|+++..|+........... .....+...+.........+
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 11234588999999999999999999999999999999996655433322110000 00111111111110000000
Q ss_pred H-----HHhhhhcC------CCCCC----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 246 M-----AKLTECLD------PNLTR----YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 246 ~-----~~l~~~~~------~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
. ......++ ..... .....+..+.+||.+||+.||.+|||+.|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 0 00000000 00000 01122345667999999999999999999986
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=290.76 Aligned_cols=235 Identities=24% Similarity=0.318 Sum_probs=182.4
Q ss_pred eccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc----CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV----HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 20 lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l----h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
||+|+||.||+|++. ++.+|+|++.... ......|..++... ||||+++++.+...+..++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999987 7889999986432 12233455555543 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+.+. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~L~~~l~-----~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 150 (330)
T cd05586 81 GELFWHLQ-----KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-- 150 (330)
T ss_pred ChHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--
Confidence 99998883 4567899999999999999999999999 9999999999999999999999999986533221
Q ss_pred hhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||...... +..
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----------------------~~~ 206 (330)
T cd05586 151 -KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----------------------QMY 206 (330)
T ss_pred -CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----------------------HHH
Confidence 112234689999999998764 4799999999999999999999999654321 111
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC----CHHHHHH
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP----DMSNAAI 291 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp----s~~~ll~ 291 (313)
..+. ...........+..+.+++++||+.||.+|| ++.++++
T Consensus 207 ~~i~---~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 207 RNIA---FGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHH---cCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1111 1111111112345678899999999999998 4566654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=279.78 Aligned_cols=245 Identities=23% Similarity=0.408 Sum_probs=198.2
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
.+|++.+.||.|++|.||+|.+. ++.+++|.+.... .+.+.+|+.+++.+ |||++++++.+...+.+++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999875 7889999886433 44577899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++++|.+++. ...+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 99 ~~~~L~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 99 AGGSLTDVVT------ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred CCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 9999999883 235889999999999999999999999 9999999999999999999999999877554322
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... +.
T Consensus 170 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-----------------------~~ 223 (296)
T cd06655 170 S---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----------------------RA 223 (296)
T ss_pred c---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------------HH
Confidence 1 112235788999999999888999999999999999999999999654321 00
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...+.....+.+ ......+..+.+++.+||..||.+|||+.+++..
T Consensus 224 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 224 LYLIATNGTPEL-QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHhcCCccc-CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 001110001111 1122344578889999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=279.43 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=198.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.++|++.+.||.|++|.||+|.+. +..+++|.+.... .+.+..|+.+++.+ |||++++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999986 7889999987554 33567899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++. .....+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++++|||.+......
T Consensus 84 ~~~~~L~~~~~----~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 84 CDGGALDSIML----ELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred cCCCcHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999984 23356899999999999999999999999 999999999999999999999999987654332
Q ss_pred hhhhhhcccccccccccCCcccc-----CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
.. ......+++.|+|||++. ...++.++|+||||+++|+|++|..||......
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------------------- 214 (280)
T cd06611 157 LQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------------------- 214 (280)
T ss_pred cc---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------------------
Confidence 11 222345788999999985 344678999999999999999999999654321
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.....+.....+.+. .....+..+.+++.+||+.+|.+||++.++++.
T Consensus 215 ----~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 215 ----RVLLKILKSEPPTLD-QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----HHHHHHhcCCCCCcC-CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001111111111111 122344578899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=274.04 Aligned_cols=246 Identities=31% Similarity=0.520 Sum_probs=197.5
Q ss_pred ccccceeccCCeEEEEEeEECC------cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 14 FSTSLKIGQGSYGSVYLGKLRG------KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~~------~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
+++.+.||.|+||.||++.+.. ..+|+|.+.... ...+..|+.+++.+ |+|++++++.+.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4678999999999999999874 779999997654 34678899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|++++++|.+++.... ...+++..++.++.|++.|+++||+.+ ++|+||+|+||++++++.++++|||.+....
T Consensus 81 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecc
Confidence 9999999999984211 112899999999999999999999999 9999999999999999999999999987655
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 155 ~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--------------------- 211 (258)
T smart00219 155 DDDYYK--KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--------------------- 211 (258)
T ss_pred cccccc--cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---------------------
Confidence 431111 111236789999999988889999999999999999998 78888653221
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
+....+.... ........+..+.+++.+||+.+|++|||+.++++.|
T Consensus 212 --~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 212 --EVLEYLKKGY---RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --HHHHHHhcCC---CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111111111 1112223566789999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=278.44 Aligned_cols=261 Identities=24% Similarity=0.334 Sum_probs=196.9
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
++|++.+.||+|++|.||+|.++ ++.+++|.+.... ...+.+|+.+++.+ |||++++++.+...+..+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999987 7889999875432 23467899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++++|..++. ....+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEK-----NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 999988888763 3456899999999999999999999999 99999999999999999999999999886554
Q ss_pred ChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ......++..|+|||++.+ ..++.++|+||+|+++|+|++|..||.+..... .+...........
T Consensus 153 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~ 221 (286)
T cd07847 153 PGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--------QLYLIRKTLGDLI 221 (286)
T ss_pred Ccc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHHhCCCC
Confidence 321 1112346788999999876 557899999999999999999999997654321 0111100000000
Q ss_pred HHHHHHh------hhhcCCCCC------CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDFMAKL------TECLDPNLT------RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~~~~l------~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
....... .....+... ......+..+.+|+.+||+.+|++|||+.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 222 PRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000 000000000 001223567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=282.26 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=198.2
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|+..+.||+|++|.||+|... ++.+++|.+.... ...+..|+++++.+ ||||+++++.+.+....+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999986 6889999987643 23477899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+.+++|.+++... ....+++..++.++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999998522 2356899999999999999999999999 9999999999999999999999999876543
Q ss_pred CChhhh--------------------------hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccC
Q 041031 163 HSPEIA--------------------------AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSR 216 (313)
Q Consensus 163 ~~~~~~--------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~ 216 (313)
...... .......++..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 221100 011123568889999999988899999999999999999999999975
Q ss_pred CCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCC----HHHHHH
Q 041031 217 DANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPD----MSNAAI 291 (313)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps----~~~ll~ 291 (313)
.... ..+.......... .....+..+.+++.+||..+|++||| +++++.
T Consensus 235 ~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 235 SNRD--------------------------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CchH--------------------------HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 4431 0011111111111 11125678999999999999999999 777665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=292.74 Aligned_cols=269 Identities=19% Similarity=0.239 Sum_probs=195.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
..+|.+.+.||+|+||.||+|.+. ++.||||.... ....+|+++++.+ |+||+++++++......+++|+++ .
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~ 243 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-R 243 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-C
Confidence 347999999999999999999987 67899996432 3456899999999 999999999999999999999999 4
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++. .....+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.........
T Consensus 244 ~~L~~~l~----~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 244 SDLYTYLG----ARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred CCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 68888874 23346899999999999999999999999 999999999999999999999999998765432111
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc------C
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN------D 241 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 241 (313)
.......+|+.|+|||++.+..++.++|||||||++|+|++|..|+....... ........+.+.+..... .
T Consensus 317 -~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~-~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 317 -PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD-ERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred -ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCccc-ccCCcHHHHHHHHHhhccccccCCC
Confidence 11123468999999999999999999999999999999999886654322110 000111111122111100 0
Q ss_pred --cHHHHHHhhhh----cCCCCCC--C--CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 --TKDFMAKLTEC----LDPNLTR--Y--HKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 --~~~~~~~l~~~----~~~~~~~--~--~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
........... ..+.... + .......+.+|+.+||+.||.+|||+.|+|+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00001111100 0000000 0 01223468889999999999999999999874
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=273.64 Aligned_cols=247 Identities=27% Similarity=0.442 Sum_probs=204.3
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.+|++.+.||.|++|.||+|.+. ++.+++|.+.... ...+.+|+.++..+ |+|++++++.+...+..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47899999999999999999987 7889999987654 45688899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
+++++|.+++. ....+++..++.++.|++.++++||+ .+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~~L~~~l~-----~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLK-----KVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999984 33678999999999999999999999 99 99999999999999999999999998876543
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 153 ~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----------------------- 206 (264)
T cd06623 153 TLD---QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP----------------------- 206 (264)
T ss_pred CCC---cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-----------------------
Confidence 222 112335788999999999888999999999999999999999999765431
Q ss_pred HHHHHhhhhcCCCCCCCCHH-HHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKD-SMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.................... .+..+.+++.+||..+|.+|||+.++++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 207 SFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01111111122222222233 56789999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=275.67 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=200.9
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
++|+..+.||.|++|.||++.++ ++.+++|.+.... ...+.+|+++++.+ |||++++++.+...+..++++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47889999999999999999997 7889999887553 23477899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
+++++|.+++.. ....+++..+..++.|++.++++||+ .+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 81 MDGGSLDKILKE----VQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred cCCCcHHHHHHH----ccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 999999999852 22678899999999999999999999 89 99999999999999999999999998765532
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .
T Consensus 154 ~~~-----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~-------------- 207 (265)
T cd06605 154 SLA-----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-------D-------------- 207 (265)
T ss_pred HHh-----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-------c--------------
Confidence 211 11567889999999999899999999999999999999999997553210 0
Q ss_pred HHHHHhhhhcCCCCCCCCH-HHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHK-DSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.....+............. ..+..+.+++.+||..+|.+|||+.+++..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 208 GIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0111111122221112122 256678999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=280.32 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=196.8
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.+|++.+.||+|+||.||++.+. ++.|++|.+.... ...+.+|+++++.+ ||||+++++.+...+.++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999987 6789999887543 33466889999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|++++++|.+++. ....+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++++|||.+....
T Consensus 81 e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLK-----NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 9999999999983 3456899999999999999999999999 9999999999999999999999999876321
Q ss_pred CChh------------hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchh
Q 041031 163 HSPE------------IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 163 ~~~~------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~ 230 (313)
.... .........++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---------- 222 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---------- 222 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------
Confidence 1000 000111234678899999998888999999999999999999999999654321
Q ss_pred HHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 231 LVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
+........ ...........+..+.+++.+||+.+|++||+..++++.|..
T Consensus 223 -------------~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 -------------ELFGQVISD-DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -------------HHHHHHHhc-ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111111110 000011111345678899999999999999997666665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=278.57 Aligned_cols=239 Identities=27% Similarity=0.413 Sum_probs=197.3
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|++.+.||+|++|.||++.+. ++.+|+|.+... ..+.+.+|+++++.+ ||||+++++.+.+.+..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999986 788999988643 234577899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++. ....+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~-----~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLR-----KSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 9999999999983 3467899999999999999999999999 9999999999999999999999999987654
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.. .....+++.|+|||.+.+...+.++|+||||+++|+|++|..||......
T Consensus 153 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------------- 204 (290)
T cd05580 153 GR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---------------------- 204 (290)
T ss_pred CC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----------------------
Confidence 32 22345788999999998888899999999999999999999999654321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAI 291 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~ 291 (313)
+....+. .... ......+..+.+++.+||..||.+|+ +++++++
T Consensus 205 -~~~~~~~---~~~~-~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 205 -QIYEKIL---EGKV-RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -HHHHHHh---cCCc-cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111111 1110 11223356788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=276.87 Aligned_cols=252 Identities=29% Similarity=0.449 Sum_probs=198.4
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc--CCCceeeeeEEEeCC------
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV--HSNLIELIGYAAGGD------ 76 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~------ 76 (313)
...++|++.+.||.|++|.||+|.++ ++.+++|.+.... .+.+.+|+.+++.+ |+|++++++.+....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45689999999999999999999986 6789999987654 45678899999988 999999999997644
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
.++++|||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999885322 12457899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccC-----CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-----GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~ 231 (313)
.+........ ......++..|+|||++.. ..++.++||||||+++|+|++|..||...... ..
T Consensus 159 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~- 226 (275)
T cd06608 159 VSAQLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------RA- 226 (275)
T ss_pred cceecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--------HH-
Confidence 8876543221 2223457889999998853 34678899999999999999999999643221 00
Q ss_pred HHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 232 VDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...+.....+... .....+..+.+++.+||..||++|||+.++++
T Consensus 227 --------------~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 227 --------------LFKIPRNPPPTLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred --------------HHHhhccCCCCCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0011111111111 12234567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=277.32 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=191.2
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHH-HHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKI-LCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~-l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
++|++.+.||+|+||.||+|.+. ++.||+|.++... ...+..|+.+ ++.+ |||++++++.+..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47999999999999999999987 7899999887542 2234456655 4444 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC-CCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY-TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|++ ++|.+++.... .....+++..++.++.|++.|++|||++ + ++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVY-DKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 995 68888775332 2336789999999999999999999997 8 9999999999999999999999999987654
Q ss_pred CChhhhhhcccccccccccCCccccC----CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD----GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...... .
T Consensus 156 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------~------- 214 (283)
T cd06617 156 DSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----------F------- 214 (283)
T ss_pred ccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----------H-------
Confidence 321 1122357888999998865 44688999999999999999999999643221 0
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+..........+.. .....+..+.+++.+||..+|.+||++.++++.
T Consensus 215 -----~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 215 -----QQLKQVVEEPSPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -----HHHHHHHhcCCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111111111111 112345678899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=281.65 Aligned_cols=248 Identities=23% Similarity=0.393 Sum_probs=199.7
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.+...+|++++.||+|++|.||+|.+. ++.+++|.+.... .+.+.+|+.+++.+ |+|++++++.+...+..++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 345589999999999999999999875 8899999986543 34567899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++++|.+++. ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++++|||.+...
T Consensus 95 ~e~~~~~~L~~~~~------~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 95 MEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (297)
T ss_pred ecccCCCCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEc
Confidence 99999999999983 245788899999999999999999999 999999999999999999999999988754
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
..... ......+++.|+|||.+.+..++.++|+||+|+++|++++|..||.........
T Consensus 166 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~------------------ 224 (297)
T cd06656 166 TPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------------------ 224 (297)
T ss_pred cCCcc---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe------------------
Confidence 43211 112235788999999999888999999999999999999999999654331100
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
......-.+.. ......+..+.+++.+||..+|.+||++.++++
T Consensus 225 -----~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 225 -----YLIATNGTPEL-QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -----eeeccCCCCCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000000 012233456788999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=272.04 Aligned_cols=244 Identities=27% Similarity=0.406 Sum_probs=197.2
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+|+..+.||+|++|.||++.+. +..+++|.+.... ...+.+|+++++.+ |||++++++.+...+..++|||+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5899999999999999999886 7789999886542 34577899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC-CcEEEeeccccccccC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN-FRAKIADFGLVKLLEH 163 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~~l~dfg~~~~~~~ 163 (313)
+++++|.+++... ....+++..+..++.+++.++.+||+++ ++|+||+|+||+++++ +.++++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999998522 2345889999999999999999999999 9999999999999855 4579999999886543
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
.. ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......
T Consensus 155 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----------------------- 207 (256)
T cd08220 155 KS----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----------------------- 207 (256)
T ss_pred Cc----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----------------------
Confidence 21 122245788999999999888999999999999999999999999654321
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...... ............+..+.+++.+||+.+|.+|||+.++++.
T Consensus 208 ~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 208 ALVLKI---MSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHH---HhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 001111 1111111222345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=277.68 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=197.8
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+|++.+.||.|++|.||+|.+. ++.+++|.+.... ...+.+|+.+++.+ |||++++++++.+.+..++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5899999999999999999986 7889999987543 34678899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+ +++|.+++. .....+++..++.++.|++.+|+|||+.+ ++|+||+|+||++++++.++++|||.+......
T Consensus 81 ~-~~~L~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLR----DEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999985 22356899999999999999999999999 999999999999999999999999998765533
Q ss_pred hhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc-
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT- 242 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 242 (313)
.. .......++..|+|||++.+. .++.++||||+|+++|+|++|.+||.+.... ..+...........
T Consensus 153 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--------~~~~~~~~~~~~~~~ 222 (286)
T cd07832 153 EP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--------EQLAIVFRTLGTPNE 222 (286)
T ss_pred CC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--------HHHHHHHHHcCCCCh
Confidence 21 112234578899999998754 4689999999999999999998888654321 11111111000000
Q ss_pred ---HHHHH--HhhhhcCCC-----CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 ---KDFMA--KLTECLDPN-----LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 ---~~~~~--~l~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
++... .......+. +.....+....+.+++.+||..+|++|||++++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 223 ETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 000000000 000112334788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=273.76 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=196.1
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
++-+.+++.....||+|+||.||+|.+. +..+++|.+.... ...+.+|+.+++.+ |+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455677777889999999999999876 6679999887553 34577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCc--cHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-CCcEEEeeccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPL--AWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIADFGL 157 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l--~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~ 157 (313)
++||+++++|.+++.. ....+ +...+..++.|++.|++|||+.+ ++|+||+|+||+++. ++.++|+|||.
T Consensus 83 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 83 FMEQVPGGSLSALLRS----KWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEecCCCCCHHHHHHH----hcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence 9999999999999852 22334 78888899999999999999999 999999999999976 67899999998
Q ss_pred cccccCChhhhhhcccccccccccCCccccCC--CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG--CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
+........ ......+++.|+|||++.+. .++.++|+||+|+++|+|++|..||.......
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-------------- 218 (268)
T cd06624 156 SKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-------------- 218 (268)
T ss_pred heecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--------------
Confidence 875432211 11223578899999998654 37889999999999999999999986433210
Q ss_pred HHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 236 LAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 236 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
......................+.+++.+||+.+|.+|||+.++++.
T Consensus 219 ----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 219 ----------AAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----------hhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00000000001111223445678899999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=273.29 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=200.6
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
++|++.+.||.|++|.||+|... +..+++|.+.... ...+.+|+.+++.+ |+|++++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999875 6789999986432 45578899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++.... ....+++..+..++.|++.|+++||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999999985321 1246889999999999999999999999 999999999999999999999999998766543
Q ss_pred hhhh-hhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 165 PEIA-AAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 165 ~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.... .......++..|+|||++... .++.++|+||||+++|+|++|..||...... .
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~------------- 214 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------K------------- 214 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------h-------------
Confidence 2211 112233578899999998776 7899999999999999999999999654331 0
Q ss_pred HHHHHHhhhhcCCCCCCC--CHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRY--HKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...+.+. ...+.+... ....+..+.+++.+||..||++|||+.+|++
T Consensus 215 -~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 215 -VLMLTLQ-NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -hHHHHhc-CCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0011111 011111111 1245567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=272.60 Aligned_cols=248 Identities=27% Similarity=0.443 Sum_probs=198.1
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+|.+.+.||+|++|.||+|.+. ++.+++|.++... ...+..|+.+++.+ |+||+++++.+.+.+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5889999999999999999875 7889999987543 34578899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++. ....+++..++.++.+++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLE-----HGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHh-----hcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 99999999984 3445788899999999999999999999 999999999999999999999999998876543
Q ss_pred hhhhhh-cccccccccccCCccccCCC---CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 165 PEIAAA-ASRIVGTFGYLAPEYVRDGC---VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 165 ~~~~~~-~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
...... .....++..|+|||++.+.. ++.++||||+|+++|++++|..||...... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--------~----------- 213 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--------F----------- 213 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--------H-----------
Confidence 221111 12245688999999998766 889999999999999999999999644321 0
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.....+.....+... .....+..+.+++.+||+.+|.+|||+.+++.
T Consensus 214 ---~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 214 ---QIMFHVGAGHKPPIP-DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---HHHHHHhcCCCCCCC-cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000011111111111 12233567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=275.75 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=193.6
Q ss_pred ceeccCCeEEEEEeEECC--------cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 18 LKIGQGSYGSVYLGKLRG--------KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~~--------~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+.||+|+||.||+|.+.. ..+++|.+.... ...+.+|+.+++.+ ||||+++++++.+....+++||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998752 568999876432 44577899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCC--CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC-----cEEEeeccc
Q 041031 85 AQNGALSDHLHWPSVK--GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF-----RAKIADFGL 157 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-----~~~l~dfg~ 157 (313)
+++++|.+++...... ....+++..++.++.|++.|++|||+.+ ++|+||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998543211 2345788999999999999999999999 99999999999999877 899999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
+......... ........+..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---------------- 220 (269)
T cd05044 158 ARDIYKSDYY-RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---------------- 220 (269)
T ss_pred cccccccccc-ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH----------------
Confidence 8754322111 11112234678999999999899999999999999999998 99998643321
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+.. ..........+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 221 -------~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 221 -------EVLQHVTA---GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -------HHHHHHhc---CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111111 1111122344567889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=276.12 Aligned_cols=242 Identities=23% Similarity=0.310 Sum_probs=198.8
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
+|++.+.||.|+||.||+|.+. ++.+++|.+... ..+.+.+|+++++++ |||++++++.+.+.+..++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999987 788999988643 245678899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+.+++|.+++. ....+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++++|||.+.....
T Consensus 81 ~~~~~~L~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLS-----QKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHH-----hcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 999999999984 3357899999999999999999999999 99999999999999999999999999876554
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ..
T Consensus 153 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~~----------- 208 (258)
T cd05578 153 DT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---------RD----------- 208 (258)
T ss_pred Cc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---------HH-----------
Confidence 32 1223457788999999998889999999999999999999999997654310 00
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH--HHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM--SNAA 290 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~--~~ll 290 (313)
.+...... .........+..+.+++.+||..||.+||++ +|++
T Consensus 209 ~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 209 QIRAKQET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHhcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11111110 1111223345788899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=290.03 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=214.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC----Cc--ceEEEecccc----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR----GK--NAAIKQMKNT----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~----~~--~~aiK~~~~~----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.+.....++||.|-||.||+|.+. |+ .||||.-+.+ +.+.+..|..+|+.+ ||||++++|++.+. ..+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 444566789999999999999876 33 4788887753 466788999999999 99999999999876 579
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+|||.++-|.|..++. .+...++......++.|++.||+|||+.+ +||+||..+|||+.....|||+|||++.
T Consensus 467 ivmEL~~~GELr~yLq----~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQ----QNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred EEEecccchhHHHHHH----hccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 9999999999999996 56678999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
...+... ...+.-.-+.-|+|||-++...++.+||||.||+++||++. |..||.+..+.+
T Consensus 540 ~~ed~~y--YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------- 600 (974)
T KOG4257|consen 540 YLEDDAY--YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------- 600 (974)
T ss_pred hccccch--hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------------
Confidence 8876543 33333445678999999999999999999999999999877 999998877642
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
.+...-.......+.+++..|+.|+.+||+++|.+||.+.+|...|+.++.++
T Consensus 601 ---------VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 601 ---------VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred ---------eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 11111122222356788889999999999999999999999999999998854
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=278.87 Aligned_cols=275 Identities=23% Similarity=0.329 Sum_probs=198.5
Q ss_pred CccccceeccCCeEEEEEeEEC----CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeC--CeEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR----GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGG--DSLF 79 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~--~~~~ 79 (313)
+|.+.++||+|++|.||+|.+. +..+|+|.+.... ...+.+|+.+++.+ |||++++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5889999999999999999985 5789999987632 35577899999999 99999999999988 8899
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC----CCcEEEeec
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS----NFRAKIADF 155 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~----~~~~~l~df 155 (313)
+|||+++ ++|.+.+..........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. ++.++++||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 47777764433333457899999999999999999999999 999999999999998 899999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccc-cchhHHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYT-EHRSLVD 233 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~-~~~~~~~ 233 (313)
|++.................++..|+|||++.+. .++.++|+||||+++|+|++|+.||............ ....+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 9988654332211122234568889999988764 5789999999999999999999999766543211000 0011111
Q ss_pred HHHHHhcCcHH----------HHHHhhhhcCCCCC-C-----CC--HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 234 YMLAVFNDTKD----------FMAKLTECLDPNLT-R-----YH--KDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 234 ~~~~~~~~~~~----------~~~~l~~~~~~~~~-~-----~~--~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
........... .............. . .. ......+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111000000 00000000000000 0 00 033456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=272.88 Aligned_cols=234 Identities=22% Similarity=0.332 Sum_probs=183.1
Q ss_pred ceeccCCeEEEEEeEEC--------------CcceEEEecccccc---HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 18 LKIGQGSYGSVYLGKLR--------------GKNAAIKQMKNTKS---KEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--------------~~~~aiK~~~~~~~---~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
+.||+|+||.||+|... ...+++|.+..... ..+.+|+.+++.+ ||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46899999999999753 22488888765432 2466788899999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc-------EEE
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR-------AKI 152 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~-------~~l 152 (313)
++|||+++++|..++. .....+++..++.++.|++.|++|||+++ ++|+||+|+||+++.++. +++
T Consensus 81 lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMH----RKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999998874 23456899999999999999999999999 999999999999986654 899
Q ss_pred eeccccccccCChhhhhhcccccccccccCCcccc-CCCCCCccchhhHHHHHHHHH-hCCCCccCCCCCCCCccccchh
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR-DGCVTTKSDVYAFGVVLMELI-TGQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~-tg~~p~~~~~~~~~~~~~~~~~ 230 (313)
+|||++....... ...++..|+|||.+. +..++.++||||||+++|+|+ +|..||......
T Consensus 154 ~d~g~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---------- 216 (262)
T cd05077 154 SDPGIPITVLSRQ-------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA---------- 216 (262)
T ss_pred CCCCCCccccCcc-------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh----------
Confidence 9999876543221 124678899999887 466899999999999999997 588887643321
Q ss_pred HHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 231 LVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
+.. .... .... ........+.+|+.+||+.||.+||++.+|++.+
T Consensus 217 -------------~~~-~~~~---~~~~-~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 217 -------------EKE-RFYE---GQCM-LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -------------HHH-HHHh---cCcc-CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 0000 0000 1112235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=286.62 Aligned_cols=247 Identities=24% Similarity=0.318 Sum_probs=199.2
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-CcceEEEecccc-----ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNT-----KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~-----~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv 81 (313)
.-..|+++++||.||.+.||++... .+.+|+|.+... ....+..|+..|.++ |.+|+.++++-..+..+|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3468999999999999999999877 556777766432 245588999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
||+- ..+|..+|. +.........++.++.|++.|+.++|+.| |||.||||.|+++-+ |.+||+|||+|...
T Consensus 439 mE~G-d~DL~kiL~----k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 439 MECG-DIDLNKILK----KKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred eecc-cccHHHHHH----hccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 9997 569999995 33334444488999999999999999999 999999999999965 58999999999877
Q ss_pred cCChhhhhhcccccccccccCCccccCC-----------CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchh
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDG-----------CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~ 230 (313)
..... ........||..|++||++... +.+.++|||||||+||+|+.|+.||....
T Consensus 510 ~~DTT-sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------------ 576 (677)
T KOG0596|consen 510 QPDTT-SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------------ 576 (677)
T ss_pred Ccccc-ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------------
Confidence 65433 2344456899999999999632 25689999999999999999999997432
Q ss_pred HHHHHHHHhcCcHHHHHHhhhhcCCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 231 LVDYMLAVFNDTKDFMAKLTECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
....++.+..+|+... ........+.++++.||+.||.+|||+.+||+
T Consensus 577 -------------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 577 -------------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -------------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2356666677775433 11112223899999999999999999999985
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=274.10 Aligned_cols=248 Identities=23% Similarity=0.391 Sum_probs=197.1
Q ss_pred CccccceeccCCeEEEEEeEEC---CcceEEEeccccc-------------cHHHHHHHHHHHh-c-CCCceeeeeEEEe
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR---GKNAAIKQMKNTK-------------SKEFSSELKILCK-V-HSNLIELIGYAAG 74 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~---~~~~aiK~~~~~~-------------~~~~~~e~~~l~~-l-h~~i~~~~~~~~~ 74 (313)
+|++.+.||+|+||.||+|.+. ++.+++|.+.... ..++..|+.++.. + |||++++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 5889999999999999999986 4778999875321 2335668887776 4 9999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCCCCcEEEe
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDSNFRAKIA 153 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~~~~l~ 153 (313)
++..+++|||+++++|.+++.... .....++...++.++.|++.++.+||+ .+ ++|+||+|+||+++.++.++++
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEe
Confidence 999999999999999998874322 234568899999999999999999996 67 9999999999999999999999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 157 dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------------- 219 (269)
T cd08528 157 DFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------------- 219 (269)
T ss_pred cccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-------------
Confidence 999988655432 222345788999999999888999999999999999999999998643321
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.....+. +..... .....+..+.+++.+||+.||.+||++.|+.++++
T Consensus 220 ----------~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 ----------SLATKIV---EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----------HHHHHHh---hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0111111 111111 11133467889999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=278.43 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=199.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC--Cc----ceEEEecccccc----HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GK----NAAIKQMKNTKS----KEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~----~~aiK~~~~~~~----~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|+..+.||+|+||.||+|.+. +. .+++|.+..... ..+.+|+.+++.+ |||++++++.+... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 467889999999999999999875 33 478898875532 2467889999999 99999999998754 467
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
++++++++|+|.+++. .....++...++.++.|++.||.|||+++ ++|+||+|+||++++++.+||+|||++.
T Consensus 85 ~v~e~~~~g~l~~~~~----~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 85 LVTQLMPHGCLLDYVH----EHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeehhcCCCCHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccc
Confidence 8999999999999984 33446888999999999999999999999 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.... ..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---------~~------- 220 (303)
T cd05110 158 LLEGDEKE-YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---------EI------- 220 (303)
T ss_pred cccCcccc-cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---------HH-------
Confidence 65432211 11122345678999999998889999999999999999998 88998643211 11
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
...+...... ......+..+.+++.+||..+|++||++.++++.|..+..+.
T Consensus 221 -------~~~~~~~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 221 -------PDLLEKGERL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -------HHHHHCCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1111110001 011233457889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=290.34 Aligned_cols=263 Identities=24% Similarity=0.391 Sum_probs=223.1
Q ss_pred hHHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 4 YNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
+++-+-..++....++||-|.+|.||.|.|+ .-.||||.++.+. .+++.+|..+|+.+ |||+|+++++|..+..+
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3555566777888899999999999999999 5678999999875 67899999999999 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
|||+||+..|+|.++|.. .+...++.-.++.++.||+.|+.||..++ ++|+||..+|.||.++..||++|||++
T Consensus 339 YIiTEfM~yGNLLdYLRe---cnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRE---CNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred EEEEecccCccHHHHHHH---hchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999953 33456777788999999999999999999 999999999999999999999999999
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
.++.......-. ...-+.-|.|||-+....++.++|||+||++|||+.| |-.||.+.+-
T Consensus 413 RlMtgDTYTAHA--GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------------------ 472 (1157)
T KOG4278|consen 413 RLMTGDTYTAHA--GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------------ 472 (1157)
T ss_pred hhhcCCceeccc--CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH------------------
Confidence 988754322111 1223577999999999999999999999999999998 7888876543
Q ss_pred HhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 238 VFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
..+...++..++. ....++..+++|+++||+++|.+||++.|+-+.++.+..++.
T Consensus 473 ---------SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 473 ---------SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred ---------HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 3334444444443 566778899999999999999999999999999999887654
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=277.19 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=212.4
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..+-|.++.+||+|++|.||+|.++ |..+|||.+..+ +.+++.+|+.+++++ .|++|++++.+-....+++|||||
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3455889999999999999999888 889999999865 478899999999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
..|++.+.+. .+.+++++.++..+++..+.+|.|||..+ -+|+|||..|||++-+|..||+|||.+-...+..
T Consensus 111 GAGSiSDI~R----~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 111 GAGSISDIMR----ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred CCCcHHHHHH----HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 9999999995 56789999999999999999999999999 8999999999999999999999999988766532
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
.......||+.|+|||++..-.|+..+||||||++.-+|..|++||....+-.
T Consensus 184 ---AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR------------------------ 236 (502)
T KOG0574|consen 184 ---AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR------------------------ 236 (502)
T ss_pred ---HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc------------------------
Confidence 34445689999999999999999999999999999999999999997655421
Q ss_pred HHHhhhhcCCCCC-CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 246 MAKLTECLDPNLT-RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 246 ~~~l~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...--...+... ......+.++.+++++||-.+|++|.|+.++++.
T Consensus 237 -AIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 237 -AIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -eeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 000000111111 1455667789999999999999999999998864
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=271.63 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=198.6
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEE--eCCeEEEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAA--GGDSLFLVY 82 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~--~~~~~~lv~ 82 (313)
+|++.+.||.|+||.||++.+. +..+++|.+.... .+.+..|+++++.+ |||++++++.+. .....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5889999999999999999876 6789999876432 34467899999999 999999999875 345689999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHh-----cCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH-----QYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh-----~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
||+++++|.+++.... .....+++..++.++.|++.||.+|| +.+ ++|+||+|+||++++++.++++|||.
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999985432 23467899999999999999999999 888 99999999999999999999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+........ ......+++.|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 157 ~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------- 216 (265)
T cd08217 157 AKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL----------------- 216 (265)
T ss_pred cccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-----------------
Confidence 887654321 122235788999999999888999999999999999999999999754321
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+. ...........+..+.+++.+||+.+|.+|||+.+|++.
T Consensus 217 ------~~~~~~~---~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 217 ------QLASKIK---EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------HHHHHHh---cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111111 111122233455678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=275.69 Aligned_cols=261 Identities=22% Similarity=0.292 Sum_probs=193.2
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+|++.+.||.|++|.||+|.+. |+.+++|.++... ...+.+|+.+++.+ |||++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5889999999999999999986 7889999886432 24567899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
++ ++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~----~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFD----SCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 96 57877764 23456899999999999999999999999 999999999999999999999999998754322
Q ss_pred hhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
.. ......++..|+|||++.+. .++.++||||||+++|+|+||..||....... ..+............
T Consensus 153 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~ 222 (284)
T cd07839 153 VR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-------DQLKRIFRLLGTPTE 222 (284)
T ss_pred CC---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-------HHHHHHHHHhCCCCh
Confidence 11 11223467899999998764 46899999999999999999998864332210 011111000000000
Q ss_pred HHHHHhhhhcC----CCCCC------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 244 DFMAKLTECLD----PNLTR------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 244 ~~~~~l~~~~~----~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+....+....+ +.... .....+..+.+++.+||+.||.+|||++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000000 00000 11224567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=271.47 Aligned_cols=244 Identities=25% Similarity=0.408 Sum_probs=197.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.+-|+..+.||.|+||.||+|.+. +..+|+|.+.... ...+.+|+.+++.+ |||++++++.+..+...++|||
T Consensus 3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 355788999999999999999876 7789999876433 24577899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++++|.+++. ...++...+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++++|||++.....
T Consensus 83 ~~~~~~l~~~i~------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 83 YLGGGSALDLLE------PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred eCCCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 999999999883 245789999999999999999999999 99999999999999999999999998875543
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......
T Consensus 154 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----------------------- 207 (277)
T cd06641 154 TQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM----------------------- 207 (277)
T ss_pred chh---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----------------------
Confidence 211 122235788899999998888899999999999999999999998643221
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.....+. ...........+..+.+++.+||+.+|.+||++.++++.
T Consensus 208 ~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 208 KVLFLIP---KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHh---cCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0011111 011111223445678899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=280.20 Aligned_cols=196 Identities=21% Similarity=0.309 Sum_probs=161.8
Q ss_pred ccceeccC--CeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 16 TSLKIGQG--SYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 16 ~~~~lg~g--~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
++++||+| +|++||++.++ ++.||+|.+.... ...+.+|+.+++.+ ||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 78999999887 7889999987542 23477899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+++.||+.........
T Consensus 82 ~~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 999999998422 1245889999999999999999999999 9999999999999999999999998654332211
Q ss_pred hhh----hhcccccccccccCCccccC--CCCCCccchhhHHHHHHHHHhCCCCccCC
Q 041031 166 EIA----AAASRIVGTFGYLAPEYVRD--GCVTTKSDVYAFGVVLMELITGQQALSRD 217 (313)
Q Consensus 166 ~~~----~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~tg~~p~~~~ 217 (313)
... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 100 01112345677999999975 45899999999999999999999999653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=270.93 Aligned_cols=242 Identities=25% Similarity=0.395 Sum_probs=196.5
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc--------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
+|+..+.||+|++|.||+|... ++.+++|.+.... ...+.+|+.+++.+ |+|++++++.+.+...++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4788899999999999999886 7889999876432 24577899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
+||+++++|.+++. ....+++..+..++.|++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLK-----KYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceec
Confidence 99999999999983 3456889999999999999999999999 999999999999999999999999988765
Q ss_pred cCChhhhhhcccccccccccCCccccCCC-CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGC-VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
.... ......++..|+|||.+.... ++.++|+||||+++|+|++|..||......
T Consensus 153 ~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------------------- 208 (258)
T cd06632 153 VEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------------------- 208 (258)
T ss_pred cccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--------------------
Confidence 4322 122345788899999997766 899999999999999999999999654311
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+....... ..............+.+++++||+.+|.+||++.+++.
T Consensus 209 ---~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 209 ---AAVFKIGR--SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---HHHHHHHh--cccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00001110 01111122334567888999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=276.89 Aligned_cols=261 Identities=24% Similarity=0.322 Sum_probs=195.1
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccccc--------HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS--------KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~--------~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
+|++.+.||.|++|.||+|.+. ++.+++|.+..... ..+..|+.+++.+ |+|++++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 5888999999999999999986 78999999875532 2356799999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+ +++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~-~~~L~~~i~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKD----KSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 8899999842 2236899999999999999999999999 999999999999999999999999998765
Q ss_pred cCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
..... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||....... .+.........
T Consensus 153 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--------~~~~~~~~~~~ 221 (298)
T cd07841 153 GSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--------QLGKIFEALGT 221 (298)
T ss_pred cCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--------HHHHHHHHcCC
Confidence 43221 1122345778999998865 457889999999999999999987776543310 01011000000
Q ss_pred -CcHHHHH--HhhhhcC------CCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 241 -DTKDFMA--KLTECLD------PNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 241 -~~~~~~~--~l~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
....... .+..... ..........+..+.+++.+||+.+|.+|||+.++++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred CchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000 0000000 00000112335678899999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=277.25 Aligned_cols=261 Identities=25% Similarity=0.354 Sum_probs=195.9
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
++|++.++||+|++|.||+|.++ ++.+|+|.+.... .+.+.+|+++++.+ |||++++++++...+..++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47899999999999999999986 7889999876432 33467899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++++|.++.. ....+++..++.++.|++.+++|||+.+ ++|+||+|+||++++++.++++|||++.....
T Consensus 81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEK-----YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 999988888763 3345899999999999999999999999 99999999999999999999999999876543
Q ss_pred ChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||...... ..............
T Consensus 153 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~--------~~~~~~~~~~~~~~ 221 (286)
T cd07846 153 PGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI--------DQLYHIIKCLGNLI 221 (286)
T ss_pred Ccc---ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH--------HHHHHHHHHhCCCc
Confidence 221 1122346889999999875 45788999999999999999999998654321 01101000000000
Q ss_pred HHHHHH------hhhhcCCCCCC------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDFMAK------LTECLDPNLTR------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~~~~------l~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...... ......+.... .....+..+.+++.+||..+|.+||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 222 PRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000 00000010000 11233567889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=277.68 Aligned_cols=245 Identities=24% Similarity=0.409 Sum_probs=196.6
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
+.|.....||+|+||.||++.+. +..++||.+.... .+.+.+|+.+++.+ |+|++++++.+...+..+++|||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 45566778999999999999876 7889999886533 34577899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++++|.+++. ...+++..++.++.|++.++.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 102 ~~~~L~~~~~------~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 102 EGGALTDIVT------HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 9999999873 235788999999999999999999999 9999999999999999999999999886543221
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
. ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... +.
T Consensus 173 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----------------------~~ 226 (292)
T cd06658 173 P---KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-----------------------QA 226 (292)
T ss_pred c---cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------------HH
Confidence 1 112245788999999998888999999999999999999999998643221 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...+.....+.... ....+..+.+++.+||..||++|||++++++.
T Consensus 227 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 227 MRRIRDNLPPRVKD-SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHhcCCCcccc-ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111122221111 12334568889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=272.24 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=198.5
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEe--CCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAG--GDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~--~~~~~lv~ 82 (313)
++|...+.||.|++|.||++.+. ++.+++|.+.... ...+.+|+++++.+ ||||+++++.+.+ .+.++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47889999999999999999986 7889999887542 34578899999999 9999999998864 44789999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++.... .....++...+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++....
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999998874322 23456888999999999999999999999 9999999999999999999999999976543
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ......
T Consensus 157 ~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~----------- 216 (287)
T cd06621 157 NSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP----LGPIEL----------- 216 (287)
T ss_pred ccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC----CChHHH-----------
Confidence 221 112356788999999998899999999999999999999999997653310 000111
Q ss_pred HHHHHHhhhhcCCCCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTR---YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
...+...-.+.+.. .....+..+.+++.+||+.+|.+|||+.|+++.-
T Consensus 217 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 217 ---LSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred ---HHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 11111100011111 1123456788999999999999999999999743
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=277.36 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=197.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.+.|.....||+|+||.||+|.+. ++.+++|.+.... .+.+.+|+.+++.+ |||++++++.+...+..++++||
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 456777889999999999999886 7889999986432 34577899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++. ...+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 100 ~~~~~L~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 100 LQGGALTDIVS------QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred CCCCCHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence 99999998873 245889999999999999999999999 999999999999999999999999988654322
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
.. ......++..|+|||++.+..++.++|+||+|+++|+|++|..||...... +
T Consensus 171 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----------------------~ 224 (297)
T cd06659 171 VP---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-----------------------Q 224 (297)
T ss_pred cc---cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------------H
Confidence 11 112245788999999999888999999999999999999999999643321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
....+......... .....+..+.+++.+||+.+|.+||++.++++.-
T Consensus 225 ~~~~~~~~~~~~~~-~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 225 AMKRLRDSPPPKLK-NAHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred HHHHHhccCCCCcc-ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 11111111111111 1223345688899999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=269.15 Aligned_cols=234 Identities=25% Similarity=0.405 Sum_probs=185.2
Q ss_pred ceeccCCeEEEEEeEECCc------------ceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 18 LKIGQGSYGSVYLGKLRGK------------NAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~~~------------~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
+.||+|+||.||+|.+.+. .+++|.+.... ...+.+|+.+++.+ |||++++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 4799999999999998732 37888876554 45677899999999 9999999999888 7789999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC-------cEEEeec
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF-------RAKIADF 155 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-------~~~l~df 155 (313)
||+++++|.+++.. ....++...+..++.|++.||+|||+++ ++|+||||+||+++.++ .++++||
T Consensus 80 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 80 EYVKFGPLDVFLHR----EKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EcCCCCcHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999842 2236889999999999999999999999 99999999999999877 7999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccCC--CCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG--CVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLV 232 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~ 232 (313)
|++...... ....++..|+|||++.+. .++.++|+||||+++|+|++ |..||......
T Consensus 153 g~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~------------ 213 (259)
T cd05037 153 GIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS------------ 213 (259)
T ss_pred Ccccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch------------
Confidence 998764431 122456789999999876 78999999999999999999 57777554321
Q ss_pred HHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 233 DYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 233 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+...... .... ........+.+++.+||..+|.+|||+.++++.|.
T Consensus 214 -----------~~~~~~~---~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 214 -----------EKERFYQ---DQHR--LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -----------hHHHHHh---cCCC--CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000000 0000 00111267889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=273.49 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=193.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++|++.+.||.|++|.||+|.++ ++.|++|.+.... ...+.+|+++++.+ ||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 478999999999999999999986 7889999986432 23466899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+. ++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~-~~L~~~~~----~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 84 YLD-TDLKQYMD----DCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred cCC-CCHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 996 58998874 22346889999999999999999999999 99999999999999999999999998765432
Q ss_pred ChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ......++..|+|||++.+ ..++.++||||+|+++|+|++|..||....... ..+...........
T Consensus 156 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-------~~~~~~~~~~~~~~ 225 (291)
T cd07844 156 PSK---TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-------DQLHKIFRVLGTPT 225 (291)
T ss_pred CCc---cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-------HHHHHHHHhcCCCC
Confidence 111 1111235788999999875 457899999999999999999999996543210 00000000000000
Q ss_pred HHHHHHhhh---hcCCC--------CCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDFMAKLTE---CLDPN--------LTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~~~~l~~---~~~~~--------~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+....... ..... +.. ........+.+++.+||+.+|.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 226 EETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000 00000 000 00111256788999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=274.60 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=197.0
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
++|++.+.||+|++|.||+|.+. ++.+++|.++... .+.+.+|+++++.+ |+|++++++.+...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999987 6789999886432 34578899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|++++.+..+. .....++...++.++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLE-----ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99886666655 33455899999999999999999999999 99999999999999999999999999876554
Q ss_pred ChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... .......++..|+|||++.+. .++.++|+||||+++|+|++|..||....... .+...........
T Consensus 153 ~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~~~~~~ 222 (288)
T cd07833 153 RPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--------QLYLIQKCLGPLP 222 (288)
T ss_pred Ccc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHhCCCC
Confidence 322 122234567889999999887 78999999999999999999999997543210 0000000000000
Q ss_pred HHHHHHhh--------hhcCCCCC-----CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDFMAKLT--------ECLDPNLT-----RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~~~~l~--------~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
........ ........ ......+..+.+++++||..+|++|||++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 223 PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 00000000 011123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=271.20 Aligned_cols=253 Identities=28% Similarity=0.416 Sum_probs=195.0
Q ss_pred ccccceeccCCeEEEEEeEEC-----CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC------
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGD------ 76 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~------ 76 (313)
|.+.+.||+|+||.||+|.+. +..+|||.+.... .+.+.+|+++++.+ |||++++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 5679999887542 33577899999999 999999999886532
Q ss_pred eEEEEEeecCCCChhhhhcCCCC-CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSV-KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
..+++++|+.+++|.+++...+. .....++...++.++.|++.|++|||+.+ ++|+||+|+||+++.++.++++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 24788999999999888743221 12235788899999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
|.+......... .......+++.|++||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 158 g~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-------------- 222 (273)
T cd05074 158 GLSKKIYSGDYY-RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-------------- 222 (273)
T ss_pred cccccccCCcce-ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--------------
Confidence 998865432211 11112234578999999988889999999999999999999 88888644321
Q ss_pred HHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 235 MLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
+....+... .........+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 223 ---------~~~~~~~~~---~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 223 ---------EIYNYLIKG---NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------HHHHHHHcC---CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111110 00111223456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=273.86 Aligned_cols=235 Identities=21% Similarity=0.358 Sum_probs=183.7
Q ss_pred ceeccCCeEEEEEeEEC---------CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 18 LKIGQGSYGSVYLGKLR---------GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~---------~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+.||.|+||.||+|.+. ...+++|...... .+.+.+|..+++.+ |||++++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 47999999999999875 2347888876543 34577889999999 99999999999998999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc--------EEEeecc
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR--------AKIADFG 156 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~--------~~l~dfg 156 (313)
+++|+|.+++. .....+++..++.++.|++.|++|||+.+ ++|+||||+||+++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLK----KNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999985 22346888999999999999999999999 999999999999987654 6999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCC-CCccCCCCCCCCccccchhHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQ-QALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~-~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
.+...... ....++..|+|||++.+ ..++.++||||||+++|+|++|. .||......
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-------------- 212 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-------------- 212 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--------------
Confidence 87654322 12346788999999986 45789999999999999999985 555432211
Q ss_pred HHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 235 MLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
........ ... ........+.+++.+||+.+|.+|||+.++++.|.
T Consensus 213 ---------~~~~~~~~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 213 ---------KKLQFYED--RHQ---LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------HHHHHHHc--ccc---CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000000 011 11223356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=270.72 Aligned_cols=249 Identities=23% Similarity=0.380 Sum_probs=194.9
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-------------cHHHHHHHHHHHhc-CCCceeeeeEEEeCC
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-------------SKEFSSELKILCKV-HSNLIELIGYAAGGD 76 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-------------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~ 76 (313)
+|.+.+.||.|++|.||+|... ++.+|+|.+.... .+.+..|+.+++.+ |||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5888999999999999999875 7889999875321 12466799999999 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
..++|+||+++++|.+++. ....++...+..++.|++.||.+||+.+ ++|+||+|+||++++++.++++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLR-----TYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecc
Confidence 9999999999999999984 3357888999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCC--CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC--VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
.+........ ........++..|+|||.+.... ++.++|+||||+++|++++|..||...... . ..
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~---~~ 221 (272)
T cd06629 154 ISKKSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--------A---AM 221 (272)
T ss_pred cccccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--------H---HH
Confidence 9875432211 11112235678999999987654 789999999999999999999998532211 0 00
Q ss_pred HHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 235 MLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.............. .....+..+.+++.+||..+|.+|||+.++++.
T Consensus 222 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 222 -----------FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -----------HHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000111111111 223345678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=265.23 Aligned_cols=245 Identities=29% Similarity=0.473 Sum_probs=200.3
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
+|.+.+.||+|++|.||++.+. ++.+++|.+.... ...+.+|+++++.+ |++++++++.+...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 5889999999999999999987 7889999987654 35688899999999 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++. .....+++..+..++.|++.++++||..+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 81 GGSLKDLLK----STNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCcHHHHHh----hcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999984 22257899999999999999999999999 99999999999999999999999998876554321
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...
T Consensus 154 ----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------------------~~~ 206 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----------------------KAL 206 (253)
T ss_pred ----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----------------------HHH
Confidence 23346788999999999888999999999999999999999999654321 001
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
........+... .....+..+.+++.+||+.||++|||+.++++.
T Consensus 207 ~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 207 FKIATNGPPGLR-NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHhcCCCCcC-cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111111111 112225678999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=280.87 Aligned_cols=263 Identities=23% Similarity=0.287 Sum_probs=197.5
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeC----
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGG---- 75 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~---- 75 (313)
..+..+|++.+.||+|+||.||+|.+. ++.+|+|.+... ....+.+|+.+++.+ |||++++++++...
T Consensus 12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 356789999999999999999999986 789999998642 234566899999999 99999999988643
Q ss_pred --CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEe
Q 041031 76 --DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIA 153 (313)
Q Consensus 76 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~ 153 (313)
...++||||+. ++|.+.+. ..++...+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQ-------MDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEc
Confidence 35799999995 58888773 12888899999999999999999999 9999999999999999999999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
|||.+....... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+... ....
T Consensus 161 Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~--------~~~~ 228 (353)
T cd07850 161 DFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID--------QWNK 228 (353)
T ss_pred cCccceeCCCCC----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH--------HHHH
Confidence 999987654321 1122356889999999999999999999999999999999999997654311 1111
Q ss_pred HHHHHhcCcHHHHHHhhhh----c-------------------CCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHH
Q 041031 234 YMLAVFNDTKDFMAKLTEC----L-------------------DPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNA 289 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~----~-------------------~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~l 289 (313)
..........++...+... . .+.... ........+.+++.+||+.||++|||+.|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei 308 (353)
T cd07850 229 IIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308 (353)
T ss_pred HHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHH
Confidence 1111111111111111100 0 000000 011235567899999999999999999999
Q ss_pred HHHH
Q 041031 290 AIRL 293 (313)
Q Consensus 290 l~~l 293 (313)
++.=
T Consensus 309 L~~~ 312 (353)
T cd07850 309 LQHP 312 (353)
T ss_pred hcCh
Confidence 9753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=271.24 Aligned_cols=243 Identities=27% Similarity=0.448 Sum_probs=195.4
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccc----ccHHHHHHHHHHHhc----CCCceeeeeEEEeCCeEEEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT----KSKEFSSELKILCKV----HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~----~~~~~~~e~~~l~~l----h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.|+..+.||.|+||.||+|.+. ++.+++|.+... ....+.+|+.+++.+ |||++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5888999999999999999986 788999988643 234577888888888 899999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++. . ..+++..++.++.|++.++.|||+.+ ++|+||+|+||++++++.++++|||.+....
T Consensus 82 e~~~~~~L~~~~~-----~-~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMK-----A-GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHH-----c-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 9999999999883 1 36889999999999999999999999 9999999999999999999999999987665
Q ss_pred CChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......
T Consensus 153 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------------------- 209 (277)
T cd06917 153 QNSS---KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------------------- 209 (277)
T ss_pred CCcc---ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh--------------------
Confidence 4321 1223457889999998865 446899999999999999999999996543210
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
....+.....+.+. ....+..+.+++.+||..||.+||++.+++..
T Consensus 210 ---~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 210 ---AMMLIPKSKPPRLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---hhhccccCCCCCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00000000001111 11245678899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=268.80 Aligned_cols=248 Identities=22% Similarity=0.299 Sum_probs=194.1
Q ss_pred hHHHHHHhcCcccccee--ccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEeCCe
Q 041031 4 YNEVRDATSNFSTSLKI--GQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAGGDS 77 (313)
Q Consensus 4 ~~~~~~~~~~y~~~~~l--g~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~ 77 (313)
.+++....++|.+.+.+ |.|+||.||++..+ +..+++|.+........ |+.....+ |||++++++.+...+.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 44555666788888887 99999999999876 77899999876533322 23333323 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC-cEEEeecc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF-RAKIADFG 156 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg 156 (313)
.++||||+++++|.+++. ....+++..++.++.|++.|+.+||+.+ ++|+||+|+||+++.++ .++++|||
T Consensus 84 ~~iv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLK-----KEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eEEEEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 999999999999999984 3347899999999999999999999999 99999999999999888 99999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
.+....... ...++..|+|||++.+..++.++|+||+|+++|+|++|..||....... .....+
T Consensus 156 ~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-------~~~~~~-- 219 (267)
T PHA03390 156 LCKIIGTPS-------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-------LDLESL-- 219 (267)
T ss_pred cceecCCCc-------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-------hhHHHH--
Confidence 887544221 2357889999999998889999999999999999999999997443221 000011
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-HHHHHH
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-MSNAAI 291 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~ll~ 291 (313)
. ....... ......+..+.+++.+||+.+|.+||+ ++++++
T Consensus 220 ---------~----~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 220 ---------L----KRQQKKL-PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---------H----HhhcccC-CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 0111111 112245567889999999999999996 588874
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=269.42 Aligned_cols=245 Identities=26% Similarity=0.417 Sum_probs=197.5
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+|++.+.||+|+||.||+|.++ +..+++|.+... ..+.+.+|+.+++.+ |+|++++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5889999999999999999987 788999998653 344577899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc-EEEeeccccccccC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR-AKIADFGLVKLLEH 163 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~-~~l~dfg~~~~~~~ 163 (313)
+++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++. ++++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999998421 2235789999999999999999999999 999999999999998764 69999998876543
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
... ......+++.|+|||++.+..++.++|+||+|+++|+|++|..||...... +.
T Consensus 155 ~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------------~~--------- 210 (257)
T cd08225 155 SME---LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------------QL--------- 210 (257)
T ss_pred Ccc---cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------------HH---------
Confidence 321 112235788999999998888999999999999999999999998643321 11
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+...............+..+.+++.+||..+|++|||+.++++.
T Consensus 211 -----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 211 -----VLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----HHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11111111112222344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=271.63 Aligned_cols=244 Identities=24% Similarity=0.413 Sum_probs=195.6
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.|...++||+|++|.||++.+. ++.+++|.+.... .+.+.+|+.+++.+ |||++++++++...+..++++||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 5666789999999999999876 6789999875432 34477899999999 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++. . ..++...+..++.|++.|+++||+.+ ++|+||+|+||+++.++.++++|||.+........
T Consensus 100 ~~~L~~~~~-----~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 100 GGALTDIVT-----H-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCHHHHHH-----h-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 999999984 2 45888999999999999999999999 99999999999999999999999998765432211
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... ...
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----------------------~~~ 224 (285)
T cd06648 171 ---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----------------------QAM 224 (285)
T ss_pred ---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----------------------HHH
Confidence 112245788999999998888999999999999999999999998643221 111
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
..+.....+... .....+..+.+++.+||..+|++|||+.++++.
T Consensus 225 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 225 KRIRDNLPPKLK-NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHhcCCCCCc-ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 111111111111 111244678999999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=271.18 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=203.1
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
+..+.|+..+.||+|++|.||+|.+. +..+++|.+.... ...+.+|+++++.+ |+|++++++.+...+..++++|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45678999999999999999999997 7889999987665 45678899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++++|.+++.. ....++...+..++.|++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 96 ~~~~~~L~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 96 YMDGGSLTDIITQ----NFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred ccCCCcHHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999852 2237899999999999999999999999 99999999999999999999999998765543
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 169 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----------------------- 222 (286)
T cd06614 169 EKS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----------------------- 222 (286)
T ss_pred chh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----------------------
Confidence 221 112234678899999998888999999999999999999999998643321
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
.....+.....+... .....+..+.+++.+||+.+|.+|||+.++++.-
T Consensus 223 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 223 RALFLITTKGIPPLK-NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred HHHHHHHhcCCCCCc-chhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 000111100001111 1222456788999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=287.60 Aligned_cols=241 Identities=29% Similarity=0.436 Sum_probs=202.8
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.-|.-++.||.|+||.||.|++. .+.||||.+.-. ...++.+|+..|+++ |||++.+.++|.-+...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 45777899999999999999987 778999998643 255688999999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||| -|+-.|++. -..+++.+..+..+..+.+.||+|||+.+ .+|+|||..|||+++.|.|||+|||.+....
T Consensus 106 EYC-lGSAsDlle----VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 106 EYC-LGSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHH-hccHHHHHH----HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC
Confidence 999 568888885 56789999999999999999999999999 9999999999999999999999999988765
Q ss_pred CChhhhhhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
+.. .+.|||.|+|||++. .+.|+-++||||||++.-++...++|+...+.-
T Consensus 178 PAn-------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM------------------- 231 (948)
T KOG0577|consen 178 PAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------------- 231 (948)
T ss_pred chh-------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------------------
Confidence 433 367999999999985 577999999999999999999999998655431
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...-.+...-.|.+ ...+.+..+++++..||+.-|.+|||.++++..
T Consensus 232 ----SALYHIAQNesPtL--qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 232 ----SALYHIAQNESPTL--QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ----HHHHHHHhcCCCCC--CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11111222222333 355667778889999999999999999988853
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=273.48 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=194.1
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCe-----
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV--HSNLIELIGYAAGGDS----- 77 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~----- 77 (313)
++|++.+.||+|+||.||+|.+. ++.||+|.+.... ...+.+|+.+++.+ |||++++++.+...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999986 7889999876442 34577899999999 6999999999877665
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-CCcEEEeecc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIADFG 156 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg 156 (313)
.+++|||+++ +|.+++..........+++..++.++.|++.||.|||+++ ++|+||+|+||+++. ++.++++|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8888875433222456899999999999999999999999 999999999999998 8899999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
.+........ ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.... ..+....
T Consensus 157 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~ 225 (295)
T cd07837 157 LGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--------QQLLHIF 225 (295)
T ss_pred cceecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHH
Confidence 8875432211 1112245788999998865 45789999999999999999999999764331 1111111
Q ss_pred HHHhcCcH-HH--HHHhhhhc-CCC-----CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 236 LAVFNDTK-DF--MAKLTECL-DPN-----LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 236 ~~~~~~~~-~~--~~~l~~~~-~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
........ .+ ...+.... .+. ........+..+.++|.+||..||.+|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 10000000 00 00000000 000 00011234567889999999999999999999885
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=266.23 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=203.4
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+|.+.+.||.|++|.||++.+. +..+++|.+.... ...+.+|+++++.+ |||++++.+.+......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999988 8889999987543 34577899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+.+.... .....++...+..++.+++.++.+||+.+ ++|+||+|+||++++++.++++|||.+......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQK-KEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhh-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999985332 12477899999999999999999999999 999999999999999999999999998765543
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. .......+++.|+|||.+.+..++.++|+||+|+++++|++|..||...... +
T Consensus 157 ~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----------------------~ 210 (258)
T cd08215 157 V---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----------------------E 210 (258)
T ss_pred c---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----------------------H
Confidence 2 1223346788999999998888999999999999999999999998654321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.... .............+..+.+++.+||..+|.+|||+.++++.
T Consensus 211 ~~~~---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 211 LALK---ILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHH---HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111 11122222233455678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=275.87 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=192.4
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEe
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e 83 (313)
++|...++||+|+||.||++.+. +..+|+|.+.... ...+.+|+.++.++ |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 46667889999999999999987 7889999987543 33567888888888 8999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC-CCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY-TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
++. +++.++...........+++..+..++.|++.||+|||+. + ++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 984 5666654211112346789999999999999999999975 8 9999999999999999999999999986544
Q ss_pred CChhhhhhcccccccccccCCccccCC---CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDG---CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
... ......++..|+|||++.+. .++.++||||+|+++|+|++|..||..... ....
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~----- 219 (288)
T cd06616 160 DSI----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----------VFDQ----- 219 (288)
T ss_pred cCC----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----------HHHH-----
Confidence 321 11223568889999999765 689999999999999999999999964321 0000
Q ss_pred cCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.........+.+.. .....+..+.+|+.+||+.+|++|||+++|++.
T Consensus 220 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 220 ------LTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ------HhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000001111111 123356678999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=265.50 Aligned_cols=246 Identities=27% Similarity=0.424 Sum_probs=202.4
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeC--CeEEEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGG--DSLFLVY 82 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~--~~~~lv~ 82 (313)
+|++.+.||+|++|.||+|.+. ++.+++|.+.... .+.+.+|+.+++++ |||++++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5888999999999999999987 7889999987655 55678899999999 99999999999988 8999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|++++++|.+++. ....+++..++.++.|++.+++|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLK-----KFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 9999999999984 3347899999999999999999999999 9999999999999999999999999988765
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
..... .......++..|+|||.+.+...+.++|+||||+++|+|++|..||......
T Consensus 153 ~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------------------- 209 (260)
T cd06606 153 DIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---------------------- 209 (260)
T ss_pred ccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----------------------
Confidence 43221 0122346788999999999888999999999999999999999999765421
Q ss_pred HHHHHHhhhhcC-CCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 KDFMAKLTECLD-PNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 ~~~~~~l~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
......... ..........+..+.+++.+|+..+|.+||++.+++..
T Consensus 210 ---~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 210 ---MAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---HHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 001111111 11112233446789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=267.81 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=183.2
Q ss_pred ceeccCCeEEEEEeEEC-C---cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCC
Q 041031 18 LKIGQGSYGSVYLGKLR-G---KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~-~---~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (313)
++||+|+||.||+|+.. + ..+++|.+.... .+.+.+|+.+++.+ |||++++++.+.+....+++|||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 46999999999999754 2 345677665432 34577888999999 999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhh
Q 041031 89 ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIA 168 (313)
Q Consensus 89 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (313)
+|.+++..... .....+...++.++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||++........ .
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-~ 155 (268)
T cd05086 81 DLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-I 155 (268)
T ss_pred cHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh-h
Confidence 99999853221 2345677778899999999999999999 99999999999999999999999998754322111 1
Q ss_pred hhcccccccccccCCccccC-------CCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 169 AAASRIVGTFGYLAPEYVRD-------GCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 169 ~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
.......++..|+|||++.. ..++.++||||||+++|+|++ |..||...... +......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------------~~~~~~~- 222 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------------EVLNHVI- 222 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHH-
Confidence 12223456789999998853 235788999999999999997 46677543221 0000000
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
........++.. .......+.+++..|| .+|.+|||+.+|++.|.
T Consensus 223 -----~~~~~~~~~~~~---~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 223 -----KDQQVKLFKPQL---ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -----hhcccccCCCcc---CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 000001111211 2234557788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=272.81 Aligned_cols=261 Identities=21% Similarity=0.347 Sum_probs=194.4
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+|++++.||.|++|.||+|.++ +..++||.+.... ...+.+|+++++.+ |||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5889999999999999999886 7889999886432 24577899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+. ++|.+++... ....+++..++.++.|++.|++|||+.+ ++|+||+|+||++++++.++++|||++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 95 6888887422 2356889999999999999999999999 999999999999999999999999988754322
Q ss_pred hhhhhhcccccccccccCCccccCCC-CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc-
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGC-VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT- 242 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 242 (313)
.. ......++..|+|||++.+.. ++.++|+||||+++|+|+||..||...... ....+.........
T Consensus 154 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~ 222 (284)
T cd07860 154 VR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIFRTLGTPDE 222 (284)
T ss_pred cc---ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHHHhCCCCh
Confidence 11 111224578899999887644 588899999999999999999999754321 11111111100000
Q ss_pred ---------HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 ---------KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ---------~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
++.......................+.+++.+||+.||.+|||++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 223 VVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000001111000111123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=267.98 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=194.5
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEecccc--------ccHHHHHHHHHHHhc-CCCceeeeeEEEeC--CeE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT--------KSKEFSSELKILCKV-HSNLIELIGYAAGG--DSL 78 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~--------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~--~~~ 78 (313)
.+|++.+.||+|++|.||+|.+. +..+++|.+... ....+.+|+++++.+ |+|++++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999876 788999987432 123577899999999 99999999998764 468
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++++|++++++|.+++. ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++++|||.+
T Consensus 82 ~~v~e~~~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK-----AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccc
Confidence 89999999999999983 3345888999999999999999999999 999999999999999999999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
.................++..|+|||.+.+..++.++|+||||+++|++++|+.||...... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~--------- 216 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------A--------- 216 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------H---------
Confidence 76532111111112245788999999999888999999999999999999999999643221 0
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
..... ...+............+.+++.+||. +|..||++.+++.
T Consensus 217 -----~~~~~---~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 217 -----AIFKI---ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----HHHHH---HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111 11111112334455678899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=275.08 Aligned_cols=262 Identities=27% Similarity=0.378 Sum_probs=194.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeC--CeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGG--DSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~--~~~~l 80 (313)
.++|++.+.||.|+||.||+|.+. ++.||+|.+.... .....+|+.+++++ |+|++++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 578999999999999999999986 7899999986432 22356799999999 99999999998765 56899
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+. ++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 86 v~e~~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDN----MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeee
Confidence 999995 588888742 2356899999999999999999999999 99999999999999999999999999876
Q ss_pred ccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... .....+....
T Consensus 158 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---------~~~~~~~~~~ 225 (309)
T cd07845 158 YGLPAK---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---------EQLDLIIQLL 225 (309)
T ss_pred cCCccC---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHHhc
Confidence 553211 1112234778999999875 55789999999999999999999999754431 1111111110
Q ss_pred cCc-HHH---HHHhhh----hcC-CCCC---CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 240 NDT-KDF---MAKLTE----CLD-PNLT---RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 240 ~~~-~~~---~~~l~~----~~~-~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
... ... ...+.. .+. .... .........+.+++.+||+.||++|||+.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 226 GTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000 000000 000 0000 0011235567889999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=268.44 Aligned_cols=238 Identities=25% Similarity=0.310 Sum_probs=185.9
Q ss_pred ceeccCCeEEEEEeEEC--CcceEEEecccccc------HHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS------KEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~------~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
+.||.|++|.||+|.+. ++.+|+|.+..... .....|..++... |+|++++++.+...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999886 78999999875431 1233444444433 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 82 ~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIK-----TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 99999983 3456899999999999999999999999 99999999999999999999999998765432
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .. ..
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------------~~-----------~~ 203 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------------AV-----------FD 203 (260)
T ss_pred ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------------HH-----------HH
Confidence 12235778899999998888899999999999999999999999643321 00 01
Q ss_pred HhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 248 KLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 248 ~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.+... ...... .....+..+.+++.+||..+|.+||++.++.+.|.
T Consensus 204 ~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 204 NILSR-RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHhc-ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 11000 000111 12234567899999999999999998876655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=273.91 Aligned_cols=248 Identities=24% Similarity=0.408 Sum_probs=198.7
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
...++|.+.+.||+|+||.||++... +..+++|.+.... .+.+.+|+.+++.+ |||++++++.+...+..++|+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 34578999999999999999999875 7789999886432 34577899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++. ...++...+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 96 e~~~~~~L~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 96 EYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred ecCCCCcHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 9999999999983 234778889999999999999999999 9999999999999999999999999876554
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.... ......+++.|+|||.+.+..++.++|+||||+++|++++|..||........
T Consensus 167 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-------------------- 223 (293)
T cd06647 167 PEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------------------- 223 (293)
T ss_pred cccc---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--------------------
Confidence 3221 12223578889999999888899999999999999999999999975433110
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...+...-.+... .....+..+.+++.+||..+|.+||++.+++..
T Consensus 224 ---~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 224 ---LYLIATNGTPELQ-NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ---eeehhcCCCCCCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000001110 122234568889999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=273.18 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=195.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeC--CeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGG--DSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~--~~~~l 80 (313)
.++|++.+.||.|++|.||+|.+. ++.+++|.++... ...+.+|+.+++.+ |||++++++++... +..++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 468999999999999999999987 7789999886433 22356799999999 99999999998877 88999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
++||++ ++|.+++. .....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++..
T Consensus 84 v~e~~~-~~L~~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 84 VMEYVE-HDLKSLME----TMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred EehhcC-cCHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceee
Confidence 999996 58988884 22346899999999999999999999999 99999999999999999999999998876
Q ss_pred ccCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...... ...........
T Consensus 156 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~--------~~~~~~~~~~~ 224 (293)
T cd07843 156 YGSPLK---PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI--------DQLNKIFKLLG 224 (293)
T ss_pred ccCCcc---ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHHhC
Confidence 554311 11223467889999998754 4688999999999999999999999754431 11111110000
Q ss_pred ---cCcHHHHHHhhhhc--------CCCCCCCCHH--HHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 240 ---NDTKDFMAKLTECL--------DPNLTRYHKD--SMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 240 ---~~~~~~~~~l~~~~--------~~~~~~~~~~--~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...+.....+.... ...+...... ....+.+++.+||+.+|++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 225 TPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000000 0000111111 3566888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=272.86 Aligned_cols=245 Identities=29% Similarity=0.420 Sum_probs=194.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
....|.+.++||+|+||.||+|.+. ++.+++|.+.... ...+.+|+++++.+ |||++++.+.+.+.+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3466999999999999999999886 7889999886332 23477899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
|+||+. |++.+++. .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 93 v~e~~~-g~l~~~~~----~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 93 VMEYCL-GSASDILE----VHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EHHhhC-CCHHHHHH----HcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCccee
Confidence 999996 57777763 23356899999999999999999999999 99999999999999999999999998865
Q ss_pred ccCChhhhhhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
..... ...+++.|+|||++. ...++.++||||||+++|+|++|..||......
T Consensus 165 ~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~----------------- 220 (307)
T cd06607 165 VSPAN-------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------------- 220 (307)
T ss_pred cCCCC-------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----------------
Confidence 43221 235678999999884 356888999999999999999999998643321
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.....+.....+.. .....+..+.+++.+||+.+|.+||++.+++....
T Consensus 221 ------~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 221 ------SALYHIAQNDSPTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred ------HHHHHHhcCCCCCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00000100000111 12234567899999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=270.81 Aligned_cols=239 Identities=25% Similarity=0.329 Sum_probs=188.6
Q ss_pred eccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCCh
Q 041031 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 20 lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (313)
||+|+||.||++.+. ++.+++|.+.... ...+..|+++++.+ |||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999876 7889999886432 23356799999999 99999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhh
Q 041031 91 SDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA 170 (313)
Q Consensus 91 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 170 (313)
.+++... ....+++..++.++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+...... ..
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~----~~ 150 (277)
T cd05577 81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG----KK 150 (277)
T ss_pred HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC----Cc
Confidence 9998422 1236899999999999999999999999 999999999999999999999999988754431 11
Q ss_pred cccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhh
Q 041031 171 ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLT 250 (313)
Q Consensus 171 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
.....++..|+|||++.+..++.++|+||+|+++|+|++|+.||....... . ...+.
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~---------------~~~~~ 207 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV--------E---------------KEELK 207 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc--------c---------------HHHHH
Confidence 122356789999999988889999999999999999999999997554321 0 00010
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 041031 251 ECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAI 291 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~ 291 (313)
..............+..+.+++.+||+.+|.+|| ++.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 208 RRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred hccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1111111112223456788999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=267.69 Aligned_cols=236 Identities=25% Similarity=0.352 Sum_probs=191.8
Q ss_pred eccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCCh
Q 041031 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 20 lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (313)
||.|++|.||+|.+. ++.+++|.+.... ...+.+|+.+++.+ |||++++++.+.+.+..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999998 8899999986432 34578899999999 99999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhh
Q 041031 91 SDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA 170 (313)
Q Consensus 91 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 170 (313)
.+++. ....++...+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~~l~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~ 148 (262)
T cd05572 81 WTILR-----DRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----K 148 (262)
T ss_pred HHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----c
Confidence 99983 3455889999999999999999999999 9999999999999999999999999988665432 1
Q ss_pred cccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhh
Q 041031 171 ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLT 250 (313)
Q Consensus 171 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
.....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... . .....
T Consensus 149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~--------------~~~~~ 204 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----------P--------------MEIYN 204 (262)
T ss_pred cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----------H--------------HHHHH
Confidence 22235788999999998888999999999999999999999999765421 0 11111
Q ss_pred hhcC-CCCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 041031 251 ECLD-PNLTRYHKDSMLQMALLSKDCVDENWKRRPD-----MSNAAI 291 (313)
Q Consensus 251 ~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~ll~ 291 (313)
.... ..........+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 205 DILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1111 1111112222567899999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=288.75 Aligned_cols=250 Identities=28% Similarity=0.414 Sum_probs=210.4
Q ss_pred cCccccceeccCCeEEEEEeEEC---Cc--ceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR---GK--NAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~---~~--~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
++....++||+|.||+|++|.|+ |+ .||||+++.+. ..++.+|+.+|..+ |+|+++++++..+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 45567789999999999999998 33 58999998765 45788999999999 9999999999988 778999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
||.+++|+|.+.|.. +....+-...+-.++.||+.|++||.+++ +||+|+-.+|+++.....|||+|||+..-.
T Consensus 189 ~ELaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hhhcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceecc
Confidence 999999999999953 34567777888899999999999999999 999999999999998889999999999887
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
..+.+.............|+|||.+....++.++|+|++|+++|||+| |..||.+....
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-------------------- 322 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-------------------- 322 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------------------
Confidence 765544433334556789999999999999999999999999999999 78999887653
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
++.+++. +.........++..+++++++||+.+|++|||+..|-+.+-
T Consensus 323 ---qIL~~iD---~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 323 ---QILKNID---AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ---HHHHhcc---ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 2233222 22222357788999999999999999999999999975444
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=270.22 Aligned_cols=264 Identities=23% Similarity=0.295 Sum_probs=192.8
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
..++|.+.+.||+|+||.||+|.+. ++.+++|.+.... ...+.+|+.+++.+ |+|++++.+++......++++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999876 7899999986432 23567899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+. ++|.+.+. .....+....+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 83 e~~~-~~l~~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMI----QHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9995 67777663 22345778888899999999999999999 9999999999999999999999999887543
Q ss_pred CChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ...+..........
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-------~~~~~~~~~~~~~~ 224 (291)
T cd07870 155 IPSQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-------FEQLEKIWTVLGVP 224 (291)
T ss_pred CCCC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-------HHHHHHHHHHcCCC
Confidence 2211 1122346889999999875 45788999999999999999999999754321 01111100000000
Q ss_pred cHHHHHHhh-------hhcC----CCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 242 TKDFMAKLT-------ECLD----PNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 242 ~~~~~~~l~-------~~~~----~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
..+....+. .... ..+.. ........+.+++.+|+..||++|||+.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000 0000 00000 00112356788999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=270.03 Aligned_cols=234 Identities=24% Similarity=0.364 Sum_probs=181.6
Q ss_pred eeccCCeEEEEEeEEC--------------------------CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceee
Q 041031 19 KIGQGSYGSVYLGKLR--------------------------GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIEL 68 (313)
Q Consensus 19 ~lg~g~~g~v~~~~~~--------------------------~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~ 68 (313)
.||+|+||.||+|... ...+++|.+.... ...+.+|+.+++.+ ||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999998742 1347888886543 23466788888888 9999999
Q ss_pred eeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC
Q 041031 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF 148 (313)
Q Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~ 148 (313)
++++...+..++||||+++++|..++. .....+++..+..++.|++.||+|||+++ ++|+||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLR----KEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence 999999999999999999999999884 23456888999999999999999999999 99999999999997543
Q ss_pred -------cEEEeeccccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHH-hCCCCccCCCC
Q 041031 149 -------RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELI-TGQQALSRDAN 219 (313)
Q Consensus 149 -------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~-tg~~p~~~~~~ 219 (313)
.++++|||.+....... ...++..|+|||.+.+ ..++.++|+||||+++|+++ +|..||.....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~~-------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSRE-------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred cccCccceeeecCCcccccccccc-------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 37999999875433211 1245778999998875 56899999999999999985 68999865433
Q ss_pred CCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 220 PGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.. . ...+.. .... .......+.+++.+||+.+|.+|||+.++++.|+
T Consensus 228 ~~---------~--------------~~~~~~--~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 SE---------K--------------ERFYEK--KHRL---PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH---------H--------------HHHHHh--ccCC---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 10 0 000000 0001 1112246888999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=269.25 Aligned_cols=237 Identities=22% Similarity=0.339 Sum_probs=183.6
Q ss_pred eeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc----CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV----HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 19 ~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l----h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.||+|+||.||++.+. ++.+|+|.+.... .....+|..+++.+ ||+++.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999986 7889999886432 11233444333333 8999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++++|||++......
T Consensus 81 ~~~L~~~i~-----~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-- 150 (279)
T cd05633 81 GGDLHYHLS-----QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 150 (279)
T ss_pred CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc--
Confidence 999999883 3456899999999999999999999999 999999999999999999999999988654322
Q ss_pred hhhhcccccccccccCCcccc-CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVR-DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
......++..|+|||.+. +..++.++|+||+||++|+|++|..||....... .. .
T Consensus 151 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~--------------~- 206 (279)
T cd05633 151 ---KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------KH--------------E- 206 (279)
T ss_pred ---CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC------HH--------------H-
Confidence 112235789999999986 4568899999999999999999999997543321 00 0
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
........... .....+..+.+++.+||..||.+|| |++++++.
T Consensus 207 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 207 IDRMTLTVNVE---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHhhcCCcC---CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00000001111 2233456788999999999999999 59888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=266.64 Aligned_cols=244 Identities=28% Similarity=0.391 Sum_probs=200.0
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+|++.+.||+|++|.||++.+. +..+++|.+.... ...+.+|+.+++.+ |+||+++.+.+.+....++++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5889999999999999999876 6789999886532 33466889999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++.... .....+++..++.++.|++.|+++||+.+ ++|+||+|+||++++++.++++|||++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999885322 22356889999999999999999999999 999999999999999999999999998765543
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.. +
T Consensus 157 -----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----------------------~ 208 (256)
T cd08530 157 -----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----------------------D 208 (256)
T ss_pred -----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------------H
Confidence 111235788999999999888999999999999999999999999654321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+...+ ............+..+.+++.+||..+|.+|||+.++++
T Consensus 209 ~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 209 LRYKV---QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHH---hcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11111 112222223355677999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=263.65 Aligned_cols=242 Identities=27% Similarity=0.449 Sum_probs=199.0
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccccc-----HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS-----KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~-----~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+|++.+.||+|++|.||++.+. ++.+++|.+..... +.+.+|++++..+ |+|++++++++.+.+..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5889999999999999999886 67899999876542 4578899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++. ....+++..++.++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIK-----KFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHH-----hccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 99999999984 3367899999999999999999999999 999999999999999999999999998876543
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
.. ......++..|+|||.+.+..++.++|+|++|+++|+|++|..||...... .
T Consensus 153 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----------------------~ 206 (254)
T cd06627 153 SK---DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----------------------A 206 (254)
T ss_pred cc---cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----------------------H
Confidence 22 122345788999999998888899999999999999999999998643221 0
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...... ...........+..+.+++.+||..+|++|||+.+++.
T Consensus 207 ~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 207 ALFRIV---QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHh---ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 000011 11111122334567889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=272.01 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=201.4
Q ss_pred CccccceeccCCeEEEEEeEEC-----CcceEEEeccccc-------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK-------SKEFSSELKILCKV--HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~-------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~ 78 (313)
+|++.+.||+|++|.||++.+. ++.++||.+.... ...+.+|+.++.++ |||++++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999998753 5679999886432 23467899999999 89999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++||||+.+++|.+++. ....+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.++.++++|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLY-----QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHh-----hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccc
Confidence 99999999999999983 3456889999999999999999999999 999999999999999999999999988
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCC--CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC--VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
........ .......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||....... ...
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~---- 218 (288)
T cd05583 153 KEFLAEEE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--------SQS---- 218 (288)
T ss_pred cccccccc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--------hHH----
Confidence 76543221 1112235788999999987654 7889999999999999999999996432210 000
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccccc
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEWE 304 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 304 (313)
+........ .+ .........+.+++.+||+.+|++|||+.++.+.|....-...+|+
T Consensus 219 -------~~~~~~~~~-~~---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 219 -------EISRRILKS-KP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred -------HHHHHHHcc-CC---CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 111111111 11 1122334568889999999999999999888887776655555553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.68 Aligned_cols=257 Identities=25% Similarity=0.337 Sum_probs=191.1
Q ss_pred ccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeC--CeEEEEEe
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGG--DSLFLVYE 83 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~--~~~~lv~e 83 (313)
|++.++||+|+||.||+|.+. ++.+|+|.++... .....+|+.+++.+ |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999886 7889999887532 12234688888888 99999999999887 88999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|++ ++|.+.+. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||.+.....
T Consensus 81 ~~~-~~l~~~l~----~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIK----GRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 996 57887774 22356899999999999999999999999 999999999999999 9999999999876543
Q ss_pred ChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... .....++..|+|||++.. ..++.++|+||+||++|+|++|..||.+.+.. .............
T Consensus 152 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---------~~~~~~~~~~~~~ 218 (282)
T cd07831 152 KPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---------DQIAKIHDVLGTP 218 (282)
T ss_pred CCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---------HHHHHHHHHcCCC
Confidence 221 122346889999997654 55788999999999999999999999764431 1111111111111
Q ss_pred -HHHHHHhhhh--cC---CC-----CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 -KDFMAKLTEC--LD---PN-----LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 -~~~~~~l~~~--~~---~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+........ .. +. ........+..+.+++.+||+.+|++|||+.++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 219 DAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 1110000000 00 00 000112346789999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=270.04 Aligned_cols=260 Identities=21% Similarity=0.329 Sum_probs=194.6
Q ss_pred ccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
|++.++||.|++|.||+|.++ ++.+++|.+.... ...+.+|+++++.+ |||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678999999999999999886 8899999886432 24577899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
+ ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 4 68999884221 146899999999999999999999999 9999999999999999999999999986543221
Q ss_pred hhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc--
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT-- 242 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (313)
. ......++..|+|||++.+. .++.++|+||||+++|+|++|..||...... ..+...........
T Consensus 154 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~ 222 (283)
T cd07835 154 R---TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--------DQLFRIFRTLGTPDED 222 (283)
T ss_pred c---ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCCCChH
Confidence 1 11122457889999988764 4688999999999999999999999754331 11111111100000
Q ss_pred --------HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 --------KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 --------~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+++...................+..+.+++.+||+.+|.+|||++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 223 VWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0111111111111111122334467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=272.53 Aligned_cols=264 Identities=22% Similarity=0.315 Sum_probs=191.7
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC----
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGD---- 76 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~---- 76 (313)
...++|++.++||+|+||.||+|.+. ++.+|||.+.... .....+|+.+++.+ |||++++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34568999999999999999999986 7889999875432 22356799999999 999999999886543
Q ss_pred ----eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEE
Q 041031 77 ----SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKI 152 (313)
Q Consensus 77 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l 152 (313)
..+++|||+. ++|.+.+. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLS----NKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKL 160 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEE
Confidence 4599999995 58888774 23346899999999999999999999999 999999999999999999999
Q ss_pred eeccccccccCChhhh-hhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchh
Q 041031 153 ADFGLVKLLEHSPEIA-AAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~ 230 (313)
+|||.+.......... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~---------~ 231 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ---------H 231 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH---------H
Confidence 9999987654322111 111223467889999988764 4688999999999999999999999755431 1
Q ss_pred HHHHHHHHh--------cCcHH--HHHHhh------hhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 231 LVDYMLAVF--------NDTKD--FMAKLT------ECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 231 ~~~~~~~~~--------~~~~~--~~~~l~------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
....+.... +.... ....+. ......+ ........+.+++.+||..||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 232 QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERL--KPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhc--ccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 111111110 00000 000000 0000000 00012345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=268.31 Aligned_cols=266 Identities=29% Similarity=0.428 Sum_probs=218.2
Q ss_pred HHHhcCccccceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc---CCCceeeeeEEEeCC----eEEE
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV---HSNLIELIGYAAGGD----SLFL 80 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l---h~~i~~~~~~~~~~~----~~~l 80 (313)
+.+..+.++.+.||+|.||.||+|.|+|+.||||++...+...+.+|.+|++.. |+||+.+++.-..++ .++|
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 456788899999999999999999999999999999999999999999999998 999999999875443 5899
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-----CCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-----YTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-----~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
|++|.+.|||.|+|. ...++.+..+.++..++.+|+|||. +|++.|.|||||..||+|.++|..-|+|+
T Consensus 287 vTdYHe~GSL~DyL~------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLN------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred eeecccCCcHHHHHh------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 999999999999993 3678899999999999999999994 46777999999999999999999999999
Q ss_pred cccccccCC-hhhhhhcccccccccccCCccccCCC------CCCccchhhHHHHHHHHHh----------CCCCccCCC
Q 041031 156 GLVKLLEHS-PEIAAAASRIVGTFGYLAPEYVRDGC------VTTKSDVYAFGVVLMELIT----------GQQALSRDA 218 (313)
Q Consensus 156 g~~~~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~DiwslG~~l~~~~t----------g~~p~~~~~ 218 (313)
|+|...... +..........||.+|+|||++...- --..+||||||.++||+.- -+.||...-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999987654 44445555678999999999997432 1236899999999999875 256776554
Q ss_pred CCCCCccccchhHHHHHHHHhcCcHHHHHHh--hhhcCCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 219 NPGNNQYTEHRSLVDYMLAVFNDTKDFMAKL--TECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+.+... +.+..+ ...+.|..++ ..-+....+.++++.||..+|..|.|+--+.++|.
T Consensus 441 p~DPs~-------------------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~ 501 (513)
T KOG2052|consen 441 PSDPSF-------------------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLA 501 (513)
T ss_pred CCCCCH-------------------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence 432111 111111 1223444444 45667788999999999999999999999999999
Q ss_pred HHHh
Q 041031 295 HILI 298 (313)
Q Consensus 295 ~~~~ 298 (313)
++..
T Consensus 502 ~l~~ 505 (513)
T KOG2052|consen 502 KLSN 505 (513)
T ss_pred HHhc
Confidence 8875
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=291.30 Aligned_cols=271 Identities=17% Similarity=0.295 Sum_probs=187.3
Q ss_pred HhcCccccceeccCCeEEEEEeEEC---CcceEEE------------------ecccc--ccHHHHHHHHHHHhc-CCCc
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR---GKNAAIK------------------QMKNT--KSKEFSSELKILCKV-HSNL 65 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~aiK------------------~~~~~--~~~~~~~e~~~l~~l-h~~i 65 (313)
..++|++++.||+|+||.||++..+ +...++| .+... ....+.+|+.+++.+ ||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998764 1111211 11111 133467899999999 9999
Q ss_pred eeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC
Q 041031 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD 145 (313)
Q Consensus 66 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~ 145 (313)
+++++++.+.+..+++++++. ++|.+++...............++.++.|++.||.|||+++ |+|+||||+||+++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999984 57777764332222233456678889999999999999999 99999999999999
Q ss_pred CCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCC-ccCCCCCCCCc
Q 041031 146 SNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQA-LSRDANPGNNQ 224 (313)
Q Consensus 146 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p-~~~~~~~~~~~ 224 (313)
.++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++|..+ +......
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~---- 375 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK---- 375 (501)
T ss_pred CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC----
Confidence 999999999999876543221 112234689999999999999999999999999999999998754 4322211
Q ss_pred cccchhHHHHHHHH------hcCc-HHHHHHhhhh-cCC---CCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 225 YTEHRSLVDYMLAV------FNDT-KDFMAKLTEC-LDP---NLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 225 ~~~~~~~~~~~~~~------~~~~-~~~~~~l~~~-~~~---~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
....+...+... +++. .+....+... ... .+.. ........+.+++.+||++||.+|||+.|+++
T Consensus 376 --~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 376 --PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred --HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 011111111111 0000 0011111000 000 0000 00112345677899999999999999999986
Q ss_pred H
Q 041031 292 R 292 (313)
Q Consensus 292 ~ 292 (313)
.
T Consensus 454 h 454 (501)
T PHA03210 454 L 454 (501)
T ss_pred C
Confidence 4
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=277.76 Aligned_cols=269 Identities=23% Similarity=0.355 Sum_probs=196.3
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeC-----Ce
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGG-----DS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~-----~~ 77 (313)
..++|++.++||+|++|.||+|.+. ++.||+|.+.... ...+.+|+.+++.+ |+|++++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999886 7889999986432 33466799999999 99999999886543 35
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.++++|++. ++|.+.+. ...+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++++|||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~------~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 83 VYIVQELME-TDLYKLIK------TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEEehhcc-cCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccc
Confidence 899999995 58887763 346899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
+.................+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+.. .....+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---------~~~~~~~ 223 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---------HQLNLIL 223 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHH
Confidence 8765432221112223457889999998754 56889999999999999999999999654321 0001111
Q ss_pred HHhcC-cH-HHHHHhh-------hhcCCCCCC----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHHH
Q 041031 237 AVFND-TK-DFMAKLT-------ECLDPNLTR----YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR--LSHIL 297 (313)
Q Consensus 237 ~~~~~-~~-~~~~~l~-------~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~--l~~~~ 297 (313)
..... .. +...... ......... .....+..+.+++.+||+.+|++|||+.++++. +....
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 10100 00 0000000 000000000 011234568899999999999999999999986 54443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=292.48 Aligned_cols=257 Identities=29% Similarity=0.492 Sum_probs=216.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC--C---cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--G---KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~---~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
.+...|.++||.|.||.|++|+.+ + ..||||.++... ..++..|+.||-++ ||||+++.++....+.+.+
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 345678899999999999999987 3 468999998654 44578899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
|+||++.|+|+.||. .+.+.++..++..+++.|+.+++||.+.+ +||+||..+||||+.+..+|++|||++..
T Consensus 708 iTEyMENGsLDsFLR----~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLR----QNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred EhhhhhCCcHHHHHh----hcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999995 45567999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
..+++........=.-+.+|.|||++...+++.+|||||+|+++||.++ |..||-...+.
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ------------------- 841 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------------------- 841 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-------------------
Confidence 8766532222221123578999999999999999999999999999887 89998655542
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+..+.+.. ...| ..+.+++..|.+|+..||++|-..||.+.+|+..|+++.-+.
T Consensus 842 ----dVIkaIe~--gyRL-PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 842 ----DVIKAIEQ--GYRL-PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ----HHHHHHHh--ccCC-CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 22222221 1222 257889999999999999999999999999999999987653
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=284.77 Aligned_cols=239 Identities=24% Similarity=0.404 Sum_probs=198.3
Q ss_pred eeccCCeEEEEEeEEC--CcceEEEeccccccH---HHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCChhh
Q 041031 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK---EFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSD 92 (313)
Q Consensus 19 ~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~---~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (313)
+||+|.+|+||.|++. ..+.|||.+.....+ -+++|+.+-+++ |.|||+++|.+..+..+-++||..+||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999998 445799998765433 377899999999 9999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCc--cHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC-CCCcEEEeeccccccccCChhhhh
Q 041031 93 HLHWPSVKGKKPL--AWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD-SNFRAKIADFGLVKLLEHSPEIAA 169 (313)
Q Consensus 93 ~l~~~~~~~~~~l--~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~ 169 (313)
++. ..=+++ .+.++--+.+||+++|.|||++. |||+|||-+|++|+ -.|.+||+|||-+.....-. .
T Consensus 662 LLr----skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin---P 731 (1226)
T KOG4279|consen 662 LLR----SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN---P 731 (1226)
T ss_pred HHH----hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC---c
Confidence 995 334556 78888899999999999999999 99999999999996 57899999999988765432 2
Q ss_pred hcccccccccccCCccccCC--CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 170 AASRIVGTFGYLAPEYVRDG--CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 170 ~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
-...+.||.-|+|||++..+ .|+.++|||||||++-||.||++||.....+. ..
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------------------------AA 787 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------------------------AA 787 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------------------------Hh
Confidence 34456899999999999754 58999999999999999999999998666531 11
Q ss_pred HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
......-..-+..+...+.+...+|.+|+..||.+||+++++|+
T Consensus 788 MFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 788 MFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred hhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 22222222223356677888899999999999999999999985
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=269.55 Aligned_cols=248 Identities=28% Similarity=0.414 Sum_probs=195.9
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
..|...+.||+|+||.||+|.+. +..+++|.+.... ...+.+|+++++.+ |||++++++++.+.+..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 45889999999999999999986 7789999886432 23477899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+. |+|.+.+. .....+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++++|||++....
T Consensus 105 e~~~-g~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 105 EYCL-GSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred eCCC-CCHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 9996 47777764 23456889999999999999999999999 9999999999999999999999999876543
Q ss_pred CChhhhhhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
.. ....+++.|+|||.+. ...++.++|+||+|+++|+|++|..||......
T Consensus 177 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------------------- 230 (317)
T cd06635 177 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------------- 230 (317)
T ss_pred Cc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-------------------
Confidence 21 1235788899999974 456889999999999999999999998643221
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
.....+.....+ .......+..+.+++.+||+.+|.+||++.++++.+..+...
T Consensus 231 ----~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 231 ----SALYHIAQNESP--TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred ----HHHHHHHhccCC--CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 000111100001 111223445688999999999999999999999876654443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=257.66 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=199.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~ 82 (313)
..+.+++..||.|.-|.||+++.. |...|||.+.... ..++...+.++... +|+||+++++|..+..+++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 345677889999999999999998 5788999997654 33355666666665 699999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|.+ ...++.++. .-.+++++..+-.+...++.||.||..++. |+|+|+||+|||+++.|++||+|||++-+..
T Consensus 171 elM-s~C~ekLlk----rik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 171 ELM-STCAEKLLK----RIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHH-HHHHHHHHH----HhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceee
Confidence 998 445555653 345679999999999999999999998864 9999999999999999999999999988776
Q ss_pred CChhhhhhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
++. ..+...|-+.|+|||.+. ...|+.++||||||++++|+.||+.||.+.+..-
T Consensus 244 dSk----AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF------------------ 301 (391)
T KOG0983|consen 244 DSK----AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF------------------ 301 (391)
T ss_pred ccc----ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH------------------
Confidence 543 333456889999999985 4679999999999999999999999998876531
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+....-+.+. .....+..+.+++..||..|+.+||...++++.
T Consensus 302 ----e~ltkvln~ePP~L~-~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 302 ----EVLTKVLNEEPPLLP-GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ----HHHHHHHhcCCCCCC-cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 334444432223332 233377888999999999999999999999864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=267.06 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=193.7
Q ss_pred ccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeC--CeEEEEEe
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGG--DSLFLVYE 83 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~--~~~~lv~e 83 (313)
|++.+.||.|++|.||+|.+. ++.+++|.+.... ...+.+|+.+++.+ |||++++++++.+. ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678999999999999999987 6889999997652 34577899999999 99999999999888 88999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|++ ++|.+++. .....+++..++.++.|++.|+++||+.+ ++|+||+|+||++++++.++++|||.+.....
T Consensus 81 ~~~-~~l~~~~~----~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLD----SPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHh----ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 996 58888874 22357899999999999999999999999 99999999999999999999999999886654
Q ss_pred ChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||....... ....+.+.........
T Consensus 153 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~ 225 (287)
T cd07840 153 RNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-----QLEKIFELCGSPTDEN 225 (287)
T ss_pred CCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCchhh
Confidence 321 11122345788999998765 457899999999999999999999996544310 0000000000000000
Q ss_pred -HHHHHH-----h--hhhcCCCCCCCCHH-HHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 -KDFMAK-----L--TECLDPNLTRYHKD-SMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 -~~~~~~-----l--~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...... . .......+...... .+..+.+++++||+.+|.+||+++++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000 0 00000000000011 25678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=268.49 Aligned_cols=242 Identities=24% Similarity=0.400 Sum_probs=193.6
Q ss_pred cccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCC
Q 041031 15 STSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 15 ~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (313)
....+||+|+||.||++... ++.+++|.+.... ...+.+|+.+++.+ |+|++++++.+...+..+++|||++++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 34568999999999999886 7889999876433 33477899999999 999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhh
Q 041031 89 ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIA 168 (313)
Q Consensus 89 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (313)
+|.+++. ...+++..++.++.|++.+++|||+.+ ++|+||+|+||++++++.++++|||.+.......
T Consensus 103 ~L~~~~~------~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--- 170 (292)
T cd06657 103 ALTDIVT------HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--- 170 (292)
T ss_pred cHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc---
Confidence 9999873 235788899999999999999999999 9999999999999999999999999876544321
Q ss_pred hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHH
Q 041031 169 AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAK 248 (313)
Q Consensus 169 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
.......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... +....
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-----------------------~~~~~ 227 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----------------------KAMKM 227 (292)
T ss_pred ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------------HHHHH
Confidence 1122235788999999998888899999999999999999999999653321 11111
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 249 LTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+...+...... ....+..+.+++.+||+.+|.+||++.++++.
T Consensus 228 ~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 228 IRDNLPPKLKN-LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHhhCCcccCC-cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 22222222111 11234568889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=266.31 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=195.3
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
+|++.+.||.|++|.||+|.+. +..++||.++... ...+.+|+.+++.+ |||++++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5899999999999999999986 7889999887542 34567899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
. ++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++++|||++.......
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 81 D-KDLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred C-ccHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 7 48888874322 1346899999999999999999999999 9999999999999999999999999886543221
Q ss_pred hhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. ......++..|+|||++.+ ..++.++|+||||+++|+|++|..||.+.... ...............+
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 223 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--------DQLLKIFRIMGTPTES 223 (284)
T ss_pred c---ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--------HHHHHHHHHhCCCChh
Confidence 1 1112345788999999865 45788999999999999999999999765432 1111111111000001
Q ss_pred HHHHhhh--hcCCCCCC--------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 245 FMAKLTE--CLDPNLTR--------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 245 ~~~~l~~--~~~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
....+.. ........ .....+..+.+++.+||+.||.+||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111100 00000000 11123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=267.61 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=192.5
Q ss_pred CccccceeccCCeEEEEEeEE-----CCcceEEEeccccc-------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKL-----RGKNAAIKQMKNTK-------SKEFSSELKILCKV--HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~-----~~~~~aiK~~~~~~-------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~ 78 (313)
+|++.+.||.|+||.||++++ .+..+|+|.+.... .+.+.+|+.+++.+ |+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 588999999999999999987 36789999986532 24567899999999 89999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++++||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLS-----QRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccc
Confidence 99999999999999984 3456888999999999999999999999 999999999999999999999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccC--CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRD--GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...... ......
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~~~-- 220 (290)
T cd05613 153 KEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--------NSQAEI-- 220 (290)
T ss_pred eecccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--------ccHHHH--
Confidence 76543211 11123457889999999875 34678999999999999999999999643221 011111
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
...+... .+ .........+.+++.+||+.+|.+|| ++.++++.
T Consensus 221 ---------~~~~~~~-~~---~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 221 ---------SRRILKS-EP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---------HHHhhcc-CC---CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1111000 01 11223445788899999999999997 66777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=275.42 Aligned_cols=268 Identities=24% Similarity=0.353 Sum_probs=198.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEE----eCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAA----GGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~----~~~~ 77 (313)
+.++|++.+.||.|++|.||+|.+. ++.|++|.+.... ...+.+|+.+++.+ ||||+++++++. ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 3489999999999999999999876 8899999886532 34567899999999 999999999875 3356
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.++|+||+. ++|.+++. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.
T Consensus 83 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 83 VYVVMDLME-SDLHHIIH-----SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred EEEEEehhh-hhHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccc
Confidence 899999995 68998883 3456899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhh-hhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 158 VKLLEHSPEIA-AAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 158 ~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
+.......... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+... .+ ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--------~~-~~~ 224 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--------QL-KLI 224 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--------HH-HHH
Confidence 87654322111 11123467889999999865 558899999999999999999999997644311 00 000
Q ss_pred HHHhcC-cHHHH-----HHhhhhcCCC-------CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 236 LAVFND-TKDFM-----AKLTECLDPN-------LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 236 ~~~~~~-~~~~~-----~~l~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
...... ..+.. ..+....+.. +.......+..+.+++.+||+.+|.+|||+.+++..-+-
T Consensus 225 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 225 LSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred HHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 000000 00000 0000000000 000112345678999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=268.54 Aligned_cols=266 Identities=24% Similarity=0.340 Sum_probs=195.2
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC---
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGD--- 76 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~--- 76 (313)
+...++|++.+.||.|+||.||+|.++ ++.+++|.++... ...+.+|+++++.+ |||++++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456789999999999999999999987 7889999986432 23467899999999 999999999987654
Q ss_pred -------eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc
Q 041031 77 -------SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR 149 (313)
Q Consensus 77 -------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~ 149 (313)
.+++++||+++ ++...+. .....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLE----SGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCc
Confidence 78999999965 7777764 23456899999999999999999999999 999999999999999999
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccc
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~ 228 (313)
++|+|||.+........ ........+..|+|||.+.+ ..++.++|||||||++|+|++|+.||......
T Consensus 155 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-------- 224 (302)
T cd07864 155 IKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-------- 224 (302)
T ss_pred EEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--------
Confidence 99999999876543321 11112235778999998864 45788999999999999999999999643321
Q ss_pred hhHHHHHHHHhcCcHHH---HHHhhh--hcCC------CCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 229 RSLVDYMLAVFNDTKDF---MAKLTE--CLDP------NLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~---~~~l~~--~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
..+.............. ...... ..+. .........+..+.+++.+||+.+|.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 225 AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111111100000000 000000 0000 000011123567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=274.47 Aligned_cols=268 Identities=24% Similarity=0.355 Sum_probs=201.2
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC-----eEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGD-----SLF 79 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~-----~~~ 79 (313)
+|++.+.||.|++|.||+|.+. ++.++||.+.... ...+.+|+.+++.+ |+||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999986 7889999886532 34578899999999 999999999987765 789
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
++|+|++ ++|.+++. ....+++..++.++.+++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 81 lv~e~~~-~~l~~~l~-----~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIK-----SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999996 58888884 3347999999999999999999999999 9999999999999999999999999988
Q ss_pred cccCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
................++..|+|||++.+. .++.++|+||||+++|+|++|..||.+..... .. ..+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--------~~-~~i~~~ 222 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--------QL-NLIVEV 222 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--------HH-HHHHHh
Confidence 765432111112233568889999999887 78999999999999999999999997654310 00 000000
Q ss_pred hcC----------cHHHHHHhhhhc---CCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHHHh
Q 041031 239 FND----------TKDFMAKLTECL---DPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR--LSHILI 298 (313)
Q Consensus 239 ~~~----------~~~~~~~l~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~--l~~~~~ 298 (313)
... .......+.... ...+.......+..+.+++.+||+.+|.+|||+.+++.. +.++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000 000000011000 000011122245678899999999999999999999975 444443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=266.92 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=196.7
Q ss_pred ccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
|++.+.||.|++|.||+|.+. ++.+++|.+.... ...+.+|+.+++.+ |+|++++++.+.+.+..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 678899999999999999986 7889999886543 34577899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++ +|.+++. .....+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~~-~l~~~l~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIK----DRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHH----hhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 65 8888874 23357899999999999999999999999 9999999999999999999999999987665432
Q ss_pred hhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....... .+.............
T Consensus 153 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 221 (283)
T cd05118 153 R---PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--------QLFKIFRTLGTPDPE 221 (283)
T ss_pred c---cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHcCCCchH
Confidence 1 11223467889999998876 78999999999999999999999997654321 000000000000000
Q ss_pred HHHHhhh-----------hcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 245 FMAKLTE-----------CLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 245 ~~~~l~~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
....+.. .............+..+.+++.+||+.||.+||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000 0000011122345678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=269.17 Aligned_cols=268 Identities=22% Similarity=0.294 Sum_probs=201.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc---CCC----ceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV---HSN----LIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l---h~~----i~~~~~~~~~~~~~~ 79 (313)
..+|.++.++|+|.||.|-.+.+. +..||||+++... .+...-|++++.++ .|+ ++.+.++|...++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 678999999999999999999888 6789999998664 33456689999999 333 788889999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-------------
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS------------- 146 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~------------- 146 (313)
+|+|.+ |.|+.+++. ..+..+++...++.++.|+++++++||+.+ ++|.|+||+||++.+
T Consensus 168 ivfell-G~S~~dFlk---~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLK---ENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred EEEecc-ChhHHHHhc---cCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 999999 779999995 234567899999999999999999999999 999999999999821
Q ss_pred -------CCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCC
Q 041031 147 -------NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDAN 219 (313)
Q Consensus 147 -------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~ 219 (313)
+..|+++|||.+...... .+....|..|+|||++.+-+++.++||||+||+|+|+.||...|...++
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 345899999999865532 2445789999999999999999999999999999999999999988875
Q ss_pred CCCCccccchhHHHHHHHHhcCcH---HHH------------HHhhhhcCCCCC-----CCCHHHHHHHHHHHhhccccC
Q 041031 220 PGNNQYTEHRSLVDYMLAVFNDTK---DFM------------AKLTECLDPNLT-----RYHKDSMLQMALLSKDCVDEN 279 (313)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~------------~~l~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~ 279 (313)
.....+.+ +.+..++........ -+. .......++... ........+|++|+++||.+|
T Consensus 315 ~EHLaMMe-rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 315 LEHLAMME-RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred HHHHHHHH-HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 42111111 111111111110000 000 000000110000 023345577999999999999
Q ss_pred cCCCCCHHHHHHH
Q 041031 280 WKRRPDMSNAAIR 292 (313)
Q Consensus 280 p~~Rps~~~ll~~ 292 (313)
|.+|+|+.|++..
T Consensus 394 P~~RiTl~EAL~H 406 (415)
T KOG0671|consen 394 PARRITLREALSH 406 (415)
T ss_pred ccccccHHHHhcC
Confidence 9999999999853
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=259.90 Aligned_cols=280 Identities=26% Similarity=0.355 Sum_probs=209.1
Q ss_pred HhcCccccceeccCCeEEEEEeEEC------CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEe-CC
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR------GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAG-GD 76 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~-~~ 76 (313)
...+|+++.+||+|.+|.||+|.-+ ...+|||.++..+ ....-+|+.+++.+ |||++.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3468999999999999999999544 2368999998663 33467899999999 9999999999876 88
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC----CcEEE
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN----FRAKI 152 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~----~~~~l 152 (313)
.+++++||.+. +|++.+...+......++...+..++.||+.++.|||++- |+|+|+||.||++..+ |+|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 99999999965 8999998877777789999999999999999999999999 9999999999999876 99999
Q ss_pred eeccccccccCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhH
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~ 231 (313)
+|+|++..+.+.-...........|.+|+|||.+.|. .|+.+.|||++||++.||+|-.+.|.+.........+-..+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999999877543322344456789999999999874 589999999999999999999999877655433322222222
Q ss_pred HHHHHHHh----cC-cHHHH------HHhhhh----cCCC-CCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 232 VDYMLAVF----ND-TKDFM------AKLTEC----LDPN-LTR---YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 232 ~~~~~~~~----~~-~~~~~------~~l~~~----~~~~-~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+.+-.+. .. ++++. ..+... .+.. +.. .....+..-.+|+.++|.+||-+|.|+++.++.
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 22222221 11 11111 111110 0110 000 001112236789999999999999999999875
Q ss_pred H
Q 041031 293 L 293 (313)
Q Consensus 293 l 293 (313)
.
T Consensus 338 ~ 338 (438)
T KOG0666|consen 338 P 338 (438)
T ss_pred c
Confidence 3
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=273.69 Aligned_cols=266 Identities=23% Similarity=0.355 Sum_probs=197.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeC-----C
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGG-----D 76 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~-----~ 76 (313)
+..+|.+.+.||.|+||.||+|.+. ++.|+||.+... ....+.+|+.+++.+ |+|++++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3468999999999999999999986 788999988642 233567899999999 99999999987644 3
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
..++++||+. ++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIR-----SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred cEEEEEeCCC-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCc
Confidence 5899999995 68988883 4467999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
++....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.... .....+
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~~~~~ 221 (337)
T cd07858 154 LARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---------HQLKLI 221 (337)
T ss_pred cccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---------HHHHHH
Confidence 987654322 11122356889999998865 46899999999999999999999999654321 001111
Q ss_pred HHHhcC----------cHH---HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHH
Q 041031 236 LAVFND----------TKD---FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR--LSHI 296 (313)
Q Consensus 236 ~~~~~~----------~~~---~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~--l~~~ 296 (313)
...... ... ....+...............+..+.+++++||+.+|++|||++++++. +..+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 222 TELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 110000 000 001111011111111122345678899999999999999999999977 5444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=257.97 Aligned_cols=253 Identities=18% Similarity=0.251 Sum_probs=202.5
Q ss_pred HHhcCccc-cceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEE----eCCeEE
Q 041031 9 DATSNFST-SLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAA----GGDSLF 79 (313)
Q Consensus 9 ~~~~~y~~-~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~----~~~~~~ 79 (313)
.++++|++ -++||-|-.|.|-.+.++ ++++|+|++.... ...+|+++--.. |||||.+++++. +...+.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 36778888 578999999999999887 8899999987664 344555543333 999999999975 456789
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcEEEeecc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFG 156 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg 156 (313)
+|||.++||.|.+.+..+ ....+++.++.++++||+.|+.|||+.+ |.|+||||+|+|.+. +..+||+|||
T Consensus 136 iVmE~meGGeLfsriq~~---g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDR---GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeeecccchHHHHHHHHc---ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 999999999999998532 3467999999999999999999999999 999999999999964 4568999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
.+......... .....|+.|.|||++..++|+...|+||+|+++|-|+.|.+||.+.....
T Consensus 210 FAK~t~~~~~L----~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--------------- 270 (400)
T KOG0604|consen 210 FAKETQEPGDL----MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--------------- 270 (400)
T ss_pred cccccCCCccc----cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---------------
Confidence 99976654332 23467999999999999999999999999999999999999998765521
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
..+....++...-......-....+....++|+.+|+.+|.+|.|++++++.
T Consensus 271 ----ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 271 ----ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ----CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1223333333322222222455667788899999999999999999999864
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=265.99 Aligned_cols=263 Identities=21% Similarity=0.327 Sum_probs=192.0
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
++|++.+.||.|++|.||+|.++ ++.+++|.+.... ...+.+|+++++.+ |||++++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 67999999999999999999987 7789999886432 24577899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-CCcEEEeecccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLLE 162 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~ 162 (313)
|++ ++|.+.+... .....++..++.++.|++.||+|||+++ ++|+||+|+||+++. ++.++++|||++....
T Consensus 82 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 995 5787777321 2234678888999999999999999999 999999999999985 5679999999987543
Q ss_pred CChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH---
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV--- 238 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 238 (313)
... .......+++.|+|||++.+ ..++.++|+||+|+++|+|+||..||...... ..+.......
T Consensus 155 ~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--------~~~~~~~~~~~~~ 223 (294)
T PLN00009 155 IPV---RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--------DELFKIFRILGTP 223 (294)
T ss_pred CCc---cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCCC
Confidence 221 11122346789999998876 45788999999999999999999999754321 0111100000
Q ss_pred ----hcCc---HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 239 ----FNDT---KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 239 ----~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+... .+....................+..+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 224 NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00000000000000000112334568889999999999999999999863
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=263.62 Aligned_cols=237 Identities=22% Similarity=0.306 Sum_probs=183.7
Q ss_pred eeccCCeEEEEEeEEC--CcceEEEecccccc------HHHHHHHHH---HHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS------KEFSSELKI---LCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 19 ~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~------~~~~~e~~~---l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.||+|+||.||+|.+. ++.||+|.+..... .....|..+ ++.. ||+++.+++.+...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999876 78899998865321 112333333 3334 8999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++. ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++++|||++......
T Consensus 81 g~~L~~~l~-----~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-- 150 (278)
T cd05606 81 GGDLHYHLS-----QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 150 (278)
T ss_pred CCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--
Confidence 999999883 3457899999999999999999999999 999999999999999999999999988754322
Q ss_pred hhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
......++..|+|||++.+. .++.++|+||+|+++|+|++|..||....... .. ..
T Consensus 151 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~---------~~-----------~~ 207 (278)
T cd05606 151 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---------KH-----------EI 207 (278)
T ss_pred ---CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc---------hH-----------HH
Confidence 11223578999999999754 68999999999999999999999997553221 00 00
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
.... ...... .....+..+.+++++||..+|.+|| ++.++++.
T Consensus 208 ~~~~-~~~~~~---~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 208 DRMT-LTMAVE---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHh-hccCCC---CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0000 001111 1222356788999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=267.64 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=193.2
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv 81 (313)
..++|++.+.||+|++|.||+|.+. ++.+|||.++... ...+..|+.++... |||++++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 4578999999999999999999998 8889999987542 22345566655555 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||++ ++++.+++. .....+++..+..++.|++.+++|||+ .+ ++|+||+|+||++++++.++|+|||.+..
T Consensus 93 ~e~~-~~~l~~l~~----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 93 MELM-STCLDKLLK----RIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred eecc-CcCHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9998 457777764 223478899999999999999999997 58 99999999999999999999999999875
Q ss_pred ccCChhhhhhcccccccccccCCccccCCC----CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGC----VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
...... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...... .
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------~---- 225 (296)
T cd06618 165 LVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----------F---- 225 (296)
T ss_pred ccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----------H----
Confidence 443211 12234678899999997553 788999999999999999999999542210 0
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
+ .+...+...... ........+.+|+.+||..||.+||++.++++.-.-..
T Consensus 226 -------~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 226 -------E---VLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred -------H---HHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0 011111111111 11134567899999999999999999999997765333
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.93 Aligned_cols=245 Identities=26% Similarity=0.396 Sum_probs=198.6
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv 81 (313)
++|.+.+.||+|++|.||+|.+. +..+++|++.... ...+.+|..+++.+ ||||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999986 7889999986532 34577889999998 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
||++.+++|.+++. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++++|||.+...
T Consensus 81 ~e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIR-----KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 99999999999984 3447999999999999999999999999 999999999999999999999999998765
Q ss_pred cCChhh-----------------hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCc
Q 041031 162 EHSPEI-----------------AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQ 224 (313)
Q Consensus 162 ~~~~~~-----------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~ 224 (313)
...... ........++..|+|||++.+..++.++|+||||++++++++|..||......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---- 228 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---- 228 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH----
Confidence 543210 01222345678999999998888999999999999999999999999755421
Q ss_pred cccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH----HHHHH
Q 041031 225 YTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM----SNAAI 291 (313)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~----~~ll~ 291 (313)
........ ... ......+..+.+++.+||+.+|.+|||+ +++++
T Consensus 229 -------------------~~~~~~~~-~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 -------------------LTFQKILK-LEY---SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -------------------HHHHHHHh-cCC---CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00011110 011 1122335678899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=281.97 Aligned_cols=245 Identities=20% Similarity=0.318 Sum_probs=202.1
Q ss_pred hcCccccceeccCCeEEEEEeEECC--cceEEEecccc---ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRG--KNAAIKQMKNT---KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~--~~~aiK~~~~~---~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.+-|.|+..||.|.||.||+|..+. -..|-|.+... ..+++.-|++||..+ ||+|+++++.|...+.++++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3558899999999999999998883 33466766544 355677899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
|+||.++..+. .-+..+++.++..+..|++.||.|||+++ |+|+|+|..|||++-+|.|+|+|||.+.....
T Consensus 111 C~GGAVDaiml----EL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~- 182 (1187)
T KOG0579|consen 111 CGGGAVDAIML----ELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS- 182 (1187)
T ss_pred cCCchHhHHHH----HhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-
Confidence 99999998874 44567999999999999999999999999 99999999999999999999999998765332
Q ss_pred hhhhhhcccccccccccCCccccC-----CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRD-----GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
.......+.|||.|+|||+..+ .+|+.++||||||++|.+|..+.+|-...++
T Consensus 183 --t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------------------- 240 (1187)
T KOG0579|consen 183 --TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------------------- 240 (1187)
T ss_pred --HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------------------
Confidence 2345566899999999999864 5789999999999999999999998754333
Q ss_pred cCcHHHHHHhhhhcCCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+..+...-....+. -+...+..+.++++.||..||..||++.+|++
T Consensus 241 ------MRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 241 ------MRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------HHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 22222222222222 34556677889999999999999999999984
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=268.08 Aligned_cols=257 Identities=19% Similarity=0.228 Sum_probs=182.1
Q ss_pred HHhcCccccceeccCCeEEEEEeEECCc-----ceEEEeccccccHH--------------HHHHHHHHHhc-CCCceee
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLRGK-----NAAIKQMKNTKSKE--------------FSSELKILCKV-HSNLIEL 68 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~aiK~~~~~~~~~--------------~~~e~~~l~~l-h~~i~~~ 68 (313)
....+|.+.++||+|+||.||+|.+.+. .+++|......... ...+...+..+ |++++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3457899999999999999999987633 55666543222110 01122233344 9999999
Q ss_pred eeEEEeCC----eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee
Q 041031 69 IGYAAGGD----SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL 144 (313)
Q Consensus 69 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 144 (313)
++...... ..+++++++ ..++.+.+. .....++..+..++.|++.||+|||+.+ ++|+||||+||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill 159 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFK-----RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMV 159 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHH-----hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 98765443 346777776 446776663 2233567788999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccccccccCChhhh----hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCC
Q 041031 145 DSNFRAKIADFGLVKLLEHSPEIA----AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANP 220 (313)
Q Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~ 220 (313)
+.++.++|+|||++.......... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 999999999999987654322111 1112246899999999999999999999999999999999999999765332
Q ss_pred CCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 221 GNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
. . ..... ..++...+. ..... ....+..+.++++.|++.+|.+||++.+|.+.+
T Consensus 240 ~--------~---~~~~~---~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 240 G--------N---LIHAA---KCDFIKRLH---EGKIK--IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred h--------H---HHHHh---HHHHHHHhh---hhhhc--cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1 0 00000 001111111 11111 112346788999999999999999999999876
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=265.38 Aligned_cols=239 Identities=29% Similarity=0.428 Sum_probs=189.7
Q ss_pred ccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
|...+.||+|+||.||+|.+. ++.+++|.+.... ...+.+|+++++.+ |||++++++++.+.+..+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 777888999999999999876 7889999886432 23567899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+. +++.+++. .....+++..++.++.|++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 103 ~~-~~l~~~l~----~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 95 57777764 23456889999999999999999999999 99999999999999999999999998764322
Q ss_pred hhhhhhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.....++..|+|||++. ...++.++|+||||+++|+|++|..||......
T Consensus 174 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--------------------- 226 (313)
T cd06633 174 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------------------- 226 (313)
T ss_pred ------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------------------
Confidence 12245788999999984 456788999999999999999999998654321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.....+.....+.. .....+..+.+++.+||+.+|.+||++.+++..
T Consensus 227 --~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 227 --SALYHIAQNDSPTL--QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --HHHHHHHhcCCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111111001111 122234568889999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=260.37 Aligned_cols=259 Identities=27% Similarity=0.374 Sum_probs=211.8
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
..+++|..+++||+|.||.|-+++-+ ++.+|+|++++.- ......|-++|+.. ||.+..+.-.|+..+++|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 45788999999999999999999887 8899999998642 33345688889988 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+||||.+||.|.-.| ++...+++...+-+-..|+.||.|||+++ ||++|+|.+|++++.+|++|+.|||++.
T Consensus 245 FVMeyanGGeLf~HL-----srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 245 FVMEYANGGELFFHL-----SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEEccCceEeeeh-----hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccch
Confidence 999999999999888 45677999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
.--..+ .....++|||.|+|||++....|+...|.|.+|+++|||++|+.||...+.. .+++.+...
T Consensus 317 E~I~~g---~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---------kLFeLIl~e- 383 (516)
T KOG0690|consen 317 EEIKYG---DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---------KLFELILME- 383 (516)
T ss_pred hccccc---ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---------HHHHHHHhh-
Confidence 533222 3455679999999999999999999999999999999999999999765442 222222211
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC--CHHHHHHHHHHHHhccccccc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP--DMSNAAIRLSHILISSKEWEK 305 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp--s~~~ll~~l~~~~~~~~~~~~ 305 (313)
+- .++...+.+...|+...|..||.+|. ...++.+....-.-.+-.|++
T Consensus 384 --------------d~---kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~ 434 (516)
T KOG0690|consen 384 --------------DL---KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA 434 (516)
T ss_pred --------------hc---cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence 11 12344455677799999999999997 456666655555555555644
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=270.54 Aligned_cols=266 Identities=24% Similarity=0.317 Sum_probs=194.2
Q ss_pred HhcCccc-cceeccCCeEEEEEeEEC--CcceEEEeccccccH-----------------HHHHHHHHHHhc-CCCceee
Q 041031 10 ATSNFST-SLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK-----------------EFSSELKILCKV-HSNLIEL 68 (313)
Q Consensus 10 ~~~~y~~-~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~-----------------~~~~e~~~l~~l-h~~i~~~ 68 (313)
+.++|.. .+.||.|+||.||+|.+. ++.+|||.+...... .+.+|+++++.+ |+|++++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4567765 577999999999999876 788999988654221 367899999999 9999999
Q ss_pred eeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC
Q 041031 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF 148 (313)
Q Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~ 148 (313)
++++...+..+++||++. ++|.+++. ....+++..+..++.|++.||++||+.+ ++|+||+|+||+++.++
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~-----~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~ 156 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVD-----RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKG 156 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCC
Confidence 999999999999999996 68999883 3456899999999999999999999999 99999999999999999
Q ss_pred cEEEeeccccccccCChh-----------hhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccC
Q 041031 149 RAKIADFGLVKLLEHSPE-----------IAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSR 216 (313)
Q Consensus 149 ~~~l~dfg~~~~~~~~~~-----------~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~ 216 (313)
.++++|||.+........ .........++..|+|||.+.+. .++.++|+||||+++|+|++|..||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999998876541110 00111122457789999998764 468999999999999999999999976
Q ss_pred CCCCCCCccccchhHHHHHHHHhcCcH-HHHH--Hhh------hhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHH
Q 041031 217 DANPGNNQYTEHRSLVDYMLAVFNDTK-DFMA--KLT------ECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS 287 (313)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~l~------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 287 (313)
..... .+............ .+.. .+. .................+.+++.+||+.+|++|||+.
T Consensus 237 ~~~~~--------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 308 (335)
T PTZ00024 237 ENEID--------QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308 (335)
T ss_pred CCHHH--------HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence 54320 11111000000000 0000 000 0000000001122345688999999999999999999
Q ss_pred HHHHH
Q 041031 288 NAAIR 292 (313)
Q Consensus 288 ~ll~~ 292 (313)
+++..
T Consensus 309 ~~l~~ 313 (335)
T PTZ00024 309 EALKH 313 (335)
T ss_pred HHhcC
Confidence 99964
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=265.45 Aligned_cols=259 Identities=23% Similarity=0.340 Sum_probs=191.6
Q ss_pred ccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc----CCCceeeeeEEEeCCe-----
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV----HSNLIELIGYAAGGDS----- 77 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l----h~~i~~~~~~~~~~~~----- 77 (313)
|++.+.||.|+||.||+|+++ ++.+|+|.+.... ...+.+|+.+++.+ |||++++++.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678999999999999999987 7889999987432 22355677777665 9999999999987776
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.+++||+++ ++|.+++... ....+++..++.++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCc
Confidence 999999996 4888887422 1235899999999999999999999999 99999999999999999999999998
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+........ .....++..|+|||++.+..++.++|+||+|+++|+|++|..||...... ..+..+...
T Consensus 154 ~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--------~~~~~~~~~ 221 (287)
T cd07838 154 ARIYSFEMA----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--------DQLDKIFDV 221 (287)
T ss_pred ceeccCCcc----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--------HHHHHHHHH
Confidence 876543211 12234678899999999888999999999999999999999998754331 111111111
Q ss_pred HhcCc-HHHH-------HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 238 VFNDT-KDFM-------AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 238 ~~~~~-~~~~-------~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
..... ..+. .....................+.+++.+||+.||.+||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 222 IGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 0000 000000000011112234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=274.82 Aligned_cols=260 Identities=29% Similarity=0.437 Sum_probs=210.7
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEECC-cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLRG-KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
-+-..+...+.++||+|-||.|.+++..+ ..||||.+++++ ..++.+|+++|.++ ||||+.++++|..++.+++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 34456778899999999999999999995 899999999876 34578999999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
++||++.|+|.+++..... ....-.....++.||+.+++||.+.+ +||+||.++|+|++.++++|++|||.+.-
T Consensus 613 I~EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence 9999999999999953321 11344556679999999999999999 99999999999999999999999999986
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh--CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT--GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
..+.+.. ..-....-+.+|+|||.+..++++.+||+|++|+++||+++ ...||....++
T Consensus 687 lysg~yy-~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e------------------ 747 (807)
T KOG1094|consen 687 LYSGDYY-RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE------------------ 747 (807)
T ss_pred cccCCce-eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH------------------
Confidence 5543322 12223455789999999999999999999999999999865 77888655442
Q ss_pred hcCcHHHHHHhhhhcCCC----CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPN----LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
+......+.++.. +...+.-++..+++++..||..+.++|||++++-..|.+.
T Consensus 748 -----~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 748 -----QVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----HHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2222222222211 1224556778899999999999999999999998888754
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=266.39 Aligned_cols=246 Identities=28% Similarity=0.403 Sum_probs=193.6
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
..|...+.||+|++|.||+|.+. +..+++|.+.... ...+.+|+++++.+ |+|++++.+++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44888999999999999999986 6789999876321 23466899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+. +++.+.+. .....+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++++|||++....
T Consensus 95 e~~~-~~l~~~~~----~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 95 EYCL-GSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EccC-CCHHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9996 57877763 23356889999999999999999999999 9999999999999999999999999887544
Q ss_pred CChhhhhhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
... ...+++.|+|||.+. ...++.++|||||||++|+|++|..||......
T Consensus 167 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------------- 220 (308)
T cd06634 167 PAN-------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------------- 220 (308)
T ss_pred Ccc-------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------------------
Confidence 321 234678999999975 345788999999999999999999998543221
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
+....+.....+.. .....+..+.+++++||+.+|.+||++.++++.-.-..
T Consensus 221 ----~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 221 ----SALYHIAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ----HHHHHHhhcCCCCc--CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 00111111111111 12234566889999999999999999999997655433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=269.75 Aligned_cols=268 Identities=22% Similarity=0.312 Sum_probs=198.7
Q ss_pred ChHHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEe
Q 041031 3 SYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAG 74 (313)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~ 74 (313)
...++..+.++|++.+.||+|+||.||+|.+. ++.||+|.+.... .+.+.+|+++++.+ ||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34567788899999999999999999999875 7889999886532 33466899999999 9999999998854
Q ss_pred C------CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC
Q 041031 75 G------DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF 148 (313)
Q Consensus 75 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~ 148 (313)
. ...+++++++ +++|.+++. ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 3 3467888887 789988873 235889999999999999999999999 99999999999999999
Q ss_pred cEEEeeccccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcccc
Q 041031 149 RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE 227 (313)
Q Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~ 227 (313)
.++++|||++...... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||......
T Consensus 158 ~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~------- 224 (345)
T cd07877 158 ELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI------- 224 (345)
T ss_pred CEEEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------
Confidence 9999999998754321 122356888999999876 56888999999999999999999999654321
Q ss_pred chhHHHHHHHHhcCcHHH------------HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 228 HRSLVDYMLAVFNDTKDF------------MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~------------~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
..+.............. ...+...............+..+.+++.+||+.||.+|||+.+++..=.
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 225 -DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred -HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 11111111000000000 0001111111111111123456889999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=271.08 Aligned_cols=273 Identities=23% Similarity=0.365 Sum_probs=199.8
Q ss_pred cChHHHHHH----hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeee
Q 041031 2 FSYNEVRDA----TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELI 69 (313)
Q Consensus 2 ~~~~~~~~~----~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~ 69 (313)
|+.+++... ..+|.+.+.||+|++|.||+|.+. ++.+|+|.+.... ...+.+|+.+++.+ ||||++++
T Consensus 1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 80 (342)
T cd07879 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80 (342)
T ss_pred CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchh
Confidence 566666655 489999999999999999999876 7899999886431 23467899999999 99999999
Q ss_pred eEEEeC------CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCee
Q 041031 70 GYAAGG------DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNIL 143 (313)
Q Consensus 70 ~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil 143 (313)
+++... ..+++++|++. .+|.+.+ ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIl 149 (342)
T cd07879 81 DVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLA 149 (342)
T ss_pred heecccccCCCCceEEEEecccc-cCHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence 998654 35689999985 4676664 135788999999999999999999999 999999999999
Q ss_pred eCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCC
Q 041031 144 LDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGN 222 (313)
Q Consensus 144 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~ 222 (313)
++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+....
T Consensus 150 l~~~~~~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-- 221 (342)
T cd07879 150 VNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-- 221 (342)
T ss_pred ECCCCCEEEeeCCCCcCCCCC------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 999999999999998754321 112346788999999876 45889999999999999999999999754321
Q ss_pred CccccchhHHHHHHHHhcCcHHHHHHhhh------------hcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 041031 223 NQYTEHRSLVDYMLAVFNDTKDFMAKLTE------------CLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAA 290 (313)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll 290 (313)
..+...........+++...+.. .....+..........+.+|+.+||+.||.+||++.+++
T Consensus 222 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 222 ------DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred ------HHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 01111111000011111111100 000000001112345688999999999999999999999
Q ss_pred HH--HHHHHhc
Q 041031 291 IR--LSHILIS 299 (313)
Q Consensus 291 ~~--l~~~~~~ 299 (313)
.. +++....
T Consensus 296 ~h~~f~~~~~~ 306 (342)
T cd07879 296 EHPYFDSFRDA 306 (342)
T ss_pred cCcchhhcccc
Confidence 65 6665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=262.08 Aligned_cols=241 Identities=26% Similarity=0.382 Sum_probs=190.7
Q ss_pred eccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCCh
Q 041031 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 20 lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (313)
||.|+||.||++++. ++.+++|.+.... ...+.+|+++++.+ |||++++++.+...+..++++|++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 8899999987543 33577889999999 99999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh---
Q 041031 91 SDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI--- 167 (313)
Q Consensus 91 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--- 167 (313)
.+++. ....+++..++.++.|++.+|++||+.+ ++|+||+|+||++++++.++++|||++.........
T Consensus 81 ~~~l~-----~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLE-----NVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99984 2346899999999999999999999999 999999999999999999999999987754432110
Q ss_pred --hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 168 --AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 168 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
........++..|+|||...+...+.++|+||||+++|++++|..||...... +.
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----------------------~~ 209 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----------------------EI 209 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----------------------HH
Confidence 01122235678899999998888999999999999999999999999644321 11
Q ss_pred HHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 246 MAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 246 ~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
...+.. ..... .....+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 210 ~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 210 FQNILN---GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHhc---CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 111111 01000 01112567889999999999999999955555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=267.61 Aligned_cols=262 Identities=20% Similarity=0.301 Sum_probs=187.9
Q ss_pred ceeccC--CeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQG--SYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g--~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
..||.| +||+||++++. ++.||+|++.... .+.+.+|+.+++.+ ||||+++++++......++++|++.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999985 8999999987543 24567889998888 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTY---FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 9999988532 1235888999999999999999999999 999999999999999999999999854432211110
Q ss_pred h----hhcccccccccccCCccccC--CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH-----
Q 041031 168 A----AAASRIVGTFGYLAPEYVRD--GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML----- 236 (313)
Q Consensus 168 ~----~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 236 (313)
. .......++..|+|||++.+ ..++.++||||+||++|+|++|..||....... .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~ 229 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--------MLLQKLKGPPYS 229 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--------HHHHHhcCCCCC
Confidence 0 00111234567999999976 347899999999999999999999997543210 0000000
Q ss_pred -----------HHhcC-cHHHHH-----Hhh-----hhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 237 -----------AVFND-TKDFMA-----KLT-----ECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 237 -----------~~~~~-~~~~~~-----~l~-----~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
..... ...... ... ......+.. .....+..+.+|+++||+.||++|||+.++++.-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 00000 000000 000 000000111 2234567889999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=300.19 Aligned_cols=266 Identities=27% Similarity=0.462 Sum_probs=202.8
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.......+...+.||+|+||.||+|.+. +..||||.+..... ....|+++++++ ||||+++++++.+.+..++|||
T Consensus 685 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3444567888899999999999999975 78899998875432 223568889999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++|+|.+++. .+++..+..++.|++.|++|||....++++|+||||+||+++.++..++. ++.......
T Consensus 764 y~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 764 YIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred CCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 999999999983 37888999999999999999994422229999999999999988877664 554332211
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
. ....+++.|+|||++.+..++.++||||+||++|||+||+.||..... ....+.+|........
T Consensus 835 ~-------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~- 899 (968)
T PLN00113 835 D-------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-------VHGSIVEWARYCYSDC- 899 (968)
T ss_pred C-------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-------CCCcHHHHHHHhcCcc-
Confidence 1 112568899999999999999999999999999999999999843222 1223333333222111
Q ss_pred HHHHHhhhhcCCCCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 244 DFMAKLTECLDPNLTR---YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
....++++.+.. ........+.+++.+||+.||++|||+.|++++|+++...+.
T Consensus 900 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 900 ----HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred ----chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 122233333322 234556678899999999999999999999999999877543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=278.94 Aligned_cols=239 Identities=26% Similarity=0.396 Sum_probs=195.0
Q ss_pred ccceeccCCeEEEEEeEEC--CcceE---EEec--c--ccccHHHHHHHHHHHhc-CCCceeeeeEEEeCCe--EEEEEe
Q 041031 16 TSLKIGQGSYGSVYLGKLR--GKNAA---IKQM--K--NTKSKEFSSELKILCKV-HSNLIELIGYAAGGDS--LFLVYE 83 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~--~~~~a---iK~~--~--~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~--~~lv~e 83 (313)
...+||+|.|-+||+|.+. |-.|| ||.- . +...+.+..|+.+|+.| ||||++++++|.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3578999999999999987 43343 2221 1 22346788999999999 9999999999987655 889999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-CCcEEEeecccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLLE 162 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~ 162 (313)
.+..|+|..++ ++.+.++.+.+..|++||+.+|.|||++. +||+|+|||-+||||+. .|.|||+|+|+|....
T Consensus 124 L~TSGtLr~Y~-----kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYR-----KKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHH-----HHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999998 56677899999999999999999999997 45999999999999985 6999999999998765
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.+ ......|||.|||||++. ..|++..||||||+++.||.|+.+||....++.
T Consensus 198 ~s-----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--------------------- 250 (632)
T KOG0584|consen 198 KS-----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--------------------- 250 (632)
T ss_pred cc-----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH---------------------
Confidence 43 222368999999999998 889999999999999999999999998766532
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
++.+++...+.|.. +..-...+++++|.+|+.. .++|||+.|+|.
T Consensus 251 -QIYKKV~SGiKP~s--l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 251 -QIYKKVTSGIKPAA--LSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -HHHHHHHcCCCHHH--hhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 33444444443321 2222245788899999999 999999999985
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=275.03 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=208.8
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
.-...|.+...||+|.|+.|.+|++. +..||||++.+.. .....+|+++|+.+ |||||+++.+......+++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567999999999999999999987 8899999998664 34478999999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||..+|.+.+++ .+.+...+..+...+.|++.|++|||++. |+|+|||++|++++.+.++||+|||++.+
T Consensus 133 V~eya~~ge~~~yl-----~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 133 VMEYASGGELFDYL-----VKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred EEEeccCchhHHHH-----HhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccccee
Confidence 99999999999999 45566777889999999999999999999 99999999999999999999999999998
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
+..... ....+|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||.+..-.
T Consensus 205 ~~~~~~----lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk------------------- 261 (596)
T KOG0586|consen 205 FDYGLM----LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK------------------- 261 (596)
T ss_pred eccccc----ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------
Confidence 875533 334579999999999998776 68899999999999999999999865442
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
..-...+..+++. ....+....++|+++|-.+|.+|++.+++.+--+.-
T Consensus 262 -------~Lr~rvl~gk~rI-p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n 310 (596)
T KOG0586|consen 262 -------ELRPRVLRGKYRI-PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN 310 (596)
T ss_pred -------cccchheeeeecc-cceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence 1111122222221 233344567799999999999999999998655443
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=270.41 Aligned_cols=262 Identities=23% Similarity=0.353 Sum_probs=196.7
Q ss_pred HHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC-
Q 041031 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGD- 76 (313)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~- 76 (313)
.+....++|++++.||+|++|.||+|.+. +..||||.+.... ...+.+|+.+++.+ ||||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 45567889999999999999999999876 7889999885422 23477899999999 999999999987553
Q ss_pred -----eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEE
Q 041031 77 -----SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAK 151 (313)
Q Consensus 77 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~ 151 (313)
..++||+++ +++|.+++. ...+++..++.++.|++.|++|||+.+ ++|+||+|+||+++.++.++
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~k 158 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMK------HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELK 158 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEE
Confidence 458999998 779988873 246889999999999999999999999 99999999999999999999
Q ss_pred EeeccccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchh
Q 041031 152 IADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~ 230 (313)
++|||.+...... .....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...... ..
T Consensus 159 l~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--------~~ 224 (343)
T cd07880 159 ILDFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--------DQ 224 (343)
T ss_pred EeecccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HH
Confidence 9999998754322 112346789999999876 45889999999999999999999999754321 01
Q ss_pred HHHHHHHHhcCcHHHHHHh------------hhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 231 LVDYMLAVFNDTKDFMAKL------------TECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~l------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.............++...+ .......+..........+.+++.+||..||.+|||+.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 225 LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111111111111111111 000001111112234456889999999999999999999994
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=265.85 Aligned_cols=267 Identities=18% Similarity=0.199 Sum_probs=194.7
Q ss_pred CccccceeccCCeEEEEEeEECCcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.|.+.+.+|.|+++.|+++...++.+|+|.+... ....+.+|+.+++.+ |+||+++++++.+.+..+++|||++
T Consensus 3 ~~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 3556677777788888887777999999998654 234688999999999 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||.+........
T Consensus 83 ~~~l~~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 83 YGSCEDLLKTH---FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred CCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence 99999998532 2245788999999999999999999999 99999999999999999999999998765432211
Q ss_pred h----hhhcccccccccccCCccccC--CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 167 I----AAAASRIVGTFGYLAPEYVRD--GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 167 ~----~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
. ........++..|+|||++.+ ..++.++|+||+|+++|+|++|..||....... ...+......+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--------~~~~~~~~~~~ 228 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--------MLLEKVRGTVP 228 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhccCc
Confidence 1 011122346778999999875 458899999999999999999999997543211 00000000000
Q ss_pred C------cHHHHHHhhh----hcCCC-----CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 241 D------TKDFMAKLTE----CLDPN-----LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 241 ~------~~~~~~~l~~----~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
. .......... ...+. ...........+.+++.+||..||++|||++++++.-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 0 0000000000 00000 0012334456788999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=270.90 Aligned_cols=266 Identities=24% Similarity=0.336 Sum_probs=195.5
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc--CCCceeeeeEEEeC--Ce
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV--HSNLIELIGYAAGG--DS 77 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~--~~ 77 (313)
.+.++|++.+.||+|+||.||+|.+. ++.+++|.+... ....+.+|+.+++++ ||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 45678999999999999999999886 778999987532 234466899999998 99999999998643 46
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.++|||+++ ++|.+++. . ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.
T Consensus 84 ~~lv~e~~~-~~L~~~~~-----~-~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 84 IYLVFEYME-TDLHAVIR-----A-NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEEEecccc-cCHHHHHh-----c-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccc
Confidence 899999996 58988873 2 26788888999999999999999999 99999999999999999999999998
Q ss_pred cccccCChhh--hhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 158 VKLLEHSPEI--AAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
+......... ........++..|+|||++.+ ..++.++|+||||+++|+|++|+.||.+..... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--------~~~~~ 225 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--------QLEKI 225 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHH
Confidence 8765433211 011222357889999998865 557889999999999999999999996543321 00000
Q ss_pred HHHHh------------cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 235 MLAVF------------NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 235 ~~~~~------------~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
..... ....++...+...-...........+..+.+++.+||+.+|.+|||+.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 226 IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000 00000011000000011111122245678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=272.30 Aligned_cols=264 Identities=21% Similarity=0.306 Sum_probs=190.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeC---------
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGG--------- 75 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~--------- 75 (313)
..+|.+.+.||.|+||.||+|.+. +..+++|.+.... .+.+.+|+++++.+ ||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 578999999999999999999886 7889999886543 34577899999999 99999999876543
Q ss_pred -----CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC-CCCc
Q 041031 76 -----DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD-SNFR 149 (313)
Q Consensus 76 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~ 149 (313)
...++++||++ ++|.+++. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++ +++.
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~ 153 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE------QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCce
Confidence 35789999996 58888873 245889999999999999999999999 99999999999997 4567
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccc
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~ 228 (313)
++++|||.+.................++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~------- 226 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE------- 226 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------
Confidence 899999998765322111111222356888999998754 557889999999999999999999996554310
Q ss_pred hhHHHHHHHHhcC----cHHHHHHhhhhcC--CCCC-C----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 229 RSLVDYMLAVFND----TKDFMAKLTECLD--PNLT-R----YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 229 ~~~~~~~~~~~~~----~~~~~~~l~~~~~--~~~~-~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
............ ...+...+..... .... . ........+.+|+.+||..||.+|||+.+++..
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 227 -QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred -HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 011111000000 0000111100000 0000 0 111234568889999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=260.34 Aligned_cols=245 Identities=23% Similarity=0.369 Sum_probs=192.3
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccc--------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT--------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~--------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
+|.+.++||+|+||.||++.+. +..+++|..+.. ....+..|+.+++.+ |||++++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999887 344555555421 223466788999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
+||+++++|.+++.... .....+++..++.++.|++.|+.|||+.+ ++|+||+|+||++++ +.++++|||.+...
T Consensus 81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeec
Confidence 99999999998874321 23457899999999999999999999999 999999999999975 56999999988765
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
..... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||......
T Consensus 156 ~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------------------- 211 (260)
T cd08222 156 MGSCD---LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--------------------- 211 (260)
T ss_pred CCCcc---cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---------------------
Confidence 43221 122235678899999998888899999999999999999999998532210
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
..... .............+..+.+++.+||..+|++||++.++++
T Consensus 212 --~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 212 --SVVLR---IVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --HHHHH---HHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11111 1111122233455668889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=260.69 Aligned_cols=263 Identities=27% Similarity=0.384 Sum_probs=191.7
Q ss_pred ccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeec
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
|++.+.||.|++|.||+|... ++.++||.+.... .....+|+..++.+ |+|++++++.+.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999986 6789999876542 22345688888887 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
+++|.+.+... ....+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 -EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred -CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 77998888422 1246899999999999999999999999 9999999999999999999999999987654322
Q ss_pred hhhhhcccccccccccCCcccc-CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH----Hhc
Q 041031 166 EIAAAASRIVGTFGYLAPEYVR-DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA----VFN 240 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 240 (313)
. .....++..|+|||++. +..++.++|+||||+++++|++|..||........ .......... .+.
T Consensus 154 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 224 (283)
T cd07830 154 P----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-----LYKICSVLGTPTKQDWP 224 (283)
T ss_pred C----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-----HHHHHHhcCCCChhhhh
Confidence 1 12235678899999885 45578999999999999999999999965543210 0000000000 000
Q ss_pred CcHHHHHHhhhhcCCC----CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPN----LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
............+... +..........+.+++++||+.+|++|||++|++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000000000 000111124568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=265.27 Aligned_cols=268 Identities=25% Similarity=0.324 Sum_probs=191.0
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeC-------
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGG------- 75 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~------- 75 (313)
.++|++.++||.|++|.||+|.+. ++.+++|.+.... .....+|+++++.+ ||||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 589999999999999999999987 7889999885432 23467899999999 99999999987543
Q ss_pred -CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 76 -DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 76 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
..++++++|+. ++|...+. .....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++++|
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~----~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLE----NPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCC-cCHHHHHh----ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence 34699999995 46777663 23457999999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhhhh--------hcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcc
Q 041031 155 FGLVKLLEHSPEIAA--------AASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQY 225 (313)
Q Consensus 155 fg~~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~ 225 (313)
||++........... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---- 234 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---- 234 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 998876543221111 1112245788999998865 457899999999999999999999996544321
Q ss_pred ccchhHHHHHHHHhcCcHHHHHHhhhhc--------CCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 226 TEHRSLVDYMLAVFNDTKDFMAKLTECL--------DPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
....+........+........+.... .+.+..........+.+++.+||..||.+|||+.+++.
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 -QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred -HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000000000000000000000000 00000011122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=255.83 Aligned_cols=231 Identities=29% Similarity=0.425 Sum_probs=189.1
Q ss_pred eccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCCh
Q 041031 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 20 lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (313)
||.|++|.||++.+. ++.+++|.+.... ...+..|+.+++.+ |||++++++.+...+..+++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999987 7889999887543 33578899999999 99999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhh
Q 041031 91 SDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA 170 (313)
Q Consensus 91 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 170 (313)
.+++. ....+++..+..++.|++.++.++|+.+ ++|+||+|+||+++.++.++++|||.+....... ..
T Consensus 81 ~~~l~-----~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~ 149 (250)
T cd05123 81 FSHLS-----KEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SR 149 (250)
T ss_pred HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC---Cc
Confidence 99984 3446899999999999999999999999 9999999999999999999999999987654432 12
Q ss_pred cccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhh
Q 041031 171 ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLT 250 (313)
Q Consensus 171 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
.....++..|+|||.+.+...+.++|+||||+++|++++|..||...... .....+.
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----------------------~~~~~~~ 206 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK-----------------------EIYEKIL 206 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----------------------HHHHHHh
Confidence 23345788999999998888899999999999999999999999644321 1111111
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHH
Q 041031 251 ECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSN 288 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 288 (313)
. ... ......+..+.+++++||..||.+||++.+
T Consensus 207 ~---~~~-~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 207 K---DPL-RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred c---CCC-CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1 111 122233567889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=264.68 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=194.3
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEe-CCe
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAG-GDS 77 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~-~~~ 77 (313)
+....++|++.+.||.|+||.||+|.+. ++.+++|.+... ....+.+|+.+++.+ |||++++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456789999999999999999999877 788999987532 234577899999999 9999999999865 567
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.++++|++ +++|.+++. ...++...+..++.|++.||+|||+.+ ++|+||+|+||++++++.++++|||.
T Consensus 85 ~~lv~e~~-~~~L~~~~~------~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT------SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred EEEEeehh-ccCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccc
Confidence 89999998 668988873 245788888899999999999999999 99999999999999999999999998
Q ss_pred cccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
+...... .....++..|+|||++.+ ..++.++|+||||+++|+|++|..||...... .......
T Consensus 155 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~---------~~~~~~~ 219 (328)
T cd07856 155 ARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV---------NQFSIIT 219 (328)
T ss_pred ccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHH
Confidence 8754321 112346788999998865 56899999999999999999999999654321 0000000
Q ss_pred HHhc-CcHHHH---------HHhhhhcCCCC---CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 237 AVFN-DTKDFM---------AKLTECLDPNL---TRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 237 ~~~~-~~~~~~---------~~l~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.... ...++. ..+........ ..........+.+++.+||+.+|++|||+.+++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 220 DLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000100 00000000000 00111234678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=263.77 Aligned_cols=245 Identities=24% Similarity=0.336 Sum_probs=197.5
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
......|+.-++||+||||.|+-+... |+.+|.|.+.+.. ..-...|..||..+ .+.||.+--+|+..+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 345567888999999999999977654 8999999876543 22356788999999 78899988889999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++|+..++||+|.-.|-+ -....++++.+.-++.+|+.+|.+||..+ ||++|+||+|||+|+.|+++|+|+|+|
T Consensus 261 ClVLtlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred EEEEEeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceE
Confidence 999999999999988842 23358999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
........ .....||.+|||||++.++.|+.+.|.|||||++|+|+.|+.||........ ..
T Consensus 335 vei~~g~~----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk--------~e------ 396 (591)
T KOG0986|consen 335 VEIPEGKP----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK--------RE------ 396 (591)
T ss_pred EecCCCCc----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh--------HH------
Confidence 98776432 2223799999999999999999999999999999999999999976654310 00
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD 285 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 285 (313)
+....+. ...-..+...+.+...+.+..|..||++|..
T Consensus 397 -----Evdrr~~----~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 397 -----EVDRRTL----EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred -----HHHHHHh----cchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 1111111 1111123455567778999999999999963
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=269.87 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=195.0
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCe---
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGGDS--- 77 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~--- 77 (313)
...++|++.+.||.|++|.||+|.+. +..+++|.+... ....+.+|+.+++.+ |||++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45778999999999999999999987 778999988643 124466799999999 9999999988765554
Q ss_pred ---EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 78 ---LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 78 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
.++|+|++ +++|.+++. ...+++..++.++.|++.||++||+.+ ++|+||+|+||++++++.++|+|
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVK------CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccEEEEEecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcc
Confidence 89999998 679999884 246899999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
||.+...... .....++..|+|||.+.+ ..++.++||||||+++|++++|..||...... ..+..
T Consensus 162 fg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--------~~~~~ 227 (343)
T cd07851 162 FGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--------DQLKR 227 (343)
T ss_pred cccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHH
Confidence 9998765432 112346788999999865 46789999999999999999999999754331 01111
Q ss_pred HHHHHhcCcHHH------------HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 234 YMLAVFNDTKDF------------MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 234 ~~~~~~~~~~~~------------~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...........+ ...+.......+.......+..+.+++.+||+.+|.+|||+.+|++.
T Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 228 IMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 111000000000 00000000011101111235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=263.34 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=190.2
Q ss_pred CccccceeccCCeEEEEEeEEC----CcceEEEeccccc-----cHHHHHHHHHHHhc--CCCceeeeeEEEe----CCe
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR----GKNAAIKQMKNTK-----SKEFSSELKILCKV--HSNLIELIGYAAG----GDS 77 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~-----~~~~~~e~~~l~~l--h~~i~~~~~~~~~----~~~ 77 (313)
+|++.+.||+|+||.||++.+. +..+|+|.+.... ...+.+|+.+++.+ ||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5889999999999999999987 4579999876421 33467899999988 9999999987542 245
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
++++++++. ++|.+.+. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.
T Consensus 81 ~~~~~e~~~-~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIR-----SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 788889884 68998883 4466899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhh-hhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 158 VKLLEHSPEI-AAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
+......... ........+++.|+|||++.+ ..++.++|+||+|+++|+|++|..||...+... .+....
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~--------~~~~~~ 223 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD--------QLNQIL 223 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH--------HHHHHH
Confidence 8765432211 111122457889999998765 568899999999999999999999997544210 000000
Q ss_pred HHHhcCcHHHH------------HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 236 LAVFNDTKDFM------------AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 236 ~~~~~~~~~~~------------~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...-....+.. ......-...+..........+.+++.+||+.||.+|||+.+++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 224 QVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000 0000000000011111234678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=259.09 Aligned_cols=259 Identities=25% Similarity=0.361 Sum_probs=194.9
Q ss_pred ccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
|+..+.||.|++|.||+|... ++.+++|.+.... .+.+..|+.+++.+ |+|++++++.+.+....++++|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 677889999999999999987 7889999987542 34567899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
+ ++|.+++.. ....+++..++.++.|++.+|++||+++ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~-~~l~~~i~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDK----RPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 6 589999852 2256899999999999999999999999 9999999999999999999999999887654322
Q ss_pred hhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. .......+..|+|||.+.+. .++.++|+||||+++|++++|..||...... ..+.............
T Consensus 153 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 221 (282)
T cd07829 153 R---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--------DQLFKIFQILGTPTEE 221 (282)
T ss_pred c---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHHHhCCCcHH
Confidence 1 11122456789999998766 7899999999999999999999999664421 1111111110000000
Q ss_pred HHHHhhhh----------cCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 245 FMAKLTEC----------LDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 245 ~~~~l~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
........ ...............+.+++++||..+|++||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000 000000011122567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=296.71 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=208.7
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
++.+.-+|+-..++|.|.||.||.|... |.-.|+|-+.-.. ...+.+|..++..+ |||+|+++++-.+...+
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 3445567888999999999999999876 7778998775322 33477899999999 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
+|.||||.+|+|.+.+ ..+...++.....+-.|++.|++|||..| |||+||||.||+++.+|.+|++|||.|
T Consensus 1310 ~IFMEyC~~GsLa~ll-----~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLL-----EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHhccCcHHHHH-----HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccce
Confidence 9999999999999998 45566788888889999999999999999 999999999999999999999999999
Q ss_pred ccccCCh-hhhhhcccccccccccCCccccC---CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 159 KLLEHSP-EIAAAASRIVGTFGYLAPEYVRD---GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 159 ~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
.....+. .....-....||+-|||||++.+ ....-+.|||||||+..||+||+.||...+..
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------------- 1447 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------------- 1447 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--------------
Confidence 9877653 11222234579999999999975 44678899999999999999999999876652
Q ss_pred HHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 235 MLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+..+-.+...-.|..++ ..+..=.+++..||..||.+|.++.||++.
T Consensus 1448 --------~aIMy~V~~gh~Pq~P~---~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1448 --------WAIMYHVAAGHKPQIPE---RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --------hHHHhHHhccCCCCCch---hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 23344444444444333 366677889999999999999999888764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=275.24 Aligned_cols=277 Identities=23% Similarity=0.344 Sum_probs=206.5
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEecccc----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCC------eE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT----KSKEFSSELKILCKV-HSNLIELIGYAAGGD------SL 78 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~------~~ 78 (313)
..|..-+.||+|+||.||+|+++ |+.+|||.++.. ..+...+|+++|+++ |||||++++.-+... ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 34566789999999999999977 999999999864 356678999999999 999999999865443 56
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC--CCC--cEEEee
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD--SNF--RAKIAD 154 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~--~~~--~~~l~d 154 (313)
.++||||.||+|...+.+.. +...+++.+++.++.+++.|+.|||+++ |+||||||.||++. ++| ..||+|
T Consensus 93 vlvmEyC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred eEEEeecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeec
Confidence 89999999999999997554 4678999999999999999999999999 99999999999984 334 359999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
||.|....++. ......||..|++||.+.. ..|+...|.|||||++|+..||..||.....+..+..........
T Consensus 168 fG~Arel~d~s----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 168 FGAARELDDNS----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred ccccccCCCCC----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 99999877653 5556789999999999995 788999999999999999999999997776653221111111111
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCC---CCCHHHHHHHHHHHhhccccCcCCCC--CHHHHHHHHHHHHh
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLT---RYHKDSMLQMALLSKDCVDENWKRRP--DMSNAAIRLSHILI 298 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp--s~~~ll~~l~~~~~ 298 (313)
-...+.....+...-.. .....++ .........+...+..+|..+|++|- ...+.-..+..|+.
T Consensus 244 kp~~v~i~~~~~eNgpv-~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 244 KPSGVAIGAQEEENGPV-EWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CCCceeEeeecccCCce-eeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 10000000000000000 0000111 12344445667788889999999999 77777777776665
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=233.73 Aligned_cols=265 Identities=22% Similarity=0.294 Sum_probs=198.4
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.+|...++||+|.+|+||+|+.. ++-||+|..+.++ +....+|+.+++.+ |.||++++++...++.+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46788899999999999999877 7789999988654 44588999999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
++ ...|..+++ .-++.++.+.++.++.|++.++.++|+.+ +.|+|+||.|++++.+|.+|++|||++.-+.-
T Consensus 82 ~c-dqdlkkyfd----slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 82 FC-DQDLKKYFD----SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred Hh-hHHHHHHHH----hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 99 458888885 45678999999999999999999999999 99999999999999999999999999886543
Q ss_pred ChhhhhhcccccccccccCCccccCCC-CCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGC-VTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.. .-.+....|.+|+||+++.+.+ |+.+.|+||.||++.|+.. |++.|.+.+..+ +...++........+
T Consensus 154 pv---rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-----qlkrif~~lg~p~ed 225 (292)
T KOG0662|consen 154 PV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-----QLKRIFRLLGTPTED 225 (292)
T ss_pred ce---EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-----HHHHHHHHhCCCccc
Confidence 21 1112246789999999998855 7899999999999999987 677777665431 111111111111111
Q ss_pred cHHHHHHhhhh-cCCCCCC--C----CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 TKDFMAKLTEC-LDPNLTR--Y----HKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~-~~~~~~~--~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+.-+..+... ..+.+.. . -+.....=++|+.+.|.-+|.+|.+++..++.
T Consensus 226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111111110 0111111 0 11112234568889999999999999988753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=270.09 Aligned_cols=242 Identities=22% Similarity=0.339 Sum_probs=199.1
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeec
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..++|.....+|.|+||.|-.+.+. +...++|++... ..+..+|..++... |||++++.+++.+....++|||.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 4678999999999999999999887 778899999877 45566777777777 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee-CCCCcEEEeeccccccccCC
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL-DSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~-~~~~~~~l~dfg~~~~~~~~ 164 (313)
.++.+.+.+. ...... ..+..|+++++.|+.|||++| ++|||+||+|||+ ++.++++|+|||.+......
T Consensus 399 ~g~ell~ri~-----~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 399 DGGELLRRIR-----SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred cccHHHHHHH-----hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9998888773 222333 677789999999999999999 9999999999999 58899999999999876643
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
+....-|..|.|||++....|++++|+||||++||+|++|+.||...... .+
T Consensus 470 ------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----------------------~e 521 (612)
T KOG0603|consen 470 ------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----------------------IE 521 (612)
T ss_pred ------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----------------------HH
Confidence 23345688999999999999999999999999999999999999766542 01
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
....+. .+. .....+....+|+.+||+.||.+||++.++...=+.
T Consensus 522 i~~~i~---~~~---~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 522 IHTRIQ---MPK---FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHhhc---CCc---cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 122221 111 124556678889999999999999999999876543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=258.97 Aligned_cols=277 Identities=24% Similarity=0.416 Sum_probs=212.9
Q ss_pred cCccccceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc---CCCceeeeeEEEeCC----eEEEEEee
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV---HSNLIELIGYAAGGD----SLFLVYEY 84 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l---h~~i~~~~~~~~~~~----~~~lv~e~ 84 (313)
......+++|+|.||.||+|...++.||||++.....+.++.|-+|+... |+||++++++-.... .++||++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 45567889999999999999999999999999999999999999999988 999999999876544 79999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCC------CCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT------KPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
.+.|+|.++|. ...+++...-+++..++++|+|||+.. +++|+|||||.+||||..+++.-|+|||++
T Consensus 290 h~kGsL~dyL~------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 290 HPKGSLCDYLK------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred ccCCcHHHHHH------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999994 456899999999999999999999764 556999999999999999999999999999
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCC-CC-----CccchhhHHHHHHHHHhCCCCccC-CCCCCCCccccchhH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC-VT-----TKSDVYAFGVVLMELITGQQALSR-DANPGNNQYTEHRSL 231 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-----~~~DiwslG~~l~~~~tg~~p~~~-~~~~~~~~~~~~~~~ 231 (313)
..+...... .......||.+|||||++.+.- +. .+.||||+|.++|||++.-.-+.. ..++-+..+.
T Consensus 364 l~~~p~~~~-~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe----- 437 (534)
T KOG3653|consen 364 LRLEPGKPQ-GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE----- 437 (534)
T ss_pred EEecCCCCC-cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh-----
Confidence 988754332 2222368999999999998632 22 357999999999999986544421 1111111111
Q ss_pred HHHHHHHhcCcHHHHHHhh-hhcCCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccc
Q 041031 232 VDYMLAVFNDTKDFMAKLT-ECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKE 302 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l~-~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 302 (313)
......+...+....+. ...+|..+. ..-.....|.+.+..||+.||+.|.|+.=+.+++.++....+.
T Consensus 438 --~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 438 --AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred --HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 01111112222222222 223343333 2224567789999999999999999999999999999887653
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=281.31 Aligned_cols=141 Identities=28% Similarity=0.449 Sum_probs=128.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|.+.++||+|+||.||+|.+. ++.||||++.... ...+..|+.+++.+ ||||+++++.+.....+++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 578999999999999999999998 8899999987543 25577899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
|||+.+++|.+++. ....+++..++.++.|++.||.|||..+ |+|+||||+|||++.++.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~-----~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLH-----IYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999984 3456888999999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=276.59 Aligned_cols=262 Identities=27% Similarity=0.412 Sum_probs=209.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC---------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR---------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAG 74 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~ 74 (313)
..++..+.+.||+|.||.|++|... ...||||.++... .+.+..|+++|+.+ |+|++.+++++..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3445567779999999999999754 2358999987654 44688999999999 9999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhcCCC---------CCCCC--CccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCee
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPS---------VKGKK--PLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNIL 143 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil 143 (313)
....++|.||+..|+|.+++...+ ..... .++....+.++.|++.++.||++.+ ++|||+-.+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999996555 11112 3899999999999999999999999 999999999999
Q ss_pred eCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCC
Q 041031 144 LDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGN 222 (313)
Q Consensus 144 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~ 222 (313)
++++..+|++|||++.................-+..|+|||.+....++.+|||||+|+++||++| |..||.+....
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-- 528 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-- 528 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--
Confidence 999999999999999865543322211111113566999999999999999999999999999999 88999764321
Q ss_pred CccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 223 NQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
.++...+... .....+..+..+++++++.||+.+|++||++.++.+.+..++.+
T Consensus 529 --------------------~~l~~~l~~G---~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 529 --------------------EELLEFLKEG---NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred --------------------HHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 1222222222 22224556678899999999999999999999999999997543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=286.05 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=202.7
Q ss_pred HHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeC
Q 041031 5 NEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGG 75 (313)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~ 75 (313)
..++--.++|.++++||+|+||.|..++.+ ++.||.|++++. ....+..|-.+|-.- .+=|+.+.-+|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 456667899999999999999999999987 778999998763 234466677777776 77799999999999
Q ss_pred CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
+.+|+||||++||+|-.++ .+...+++..++-++..++.||.-+|+.| +||+||||+|||++..|++||+||
T Consensus 148 ~~LYlVMdY~pGGDlltLl-----Sk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLL-----SKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred cceEEEEecccCchHHHHH-----hhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999 45558999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCcccc----C-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchh
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR----D-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~ 230 (313)
|.+.....++. ..+....|||.|.+||++. + +.|+..+|.||+|+++|||+.|..||....-.
T Consensus 220 GsClkm~~dG~--V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv---------- 287 (1317)
T KOG0612|consen 220 GSCLKMDADGT--VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV---------- 287 (1317)
T ss_pred hhHHhcCCCCc--EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH----------
Confidence 99988876554 5666678999999999995 3 56899999999999999999999999755321
Q ss_pred HHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC---HHHHHH
Q 041031 231 LVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD---MSNAAI 291 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~ll~ 291 (313)
.-...+.... . .+ .++ -..+.+.+..+||.+.+. +|..|.. ++++-.
T Consensus 288 --eTY~KIm~hk----~----~l--~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 288 --ETYGKIMNHK----E----SL--SFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred --HHHHHHhchh----h----hc--CCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1111111110 0 00 011 123456677788887665 6777776 766653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=248.69 Aligned_cols=217 Identities=23% Similarity=0.217 Sum_probs=173.0
Q ss_pred CCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCC
Q 041031 23 GSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSV 99 (313)
Q Consensus 23 g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 99 (313)
|.+|.||++.++ ++.+|+|.+.... ....|...+... |||++++++.+.+.+..+++|||+++++|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---- 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS---- 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH----
Confidence 889999999987 7889999997654 233444444444 9999999999999999999999999999999984
Q ss_pred CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhccccccccc
Q 041031 100 KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179 (313)
Q Consensus 100 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 179 (313)
....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||.+....... ....++..
T Consensus 78 -~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~ 147 (237)
T cd05576 78 -KFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVENM 147 (237)
T ss_pred -HhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcCcc
Confidence 3345899999999999999999999999 9999999999999999999999999776544321 12245677
Q ss_pred ccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC
Q 041031 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR 259 (313)
Q Consensus 180 ~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 259 (313)
|+|||.+.+..++.++|+||+|+++|+|++|..|+....... .......
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------------------~~~~~~~--- 196 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------------------NTHTTLN--- 196 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------------------ccccccC---
Confidence 999999988888999999999999999999998874321100 0000000
Q ss_pred CCHHHHHHHHHHHhhccccCcCCCCCH
Q 041031 260 YHKDSMLQMALLSKDCVDENWKRRPDM 286 (313)
Q Consensus 260 ~~~~~~~~l~~li~~cl~~~p~~Rps~ 286 (313)
.....+..+.+++.+||+.||++||++
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 112234568889999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=262.11 Aligned_cols=278 Identities=20% Similarity=0.195 Sum_probs=214.5
Q ss_pred cChHHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccH--HHHHHHHHHHhc---C----CCceeeee
Q 041031 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK--EFSSELKILCKV---H----SNLIELIG 70 (313)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~--~~~~e~~~l~~l---h----~~i~~~~~ 70 (313)
|.++.-+.+-+.|.+....|+|-||+|.+|.+. +..||||++...... .=..|+++|++| . -|+++++.
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 566677788899999999999999999999998 789999999887633 246799999999 2 27999999
Q ss_pred EEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC-c
Q 041031 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF-R 149 (313)
Q Consensus 71 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~ 149 (313)
.|...+++|||||.+ ..+|.+.|+.- ..+-.+....+..++.|++.||.+|...+ |+|.||||+||||++.. .
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKy--G~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKY--GRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNI 575 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHh--CcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcce
Confidence 999999999999999 67999998633 23456889999999999999999999999 99999999999999865 4
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccc-
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEH- 228 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~- 228 (313)
+||||||.|.....+.... ...+..|.|||++.|-.|+...|+||+||+|||+.||+..|++..+..+..+-..
T Consensus 576 LKLCDfGSA~~~~eneitP-----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEITP-----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred eeeccCccccccccccccH-----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 6999999999877654322 2356789999999999999999999999999999999999988876322111000
Q ss_pred -----hh---HHHHHHHHhcC--------------------------cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhh
Q 041031 229 -----RS---LVDYMLAVFND--------------------------TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKD 274 (313)
Q Consensus 229 -----~~---~~~~~~~~~~~--------------------------~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~ 274 (313)
.. -..|....+.. ..++...+.. .+.+..-......+|.+|+.+
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~--~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA--VQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc--cCCCCchhHHHHHHHHHHHHH
Confidence 00 00011111100 1111111111 122333445566789999999
Q ss_pred ccccCcCCCCCHHHHHHH
Q 041031 275 CVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 275 cl~~~p~~Rps~~~ll~~ 292 (313)
||..||++|.|..++|+.
T Consensus 729 ml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKH 746 (752)
T ss_pred HhccChhhcCCHHHHhcC
Confidence 999999999999998863
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=278.83 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=185.6
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeC------
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGG------ 75 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~------ 75 (313)
+-..+|+.++.||+||||.||+++.+ |+.||||.+.... ...+.+|+..+.++ |||||+++..|...
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45678999999999999999999998 9999999997653 33478899999999 99999998742110
Q ss_pred --------------------------------------------------------------------------------
Q 041031 76 -------------------------------------------------------------------------------- 75 (313)
Q Consensus 76 -------------------------------------------------------------------------------- 75 (313)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHH
Q 041031 76 ---------------------------------DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLE 122 (313)
Q Consensus 76 ---------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~ 122 (313)
..+|+=||||+..++.+++. .+...-.....|.++++|++||+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~----~N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIR----RNHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHH----hcccchhhHHHHHHHHHHHHHHH
Confidence 01467788887777777763 11111157788999999999999
Q ss_pred HHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC---C------------hhhhhhcccccccccccCCcccc
Q 041031 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH---S------------PEIAAAASRIVGTFGYLAPEYVR 187 (313)
Q Consensus 123 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~---~------------~~~~~~~~~~~~~~~~~aPE~~~ 187 (313)
|+|++| ++||||||.|||+++++.|||+|||++..... . +..........||.-|+|||++.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999999 99999999999999999999999999987220 0 00001122357899999999998
Q ss_pred CC---CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC---CC
Q 041031 188 DG---CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR---YH 261 (313)
Q Consensus 188 ~~---~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~---~~ 261 (313)
+. .|+.++|+||||++|+||+. ||...- +-...+...-+..++. +.
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-------------------------ERa~iL~~LR~g~iP~~~~f~ 840 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-------------------------ERASILTNLRKGSIPEPADFF 840 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchH-------------------------HHHHHHHhcccCCCCCCcccc
Confidence 65 49999999999999999985 453211 1122222222232222 23
Q ss_pred HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 262 KDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 262 ~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+....=..+|++|++.||.+||||.|+|.
T Consensus 841 ~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 841 DPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 334444566999999999999999999985
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=260.93 Aligned_cols=240 Identities=23% Similarity=0.385 Sum_probs=197.3
Q ss_pred cceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCC
Q 041031 17 SLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (313)
-+.||.|.||+||-|+++ |+.||||++.+- ....+..|+.||+.+ ||+||.+-..|+..+.+|.|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 579999999999999887 999999998643 356688999999999 999999999999999999999999776
Q ss_pred ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcEEEeeccccccccCCh
Q 041031 89 ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 89 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~~~~~~~~~ 165 (313)
-|+-+|. ...+.+++....-++.||+.||+|||.++ |+|+|+||+|||+.+ -..+||+|||.+.......
T Consensus 649 MLEMILS----sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 649 MLEMILS----SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred HHHHHHH----hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 6666664 56678999999999999999999999999 999999999999964 4579999999999877532
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
......||+.|+|||++.+..|+.+-|+||+|+++|--++|.-||..+.+. .+.++.
T Consensus 722 ----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-----------ndQIQN-------- 778 (888)
T KOG4236|consen 722 ----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-----------NDQIQN-------- 778 (888)
T ss_pred ----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-----------hHHhhc--------
Confidence 233457999999999999999999999999999999999999999765432 111111
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+...+ .....+.+....+||...|+..-++|-|...-+..
T Consensus 779 ----AaFMyP--p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 779 ----AAFMYP--PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ----cccccC--CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 011111 12345566678889999999999999998876644
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=271.44 Aligned_cols=276 Identities=17% Similarity=0.180 Sum_probs=173.4
Q ss_pred cChHHHHH------HhcCccccceeccCCeEEEEEeEEC------CcceEEEeccccccHHHHHHHHHHHhcCCCceeee
Q 041031 2 FSYNEVRD------ATSNFSTSLKIGQGSYGSVYLGKLR------GKNAAIKQMKNTKSKEFSSELKILCKVHSNLIELI 69 (313)
Q Consensus 2 ~~~~~~~~------~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~aiK~~~~~~~~~~~~e~~~l~~lh~~i~~~~ 69 (313)
|+.+.++. ..++|.+.++||+|+||.||+|.+. +..+|+|.+......+......+.+..+.++....
T Consensus 116 ~~l~~l~~~~~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~ 195 (566)
T PLN03225 116 FVLAPLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFV 195 (566)
T ss_pred eeechhhhccCCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHH
Confidence 44455555 6679999999999999999999886 46899998875543332222222222222222222
Q ss_pred eE------EEeCCeEEEEEeecCCCChhhhhcCCCCC---------------CCCCccHHHHHHHHHHHHHHHHHHhcCC
Q 041031 70 GY------AAGGDSLFLVYEYAQNGALSDHLHWPSVK---------------GKKPLAWTTRVQIALDAAKGLEYIHQYT 128 (313)
Q Consensus 70 ~~------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~ 128 (313)
.. .......++|+||+++++|.+++...... .........+..++.|++.||.|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g 275 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG 275 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC
Confidence 11 24566789999999999999988532100 0011223456789999999999999999
Q ss_pred CCceEEeccCCCCeeeCC-CCcEEEeeccccccccCChhhhhhcccccccccccCCccccCC------------------
Q 041031 129 KPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG------------------ 189 (313)
Q Consensus 129 ~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------------------ 189 (313)
|+|+||||+|||+++ ++.+||+|||++........ .......+++.|+|||.+...
T Consensus 276 ---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~ 350 (566)
T PLN03225 276 ---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV 350 (566)
T ss_pred ---EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccch
Confidence 999999999999985 67899999999975443211 122335678999999976422
Q ss_pred ----CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC---CCH
Q 041031 190 ----CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR---YHK 262 (313)
Q Consensus 190 ----~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~---~~~ 262 (313)
.++.++||||+||++|+|+++..|+.... ......+.....+...+...+.....+.+.. ...
T Consensus 351 l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~----------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 420 (566)
T PLN03225 351 LWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNL----------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLD 420 (566)
T ss_pred hccccCCCCcccHHHHHHHHHHHhCcCCCchHH----------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhcc
Confidence 23456699999999999998765532110 0000111110000011111111000000000 000
Q ss_pred HHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 263 DSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 263 ~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.......+|+.+||+.||++|||+.++++.
T Consensus 421 ~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 421 LDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred ccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 012235589999999999999999999974
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=240.89 Aligned_cols=259 Identities=21% Similarity=0.303 Sum_probs=197.8
Q ss_pred cceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCCCC
Q 041031 17 SLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQNGA 89 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (313)
.+.||+|.++.|-.+... +..||||++.+.. ..++.+|++++.+. |+||+.++++|+++...|||||.+.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 468999999999988765 8899999997653 56688999999999 9999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC---cEEEeeccccccccCChh
Q 041031 90 LSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF---RAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 90 L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~---~~~l~dfg~~~~~~~~~~ 166 (313)
|.+.+ .+...+++.++..+.++++.||.+||.+| |.|+|+||+|||-.+.. -|||+||.+......+..
T Consensus 163 lLshI-----~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 163 LLSHI-----QKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred HHHHH-----HHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99998 45678999999999999999999999999 99999999999986543 479999988765433222
Q ss_pred hh----hhcccccccccccCCcccc-----CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 167 IA----AAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 167 ~~----~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
.. ..--...|+-.|||||+.. ...|+.+.|.||||+++|-|++|.+||.+.-..+..+... ..-... +.
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG-e~Cr~C-Q~ 312 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG-EVCRVC-QN 312 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC-CccHHH-HH
Confidence 11 1111246778999999874 2458999999999999999999999999887755443332 111111 11
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+...+.+....-...-....+....+|++..|..|+.+|.++.+++.
T Consensus 313 ------~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 313 ------KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ------HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111111111111123334556778999999999999999998886
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=243.22 Aligned_cols=268 Identities=22% Similarity=0.332 Sum_probs=195.2
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEE--------
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAA-------- 73 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~-------- 73 (313)
..+.|....++|+|.||.||+|+.+ ++.||+|++--+ -.....+|+.+|..+ |+|++.+++.+.
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 4578899999999999999999877 777888765432 244577899999999 999998887763
Q ss_pred eCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEe
Q 041031 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIA 153 (313)
Q Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~ 153 (313)
+...+++||++++. +|.-++. .....++...+..+++++..+|.|+|+.. |+|+|+||.|++++.+|.++|+
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLs----n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLS----NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhc----CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEee
Confidence 34468999999954 7888884 34467899999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCChh-hhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhH
Q 041031 154 DFGLVKLLEHSPE-IAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 154 dfg~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~ 231 (313)
|||++..+..... ....-.....|.+|++||.+.|. .|+++.|||+.||++.+|+|+.+.|.++.... ....+
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq-----ql~~I 241 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ-----QLHLI 241 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH-----HHHHH
Confidence 9999965543322 12222335679999999999874 58999999999999999999999998776521 00011
Q ss_pred HHHHHHHhcCcHHHHHHh---hhh------------cCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 232 VDYMLAVFNDTKDFMAKL---TEC------------LDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l---~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...+.+..++.+.....+ .++ +...+.. -.......+|+.++|..||.+|+.+.+++..
T Consensus 242 s~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp--~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 242 SQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKP--YVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhccc--ccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111111111111111 000 0000100 0012356789999999999999999998854
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=263.64 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=211.8
Q ss_pred hHHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc--CCCceeeeeEEE----
Q 041031 4 YNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV--HSNLIELIGYAA---- 73 (313)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l--h~~i~~~~~~~~---- 73 (313)
++.+.+..+.|++.+.+|.|.+|.||+++.. ++.+|+|++..+. .+++..|.++++.+ |||++.+++++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 5667778899999999999999999999876 7888888887654 66788999999999 999999999985
Q ss_pred -eCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEE
Q 041031 74 -GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKI 152 (313)
Q Consensus 74 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l 152 (313)
.++.++||||||.+||.-|+++... +..+.++.+..+++.++.++.|||.+. ++|+|||-.|||++.++.|||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 3567999999999999999996442 678999999999999999999999999 999999999999999999999
Q ss_pred eeccccccccCChhhhhhcccccccccccCCccccCC-----CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcccc
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-----CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE 227 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~ 227 (313)
+|||.+....... .......||+.|+|||++... .|+.++|+||||++..||.-|.+|+...-+.
T Consensus 165 vDFGvSaQldsT~---grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------- 234 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV---GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------- 234 (953)
T ss_pred eeeeeeeeeeccc---ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------
Confidence 9999988766543 344456899999999999743 4788999999999999999999999766542
Q ss_pred chhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 228 HRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.....-.-.|...- .+...+.++.++|..||-.|-.+||+..++++
T Consensus 235 ------------------raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 ------------------RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------------------hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111111222222 36677788999999999999999999998874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=254.08 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=198.8
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----------cHHHHHHHHHHHhc-CCCceeeeeEEE-
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----------SKEFSSELKILCKV-HSNLIELIGYAA- 73 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----------~~~~~~e~~~l~~l-h~~i~~~~~~~~- 73 (313)
+.+-++|..+.+||+|||+.||+|.+- .+.||+|+-.... .....+|.+|-+.| ||.||+++++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 345678999999999999999999887 7788999864321 12256799999999 999999999996
Q ss_pred eCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcE
Q 041031 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRA 150 (313)
Q Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~ 150 (313)
+.+.+|-|+||++|.+|+=+| .....+++++++.++.|++.||.||.... +||+|-|+||.|||+-. -|.+
T Consensus 539 DtdsFCTVLEYceGNDLDFYL-----KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYL-----KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred ccccceeeeeecCCCchhHHH-----HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCccccee
Confidence 556788999999999999888 56778999999999999999999999996 45999999999999953 4789
Q ss_pred EEeeccccccccCChhhh----hhcccccccccccCCccccC----CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCC
Q 041031 151 KIADFGLVKLLEHSPEIA----AAASRIVGTFGYLAPEYVRD----GCVTTKSDVYAFGVVLMELITGQQALSRDANPGN 222 (313)
Q Consensus 151 ~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~ 222 (313)
||.|||++....+..... .-.+...||++|+|||.+.- ++++.+.||||+|+++|.++.|+.||+.+...
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-- 690 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-- 690 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--
Confidence 999999999877554321 22334579999999998853 45789999999999999999999999865432
Q ss_pred CccccchhHHHHHHHHhcCcHHHHHHhhh--hcCCC-CCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 223 NQYTEHRSLVDYMLAVFNDTKDFMAKLTE--CLDPN-LTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~-~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+.+.+ .+... +.- ..+..+.....+|++||++..++|....+++.
T Consensus 691 -----------------------QdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 691 -----------------------QDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -----------------------HHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111 11111 111 23344556778999999999999998888763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=271.10 Aligned_cols=244 Identities=26% Similarity=0.360 Sum_probs=196.4
Q ss_pred ccccceeccCCeE-EEEEeEECCcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCCCCh
Q 041031 14 FSTSLKIGQGSYG-SVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 14 y~~~~~lg~g~~g-~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (313)
|...+.+|.|+.| .||+|...++.||||.+-.+..+.+++|+..|+.- ||||++.++.-.+....|+..|.|. .+|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL 589 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSL 589 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhH
Confidence 4446778899886 57899999999999999999889999999999999 9999999999999999999999995 599
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---C--CcEEEeeccccccccCCh
Q 041031 91 SDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---N--FRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 91 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~--~~~~l~dfg~~~~~~~~~ 165 (313)
.+++... ........-...+.++.|++.||+|||+.+ |||+|+||.||||+. + .+++|+|||++.......
T Consensus 590 ~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 590 QDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999653 111111222456788999999999999999 999999999999975 3 468999999999988766
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhC-CCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG-QQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
..-.......||.+|+|||++....-+.++|||||||++|+.++| .+||+.....
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R------------------------ 721 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER------------------------ 721 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh------------------------
Confidence 655556667899999999999998888899999999999999885 8999754432
Q ss_pred HHHHhhhhcCCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 041031 245 FMAKLTECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAA 290 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll 290 (313)
...+ +..+..- ..........+||.+|++.+|..||+|.+|+
T Consensus 722 -~~NI---l~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 722 -QANI---LTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -hhhh---hcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 1111 1111111 1111111677899999999999999999998
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=259.86 Aligned_cols=239 Identities=22% Similarity=0.310 Sum_probs=201.9
Q ss_pred HhcCccccceeccCCeEEEEEeEECCcc--eEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRGKN--AAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~--~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..+++.++..||-|+||.|=++..+++. +|+|++++.. .+.+..|-++|..+ .|.||+++.+|.+.+.+|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 4567888899999999999999888544 8999887542 44577899999999 8999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
.||.|-||.|+..+ +..+.+.....+-+...+++|+.|||+++ |+++|+||+|++++.+|-+||.|||.+..
T Consensus 498 LmEaClGGElWTiL-----rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 498 LMEACLGGELWTIL-----RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hHHhhcCchhhhhh-----hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHH
Confidence 99999999999999 56678999999999999999999999999 99999999999999999999999999998
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
...+. ....++|||.|.|||++.+..++.+.|.||||+++||+++|.+||.+.++-
T Consensus 570 i~~g~----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-------------------- 625 (732)
T KOG0614|consen 570 IGSGR----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-------------------- 625 (732)
T ss_pred hccCC----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH--------------------
Confidence 87653 445678999999999999999999999999999999999999999987763
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD 285 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 285 (313)
.....+...++.. .++........+|+++..+.+|.+|..
T Consensus 626 ---ktYn~ILkGid~i--~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 626 ---KTYNLILKGIDKI--EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---HHHHHHHhhhhhh--hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1122222222221 123334455678999999999999975
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=244.60 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=194.0
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEecccccc----HHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS----KEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~----~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+.+-+..||.|.||+|++-.++ |+..|||.++.... .++..|.+...+- .||||+++|..-.+...++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3445678999999999999888 88899999986643 3355566544444 89999999999988999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+ ..||+.+.......+...+++..+-.+....+.||.||...-+ ++|+|+||+|||++..|.+||+|||++-...++
T Consensus 145 M-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 M-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred H-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 9 5688876644333455678999999999999999999988754 999999999999999999999999998765543
Q ss_pred hhhhhhcccccccccccCCcccc--CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVR--DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
- ....-.|-..|+|||.+. +..|+.+||+||||++|||+.||..|+...+. +++.+..+-...
T Consensus 222 i----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----------vfeql~~Vv~gd 286 (361)
T KOG1006|consen 222 I----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----------VFEQLCQVVIGD 286 (361)
T ss_pred H----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----------HHHHHHHHHcCC
Confidence 2 222235778899999985 34599999999999999999999999975542 222222221111
Q ss_pred HHHHHHhhhhcCCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+ +.+.. -....+..+.++|..||-.|-++||+..++++.
T Consensus 287 p-----------p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 287 P-----------PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred C-----------CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 11111 223466789999999999999999999998865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=236.51 Aligned_cols=231 Identities=32% Similarity=0.459 Sum_probs=188.6
Q ss_pred CeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCChhhhhcC
Q 041031 24 SYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHW 96 (313)
Q Consensus 24 ~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 96 (313)
+||.||+|.+. ++.+++|.+.... .+.+.+|++.++.+ |+|++++++.+......++++|++++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~- 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK- 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH-
Confidence 58999999987 5889999997654 46788999999999 9999999999999999999999999999999984
Q ss_pred CCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccc
Q 041031 97 PSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176 (313)
Q Consensus 97 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 176 (313)
....++...++.++.+++.++.+||+.+ ++|+||+|+||++++++.++++|||.+....... ......+
T Consensus 80 ----~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~ 148 (244)
T smart00220 80 ----KRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVG 148 (244)
T ss_pred ----hccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccC
Confidence 2233889999999999999999999999 9999999999999999999999999988765432 2223457
Q ss_pred cccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCC
Q 041031 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPN 256 (313)
Q Consensus 177 ~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 256 (313)
+..|+|||.+.+..++.++|+|++|++++++++|..||...... . .....+. ...
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--------~--------------~~~~~~~---~~~ 203 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--------L--------------ELFKKIG---KPK 203 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--------H--------------HHHHHHh---ccC
Confidence 88999999999888999999999999999999999999653221 0 1111111 111
Q ss_pred CCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 257 LTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 257 ~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
... ........+.+++.+||..+|++||++.++++
T Consensus 204 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 204 PPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 111 11115567889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=247.11 Aligned_cols=238 Identities=26% Similarity=0.390 Sum_probs=196.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV--HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~ 79 (313)
-.++|..+.+||+|+||.|-+|+.+ .+.+|||+++++- .+-...|.++|... .|.++++...|+.-+++|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3568889999999999999999988 4679999998653 22244566677666 789999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+||||++||+|...+ ++-+.+.+..+.-++..|+.+|-+||++| |+++|+|.+||+++.+|++||+|||++.
T Consensus 427 FVMEyvnGGDLMyhi-----QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHI-----QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eEEEEecCchhhhHH-----HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999988 56788999999999999999999999999 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
.---. ......+.|||.|+|||++..++|+.+.|.||+|++||||+.|++||.+.+..
T Consensus 499 Eni~~---~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~------------------- 556 (683)
T KOG0696|consen 499 ENIFD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------------------- 556 (683)
T ss_pred ccccC---CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-------------------
Confidence 53322 23455678999999999999999999999999999999999999999877653
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD 285 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 285 (313)
....+..+.+.. .....+.+...+.+..|-..|.+|..
T Consensus 557 -------elF~aI~ehnvs-yPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 557 -------ELFQAIMEHNVS-YPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -------HHHHHHHHccCc-CcccccHHHHHHHHHHhhcCCccccC
Confidence 111122222211 24455566777889999999999964
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=262.23 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=210.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC------CcceEEEecccc----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR------GKNAAIKQMKNT----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~------~~~~aiK~~~~~----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
..+....++||+|.||+||+|.|- +-+||||++... +..++.+|+-+|..+ |||++++++++.... +.
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 345667889999999999999886 346899988643 356688999999999 999999999998776 88
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
||++|++.|+|.+++. .+..++..+..+.|..||++|+.|||.++ ++||||-.+|+||.+-..+|+.|||++.
T Consensus 774 lvtq~mP~G~LlDyvr----~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ 846 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVR----EHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAK 846 (1177)
T ss_pred HHHHhcccchHHHHHH----HhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhh
Confidence 9999999999999996 45678999999999999999999999999 9999999999999999999999999999
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
....... ......-...+-|+|-|.+....++..+||||+|+++||++| |..|+.+....
T Consensus 847 ll~~d~~-ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------------------ 907 (1177)
T KOG1025|consen 847 LLAPDEK-EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------------------ 907 (1177)
T ss_pred ccCcccc-cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------------------
Confidence 8765433 222222345677999999999999999999999999999998 99999876553
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
++.+.+....+ + .-...+..+++.++.+||..|+..||+++++.+++.++.-+.
T Consensus 908 -----eI~dlle~geR--L-sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 908 -----EIPDLLEKGER--L-SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred -----HhhHHHhcccc--C-CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 32333322111 2 235567788999999999999999999999999999876543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=228.55 Aligned_cols=267 Identities=20% Similarity=0.292 Sum_probs=199.8
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEeC--CeEEEEEe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAGG--DSLFLVYE 83 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~--~~~~lv~e 83 (313)
..++|++++++|+|.+|.||.|... +++++||++++.....+.+|+.+|+.+ ||||+++++...+. ....||+|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 4578999999999999999999854 889999999999999999999999999 99999999998654 56889999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-CCcEEEeecccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLLE 162 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~ 162 (313)
+++..+...+. ..++...+..++.+++.||.|||+.| |.|+|+||.|++++. .-.++|+|+|+|.+..
T Consensus 116 ~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 116 YVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99887777665 55788889999999999999999999 999999999999985 4568999999999988
Q ss_pred CChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccch-----hHHHHHH
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHR-----SLVDYML 236 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~~ 236 (313)
.....+ -...+..|--||.+.. +.|+.+-|+|||||.+..|+..+.||........+.....+ .+..++.
T Consensus 185 p~~eYn----VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 185 PGKEYN----VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCceee----eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 654322 2356778999998875 55889999999999999999999887655432211111111 1111111
Q ss_pred HHh-cCcHHHHHHhhhhcCCCCCC----C-CHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 237 AVF-NDTKDFMAKLTECLDPNLTR----Y-HKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 237 ~~~-~~~~~~~~~l~~~~~~~~~~----~-~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
..- .-.+++...+..--...... . ..-...+..+|+.+.|.+|-.+|+|++|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 110 11111111111110100000 0 1112356788999999999999999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=229.83 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=195.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~l 80 (313)
..+|..+++||+|++..|..++.+ .+-+|+|++++.- .+=++.|..+..+- ||.+|.+...|+..+++++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357999999999999999999987 5678999987532 23367888888888 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
|.||.+||+|.-.+ ++...++++.++-+...|+.||.|||++| |+++|+|.+|++++..|.+||.|+|.+..
T Consensus 329 vieyv~ggdlmfhm-----qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM-----QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeeh-----hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999998777 45567999999999999999999999999 99999999999999999999999999876
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
.-..+ ...+.+.|||.|.|||++.+..|+.+.|.|+||++++||+.|+.||.-......+...+ +++-++
T Consensus 401 ~l~~g---d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nte-----dylfqv-- 470 (593)
T KOG0695|consen 401 GLGPG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTE-----DYLFQV-- 470 (593)
T ss_pred CCCCC---cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchh-----HHHHHH--
Confidence 44332 34566789999999999999999999999999999999999999997555332222221 111111
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP 284 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 284 (313)
. ++...+ .+...+-....+++..|..||.+|.
T Consensus 471 -------i----lekqir-iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 471 -------I----LEKQIR-IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -------H----hhhccc-ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1 111111 1222333445688899999999986
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=231.85 Aligned_cols=127 Identities=23% Similarity=0.435 Sum_probs=109.3
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc---C------CCceeeeeEEE----e
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV---H------SNLIELIGYAA----G 74 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l---h------~~i~~~~~~~~----~ 74 (313)
.+|.+.++||.|.|++||+|.+. .+.||+|+.+... .+....|+.+|+++ . .+||++++.|. +
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 57999999999999999999998 6789999988654 55678899999998 2 25999999996 4
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL 144 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 144 (313)
..++++|+|++ |.+|..+|.. .....++...+++|++|++.+|.|||..-+ |+|.||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~---s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKY---SNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHH---hCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 56899999999 6688887742 356779999999999999999999998743 9999999999997
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=237.09 Aligned_cols=277 Identities=21% Similarity=0.299 Sum_probs=203.9
Q ss_pred hHHHHHHhcCccccceeccCCeEEEEEeEEC-----CcceEEEecccc-ccHHHHHHHHHHHhc--CCCceeeeeEEEeC
Q 041031 4 YNEVRDATSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNT-KSKEFSSELKILCKV--HSNLIELIGYAAGG 75 (313)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~-~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~ 75 (313)
++++..+...|..+++||.|+|++||++.+. ++.||+|.+... .+..+..|+++|..+ +.||+++.+.+..+
T Consensus 28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 4567788899999999999999999999764 567999998765 477899999999999 99999999999999
Q ss_pred CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC-CCCcEEEee
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD-SNFRAKIAD 154 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~~l~d 154 (313)
+.+.+|+||++.....++. ..++...+..++..++.||+++|.+| |+|+||||+|++.+ ..++-.|+|
T Consensus 108 d~v~ivlp~~~H~~f~~l~--------~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLY--------RSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred CeeEEEecccCccCHHHHH--------hcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEe
Confidence 9999999999998888887 34668889999999999999999999 99999999999998 467889999
Q ss_pred ccccccccCCh------h-----------------------------------hhhhcccccccccccCCccccC-CCCC
Q 041031 155 FGLVKLLEHSP------E-----------------------------------IAAAASRIVGTFGYLAPEYVRD-GCVT 192 (313)
Q Consensus 155 fg~~~~~~~~~------~-----------------------------------~~~~~~~~~~~~~~~aPE~~~~-~~~~ 192 (313)
||++....... . .........||++|+|||++.. +..+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99988211000 0 0000112469999999999975 5578
Q ss_pred CccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH---------------HHhcCcHHHHHHhhhh----c
Q 041031 193 TKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML---------------AVFNDTKDFMAKLTEC----L 253 (313)
Q Consensus 193 ~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~l~~~----~ 253 (313)
.++||||.|+++.-++++++||....+.......+......... ...+...+........ +
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 99999999999999999999986554422111111000000000 0000111111111111 1
Q ss_pred CC----CCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 254 DP----NLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 254 ~~----~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+ ++.. +..-.+..+.+|+++|+..||.+|.|++++|+
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 11 1111 23333447899999999999999999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-31 Score=240.03 Aligned_cols=264 Identities=17% Similarity=0.208 Sum_probs=175.3
Q ss_pred HhcCccccceeccCCeEEEEEeEE------------------CCcceEEEecccccc-----------------HHHHHH
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKL------------------RGKNAAIKQMKNTKS-----------------KEFSSE 54 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~------------------~~~~~aiK~~~~~~~-----------------~~~~~e 54 (313)
..++|.+.++||+|+||.||+|.+ .++.||||.+..... +....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357999999999999999999964 145799999865431 112235
Q ss_pred HHHHHhc-CCC-----ceeeeeEEEe--------CCeEEEEEeecCCCChhhhhcCCCCC-------------------C
Q 041031 55 LKILCKV-HSN-----LIELIGYAAG--------GDSLFLVYEYAQNGALSDHLHWPSVK-------------------G 101 (313)
Q Consensus 55 ~~~l~~l-h~~-----i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~ 101 (313)
+.++.++ |.+ ++++++++.. ....++||||+++++|.+++...... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 5666666 443 3566666542 34679999999999999988532110 1
Q ss_pred CCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhccccccccccc
Q 041031 102 KKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181 (313)
Q Consensus 102 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (313)
...+++..++.++.|++.+|.|||+.+ ++|+||||+||+++.++.++++|||++........ ........++.|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~g~~tp~Y~ 377 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--FNPLYGMLDPRYS 377 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc--cCccccCCCccee
Confidence 123456778899999999999999999 99999999999999999999999999865433211 1111123478999
Q ss_pred CCccccCCC--------------------C--CCccchhhHHHHHHHHHhCCC-CccCCCCCCCCccccchhHHHHHHHH
Q 041031 182 APEYVRDGC--------------------V--TTKSDVYAFGVVLMELITGQQ-ALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 182 aPE~~~~~~--------------------~--~~~~DiwslG~~l~~~~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
|||.+.... + ..+.|+||+||++|+|++|.. ||................+..|..
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-- 455 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-- 455 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--
Confidence 999886422 1 234799999999999999875 664322111000000011111100
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCc---CCCCCHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENW---KRRPDMSNAAIR 292 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~Rps~~~ll~~ 292 (313)
.... ..... .....+....+|+.++|..+| .+|+|++|+|+.
T Consensus 456 ---------~~~~--~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 ---------YKGQ--KYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ---------hccc--CCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0000 00110 112234567889999999866 689999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=213.43 Aligned_cols=205 Identities=38% Similarity=0.627 Sum_probs=180.6
Q ss_pred eccCCeEEEEEeEEC--CcceEEEecccccc----HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCChhh
Q 041031 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKS----KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSD 92 (313)
Q Consensus 20 lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~----~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (313)
||.|++|.||++... ++.+++|.+..... ..+.+|++.++.+ |++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999998 88999999988765 6788999999999 9999999999999999999999999899999
Q ss_pred hhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-CCcEEEeeccccccccCChhhhhhc
Q 041031 93 HLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLLEHSPEIAAAA 171 (313)
Q Consensus 93 ~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~ 171 (313)
++... ...++...++.++.+++.++++||+.+ ++|+||+|.||+++. ++.++++|||.+........ ..
T Consensus 81 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~ 150 (215)
T cd00180 81 LLKEN----EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LL 150 (215)
T ss_pred HHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hh
Confidence 98421 146889999999999999999999999 999999999999999 89999999999886654321 12
Q ss_pred ccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhh
Q 041031 172 SRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLT 250 (313)
Q Consensus 172 ~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (313)
....+...|++||.+... ..+.++|+|++|++++++
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 234578899999999877 788999999999999999
Q ss_pred hhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 251 ECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
..+.+++.+|++.+|.+||++.++++.
T Consensus 188 ---------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 247779999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=239.82 Aligned_cols=193 Identities=26% Similarity=0.411 Sum_probs=169.8
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----------cHHHHHHHHHHHhc----CCCceeeeeEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----------SKEFSSELKILCKV----HSNLIELIGYA 72 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----------~~~~~~e~~~l~~l----h~~i~~~~~~~ 72 (313)
..++|+.++.+|.|.||.|++|.++ ...|+||.+.+.+ ...+-.|++||..+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3567999999999999999999998 5568999887654 22356799999999 89999999999
Q ss_pred EeCCeEEEEEeecC-CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEE
Q 041031 73 AGGDSLFLVYEYAQ-NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAK 151 (313)
Q Consensus 73 ~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~ 151 (313)
++++.+||+||... +.+|.+++ .....+++..+..+++|++.++++||+++ |+|||||-+|+.++.+|-+|
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~I-----E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFI-----EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhh-----hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEE
Confidence 99999999999653 46788888 45678999999999999999999999999 99999999999999999999
Q ss_pred EeeccccccccCChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCcc
Q 041031 152 IADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALS 215 (313)
Q Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~ 215 (313)
|+|||.+....+ .....+.||..|.|||++.|.+| +..-|||+||++||.+.....||.
T Consensus 711 lidfgsaa~~ks-----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 711 LIDFGSAAYTKS-----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EeeccchhhhcC-----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999886554 34456789999999999999887 677899999999999999999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=223.18 Aligned_cols=263 Identities=21% Similarity=0.275 Sum_probs=204.3
Q ss_pred HHHHHHhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEE
Q 041031 5 NEVRDATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYA 72 (313)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~ 72 (313)
+++..-.++++..-++-+|.||.||.|.|. .+.+.+|.++... ...+..|.-++..+ |||+..+.++.
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 455566677888999999999999999776 2346777776543 22344565555556 99999999987
Q ss_pred E-eCCeEEEEEeecCCCChhhhhcCCC---CCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC
Q 041031 73 A-GGDSLFLVYEYAQNGALSDHLHWPS---VKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF 148 (313)
Q Consensus 73 ~-~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~ 148 (313)
. +....+.++.+.+-|+|..++...+ .+....++-.+...++.|++.|++|||..+ ++|.||..+|.++++.-
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 4 5567889999999999999985222 123345677788899999999999999999 99999999999999999
Q ss_pred cEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCcccc
Q 041031 149 RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTE 227 (313)
Q Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~ 227 (313)
++||+|=.+++..-+..... -......+..|++||.+....|+..+|+||||+++|||+| |+.|+...++.
T Consensus 434 qVkltDsaLSRDLFP~DYhc-LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf------- 505 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHC-LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF------- 505 (563)
T ss_pred eEEeccchhccccCcccccc-cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-------
Confidence 99999988877654432211 1122245678999999999999999999999999999999 99999876653
Q ss_pred chhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 228 HRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
+....+. +...-.-+.+++.+|+.++.-||+..|++||+++++..-|.++-
T Consensus 506 ----------------Em~~ylk---dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 506 ----------------EMEHYLK---DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ----------------HHHHHHh---ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 2222222 22211235678899999999999999999999999999887653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=235.30 Aligned_cols=201 Identities=26% Similarity=0.400 Sum_probs=170.9
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
+-|..++.||-|.||.|.+++.. ...||.|.+++.+ ...+..|-.||..- ++=||+++-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 45888999999999999999765 6678999887543 33456777888887 888999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
+|++||++..+| -+.+-+.+.-++-++..+..|+.+.|..| ++|+||||+|||||.+|+|||.|||++.-+.
T Consensus 709 dYIPGGDmMSLL-----IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 709 DYIPGGDMMSLL-----IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eccCCccHHHHH-----HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence 999999999998 46678899999999999999999999999 9999999999999999999999999976432
Q ss_pred CC--------hh----------------------hh---------hhcccccccccccCCccccCCCCCCccchhhHHHH
Q 041031 163 HS--------PE----------------------IA---------AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVV 203 (313)
Q Consensus 163 ~~--------~~----------------------~~---------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~ 203 (313)
-. ++ +. .......||+.|+|||++....++..+|.||.|++
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 10 00 00 01112579999999999999999999999999999
Q ss_pred HHHHHhCCCCccCCCCC
Q 041031 204 LMELITGQQALSRDANP 220 (313)
Q Consensus 204 l~~~~tg~~p~~~~~~~ 220 (313)
||+|+.|+.||-...+.
T Consensus 861 l~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPG 877 (1034)
T ss_pred HHHHhhCCCCccCCCCC
Confidence 99999999999877654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=219.10 Aligned_cols=260 Identities=23% Similarity=0.277 Sum_probs=198.3
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeC-----
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGG----- 75 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~----- 75 (313)
.+..+|..++.+|.|.- .|..|.+. +++|++|..... ......+|+.++..+ |+|+++++.+|.-.
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 35678999999999998 77777776 889999987543 355688999999999 99999999998644
Q ss_pred -CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 76 -DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 76 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
...|+|||++ ..+|.+.+. ..++-+.+..++.|++.|++|||+.+ |+|+|+||+||++..+..+|+.|
T Consensus 93 ~~e~y~v~e~m-~~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 93 FQEVYLVMELM-DANLCQVIL-------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred HHhHHHHHHhh-hhHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeecc
Confidence 3579999999 568988873 45677788999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
||++...... ...+....+..|+|||++.+..+.+..||||+||++.||++|+..|.+.+-.+ +....
T Consensus 162 fg~ar~e~~~----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id--------Q~~ki 229 (369)
T KOG0665|consen 162 FGLARTEDTD----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHID--------QWNKI 229 (369)
T ss_pred chhhcccCcc----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHH--------HHHHH
Confidence 9998864432 23334467899999999999889999999999999999999999998654422 11111
Q ss_pred HHHHhcCcHHHHHHhhhh--------------------cCCC---CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 235 MLAVFNDTKDFMAKLTEC--------------------LDPN---LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~--------------------~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
....-.-.+.+.+.+... -+.. ..+...-....+++|+.+||-.||++|.|+.++|.
T Consensus 230 ~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 230 IEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 122222222222222110 0111 11122234467888999999999999999999986
Q ss_pred H
Q 041031 292 R 292 (313)
Q Consensus 292 ~ 292 (313)
.
T Consensus 310 H 310 (369)
T KOG0665|consen 310 H 310 (369)
T ss_pred C
Confidence 4
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=208.36 Aligned_cols=205 Identities=23% Similarity=0.354 Sum_probs=169.8
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeE
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~ 78 (313)
++...+....+..||+|++|.|-+.++. |...|+|.+...- ..+..+|+.+.... +|.+|++++.......+
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4455677778889999999999888877 7888999886442 44466788877777 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++.||.+ ..||+.+.... ...++.+++..+-+++..++.||.|||++-. ++|+|+||+|||++.+|++|++|||++
T Consensus 121 wIcME~M-~tSldkfy~~v-~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKV-LKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEeHHHh-hhhHHHHHHHH-HhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccc
Confidence 9999999 56887665322 2456789999999999999999999999843 999999999999999999999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccC----CCCCCccchhhHHHHHHHHHhCCCCccCCCC
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRD----GCVTTKSDVYAFGVVLMELITGQQALSRDAN 219 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~ 219 (313)
-...++-- .+...|-..|+|||.+.. ..|+.+|||||||+++.||.+++.||.....
T Consensus 197 G~L~dSiA----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 197 GYLVDSIA----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eeehhhhH----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 87765422 122356788999998863 3689999999999999999999999987665
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=218.31 Aligned_cols=262 Identities=23% Similarity=0.362 Sum_probs=196.6
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccc-----cccHHHHHHHHHHHhc-CCCceeeeeEEEeCC-----eEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKN-----TKSKEFSSELKILCKV-HSNLIELIGYAAGGD-----SLF 79 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~-----~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~-----~~~ 79 (313)
+.+.-+.||.|.||+||.+.+. |+.|++|.+.. .+...+.+|+.+|... |.|++..++...-.+ .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4566789999999999999987 89999998864 3567789999999999 999999988765433 356
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
.++|.+ ..+|..++ -....++...+.-++.||+.+|.|||+.+ |.|+||||.|++++.+..+|++|||++.
T Consensus 134 V~TELm-QSDLHKII-----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 134 VLTELM-QSDLHKII-----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHH-Hhhhhhee-----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccc
Confidence 788888 55888887 35577899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
........ .......|..|+|||+++|. .|+...||||.||++.|++..+..|..-++.. ..+.+...
T Consensus 205 vee~d~~~--hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq---------QL~lItdL 273 (449)
T KOG0664|consen 205 TWDQRDRL--NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE---------QLQMIIDL 273 (449)
T ss_pred ccchhhhh--hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH---------HHHHHHHH
Confidence 76543322 22223568899999999974 58999999999999999999999997766531 11222222
Q ss_pred hcC-cHHHH---------HHhhhhcC-CCCCC-----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 239 FND-TKDFM---------AKLTECLD-PNLTR-----YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 239 ~~~-~~~~~---------~~l~~~~~-~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
... ..+.+ ..+..... +.+.. ........-.+++.+++..||.+|.+..+.+..+.
T Consensus 274 LGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 274 LGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111 00111 11111111 11111 12233455677889999999999999998876543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=205.73 Aligned_cols=193 Identities=35% Similarity=0.559 Sum_probs=167.5
Q ss_pred ccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
|.+.+.||.|++|.||++... ++.+++|.+.... ...+.+|++.++.+ |+|++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 677899999999999999987 5889999998663 45678899999999 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCC-ccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 87 NGALSDHLHWPSVKGKKP-LAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~-l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
+++|.+++... .. ++...++.++.+++.++.+||+.+ ++|+|++|+||+++.++.++++|||.+.......
T Consensus 81 ~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 81 GGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999998522 22 788999999999999999999999 9999999999999999999999999888765432
Q ss_pred hhhhhcccccccccccCCccc-cCCCCCCccchhhHHHHHHHHHhCCCCccC
Q 041031 166 EIAAAASRIVGTFGYLAPEYV-RDGCVTTKSDVYAFGVVLMELITGQQALSR 216 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~~~tg~~p~~~ 216 (313)
. .......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 153 ~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 A--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred c--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0 012234567889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=233.47 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=201.3
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.-.++|..+..+|.|.+|.||+++++ ++..|+|+++... ...+++|+-+++.. ||||+.+++.+.-...+++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 34578999999999999999999998 8889999887654 44578899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+.+|+|.+.. ...+++++.++..+.+....+++|||+++ =+|||||-.||++++.|.+|++|||.+-...
T Consensus 92 EycgggslQdiy-----~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 92 EYCGGGSLQDIY-----HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EecCCCccccee-----eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh
Confidence 999999999987 35678999999999999999999999999 8999999999999999999999999877655
Q ss_pred CChhhhhhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
... .+...+.||+.|+|||+.. .+.|+..+|+|++|++.-++-.-++|....-+. .
T Consensus 164 ati---~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---------r--------- 222 (829)
T KOG0576|consen 164 ATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---------R--------- 222 (829)
T ss_pred hhh---hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---------H---------
Confidence 432 3445578999999999873 577999999999999999998877775322211 0
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...-...+..++.-..-.......+.+|++.||-.+|.+|||++.++.
T Consensus 223 ----~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 223 ----ALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ----HHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 001111112222211112233456777999999999999999988774
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=203.16 Aligned_cols=251 Identities=20% Similarity=0.355 Sum_probs=189.3
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc--ccHHHHHHHHHHHhc--CCCceeeeeE-EEeCCeEEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT--KSKEFSSELKILCKV--HSNLIELIGY-AAGGDSLFLV 81 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~--~~~~~~~e~~~l~~l--h~~i~~~~~~-~~~~~~~~lv 81 (313)
+..+.|.+.+.||+|.||.+-+++++ ++.+++|.+... ...++.+|..---.| |.||+.-+++ |+..+-++++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 46789999999999999999999999 567899988754 356678887544445 8899988876 5667788899
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC--CCCcEEEeeccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD--SNFRAKIADFGLVK 159 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~--~~~~~~l~dfg~~~ 159 (313)
+||++.|+|.+-+. ...+.+.....++.|+++|+.|+|+++ +||+|||.+||||. +..+|||+|||+..
T Consensus 101 qE~aP~gdL~snv~------~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE------AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eccCccchhhhhcC------cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccc
Confidence 99999999998873 356788888999999999999999999 99999999999994 44589999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccC-----CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRD-----GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
....... .......|.+||.... ....+.+|+|.||+++|.++||..||......+ +...+|
T Consensus 172 k~g~tV~------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-------~~Y~~~ 238 (378)
T KOG1345|consen 172 KVGTTVK------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-------KPYWEW 238 (378)
T ss_pred ccCceeh------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-------chHHHH
Confidence 6543322 2234667889997742 234788999999999999999999997433221 111111
Q ss_pred HHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 235 MLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
..... ...+.++......+..+.++.++-|..+|++|=...++.++-
T Consensus 239 -----------~~w~~-rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 239 -----------EQWLK-RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred -----------HHHhc-ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 11111 122344444555666788899999999999995555554443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=192.80 Aligned_cols=171 Identities=19% Similarity=0.218 Sum_probs=128.2
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
|+|.+++. .....+++..++.++.|++.||+|||+.+ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~----~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILE----VRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc--
Confidence 68889884 23457999999999999999999999996 999999999999999 99887654321
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (313)
..+++.|+|||++.+..++.++|||||||++|+|+||..||....... ..+.........
T Consensus 64 ------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-------~~~~~~~~~~~~------- 123 (176)
T smart00750 64 ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-------AILEILLNGMPA------- 123 (176)
T ss_pred ------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-------HHHHHHHHHhcc-------
Confidence 147899999999999999999999999999999999999996432210 111111111000
Q ss_pred HhhhhcCCCCCCCCHHHHH--HHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 248 KLTECLDPNLTRYHKDSML--QMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 248 ~l~~~~~~~~~~~~~~~~~--~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
..+.-......... .+.+++.+||+.+|.+||++.++++.+..+..+.
T Consensus 124 -----~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 124 -----DDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred -----CCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 00000001122222 5899999999999999999999999998876554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=236.67 Aligned_cols=194 Identities=18% Similarity=0.172 Sum_probs=134.0
Q ss_pred CCceeeeeEE-------EeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEe
Q 041031 63 SNLIELIGYA-------AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHR 135 (313)
Q Consensus 63 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~ 135 (313)
+||.++++++ .....+++++|+. +++|.+++. .....++...++.++.|++.||.|||+++ |+|+
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHr 104 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLD----NPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVH 104 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHh----cccccccHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 4677777766 2334677788987 669999995 23456899999999999999999999999 9999
Q ss_pred ccCCCCeeeCCCCcE-------------------EEeeccccccccCChh-----hh--------hhcccccccccccCC
Q 041031 136 DVKTSNILLDSNFRA-------------------KIADFGLVKLLEHSPE-----IA--------AAASRIVGTFGYLAP 183 (313)
Q Consensus 136 di~p~nil~~~~~~~-------------------~l~dfg~~~~~~~~~~-----~~--------~~~~~~~~~~~~~aP 183 (313)
||||+|||++..+.+ |++|||++........ .. .......+|+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 999999999655444 4555555432111000 00 000112468889999
Q ss_pred ccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHH
Q 041031 184 EYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKD 263 (313)
Q Consensus 184 E~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 263 (313)
|++.+..++.++|||||||++|||++|..|+..... ..... ....+.+. ...
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----------~~~~~--------------~~~~~~~~----~~~ 236 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----------TMSSL--------------RHRVLPPQ----ILL 236 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----------HHHHH--------------HHhhcChh----hhh
Confidence 999999999999999999999999998887642110 00000 00001010 011
Q ss_pred HHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 264 SMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 264 ~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.......++.+||..+|.+||++.|+++.
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 12335578889999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-24 Score=187.48 Aligned_cols=259 Identities=20% Similarity=0.264 Sum_probs=194.5
Q ss_pred CccccceeccCCeEEEEEeEECCc---ceEEEeccccc---cHHHHHHHHHHHhc-C----CCceeeeeEE-EeCCeEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLRGK---NAAIKQMKNTK---SKEFSSELKILCKV-H----SNLIELIGYA-AGGDSLFL 80 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~~~---~~aiK~~~~~~---~~~~~~e~~~l~~l-h----~~i~~~~~~~-~~~~~~~l 80 (313)
+|.+.++||+|+||.||.+.+... .+|+|.-.... ...+..|..++..+ . +++..+++.. .....-++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999998743 58888776542 22677888888888 2 4899999998 47777899
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC-----CcEEEeec
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN-----FRAKIADF 155 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~-----~~~~l~df 155 (313)
||+.+ |.+|.++..... ...++..++..++.|++.+|.++|+.| ++|+||||.|+++... -.+++.||
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99998 889999874222 478999999999999999999999999 9999999999999754 35899999
Q ss_pred ccccccc--CChhh---hh-h-cccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccc
Q 041031 156 GLVKLLE--HSPEI---AA-A-ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 156 g~~~~~~--~~~~~---~~-~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~ 228 (313)
|++.... ..... .. . .....||..|.++.+..+...+.+.|+||++.++.+++.|..||........
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~------ 245 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL------ 245 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch------
Confidence 9998332 22111 11 1 2345699999999999999999999999999999999999999965544210
Q ss_pred hhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
.. .+............ ....+..+..+...+-+.+..++|....+...+.+.....
T Consensus 246 --~~-----------~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 246 --KS-----------KFEKDPRKLLTDRF---GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred --HH-----------HHHHHhhhhccccc---cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00 00111111111101 1122234455555566689999999999999998887764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=188.57 Aligned_cols=165 Identities=15% Similarity=0.184 Sum_probs=127.5
Q ss_pred HHHHHhcCccccceeccCCeEEEEEeEEC---CcceEEEecccc--------ccHHHHHHHHHHHhc-CCCceeeeeEEE
Q 041031 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLR---GKNAAIKQMKNT--------KSKEFSSELKILCKV-HSNLIELIGYAA 73 (313)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~aiK~~~~~--------~~~~~~~e~~~l~~l-h~~i~~~~~~~~ 73 (313)
-++.+.++|.+.+.||+|+||.||+|.++ ++.+|||.+... ....+.+|+++|+.+ |+|++..+..
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 35677889999999999999999999874 566799986432 133478999999999 9998853322
Q ss_pred eCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEecc-CCCCeeeCCCCcEEE
Q 041031 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDV-KTSNILLDSNFRAKI 152 (313)
Q Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di-~p~nil~~~~~~~~l 152 (313)
....++||||++|++|.... .. . ...++.+++.+|.|||+.+ |+|+|| ||+||+++.++.++|
T Consensus 90 -~~~~~LVmE~~~G~~L~~~~-----~~-~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHLAR-----PH-G------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred -cCCcEEEEEccCCCCHHHhC-----cc-c------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEE
Confidence 24579999999999996321 11 1 1457889999999999999 999999 999999999999999
Q ss_pred eeccccccccCChhhhhh-----cccccccccccCCccccC
Q 041031 153 ADFGLVKLLEHSPEIAAA-----ASRIVGTFGYLAPEYVRD 188 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~ 188 (313)
+|||++............ -....+++.|++||.+..
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999876654322111 123457788999998863
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=175.58 Aligned_cols=247 Identities=19% Similarity=0.322 Sum_probs=188.9
Q ss_pred cCccccceeccCCeEEEEEeEECCcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
++...+.+|.....|..|+|+|+|..++.|++.... ..++..|.-.|+.+ ||||+.+++.+....++.++..|+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 345567789999999999999999998888886433 45678888888888 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEe--eccccccccC
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIA--DFGLVKLLEH 163 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~--dfg~~~~~~~ 163 (313)
+.|+|...+..+ .+--.+-.++.+++.+++.+++|||+..+. +.--.++...++++++.+.++. |--.+.
T Consensus 270 p~gslynvlhe~---t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsf---- 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSF---- 341 (448)
T ss_pred cchHHHHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeee----
Confidence 999999999522 334456778888999999999999999742 3344788999999998765543 322211
Q ss_pred ChhhhhhcccccccccccCCccccCCC---CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGC---VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
+.....-.|.|++||.+...+ .-.++|+|||++++||+.|...||....+-.
T Consensus 342 ------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme------------------- 396 (448)
T KOG0195|consen 342 ------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME------------------- 396 (448)
T ss_pred ------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-------------------
Confidence 111224578999999997654 3457899999999999999999998665531
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
--++.-.+.+.... .+..+..+..|+.-|+..||.+||.+..|.-.|+++.
T Consensus 397 ---cgmkialeglrv~i---ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 397 ---CGMKIALEGLRVHI---PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---hhhhhhhccccccC---CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11222233333333 3345567888999999999999999999998888764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=166.33 Aligned_cols=203 Identities=23% Similarity=0.322 Sum_probs=170.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEee
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
...+|.++++||.|+||.+|.|... |+.||||.-+... -..+..|..+++.+ ...|..+..+..+...-.+||+.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 4678999999999999999999876 8999999876553 44577899999999 56788888888888888999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcEEEeeccccccc
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLL 161 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~~~~~ 161 (313)
+ |.||++++... ...++.++++-++-|++.-+.|+|.++ ++|+||||+|++..- ...+.++|||++...
T Consensus 93 L-GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 93 L-GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred c-CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 9 77999988522 356899999999999999999999999 999999999999963 356899999999877
Q ss_pred cCChhhh----hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCC
Q 041031 162 EHSPEIA----AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANP 220 (313)
Q Consensus 162 ~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~ 220 (313)
.+..... .......||-+|.+--+..+-..+.+-|+=|+|.++.++.-|..||.+....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 6543211 1223356889999888888878889999999999999999999999988765
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-22 Score=174.34 Aligned_cols=254 Identities=31% Similarity=0.480 Sum_probs=194.8
Q ss_pred ccccceeccCCeEEEEEeEECCcceEEEeccccc------cHHHHHHHHHHHhc-CC-CceeeeeEEEeCCeEEEEEeec
Q 041031 14 FSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK------SKEFSSELKILCKV-HS-NLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~-~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
|.+.+.||.|+||.||++.+. ..+++|.+.... ...+.+|..++..+ |+ +++++.+.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 778899999999999999998 778888886442 44578899999999 66 7999999998888889999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC-cEEEeeccccccccCC
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF-RAKIADFGLVKLLEHS 164 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~~~~~~ 164 (313)
.++++.+++...... ..+.......++.|++.++.++|+.+ ++|+|+||+||+++..+ .++++|||.+......
T Consensus 81 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 81 DGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999777422111 37889999999999999999999999 99999999999999988 7999999998755433
Q ss_pred hhhhh---hcccccccccccCCccccC---CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 165 PEIAA---AASRIVGTFGYLAPEYVRD---GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 165 ~~~~~---~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
..... ......++..|.+||.+.+ ...+...|+|++|++++++++|..||......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~------------------ 217 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS------------------ 217 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc------------------
Confidence 22111 2345678999999999987 57889999999999999999999997655431
Q ss_pred hcCcHHHHHHhhhhcCC-CCCCCC----HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDP-NLTRYH----KDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~-~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.........+.....+ ...... ......+.+++..++..+|..|.+..+....
T Consensus 218 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 218 -SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000112222222211 111111 1223567789999999999999999887765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=166.57 Aligned_cols=203 Identities=21% Similarity=0.321 Sum_probs=173.0
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecc-ccccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeec
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMK-NTKSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~-~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
.-.|.+.++||+|+||.+|.|+.- ++.||||.=. +.+..++..|.+.++.| .++|..++-+......=.||+|.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 346999999999999999999876 8999999765 34567799999999999 899999998888888888999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-----CCcEEEeecccccc
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-----NFRAKIADFGLVKL 160 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-----~~~~~l~dfg~~~~ 160 (313)
|-||+|+++-. +..++.+++.-++.|++.-+.++|++. ++++||||+|+||.. ...|.++|||++..
T Consensus 107 -GPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 107 -GPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred -CcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 77999988522 356999999999999999999999999 999999999999963 23489999999998
Q ss_pred ccCChhhh----hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCC
Q 041031 161 LEHSPEIA----AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPG 221 (313)
Q Consensus 161 ~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~ 221 (313)
..+..... .......||-+||+---..+...+.+-|+=|||=++++++-|..||.+.....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 76543322 12233578999999888888889999999999999999999999999887753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.7e-23 Score=168.16 Aligned_cols=168 Identities=14% Similarity=0.125 Sum_probs=132.1
Q ss_pred HhcCccccceeccCCeEEEEEeEECCcceEEEeccccc--cHH----------HHHHHHHHHhc-CCCceeeeeEEEeC-
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK--SKE----------FSSELKILCKV-HSNLIELIGYAAGG- 75 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~--~~~----------~~~e~~~l~~l-h~~i~~~~~~~~~~- 75 (313)
+..+|.+.+++|.|+||.||++...+..+|||.+.+.. .+. +.+|++.+.++ |++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 45789999999999999999988878899999997542 111 46888899999 99999998886533
Q ss_pred -------CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC
Q 041031 76 -------DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF 148 (313)
Q Consensus 76 -------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~ 148 (313)
...+++|||++|.+|.++.. +++ ....+++.++..+|+.| ++|+|++|+||+++.+|
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 35789999999999988741 222 24669999999999999 99999999999999988
Q ss_pred cEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh
Q 041031 149 RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209 (313)
Q Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t 209 (313)
++++|||............ .++....++.++|+||||+++..+..
T Consensus 173 -i~liDfg~~~~~~e~~a~d---------------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAKD---------------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred -EEEEECCCcccccchhhHH---------------HHHHHhHhcccccccceeEeehHHHH
Confidence 9999999876543221110 02334456689999999999877653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-24 Score=199.57 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=186.5
Q ss_pred cccceeccCCeEEEEEeEEC--CcceEEEecc----ccc-cHH----HHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 15 STSLKIGQGSYGSVYLGKLR--GKNAAIKQMK----NTK-SKE----FSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 15 ~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~----~~~-~~~----~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
...+++|.|.+|.|+..... .+..+.|... +.. ... +..|+.+=..+ |+|++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 46789999999988877654 3333333322 222 111 33455555556 999887777776666555569
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++ +|..++. ....+....+-.+++|+..+++|+|+.| +.|+|+|++|++++.+|.+|++|||.+..+.
T Consensus 401 E~~~~-Dlf~~~~-----~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM-----SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHh-----cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence 99988 9999983 3357888899999999999999999999 9999999999999999999999999988766
Q ss_pred CChhh-hhhcccccccccccCCccccCCCCCCc-cchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 163 HSPEI-AAAASRIVGTFGYLAPEYVRDGCVTTK-SDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 163 ~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
..... ........|+..|+|||++.+..|++. .||||.|+++..|.+|+.||......+........ .
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~----------~ 541 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY----------S 541 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc----------c
Confidence 43221 133445678999999999999888765 69999999999999999999766554221100000 0
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccc-ccccccc
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW-EKMECCH 310 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~-~~~~~~~ 310 (313)
. ...+...........+..-+.++..||+.+|.+|.|+++|++ .+| ..+.||+
T Consensus 542 ~--------~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~---------d~W~~~i~~c~ 595 (601)
T KOG0590|consen 542 D--------QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN---------DEWIRSIECCH 595 (601)
T ss_pred c--------ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh---------ChHhhhcceEE
Confidence 0 000000111123344556777999999999999999999987 455 6667775
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-23 Score=175.09 Aligned_cols=231 Identities=19% Similarity=0.296 Sum_probs=147.3
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-----------CCCceeeeeEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-----------HSNLIELIGYA 72 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-----------h~~i~~~~~~~ 72 (313)
..+...+.||.|+++.||.+.+. ++.+++|+..... .+.+.+|......+ |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 34567889999999999999998 6899999875332 33344444333332 11233333332
Q ss_pred E------------eCC-----eEEEEEeecCCCChhhhhcCCCC--CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceE
Q 041031 73 A------------GGD-----SLFLVYEYAQNGALSDHLHWPSV--KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133 (313)
Q Consensus 73 ~------------~~~-----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~ 133 (313)
. +.+ +.+++|+-+ .++|.+++..-.. .....+.......+..|++..+++||..| ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 1 111 236788887 5688887531110 11233445555677799999999999999 99
Q ss_pred EeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccC--------CCCCCccchhhHHHHHH
Q 041031 134 HRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD--------GCVTTKSDVYAFGVVLM 205 (313)
Q Consensus 134 h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~~l~ 205 (313)
|+||+|+|++++.+|.++|+||+.......... . ...+..|.|||.... -.++.+.|.|+||+++|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceee----c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 999999999999999999999988775443211 1 234578999997743 24688899999999999
Q ss_pred HHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCC
Q 041031 206 ELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRR 283 (313)
Q Consensus 206 ~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 283 (313)
.|++|..||+.......... ....+. +.+..+..||.++|+.+|.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~~~~------------------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADPEW------------------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTSGG------------------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCccccccc------------------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999986544211100 223344 778889999999999999998
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-24 Score=198.96 Aligned_cols=248 Identities=19% Similarity=0.216 Sum_probs=182.2
Q ss_pred cCccccceeccCCeEEEEEeEECCcceEEEeccccc----cHHHHHHHHHHHhc---CCCceeeeeEEEeCCeEEEEEee
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK----SKEFSSELKILCKV---HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~----~~~~~~e~~~l~~l---h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.+|...+.||.+.|=.|.+|++....++||++-... ...+.++++-.+.. +||.+.+..+...++..|||-+|
T Consensus 23 ~e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 23 VECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred cceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 378899999999999999999996679999885433 44455544444433 99999998887777778888888
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
.. -+|.|.+ .....+...+.+.++.|++.||.-+|..| |+|||||.+|||++.-.-+.|.||.......-.
T Consensus 103 vk-hnLyDRl-----STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 103 VK-HNLYDRL-----STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred Hh-hhhhhhh-----ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCC
Confidence 85 4899988 45677888899999999999999999999 999999999999999888999999876533211
Q ss_pred hhhh----hhcccccccccccCCccccCC-----------CCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccc
Q 041031 165 PEIA----AAASRIVGTFGYLAPEYVRDG-----------CVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 165 ~~~~----~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~ 228 (313)
-++. ........-.+|.|||.+... ..+++-||||+||++.|+++ |++||.-
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------------ 241 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------------ 241 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------------
Confidence 1111 111222344689999988531 15678899999999999987 7888841
Q ss_pred hhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
-.+..+... ...+....+..+-+. .+++|+..|++.||++|.++++.|+.-.
T Consensus 242 SQL~aYr~~---~~~~~e~~Le~Ied~-----------~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 242 SQLLAYRSG---NADDPEQLLEKIEDV-----------SLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHHHhHhcc---CccCHHHHHHhCcCc-----------cHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 112121111 111222222222222 4777999999999999999999998733
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=158.71 Aligned_cols=135 Identities=19% Similarity=0.174 Sum_probs=106.0
Q ss_pred cceeccCCeEEEEEeEEC-CcceEEEecccccc------------H-----------------HHHHHHHHHHhc-CCCc
Q 041031 17 SLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKS------------K-----------------EFSSELKILCKV-HSNL 65 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~~------------~-----------------~~~~e~~~l~~l-h~~i 65 (313)
...||+|++|.||+|.+. |+.||||+++.... . ....|.+.+..+ ++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 468999999999999986 89999999875421 0 123488999999 7776
Q ss_pred eeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHH-hcCCCCceEEeccCCCCeee
Q 041031 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYI-HQYTKPYYVHRDVKTSNILL 144 (313)
Q Consensus 66 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~~i~h~di~p~nil~ 144 (313)
......... ..++||||++++++.... .....++...+..++.|++.+|.++ |+.+ ++|+||||+||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPR-----LKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchh-----hhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 444333222 238999999887766543 1235688899999999999999999 7999 9999999999999
Q ss_pred CCCCcEEEeecccccccc
Q 041031 145 DSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 145 ~~~~~~~l~dfg~~~~~~ 162 (313)
+ ++.++|+|||++....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=184.80 Aligned_cols=197 Identities=22% Similarity=0.276 Sum_probs=163.2
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccccHHHHHHHHHHHhc----CCCceeeeeEEEeCCeEEEE
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKSKEFSSELKILCKV----HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~~~~~~~e~~~l~~l----h~~i~~~~~~~~~~~~~~lv 81 (313)
++.-...|.|.+.+|+|++|.||.|... ++.+|+|+=++...=++.=-.+++.+| -+.|.++...+...+..+||
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 3445578999999999999999999877 889999998877643333223333444 36677888888888888999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC-------CCCcEEEee
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD-------SNFRAKIAD 154 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-------~~~~~~l~d 154 (313)
++|.+.|||.+++ ...+.+++..+..++.|++..+.+||..+ |+||||||+|+++. ++.-++|+|
T Consensus 773 ~ey~~~Gtlld~~-----N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 773 SEYSPYGTLLDLI-----NTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeccccccHHHhh-----ccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999 46778899999999999999999999999 99999999999994 234589999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCC
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQ 212 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~ 212 (313)
||.+..+.--+.. ......++|-.|-.+|+..|..++..+|-|.|+.+++.|+.|++
T Consensus 845 fG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9998766543332 34555688999999999999999999999999999999999964
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=152.96 Aligned_cols=137 Identities=19% Similarity=0.176 Sum_probs=108.2
Q ss_pred ccceeccCCeEEEEEeEEC-CcceEEEecccccc-----------------------------HHHHHHHHHHHhc-CCC
Q 041031 16 TSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKS-----------------------------KEFSSELKILCKV-HSN 64 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~~-----------------------------~~~~~e~~~l~~l-h~~ 64 (313)
+...||+|++|.||+|.+. |+.||||+++.... .....|.+.+..+ +++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 3578999999999999986 99999999876421 1124678888888 887
Q ss_pred ceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCee
Q 041031 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNIL 143 (313)
Q Consensus 65 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil 143 (313)
+.....+.... .++||||++|+++.... .....++......++.|++.++.++|+ .| ++|+||||+||+
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~-----l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPR-----LKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL 150 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhh-----hhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence 75544443332 48999999887554432 122457788899999999999999999 99 999999999999
Q ss_pred eCCCCcEEEeeccccccccC
Q 041031 144 LDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 144 ~~~~~~~~l~dfg~~~~~~~ 163 (313)
++ ++.++++|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 78999999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=151.13 Aligned_cols=186 Identities=15% Similarity=0.135 Sum_probs=141.2
Q ss_pred cccceeccCCeEEEEEeEECCcceEEEecccccc--H-----HHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeec
Q 041031 15 STSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKS--K-----EFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 15 ~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~--~-----~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
.+...|++|+||+|+.+...+.+++.+.+..... . -+.+|+++|+++ ++++.+++++ +..+++|+|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 4567899999999998888888898887765542 2 367899999999 5789999886 4569999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEecc-CCCCeeeCCCCcEEEeeccccccccCC
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDV-KTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di-~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
.|.+|.+.+. . . ...++.|++.+|.++|++| ++|+|| +|+||+++.++.++|+|||++......
T Consensus 81 ~G~~L~~~~~-----~-~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 81 AGAAMYQRPP-----R-G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred cCccHHhhhh-----h-h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9988875431 1 1 1346789999999999999 999999 799999999999999999999865544
Q ss_pred hhh----h------hhcccccccccccCCccccCC-CCC-CccchhhHHHHHHHHHhCCCCccCCCC
Q 041031 165 PEI----A------AAASRIVGTFGYLAPEYVRDG-CVT-TKSDVYAFGVVLMELITGQQALSRDAN 219 (313)
Q Consensus 165 ~~~----~------~~~~~~~~~~~~~aPE~~~~~-~~~-~~~DiwslG~~l~~~~tg~~p~~~~~~ 219 (313)
... . ........++.++.|+...-- ..+ ...+.++.|+-+|.++|+..|.-++..
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 321 0 001112356677777654322 233 566888999999999999988765543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-21 Score=173.87 Aligned_cols=237 Identities=25% Similarity=0.344 Sum_probs=184.3
Q ss_pred eeccCCeEEEEEeE-----ECCcceEEEeccccc-----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 19 KIGQGSYGSVYLGK-----LRGKNAAIKQMKNTK-----SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 19 ~lg~g~~g~v~~~~-----~~~~~~aiK~~~~~~-----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.+|+|.+|.|++++ +.+.-++.|..+... ......|-.++... ||.++++.-.++.+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999764 336677887765432 11344566677777 8999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+|.|...+ .....+.+.....+...++-++.++|+.+ ++|+|+|++||+++.+|.+++.|||++...-....
T Consensus 81 gg~lft~l-----~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRL-----SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhcc-----ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99998887 56677889999999999999999999999 99999999999999999999999999876443221
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
.+||..|+|||+++ .+..+.|.||+|++.++|+||..||.. +..
T Consensus 153 -------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------------------------~~~ 196 (612)
T KOG0603|consen 153 -------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------------------------DTM 196 (612)
T ss_pred -------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------------------------HHH
Confidence 17899999999998 678899999999999999999999974 112
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH--HHHHHHHHHHHhccccc
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM--SNAAIRLSHILISSKEW 303 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~--~~ll~~l~~~~~~~~~~ 303 (313)
..+.. .. ............+++.+++..+|..|.-. ..+.+..+.-....-+|
T Consensus 197 ~~Il~---~~-~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 197 KRILK---AE-LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred HHHhh---hc-cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence 22221 11 11345566677889999999999999855 45555544444333333
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.5e-20 Score=155.82 Aligned_cols=207 Identities=19% Similarity=0.193 Sum_probs=151.6
Q ss_pred CCCceeeeeEEEe---------------------------CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHH
Q 041031 62 HSNLIELIGYAAG---------------------------GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA 114 (313)
Q Consensus 62 h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~ 114 (313)
||||+.+..+|.+ ...+|+||..++ .+|.+++.. ...+.....-++
T Consensus 275 HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~~l 347 (598)
T KOG4158|consen 275 HPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRVIL 347 (598)
T ss_pred CCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHHHH
Confidence 9999999988743 235799999984 599999842 335566677789
Q ss_pred HHHHHHHHHHhcCCCCceEEeccCCCCeeeC--CC--CcEEEeeccccccccCChh---hhhhcccccccccccCCcccc
Q 041031 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLD--SN--FRAKIADFGLVKLLEHSPE---IAAAASRIVGTFGYLAPEYVR 187 (313)
Q Consensus 115 ~~i~~~l~~lh~~~~~~i~h~di~p~nil~~--~~--~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~ 187 (313)
.|+++|+.|||++| +.|+|+|.+||++. ++ ..++++|||.+--....+- .........|.-..+|||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 99999999999993 33 3478999997542221100 011122345777899999986
Q ss_pred CCC------CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCC
Q 041031 188 DGC------VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYH 261 (313)
Q Consensus 188 ~~~------~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 261 (313)
... .-.++|.|+.|.+.||+++...||.+.+... -.....-+..+....
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-------------------------L~~r~Yqe~qLPalp 479 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-------------------------LDTRTYQESQLPALP 479 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-------------------------echhhhhhhhCCCCc
Confidence 321 2458999999999999999999998754321 001112223344456
Q ss_pred HHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccc
Q 041031 262 KDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW 303 (313)
Q Consensus 262 ~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 303 (313)
..++..+++|+...|+.||++|+++.-....|.-.++..-+|
T Consensus 480 ~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 480 SRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGED 521 (598)
T ss_pred ccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchH
Confidence 666778889999999999999999998888888777765555
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.2e-19 Score=145.48 Aligned_cols=131 Identities=21% Similarity=0.368 Sum_probs=111.4
Q ss_pred cceeccCCeEEEEEeEECCcceEEEeccccc-----------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 17 SLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-----------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-----------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
++.||+|++|.||+|.+.+..+++|...+.. .....+|+.++..+ |+++.....++.+.+..+++|||
T Consensus 1 ~~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred CcccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 3679999999999999999999999866432 12366788999999 88888777777777888999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
++|++|.+++.. .. . ....++.+++.++.++|+.+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~-----~~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINS-----NG---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHh-----cc---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999841 11 1 77889999999999999999 99999999999999 78899999998765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.2e-19 Score=158.38 Aligned_cols=217 Identities=27% Similarity=0.449 Sum_probs=162.2
Q ss_pred Hhc-CCCceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCce-EEec
Q 041031 59 CKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY-VHRD 136 (313)
Q Consensus 59 ~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i-~h~d 136 (313)
+.+ |.|+.++++.+.+....+.|.+++..|+|.+.+. .....++......++++++.+++|+|.-. + +|+.
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~----~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILS----NEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHh----ccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 456 9999999999999999999999999999999995 34567888899999999999999999987 5 9999
Q ss_pred cCCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCC-------CCCCccchhhHHHHHHHHHh
Q 041031 137 VKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-------CVTTKSDVYAFGVVLMELIT 209 (313)
Q Consensus 137 i~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~DiwslG~~l~~~~t 209 (313)
++.+|.+++..-.+|+.|||+.......... ...........|.|||.+.+. ..+.+.|+||+|++++|+++
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~-~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEP-EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccc-cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 9999999999999999999998776431110 111112345789999999753 14677999999999999999
Q ss_pred CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHH
Q 041031 210 GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNA 289 (313)
Q Consensus 210 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l 289 (313)
...||......... .+.+..+.. .-.....|...... .....+..++++||..+|.+||++.++
T Consensus 154 r~~~~~~~~~~~~~--------~eii~~~~~-------~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i 217 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDP--------DEIILRVKK-------GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQI 217 (484)
T ss_pred ccCccccccccCCh--------HHHHHHHHh-------cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHH
Confidence 99999764432100 111111100 00111112211111 333468899999999999999999999
Q ss_pred HHHHHHHHhc
Q 041031 290 AIRLSHILIS 299 (313)
Q Consensus 290 l~~l~~~~~~ 299 (313)
-..+..+...
T Consensus 218 ~~~~~~~~~~ 227 (484)
T KOG1023|consen 218 RSKLLTINKG 227 (484)
T ss_pred Hhhhhhhccc
Confidence 9998887765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-18 Score=144.72 Aligned_cols=139 Identities=18% Similarity=0.167 Sum_probs=108.4
Q ss_pred cCccccceeccCCeEEEEEeE-E--CCcceEEEecccccc---------------------------HHHHHHHHHHHhc
Q 041031 12 SNFSTSLKIGQGSYGSVYLGK-L--RGKNAAIKQMKNTKS---------------------------KEFSSELKILCKV 61 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~-~--~~~~~aiK~~~~~~~---------------------------~~~~~e~~~l~~l 61 (313)
.-|.+.+.||+|++|.||+|. + .|+.||+|+++.... ..+.+|+..+..+
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 3 389999999874321 1245799999999
Q ss_pred -CC--CceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccC
Q 041031 62 -HS--NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVK 138 (313)
Q Consensus 62 -h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~ 138 (313)
+. .+.++++. . ..++|||++++.+|..... .........+..++.|++.++++||+.++ ++|+||+
T Consensus 108 ~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dik 176 (237)
T smart00090 108 YEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRL-----KDVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLS 176 (237)
T ss_pred HhcCCCCCeeeEe---c-CceEEEEEecCCccccccc-----ccCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCC
Confidence 42 23344432 2 3489999999988876542 23345666778999999999999999975 9999999
Q ss_pred CCCeeeCCCCcEEEeecccccccc
Q 041031 139 TSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 139 p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|+||+++ ++.++++|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 7899999999877543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-18 Score=140.18 Aligned_cols=133 Identities=19% Similarity=0.239 Sum_probs=102.9
Q ss_pred ccccceeccCCeEEEEEeEEC-CcceEEEecccc---ccHHHHHHHHHHHhc------CCCceeeeeEEEeCC---eEE-
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNT---KSKEFSSELKILCKV------HSNLIELIGYAAGGD---SLF- 79 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~---~~~~~~~e~~~l~~l------h~~i~~~~~~~~~~~---~~~- 79 (313)
+.-.+.||+|+||.||. +. ....+||++... ..+.+.+|+.+++.+ ||||++++++++.+. .++
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 45578999999999996 43 333479988754 456688999999998 599999999998774 333
Q ss_pred EEEee--cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHH-HHHhcCCCCceEEeccCCCCeeeCC----CCcEEE
Q 041031 80 LVYEY--AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGL-EYIHQYTKPYYVHRDVKTSNILLDS----NFRAKI 152 (313)
Q Consensus 80 lv~e~--~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l-~~lh~~~~~~i~h~di~p~nil~~~----~~~~~l 152 (313)
+|+|| ..+++|.+++.. ..+++. ..++.+++.++ .|||+++ |+|+||||+||+++. ++.++|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 447899999942 234444 35577888777 9999999 999999999999974 347999
Q ss_pred ee-ccccc
Q 041031 153 AD-FGLVK 159 (313)
Q Consensus 153 ~d-fg~~~ 159 (313)
+| ||...
T Consensus 151 iDg~G~~~ 158 (210)
T PRK10345 151 CDNIGEST 158 (210)
T ss_pred EECCCCcc
Confidence 99 55433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=141.55 Aligned_cols=127 Identities=24% Similarity=0.377 Sum_probs=104.8
Q ss_pred eeccCCeEEEEEeEECCcceEEEeccccc-----------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTK-----------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 19 ~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-----------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.||+|++|.||+|.+.+..+++|...... ...+.+|+++++.+ |+++.....++.+.+..+++||+++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 48999999999999889999999865321 13456799999999 7776655555566667789999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|++|.+.+.. ... .++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||.+...
T Consensus 81 g~~l~~~~~~-----~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEE-----GND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhh-----cHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998731 111 78899999999999999 99999999999999 789999999987753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.2e-19 Score=166.08 Aligned_cols=213 Identities=26% Similarity=0.337 Sum_probs=147.1
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
...++|..++++..|.+|.||..+++ ..++|+|+-+.. -+.+- ++... +|.++
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~---lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN---LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcccccc---hhhhc--cccccCCccee-------------------
Confidence 34678999999999999999999888 677888442222 11110 22222 44333
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
|+-...+ +..+.++.. ++.++.|+|..+ |+|+|+||+|.+|+.-|++|+.|||+........
T Consensus 136 --gDc~tll-----k~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 --GDCATLL-----KNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred --chhhhhc-----ccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 3444444 233344432 288999999999 9999999999999999999999999876432111
Q ss_pred h------------hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 166 E------------IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 166 ~------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
. .........+|+.|.|||++..+.|+...|.|++|+++|+++.|..||.++.++
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe------------- 264 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------------- 264 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-------------
Confidence 1 011222348999999999999999999999999999999999999999887653
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHH
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS 287 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 287 (313)
++...+.... -...+.......+..+++.+.|..+|..|--..
T Consensus 265 ----------elfg~visd~-i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 265 ----------ELFGQVISDD-IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ----------HHHhhhhhhh-ccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 2122111110 001112333445678899999999999997433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.3e-17 Score=133.78 Aligned_cols=139 Identities=19% Similarity=0.165 Sum_probs=108.4
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc-------------------------cHHHHHHHHHHHh
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK-------------------------SKEFSSELKILCK 60 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~-------------------------~~~~~~e~~~l~~ 60 (313)
+......|.+.+.||.|+||.||++.+. ++.+|||++.... ......|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3344445899999999999999999886 8899999865432 0124567888888
Q ss_pred c-CCC--ceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEecc
Q 041031 61 V-HSN--LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDV 137 (313)
Q Consensus 61 l-h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di 137 (313)
+ +++ +...++ ....+++|||+++++|..... ......++.+++.++.++|+.+ ++|+||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-----------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-----------LEDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc-----------cccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 8 653 444443 234589999999998876541 0234678899999999999999 999999
Q ss_pred CCCCeeeCCCCcEEEeeccccccccC
Q 041031 138 KTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 138 ~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
+|+||++++++.++++|||.+.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999865544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=154.89 Aligned_cols=132 Identities=23% Similarity=0.341 Sum_probs=110.1
Q ss_pred cCccccceeccCCeEEEEEeEECCcceEEEecccc--c---------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNT--K---------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~--~---------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
..|...++||+|+||.||+|.+.+..+++|..... . .+.+.+|+++++.+ |++++....+..+....+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 34566889999999999999998776666543211 1 23467899999999 999988877777777789
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+||||+++++|.+++. ....++.+++.++.+||+.+ ++|+|+||+||++ +++.++++|||++.
T Consensus 413 lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 9999999999999872 34678999999999999999 9999999999999 67789999999987
Q ss_pred c
Q 041031 160 L 160 (313)
Q Consensus 160 ~ 160 (313)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.2e-18 Score=149.67 Aligned_cols=125 Identities=31% Similarity=0.507 Sum_probs=105.0
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
.+++.|+++.-.+|.+++..++ .....+....+.++.|++.++.| ++ .+|+|++|.||+...+..++|+|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 4789999999999999996554 34556777788999999999999 77 8999999999999999999999999
Q ss_pred ccccccCChh---hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh
Q 041031 157 LVKLLEHSPE---IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209 (313)
Q Consensus 157 ~~~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t 209 (313)
+......... .........+|..|++||.+.+..|+.++||||||++|+|++.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9876554331 0112223478999999999999999999999999999999987
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.7e-16 Score=119.66 Aligned_cols=133 Identities=19% Similarity=0.223 Sum_probs=112.7
Q ss_pred ccceeccCCeEEEEEeEECCcceEEEeccccc-cHHHHHHHHHHHhc-C--CCceeeeeEEEeCCeEEEEEeecCCCChh
Q 041031 16 TSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-SKEFSSELKILCKV-H--SNLIELIGYAAGGDSLFLVYEYAQNGALS 91 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (313)
+++.+|.|.++.||++...+..+++|...... ...+.+|..+++.+ + .++.+++.+....+..++++||++++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 56889999999999999988899999987654 35688999999999 4 58899999888888899999999887665
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 92 DHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 92 ~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
.+ +......++.+++.+++.+|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 82 ~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 43 4455677889999999999996333399999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=1e-15 Score=128.15 Aligned_cols=133 Identities=18% Similarity=0.215 Sum_probs=104.0
Q ss_pred cceec-cCCeEEEEEeEECCcceEEEecccc----------------ccHHHHHHHHHHHhc-CCCc--eeeeeEEEeCC
Q 041031 17 SLKIG-QGSYGSVYLGKLRGKNAAIKQMKNT----------------KSKEFSSELKILCKV-HSNL--IELIGYAAGGD 76 (313)
Q Consensus 17 ~~~lg-~g~~g~v~~~~~~~~~~aiK~~~~~----------------~~~~~~~e~~~l~~l-h~~i--~~~~~~~~~~~ 76 (313)
...|| .||.|+||.+...+..++||.+... ....+.+|++++..+ |+++ +..++......
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 45687 8999999999888899999877531 123467899999999 7764 66776644322
Q ss_pred ----eEEEEEeecCC-CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEE
Q 041031 77 ----SLFLVYEYAQN-GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAK 151 (313)
Q Consensus 77 ----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~ 151 (313)
..++|||+++| .+|.+++.. ..++.. .+.+++.++.+||+.| |+|+||+|.||+++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 23599999987 689888742 234443 3678999999999999 99999999999999988999
Q ss_pred Eeecccccccc
Q 041031 152 IADFGLVKLLE 162 (313)
Q Consensus 152 l~dfg~~~~~~ 162 (313)
|+|||.+....
T Consensus 183 LIDfg~~~~~~ 193 (239)
T PRK01723 183 LIDFDRGELRT 193 (239)
T ss_pred EEECCCcccCC
Confidence 99999887644
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.4e-18 Score=157.91 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=189.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC---CcceEEEeccccc-----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR---GKNAAIKQMKNTK-----SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~aiK~~~~~~-----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~l 80 (313)
...|...+.||+|.|+.|-..... ...+++|.+.... ...+..|..+-+.+ |+|++++++...+....++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 467899999999999999987765 3345555554332 22344566666666 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHh-cCCCCceEEeccCCCCeeeCCCC-cEEEeecccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH-QYTKPYYVHRDVKTSNILLDSNF-RAKIADFGLV 158 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~ 158 (313)
++++..++++.+.+.. ......+......++.|+..++.|+| ..+ +.|+|++|+|.+++..+ .+++.|||++
T Consensus 99 ~~~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred ccCccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhh
Confidence 9999999999988731 22225666677789999999999999 888 99999999999999999 9999999999
Q ss_pred ccccCChhhhhhcccccc-cccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVG-TFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~-~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
.................+ ++.|.|||.+.+. ......|+||.|+++.-+++|..|+....... .
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-------~------- 238 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-------G------- 238 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-------c-------
Confidence 987763333344445567 9999999999885 45778999999999999999999997655432 0
Q ss_pred HHhcCcHHHHHHhhhhcCCC---CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 237 AVFNDTKDFMAKLTECLDPN---LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
....+.+.. ..............++.+++..+|..|.+.+++-.-
T Consensus 239 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 239 -----------RYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred -----------cceeecccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 000111110 011233344556778999999999999999887643
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.7e-15 Score=121.35 Aligned_cols=133 Identities=20% Similarity=0.267 Sum_probs=96.9
Q ss_pred ccceeccCCeEEEEEeEEC-CcceEEEeccccccH-----H----------------------HHHHHHHHHhc-CC--C
Q 041031 16 TSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKSK-----E----------------------FSSELKILCKV-HS--N 64 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~~~-----~----------------------~~~e~~~l~~l-h~--~ 64 (313)
+.+.||+|+||.||+|.+. ++.||||++...... . ...|.+.+..+ +. .
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 3578999999999999988 889999988753211 1 13455556665 22 2
Q ss_pred ceeeeeEEEeCCeEEEEEeecCCCChhhh-hcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCe
Q 041031 65 LIELIGYAAGGDSLFLVYEYAQNGALSDH-LHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNI 142 (313)
Q Consensus 65 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~ni 142 (313)
+.++++. ...+++|||++++++... +. . .... .....++.+++.++.++|. .+ ++|+||+|+||
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~-----~-~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Ni 146 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLK-----D-VRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNI 146 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhh-----h-hhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhE
Confidence 4444443 235899999998554321 11 0 0011 5678899999999999999 99 99999999999
Q ss_pred eeCCCCcEEEeeccccccccC
Q 041031 143 LLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 143 l~~~~~~~~l~dfg~~~~~~~ 163 (313)
+++ ++.++++|||.+.....
T Consensus 147 li~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEE-CCcEEEEECcccccccC
Confidence 999 88999999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.6e-14 Score=127.11 Aligned_cols=144 Identities=21% Similarity=0.247 Sum_probs=98.4
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccccHHHHH----------------------------------
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKSKEFSS---------------------------------- 53 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~~~~~~~---------------------------------- 53 (313)
.....|. .+.||.|++|.||+|+.+ |+.||||+.++...+.+..
T Consensus 115 ~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 193 (437)
T TIGR01982 115 ELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKT 193 (437)
T ss_pred HHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHH
Confidence 3344444 368999999999999987 8999999998764333333
Q ss_pred ---------HHHHHHhc------CCCceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHH
Q 041031 54 ---------ELKILCKV------HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAA 118 (313)
Q Consensus 54 ---------e~~~l~~l------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~ 118 (313)
|...+.++ ++++.-..-+....+..++||||++|++|.+..... ..... ...++..++
T Consensus 194 l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~----~~~~~---~~~ia~~~~ 266 (437)
T TIGR01982 194 LRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD----EAGLD---RKALAENLA 266 (437)
T ss_pred HHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH----hcCCC---HHHHHHHHH
Confidence 33333333 222221111222344568999999999998876311 11122 234555555
Q ss_pred H-HHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 119 K-GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 119 ~-~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
. .+..+|..| ++|+|++|.||++++++.++++|||++.....
T Consensus 267 ~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 267 RSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 5 467889999 99999999999999999999999999876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.4e-13 Score=122.12 Aligned_cols=159 Identities=18% Similarity=0.242 Sum_probs=121.1
Q ss_pred CcceEEEecccccc---HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHH
Q 041031 35 GKNAAIKQMKNTKS---KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTR 110 (313)
Q Consensus 35 ~~~~aiK~~~~~~~---~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~ 110 (313)
+.+|.|...+.... +.+.+-++.|+.+ ||+|+++++.++.+...|+|+|-+ ..|...++ .+....+
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk--------~l~~~~v 106 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLK--------ELGKEEV 106 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHH--------HhHHHHH
Confidence 66777766654443 4466778888888 999999999999999999999987 46887773 2336667
Q ss_pred HHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCC
Q 041031 111 VQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190 (313)
Q Consensus 111 ~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 190 (313)
-.-+.||+.||.+||..+. ++|++|..+.|+|++.|..||++|.++......+. .......-..|..|+.....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s- 180 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPS- 180 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCcc-
Confidence 7789999999999984433 99999999999999999999999998876554322 11122233456666644322
Q ss_pred CCCccchhhHHHHHHHHHhC
Q 041031 191 VTTKSDVYAFGVVLMELITG 210 (313)
Q Consensus 191 ~~~~~DiwslG~~l~~~~tg 210 (313)
....|.|.|||++++++.|
T Consensus 181 -~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 -EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -ccchhhhhHHHHHHHHhCc
Confidence 1457999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.4e-13 Score=107.21 Aligned_cols=128 Identities=16% Similarity=0.144 Sum_probs=97.3
Q ss_pred cceeccCCeEEEEEeEECCcceEEEeccccc--cHHHHHHHHHHHhc-CCCc-eeeeeEEEeCCeEEEEEeecCCCChhh
Q 041031 17 SLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK--SKEFSSELKILCKV-HSNL-IELIGYAAGGDSLFLVYEYAQNGALSD 92 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (313)
++.++.|.++.||+++..+..+++|...... ......|+.+++.+ +.++ .+++... ....++||||++|.++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 4678999999999999999999999987654 34567899999998 4343 4455443 334579999999987754
Q ss_pred hhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCC--CCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 93 HLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT--KPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 93 ~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
.- . .....+.+++.+++.||+.+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 81 ~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 31 0 01235678999999999997 11249999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=9.1e-14 Score=116.34 Aligned_cols=198 Identities=21% Similarity=0.269 Sum_probs=137.9
Q ss_pred CCCceeeeeEEEeC-----CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEec
Q 041031 62 HSNLIELIGYAAGG-----DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRD 136 (313)
Q Consensus 62 h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 136 (313)
|.||++...++.+. ....+++||+..|++.++|+... .....+......+|+-|+..||.|||+..+ +++|++
T Consensus 126 HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs~~P-piihgn 203 (458)
T KOG1266|consen 126 HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHSCDP-PIIHGN 203 (458)
T ss_pred HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhccCC-ccccCC
Confidence 99999999998654 45788999999999999996443 234567778888999999999999999974 489999
Q ss_pred cCCCCeeeCCCCcEEEeeccccccccC--ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCc
Q 041031 137 VKTSNILLDSNFRAKIADFGLVKLLEH--SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQAL 214 (313)
Q Consensus 137 i~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~ 214 (313)
+.-+.|++..+|.+|++- +.-..... +.......+...+.++|.+||.=...+.+-++|||++|+...+|..+..--
T Consensus 204 lTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~ 282 (458)
T KOG1266|consen 204 LTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQS 282 (458)
T ss_pred cchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheecc
Confidence 999999999999888753 22111111 111122333345678999999877777888999999999999998876432
Q ss_pred cCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 215 SRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...... .... +......-.+...+ =+.++..|++-.|..||++.+++-
T Consensus 283 tnseS~--------~~~e-----------e~ia~~i~~len~l----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 283 TNSESK--------VEVE-----------ENIANVIIGLENGL----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred CCCcce--------eehh-----------hhhhhheeeccCcc----------ccCcCcccccCCCCCCcchhhhhc
Confidence 111100 0000 00111111111111 123889999999999999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.4e-13 Score=123.81 Aligned_cols=245 Identities=25% Similarity=0.275 Sum_probs=178.1
Q ss_pred cCccccceecc--CCeEEEEEeEE--C--CcceEEEecc--cc---ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeE
Q 041031 12 SNFSTSLKIGQ--GSYGSVYLGKL--R--GKNAAIKQMK--NT---KSKEFSSELKILCKV--HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 12 ~~y~~~~~lg~--g~~g~v~~~~~--~--~~~~aiK~~~--~~---~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~ 78 (313)
..+.+..-+|. |.+|.+|.+.. . +..+|+|.-+ .. ....-.+|+...+.+ |++.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34667788999 99999999877 3 6677887632 11 122233566666666 89999988899999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHH----HHHHHhcCCCCceEEeccCCCCeeeCCC-CcEEEe
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK----GLEYIHQYTKPYYVHRDVKTSNILLDSN-FRAKIA 153 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~----~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~~l~ 153 (313)
++-+|.+ +.+|.++.. .....++...++..+.+... |+.++|... ++|-|++|.||+..++ ...+++
T Consensus 194 fiqtE~~-~~sl~~~~~----~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCH----TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eeeeccc-cchhHHhhh----cccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence 9999998 568888774 33344777788888888888 999999999 9999999999999998 889999
Q ss_pred eccccccccCChhh-hhhc-ccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhH
Q 041031 154 DFGLVKLLEHSPEI-AAAA-SRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 154 dfg~~~~~~~~~~~-~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~ 231 (313)
|||+.....+.... .... ....+...|++||..+ .-++...|+|++|.++.+-.+|..+..........+......-
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 99998877755421 1111 2236788999999886 4478899999999999999998776654433221111111100
Q ss_pred HHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 232 VDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+ ........+...+.+|++.+|..|++.+.+..
T Consensus 345 ------------------~e--------~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 345 ------------------LE--------FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------------------hh--------hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00 11122234555899999999999999888764
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.2e-12 Score=108.00 Aligned_cols=269 Identities=14% Similarity=0.130 Sum_probs=167.1
Q ss_pred cccceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeE------E-EeCCeEEEEEeec
Q 041031 15 STSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGY------A-AGGDSLFLVYEYA 85 (313)
Q Consensus 15 ~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~------~-~~~~~~~lv~e~~ 85 (313)
...+.||+|+.+.+|...--+. .+-|++.......-.+.+..|... ||-+..-+.+ . .......+.|+.+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d-~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v 92 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD-QVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV 92 (637)
T ss_pred CCCccccCCccceeeecchhhc-hhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence 4578899999999995543333 344666554444444445555555 5533321222 1 1122367888888
Q ss_pred CCCC-hhhhhcC-CCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 86 QNGA-LSDHLHW-PSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 86 ~~~~-L~~~l~~-~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
.+.. +..++.. .+++......+.....+++.++.+.+.||..| .+-||++++|+++++++.+.|+|-........
T Consensus 93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n 169 (637)
T COG4248 93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN 169 (637)
T ss_pred CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccC
Confidence 7642 3333322 22334556789999999999999999999999 99999999999999999999998766554322
Q ss_pred ChhhhhhcccccccccccCCcccc-----CCCCCCccchhhHHHHHHHHHhC-CCCccCCCCCCCCccccchhHHHHHHH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITG-QQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
. .......+...|+|||.-. +...+..+|.|.||+++++++.| ++||.+......-.-.... +.-..
T Consensus 170 g----~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~Ia~g 242 (637)
T COG4248 170 G----TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DIAHG 242 (637)
T ss_pred C----ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hhhcc
Confidence 1 1222346889999999654 44567889999999999998775 9999776432111000000 01011
Q ss_pred HhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccC--cCCCCCHHHHHHHHHHHHh
Q 041031 238 VFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDEN--WKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~--p~~Rps~~~ll~~l~~~~~ 298 (313)
.+....+ -.....+-... ...-.+..+..|..+|+... +.-|||++.++..|..+..
T Consensus 243 ~f~ya~~----~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 243 RFAYASD----QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred eeeechh----ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 1111111 00111111111 12223345666777888764 4679999999999986544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4e-12 Score=98.56 Aligned_cols=140 Identities=21% Similarity=0.213 Sum_probs=106.2
Q ss_pred ccceeccCCeEEEEEeEECCcceEEEeccccc-----------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 16 TSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-----------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-----------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
....+-+|.-+.|+++.+.|+.++||.-.+.. .....+|.+++.++ --.|.-..-++.+...-.++||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 67889999999999999999999998765432 23356788898888 3355555555666677789999
Q ss_pred ecCC-CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC---cEEEeeccccc
Q 041031 84 YAQN-GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF---RAKIADFGLVK 159 (313)
Q Consensus 84 ~~~~-~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~---~~~l~dfg~~~ 159 (313)
|++| .++.+++.... ......+....++.++-+.+.-||.++ ++|||+..+||++..++ .+.++|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~---~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTM---EDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHc---cCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 9976 47778774221 222333334788999999999999999 99999999999996544 35899999976
Q ss_pred cc
Q 041031 160 LL 161 (313)
Q Consensus 160 ~~ 161 (313)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 53
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=5.1e-13 Score=122.94 Aligned_cols=146 Identities=18% Similarity=0.179 Sum_probs=96.6
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHH----------------------------------
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE---------------------------------- 50 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~---------------------------------- 50 (313)
+...++.|.. +.||+|++|.||+|+.+ |+.||||+.++.-.+.
T Consensus 115 ~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 115 VEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 4455667887 79999999999999986 7999999998653222
Q ss_pred ---------HHHHHHHHHhc-----CCCceeeeeEEE-eCCeEEEEEeecCCCChhhhhcCC-CCCCCCCccHHHHHHHH
Q 041031 51 ---------FSSELKILCKV-----HSNLIELIGYAA-GGDSLFLVYEYAQNGALSDHLHWP-SVKGKKPLAWTTRVQIA 114 (313)
Q Consensus 51 ---------~~~e~~~l~~l-----h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~l~~~~~~~~~ 114 (313)
+.+|+..+.++ +.+.+.+-.++. ..+..++||||+.|+++.+.-.-. .......+....+..++
T Consensus 194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence 22233333333 222233223332 244567999999999998742100 00011134444455555
Q ss_pred HHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC----cEEEeeccccccccC
Q 041031 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF----RAKIADFGLVKLLEH 163 (313)
Q Consensus 115 ~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----~~~l~dfg~~~~~~~ 163 (313)
.|++ ..| ++|+|++|.||+++.+| .++++|||++.....
T Consensus 274 ~Qif-------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVF-------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHH-------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5544 477 99999999999999887 999999999887654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=7e-12 Score=97.60 Aligned_cols=128 Identities=27% Similarity=0.358 Sum_probs=101.5
Q ss_pred ceeccCCeEEEEEeEECCcceEEEeccccc-----------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 18 LKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-----------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-----------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..+++|.-+.++.+.+.+.++++|.-.+.. .....+|++++.++ --.|....-+..+.+...++|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 467899999999999998888888654332 22355789999888 446666666667777788999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
+|..|.+.+... ...++..+-.-+.-||..| |+|||+.++||+++.++ +.++|||++...
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888422 1446777778888899999 99999999999998775 899999998753
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=8e-12 Score=100.40 Aligned_cols=132 Identities=16% Similarity=0.115 Sum_probs=96.5
Q ss_pred cceeccCCeEEEEEeEEC--------CcceEEEeccccc------------------------cH-H----HHHHHHHHH
Q 041031 17 SLKIGQGSYGSVYLGKLR--------GKNAAIKQMKNTK------------------------SK-E----FSSELKILC 59 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~--------~~~~aiK~~~~~~------------------------~~-~----~~~e~~~l~ 59 (313)
...||.|--+.||.|... +..+|||+.+... .. . ..+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 457899999999999765 2689999874210 01 1 237999999
Q ss_pred hc---CCCceeeeeEEEeCCeEEEEEeecCCCChhh-hhcCCCCCCCCCccHHHHHHHHHHHHHHHHHH-hcCCCCceEE
Q 041031 60 KV---HSNLIELIGYAAGGDSLFLVYEYAQNGALSD-HLHWPSVKGKKPLAWTTRVQIALDAAKGLEYI-HQYTKPYYVH 134 (313)
Q Consensus 60 ~l---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~~i~h 134 (313)
++ --++..++++ ..-++|||++.+..+.. .+ ....++......+..+++.++..+ |..+ ++|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L------kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVH 148 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL------KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVH 148 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh------hccccCHHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 98 2356666654 45688999997643322 12 112344556677889999999988 8999 999
Q ss_pred eccCCCCeeeCCCCcEEEeecccccccc
Q 041031 135 RDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 135 ~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++.||++++ +.+.++|||.+....
T Consensus 149 GDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999999974 679999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=2e-10 Score=95.24 Aligned_cols=138 Identities=20% Similarity=0.300 Sum_probs=107.2
Q ss_pred cceeccCCeEEEEEeEECC-cceEEEeccccc----cHHHHHHHHHHHhc-C--CCceeeeeEEEeCC---eEEEEEeec
Q 041031 17 SLKIGQGSYGSVYLGKLRG-KNAAIKQMKNTK----SKEFSSELKILCKV-H--SNLIELIGYAAGGD---SLFLVYEYA 85 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~~-~~~aiK~~~~~~----~~~~~~e~~~l~~l-h--~~i~~~~~~~~~~~---~~~lv~e~~ 85 (313)
.+.++.|..+.+|++...+ +.+++|...... ...+..|..+++.+ + ..+.+++.+..... ..+++||++
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 3578999999999998875 899999987543 45688999999999 3 34567777766542 568999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT------------------------------------- 128 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------------------------------------- 128 (313)
+|.++.+.+. ...++......++.+++.+++.||+..
T Consensus 83 ~G~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLL------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCC------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 9988887652 134677777788888888888888532
Q ss_pred ----------------CCceEEeccCCCCeeeCC--CCcEEEeecccccc
Q 041031 129 ----------------KPYYVHRDVKTSNILLDS--NFRAKIADFGLVKL 160 (313)
Q Consensus 129 ----------------~~~i~h~di~p~nil~~~--~~~~~l~dfg~~~~ 160 (313)
...++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 122799999999999998 56688999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.4e-10 Score=100.67 Aligned_cols=166 Identities=20% Similarity=0.311 Sum_probs=128.8
Q ss_pred CeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEE----eCCeEEEEEeecCC-CChhh
Q 041031 24 SYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAA----GGDSLFLVYEYAQN-GALSD 92 (313)
Q Consensus 24 ~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~ 92 (313)
-..+.|++... |..|++|.++.+. ......-+++++++ |.|+|.+.+++. ++..+++|++|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44788999876 8889999995443 44456678999999 999999999886 45678999999986 56666
Q ss_pred hhcCCC----------CCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 93 HLHWPS----------VKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 93 ~l~~~~----------~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
+.-... ...+...++..+|.++.|+..||.++|+.| +.-.-+.|++|+++.+.++++...|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 542211 123446788999999999999999999999 9999999999999999999999999887766
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCC
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQ 212 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~ 212 (313)
.++. +| +. --.+-|.=.||.++..+.||..
T Consensus 445 ~d~~---------------~~--le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT---------------EP--LE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC---------------cc--hh---HHhhhhHHHHHHHHHHHhhccc
Confidence 5431 00 11 1234678899999999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.9e-10 Score=93.75 Aligned_cols=137 Identities=14% Similarity=0.108 Sum_probs=99.5
Q ss_pred ceeccCCeEEEEEeEECCcceEEEecccccc--------------HHHHHHHHHHHhc-CCC--ceeeeeEEEe-----C
Q 041031 18 LKIGQGSYGSVYLGKLRGKNAAIKQMKNTKS--------------KEFSSELKILCKV-HSN--LIELIGYAAG-----G 75 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~--------------~~~~~e~~~l~~l-h~~--i~~~~~~~~~-----~ 75 (313)
+.+-......|++....|+.+.||....... ....+|.+.+..+ .-+ +..++++... .
T Consensus 28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 3444444455778888889999997644321 1367898888888 333 3344555532 2
Q ss_pred CeEEEEEeecCCC-ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-------C
Q 041031 76 DSLFLVYEYAQNG-ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-------N 147 (313)
Q Consensus 76 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-------~ 147 (313)
...++|||++++. +|.+++... .....+......++.+++..++.||+.| ++|+|++++||+++. +
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~---~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADW---ATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence 3578999999875 788887311 1234556677889999999999999999 999999999999974 4
Q ss_pred CcEEEeecccccc
Q 041031 148 FRAKIADFGLVKL 160 (313)
Q Consensus 148 ~~~~l~dfg~~~~ 160 (313)
+.+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6799999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.8e-11 Score=110.40 Aligned_cols=242 Identities=22% Similarity=0.253 Sum_probs=170.5
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC---CcceEEEeccccccHH-----HHHHHHHHHhc--CCCceeeeeEEEeCCeE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR---GKNAAIKQMKNTKSKE-----FSSELKILCKV--HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~aiK~~~~~~~~~-----~~~e~~~l~~l--h~~i~~~~~~~~~~~~~ 78 (313)
....+|..+..||.|.|+.|+..... +..|++|-........ -..|+-+...+ |.+++.....+....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34568999999999999999987644 5667887766543222 22455555555 88889888888877788
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC-CcEEEeeccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN-FRAKIADFGL 157 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~~l~dfg~ 157 (313)
++=-||++++++.... .-...+.+...+.+..|++.++.++|+.. ++|.|++|+||++..+ +.-+++|||.
T Consensus 342 ~ip~e~~~~~s~~l~~-----~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS-----VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred cCchhhhcCcchhhhh-----HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccc
Confidence 8889999998887765 34466788889999999999999999999 9999999999999875 6778999998
Q ss_pred cccccCChhhhhhccccccccccc--CCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYL--APEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~--aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
+....-. .....+.-++. +|.......+..+.|++|||..+.+..+|...-.....
T Consensus 414 ~t~~~~~------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---------------- 471 (524)
T KOG0601|consen 414 WTRLAFS------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---------------- 471 (524)
T ss_pred cccccee------cccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------------
Confidence 7642211 11112233333 55555567788999999999999999998643211110
Q ss_pred HHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 236 LAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 236 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
...+. ...+....... .++..+.+.+...++..||.+.++.....
T Consensus 472 ----------~~~i~---~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 472 ----------SLTIR---SGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ----------ceeee---cccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00011 11111112222 56667888899999999999888765433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.4e-11 Score=115.66 Aligned_cols=246 Identities=21% Similarity=0.267 Sum_probs=169.3
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccc------cccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKN------TKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~------~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
-.+++.+.+-+-.|.++.++.++-. +...++|.... ...+.+..+-.+...- +|-++...-.+.-.....|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4677888888999999999987655 33333332221 1122222232222222 4556655555666778899
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
+++++++++|...+. ..+..+.+..+..+..++.++.+||... +.|+|++|.|.+...+|..++.|||....
T Consensus 882 ~~~~~~~~~~~Skl~-----~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLH-----NSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhHHhccCCchhhhh-----cCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 999999999999884 3345666667778888999999999998 89999999999999999999999973221
Q ss_pred ccC------C------------------hhh----hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCC
Q 041031 161 LEH------S------------------PEI----AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQ 212 (313)
Q Consensus 161 ~~~------~------------------~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~ 212 (313)
... . +.. ........+|+.|.+||...+......+|.|++|+++++.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 110 0 000 011233568999999999999999999999999999999999999
Q ss_pred CccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHH
Q 041031 213 ALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS 287 (313)
Q Consensus 213 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 287 (313)
||...... .+ ...+... +...............+++...+..+|.+|..+.
T Consensus 1034 p~na~tpq---------~~--------------f~ni~~~-~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQ---------QI--------------FENILNR-DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchh---------hh--------------hhccccC-CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99866553 11 1111111 1111223334445566788889999999998876
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.9e-09 Score=89.09 Aligned_cols=133 Identities=19% Similarity=0.191 Sum_probs=101.6
Q ss_pred CccccceeccCCeEEEEEeEEC-CcceEEEeccccc-------------------------cHHHHHHHHHHHhcCC---
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK-------------------------SKEFSSELKILCKVHS--- 63 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~-------------------------~~~~~~e~~~l~~lh~--- 63 (313)
=..+..+||-|--|.||.|.+. +.+++||.-+... ....++|.++|..++|
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 4567889999999999999998 9999999643211 1226789999999954
Q ss_pred CceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCee
Q 041031 64 NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNIL 143 (313)
Q Consensus 64 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil 143 (313)
.+.+.+++ +...+|||+++|..|...- ++.+....++..++..+..+-..| ++|||+++-||+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIl 234 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNIL 234 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEE
Confidence 46677765 5567999999886665442 133444556667777777777888 999999999999
Q ss_pred eCCCCcEEEeecccccccc
Q 041031 144 LDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 144 ~~~~~~~~l~dfg~~~~~~ 162 (313)
++++|.++++||--+....
T Consensus 235 V~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 235 VTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred EecCCCEEEEeCcccccCC
Confidence 9999999999998766533
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.7e-09 Score=86.61 Aligned_cols=121 Identities=21% Similarity=0.254 Sum_probs=78.4
Q ss_pred EEEEeEEC-CcceEEEeccccc-----------------------------cHHHHHHHHHHHhc-CC--CceeeeeEEE
Q 041031 27 SVYLGKLR-GKNAAIKQMKNTK-----------------------------SKEFSSELKILCKV-HS--NLIELIGYAA 73 (313)
Q Consensus 27 ~v~~~~~~-~~~~aiK~~~~~~-----------------------------~~~~~~e~~~l~~l-h~--~i~~~~~~~~ 73 (313)
.||.|... +..+|||+.+... .....+|.+.|..+ .- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 37888876 7889999875311 11256799999999 33 456666442
Q ss_pred eCCeEEEEEeecC--CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHH-HhcCCCCceEEeccCCCCeeeCCCCcE
Q 041031 74 GGDSLFLVYEYAQ--NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEY-IHQYTKPYYVHRDVKTSNILLDSNFRA 150 (313)
Q Consensus 74 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~-lh~~~~~~i~h~di~p~nil~~~~~~~ 150 (313)
.-.+||||++ |..+..+.. ..++......++.+++..+.. +|..| ++|||+++.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-------~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-------VDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-------CGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHh-------ccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 2369999998 655655432 111233455667777775444 57999 9999999999999988 89
Q ss_pred EEeecccccccc
Q 041031 151 KIADFGLVKLLE 162 (313)
Q Consensus 151 ~l~dfg~~~~~~ 162 (313)
.++|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-10 Score=106.19 Aligned_cols=152 Identities=20% Similarity=0.303 Sum_probs=107.0
Q ss_pred HHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhh------cccccccccccCCcccc
Q 041031 114 ALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA------ASRIVGTFGYLAPEYVR 187 (313)
Q Consensus 114 ~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~------~~~~~~~~~~~aPE~~~ 187 (313)
+.+.+.|+.++|..-+ +||++|.|++|.++.++..|++.|+.+............ .........|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4455589999998854 999999999999999999999999987765542221100 01123456899999999
Q ss_pred CCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHH
Q 041031 188 DGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSML 266 (313)
Q Consensus 188 ~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 266 (313)
+...+.++|+||+|+++|.+.. |+..+...+... ....-....+....-...+.+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----------------------~~~~~~~~~~~~~~~~s~~~p~ 239 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----------------------SYSFSRNLLNAGAFGYSNNLPS 239 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcc-----------------------hhhhhhcccccccccccccCcH
Confidence 9888999999999999999995 555454443321 0111111222222224456677
Q ss_pred HHHHHHhhccccCcCCCCCHHHHH
Q 041031 267 QMALLSKDCVDENWKRRPDMSNAA 290 (313)
Q Consensus 267 ~l~~li~~cl~~~p~~Rps~~~ll 290 (313)
+|++=+.+++..++.-||++..+.
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhh
Confidence 888899999999999999776665
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.8e-08 Score=81.38 Aligned_cols=135 Identities=14% Similarity=0.091 Sum_probs=101.3
Q ss_pred eccCCeEEEEEeEECCcceEEEecc---------ccccHHHHHHHHHHHhc---CCCceeeeeEEEe----CCeEEEEEe
Q 041031 20 IGQGSYGSVYLGKLRGKNAAIKQMK---------NTKSKEFSSELKILCKV---HSNLIELIGYAAG----GDSLFLVYE 83 (313)
Q Consensus 20 lg~g~~g~v~~~~~~~~~~aiK~~~---------~~~~~~~~~e~~~l~~l---h~~i~~~~~~~~~----~~~~~lv~e 83 (313)
-|.||-|.|++....|..+-+|.-. +-....+.+|...++.+ .-.+.++...... .-.-+||+|
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 3669999999998888888888765 33456789999999999 2224444422211 224689999
Q ss_pred ecCC-CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc--EEEeecccccc
Q 041031 84 YAQN-GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR--AKIADFGLVKL 160 (313)
Q Consensus 84 ~~~~-~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~--~~l~dfg~~~~ 160 (313)
-+++ .+|.+++... .-.+.+......++.+++.+++-||+.| +.|+|+.+.||+++.+|. +.++||.-+..
T Consensus 106 ~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7643 6788887321 1235677777899999999999999999 999999999999986666 99999986553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.4e-09 Score=84.56 Aligned_cols=107 Identities=21% Similarity=0.238 Sum_probs=83.3
Q ss_pred cHHHHHHHHHHHhc---CCCceeeeeEEEeCC----eEEEEEeecCC-CChhhhhcCCCCCCCCCccHHHHHHHHHHHHH
Q 041031 48 SKEFSSELKILCKV---HSNLIELIGYAAGGD----SLFLVYEYAQN-GALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119 (313)
Q Consensus 48 ~~~~~~e~~~l~~l---h~~i~~~~~~~~~~~----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~ 119 (313)
.....+|...+..+ .=.+..++++..... ..++|+|.+++ .+|.+++. .....+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~-----~~~~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ-----QWEQLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH-----hhcccchhhHHHHHHHHHH
Confidence 44577888888888 223556666665432 45899999987 47999884 2222666677889999999
Q ss_pred HHHHHhcCCCCceEEeccCCCCeeeCCCC---cEEEeecccccccc
Q 041031 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNF---RAKIADFGLVKLLE 162 (313)
Q Consensus 120 ~l~~lh~~~~~~i~h~di~p~nil~~~~~---~~~l~dfg~~~~~~ 162 (313)
.++-||+.| ++|+|++++|||++.++ .+.++||+.+....
T Consensus 130 ~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 130 LIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999999 99999999999999876 89999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.6e-08 Score=91.51 Aligned_cols=148 Identities=21% Similarity=0.271 Sum_probs=97.5
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccccHHHHHHHHHHHhc------------------------
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKSKEFSSELKILCKV------------------------ 61 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~~~~~~~e~~~l~~l------------------------ 61 (313)
++...+.|.. +.++.++-|.||+|+.+ |+.||||+.+++-.+.+...+.+|+.+
T Consensus 121 iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~ 199 (517)
T COG0661 121 IEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE 199 (517)
T ss_pred HHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence 3445555554 58999999999999999 999999999876544443333333333
Q ss_pred -------------------------CCCceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHH
Q 041031 62 -------------------------HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALD 116 (313)
Q Consensus 62 -------------------------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~ 116 (313)
.+++.-..-+++..+.-.|+|||++|..+.+... ......+.+.+...+.+
T Consensus 200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~----l~~~g~d~k~ia~~~~~ 275 (517)
T COG0661 200 KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAA----LKSAGIDRKELAELLVR 275 (517)
T ss_pred HHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHH----HHhcCCCHHHHHHHHHH
Confidence 2222222222333456689999999999988842 11233443333322222
Q ss_pred HHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 117 i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+. +..+=..| ++|+|..|.||+++.+|++.+.|||+.......
T Consensus 276 ~f--~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 276 AF--LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HH--HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 21 22233366 999999999999999999999999998776543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.3e-08 Score=77.54 Aligned_cols=132 Identities=18% Similarity=0.209 Sum_probs=92.1
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEeccccccH------------HHHHHHHHHHhc-C---CCceeeeeE---
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSK------------EFSSELKILCKV-H---SNLIELIGY--- 71 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~------------~~~~e~~~l~~l-h---~~i~~~~~~--- 71 (313)
-.+|.+.+++-......|.+-...+..+++|..++.... ...+.+.....+ . .....++.+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 457888889999888999999889999999988764311 122333333333 1 122232222
Q ss_pred --EEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc
Q 041031 72 --AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR 149 (313)
Q Consensus 72 --~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~ 149 (313)
+......+++|||++|..|.+... +++ .+...+.+++.-+|+.| ++|||.+|.|+++++++
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 223345678999999988877641 222 24456778899999999 99999999999999765
Q ss_pred EEEeeccccc
Q 041031 150 AKIADFGLVK 159 (313)
Q Consensus 150 ~~l~dfg~~~ 159 (313)
++++||+...
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 8999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.3e-07 Score=77.06 Aligned_cols=131 Identities=18% Similarity=0.161 Sum_probs=86.1
Q ss_pred ceeccCCeEEEEEeEECCcceEEEeccccc-cHHHHHHHHHHHhc-CCC--ceeeeeEEEeCCeEEEEEeecCCCC-hhh
Q 041031 18 LKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-SKEFSSELKILCKV-HSN--LIELIGYAAGGDSLFLVYEYAQNGA-LSD 92 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h~~--i~~~~~~~~~~~~~~lv~e~~~~~~-L~~ 92 (313)
..+|+|..+.||+. .+..+++|...... ...+.+|.++++.+ .-+ +.+++.+..+.+...++|++++|.+ +..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~ 84 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSR 84 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhh
Confidence 67899999999984 36678899987643 55688999999999 222 5778888888888899999998863 221
Q ss_pred hhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc---------------------------------------C-CCCce
Q 041031 93 HLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ---------------------------------------Y-TKPYY 132 (313)
Q Consensus 93 ~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---------------------------------------~-~~~~i 132 (313)
.+. .+......++.+++..+.-+|+ . ....+
T Consensus 85 ~~~---------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 85 IIS---------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred hhc---------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 110 0000001111111111111111 1 12227
Q ss_pred EEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 133 VHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 133 ~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
+|+|+.|.||++++++ +.++||+.+..
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 8999999999999988 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=7e-08 Score=74.92 Aligned_cols=127 Identities=20% Similarity=0.267 Sum_probs=94.3
Q ss_pred cccceeccCCeEEEEEeEECCcceEEEeccccc-cHHHHHHHHHHHhc-C-CCceeeeeEEEeCCeEEEEEeecCCCChh
Q 041031 15 STSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-SKEFSSELKILCKV-H-SNLIELIGYAAGGDSLFLVYEYAQNGALS 91 (313)
Q Consensus 15 ~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (313)
...+.||+|++|.||++.|.+..+|+|+-+.++ ...+..|+++|+.+ - .--.+++.+..+ ++.|||+.|.+|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~ 100 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchh
Confidence 457889999999999999999999999988776 45588999999999 2 223455555433 3459999998888
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccC-CCCeeeCCCCcEEEeecccccc
Q 041031 92 DHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVK-TSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 92 ~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~-p~nil~~~~~~~~l~dfg~~~~ 160 (313)
+... . .+. +.+..++++..-|-..| |-|+.|+ |...++..++.+.|+||..+..
T Consensus 101 ~~~~-----~---~~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEI-----G---GDR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhh-----c---ccH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7752 1 122 33455666666778888 9999998 5555555555899999998873
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.67 E-value=6.1e-07 Score=73.70 Aligned_cols=147 Identities=21% Similarity=0.289 Sum_probs=101.4
Q ss_pred ChHHHHHHhcCccccceec---cCCeEEEEEeEEC-CcceEEEeccccccH----------------------H-----H
Q 041031 3 SYNEVRDATSNFSTSLKIG---QGSYGSVYLGKLR-GKNAAIKQMKNTKSK----------------------E-----F 51 (313)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg---~g~~g~v~~~~~~-~~~~aiK~~~~~~~~----------------------~-----~ 51 (313)
|...+..+.+...+....| .|--+.||+|... +..+|+|+++..... . .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 5567778888888877766 4555689998865 889999998643211 0 3
Q ss_pred HHHHHHHHhc---CCCceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-C
Q 041031 52 SSELKILCKV---HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-Y 127 (313)
Q Consensus 52 ~~e~~~l~~l---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~ 127 (313)
.+|..-|+++ +-.+.+.+.+.. -.||||+++...... .. -..-++...+...+..++++.+.-|-. .
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pA----P~-LkDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPA----PR-LKDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCC----CC-cccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 4577777777 444556665543 358999996541110 00 111223333677778888888888877 7
Q ss_pred CCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 128 ~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
+ +||+|++.-|||+. ++.+.++|+|-+....
T Consensus 187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred C---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 7 99999999999999 6789999999887654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.9e-07 Score=74.90 Aligned_cols=76 Identities=16% Similarity=0.238 Sum_probs=58.7
Q ss_pred cceeccCCeEEEEEeEECCcceEEEecccc-ccHHHHHHHHHHHhc--C-CCceeeeeEEE---eCCeEEEEEeecCCCC
Q 041031 17 SLKIGQGSYGSVYLGKLRGKNAAIKQMKNT-KSKEFSSELKILCKV--H-SNLIELIGYAA---GGDSLFLVYEYAQNGA 89 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~-~~~~~~~e~~~l~~l--h-~~i~~~~~~~~---~~~~~~lv~e~~~~~~ 89 (313)
++.++.|..+.||+....++.+++|..... ....+..|..+++.+ + ..+.+++.... .....+++|++++|.+
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~ 81 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP 81 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence 468899999999999999889999998776 566788999999998 3 22556666432 3345789999999987
Q ss_pred hhh
Q 041031 90 LSD 92 (313)
Q Consensus 90 L~~ 92 (313)
+..
T Consensus 82 ~~~ 84 (239)
T PF01636_consen 82 LDD 84 (239)
T ss_dssp HHH
T ss_pred ccc
Confidence 777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.62 E-value=9.3e-07 Score=74.49 Aligned_cols=74 Identities=15% Similarity=0.156 Sum_probs=56.6
Q ss_pred eccCCe-EEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCCCChhhh
Q 041031 20 IGQGSY-GSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQNGALSDH 93 (313)
Q Consensus 20 lg~g~~-g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 93 (313)
|..|.. +.||+....+..+.+|+........+.+|+++++.+ +--+.++++........++||++++|.++.+.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 333444 889999877788999998776556788899999999 43355777777766678999999999877644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.2e-05 Score=69.76 Aligned_cols=156 Identities=15% Similarity=0.168 Sum_probs=93.7
Q ss_pred HHHHHHhcCccc-----cceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc-CCC--ceeeeeE-----
Q 041031 5 NEVRDATSNFST-----SLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV-HSN--LIELIGY----- 71 (313)
Q Consensus 5 ~~~~~~~~~y~~-----~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~--i~~~~~~----- 71 (313)
+++..+...|.+ .+.+..|....+|+....+..+++|+........+..|+.+++.+ +.+ +.+++..
T Consensus 2 ~~l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~ 81 (296)
T cd05153 2 EELASFLADYDLGELLSFEGISAGIENTNYFVTTDSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEY 81 (296)
T ss_pred HHHHHHHHHcCCCchhheecccCccccceEEEEeCCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcE
Confidence 345555555553 567777888899998877778999998875566788899998888 222 3444432
Q ss_pred -EEeCCeEEEEEeecCCCChhh-----------hh---cC---CCCCC---CCCccHHHH----------HHHHHHHHHH
Q 041031 72 -AAGGDSLFLVYEYAQNGALSD-----------HL---HW---PSVKG---KKPLAWTTR----------VQIALDAAKG 120 (313)
Q Consensus 72 -~~~~~~~~lv~e~~~~~~L~~-----------~l---~~---~~~~~---~~~l~~~~~----------~~~~~~i~~~ 120 (313)
....+..++++++++|.++.. .+ +. ..... .....+... ......+..+
T Consensus 82 ~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 161 (296)
T cd05153 82 LSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADE 161 (296)
T ss_pred eeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHH
Confidence 233456789999999876532 00 00 00000 000000000 0011112233
Q ss_pred HHHHhcC----CCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 121 LEYIHQY----TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 121 l~~lh~~----~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
+..+... ....++|+|+.|.|+++++++.+.++||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 162 LARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4444431 112289999999999999887678999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.7e-05 Score=66.72 Aligned_cols=78 Identities=12% Similarity=0.034 Sum_probs=60.8
Q ss_pred CccccceeccCCeEEEEEeEECCcceEEEecccc-ccHHHHHHHHHHHhc--C--CCceeeeeEEEe---CCeEEEEEee
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNT-KSKEFSSELKILCKV--H--SNLIELIGYAAG---GDSLFLVYEY 84 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~-~~~~~~~e~~~l~~l--h--~~i~~~~~~~~~---~~~~~lv~e~ 84 (313)
.-.-.+.||.|..+.||.....+..+++|..+.. ....+..|...++.+ + -.+.++++++.+ .+..++|||+
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 4445678999999999998877667888886653 456889999999999 2 257788887754 3568999999
Q ss_pred cCCCCh
Q 041031 85 AQNGAL 90 (313)
Q Consensus 85 ~~~~~L 90 (313)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.2e-05 Score=60.57 Aligned_cols=103 Identities=23% Similarity=0.293 Sum_probs=80.4
Q ss_pred HHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCC
Q 041031 53 SELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130 (313)
Q Consensus 53 ~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 130 (313)
.|..+++.+ .+++.+++|++. .+++.|+.+.+++..... ........++..+..++.++++.+.+++.....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~--~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYR--PLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccc--ccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 477888888 468999999984 367999998766643200 001223468889999999999999999996555
Q ss_pred ceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 131 ~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
++...|++|+|+-++++|++|++|.+.+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5889999999999999999999999876643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.9e-05 Score=66.99 Aligned_cols=136 Identities=15% Similarity=0.107 Sum_probs=79.8
Q ss_pred eeccCCeEEEEEeEECCcceEEEeccccccH---HHHHHHHHHHhc-CCCc-eeeeeEEEeCCeEEEEEeecCCCChhhh
Q 041031 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTKSK---EFSSELKILCKV-HSNL-IELIGYAAGGDSLFLVYEYAQNGALSDH 93 (313)
Q Consensus 19 ~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~---~~~~e~~~l~~l-h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 93 (313)
.+..|-.+.+|+....++.+++|........ ...+|..+++.+ ..++ .+++.... -++|+||++|.++...
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 4556888899999877888999987654322 467899999999 2223 34444332 3689999998766431
Q ss_pred -----------------hcCCCCCCCCCccHH-HHHHHHHHH---------HHHHHHHhcC-----CCCceEEeccCCCC
Q 041031 94 -----------------LHWPSVKGKKPLAWT-TRVQIALDA---------AKGLEYIHQY-----TKPYYVHRDVKTSN 141 (313)
Q Consensus 94 -----------------l~~~~~~~~~~l~~~-~~~~~~~~i---------~~~l~~lh~~-----~~~~i~h~di~p~n 141 (313)
++.... ...+++.. .+..+..++ ...+..+... .+..++|+|+.|.|
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPR-FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 111110 11112211 111211111 1112222111 01228999999999
Q ss_pred eeeCCCCcEEEeecccccc
Q 041031 142 ILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 142 il~~~~~~~~l~dfg~~~~ 160 (313)
|++++++ +.++||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999887 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.5e-05 Score=68.16 Aligned_cols=158 Identities=16% Similarity=0.198 Sum_probs=92.9
Q ss_pred ChHHHHHHhcCccc-----cceeccCCeEEEEEeEECCcceEEEecccc-ccHHHHHHHHHHHhc-CCC--ceeeeeEE-
Q 041031 3 SYNEVRDATSNFST-----SLKIGQGSYGSVYLGKLRGKNAAIKQMKNT-KSKEFSSELKILCKV-HSN--LIELIGYA- 72 (313)
Q Consensus 3 ~~~~~~~~~~~y~~-----~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~-~~~~~~~e~~~l~~l-h~~--i~~~~~~~- 72 (313)
|.+.+....++|.+ ++.++.|....+|+....+..+++|+.... ..+.+..|.++++.+ ..+ +.+++...
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~ 87 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRD 87 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCC
Confidence 45677777777755 456777777899998877678899987654 355677788888888 222 34444321
Q ss_pred -----EeCCeEEEEEeecCCCChhh-----------hh---cCCCC---CC--C-CCcc-HHHH-H-----------HHH
Q 041031 73 -----AGGDSLFLVYEYAQNGALSD-----------HL---HWPSV---KG--K-KPLA-WTTR-V-----------QIA 114 (313)
Q Consensus 73 -----~~~~~~~lv~e~~~~~~L~~-----------~l---~~~~~---~~--~-~~l~-~~~~-~-----------~~~ 114 (313)
...+..+++++|++|.++.. .+ +.... .. . .... +... . ...
T Consensus 88 g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~ 167 (307)
T TIGR00938 88 GRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMG 167 (307)
T ss_pred CCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHH
Confidence 23456789999998865431 11 10000 00 0 0000 0000 0 011
Q ss_pred HHHHHHHHHHhc----CCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 115 LDAAKGLEYIHQ----YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 115 ~~i~~~l~~lh~----~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
..+...+.++.. .-...++|+|+++.|+++++++.+.++||+.+..
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 168 AELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 122333444432 1122399999999999999887678999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.7e-05 Score=75.99 Aligned_cols=75 Identities=13% Similarity=0.319 Sum_probs=56.3
Q ss_pred ccceeccCCeEEEEEeEECC----cceEEEecccc----ccHHHHHHHHHHHhc--CCCc--eeeeeEEEeC---CeEEE
Q 041031 16 TSLKIGQGSYGSVYLGKLRG----KNAAIKQMKNT----KSKEFSSELKILCKV--HSNL--IELIGYAAGG---DSLFL 80 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~~----~~~aiK~~~~~----~~~~~~~e~~~l~~l--h~~i--~~~~~~~~~~---~~~~l 80 (313)
.++.++.|.++.+|+....+ ..+++|..... ....+.+|.++++.+ |+++ .+++.++.+. ...|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 36778999999999887763 46788876543 235688999999999 5554 6777777654 45789
Q ss_pred EEeecCCCCh
Q 041031 81 VYEYAQNGAL 90 (313)
Q Consensus 81 v~e~~~~~~L 90 (313)
|||+++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999988654
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.21 E-value=4e-05 Score=67.26 Aligned_cols=88 Identities=7% Similarity=0.043 Sum_probs=59.4
Q ss_pred ChHHHHHHhcCccc-----cceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc-CCC--ceeeeeE---
Q 041031 3 SYNEVRDATSNFST-----SLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV-HSN--LIELIGY--- 71 (313)
Q Consensus 3 ~~~~~~~~~~~y~~-----~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~--i~~~~~~--- 71 (313)
|.++++.....|-+ .+.++.|....+|+....+..+++|+......+.+..+..+++.+ ..+ +.+++..
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G 87 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDG 87 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCC
Confidence 56777777777855 355667777899998877778999988643455666677777777 212 3333321
Q ss_pred ---EEeCCeEEEEEeecCCCCh
Q 041031 72 ---AAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 72 ---~~~~~~~~lv~e~~~~~~L 90 (313)
....+..+++++|++|..+
T Consensus 88 ~~~~~~~g~~~~l~~~l~G~~~ 109 (319)
T PRK05231 88 AALGELAGKPAAIVTFLEGKWP 109 (319)
T ss_pred CEeeeeCCEEEEEEEecCCCCC
Confidence 2334567899999988754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.2e-05 Score=74.04 Aligned_cols=146 Identities=21% Similarity=0.235 Sum_probs=91.6
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccccHH-----------------------------------
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKSKE----------------------------------- 50 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~~~~----------------------------------- 50 (313)
++++.+.|.. +.||..+.|.||+|+.+ |+.||||+-++.-.+.
T Consensus 157 ie~if~~f~~-~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L 235 (538)
T KOG1235|consen 157 IEDIFSEFDE-EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSL 235 (538)
T ss_pred HHHHHHhcCc-chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhh
Confidence 3444455543 48999999999999998 8889999877643221
Q ss_pred -----HHHHHHHHHhc-----CCC---ceeeeeEE-EeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHH
Q 041031 51 -----FSSELKILCKV-----HSN---LIELIGYA-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALD 116 (313)
Q Consensus 51 -----~~~e~~~l~~l-----h~~---i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~ 116 (313)
+.+|.+-.... |-+ -+.+=.++ .......|+|||++|..+.+.-. -....++... ++..
T Consensus 236 ~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~----i~~~gi~~~~---i~~~ 308 (538)
T KOG1235|consen 236 PQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA----IDKRGISPHD---ILNK 308 (538)
T ss_pred HhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH----HHHcCCCHHH---HHHH
Confidence 22233322222 323 11122222 23346789999999988876632 1233455443 3344
Q ss_pred HHHHHHH-HhcCCCCceEEeccCCCCeeeCC----CCcEEEeeccccccccC
Q 041031 117 AAKGLEY-IHQYTKPYYVHRDVKTSNILLDS----NFRAKIADFGLVKLLEH 163 (313)
Q Consensus 117 i~~~l~~-lh~~~~~~i~h~di~p~nil~~~----~~~~~l~dfg~~~~~~~ 163 (313)
+.++... +=..| ++|+|-.|-||+++. ++.+.+.|||+......
T Consensus 309 l~~~~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 309 LVEAYLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 4443222 23445 899999999999984 56899999999876554
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.9e-05 Score=60.68 Aligned_cols=121 Identities=23% Similarity=0.353 Sum_probs=87.2
Q ss_pred cCccccceeccCCe-EEEEEeEECCcceEEEecc---ccc---------------------cHHHHHHHHHHHhc----C
Q 041031 12 SNFSTSLKIGQGSY-GSVYLGKLRGKNAAIKQMK---NTK---------------------SKEFSSELKILCKV----H 62 (313)
Q Consensus 12 ~~y~~~~~lg~g~~-g~v~~~~~~~~~~aiK~~~---~~~---------------------~~~~~~e~~~l~~l----h 62 (313)
++++.++.||.|.. |.||+++..|+.+|+|.+. ... .+-+..|-+..-++ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78999999999999 9999999999999999932 111 11256677777777 4
Q ss_pred CCc--eeeeeEEEeC------------------CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHH
Q 041031 63 SNL--IELIGYAAGG------------------DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLE 122 (313)
Q Consensus 63 ~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~ 122 (313)
.++ ++++++..-. ..+.||.||.+... .++... +.++.+-+.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~~~----~~~~~~dl~ 178 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQIRD----IPQMLRDLK 178 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccchhH----HHHHHHHHH
Confidence 466 8999886322 12456777664421 233333 455666677
Q ss_pred HHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 123 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
.+|..| |+-+|+++.|.. +| +|+|||.+
T Consensus 179 ~~~k~g---I~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLG---IVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HHHHCC---eeeccCcccccc---CC--EEEecccC
Confidence 799999 999999999987 33 78999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.6e-05 Score=64.48 Aligned_cols=73 Identities=12% Similarity=0.214 Sum_probs=47.6
Q ss_pred cceeccCCeE-EEEEeEECCcceEEEecccc-ccHHHHHHHHHHHhcCC----CceeeeeEEEeC---CeEEEEEeecCC
Q 041031 17 SLKIGQGSYG-SVYLGKLRGKNAAIKQMKNT-KSKEFSSELKILCKVHS----NLIELIGYAAGG---DSLFLVYEYAQN 87 (313)
Q Consensus 17 ~~~lg~g~~g-~v~~~~~~~~~~aiK~~~~~-~~~~~~~e~~~l~~lh~----~i~~~~~~~~~~---~~~~lv~e~~~~ 87 (313)
++.++.|+.. .||+. +..+++|..+.. ....+.+|.++++.+.. -+.++++..... ...+++|++++|
T Consensus 2 ~~~~~~gG~~n~vy~~---~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G 78 (235)
T cd05155 2 IEPVDSGGTDNATFRL---GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG 78 (235)
T ss_pred ceeccCCCcccceEEc---CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence 4567767766 58875 346888887654 34578899999998832 233444433322 234789999999
Q ss_pred CChhh
Q 041031 88 GALSD 92 (313)
Q Consensus 88 ~~L~~ 92 (313)
.++.+
T Consensus 79 ~~l~~ 83 (235)
T cd05155 79 ETATA 83 (235)
T ss_pred CCCCc
Confidence 77753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.11 E-value=7.4e-05 Score=62.48 Aligned_cols=71 Identities=15% Similarity=0.149 Sum_probs=48.6
Q ss_pred cceeccCCeEEEEEeEEC---CcceEEEecccccc--HHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCCCC
Q 041031 17 SLKIGQGSYGSVYLGKLR---GKNAAIKQMKNTKS--KEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQNGA 89 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~---~~~~aiK~~~~~~~--~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (313)
++.|..|-...+|+.... ++.+++|+...... -...+|..+++.+ +.-..+++.... + .++|||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 456778888999998766 46889998765432 2345788889888 323344444332 2 47999999877
Q ss_pred hh
Q 041031 90 LS 91 (313)
Q Consensus 90 L~ 91 (313)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 64
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00024 Score=57.54 Aligned_cols=128 Identities=23% Similarity=0.262 Sum_probs=89.5
Q ss_pred ccceeccCCeEEEEEeEECCcceEEEeccccc-------------------cHHHHHHHHHHHhc-------CCCceeee
Q 041031 16 TSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-------------------SKEFSSELKILCKV-------HSNLIELI 69 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-------------------~~~~~~e~~~l~~l-------h~~i~~~~ 69 (313)
-...||+|+.-.||.--. +...+||+..+.. ..+..+|+.-+..+ +.+|.+++
T Consensus 5 ~~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CCcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 356799999999984322 4567888887766 45555665554444 67899999
Q ss_pred eEEEeCCeEEEEEeecCC------CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCee
Q 041031 70 GYAAGGDSLFLVYEYAQN------GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNIL 143 (313)
Q Consensus 70 ~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil 143 (313)
|+.+.+-...+|+|.+.+ .||.+++. .+.++. . +...+-+-..+|-+.+ |+..|++|+||+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~------~~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK------EGGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH------cCCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEE
Confidence 999999999999997654 45777762 233444 3 3444455566778888 999999999999
Q ss_pred eCCC--C--cEEEee-ccc
Q 041031 144 LDSN--F--RAKIAD-FGL 157 (313)
Q Consensus 144 ~~~~--~--~~~l~d-fg~ 157 (313)
+..+ + .++++| ||.
T Consensus 151 ~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EEecCCCceEEEEEeCCCC
Confidence 9532 2 467776 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.4e-06 Score=80.05 Aligned_cols=192 Identities=19% Similarity=0.194 Sum_probs=136.5
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEECC-cceEEEeccccccHHHHHHHHHHHhc-CCC-ceeeeeEEEeCCeEEEEEe
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLRG-KNAAIKQMKNTKSKEFSSELKILCKV-HSN-LIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~-i~~~~~~~~~~~~~~lv~e 83 (313)
+++-..-+...+-++++..+.+++.+... +....+.+... ....-++++|.++ ||| .+..++-++.+....+.++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 34444556667778889999999887763 33334444433 4555678999999 999 6777777777788889999
Q ss_pred ecCCC-ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 84 YAQNG-ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 84 ~~~~~-~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
++.++ +...... .....+..-+.....+.-+.+++++|+.. =+|+| ||+.++ +..+.++|+......
T Consensus 315 i~s~~rs~~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 315 ICSTGRSSALEMT----VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhcCCccccccCC----hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccC
Confidence 98776 2322221 12223344445566677778899999885 47777 777766 468999999877665
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccC
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSR 216 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~ 216 (313)
... ......+++.++|||+.....+....|+|++|.-..++--|.+|-..
T Consensus 383 ~~~----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 383 RTM----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccc----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 432 34445789999999999999999999999999987788777776544
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.89 E-value=9.7e-05 Score=63.46 Aligned_cols=75 Identities=17% Similarity=0.256 Sum_probs=53.2
Q ss_pred ccccceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc----CCCceeeeeEEEeCCeEEEEEeecCCC
Q 041031 14 FSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV----HSNLIELIGYAAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l----h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (313)
.+-.+.++.|....+|+....++.+.||+-.......+..|..-|+.+ .-.+.+++++....+..+|++||++.+
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 445778899999999999977999999998866677889999999998 335778999888777789999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=2.9e-05 Score=66.45 Aligned_cols=131 Identities=16% Similarity=0.146 Sum_probs=94.2
Q ss_pred cCccccceeccCCeEEEEEeEEC-CcceEEEeccccc-------------------------cHHHHHHHHHHHhc--CC
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK-------------------------SKEFSSELKILCKV--HS 63 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~-------------------------~~~~~~e~~~l~~l--h~ 63 (313)
.-+.+.+.||-|--+.+|.+.+. |++.++|.-+... .-...+|...|+.+ |.
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 35678999999999999999988 8888888543211 00145688888888 32
Q ss_pred C-ceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCe
Q 041031 64 N-LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNI 142 (313)
Q Consensus 64 ~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~ni 142 (313)
. +.+.++ .++.++|||++.|.+|.+.-. -.. ...+...+...+.-|...| ++|||++-=||
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~--------v~d---~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNi 233 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRH--------VED---PPTLYDDLMGLIVRLANHG---LIHGDFNEFNI 233 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeee--------cCC---hHHHHHHHHHHHHHHHHcC---ceecccchhee
Confidence 2 344443 356788999999988876531 111 1223445555666688889 99999999999
Q ss_pred eeCCCCcEEEeecccccc
Q 041031 143 LLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 143 l~~~~~~~~l~dfg~~~~ 160 (313)
++.+++.++++||.-...
T Consensus 234 mv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 234 MVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred EEecCCCEEEeechHhhc
Confidence 999999999999986543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00044 Score=62.08 Aligned_cols=71 Identities=17% Similarity=0.108 Sum_probs=52.3
Q ss_pred cceeccCCeEEEEEeEECC--cceEEEecccc----------ccHHHHHHHHHHHhc----CCCceeeeeEEEeCCeEEE
Q 041031 17 SLKIGQGSYGSVYLGKLRG--KNAAIKQMKNT----------KSKEFSSELKILCKV----HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~~--~~~aiK~~~~~----------~~~~~~~e~~~l~~l----h~~i~~~~~~~~~~~~~~l 80 (313)
.+.||.|.+..||++...+ +.++||+-.+. ..+....|.+.|+.+ ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4689999999999999884 38999985421 244566788888887 3456777777 3355789
Q ss_pred EEeecCCCC
Q 041031 81 VYEYAQNGA 89 (313)
Q Consensus 81 v~e~~~~~~ 89 (313)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997644
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00014 Score=71.69 Aligned_cols=197 Identities=20% Similarity=0.189 Sum_probs=134.2
Q ss_pred HHHHHHHHhc-CCCceeeeeEEEeCCeEE----EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc
Q 041031 52 SSELKILCKV-HSNLIELIGYAAGGDSLF----LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126 (313)
Q Consensus 52 ~~e~~~l~~l-h~~i~~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~ 126 (313)
..|++.+... |+|++.++.+........ +..+++...++.+.+ ......+....+.+..+...+++++|+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-----q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-----QSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-----hhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3456666666 999999999876544332 345677777888777 456778999999999999999999999
Q ss_pred CCCCceEEeccCCC---CeeeCCCCcEEEe--eccccccccCChhhhhhcccccccccccCCccccCCCC--CCccchhh
Q 041031 127 YTKPYYVHRDVKTS---NILLDSNFRAKIA--DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV--TTKSDVYA 199 (313)
Q Consensus 127 ~~~~~i~h~di~p~---nil~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~Diws 199 (313)
.. ..|.-+..+ +-.++..+.+... ||+......... .......+..+.+||....... +...|+|.
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~----~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE----KSFSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcc----cchhhcCccccccccccccccchhhhhhHHHH
Confidence 98 777666666 4444555666666 888776555432 1222234566777777765544 34479999
Q ss_pred HHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccC
Q 041031 200 FGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDEN 279 (313)
Q Consensus 200 lG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 279 (313)
+|.....+..|..+-... ......+.. .....+.++..+|+..+
T Consensus 378 lgll~~~~~~~~~i~~~~-----------------------------~~~~~~l~~-------~~~~~~~d~~~~~~~~~ 421 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKS-----------------------------AVPVSLLDV-------LSTSELLDALPKCLDED 421 (1351)
T ss_pred HHHHHhhhhhcCcccccc-----------------------------cchhhhhcc-------ccchhhhhhhhhhcchh
Confidence 999999999886543211 111111111 11114667889999999
Q ss_pred cCCCCCHHHHHHHHHHH
Q 041031 280 WKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 280 p~~Rps~~~ll~~l~~~ 296 (313)
+++|+++.+++...-.-
T Consensus 422 ~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 422 SEERLSALELLTHPFLR 438 (1351)
T ss_pred hhhccchhhhhhchhcc
Confidence 99999999999765533
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00042 Score=60.07 Aligned_cols=143 Identities=17% Similarity=0.240 Sum_probs=93.5
Q ss_pred CccccceeccCCeEEEEEeEECCcceEEEeccc-----cccHHHHHHHHHHHhcCCC---ceeeeeEEEeCC--eEEEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKN-----TKSKEFSSELKILCKVHSN---LIELIGYAAGGD--SLFLVY 82 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~-----~~~~~~~~e~~~l~~lh~~---i~~~~~~~~~~~--~~~lv~ 82 (313)
...+++.+..|....+|.....+++++++ ..+ .......+|+.+++.+++. +...++.+.++. ..|.||
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CCceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34455566556666777777778889998 432 2344567888999988442 345566665555 679999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHH-HHHHHHHHHHhcCC---------------------------------
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA-LDAAKGLEYIHQYT--------------------------------- 128 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~-~~i~~~l~~lh~~~--------------------------------- 128 (313)
+|.+|..+.+.+.. .... .+.+ ..++..|+-||+-.
T Consensus 105 ~~veGe~~~~~~~~------~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~ 174 (321)
T COG3173 105 EWVEGEVVWSALPP------ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELG 174 (321)
T ss_pred EEecceeccCcCCc------ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhcc
Confidence 99988655444310 1111 1122 35556666666443
Q ss_pred ----------------------CCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 129 ----------------------KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 129 ----------------------~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+..++|||+.+.|++++.++.+-++||+.+.......+
T Consensus 175 ~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~~D 234 (321)
T COG3173 175 GRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPLED 234 (321)
T ss_pred CCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcHHH
Confidence 11289999999999999888899999999887555443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00051 Score=58.92 Aligned_cols=30 Identities=30% Similarity=0.485 Sum_probs=25.4
Q ss_pred eEEeccCCCCeeeCCCCcE-EEeeccccccc
Q 041031 132 YVHRDVKTSNILLDSNFRA-KIADFGLVKLL 161 (313)
Q Consensus 132 i~h~di~p~nil~~~~~~~-~l~dfg~~~~~ 161 (313)
++|+|++|.||++++++.+ -++||+.+...
T Consensus 187 lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 187 LVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 8999999999999975654 69999987753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00069 Score=58.97 Aligned_cols=72 Identities=17% Similarity=0.182 Sum_probs=48.9
Q ss_pred cceeccCCeEEEEEeEEC--------CcceEEEeccccc--cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEee
Q 041031 17 SLKIGQGSYGSVYLGKLR--------GKNAAIKQMKNTK--SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~--------~~~~aiK~~~~~~--~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
++.+..|-...+|+.... ++.+++|+..... ......|..+++.+ +.-..+++..+.+ .+|++|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345666777899988765 3689999977643 34577899999998 2223455555432 358999
Q ss_pred cCCCChhh
Q 041031 85 AQNGALSD 92 (313)
Q Consensus 85 ~~~~~L~~ 92 (313)
++|.++..
T Consensus 79 i~G~~l~~ 86 (302)
T cd05156 79 IPSRTLTT 86 (302)
T ss_pred eCCCcCCH
Confidence 98877643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0041 Score=55.15 Aligned_cols=139 Identities=18% Similarity=0.263 Sum_probs=79.6
Q ss_pred cceeccCCeEEEEEeEEC------CcceEEEeccccccH--HHHHHHHHHHhc-CCC-ceeeeeEEEeCCeEEEEEeecC
Q 041031 17 SLKIGQGSYGSVYLGKLR------GKNAAIKQMKNTKSK--EFSSELKILCKV-HSN-LIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~------~~~~aiK~~~~~~~~--~~~~e~~~l~~l-h~~-i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
++.+..|-...+|+.... ++.+++|+....... ....|..+++.+ ..+ -.++++.+.+. .|.+|++
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 445555888999998753 257899988765322 246788898888 223 34556655332 5799998
Q ss_pred CCChhhh-h----------------cCCCCCCCC-CccHHHHHHHHHHH-----------------HHHHHHH----hc-
Q 041031 87 NGALSDH-L----------------HWPSVKGKK-PLAWTTRVQIALDA-----------------AKGLEYI----HQ- 126 (313)
Q Consensus 87 ~~~L~~~-l----------------~~~~~~~~~-~l~~~~~~~~~~~i-----------------~~~l~~l----h~- 126 (313)
+.++... + +........ ......+..++.++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 1 111100011 11122232332221 1111111 11
Q ss_pred CCCCceEEeccCCCCeeeCC-CCcEEEeeccccc
Q 041031 127 YTKPYYVHRDVKTSNILLDS-NFRAKIADFGLVK 159 (313)
Q Consensus 127 ~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~ 159 (313)
....-++|+|+++.||++++ ++.+.++||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11122899999999999986 4679999998765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0072 Score=54.31 Aligned_cols=77 Identities=17% Similarity=0.140 Sum_probs=54.7
Q ss_pred ccceeccCCeEEEEEeEECCcceEEEecccc----------ccHHHHHHHHHHHhc----CCCceeeeeEEEeCCeEEEE
Q 041031 16 TSLKIGQGSYGSVYLGKLRGKNAAIKQMKNT----------KSKEFSSELKILCKV----HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~----------~~~~~~~e~~~l~~l----h~~i~~~~~~~~~~~~~~lv 81 (313)
..+.+|.|....||+....+..++||+-.+. .......|.+.|+.+ ...+.+++.++.+. .+++
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlv 113 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIG 113 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEE
Confidence 4678899999999999887778999987621 234445567777766 24677888887744 5778
Q ss_pred EeecCC--CChhhhh
Q 041031 82 YEYAQN--GALSDHL 94 (313)
Q Consensus 82 ~e~~~~--~~L~~~l 94 (313)
||++++ ..+.+-+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3455444
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0021 Score=52.77 Aligned_cols=29 Identities=28% Similarity=0.560 Sum_probs=20.7
Q ss_pred eEEeccCCCCeee-CCCCcEEEeecccccc
Q 041031 132 YVHRDVKTSNILL-DSNFRAKIADFGLVKL 160 (313)
Q Consensus 132 i~h~di~p~nil~-~~~~~~~l~dfg~~~~ 160 (313)
++|+|+.|.||++ +.++.++++||..+..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 7899999999999 8889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0094 Score=52.60 Aligned_cols=71 Identities=10% Similarity=0.210 Sum_probs=46.4
Q ss_pred cceeccCCeEEEEEeEECC-----cceEEEecccccc--HHHHHHHHHHHhc-CCCc-eeeeeEEEeCCeEEEEEeecCC
Q 041031 17 SLKIGQGSYGSVYLGKLRG-----KNAAIKQMKNTKS--KEFSSELKILCKV-HSNL-IELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~~-----~~~aiK~~~~~~~--~~~~~e~~~l~~l-h~~i-~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
++.|..|-...+|+....+ ..+++|+...... -...+|..+++.+ .-++ .++++++. +. +|.+|+++
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~g 94 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFINA 94 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC--Cc--EeehhhcC
Confidence 3455558889999887653 2789998865432 2346788899888 3333 35555553 22 58899987
Q ss_pred CChh
Q 041031 88 GALS 91 (313)
Q Consensus 88 ~~L~ 91 (313)
.++.
T Consensus 95 ~~l~ 98 (330)
T PLN02421 95 RTLT 98 (330)
T ss_pred CCCC
Confidence 7653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0053 Score=53.64 Aligned_cols=65 Identities=11% Similarity=0.114 Sum_probs=42.6
Q ss_pred CCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc-C---CCceeeeeE------EEeCCeEEEEEeecCCC
Q 041031 23 GSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV-H---SNLIELIGY------AAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 23 g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l-h---~~i~~~~~~------~~~~~~~~lv~e~~~~~ 88 (313)
+.-+.||+....+..+++|.+. .+.+++...+.++..+ . +.++.++.. ...++..+++++|++|.
T Consensus 17 ~~~~~v~~v~T~~G~~~Lk~~~-~~~~~l~~~~~~~~~L~~~G~~~~~~~~~t~~G~~~~~~~~~~~~L~~wi~G~ 91 (309)
T TIGR02904 17 QVTGKLFKVYTDQGVFALKKLY-ADRNTIESFVSQIQVLSEKGFSRIVPVYPTKDGSYYLFHGHFLYYLMPWLDIE 91 (309)
T ss_pred cccCcEEEEEeCCCCEEEEEec-cchHhHHHHHHHHHHHHHcCCCcCCceeecCCCCeeeEECCEEEEEeCCcccc
Confidence 3357899988887789999998 4455555566666666 2 234444332 23345568999999873
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.015 Score=47.77 Aligned_cols=75 Identities=19% Similarity=0.222 Sum_probs=60.8
Q ss_pred cceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc----CCCceeeeeEEEeCCeEEEEEeecCCCChh
Q 041031 17 SLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV----HSNLIELIGYAAGGDSLFLVYEYAQNGALS 91 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (313)
.+.+.-|..-..|...+-..++.||.-.......+..|+.-|+.+ .-.+.+++.+..+..+.|+|+||++-+.+.
T Consensus 21 r~~v~gG~inea~~v~dg~~~~FvK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 21 REEVSGGDINEAWRLRDGTDPFFVKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccccCCccccceeEeecCCcceEEEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 455666777777777777889999998777777788888888888 246788999999999999999999987766
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.032 Score=48.62 Aligned_cols=63 Identities=13% Similarity=0.206 Sum_probs=41.5
Q ss_pred EEEEeEECCcceEEEeccccccHHHHHHHHHHHhc-CC--CceeeeeE------EEeCCeEEEEEeecCCCCh
Q 041031 27 SVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV-HS--NLIELIGY------AAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 27 ~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~--~i~~~~~~------~~~~~~~~lv~e~~~~~~L 90 (313)
.||+....+..+++|.+... ...+..+...+..+ .. .++.++.. ...++..+.+++|++|.++
T Consensus 11 ~v~~v~t~~g~~~LK~~~~~-~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSGNKCLKKINYP-PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCCCeEEEEcCCC-HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 48888876668999998643 34566677777777 22 23344433 2335578899999988655
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.012 Score=53.83 Aligned_cols=66 Identities=20% Similarity=0.355 Sum_probs=45.2
Q ss_pred EEEeEEC-CcceEEEecccc-ccHHHHHHHHHHHhc-CCCceeeeeEEEeC-CeEEEEEeecCCCChhhhhc
Q 041031 28 VYLGKLR-GKNAAIKQMKNT-KSKEFSSELKILCKV-HSNLIELIGYAAGG-DSLFLVYEYAQNGALSDHLH 95 (313)
Q Consensus 28 v~~~~~~-~~~~aiK~~~~~-~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 95 (313)
+|.|..+ |..+ .--+... ....+....++++.+ |+|+...++..... .+..+|+|++ +.||.+.+.
T Consensus 5 ~~~a~~~~~~~c-~nglplt~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPLTPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred EEehhcCCCccc-cCCCcCCCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 4555554 4444 4444322 234466678889999 99999999987644 4577889998 779999884
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.01 Score=53.16 Aligned_cols=69 Identities=14% Similarity=0.092 Sum_probs=47.8
Q ss_pred cceeccCCeEEEEEeEEC--CcceEEEeccc---------cccHHHHHHHHHHHhc---CC-CceeeeeEEEeCCeEEEE
Q 041031 17 SLKIGQGSYGSVYLGKLR--GKNAAIKQMKN---------TKSKEFSSELKILCKV---HS-NLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~---------~~~~~~~~e~~~l~~l---h~-~i~~~~~~~~~~~~~~lv 81 (313)
.+.||.|.-..||++.+. ++.++||+-.+ -..++..-|.+.|+.. .| .+.+++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 568899999999999985 56799987642 1245566788888877 44 45556554 33344678
Q ss_pred EeecCC
Q 041031 82 YEYAQN 87 (313)
Q Consensus 82 ~e~~~~ 87 (313)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 887754
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.07 Score=46.87 Aligned_cols=136 Identities=16% Similarity=0.213 Sum_probs=79.8
Q ss_pred CeEEEEEeEECCcceEEEecccc-ccHHHHHHHHHHHhc--C--CCcee---e----eeEEEeCCeEEEEEeecCCCChh
Q 041031 24 SYGSVYLGKLRGKNAAIKQMKNT-KSKEFSSELKILCKV--H--SNLIE---L----IGYAAGGDSLFLVYEYAQNGALS 91 (313)
Q Consensus 24 ~~g~v~~~~~~~~~~aiK~~~~~-~~~~~~~e~~~l~~l--h--~~i~~---~----~~~~~~~~~~~lv~e~~~~~~L~ 91 (313)
.-..+|+....+..+++|+..+. ...++..|+..+..+ + +-.+. . +.........+-+++|++|..+.
T Consensus 37 ~eN~~f~~~~~~g~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~ 116 (331)
T COG2334 37 EENSNFRVQTEDGRYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLE 116 (331)
T ss_pred ccCceEEEEecCCCeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcC
Confidence 45678888888777799999986 677788999999998 2 11111 1 11112223778899999998877
Q ss_pred h-hh-----------------cCCC----CCCCCCccHH-------------HHHHHHHHHHHHHHHHhcC----CCCc-
Q 041031 92 D-HL-----------------HWPS----VKGKKPLAWT-------------TRVQIALDAAKGLEYIHQY----TKPY- 131 (313)
Q Consensus 92 ~-~l-----------------~~~~----~~~~~~l~~~-------------~~~~~~~~i~~~l~~lh~~----~~~~- 131 (313)
. .- .... ........+. .-.....++...+..+.+. -+..
T Consensus 117 ~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~ 196 (331)
T COG2334 117 RDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALG 196 (331)
T ss_pred CCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCccc
Confidence 3 10 0000 0000011111 0001222233333333322 1222
Q ss_pred --eEEeccCCCCeeeCCCCc-EEEeeccccc
Q 041031 132 --YVHRDVKTSNILLDSNFR-AKIADFGLVK 159 (313)
Q Consensus 132 --i~h~di~p~nil~~~~~~-~~l~dfg~~~ 159 (313)
++|+|+.|.||+++.+.. +-++||+-+.
T Consensus 197 ~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 197 DQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred ceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998875 7899999765
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0078 Score=53.54 Aligned_cols=131 Identities=21% Similarity=0.256 Sum_probs=85.4
Q ss_pred HHHHHhcCccccceeccCCeEEEEEeEEC-----------------CcceEEEeccccccHHHHHHHHHHHhc--CCCce
Q 041031 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLR-----------------GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLI 66 (313)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-----------------~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~ 66 (313)
+++.+.+.|.- ..||.|+.+.||+|..+ .+.||||+..+.....+...+.+|... -+|.+
T Consensus 184 ~~~eiF~efn~-~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~v 262 (565)
T KOG1236|consen 184 KIEEIFSEFNR-EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNV 262 (565)
T ss_pred cHHHHHHhcCC-cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhc
Confidence 45555555544 48999999999998532 245899999988877777777777665 22333
Q ss_pred eeeeEE----------------------------------------------EeCCeEEEEEeecCCCChhhhhcCCCCC
Q 041031 67 ELIGYA----------------------------------------------AGGDSLFLVYEYAQNGALSDHLHWPSVK 100 (313)
Q Consensus 67 ~~~~~~----------------------------------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 100 (313)
.-..+- ....+..++-+|..|.++..+++
T Consensus 263 P~l~wL~l~~~vkqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~----- 337 (565)
T KOG1236|consen 263 PDLSWLSLPLEVKQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVK----- 337 (565)
T ss_pred CccccccCcchHHHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhh-----
Confidence 222220 01123346667888888888873
Q ss_pred CCCCccHHHHHHHHHHHHHHHHHHh-cCCCCceEEeccCCCCeeeCC
Q 041031 101 GKKPLAWTTRVQIALDAAKGLEYIH-QYTKPYYVHRDVKTSNILLDS 146 (313)
Q Consensus 101 ~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~~i~h~di~p~nil~~~ 146 (313)
....+++....++.-.+.|+--+- -.+ ++|.|+.|.||++..
T Consensus 338 -~~~~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 338 -WKSQPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIRF 380 (565)
T ss_pred -cccChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEEe
Confidence 233444566666776677654433 334 999999999999953
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.047 Score=49.10 Aligned_cols=72 Identities=17% Similarity=0.225 Sum_probs=46.0
Q ss_pred ccceeccCCeEEEEEeEECC---cc-----eEEEeccccc--cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEe
Q 041031 16 TSLKIGQGSYGSVYLGKLRG---KN-----AAIKQMKNTK--SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~~---~~-----~aiK~~~~~~--~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++.+..|-...+|++...+ .. |.++...... .-+..+|.++++.+ +..-.++++.+.+ +++.|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 44566569999999987552 12 4444432221 12245689999999 4444566666653 58999
Q ss_pred ecCCCChh
Q 041031 84 YAQNGALS 91 (313)
Q Consensus 84 ~~~~~~L~ 91 (313)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99987765
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.033 Score=48.99 Aligned_cols=89 Identities=19% Similarity=0.195 Sum_probs=61.1
Q ss_pred CCCceeeeeEEEeCC-eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCC
Q 041031 62 HSNLIELIGYAAGGD-SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTS 140 (313)
Q Consensus 62 h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~ 140 (313)
.+++.+.+-+-.++. -.|++|++. |+++.-. ..-..+++..++.+.+..++-+..+-+ +-|+|+...
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i---------k~~~~~e~lsff~s~~sil~~lekkf~--fehrnlt~~ 351 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISII---------KADRSEEELSFFWSCISILDILEKKFP--FEHRNLTLD 351 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceeeee---------ecccHHHHHHHHHHHHHHHhhhhhcCC--ccccccccc
Confidence 344444443332332 356677775 5555322 234567778888888888887776643 789999999
Q ss_pred CeeeCCCCcEEEeeccccccccC
Q 041031 141 NILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 141 nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
||+++ +|+|.|+||.++....+
T Consensus 352 niLId-~GnvtLIDfklsRl~~~ 373 (488)
T COG5072 352 NILID-EGNVTLIDFKLSRLSYS 373 (488)
T ss_pred ceeee-cCceEEEEeeeeecccC
Confidence 99999 89999999999885443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.026 Score=49.75 Aligned_cols=131 Identities=18% Similarity=0.163 Sum_probs=85.3
Q ss_pred eeccCCeEEEEEeEEC-CcceEEEeccccc------------------------cHH-----HHHHHHHHHhc-CCCcee
Q 041031 19 KIGQGSYGSVYLGKLR-GKNAAIKQMKNTK------------------------SKE-----FSSELKILCKV-HSNLIE 67 (313)
Q Consensus 19 ~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~------------------------~~~-----~~~e~~~l~~l-h~~i~~ 67 (313)
-|..|--+.||-|... |+.+|||+++.+- +.. ..+|++-|+++ ... ++
T Consensus 151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG-IP 229 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG-IP 229 (520)
T ss_pred ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC-CC
Confidence 3556677788988766 8889999885310 111 45677777777 223 22
Q ss_pred eeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCC
Q 041031 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDS 146 (313)
Q Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~ 146 (313)
+-.-+.-. ...|||+++. +.-+-.- . -....++...+..+-.+++.-+.-|-+ .+ +||.||+--|+|+.+
T Consensus 230 ~PePIlLk-~hVLVM~FlG-rdgw~aP---k-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~---LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 230 CPEPILLK-NHVLVMEFLG-RDGWAAP---K-LKDASLSTSKARELYQQCVRIMRRLYQKCR---LVHADLSEFNLLYHD 300 (520)
T ss_pred CCCceeee-cceEeeeecc-CCCCcCc---c-cccccCChHHHHHHHHHHHHHHHHHHHHhc---eeccchhhhhheEEC
Confidence 22222222 2368999994 3322211 1 234456777788888888888777754 46 999999999999976
Q ss_pred CCcEEEeecccccc
Q 041031 147 NFRAKIADFGLVKL 160 (313)
Q Consensus 147 ~~~~~l~dfg~~~~ 160 (313)
+ .++++|.+-+..
T Consensus 301 G-~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 G-KLYIIDVSQSVE 313 (520)
T ss_pred C-EEEEEEcccccc
Confidence 5 689999987664
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.21 Score=43.94 Aligned_cols=89 Identities=11% Similarity=0.095 Sum_probs=55.0
Q ss_pred cChHHHHHHhcCcccc---c-eeccCCeEEEEEeEEC-CcceEEEecccc--ccHHHHHHHHHHHhc-CCC--ceeee--
Q 041031 2 FSYNEVRDATSNFSTS---L-KIGQGSYGSVYLGKLR-GKNAAIKQMKNT--KSKEFSSELKILCKV-HSN--LIELI-- 69 (313)
Q Consensus 2 ~~~~~~~~~~~~y~~~---~-~lg~g~~g~v~~~~~~-~~~~aiK~~~~~--~~~~~~~e~~~l~~l-h~~--i~~~~-- 69 (313)
.|.+.+-++...+-+. + ..-.+.-..||+.... +..+++|+.++. ....+..|++.+..+ ... ++...
T Consensus 11 l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~ 90 (325)
T PRK11768 11 LTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAF 90 (325)
T ss_pred CChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccC
Confidence 3566677776666432 0 1223556788988876 668999988754 355677888888887 111 22211
Q ss_pred -e--EEEeCCeEEEEEeecCCCCh
Q 041031 70 -G--YAAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 70 -~--~~~~~~~~~lv~e~~~~~~L 90 (313)
+ ....+...+.++++++|...
T Consensus 91 ~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 91 NGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred CCCEEEEECCEEEEEEeeeCCCCC
Confidence 1 12234567789999987653
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.00079 Score=68.50 Aligned_cols=185 Identities=14% Similarity=-0.006 Sum_probs=123.4
Q ss_pred EEEEEeEECCc---ceEEEeccccccHH--------HHHHHHHHHhc-CCCceeeeeEEEe--CCeEEEEEeecCCCChh
Q 041031 26 GSVYLGKLRGK---NAAIKQMKNTKSKE--------FSSELKILCKV-HSNLIELIGYAAG--GDSLFLVYEYAQNGALS 91 (313)
Q Consensus 26 g~v~~~~~~~~---~~aiK~~~~~~~~~--------~~~e~~~l~~l-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~ 91 (313)
+.-+++.+-+. -+.+++.+...-+. ...|...++.. |+++......... ....+..++++.+|.+.
T Consensus 1240 ~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1240 HFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred ceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence 34445555422 24666666543222 12233333334 7777766666543 23457788899999999
Q ss_pred hhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCC--CCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhh
Q 041031 92 DHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT--KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAA 169 (313)
Q Consensus 92 ~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 169 (313)
+.+-.+. .+...+....+.....+.+.+..-+|+.. +...+|.++++-|.++..+.+++++++|+........ .
T Consensus 1320 ~iIikg~-ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~---s 1395 (2724)
T KOG1826|consen 1320 SIIIKGL-EESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL---S 1395 (2724)
T ss_pred HHHHhcc-ccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH---h
Confidence 9885443 23445555555555555566666655543 2336899999999999999999999999988322211 2
Q ss_pred hcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCc
Q 041031 170 AASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQAL 214 (313)
Q Consensus 170 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~ 214 (313)
......+++.|+.|++.+.-.++.++|+|..|+.+|....|..+|
T Consensus 1396 f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1396 FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 223345677889999988888899999999999999998887776
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.039 Score=45.21 Aligned_cols=115 Identities=15% Similarity=0.162 Sum_probs=72.5
Q ss_pred CCeEEEEEeEECCcceEEEeccccc----cHHHHHHHHHHHhcCCCceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCC
Q 041031 23 GSYGSVYLGKLRGKNAAIKQMKNTK----SKEFSSELKILCKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPS 98 (313)
Q Consensus 23 g~~g~v~~~~~~~~~~aiK~~~~~~----~~~~~~e~~~l~~lh~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 98 (313)
++.++.-.++-+-.+..+|.+..-. ..-+..+.+++.++| +|+++..- +.-.+.++.|.+...
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh-GilrL~ND--n~~~yGvIlE~Cy~~---------- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH-GILRLKND--NNYKYGVILERCYKI---------- 139 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh-heeEeecC--CCceeEEEEeeccCc----------
Confidence 4445555555443445556555432 234667888888887 57877733 445678899987321
Q ss_pred CCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 99 VKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 99 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
.-.... ++.--+.+|.-+|+.... .+|||-+|+||+=++.|.+|+.|-+...
T Consensus 140 ----~i~~~N----~i~agi~~L~~fH~~~~~-~lHGD~np~NiM~D~~G~lKlVDP~~Ll 191 (308)
T PF07387_consen 140 ----KINFSN----FITAGIKDLMDFHSENQH-CLHGDCNPDNIMCDKFGYLKLVDPVCLL 191 (308)
T ss_pred ----ccchhH----HHHHhHHHHHHhhccCCC-eecCCCChhheeecCCCCEEecChhhhh
Confidence 111111 111124556667855422 8999999999999999999999987543
|
The function of this family is unknown. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.096 Score=46.41 Aligned_cols=68 Identities=15% Similarity=0.127 Sum_probs=45.9
Q ss_pred ceeccCCeEEEEEeEECC--cceEEEecccc----------ccHHHHHHHHHHHhc---CC-CceeeeeEEEeCCeEEEE
Q 041031 18 LKIGQGSYGSVYLGKLRG--KNAAIKQMKNT----------KSKEFSSELKILCKV---HS-NLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~~--~~~aiK~~~~~----------~~~~~~~e~~~l~~l---h~-~i~~~~~~~~~~~~~~lv 81 (313)
+.+|.|....||++...+ +.++||+-.+. ..++..-|.+.|+.. .| .+.+++.+ +.....++
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 357999999999999874 57999876421 244456677888776 34 34454443 34445689
Q ss_pred EeecCC
Q 041031 82 YEYAQN 87 (313)
Q Consensus 82 ~e~~~~ 87 (313)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 998854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.36 Score=44.37 Aligned_cols=72 Identities=11% Similarity=0.092 Sum_probs=47.0
Q ss_pred ccceeccCCeEEEEEeEEC----------CcceEEEeccccccH--HHHHHHHHHHhc-CCCc-eeeeeEEEeCCeEEEE
Q 041031 16 TSLKIGQGSYGSVYLGKLR----------GKNAAIKQMKNTKSK--EFSSELKILCKV-HSNL-IELIGYAAGGDSLFLV 81 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~----------~~~~aiK~~~~~~~~--~~~~e~~~l~~l-h~~i-~~~~~~~~~~~~~~lv 81 (313)
.++.|..|-.-.+|+.... ++.|++++....... ....|..+++.+ .-++ .++++.+. -..+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 4567777888899988754 357888887655322 345688888887 2233 24555543 2357
Q ss_pred EeecCCCChh
Q 041031 82 YEYAQNGALS 91 (313)
Q Consensus 82 ~e~~~~~~L~ 91 (313)
.+|++|.+|.
T Consensus 185 ~efi~g~~l~ 194 (442)
T PTZ00296 185 EEWLYGDPLR 194 (442)
T ss_pred EEeeCCccCC
Confidence 8999887553
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 313 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-44 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-43 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-26 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-23 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-23 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-22 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-22 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-22 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-21 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-21 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-21 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-21 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-21 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-21 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-17 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-17 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-17 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-17 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-17 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-17 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-16 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-104
Identities = 107/312 (34%), Positives = 167/312 (53%), Gaps = 33/312 (10%)
Query: 2 FSYNEVRDATSNFSTSL------KIGQGSYGSVYLGKLRGKNAAIKQMKNTKS------- 48
FS+ E+++ T+NF K+G+G +G VY G + A+K++
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 49 KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAW 107
++F E+K++ K H NL+EL+G+++ GD L LVY Y NG+L D L G PL+W
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSW 132
Query: 108 TTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167
R +IA AA G+ ++H+ +++HRD+K++NILLD F AKI+DFGL + E
Sbjct: 133 HMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKF-AQ 188
Query: 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE 227
SRIVGT Y+APE +R G +T KSD+Y+FGVVL+E+ITG A+ P
Sbjct: 189 TVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL----- 242
Query: 228 HRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS 287
L+D + ++ K + + +D + S+ M ++ C+ E +RPD+
Sbjct: 243 ---LLDIKEEIEDEEK----TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 288 NAAIRLSHILIS 299
L + S
Sbjct: 296 KVQQLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = e-102
Identities = 100/296 (33%), Positives = 162/296 (54%), Gaps = 25/296 (8%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKS----KEFSSELK 56
FS E++ A+ NFS +G+G +G VY G+L G A+K++K ++ +F +E++
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 57 ILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL 115
++ H NL+ L G+ LVY Y NG+++ L + + PL W R +IAL
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPESQPPLDWPKRQRIAL 138
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIV 175
+A+GL Y+H + P +HRDVK +NILLD F A + DFGL KL+++ + + +
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY--KDTHVTTAVR 196
Query: 176 GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235
GT G++APEY+ G + K+DV+ +GV+L+ELITGQ+A + + L+D++
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND----DDVMLLDWV 252
Query: 236 LAVFNDTKDFMAKLTECLDPNL-TRYHKDSMLQM---ALLSKDCVDENWKRRPDMS 287
+ + KL +D +L Y + + Q+ ALL C + RP MS
Sbjct: 253 KGLLKE-----KKLEALVDVDLQGNYKDEEVEQLIQVALL---CTQSSPMERPKMS 300
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = e-101
Identities = 97/294 (32%), Positives = 156/294 (53%), Gaps = 26/294 (8%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKS---KEFSSELKI 57
++ +AT+NF IG G +G VY G LR G A+K+ S +EF +E++
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 58 LCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALD 116
L H +L+ LIG+ + + L+Y+Y +NG L HL+ S ++W R++I +
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY-GSDLPTMSMSWEQRLEICIG 147
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA--ASRI 174
AA+GL Y+H +HRDVK+ NILLD NF KI DFG+ K E+ ++ +
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK---GTELDQTHLSTVV 201
Query: 175 VGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234
GT GY+ PEY G +T KSDVY+FGVVL E++ + A+ + + E +L ++
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ------SLPREMVNLAEW 255
Query: 235 MLAVFNDTKDFMAKLTECLDPNLT-RYHKDSMLQMALLSKDCVDENWKRRPDMS 287
+ N+ +L + +DPNL + +S+ + + C+ + + RP M
Sbjct: 256 AVESHNN-----GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMG 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 7e-79
Identities = 78/320 (24%), Positives = 129/320 (40%), Gaps = 42/320 (13%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNT--KSKEFSSELKILC 59
+ + +G +G V+ +L + A+K +S + E+ L
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLP 73
Query: 60 KV-HSNLIELIGYAAGGDS----LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA 114
+ H N+++ IG G S L+L+ + + G+LSD L ++W IA
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK------ANVVSWNELCHIA 127
Query: 115 LDAAKGLEYIHQ-------YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167
A+GL Y+H+ KP HRD+K+ N+LL +N A IADFGL E +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG-KS 186
Query: 168 AAAASRIVGTFGYLAPEYVRDG-----CVTTKSDVYAFGVVLMELITGQQALSRDANPGN 222
A VGT Y+APE + + D+YA G+VL EL + A +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 223 NQYTE----HRSLVDYMLAVFNDTKDFMAKLTECLDPNL-TRYHKDSML-QMALLSKDCV 276
+ E H SL D V + + P L + K + + + ++C
Sbjct: 247 LPFEEEIGQHPSLEDMQEVV----------VHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
Query: 277 DENWKRRPDMSNAAIRLSHI 296
D + + R R++ +
Sbjct: 297 DHDAEARLSAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 3e-70
Identities = 74/333 (22%), Positives = 129/333 (38%), Gaps = 45/333 (13%)
Query: 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKI--LC 59
+ +E N IG+G YG+VY G L + A+K + F +E I +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVP 62
Query: 60 KV-HSNLIELIGY-----AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQI 113
+ H N+ I A G LV EY NG+L +L W + ++
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWVSSCRL 116
Query: 114 ALDAAKGLEYIHQ------YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP-- 165
A +GL Y+H + KP HRD+ + N+L+ ++ I+DFGL L +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 166 ---EIAAAASRIVGTFGYLAPEYVRD-------GCVTTKSDVYAFGVVLMELITGQQALS 215
E AA VGT Y+APE + + D+YA G++ E+ L
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 216 RDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLD------PNLTRYHKDSMLQMA 269
+ Q + + V N ++ + P + + ++ +
Sbjct: 237 PGESVPEYQ-------MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289
Query: 270 LLSKDCVDENWKRRPDMSNAAIRLSHILISSKE 302
+DC D++ + R A R++ +++ +
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-64
Identities = 83/288 (28%), Positives = 137/288 (47%), Gaps = 37/288 (12%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTKS-----KEFSSELKILCKV-HSNLIELIGYA 72
KIG GS+G+V+ + G + A+K + EF E+ I+ ++ H N++ +G
Sbjct: 44 KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
+L +V EY G+L LH ++ L R+ +A D AKG+ Y+H P
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 133 VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVT 192
VHR++K+ N+L+D + K+ DFGL +L + + +A GT ++APE +RD
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA---AGTPEWMAPEVLRDEPSN 217
Query: 193 TKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTEC 252
KSDVY+FGV+L EL T QQ P + + + + AV K ++
Sbjct: 218 EKSDVYSFGVILWELATLQQ-------P----W-GNLNPAQVVAAVGF--KCKRLEIPRN 263
Query: 253 LDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300
L+P Q+A + + C +RP + L ++ S+
Sbjct: 264 LNP-----------QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 6e-64
Identities = 75/285 (26%), Positives = 128/285 (44%), Gaps = 39/285 (13%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIELIGYAAGGD 76
+G+G++G V K R K+ AIKQ+++ K F EL+ L +V H N+++L G A +
Sbjct: 15 VVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYG--ACLN 72
Query: 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRD 136
+ LV EYA+ G+L + LH + + L ++G+ Y+H +HRD
Sbjct: 73 PVCLVMEYAEGGSLYNVLH--GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 137 VKTSNILLDSNFR-AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKS 195
+K N+LL + KI DFG +I + G+ ++APE + K
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC------DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 196 DVYAFGVVLMELITGQQALSRDANPGNNQYTE-HRSLVDYMLAVFNDTKDFMAKLTECLD 254
DV+++G++L E+IT ++ P + E M AV N T+ L + L
Sbjct: 185 DVFSWGIILWEVITRRK-------P----FDEIGGPAFRIMWAVHNGTR---PPLIKNLP 230
Query: 255 PNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299
+ L C ++ +RP M ++H++
Sbjct: 231 K-----------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 6e-60
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTKS-------KEFSSELKILCKV-HSNLIELIG 70
IG G +G VY G A+K ++ + E K+ + H N+I L G
Sbjct: 14 IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+L LV E+A+ G L+ L K + V A+ A+G+ Y+H
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 131 YYVHRDVKTSNILLD--------SNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
+HRD+K+SNIL+ SN KI DFGL + + +++AA G + ++A
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA-----GAYAWMA 182
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELITGQQ 212
PE +R + SDV+++GV+L EL+TG+
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEV 212
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-58
Identities = 80/305 (26%), Positives = 127/305 (41%), Gaps = 40/305 (13%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV---HSNLIELIGYAAGG 75
+IG+G YG V++GK RG+ A+K T+ + E +I V H N++ I G
Sbjct: 44 QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103
Query: 76 DS----LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH-----Q 126
L+L+ +Y +NG+L D+L L + +++A + GL ++H
Sbjct: 104 TGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGL-VKLLEHSPEIAAAASRIVGTFGYLAPE- 184
KP HRD+K+ NIL+ N IAD GL VK + + E+ + VGT Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 185 -----YVRDGCVTTKSDVYAFGVVLMELITGQQALSRDAN---PGNNQYTEHRSLVDYML 236
+D+Y+FG++L E+ + P ++ S D
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 237 AVFNDTKDFMAKLTECLDPNL-TRYHKDSML-QMALLSKDCVDENWKRRPDMSNAAIRLS 294
V + L P+ R+ D L QM L +C N R L+
Sbjct: 278 IV----------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 295 HILIS 299
+ S
Sbjct: 328 KMSES 332
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 3e-58
Identities = 75/299 (25%), Positives = 131/299 (43%), Gaps = 58/299 (19%)
Query: 19 KIGQGSYGSVYLGKL--RGKNAAIKQMKNTKS----------KEFSSELKILCKV-HSNL 65
+IG+G +G V+ G+L AIK + S +EF E+ I+ + H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
++L G + +V E+ G L L P+ W+ ++++ LD A G+EY+
Sbjct: 86 VKLYG--LMHNPPRMVMEFVPCGDLYHRLL----DKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 126 QYTKPYYVHRDVKTSNILLDS-----NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
P VHRD+++ NI L S AK+ADFGL + HS S ++G F +
Sbjct: 140 NQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VSGLLGNFQW 192
Query: 181 LAPE--YVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL-VDYMLA 237
+APE + T K+D Y+F ++L ++TG+ P + E+ + ++
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEG-------P----FDEYSYGKIKFINM 241
Query: 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296
+ + + E P ++ + + C + K+RP S LS +
Sbjct: 242 IRE--EGLRPTIPEDCPP-----------RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 6e-58
Identities = 76/302 (25%), Positives = 123/302 (40%), Gaps = 40/302 (13%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV---HSNLIELIGYAAGG 75
+G+G YG V+ G +G+N A+K + K + E ++ V H N++ I
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTS 74
Query: 76 DS----LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH-----Q 126
L+L+ Y + G+L D+L L + ++I L A GL ++H
Sbjct: 75 RHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP-EIAAAASRIVGTFGYLAPE- 184
KP HRD+K+ NIL+ N + IAD GL + S ++ + VGT Y+APE
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 185 -----YVRDGCVTTKSDVYAFGVVLMELITGQQALSRDAN---PGNNQYTEHRSLVDYML 236
V + D++AFG+VL E+ + + P + S D
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248
Query: 237 AVFNDTK--DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294
V D + + PN ++ +A L K+C +N R L+
Sbjct: 249 VVCVDQQRPNI---------PNRWFSD-PTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 295 HI 296
I
Sbjct: 299 KI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 1e-57
Identities = 72/305 (23%), Positives = 125/305 (40%), Gaps = 40/305 (13%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV---HSNLIELIG----Y 71
IG+G +G V+ GK RG+ A+K + + + + E +I V H N++ I
Sbjct: 49 SIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 108
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT--- 128
L+LV +Y ++G+L D+L+ + + +++AL A GL ++H
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 129 --KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI-VGTFGYLAPE- 184
KP HRD+K+ NIL+ N IAD GL + + + A VGT Y+APE
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 185 -----YVRDGCVTTKSDVYAFGVVLMELITGQQALSRDAN---PGNNQYTEHRSLVDYML 236
++ ++D+YA G+V E+ + P + S+ +
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 237 AVFNDTK--DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294
V + PN + +++ MA + ++C N R LS
Sbjct: 283 VVCEQKLRPNI---------PNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 295 HILIS 299
+
Sbjct: 333 QLSQQ 337
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 8e-57
Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTKS-----KEFSSELKILCKV-HSNLIELIGYA 72
+IG GS+G+VY GK G A+K + T + F +E+ +L K H N++ +G
Sbjct: 31 RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-Y 88
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
+ L +V ++ + +L HLH + + IA A+G++Y+H
Sbjct: 89 STAPQLAIVTQWCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 133 VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD---G 189
+HRD+K++NI L + KI DFGL G+ ++APE +R
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS-GSILWMAPEVIRMQDSN 200
Query: 190 CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKL 249
+ +SDVYAFG+VL EL+TGQ P Y+ + + V +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQL-------P----YSNINNRDQIIEMVGRGS------- 242
Query: 250 TECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297
L P+L++ + +M L +C+ + RP + +
Sbjct: 243 ---LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-56
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 19 KIGQGSYGSVYLGKLRGKN--AAIKQMKNTKS---KEFSSELKILCKV-HSNLIELIGYA 72
+G+G +G R +K++ + F E+K++ + H N+++ IG
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
L + EY + G L + W+ RV A D A G+ Y+H
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIK----SMDSQYPWSQRVSFAKDIASGMAYLHSMN---I 129
Query: 133 VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR-----------IVGTFGYL 181
+HRD+ + N L+ N +ADFGL +L+ +VG ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMELITGQQA 213
APE + K DV++FG+VL E+I A
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-55
Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 26/211 (12%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTKS-----KEFSSELKILCKV-HSNLIELIGYA 72
IG+G +G VY G+ G+ AI+ + + K F E+ + H N++ +G
Sbjct: 40 LIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
L ++ + L + K L QIA + KG+ Y+H
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVR----DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 133 VHRDVKTSNILLDSNFRAKIADFGL--VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
+H+D+K+ N+ D N + I DFGL + + + G +LAPE +R
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 191 V---------TTKSDVYAFGVVLMELITGQQ 212
+ SDV+A G + EL +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREW 241
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-54
Identities = 40/205 (19%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGY- 71
K+ + G ++ G+ +G + +K +K KS++F+ E L H N++ ++G
Sbjct: 17 KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 72 -AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+ L+ + G+L + LH + + V+ ALD A+G+ ++H +P
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLH---EGTNFVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-- 188
+ + ++++D + A+I+ + + + ++APE ++
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQS--------PGRMYAPAWVAPEALQKKP 184
Query: 189 -GCVTTKSDVYAFGVVLMELITGQQ 212
+D+++F V+L EL+T +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREV 209
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-43
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 19 KIGQGSYGSVYLGKLRGKNA--AIKQMKNTKSK----EFSSELKILCKV-HSNLIELIGY 71
+IG+G++G V+ G+LR N A+K + T +F E +IL + H N++ LIG
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPY 131
+++V E Q G L L T +Q+ DAA G+EY+ K
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR----TEGARLRVKTLLQMVGDAAAGMEYLES--KCC 234
Query: 132 YVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY--LAPEYVRDG 189
+HRD+ N L+ KI+DFG+ + A+ APE + G
Sbjct: 235 -IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL---RQVPVKWTAPEALNYG 290
Query: 190 CVTTKSDVYAFGVVLMELIT-GQQ 212
+++SDV++FG++L E + G
Sbjct: 291 RYSSESDVWSFGILLWETFSLGAS 314
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-42
Identities = 64/203 (31%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 19 KIGQGSYGSVYLGKLRGKNA------AIKQMK---NTKSKEFSSELKILCKV-HSNLIEL 68
++G+G++GSV + + A+K+++ ++F E++IL + H N+++
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 69 IG--YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
G Y+AG +L L+ EY G+L D+L K K+ + +Q KG+EY+
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
Y+HRD+ T NIL+++ R KI DFGL K+L E + APE +
Sbjct: 133 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 187 RDGCVTTKSDVYAFGVVLMELIT 209
+ + SDV++FGVVL EL T
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 64/203 (31%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 19 KIGQGSYGSVYLGKLRGKNA------AIKQMK---NTKSKEFSSELKILCKV-HSNLIEL 68
++G+G++GSV + + A+K+++ ++F E++IL + H N+++
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 69 IG--YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
G Y+AG +L L+ EY G+L D+L K K+ + +Q KG+EY+
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
Y+HRD+ T NIL+++ R KI DFGL K+L E + APE +
Sbjct: 164 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 187 RDGCVTTKSDVYAFGVVLMELIT 209
+ + SDV++FGVVL EL T
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 19 KIGQGSYGSVYLGKLRGKNA------AIKQMKNTKS----KEFSSELKILCKV-HSNLIE 67
+G+G +G V L N A+K +K + E+ IL + H ++I+
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 68 LIG--YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
G AG SL LV EY G+L D+L + + + A +G+ Y+H
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLP------RHSIGLAQLLLFAQQICEGMAYLH 151
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
Y+HRD+ N+LLD++ KI DFGL K + E + APE
Sbjct: 152 AQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 186 VRDGCVTTKSDVYAFGVVLMELIT-GQQALS 215
+++ SDV++FGV L EL+T + S
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-41
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 19 KIGQGSYGSVYLGKLRGKNA------AIKQMKNTKS----KEFSSELKILCKV-HSNLIE 67
+G+G +G V L + + A+K +K + E++IL + H N+++
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 68 LIG--YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
G GG+ + L+ E+ +G+L ++L K K + +++ A+ KG++Y+
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLP----KNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL---- 181
YVHRD+ N+L++S + KI DFGL K +E E
Sbjct: 144 SRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD-----RDSPVFW 195
Query: 182 -APEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANP 220
APE + SDV++FGV L EL+T S A
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 19 KIGQGSYGSVYLGKLRGKNA------AIKQMKNT---KSKEFSSELKILCKV-HSNLIEL 68
++G+G++GSV L + A+KQ++++ + ++F E++IL + +++
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 69 IG--YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
G Y G SL LV EY +G L D L + + L + + + KG+EY+
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ----RHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL----- 181
VHRD+ NIL++S KIADFGL KLL + G
Sbjct: 146 RR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP-----GQSPIFWY 197
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMELIT 209
APE + D + +SDV++FGVVL EL T
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-40
Identities = 55/196 (28%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 19 KIGQGSYGSVYLGKLRGKNA--AIKQMK--NTKSKEFSSELKILCKV-HSNLIELIGYAA 73
K+G G YG VY G + + A+K +K + +EF E ++ ++ H NL++L+G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
+++ E+ G L D+L ++ ++ + +A + +EY+ + ++
Sbjct: 287 REPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 340
Query: 134 HRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTT 193
HR++ N L+ N K+ADFGL +L+ A A ++ + APE + +
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSI 398
Query: 194 KSDVYAFGVVLMELIT 209
KSDV+AFGV+L E+ T
Sbjct: 399 KSDVWAFGVLLWEIAT 414
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-39
Identities = 53/199 (26%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-AIKQMKN--TKSKEFSSELKILCKV-HSNLIELIGYAAG 74
+IG G +G V+LG K+ AIK ++ ++F E +++ K+ H L++L G
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
+ LV E+ ++G LSD+L + A T + + LD +G+ Y+ + +H
Sbjct: 75 QAPICLVTEFMEHGCLSDYLR----TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTK 194
RD+ N L+ N K++DFG+ + + ++ ++ + +PE ++K
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFSRYSSK 185
Query: 195 SDVYAFGVVLMELIT-GQQ 212
SDV++FGV++ E+ + G+
Sbjct: 186 SDVWSFGVLMWEVFSEGKI 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-39
Identities = 57/197 (28%), Positives = 101/197 (51%), Gaps = 15/197 (7%)
Query: 19 KIGQGSYGSVYLGKLRGKNA--AIKQMKN--TKSKEFSSELKILCKV-HSNLIELIGYAA 73
K+G G YG VY G + + A+K +K + +EF E ++ ++ H NL++L+G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
+++ E+ G L D+L ++ ++ + +A + +EY+ K ++
Sbjct: 80 REPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 134 HRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI-VGTFGYLAPEYVRDGCVT 192
HRD+ N L+ N K+ADFGL +L+ A A ++ + + APE + +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFS 190
Query: 193 TKSDVYAFGVVLMELIT 209
KSDV+AFGV+L E+ T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-38
Identities = 51/199 (25%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-AIKQMKN--TKSKEFSSELKILCKV-HSNLIELIGYAAG 74
++G G +G V LGK +G+ A+K +K EF E + + K+ H L++ G +
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
+++V EY NG L ++L K L + +++ D +G+ ++ + ++H
Sbjct: 75 EYPIYIVTEYISNGCLLNYLR----SHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIH 127
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTK 194
RD+ N L+D + K++DFG+ + + +++ ++ + APE ++K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF--PVKWSAPEVFHYFKYSSK 185
Query: 195 SDVYAFGVVLMELIT-GQQ 212
SDV+AFG+++ E+ + G+
Sbjct: 186 SDVWAFGILMWEVFSLGKM 204
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-38
Identities = 60/194 (30%), Positives = 107/194 (55%), Gaps = 15/194 (7%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMK-NTKSKEFSSELKILCKV-HSNLIELIGY-AAGG 75
IG+G +G V LG RG A+K +K + ++ F +E ++ ++ HSNL++L+G
Sbjct: 28 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87
Query: 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHR 135
L++V EY G+L D+L +G+ L ++ +LD + +EY+ +VHR
Sbjct: 88 GGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 136 DVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKS 195
D+ N+L+ + AK++DFGL K + + + + APE +R+ +TKS
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKS 195
Query: 196 DVYAFGVVLMELIT 209
DV++FG++L E+ +
Sbjct: 196 DVWSFGILLWEIYS 209
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 60/194 (30%), Positives = 107/194 (55%), Gaps = 15/194 (7%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMK-NTKSKEFSSELKILCKV-HSNLIELIGYA-AGG 75
IG+G +G V LG RG A+K +K + ++ F +E ++ ++ HSNL++L+G
Sbjct: 200 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259
Query: 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHR 135
L++V EY G+L D+L +G+ L ++ +LD + +EY+ +VHR
Sbjct: 260 GGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR 313
Query: 136 DVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKS 195
D+ N+L+ + AK++DFGL K + + + + APE +R+ +TKS
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKS 367
Query: 196 DVYAFGVVLMELIT 209
DV++FG++L E+ +
Sbjct: 368 DVWSFGILLWEIYS 381
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-38
Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-AIKQMKN--TKSKEFSSELKILCKV-HSNLIELIGYAAG 74
++G G +G V GK RG+ AIK +K EF E K++ + H L++L G
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
+F++ EY NG L ++L + + +++ D + +EY+ ++H
Sbjct: 91 QRPIFIITEYMANGCLLNYLR----EMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 143
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR--IVGTFGYLAPEYVRDGCVT 192
RD+ N L++ K++DFGL + + ++ S+ + + PE + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSKFS 199
Query: 193 TKSDVYAFGVVLMELIT-GQQ 212
+KSD++AFGV++ E+ + G+
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKM 220
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-38
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKN------TKSKEFSSELKILCKV-HSNLI 66
K+G GS+G V G+ + A+K +K +F E+ + + H NLI
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
L G + +V E A G+L D L K + T + A+ A+G+ Y+
Sbjct: 85 RLYGVVLT-PPMKMVTELAPLGSLLDRLR----KHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT---FGYLAP 183
++HRD+ N+LL + KI DFGL++ L + + F + AP
Sbjct: 140 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE---HRKVPFAWCAP 193
Query: 184 EYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
E ++ + SD + FGV L E+ T GQ+
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-38
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMK----NTKSKEFS-SELKILCKV-HSNLIELIG 70
KIG+GS+G L K G+ IK++ ++K +E S E+ +L + H N+++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPL----AWTTRVQIALDAAKGLEYIHQ 126
SL++V +Y + G L + + + VQI L L+++H
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICL----ALKHVHD 143
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
+HRD+K+ NI L + ++ DFG+ ++L + A +GT YL+PE
Sbjct: 144 RKI---LHRDIKSQNIFLTKDGTVQLGDFGIARVLNST---VELARACIGTPYYLSPEIC 197
Query: 187 RDGCVTTKSDVYAFGVVLMELITGQ 211
+ KSD++A G VL EL T +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-38
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 19 KIGQGSYGSVYLGKLRGKNA------AIKQMKNTKS----KEFSSELKILCKV-HSNLIE 67
+G G++G+VY G + AIK+++ S KE E ++ V + ++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L+G ++ L+ + G L D++ + K + + + AKG+ Y+
Sbjct: 82 LLG-ICLTSTVQLITQLMPFGCLLDYVR----EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH-SPEIAAAASRIVGTFGYLAPEYV 186
VHRD+ N+L+ + KI DFGL KLL E A ++ ++A E +
Sbjct: 137 R---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMALESI 191
Query: 187 RDGCVTTKSDVYAFGVVLMELIT-GQQ 212
T +SDV+++GV + EL+T G +
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 70/226 (30%), Positives = 110/226 (48%), Gaps = 49/226 (21%)
Query: 19 KIGQGSYGSVYLGKLRGKN----AAIKQMKNTKS----KEFSSELKILCKV--HSNLIEL 68
IG+G++G V +++ AAIK+MK S ++F+ EL++LCK+ H N+I L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHL-----------HWPSVKGKKPLAWTTRVQIALDA 117
+G L+L EYA +G L D L + L+ + A D
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR---- 173
A+G++Y+ ++ ++HRD+ NIL+ N+ AKIADFGL SR
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL--------------SRGQEV 194
Query: 174 -IVGTFGYL-----APEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
+ T G L A E + TT SDV+++GV+L E+++ G
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMK----NTKSKEFS-SELKILCKV-HSNLIELIG 70
IG GSYG + + GK K++ K+ SE+ +L ++ H N++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 71 --YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKK---PLAWTTRVQIALDAAKGLEYIH 125
+L++V EY + G L+ + + + + Q+ L L+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL----ALKECH 128
Query: 126 QYTKPYY--VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAP 183
+ + + +HRD+K +N+ LD K+ DFGL ++L H + A VGT Y++P
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD---TSFAKTFVGTPYYMSP 185
Query: 184 EYVRDGCVTTKSDVYAFGVVLMELITGQ 211
E + KSD+++ G +L EL
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMK-----NTKSKEFS-SELKILCKV-HSNLIELI 69
KIG+G + VY L G A+K+++ + K++ E+ +L ++ H N+I+
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKK---PLAWTTRVQIALDAAKGLEYIHQ 126
+ L +V E A G LS + + + W VQ+ LE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS----ALEHMHS 154
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
+HRD+K +N+ + + K+ D GL + AA +VGT Y++PE +
Sbjct: 155 RRV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSK---TTAAHSLVGTPYYMSPERI 208
Query: 187 RDGCVTTKSDVYAFGVVLMELITGQ 211
+ KSD+++ G +L E+ Q
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
IG G G V G+LR AIK +K + ++F SE I+ + H N+I L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
G G +V EY +NG+L L V + G+ Y+ +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLR----THDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL-----AP 183
YVHRD+ N+L+DSN K++DFGL ++LE P+ A + G + AP
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG-----GKIPIRWTAP 223
Query: 184 EYVRDGCVTTKSDVYAFGVVLMELIT 209
E + ++ SDV++FGVV+ E++
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-37
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
+G+G +G VY G A+K K + ++F SE I+ + H ++++L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
IG + +++ E G L +L + K L T V +L K + Y+
Sbjct: 79 IG-IIEEEPTWIIMELYPYGELGHYLE----RNKNSLKVLTLVLYSLQICKAMAYLESI- 132
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
VHRD+ NIL+ S K+ DFGL + +E A+ +R+ +++PE +
Sbjct: 133 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINF 188
Query: 189 GCVTTKSDVYAFGVVLMELIT-GQQ 212
TT SDV+ F V + E+++ G+Q
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 52/258 (20%), Positives = 99/258 (38%), Gaps = 45/258 (17%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS---ELKILCKV-HSNLIELIGYA 72
K+G+G + V L + G A+K++ + ++ E + H N++ L+ Y
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 73 ----AGGDSLFLVYEYAQNGALSDHLHWPSVKGKK---PLAWTTRVQIALDAAKGLEYIH 125
+L+ + + G L + + KG + L +GLE IH
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL----WLLLGICRGLEAIH 151
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI------VGTFG 179
Y HRD+K +NILL + + D G + E + A + T
Sbjct: 152 A---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 180 YLAPEYV---RDGCVTTKSDVYAFGVVLMELITGQ---QALSRDAN------------PG 221
Y APE + ++DV++ G VL ++ G+ + + + P
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQ 268
Query: 222 NNQYTEH-RSLVDYMLAV 238
+ +++ L++ M+ V
Sbjct: 269 SPRHSSALWQLLNSMMTV 286
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 29/211 (13%)
Query: 19 KIGQGSYGSVYLGKLRGKNA------AIKQMKNTKS----KEFSSELKILCKV-HSNLIE 67
IG G +G VY G L+ + AIK +K + +F E I+ + H N+I
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L G + + ++ EY +NGAL L + + V + A G++Y+
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR----EKDGEFSVLQLVGMLRGIAAGMKYL--- 163
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL-----A 182
YVHRD+ NIL++SN K++DFGL ++LE PE S G + A
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG-----GKIPIRWTA 218
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
PE + T+ SDV++FG+V+ E++T G++
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 54/195 (27%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 19 KIGQGSYGSVYLGKLRGK-NAAIKQMK--NTKSKEFSSELKILCKV-HSNLIELIGYAAG 74
K+G G +G V++ A+K MK + + F +E ++ + H L++L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVT 253
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
+ ++++ E+ G+L D L + + A+G+ +I Q Y+H
Sbjct: 254 KEPIYIITEFMAKGSLLDFLK---SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTK 194
RD++ +NIL+ ++ KIADFGL +++E + A ++ + APE + G T K
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIK 365
Query: 195 SDVYAFGVVLMELIT 209
SDV++FG++LME++T
Sbjct: 366 SDVWSFGILLMEIVT 380
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-37
Identities = 57/195 (29%), Positives = 102/195 (52%), Gaps = 13/195 (6%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-AIKQMK--NTKSKEFSSELKILCKV-HSNLIELIGYAAG 74
++G G +G V++G G A+K +K + F +E ++ ++ H L+ L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
+ ++++ EY +NG+L D L L + +A A+G+ +I + Y+H
Sbjct: 79 QEPIYIITEYMENGSLVDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTK 194
RD++ +NIL+ KIADFGL +L+E + A ++ + APE + G T K
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIK 190
Query: 195 SDVYAFGVVLMELIT 209
SDV++FG++L E++T
Sbjct: 191 SDVWSFGILLTEIVT 205
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-37
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
IG+G +G V+ G AIK KN S ++F E + + H ++++L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
IG + ++++ E G L L K L + + A + L Y+
Sbjct: 82 IG-VITENPVWIIMELCTLGELRSFLQ----VRKYSLDLASLILYAYQLSTALAYLESK- 135
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
+VHRD+ N+L+ SN K+ DFGL + +E S A+ ++ ++APE +
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 191
Query: 189 GCVTTKSDVYAFGVVLMELIT-GQQ 212
T+ SDV+ FGV + E++ G +
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 3e-37
Identities = 65/195 (33%), Positives = 102/195 (52%), Gaps = 13/195 (6%)
Query: 19 KIGQGSYGSVYLGKLRGK-NAAIKQMK--NTKSKEFSSELKILCKV-HSNLIELIGYAAG 74
K+GQG +G V++G G AIK +K + F E +++ K+ H L++L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 332
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
+ +++V EY G+L D L + K L V +A A G+ Y+ + YVH
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTK 194
RD++ +NIL+ N K+ADFGL +L+E + A ++ + APE G T K
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIK 444
Query: 195 SDVYAFGVVLMELIT 209
SDV++FG++L EL T
Sbjct: 445 SDVWSFGILLTELTT 459
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-37
Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 19 KIGQGSYGSVYLGKLRGKNA----AIKQMKN-----TKSKEFSSELKILCKV-HSNLIEL 68
++G G++G+V G + K A+K +KN E +E ++ ++ + ++ +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
IG +S LV E A+ G L+ +L + + + +++ + G++Y+ +
Sbjct: 84 IGICEA-ESWMLVMEMAELGPLNKYL-----QQNRHVKDKNIIELVHQVSMGMKYLEES- 136
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTF--GYLAPEYV 186
+VHRD+ N+LL + AKI+DFGL K L A + G + + APE +
Sbjct: 137 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH--GKWPVKWYAPECI 192
Query: 187 RDGCVTTKSDVYAFGVVLMELIT-GQQ 212
++KSDV++FGV++ E + GQ+
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 65/195 (33%), Positives = 102/195 (52%), Gaps = 13/195 (6%)
Query: 19 KIGQGSYGSVYLGKLRGK-NAAIKQMK--NTKSKEFSSELKILCKV-HSNLIELIGYAAG 74
K+GQG +G V++G G AIK +K + F E +++ K+ H L++L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
+ +++V EY G+L D L + K L V +A A G+ Y+ + YVH
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTK 194
RD++ +NIL+ N K+ADFGL +L+E + A ++ + APE G T K
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIK 361
Query: 195 SDVYAFGVVLMELIT 209
SDV++FG++L EL T
Sbjct: 362 SDVWSFGILLTELTT 376
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
+G G +G V G+L+ + AIK +K + ++F E I+ + H N+I L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
G + +V EY +NG+L L K V + A G++Y+
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLR----KHDAQFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL--APEYV 186
YVHRD+ NIL++SN K++DFGL ++LE PE A G +PE +
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG--GKIPIRWTSPEAI 222
Query: 187 RDGCVTTKSDVYAFGVVLMELIT-GQQ 212
T+ SDV+++G+VL E+++ G++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-37
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 36/216 (16%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGY---- 71
IG G +G V+ ++ GK IK++ +++ E+K L K+ H N++ G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRV-KYNNEKAEREVKALAKLDHVNIVHYNGCWDGF 76
Query: 72 ------------AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKK---PLAWTTRVQIALD 116
+ LF+ E+ G L + +G+K LA QI
Sbjct: 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQITK- 133
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
G++YIH ++RD+K SNI L + KI DFGLV L++ + +R G
Sbjct: 134 ---GVDYIHSKKL---INRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK----RTRSKG 183
Query: 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQ 212
T Y++PE + + D+YA G++L EL+
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-37
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 37/230 (16%)
Query: 11 TSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFS--SELKILCKV-HSNL 65
S+F +GQG++G V L + AIK++++T+ K + SE+ +L + H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 66 IELIG-------------YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQ 112
+ +LF+ EY +NG L D +H ++ ++ W Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA-- 170
I L YIH +HRD+K NI +D + KI DFGL K + S +I
Sbjct: 125 ILE----ALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 171 ---------ASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITG 210
+ +GT Y+A E + G K D+Y+ G++ E+I
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 18 LKIGQGSYGSVYLGKLRGKNA----AIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
+++G G++GSV G R + AIK +K +E E +I+ ++ + ++ L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
IG ++L LV E A G L L ++ + + ++ + G++Y+
Sbjct: 76 IG-VCQAEALMLVMEMAGGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
+ +VHRD+ N+LL + AKI+DFGL K L A S + APE +
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 189 GCVTTKSDVYAFGVVLMELIT-GQQ 212
+++SDV+++GV + E ++ GQ+
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 50/203 (24%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 19 KIGQGSYGSVYLGKLRGKNA------AIKQMKNTKS----KEFSSELKILCKV-HSNLIE 67
+G G +G+V+ G + IK +++ + + + + + H++++
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L+G G SL LV +Y G+L DH+ + + L + + AKG+ Y+ ++
Sbjct: 80 LLG-LCPGSSLQLVTQYLPLGSLLDHVR----QHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH-SPEIAAAASRIVGTFGYLAPEYV 186
VHR++ N+LL S + ++ADFG+ LL ++ + ++ ++A E +
Sbjct: 135 G---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT--PIKWMALESI 189
Query: 187 RDGCVTTKSDVYAFGVVLMELIT 209
G T +SDV+++GV + EL+T
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMT 212
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-36
Identities = 53/203 (26%), Positives = 82/203 (40%), Gaps = 22/203 (10%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMK--NTKSKEFSS---ELKILCKV--HSNLIELI 69
++G GSYG V+ K G+ A+K+ K+ + E+ KV H + L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
G L+L E +L H + W L L ++H
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLL----ALAHLHSQGL 178
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
VH DVK +NI L R K+ DFGL+ L A A G Y+APE ++
Sbjct: 179 ---VHLDVKPANIFLGPRGRCKLGDFGLLVELGT----AGAGEVQEGDPRYMAPELLQGS 231
Query: 190 CVTTKSDVYAFGVVLMELITGQQ 212
T +DV++ G+ ++E+ +
Sbjct: 232 Y-GTAADVFSLGLTILEVACNME 253
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-36
Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 57/234 (24%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-------AIKQMK-NTKSKE---FSSELKILCKV--HSNL 65
+G G++G V G A+K +K + E SELK+L + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHL-----------HWPSVKGKKPLAWTTR--VQ 112
+ L+G G ++ EY G L + L P++ LA +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
+ AKG+ ++ +HRD+ NILL KI DFGL +
Sbjct: 150 FSYQVAKGMAFLAS-KN--CIHRDLAARNILLTHGRITKICDFGL--------------A 192
Query: 173 RIVGTFGY-------------LAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
R + +APE + + T +SDV+++G+ L EL + G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-36
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 48/225 (21%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-------AIKQMKNTKS----KEFSSELKILCKV-HSNLI 66
++GQGS+G VY G +G AIK + S EF +E ++ + +++
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHL-----HWPSVKGKKPLAWTTRVQIALDAAKGL 121
L+G + G ++ E G L +L + P + + +Q+A + A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY- 180
Y++ +VHRD+ N ++ +F KI DFG+ +R + Y
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM--------------TRDIYETDYY 194
Query: 181 ------------LAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
++PE ++DG TT SDV++FGVVL E+ T +Q
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-36
Identities = 56/234 (23%), Positives = 103/234 (44%), Gaps = 57/234 (24%)
Query: 19 KIGQGSYGSVYLGKLRGKNA---------AIKQMKNTKS----KEFSSELKILCKV--HS 63
+G+G++G V + + G + A+K +K+ + + SE++++ + H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 64 NLIELIGYAAGGDSLFLVYEYAQNGALSDHL-----------HWPSVKGKKPLAWTTRVQ 112
N+I L+G L+++ EYA G L ++L + + ++ + + V
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
A+G+EY+ +HRD+ N+L+ N KIADFGL +
Sbjct: 162 CTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGL--------------A 204
Query: 173 RIVGTFGY-------------LAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
R + Y +APE + D T +SDV++FGV++ E+ T G
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 19 KIGQGSYGSVYLGKLRGKNA------AIKQMKNTKS----KEFSSELKILCKV-HSNLIE 67
+G G++G+VY G + AIK+++ S KE E ++ V + ++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L+G ++ L+ + G L D++ + K + + + AKG+ Y+
Sbjct: 82 LLG-ICLTSTVQLITQLMPFGCLLDYVR----EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH-SPEIAAAASRIVGTFGYLAPEYV 186
VHRD+ N+L+ + KI DFGL KLL E A ++ ++A E +
Sbjct: 137 R---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMALESI 191
Query: 187 RDGCVTTKSDVYAFGVVLMELIT-GQQ 212
T +SDV+++GV + EL+T G +
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 37/222 (16%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-------AIKQMKN-TKS--KEFSSELKILCKV-HSNLIE 67
++G+G++G V+L + + A+K +K+ T + K+F E ++L + H ++++
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHL-----------HWPSVKGKKPLAWTTRVQIALD 116
G GD L +V+EY ++G L+ L + K L + + IA
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
A G+ Y+ +VHRD+ T N L+ +N KI DFG+ + + + VG
Sbjct: 142 IASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR------VG 192
Query: 177 TFGYL-----APEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
L PE + TT+SDV++FGV+L E+ T G+Q
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 57/234 (24%)
Query: 19 KIGQGSYGSVYLGKLRGKNA---------AIKQMKNTKS----KEFSSELKILCKV--HS 63
+G+G +G V + + G + A+K +K+ + + SE++++ + H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 64 NLIELIGYAAGGDSLFLVYEYAQNGALSDHL-----------HWPSVKGKKPLAWTTRVQ 112
N+I L+G L+++ EYA G L ++L + + ++ + + V
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
A+G+EY+ +HRD+ N+L+ N KIADFGL +
Sbjct: 208 CTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGL--------------A 250
Query: 173 RIVGTFGY-------------LAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
R + Y +APE + D T +SDV++FGV++ E+ T G
Sbjct: 251 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 304
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
IG+G +G VY G+ + AIK + + F E ++ + H N++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 69 IGYAAGGD-SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
IG + ++ Y +G L + ++ + L A+G+EY+ +
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIR----SPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTF--GYLAPEY 185
+VHRD+ N +LD +F K+ADFGL + + E + + A E
Sbjct: 144 K---FVHRDLAARNCMLDESFTVKVADFGLARDILDR-EYYSVQQHRHARLPVKWTALES 199
Query: 186 VRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
++ TTKSDV++FGV+L EL+T G
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAP 227
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-35
Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 56/233 (24%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-------AIKQMKNTKS----KEFSSELKILCKV--HSNL 65
+G+G++G V G + A+K +K + + SELKIL + H N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 66 IELIGY-AAGGDSLFLVYEYAQNGALSDHL-----------HWPSVKGKKPLAWTTRVQI 113
+ L+G G L ++ E+ + G LS +L P K L +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 114 ALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR 173
+ AKG+E++ +HRD+ NILL KI DFGL +R
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGL--------------AR 196
Query: 174 IVGTFGY-------------LAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
+ +APE + D T +SDV++FGV+L E+ + G
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-35
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 32/217 (14%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-------AIKQMKNTKS----KEFSSELKILCKV-HSNLI 66
+G G++G VY G++ G A+K + S +F E I+ K H N++
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHL--HWPSVKGKKPLAWTTRVQIALDAAKGLEYI 124
IG + F++ E G L L P LA + +A D A G +Y+
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 125 HQYTKPYYVHRDVKTSNILLD---SNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
+ +++HRD+ N LL AKI DFG+ + +I A+ G L
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM------ARDIYRASYYRKGGCAML 207
Query: 182 -----APEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
PE +G T+K+D ++FGV+L E+ + G
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-35
Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 37/222 (16%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-------AIKQMKNTKS----KEFSSELKILCKV--HSNL 65
+G G++G V G A+K +K+T + SELKI+ + H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHL---------HWPSVKGKKPLAWTTRVQIALD 116
+ L+G G + ++ EY G L + L + + +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
A+G+ ++ +HRDV N+LL + AKI DFGL + + + IV
Sbjct: 173 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY------IVK 223
Query: 177 TFGYL-----APEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
L APE + D T +SDV+++G++L E+ + G
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-35
Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 57/234 (24%)
Query: 19 KIGQGSYGSVYLGKLRGKNA---------AIKQMKNTKS----KEFSSELKILCKV--HS 63
+G+G++G V L + G + A+K +K+ + + SE++++ + H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 64 NLIELIGYAAGGDSLFLVYEYAQNGALSDHL-----------HWPSVKGKKPLAWTTRVQ 112
N+I L+G L+++ EYA G L ++L + PS ++ L+ V
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
A A+G+EY+ +HRD+ N+L+ + KIADFGL +
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL--------------A 238
Query: 173 RIVGTFGY-------------LAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
R + Y +APE + D T +SDV++FGV+L E+ T G
Sbjct: 239 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 292
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 60/239 (25%), Positives = 97/239 (40%), Gaps = 62/239 (25%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-------AIKQMKNTKS----KEFSSELKILCKV-HSNLI 66
+G+G +G V A+K +K S ++ SE +L +V H ++I
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHL-------------------HWPSVKGKKPLAW 107
+L G + L L+ EYA+ G+L L ++ L
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 108 TTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167
+ A ++G++Y+ + K VHRD+ NIL+ + KI+DFGL
Sbjct: 150 GDLISFAWQISQGMQYLAE-MK--LVHRDLAARNILVAEGRKMKISDFGL---------- 196
Query: 168 AAAASRIVGTFGY-------------LAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
SR V +A E + D TT+SDV++FGV+L E++T G
Sbjct: 197 ----SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 5e-35
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
IG+G +G V+ G AIK KN S ++F E + + H ++++L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
IG + ++++ E G L L K L + + A + L Y+
Sbjct: 457 IG-VITENPVWIIMELCTLGELRSFLQ----VRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
+VHRD+ N+L+ SN K+ DFGL + +E S A+ ++ ++APE +
Sbjct: 512 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINF 566
Query: 189 GCVTTKSDVYAFGVVLMELIT-GQQ 212
T+ SDV+ FGV + E++ G +
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVK 591
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 32/217 (14%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-------AIKQMKNTKS----KEFSSELKILCKV-HSNLI 66
+G G++G VY G++ G A+K + S +F E I+ K H N++
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHL--HWPSVKGKKPLAWTTRVQIALDAAKGLEYI 124
IG + F++ E G L L P LA + +A D A G +Y+
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 125 HQYTKPYYVHRDVKTSNILLD---SNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
+ +++HRD+ N LL AKI DFG+ + +I A G L
Sbjct: 198 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM------ARDIYRAGYYRKGGCAML 248
Query: 182 -----APEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
PE +G T+K+D ++FGV+L E+ + G
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 285
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 44/224 (19%), Positives = 83/224 (37%), Gaps = 51/224 (22%)
Query: 19 KIGQGSYGSVYLGKLRGKNA---------AIKQMKNT---KSKEFSSELKILCKV-HSNL 65
+GQG++ ++ G R +K + S+ F ++ K+ H +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
+ G GD LV E+ + G+L +L K K + ++++A A + ++
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLK----KNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 126 QYTKPYYVHRDVKTSNILLDSNFR--------AKIADFGLVKLLEHSPEIAAAASRIVGT 177
+ +H +V NILL K++D G+ S V
Sbjct: 131 EN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI--------------SITVLP 173
Query: 178 FGYL-------APEYVRDGCV-TTKSDVYAFGVVLMELIT-GQQ 212
L PE + + +D ++FG L E+ + G +
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-34
Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 19 KIGQGSYGSVYLGKLRGKNA----AIKQMKNTKS----KEFSSELKILCKV-HSNLIELI 69
++G G++GSV G R + AIK +K +E E +I+ ++ + ++ LI
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
G ++L LV E A G L L ++ + + ++ + G++Y+ +
Sbjct: 403 G-VCQAEALMLVMEMAGGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYL---EE 454
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
+VHR++ N+LL + AKI+DFGL K L A S + APE +
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 190 CVTTKSDVYAFGVVLMELIT-GQQ 212
+++SDV+++GV + E ++ GQ+
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-34
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 38/223 (17%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-------AIKQMKNTKS----KEFSSELKILCKV-HSNLI 66
++G+ +G VY G L G AIK +K+ +EF E + ++ H N++
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHL-----------HWPSVKGKKPLAWTTRVQIAL 115
L+G L +++ Y +G L + L K L V +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIV 175
A G+EY+ + VH+D+ T N+L+ KI+D GL + + +
Sbjct: 136 QIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL------ 186
Query: 176 GTFGYL-----APEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
L APE + G + SD++++GVVL E+ + G Q
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-34
Identities = 49/219 (22%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKS----KEFSSELKILCKV-HSNLIELIGY 71
+G+G +G V+ K+ N AIK+++ ++ E+K L K+ H ++
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 72 ------------AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
++ L++ + + L D ++ + + + I L A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN--GRCTIEERERSVCLHIFLQIAE 129
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIA---------AA 170
+E++H +HRD+K SNI + K+ DFGLV ++ E A
Sbjct: 130 AVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 171 ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
+ VGT Y++PE + + K D+++ G++L EL+
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 61/235 (25%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-------AIKQMK-NTKSKE---FSSELKILCKV--HSNL 65
+G G++G V G + A+K +K S E SELK++ ++ H N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHL------------------HWPSVKGKKPLAW 107
+ L+G ++L++EY G L ++L + L +
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 108 TTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167
+ A AKG+E++ + VHRD+ N+L+ KI DFGL
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGL---------- 218
Query: 168 AAAASRIVGTFGY-------------LAPEYVRDGCVTTKSDVYAFGVVLMELIT 209
+R + + +APE + +G T KSDV+++G++L E+ +
Sbjct: 219 ----ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 63/257 (24%), Positives = 112/257 (43%), Gaps = 40/257 (15%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQM---KNTKSKEFSSELKILCKV--HSNLIELIGY 71
+ +G + VY + G+ A+K++ + K++ E+ + K+ H N+++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 72 AA-------GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYI 124
A+ G + FL+ G L + L ++ + PL+ T ++I + ++++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLK--KMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI---------V 175
H KP +HRD+K N+LL + K+ DFG + H P+ + +A R
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 176 GTFGYLAPEYV---RDGCVTTKSDVYAFGVVLMELITGQ-----QALSRDAN------PG 221
T Y PE + + + K D++A G +L L Q A R N P
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPH 271
Query: 222 NNQYTEHRSLVDYMLAV 238
+ QYT SL+ ML V
Sbjct: 272 DTQYTVFHSLIRAMLQV 288
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 51/227 (22%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKN-----TKSKEFSSELKILCKV-HSNLIE 67
+G+G +GSV +L+ ++ A+K +K + +EF E + + H ++ +
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 68 LIG------YAAGGDSLFLVYEYAQNGALSDHL--HWPSVKGKKPLAWTTRVQIALDAAK 119
L+G ++ + ++G L L + L T V+ +D A
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG-ENPFNLPLQTLVRFMVDIAC 148
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
G+EY+ ++HRD+ N +L + +ADFGL SR + +
Sbjct: 149 GMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGL--------------SRKIYSGD 191
Query: 180 Y-------------LAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
Y LA E + D T SDV+AFGV + E++T GQ
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKNTKS-----KEFSSELKILCKV-HSNLIE 67
+G+G +GSV G L+ ++ A+K MK S +EF SE + H N+I
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 68 LIG-----YAAGGDSLFLVYEYAQNGALSDHL--HWPSVKGKKPLAWTTRVQIALDAAKG 120
L+G + G ++ + + G L +L G K + T ++ +D A G
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE-TGPKHIPLQTLLKFMVDIALG 159
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
+EY+ ++HRD+ N +L + +ADFGL K + G
Sbjct: 160 MEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ------GRIAK 210
Query: 181 L-----APEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
+ A E + D T+KSDV+AFGV + E+ T G
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMT 248
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-34
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
IG+G +G VY G L + A+K + +F +E I+ H N++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 69 IGYAAGGDS-LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
+G + +V Y ++G L + + + L AKG++Y+
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIR----NETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTF--GYLAPEY 185
+VHRD+ N +LD F K+ADFGL + + E + ++ ++A E
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK-EYYSVHNKTGAKLPVKWMALES 203
Query: 186 VRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
++ TTKSDV++FGV+L EL+T G
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAP 231
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-34
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 37/212 (17%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKS-----KEFSSELKILCKV-HSNLIELIG 70
+IG+GS+ +VY G A ++++ K + F E ++L + H N++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 71 Y----AAGGDSLFLVYEYAQNGALSD------HLHWPSVKGKKPLAWTTRVQIALDAAKG 120
G + LV E +G L + ++ +W QI KG
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-----SWCR--QIL----KG 141
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
L+++H T P +HRD+K NI + KI D GL L S A ++GT
Sbjct: 142 LQFLHTRTPPI-IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPE 195
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
++APE + DVYAFG+ ++E+ T +
Sbjct: 196 FMAPEMYEEKY-DESVDVYAFGMCMLEMATSE 226
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 52/229 (22%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-------AIKQMKNTKSKE---FSSELKILCKV-HSNLIE 67
++G+G++G V+L + A+K +K F E ++L + H +++
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHL----------HWPSVKGKKPLAWTTRVQIALDA 117
G G L +V+EY ++G L+ L PL + +A
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
A G+ Y+ +VHRD+ T N L+ KI DFG+ SR + +
Sbjct: 168 AAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGM--------------SRDIYS 210
Query: 178 FGY-------------LAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
Y + PE + TT+SDV++FGVVL E+ T G+Q
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
IG+G +G VY G L + A+K + +F +E I+ H N++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 69 IGY-AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
+G S +V Y ++G L + + + L AKG++++
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIR----NETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL-----A 182
+VHRD+ N +LD F K+ADFGL + + + T L A
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPVKWMA 264
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
E ++ TTKSDV++FGV+L EL+T G
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 62/239 (25%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-------AIKQMKNTKS----KEFSSELKILCKV-HSNLI 66
IG+G++G V+ + G A+K +K S +F E ++ + + N++
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHL-------------------HWPSVKGKKPLAW 107
+L+G A G + L++EY G L++ L S G PL+
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 108 TTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167
++ IA A G+ Y+ + +VHRD+ T N L+ N KIADFGL
Sbjct: 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL---------- 220
Query: 168 AAAASRIV--------GTFGYL-----APEYVRDGCVTTKSDVYAFGVVLMELIT-GQQ 212
SR + + PE + TT+SDV+A+GVVL E+ + G Q
Sbjct: 221 ----SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 48/209 (22%), Positives = 85/209 (40%), Gaps = 19/209 (9%)
Query: 13 NFSTSLKIGQGSYGSVYL-GKLRGKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELI 69
+F +G G+ G++ G ++ A+K++ E+++L + H N+I
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
++ E L +++ T Q GL ++H
Sbjct: 85 CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTT----SGLAHLHSLNI 139
Query: 130 PYYVHRDVKTSNILL-----DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
VHRD+K NIL+ +A I+DFGL K L + S + GT G++APE
Sbjct: 140 ---VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 185 YVRDGCV---TTKSDVYAFGVVLMELITG 210
+ + C T D+++ G V +I+
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-33
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 26/214 (12%)
Query: 8 RDATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSS---ELKIL--CK 60
D ++ KIGQG+ G+VY G+ AI+QM + + E+ ++ K
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 61 VHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL---DA 117
+ N++ + GD L++V EY G+L+D + + + QIA +
Sbjct: 76 -NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCM---DEGQIAAVCREC 125
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
+ LE++H +HRD+K+ NILL + K+ DFG + +PE + ++ +VGT
Sbjct: 126 LQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRST-MVGT 179
Query: 178 FGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
++APE V K D+++ G++ +E+I G+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 63/220 (28%), Positives = 110/220 (50%), Gaps = 28/220 (12%)
Query: 3 SYNEVRDATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQMK-NTKSKEFSSELKIL- 58
+ + F K+G+GSYGSVY K G+ AIKQ+ + +E E+ I+
Sbjct: 20 EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQ 79
Query: 59 -CKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL-- 115
C ++++ G L++V EY G++SD + K L T +IA
Sbjct: 80 QCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR----LRNKTL---TEDEIATIL 131
Query: 116 -DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR- 173
KGLEY+H K +HRD+K NILL++ AK+ADFG+ + ++ ++
Sbjct: 132 QSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGV------AGQLTDTMAKR 182
Query: 174 --IVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
++GT ++APE +++ +D+++ G+ +E+ G+
Sbjct: 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-32
Identities = 60/214 (28%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 8 RDATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSS---ELKIL--CK 60
D + +KIG+GS G V L K G+ A+K M K + E+ I+ +
Sbjct: 41 GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100
Query: 61 VHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL---DA 117
H N++E+ G+ L+++ E+ Q GAL+D + + L QIA
Sbjct: 101 -HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS------QVRL---NEEQIATVCEAV 150
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
+ L Y+H +HRD+K+ +ILL + R K++DFG + S ++ S +VGT
Sbjct: 151 LQALAYLHAQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKS-LVGT 204
Query: 178 FGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
++APE + T+ D+++ G++++E++ G+
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMK----NTKSKEFSSELKIL--CKVHSNLIELIG 70
IG G+ V + + AIK++ T E E++ + C H N++
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYYT 80
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL---DAAKGLEYIHQY 127
D L+LV + G++ D + KG+ IA + +GLEY+H+
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR--IVGTFGYLAPEY 185
+ +HRDVK NILL + +IADFG+ L +I R VGT ++APE
Sbjct: 141 GQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 186 V-RDGCVTTKSDVYAFGVVLMELITGQ 211
+ + K+D+++FG+ +EL TG
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGA 224
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 19 KIGQGSYGSVYLGK--LRGKNAAIKQMKNTKSKE------FSSELKILCKV-HSNLIELI 69
K+G G +VYL + + AIK + ++ F E+ ++ H N++ +I
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
D +LV EY + LS+++ PL+ T + G+++ H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIE-----SHGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
VHRD+K NIL+DSN KI DFG+ K L + + ++GT Y +PE +
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS--LTQTNHVLGTVQYFSPEQAKGE 187
Query: 190 CVTTKSDVYAFGVVLMELITGQQ 212
+D+Y+ G+VL E++ G+
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEP 210
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 18/213 (8%)
Query: 6 EVRDATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSSELKIL--CKV 61
E R+ + ++G+GS+G V+ K G A+K+++ + EL
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--EELVACAGLS- 108
Query: 62 HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGL 121
++ L G G + + E + G+L + K L + A +GL
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQALEGL 163
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSN-FRAKIADFGLVKLLEHSPEIAAAASR--IVGTF 178
EY+H +H DVK N+LL S+ RA + DFG L+ + + I GT
Sbjct: 164 EYLHTRRI---LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 179 GYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
++APE V K D+++ +++ ++ G
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 19 KIGQGSYGSVYLGK-LR-GKNAAIKQMKNTKSKE------FSSELKILCKV-HSNLIEL- 68
+G G V+L + LR ++ A+K ++ +++ F E + + H ++ +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 69 -IG--YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
G G ++V EY L D +H + P+ +++ DA + L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSH 133
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
Q +HRDVK +NI++ + K+ DFG+ + + S + ++GT YL+PE
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 186 VRDGCVTTKSDVYAFGVVLMELITGQQ 212
R V +SDVY+ G VL E++TG+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-31
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 5 NEVRDATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQMK----NTKSKEFSSELKIL 58
N D F+ KIG+GS+G V+ G K AIK + + ++ E+ +L
Sbjct: 15 NLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74
Query: 59 --CKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL- 115
C + + G L+++ EY G+ D L PL QIA
Sbjct: 75 SQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE------PGPL---DETQIATI 124
Query: 116 --DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR 173
+ KGL+Y+H K +HRD+K +N+LL + K+ADFG+ + ++ +
Sbjct: 125 LREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGV------AGQLTDTQIK 175
Query: 174 ---IVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
VGT ++APE ++ +K+D+++ G+ +EL G+
Sbjct: 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 47/207 (22%), Positives = 81/207 (39%), Gaps = 32/207 (15%)
Query: 19 KIGQGSYGSVYLGK---LRGKNAAIKQMKNTKSKE----FSSELKILCKV-HSNLIELIG 70
I G G +YL + G+ +K + ++ E +E + L +V H +++++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 71 Y-----AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
+ G ++V EY +L + L + L+ L Y+H
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-------GQKLPVAEAIAYLLEILPALSYLH 199
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
V+ D+K NI+L + K+ D G V + + + GT G+ APE
Sbjct: 200 SIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-------SFGYLYGTPGFQAPEI 248
Query: 186 VRDGCVTTKSDVYAFGVVLMELITGQQ 212
VR G T +D+Y G L L
Sbjct: 249 VRTG-PTVATDIYTVGRTLAALTLDLP 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 32/215 (14%), Positives = 71/215 (33%), Gaps = 26/215 (12%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-------AIKQMKNTKSKEFSSELKIL----CKVHSNLIE 67
+G+G++ VY N +K K EF +++ + ++
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
+ LV E G L + ++ +K + + A+ +E +H
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191
Query: 128 TKPYYVHRDVKTSNILL-----------DSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
+H D+K N +L D + + D G ++ P+ ++
Sbjct: 192 E---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-E 247
Query: 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
T G+ E + + + D + + ++ G
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-30
Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQM----KNTKSKEFSSELKILCKVHS-NLIELIGY 71
++G G+ G V+ + G A K + K + EL++L + +S ++ G
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPY 131
+ + E+ G+L L ++ L ++++ KGL Y+ + K
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHK-- 152
Query: 132 YVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV 191
+HRDVK SNIL++S K+ DFG+ L S A+ VGT Y++PE ++
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHY 207
Query: 192 TTKSDVYAFGVVLMELITGQ 211
+ +SD+++ G+ L+E+ G+
Sbjct: 208 SVQSDIWSMGLSLVEMAVGR 227
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-30
Identities = 50/202 (24%), Positives = 81/202 (40%), Gaps = 19/202 (9%)
Query: 19 KIGQGSYGSVYLGK--LRGKNAAIKQMKNTKSKE------FSSELKILCK-VHSNLIELI 69
+G+G G VY + +R + A+K M T S + E + + +++ +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
+ L++ L+ L + + PLA V I L+ H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML-----RRQGPLAPPRAVAIVRQIGSALDAAHAAG- 154
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
HRDVK NIL+ ++ A + DFG+ VGT Y+APE +
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIASATTDEK--LTQLGNTVGTLYYMAPERFSES 210
Query: 190 CVTTKSDVYAFGVVLMELITGQ 211
T ++D+YA VL E +TG
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-30
Identities = 58/274 (21%), Positives = 105/274 (38%), Gaps = 46/274 (16%)
Query: 19 KIGQGSYGSVYL-GKLRGKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAGG 75
+G GS G+V G +G+ A+K+M E+K+L + H N+I
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD 81
Query: 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK-------GLEYIHQYT 128
L++ E N L D V+ K ++Q + G+ ++H
Sbjct: 82 RFLYIALELC-NLNLQDL-----VESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 129 KPYYVHRDVKTSNILLDS-------------NFRAKIADFGLVKLLEHS-PEIAAAASRI 174
+HRD+K NIL+ + N R I+DFGL K L+ +
Sbjct: 136 ---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 175 VGTFGYLAPEYVRDGCV-------TTKSDVYAFGVVLMELITG-----QQALSRDANPGN 222
GT G+ APE + + T D+++ G V +++ SR++N
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 223 NQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPN 256
++ + ++ + D ++++ DP
Sbjct: 253 GIFSLDEMKCLHDRSLIAEATDLISQMI-DHDPL 285
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 48/226 (21%), Positives = 81/226 (35%), Gaps = 48/226 (21%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSSE--------LKILCKVHSNLIEL 68
KIG G +GSV+ +L G AIK+ K + + +L + HS+++
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ-HSHVVRY 76
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKK---PLAWTTRVQIALDAAKGLEYIH 125
A D + + EY G+L+D + +Q+ GL YIH
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR----GLRYIH 132
Query: 126 QYTKPYYVHRDVKTSNILLDSN-------------------FRAKIADFGLVKLLEHSPE 166
+ VH D+K SNI + KI D G V +
Sbjct: 133 SMSL---VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--- 186
Query: 167 IAAAASRIVGTFGYLAPEYVR-DGCVTTKSDVYAFGVVLMELITGQ 211
G +LA E ++ + K+D++A + ++ +
Sbjct: 187 ----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 9 DATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSS---ELKIL--CKV 61
D + ++G G++G VY K G AA K ++ +E E++IL C
Sbjct: 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD- 74
Query: 62 HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL---DAA 118
H +++L+G L+++ E+ GA+ + + + L T QI +
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML----ELDRGL---TEPQIQVVCRQML 127
Query: 119 KGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR---IV 175
+ L ++H +HRD+K N+L+ ++ADFG+ S + + +
Sbjct: 128 EALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGV------SAKNLKTLQKRDSFI 178
Query: 176 GTFGYLAPEYV-----RDGCVTTKSDVYAFGVVLMELITGQ 211
GT ++APE V +D K+D+++ G+ L+E+ +
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-29
Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 38/230 (16%)
Query: 5 NEVRDATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQMKNTKS--KEFSSELKILCK 60
+ +RD F +G G+YG VY G G+ AAIK M T +E E+ +L K
Sbjct: 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKK 76
Query: 61 V--HSNLIELIG------YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQ 112
H N+ G D L+LV E+ G+++D + L
Sbjct: 77 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK---NTKGNTL---KEEW 130
Query: 113 IAL---DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAA 169
IA + +GL ++HQ+ +HRD+K N+LL N K+ DFG+ S ++
Sbjct: 131 IAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGV------SAQLDR 181
Query: 170 AASR---IVGTFGYLAPEYVRDGCVT-----TKSDVYAFGVVLMELITGQ 211
R +GT ++APE + KSD+++ G+ +E+ G
Sbjct: 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 28/203 (13%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIG 70
+G+G +G+VYL + + A+K + + + E++I + H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKK---PLAWTTRVQIALDAAKGLEYIHQY 127
Y ++L+ EYA G + L K K T ++A L Y H
Sbjct: 77 YFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELAN----ALSYCHSK 128
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
+HRD+K N+LL S KIADFG S + + GT YL PE +
Sbjct: 129 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RTDLCGTLDYLPPEMIE 180
Query: 188 DGCVTTKSDVYAFGVVLMELITG 210
K D+++ GV+ E + G
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVG 203
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 44/218 (20%), Positives = 81/218 (37%), Gaps = 33/218 (15%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIK-----QMKNTKSKEFSS---------------ELKIL 58
+ QG + + L + K A+K ++ + S+ EL+I+
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 59 CKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHL---HWPSVKGKKPLAWTTRVQIA 114
+ + + G D ++++YEY +N ++ + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI 174
YIH + HRDVK SNIL+D N R K++DFG + +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGS 210
Query: 175 VGTFGYLAPEYV--RDGCVTTKSDVYAFGVVLMELITG 210
GT+ ++ PE+ K D+++ G+ L +
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-29
Identities = 50/213 (23%), Positives = 87/213 (40%), Gaps = 31/213 (14%)
Query: 19 KIGQGSYGSVYLGKLR-GKNAAIKQMKNTKSKE-----FSSELKILCKV---HSNLIELI 69
+IG G V+ + AIK + ++ + +E+ L K+ +I L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
Y +++V E N L+ L K KK + R + + + IHQ+
Sbjct: 95 DYEITDQYIYMVMECG-NIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQHG- 147
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
VH D+K +N L+ K+ DFG+ ++ S VGT Y+ PE ++D
Sbjct: 148 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIKDM 203
Query: 190 C-----------VTTKSDVYAFGVVLMELITGQ 211
++ KSDV++ G +L + G+
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-29
Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 19 KIGQGSYGSVYLGKLR-GKNAAIKQ-----MKNTKSKEFSSELKILCKV---HSNLIELI 69
+IG G V+ + AIK N + +E+ L K+ +I L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
Y +++V E N L+ L K KK + R + + + IHQ+
Sbjct: 76 DYEITDQYIYMVMECG-NIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQHG- 128
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
VH D+K +N L+ K+ DFG+ ++ S VGT Y+ PE ++D
Sbjct: 129 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAIKDM 184
Query: 190 C-----------VTTKSDVYAFGVVLMELITGQ 211
++ KSDV++ G +L + G+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 31/206 (15%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIK-----QMKNTKSKE-FSSELKILCKV-HSNLIELIG 70
+G+GS+ VY + G AIK M + +E+KI C++ H +++EL
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKK---PLAWTTRVQIALDAAKGLEYIHQY 127
Y + ++LV E NG ++ +L + K A QI G+ Y+H +
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMHQII----TGMLYLHSH 131
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR---IVGTFGYLAPE 184
+HRD+ SN+LL N KIADFGL + ++ + + GT Y++PE
Sbjct: 132 G---ILHRDLTLSNLLLTRNMNIKIADFGL------ATQLKMPHEKHYTLCGTPNYISPE 182
Query: 185 YVRDGCVTTKSDVYAFGVVLMELITG 210
+SDV++ G + L+ G
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIG 70
+G+G +G+VYL + + A+K + ++ + E++I + H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKK---PLAWTTRVQIALDAAKGLEYIHQY 127
Y ++L+ E+A G L L K + + T ++A L Y H+
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELAD----ALHYCHER 133
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
+HRD+K N+L+ KIADFG + GT YL PE +
Sbjct: 134 K---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-----RRTMCGTLDYLPPEMIE 185
Query: 188 DGCVTTKSDVYAFGVVLMELITG 210
K D++ GV+ E + G
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVG 208
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-28
Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 32/206 (15%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIK-----QMKNTKSKE-FSSELKILCKV-HSNLIELIG 70
+G+G + + + A K + +E S E+ I + H +++ G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKK---PLAWTTRVQIALDAAKGLEYIHQY 127
+ D +F+V E + +L + + K P A QI G +Y+H+
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIV----LGCQYLHRN 134
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR---IVGTFGYLAPE 184
+HRD+K N+ L+ + KI DFGL + ++ R + GT Y+APE
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDFGL------ATKVEYDGERKKVLCGTPNYIAPE 185
Query: 185 YVRDGCVTTKSDVYAFGVVLMELITG 210
+ + + DV++ G ++ L+ G
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 55/319 (17%), Positives = 100/319 (31%), Gaps = 49/319 (15%)
Query: 5 NEVRDATSNFSTSLKIGQG--SYGSVYLG--KLRGKNAAIKQMK-----NTKSKEFSSEL 55
+ + IG+G +V L K G+ ++++ N EL
Sbjct: 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77
Query: 56 KIL--CKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQI 113
+ H N++ + L++V + G+ D + + G + I
Sbjct: 78 HVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG------MNELAI 130
Query: 114 AL---DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG----LVKLLEHSPE 166
A K L+YIH VHR VK S+IL+ + + ++ ++ +
Sbjct: 131 AYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
Query: 167 IAAAASRIVGTFGYLAPEYVRDGCV--TTKSDVYAFGVVLMELITGQ---------QAL- 214
+ V +L+PE ++ KSD+Y+ G+ EL G Q L
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247
Query: 215 --SRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLS 272
P + + M + ++ P + S S
Sbjct: 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307
Query: 273 KD-------CVDENWKRRP 284
C+ N RP
Sbjct: 308 PHFHHFVEQCLQRNPDARP 326
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-28
Identities = 47/216 (21%), Positives = 77/216 (35%), Gaps = 34/216 (15%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKE----FSSELKILCKV-HSNLIELIGY 71
+GQG+ +V+ G K G AIK N E ++L K+ H N+++L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 72 --AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV--QIALDAAKGLEYIHQY 127
L+ E+ G+L L + + D G+ ++ +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 128 TKPYYVHRDVKTSNILL----DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAP 183
VHR++K NI+ D K+ DFG + LE + GT YL P
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD----EQFVSLYGTEEYLHP 184
Query: 184 EYVRDGCVTT--------KSDVYAFGVVLMELITGQ 211
+ + D+++ GV TG
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-28
Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 34/207 (16%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIK-----QMKNTKSKE-FSSELKILCKV-HSNLIELIG 70
+G+G + + + A K + +E S E+ I + H +++ G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLA-WTTR---VQIALDAAKGLEYIHQ 126
+ D +F+V E + +L + K +K L R QI G +Y+H+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIV----LGCQYLHR 159
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR---IVGTFGYLAP 183
+HRD+K N+ L+ + KI DFGL + ++ R + GT Y+AP
Sbjct: 160 NR---VIHRDLKLGNLFLNEDLEVKIGDFGL------ATKVEYDGERKKVLCGTPNYIAP 210
Query: 184 EYVRDGCVTTKSDVYAFGVVLMELITG 210
E + + + DV++ G ++ L+ G
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 31/213 (14%)
Query: 19 KIGQGSYGSVYLGKLR-GKNAAIKQ-----MKNTKSKEFSSELKILCKV---HSNLIELI 69
+IG G V+ + AIK N + +E+ L K+ +I L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
Y +++V E N L+ L K KK + R + + + IHQ+
Sbjct: 123 DYEITDQYIYMVMECG-NIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIHQHG- 175
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
VH D+K +N L+ K+ DFG+ ++ S VG Y+ PE ++D
Sbjct: 176 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS-QVGAVNYMPPEAIKDM 231
Query: 190 C-----------VTTKSDVYAFGVVLMELITGQ 211
++ KSDV++ G +L + G+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSS---ELKILCKV-HSNLIELIGYAA 73
+G+G+YG VY G AIK++ S+ E+ + + H N+++ +G +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
+ + E G+LS L S G T +GL+Y+H V
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI---V 144
Query: 134 HRDVKTSNILLDS-NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV- 191
HRD+K N+L+++ + KI+DFG K L I GT Y+APE + G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLA---GINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 192 -TTKSDVYAFGVVLMELITGQ 211
+D+++ G ++E+ TG+
Sbjct: 202 YGKAADIWSLGCTIIEMATGK 222
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 24/206 (11%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQM----KNTKSKEFSSELKILCKV--HSNLIELIG 70
++G G+ G V+ + R G A+KQM ++K +L ++ K +++ G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+F+ E A ++ L ++ + K L Y+ +
Sbjct: 92 TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLKEKHG- 145
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE-----Y 185
+HRDVK SNILLD + K+ DFG+ L A R G Y+APE
Sbjct: 146 -VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD----KAKDRSAGCAAYMAPERIDPPD 200
Query: 186 VRDGCVTTKSDVYAFGVVLMELITGQ 211
++DV++ G+ L+EL TGQ
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 6e-27
Identities = 47/216 (21%), Positives = 77/216 (35%), Gaps = 34/216 (15%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKE----FSSELKILCKV-HSNLIELIGY 71
+GQG+ +V+ G K G AIK N E ++L K+ H N+++L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 72 --AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV--QIALDAAKGLEYIHQY 127
L+ E+ G+L L + + D G+ ++ +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 128 TKPYYVHRDVKTSNILL----DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAP 183
VHR++K NI+ D K+ DFG + LE + GT YL P
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD----EQFVSLYGTEEYLHP 184
Query: 184 EYVRDGCVTT--------KSDVYAFGVVLMELITGQ 211
+ + D+++ GV TG
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKE----FSSELKILCKV-HSNLIELI-- 69
++G G +G V + G+ AIKQ + S + + E++I+ K+ H N++
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 70 ----GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
A D L EY + G L +L+ + L + D + L Y+H
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRA---KIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
+ +HRD+K NI+L + KI D G K L+ + VGT YLA
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG----ELCTEFVGTLQYLA 191
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
PE + T D ++FG + E ITG
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 30/210 (14%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQM----KNTKSKEFSSELKILCKV--HSNLIELIG 70
++G+G+YG V + G+ A+K++ + + K +L I + + G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 71 -YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK----KPLAWTTRVQIALDAAKGLEYIH 125
GD +++ E + +L KG+ L +IA+ K LE++H
Sbjct: 74 ALFREGD-VWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVKALEHLH 126
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE- 184
+HRDVK SN+L+++ + K+ DFG+ L A G Y+APE
Sbjct: 127 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD----VAKDIDAGCKPYMAPER 180
Query: 185 ---YVRDGCVTTKSDVYAFGVVLMELITGQ 211
+ + KSD+++ G+ ++EL +
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNT---KSKEFS---SELKILCKV-HSNLIELIG 70
+G+GS+ +V L + + AIK ++ K + E ++ ++ H ++L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV---QIALDAAKGLEYIHQY 127
+ L+ YA+NG L ++ K TR +I LEY+H
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVS----ALEYLHGK 149
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
+HRD+K NILL+ + +I DFG K+L + A A S VGT Y++PE +
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVSPELLT 205
Query: 188 DGCVTTKSDVYAFGVVLMELITGQ 211
+ SD++A G ++ +L+ G
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGL 229
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQM----KNTKSKEFSSELKILCKV--HSNLIELIG 70
+IG+G+YGSV + G+ A+K++ + K+ +L ++ + +++ G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
++ E + + + + +I L K L ++ + K
Sbjct: 89 ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK- 146
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE----YV 186
+HRD+K SNILLD + K+ DFG+ L S A +R G Y+APE
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS----IAKTRDAGCRPYMAPERIDPSA 201
Query: 187 RDGCVTTKSDVYAFGVVLMELITGQ 211
+SDV++ G+ L EL TG+
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGR 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 69/223 (30%), Positives = 100/223 (44%), Gaps = 41/223 (18%)
Query: 8 RDATSNFSTSLKIGQGSYGSVYLG--KLRGKNAAIKQM------KNTKSKEFSSELKIL- 58
D FS +IG GS+G+VY + AIK+M N K ++ E++ L
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 59 -CKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL-- 115
+ H N I+ G + +LV EY G+ SD L KKPL V+IA
Sbjct: 110 KLR-HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE----VHKKPL---QEVEIAAVT 160
Query: 116 -DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR- 173
A +GL Y+H + +HRDVK NILL K+ DFG A+ +
Sbjct: 161 HGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFG----------SASIMAPA 207
Query: 174 --IVGTFGYLAPEYV---RDGCVTTKSDVYAFGVVLMELITGQ 211
VGT ++APE + +G K DV++ G+ +EL +
Sbjct: 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 35/146 (23%), Positives = 64/146 (43%), Gaps = 18/146 (12%)
Query: 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKP--LAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
L++ + + L D ++ + + +QIA +E++H +
Sbjct: 134 VYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE----AVEFLHSKG---LM 186
Query: 134 HRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIA---------AAASRIVGTFGYLAPE 184
HRD+K SNI + K+ DFGLV ++ E A + VGT Y++PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 185 YVRDGCVTTKSDVYAFGVVLMELITG 210
+ + K D+++ G++L EL+
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 19/231 (8%), Positives = 51/231 (22%), Gaps = 49/231 (21%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIK------QMKNTKSKEFSSELKILCKV-HSNLIELIG 70
+ G V+L R ++ A+K + ++ + ++ + E
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 71 YA--------------------------AGGDSLFLVYEYAQNGALSDHLHWPS--VKGK 102
+ L+ A L +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 103 KPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162
+ + + VH N+ + + R + D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 163 HSPEIAAAASRIVGTFGYLAPEYV--RDGCVTTKSDVYAFGVVLMELITGQ 211
++ Y E++ T + + G+ + +
Sbjct: 243 ---KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 32/235 (13%), Positives = 62/235 (26%), Gaps = 49/235 (20%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIKQM------KNTKSKEFSSELKILCKV---------- 61
+GQ + + G++ + + K+ E+ L +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 62 ----------------HSNLIELIGYAAGGD--SLFLVYEYAQNGALSDHLHWPSVKGK- 102
+I + S F +Y Q L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSST 204
Query: 103 -KPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161
K L R+Q+ L + L +H Y VH ++ +I+LD + F +
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 162 EHSPEIAAAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQ 211
S + R A + +T D + G+ + +
Sbjct: 262 GASAV--SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 7e-24
Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 29/205 (14%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQMKNTKSKEFSS----ELKILCKV-HSNLIELIGYA 72
+G+G+YG V L + + A+K + ++ + E+ I + H N+++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV---QIALDAAKGLEYIHQYTK 129
G+ +L EY G L D + + Q+ G+ Y+H
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMA----GVVYLHGIG- 125
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR-- 187
HRD+K N+LLD KI+DFGL + ++ GT Y+APE ++
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRR 182
Query: 188 --DGCVTTKSDVYAFGVVLMELITG 210
DV++ G+VL ++ G
Sbjct: 183 EFHA---EPVDVWSCGIVLTAMLAG 204
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 1e-23
Identities = 38/240 (15%), Positives = 69/240 (28%), Gaps = 60/240 (25%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKS---------KEFSSELKILCKV------- 61
+GQ + + G++ + T+ KE L++L +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 62 ----------------HSNLIELIGYAAGGD--SLFLVYEYAQ--NGALSDHLHWPSVKG 101
+I + S F +Y Q + L S
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 102 KKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161
K L R+Q+ L + L +H Y VH ++ +I+LD + F +
Sbjct: 201 K-SLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 162 EHSPEIAAAASRIVGTFGYLAPEYV-----------RDGCVTTKSDVYAFGVVLMELITG 210
+ G+ PE R +T D +A G+V+ +
Sbjct: 257 GARVV-------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIK-----QMKNTKSKEFSSELKILCKV-HSNLIELIG 70
K+G G+YG V L + + AIK + + + + E+ +L + H N+++L
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+ + +LV E + G L D + + I G+ Y+H++
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDE-----IIHRMKFNEVDAAVIIKQVLSGVTYLHKHN-- 156
Query: 131 YYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
VHRD+K N+LL+S + KI DFGL + E+ ++ +GT Y+APE V
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM----KERLGTAYYIAPE-VL 210
Query: 188 DGCVTTKSDVYAFGVVLMELITG 210
K DV++ GV+L L+ G
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAG 233
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-23
Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 29/205 (14%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQMKNTKSKEFSS----ELKILCKV-HSNLIELIGYA 72
+G+G+YG V L + + A+K + ++ + E+ I + H N+++ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV---QIALDAAKGLEYIHQYTK 129
G+ +L EY G L D + + Q+ G+ Y+H
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMA----GVVYLHGIG- 125
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR-- 187
HRD+K N+LLD KI+DFGL + ++ GT Y+APE ++
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM-CGTLPYVAPELLKRR 182
Query: 188 --DGCVTTKSDVYAFGVVLMELITG 210
DV++ G+VL ++ G
Sbjct: 183 EFHA---EPVDVWSCGIVLTAMLAG 204
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-23
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 33/206 (16%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIK-----QMKNTKSKEFSSELKILCKV-HSNLIELIGY 71
IG+G++ V L + L G+ AIK Q+ T ++ E++I+ + H N+++L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV---QIALDAAKGLEYIHQYT 128
+L+L+ EYA G + D+L V + R QI ++Y HQ
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVS----AVQYCHQK- 133
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR- 187
VHRD+K N+LLD++ KIADFG ++ A G Y APE +
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF----CGAPPYAAPELFQG 187
Query: 188 ---DGCVTTKSDVYAFGVVLMELITG 210
DG + DV++ GV+L L++G
Sbjct: 188 KKYDG---PEVDVWSLGVILYTLVSG 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 9e-23
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 25/222 (11%)
Query: 1 MFSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIK-----QMKNTKSKE-FS 52
MF + + + +G+GS+G V L K + G+ A+K Q+K KE
Sbjct: 15 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 53 SELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV 111
E+++L ++ H N+++L + +LV E G L D + +K +
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE-----IISRKRFSEVDAA 129
Query: 112 QIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIA 168
+I G+ Y+H+ VHRD+K N+LL+S + +I DFGL E S ++
Sbjct: 130 RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM- 185
Query: 169 AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
+GT Y+APE V G K DV++ GV+L L++G
Sbjct: 186 ---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 38/213 (17%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQMKNTKSKEFSS-------ELKILCKV-HSNLIEL- 68
+G+GSYG V A+K +K K + + E+++L ++ H N+I+L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 69 -IGYAAGGDSLFLVYEYAQNGA--LSDHLHWPSVKGKKPLAWTTR---VQIALDAAKGLE 122
+ Y +++V EY G + D + + + P+ Q+ GLE
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSV----PEKRFPV-CQAHGYFCQLID----GLE 123
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
Y+H VH+D+K N+LL + KI+ G+ + L G+ +
Sbjct: 124 YLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA-DDTCRTSQGSPAFQP 179
Query: 183 PEYVR-----DGCVTTKSDVYAFGVVLMELITG 210
PE G K D+++ GV L + TG
Sbjct: 180 PEIANGLDTFSG---FKVDIWSAGVTLYNITTG 209
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE----FSSELKILCKV-HSNLIELIGY 71
K+G G++G V+L + R G IK + +S+ +E+++L + H N+I++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKK---PLAWTTRVQIALDAAKGLEYIHQYT 128
++++V E + G L + + +GK Q+ L Y H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM----NALAYFHSQ- 143
Query: 129 KPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
+ VH+D+K NIL + KI DFGL +L + + GT Y+APE
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS----TNAAGTALYMAPE- 196
Query: 186 VRDGCVTTKSDVYAFGVVLMELITG 210
V VT K D+++ GVV+ L+TG
Sbjct: 197 VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 49/229 (21%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQM-KNTKSKEFSS----------------------- 53
IG+GSYG V L A+K + K ++
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 54 -----ELKILCKV-HSNLIEL--IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPL 105
E+ IL K+ H N+++L + D L++V+E G + + V KPL
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME------VPTLKPL 134
Query: 106 AWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165
+ D KG+EY+H +HRD+K SN+L+ + KIADFG+ + S
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 166 EIAAAASRIVGTFGYLAPEYVRDGCVT---TKSDVYAFGVVLMELITGQ 211
+ + VGT ++APE + + DV+A GV L + GQ
Sbjct: 192 ALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 34/208 (16%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIK-----QMKNTKSKEFSSELKILCKV-HSNLIELIG 70
+G+GS+G V K R + A+K KN + E+++L K+ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPL-----AWTTRVQIALDAAKGLEYIH 125
S ++V E G L D + +K A + Q+ G+ Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDE-----IIKRKRFSEHDAARIIK-QVF----SGITYMH 138
Query: 126 QYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
++ VHRD+K NILL+S + KI DFGL + + ++ +GT Y+A
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM----KDRIGTAYYIA 191
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELITG 210
PE V G K DV++ GV+L L++G
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-22
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 38/212 (17%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFS-----------SELKILCKV-HSNL 65
+G G++G V+ K + K +K +K K E E+ IL +V H+N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 66 IELIGYAAGGDSLFLVYEYAQNGA-LSDHLHWPSVKGK--KPLAWTTRVQIALDAAKGLE 122
I+++ LV E +G L + + +PLA Q+ +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFI---DRHPRLDEPLASYIFRQLVS----AVG 144
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
Y+ +HRD+K NI++ +F K+ DFG LE GT Y A
Sbjct: 145 YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF----YTFCGTIEYCA 197
Query: 183 PEYVR----DGCVTTKSDVYAFGVVLMELITG 210
PE + G + ++++ GV L L+
Sbjct: 198 PEVLMGNPYRG---PELEMWSLGVTLYTLVFE 226
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-22
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 40/213 (18%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQMKNTKSKEFSSE------------LKILCKVHSNL 65
+G G +GSVY G AIK ++ + ++ LK + S +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 66 IELIGYAAGGDSLFLVYEYAQN-GALSDHLHWPSVKGK--KPLAWTTRVQIALDAAKGLE 122
I L+ + DS L+ E + L D + + +G + LA + Q+ + +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVL----EAVR 163
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSN-FRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
+ H +HRD+K NIL+D N K+ DFG LL+ + + GT Y
Sbjct: 164 HCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-----YTDFDGTRVYS 215
Query: 182 APEYVR----DGCVTTKSDVYAFGVVLMELITG 210
PE++R G + V++ G++L +++ G
Sbjct: 216 PPEWIRYHRYHG---RSAAVWSLGILLYDMVCG 245
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 7e-22
Identities = 45/207 (21%), Positives = 83/207 (40%), Gaps = 33/207 (15%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE---FSSELKILCKV-HSNLIELIGYA 72
++G G++G V+ + G+ K + + +E+ I+ ++ H LI L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK-------GLEYIH 125
+ L+ E+ G L D + + + + GL+++H
Sbjct: 118 EDKYEMVLILEFLSGGELFDRI------AAEDYKMSEA-----EVINYMRQACEGLKHMH 166
Query: 126 QYTKPYYVHRDVKTSNILLDS--NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAP 183
++ VH D+K NI+ ++ KI DFGL L + T + AP
Sbjct: 167 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAP 219
Query: 184 EYVRDGCVTTKSDVYAFGVVLMELITG 210
E V V +D++A GV+ L++G
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 42/215 (19%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQMKNTKSKEFSS---------ELKILCKV-----HS 63
+G+G +G+V+ G AIK + + +S E+ +L KV H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 64 NLIELIGYAAGGDSLFLVYEYAQNGA-LSDHLHWPSVKGK--KPLAWTTRVQIALDAAKG 120
+I L+ + + LV E L D++ + KG + + Q+
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGPSRCFFGQVVA----A 151
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
+++ H VHRD+K NIL+D AK+ DFG LL P + GT
Sbjct: 152 IQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-----YTDFDGTRV 203
Query: 180 YLAPEYVR----DGCVTTKSDVYAFGVVLMELITG 210
Y PE++ + V++ G++L +++ G
Sbjct: 204 YSPPEWISRHQYHA---LPATVWSLGILLYDMVCG 235
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-21
Identities = 53/243 (21%), Positives = 82/243 (33%), Gaps = 54/243 (22%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS--------ELKILCKV-HSNLIE 67
IGQGSYG V + AIK M K ++ + E++++ K+ H N+
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL------------ 115
L + LV E G L D L+ A
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 116 ----------------DAAK-------GLEYIHQYTKPYYVHRDVKTSNILLDS--NFRA 150
+ L Y+H HRD+K N L + +F
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 151 KIADFGL-VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC--VTTKSDVYAFGVVLMEL 207
K+ DFGL + + + + GT ++APE + K D ++ GV+L L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 208 ITG 210
+ G
Sbjct: 270 LMG 272
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 40/211 (18%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSS------------ELKILCKV--H 62
+G+G V K K A+K + T FS+ E+ IL KV H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK---KPLAWTTRVQIALDAAK 119
N+I+L FLV++ + G L D+L + K K R + +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMR-ALL----E 135
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
+ +H+ VHRD+K NILLD + K+ DFG L+ ++ + GT
Sbjct: 136 VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 188
Query: 180 YLAPEYVRDGCVTTKS------DVYAFGVVL 204
YLAPE + D+++ GV++
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-21
Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 55/236 (23%)
Query: 4 YNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV 61
R +++ + IG GS+G VY KL G+ AIK++ K + EL+I+ K+
Sbjct: 46 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-ELQIMRKL 104
Query: 62 -HSNLIELIGY------AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA 114
H N++ L + L LV +Y + + ++ + +R +
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDY-----VPETVY-------RVARHYSRAKQT 152
Query: 115 LDAA----------KGLEYIHQYTKPYYVHRDVKTSNILLDSN-FRAKIADFGLVKLLEH 163
L + L YIH + HRD+K N+LLD + K+ DFG K L
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209
Query: 164 S-PEIAAAASRIVGTFGYLAPE-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
P ++ SR Y APE Y T+ DV++ G VL EL+ GQ
Sbjct: 210 GEPNVSYICSRY-----YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFS------SELKILCKVHSNLIELIGY 71
+G+G +G V+ +++ GK A K++ + K+ E KIL KVHS I + Y
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKK---PLAWTTRVQIALDAAKGLEYIHQY 127
A L LV G + H++ P A QI GLE++HQ
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS----GLEHLHQR 308
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
++RD+K N+LLD + +I+D GL E GT G++APE +
Sbjct: 309 ---NIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGY-AGTPGFMAPELLL 362
Query: 188 DGCVTTKSDVYAFGVVLMELITGQ 211
D +A GV L E+I +
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK---EFSSELKILCKV-HSNLI 66
S + +G G +G V+ + G A K +K K E +E+ ++ ++ H+NLI
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPL-----AWTTRVQIALDAAKGL 121
+L + + LV EY G L D + + L + QI +G+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRI----IDESYNLTELDTILFMK-QIC----EGI 200
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFRA--KIADFGLVKLLEHSPEIAAAASRIVGTFG 179
++HQ Y +H D+K NIL + KI DFGL + + ++ GT
Sbjct: 201 RHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL----KVNFGTPE 253
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
+LAPE V V+ +D+++ GV+ L++G
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-21
Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 28/198 (14%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE---FSSELKILCKV-HSNLIELIGYA 72
+G G++ V+L K R GK A+K +K + + +E+ +L K+ H N++ L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGK---KPLAWTTRVQIALDAAKGLEYIHQYTK 129
+LV + G L D + +G K + + Q+ ++Y+H+
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRI---LERGVYTEKDASLVIQ-QVL----SAVKYLHENG- 126
Query: 130 PYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
VHRD+K N+L + N + I DFGL K+ ++ S GT GY+APE +
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-----MSTACGTPGYVAPEVL 179
Query: 187 RDGCVTTKSDVYAFGVVL 204
+ D ++ GV+
Sbjct: 180 AQKPYSKAVDCWSIGVIT 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-21
Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 34/211 (16%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK---------EFSSELKILCKV-HSNLI 66
++G G + V + + G A K +K +S+ E E+ IL +V H N+I
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK---KPLAWTTRVQIALDAAKGLEY 123
L + L+ E G L D L + K + + QI G+ Y
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIK-QIL----DGVNY 130
Query: 124 IHQYTKPYYVHRDVKTSNILLDS----NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
+H H D+K NI+L K+ DFGL +E E I GT
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGTPE 183
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
++APE V + ++D+++ GV+ L++G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-21
Identities = 71/329 (21%), Positives = 120/329 (36%), Gaps = 66/329 (20%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK---------EFSSELKILCKV-HSNLI 66
++G G + V + + G A K +K +S+ E E+ IL +V H N+I
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK---KPLAWTTRVQIALDAAKGLEY 123
L + L+ E G L D L + K + + QI G+ Y
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIK-QIL----DGVNY 130
Query: 124 IHQYTKPYYVHRDVKTSNILLDS----NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
+H H D+K NI+L K+ DFGL +E E I GT
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGTPE 183
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITG--------QQALSRDANPGNNQYTEHRSL 231
++APE V + ++D+++ GV+ L++G +Q + + + E
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE---- 239
Query: 232 VDYMLAVFNDTKDFMAKL-----------TECL--------DPNLTRYHKDSMLQMALLS 272
++ KDF+ KL E L D ++S++ +
Sbjct: 240 -EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFK 298
Query: 273 KDCVDENWKRRPDMSNAAIRLSHILISSK 301
K V WK + + L+ L+
Sbjct: 299 KQYVRRRWKLSFSIVSLCNHLTRSLMKKV 327
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 5e-21
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 36/210 (17%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-FSS----ELKILCKV-HSNLIELIG 70
KIG+GSYG V+ + R G+ AIK+ ++ E+++L ++ H NL+ L+
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 71 YAAGGDSLFLVYEYAQN---GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L LV+EY + L + K + W Q + + + H++
Sbjct: 70 VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW----QTL----QAVNFCHKH 121
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGL-----VKLLEHSPEIAAAASRIVGTFGYLA 182
+HRDVK NIL+ + K+ DFG + E+A T Y +
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--------TRWYRS 170
Query: 183 PEY-VRDGCVTTKSDVYAFGVVLMELITGQ 211
PE V D DV+A G V EL++G
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-21
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 44/212 (20%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQMKNTKSKEFSS------ELKILCKV-HSNLIELIG 70
+G G++G V +G+ L G A+K + K + E++ L H ++I+L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK--KPLAWTTRVQIALDAAKGLEYIHQYT 128
+ F+V EY G L D++ G+ + A QI ++Y H++
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQIL----SAVDYCHRHM 131
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLV------KLLEHSPEIAAAASRIVGTFGYLA 182
VHRD+K N+LLD++ AKIADFGL + L S G+ Y A
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS----------CGSPNYAA 178
Query: 183 PEYVR----DGCVTTKSDVYAFGVVLMELITG 210
PE + G + D+++ GV+L L+ G
Sbjct: 179 PEVISGRLYAG---PEVDIWSCGVILYALLCG 207
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-21
Identities = 61/241 (25%), Positives = 99/241 (41%), Gaps = 57/241 (23%)
Query: 3 SYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIK---QMKNTKSKEFSSELKI 57
+ R F GQG++G+V LGK + G + AIK Q +++E ++
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQD 72
Query: 58 LCKV-HSNLIEL--IGYAAGGDS-----LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTT 109
L + H N+++L Y G L +V EY + D LH +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY-----VPDTLH-------RCCRNYY 120
Query: 110 RVQIALDAA----------KGLEYIHQYTKPYYVHRDVKTSNILLD-SNFRAKIADFGLV 158
R Q+A + + +H + HRD+K N+L++ ++ K+ DFG
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNV-CHRDIKPHNVLVNEADGTLKLCDFGSA 179
Query: 159 KLLEHS-PEIAAAASRIVGTFGYLAPE-------YVRDGCVTTKSDVYAFGVVLMELITG 210
K L S P +A SR Y APE Y TT D+++ G + E++ G
Sbjct: 180 KKLSPSEPNVAYICSRY-----YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLG 228
Query: 211 Q 211
+
Sbjct: 229 E 229
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 7e-21
Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKNTKSKEFS------SELKILCKVHSNLIELIGY 71
+G+G +G V ++R A K+++ + K+ +E +IL KV+S + + Y
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 72 AA-GGDSLFLVYEYAQNGALSDHLHWPSVKG-KKPLAWTTRVQIALDAAKGLEYIHQYTK 129
A D+L LV G L H++ G + A +I GLE +H+
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC----GLEDLHRE-- 305
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
V+RD+K NILLD + +I+D GL H PE R VGT GY+APE V++
Sbjct: 306 -RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGR-VGTVGYMAPEVVKNE 360
Query: 190 CVTTKSDVYAFGVVLMELITGQ 211
T D +A G +L E+I GQ
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-21
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 33/200 (16%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-FSSELKILCKV-HSNLIELIGYAAG 74
++G+G+ VY K + K A+K +K T K+ +E+ +L ++ H N+I+L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK-------GLEYIHQY 127
+ LV E G L D + KG ++ R DAA + Y+H+
Sbjct: 120 PTEISLVLELVTGGELFDRI---VEKGY----YSER-----DAADAVKQILEAVAYLHEN 167
Query: 128 TKPYYVHRDVKTSNILL---DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
VHRD+K N+L + KIADFGL K++EH + + GT GY APE
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM----KTVCGTPGYCAPE 220
Query: 185 YVRDGCVTTKSDVYAFGVVL 204
+R + D+++ G++
Sbjct: 221 ILRGCAYGPEVDMWSVGIIT 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 37/217 (17%), Positives = 83/217 (38%), Gaps = 32/217 (14%)
Query: 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE--FSSELKILCKV-H 62
++ + + +G+G +G V+ K K +K + + E+ IL H
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK--- 119
N++ L + L +++E+ + + + R +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERI------NTSAFELNER-----EIVSYVH 109
Query: 120 ----GLEYIHQYTKPYYVHRDVKTSNILLDS--NFRAKIADFGLVKLLEHSPEIAAAASR 173
L+++H + H D++ NI+ + + KI +FG + L+
Sbjct: 110 QVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF----RL 162
Query: 174 IVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
+ Y APE + V+T +D+++ G ++ L++G
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 26/205 (12%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFS------SELKILCKVHSN----LIE 67
IG+G +G VY + GK A+K + + K +E +L V + ++
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
+ D L + + G L HL + +I L GLE++H
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIIL----GLEHMHNR 311
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
+ V+RD+K +NILLD + +I+D GL VGT GY+APE ++
Sbjct: 312 ---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQ 363
Query: 188 DGCVTTKS-DVYAFGVVLMELITGQ 211
G S D ++ G +L +L+ G
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 45/219 (20%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----------------SKEFSSELKILCK 60
K+G G+YG V L K + AIK +K ++ +E +E+ +L
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 61 V-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPL-----AWTTRVQIA 114
+ H N+I+L +LV E+ + G L + + + A + QI
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-----INRHKFDECDAANIMK-QIL 156
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAA 171
G+ Y+H++ VHRD+K NILL++ KI DFGL ++
Sbjct: 157 ----SGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---- 205
Query: 172 SRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
+GT Y+APE V K DV++ GV++ L+ G
Sbjct: 206 RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-20
Identities = 45/198 (22%), Positives = 81/198 (40%), Gaps = 28/198 (14%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE---FSSELKILCKV-HSNLIELIGYA 72
IG+GS+G V + + A K++ ++ F E++I+ + H N+I L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGK---KPLAWTTRVQIALDAAKGLEYIHQYTK 129
++LV E G L + + K A + + + Y H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERV---VHKRVFRESDAARIMK-DVL----SAVAYCHKLN- 126
Query: 130 PYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
HRD+K N L + + K+ DFGL + + VGT Y++P+ V
Sbjct: 127 --VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM----RTKVGTPYYVSPQ-V 179
Query: 187 RDGCVTTKSDVYAFGVVL 204
+G + D ++ GV++
Sbjct: 180 LEGLYGPECDEWSAGVMM 197
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 53/208 (25%), Positives = 85/208 (40%), Gaps = 25/208 (12%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMK------NTKSKEFSSELKILCKVHSNLIELIGY 71
IG+G++ V + K++ A+K M + F E +L I + +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
A + L+LV EY G L L + +A +I + ++ +H+
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM----AIDSVHRLG-- 182
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
YVHRD+K NILLD ++ADFG + + + VGT YL+PE ++
Sbjct: 183 -YVHRDIKPDNILLDRCGHIRLADFGSCL--KLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 191 VTTKSDVY-------AFGVVLMELITGQ 211
+ Y A GV E+ GQ
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-20
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIK-----QMKNTKSKEFSSELKILCKV-HSNLIELIG 70
+G+GS+G V K R + A+K KN + E+++L K+ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK---KPLAWTTRVQIALDAAKGLEYIHQY 127
S ++V E G L D + + + A + Q+ G+ Y+H++
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIK-QVF----SGITYMHKH 140
Query: 128 TKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
VHRD+K NILL+S + KI DFGL + + ++ +GT Y+APE
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM----KDRIGTAYYIAPE 193
Query: 185 YVRDGCVTTKSDVYAFGVVL 204
V G K DV++ GV+L
Sbjct: 194 -VLRGTYDEKCDVWSAGVIL 212
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 39/210 (18%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSK-----------EFSSELKILCKV--HS 63
IG+G V + G A+K M+ T + E IL +V H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 64 NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK---KPLAWTTRVQIALDAAKG 120
++I LI +FLV++ + G L D+L + K K R + +
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMR-SLL----EA 212
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
+ ++H VHRD+K NILLD N + +++DFG LE ++ + GT GY
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL----RELCGTPGY 265
Query: 181 LAPEYVRDGCVTT------KSDVYAFGVVL 204
LAPE ++ T + D++A GV+L
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 46/200 (23%), Positives = 86/200 (43%), Gaps = 19/200 (9%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS---ELKILCKV-HSNLIELIGYA 72
++G G++G V+ R G N A K + + + E++ + + H L+ L
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
+ + ++YE+ G L + + ++ V+ KGL ++H+ Y
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKV----ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NY 276
Query: 133 VHRDVKTSNILLDSNFRA--KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
VH D+K NI+ + K+ DFGL L+ + GT + APE
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV----KVTTGTAEFAAPEVAEGKP 332
Query: 191 VTTKSDVYAFGVVLMELITG 210
V +D+++ GV+ L++G
Sbjct: 333 VGYYTDMWSVGVLSYILLSG 352
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-20
Identities = 54/211 (25%), Positives = 87/211 (41%), Gaps = 34/211 (16%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK---------EFSSELKILCKV-HSNLI 66
++G G + V + + GK A K +K + E E+ IL ++ H N+I
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK---KPLAWTTRVQIALDAAKGLEY 123
L + L+ E G L D L + K + QI G+ Y
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLK-QIL----DGVHY 123
Query: 124 IHQYTKPYYVHRDVKTSNILLDS----NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
+H H D+K NI+L N R K+ DFG+ +E E I GT
Sbjct: 124 LHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----KNIFGTPE 176
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
++APE V + ++D+++ GV+ L++G
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKNT---KSKE---FSSELKILCKVHSNLIELIGY 71
IG+G++G V + KL+ + A+K + K E F E +L S I + Y
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
A ++L+LV +Y G L L + + +A ++ + ++ +HQ
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI----AIDSVHQLH-- 195
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
YVHRD+K NIL+D N ++ADFG + + +S VGT Y++PE ++
Sbjct: 196 -YVHRDIKPDNILMDMNGHIRLADFGSCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 191 VTTKS-----DVYAFGVVLMELITGQ 211
D ++ GV + E++ G+
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 36/211 (17%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSK-----EFSSELKILCKV--HSNLIELI 69
++G+G + V K G+ A K +K + E E+ +L +I L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK-------GLE 122
+ L+ EYA G + + + D + G+
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSL-----CLPELAEMVSEN-----DVIRLIKQILEGVY 145
Query: 123 YIHQYTKPYYVHRDVKTSNILL---DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
Y+HQ VH D+K NILL KI DFG+ + + H+ E+ I+GT
Sbjct: 146 YLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL----REIMGTPE 198
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
YLAPE + +TT +D++ G++ L+T
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-20
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 34/211 (16%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK---------EFSSELKILCKV-HSNLI 66
++G G + V + + G A K +K ++K + E+ IL ++ H N+I
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK---KPLAWTTRVQIALDAAKGLEY 123
L + L+ E G L D L + K + + QI G+ Y
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLK-QIL----NGVYY 129
Query: 124 IHQYTKPYYVHRDVKTSNILLDS----NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
+H H D+K NI+L R KI DFGL ++ E I GT
Sbjct: 130 LHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPE 182
Query: 180 YLAPEYVRDGCVTTKSDVYAFGVVLMELITG 210
++APE V + ++D+++ GV+ L++G
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 44/212 (20%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQMKNTKSKEFSS------ELKILCKV-HSNLIELIG 70
+G G++G V +GK L G A+K + K + E++ L H ++I+L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK--KPLAWTTRVQIALDAAKGLEYIHQYT 128
+ +F+V EY G L D++ G+ + + QI G++Y H++
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQIL----SGVDYCHRHM 136
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLV------KLLEHSPEIAAAASRIVGTFGYLA 182
VHRD+K N+LLD++ AKIADFGL + L S G+ Y A
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS----------CGSPNYAA 183
Query: 183 PEYVR----DGCVTTKSDVYAFGVVLMELITG 210
PE + G + D+++ GV+L L+ G
Sbjct: 184 PEVISGRLYAG---PEVDIWSSGVILYALLCG 212
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-20
Identities = 43/196 (21%), Positives = 74/196 (37%), Gaps = 24/196 (12%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKIL--CKVHSNLIELIGYAAG 74
+G+GS+ + + A+K + E+ L C+ H N+++L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD 77
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGK---KPLAWTTRVQIALDAAKGLEYIHQYTKPY 131
FLV E G L + + K ++ R ++ + ++H
Sbjct: 78 QLHTFLVMELLNGGELFERIK---KKKHFSETEASYIMR-KLV----SAVSHMHDVG--- 126
Query: 132 YVHRDVKTSNILL---DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
VHRD+K N+L + N KI DFG +L + T Y APE +
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL---KTPCFTLHYAAPELLNQ 183
Query: 189 GCVTTKSDVYAFGVVL 204
D+++ GV+L
Sbjct: 184 NGYDESCDLWSLGVIL 199
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-20
Identities = 47/200 (23%), Positives = 83/200 (41%), Gaps = 29/200 (14%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIK-----QMKNTKSKEFSSELKILCKV-HSNLIELIG 70
++G+G++ V + G A K ++ ++ E +I K+ H N++ L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK---KPLAWTTRVQIALDAAKGLEYIHQY 127
+LV++ G L + + + + + QI + + Y H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQ-QIL----ESIAYCHSN 124
Query: 128 TKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
VHR++K N+LL S K+ADFGL + S GT GYL+PE
Sbjct: 125 G---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW----HGFAGTPGYLSPE 177
Query: 185 YVRDGCVTTKSDVYAFGVVL 204
++ + D++A GV+L
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 44/215 (20%)
Query: 19 KIGQGSYGSVYLGKLRGKN-AAIKQMKNTKSKEFSSELKILCKV-HSNLIEL--IGYAAG 74
IG GS+G V+ KL + AIK++ K + + EL+I+ V H N+++L Y+ G
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-NRELQIMRIVKHPNVVDLKAFFYSNG 105
Query: 75 GDS----LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAA----------KG 120
L LV EY + + ++ + +++ + +
Sbjct: 106 DKKDEVFLNLVLEY-----VPETVY-------RASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSN-FRAKIADFGLVKLLEHS-PEIAAAASRIVGTF 178
L YIH HRD+K N+LLD K+ DFG K+L P ++ SR
Sbjct: 154 LAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY---- 206
Query: 179 GYLAPEYVRDGCV--TTKSDVYAFGVVLMELITGQ 211
Y APE + G TT D+++ G V+ EL+ GQ
Sbjct: 207 -YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 41/199 (20%), Positives = 77/199 (38%), Gaps = 28/199 (14%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGY--- 71
+G G G V R G+ A+K + S + E+ + +++ ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHIVCILDVYEN 93
Query: 72 -AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTR--VQIALDAAKGLEYIHQYT 128
G L ++ E + G L + + A+T R +I D ++++H +
Sbjct: 94 MHHGKRCLLIIMECMEGGELFSRIQ-----ERGDQAFTEREAAEIMRDIGTAIQFLHSHN 148
Query: 129 KPYYVHRDVKTSNILL---DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
HRDVK N+L + + K+ DFG K + T Y+APE
Sbjct: 149 ---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQTPCYTPYYVAPEV 200
Query: 186 VRDGCVTTKSDVYAFGVVL 204
+ D+++ GV++
Sbjct: 201 LGPEKYDKSCDMWSLGVIM 219
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-19
Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 30/207 (14%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-FSS----ELKILCKV-HSNLIELIG 70
+G+GSYG V + + G+ AIK+ + + E+K+L ++ H NL+ L+
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
+LV+E+ + + D L L + + G+ + H +
Sbjct: 92 VCKKKKRWYLVFEFVDHT-ILDDLE----LFPNGLDYQVVQKYLFQIINGIGFCHSH--- 143
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGL-----VKLLEHSPEIAAAASRIVGTFGYLAPEY 185
+HRD+K NIL+ + K+ DFG + E+A T Y APE
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--------TRWYRAPEL 195
Query: 186 -VRDGCVTTKSDVYAFGVVLMELITGQ 211
V D DV+A G ++ E+ G+
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 35/213 (16%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQM-----------KNTKSKEFSSELKILCKV-HSN 64
+G G+ G V L + K AI+ + + + +E++IL K+ H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 65 LIELIG-YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEY 123
+I++ + A + ++V E + G L D V G K L T ++Y
Sbjct: 202 IIKIKNFFDA--EDYYIVLELMEGGELFDK-----VVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 124 IHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
+H+ +HRD+K N+LL S + KI DFG K+L + + + GT Y
Sbjct: 255 LHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTPTY 307
Query: 181 LAPEYVRDGCV---TTKSDVYAFGVVLMELITG 210
LAPE + D ++ GV+L ++G
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-19
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 18 LKIGQGSYGSVYLGKLR----GKNAAIKQMKNTKSKEFSS--ELKILCKV-HSNLIELIG 70
K+G+G+YG VY K + K+ A+KQ++ T S+ E+ +L ++ H N+I L
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQK 85
Query: 71 --YAAGGDSLFLVYEYAQN---GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
+ ++L+++YA++ + H + K L + G+ Y+H
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRA----KIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
+ +HRD+K +NIL+ KIAD G +L + A +V TF Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202
Query: 182 APE-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
APE Y T D++A G + EL+T +
Sbjct: 203 APELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 48/207 (23%), Positives = 82/207 (39%), Gaps = 35/207 (16%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--------SKEFSSELKILCKV-HSNLIE 67
IG+G + V R G+ A+K + K +++ E I + H +++E
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK-------G 120
L+ + L++V+E+ L + + ++ A+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEI---VKRADAGFVYSEA-----VASHYMRQILEA 142
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
L Y H +HRDVK +LL S + K+ FG+ L S +A VGT
Sbjct: 143 LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA---GGRVGT 196
Query: 178 FGYLAPEYVRDGCVTTKSDVYAFGVVL 204
++APE V+ DV+ GV+L
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-19
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 40/218 (18%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE---FSS--ELKILCKV-HSNLIELIG 70
KIGQG++G V+ + R G+ A+K++ KE ++ E+KIL + H N++ LI
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 71 --------YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLE 122
Y S++LV+++ ++ L+ L VK + GL
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLL----NGLY 138
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAA--SRIVGTFGY 180
YIH+ +HRD+K +N+L+ + K+ADFGL + + +R+V T Y
Sbjct: 139 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWY 194
Query: 181 LAPE-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
PE Y D++ G ++ E+ T
Sbjct: 195 RPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 47/200 (23%), Positives = 83/200 (41%), Gaps = 29/200 (14%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIK-----QMKNTKSKEFSSELKILCKV-HSNLIELIG 70
++G+G++ V + G A K ++ ++ E +I K+ H N++ L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK---KPLAWTTRVQIALDAAKGLEYIHQY 127
+LV++ G L + + + + + QI + + Y H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQ-QIL----ESIAYCHSN 147
Query: 128 TKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
VHR++K N+LL S K+ADFGL + S GT GYL+PE
Sbjct: 148 G---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW----HGFAGTPGYLSPE 200
Query: 185 YVRDGCVTTKSDVYAFGVVL 204
++ + D++A GV+L
Sbjct: 201 VLKKDPYSKPVDIWACGVIL 220
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-19
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 41/212 (19%)
Query: 19 KIGQGSYGSVYLGKLR-GKNAAIKQMKNTKSKE---FSS--ELKILCKV-HSNLIELIGY 71
K+G+G+YG VY K G+ A+K+++ E ++ E+ +L ++ H N++ LI
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPY 131
L LV+E+ + L L + K L + +G+ + HQ+
Sbjct: 88 IHSERCLTLVFEFMEKD-LKKVLD----ENKTGLQDSQIKIYLYQLLRGVAHCHQH---R 139
Query: 132 YVHRDVKTSNILLDSNFRAKIADFGL-----VKLLEHSPEIAAAASRIVGTFGYLAPE-- 184
+HRD+K N+L++S+ K+ADFGL + + ++ E V T Y AP+
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE--------VVTLWYRAPDVL 191
Query: 185 -----YVRDGCVTTKSDVYAFGVVLMELITGQ 211
Y +T D+++ G + E+ITG+
Sbjct: 192 MGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 46/200 (23%), Positives = 81/200 (40%), Gaps = 28/200 (14%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFS-----SELKILCKV-HSNLIELIG 70
++G+G++ V G+ A + K E +I + H N++ L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK---KPLAWTTRVQIALDAAKGLEYIHQY 127
+ +L+++ G L + + + + + QI + + + HQ
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQ-QIL----EAVLHCHQM 129
Query: 128 TKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
VHR++K N+LL S K+ADFGL +E + GT GYL+PE
Sbjct: 130 G---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW---FGFAGTPGYLSPE 183
Query: 185 YVRDGCVTTKSDVYAFGVVL 204
+R D++A GV+L
Sbjct: 184 VLRKDPYGKPVDLWACGVIL 203
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-19
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 48/218 (22%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS----ELKIL--CKVHSNLIELIG 70
K+G G+Y +VY G + G A+K++K + S E+ ++ K H N++ L
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK-HENIVRLYD 70
Query: 71 YAAGGDSLFLVYEYAQN---GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
+ L LV+E+ N + + L +GL + H+
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDSR---TVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGL-------VKLLEHSPEIAAAASRIVGTFGY 180
+HRD+K N+L++ + K+ DFGL V +V T Y
Sbjct: 128 ---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---------EVV-TLWY 174
Query: 181 LAPE-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
AP+ Y +T D+++ G +L E+ITG+
Sbjct: 175 RAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-19
Identities = 59/201 (29%), Positives = 87/201 (43%), Gaps = 19/201 (9%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKN---TKSKEFSS---ELKILCKV-HSNLIELIG 70
+G+G++G V L K + A+K +K E + E ++L H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
D L V EYA G L HL + A +I L+Y+H ++
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVS----ALDYLH--SEK 268
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
V+RD+K N++LD + KI DFGL K + A GT YLAPE + D
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 191 VTTKSDVYAFGVVLMELITGQ 211
D + GVV+ E++ G+
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGR 346
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 5e-19
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 48/219 (21%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-FSS----ELKILCKV-HSNLIELIG 70
KIG+G+YG+V+ K R + A+K+++ E S E+ +L ++ H N++ L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 71 YAAGGDSLFLVYEYAQN---GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L LV+E+ + K + Q+ KGL + H
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF----QLL----KGLGFCHSR 120
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGL-----VKLLEHSPEIAAAASRIVGTFGYLA 182
+HRD+K N+L++ N K+A+FGL + + +S E V T Y
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE--------VVTLWYRP 169
Query: 183 PE-------YVRDGCVTTKSDVYAFGVVLMELITGQQAL 214
P+ Y +T D+++ G + EL + L
Sbjct: 170 PDVLFGAKLY------STSIDMWSAGCIFAELANAGRPL 202
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 6e-19
Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 65/239 (27%)
Query: 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS--------EL 55
+V+ + +G+G + +VY + + + AIK++K E E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 56 KILCKV-HSNLIELIGYAAGGDSLFLVYEY----------AQNGALSDHLHWPSVKGKKP 104
K+L ++ H N+I L+ ++ LV+++ + L+ +K
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH----IK---- 115
Query: 105 LAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL-----VK 159
A+ + +GLEY+HQ+ + +HRD+K +N+LLD N K+ADFGL
Sbjct: 116 -AYM--LMTL----QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165
Query: 160 LLEHSPEIAAAASRIVGTFGYLAPE-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
++ + V T Y APE Y D++A G +L EL+
Sbjct: 166 NRAYTHQ--------VVTRWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 7e-19
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 47/215 (21%)
Query: 19 KIGQGSYGSVYLGKLR-GKNAAIKQMKNTKSKE-FSS----ELKIL--CKVHSNLIELIG 70
KIG+G+YG VY + G+ A+K+++ K E S E+ IL K HSN+++L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYD 67
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
L LV+E+ L L + A + +Q+ G+ Y H
Sbjct: 68 VIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLL----NGIAYCHDR--- 119
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGL-------VKLLEHSPEIAAAASRIVGTFGYLAP 183
+HRD+K N+L++ KIADFGL V+ H IV T Y AP
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---------EIV-TLWYRAP 169
Query: 184 E-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
+ Y +T D+++ G + E++ G
Sbjct: 170 DVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-19
Identities = 49/225 (21%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 10 ATSNFSTSLK---------IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE---FSSEL 55
+T +FS + +G+G++ V + A+K ++ E+
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 56 KIL--CKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTR--V 111
++L C+ H N++ELI + D +LV+E + G++ H+H + +
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH---KRRH----FNELEAS 114
Query: 112 QIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL---DSNFRAKIADFGLVKLLEHSPEIA 168
+ D A L+++H HRD+K NIL + KI DF L ++ + + +
Sbjct: 115 VVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 169 AAASR----IVGTFGYLAPEYVRDGCVTTKS-----DVYAFGVVL 204
++ G+ Y+APE V D+++ GV+L
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-19
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 45/212 (21%)
Query: 20 IGQGSYGSVYLGK--LRGKNAAIKQMKNTKSKEFSS------ELKILCKV-HSNLIELIG 70
+G+GS+G V L + A+K + K+ E+ L + H ++I+L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK--KPLAWTTRVQIALDAAKGLEYIHQYT 128
+ +V EYA G L D++ K + + QI +EY H++
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYI---VEKKRMTEDEGRRFFQQII----CAIEYCHRHK 128
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLV------KLLEHSPEIAAAASRIVGTFGYLA 182
VHRD+K N+LLD N KIADFGL L+ S G+ Y A
Sbjct: 129 ---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS----------CGSPNYAA 175
Query: 183 PEYVR----DGCVTTKSDVYAFGVVLMELITG 210
PE + G + DV++ G+VL ++ G
Sbjct: 176 PEVINGKLYAG---PEVDVWSCGIVLYVMLVG 204
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 48/196 (24%), Positives = 80/196 (40%), Gaps = 24/196 (12%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAG 74
IG GSY + A+K + + ++ + E++IL + H N+I L
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKII-DKSKRDPTEEIEILLRYGQHPNIITLKDVYDD 87
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTR--VQIALDAAKGLEYIHQYTKPYY 132
G +++V E + G L D + + ++ R + K +EY+H
Sbjct: 88 GKYVYVVTELMKGGELLDKIL---RQKF----FSEREASAVLFTITKTVEYLHAQG---V 137
Query: 133 VHRDVKTSNILLDSNFRA----KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
VHRD+K SNIL +I DFG K L + T ++APE +
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL---LMTPCYTANFVAPEVLER 194
Query: 189 GCVTTKSDVYAFGVVL 204
D+++ GV+L
Sbjct: 195 QGYDAACDIWSLGVLL 210
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKNT---KSKE---FSSELKILCKVHSNLIELIGY 71
IG+G++G V L + + A+K + K + F E I+ +S + + Y
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 72 A-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
A L++V EY G L + + P W R A + L+ IH
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMS----NYDVPEKWA-RFYTA-EVVLALDAIHSMG-- 188
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR--- 187
++HRDVK N+LLD + K+ADFG + + E VGT Y++PE ++
Sbjct: 189 -FIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 188 -DGCVTTKSDVYAFGVVLMELITGQ 211
DG + D ++ GV L E++ G
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 41/199 (20%), Positives = 77/199 (38%), Gaps = 27/199 (13%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGY--- 71
+G G G V + + A+K ++ + E+++ + +++ ++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYEN 126
Query: 72 -AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTR--VQIALDAAKGLEYIHQYT 128
AG L +V E G L + + A+T R +I + ++Y+H
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQ-----DRGDQAFTEREASEIMKSIGEAIQYLHSIN 181
Query: 129 KPYYVHRDVKTSNILLDSNFRA---KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
HRDVK N+L S K+ DFG K + + T Y+APE
Sbjct: 182 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL----TTPCYTPYYVAPEV 234
Query: 186 VRDGCVTTKSDVYAFGVVL 204
+ D+++ GV++
Sbjct: 235 LGPEKYDKSCDMWSLGVIM 253
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 46/217 (21%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-FSS----ELKIL--CKVHSNLIELI 69
K+G+G+YG VY + AIK+++ +E E+ +L + H N+IEL
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIELK 99
Query: 70 GYAAGGDSLFLVYEYAQN---GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
L L++EYA+N + + K L Q+ G+ + H
Sbjct: 100 SVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLY-----QLI----NGVNFCHS 150
Query: 127 YTKPYYVHRDVKTSNILLDSNFRA-----KIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
+HRD+K N+LL + + KI DFGL + I I+ T Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR--AFGIPIRQFTHEII-TLWYR 204
Query: 182 APE-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
PE Y +T D+++ + E++
Sbjct: 205 PPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 40/212 (18%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMK-----------NTKSKEFSSELKILCKV-HSNL 65
IG+GS+G V + + K A+K M N EL+I+ + H L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-----ELQIMQGLEHPFL 77
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV---QIALDAAKGLE 122
+ L + +F+V + G L HL T ++ ++ + L+
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEE-TVKLFICELVM----ALD 129
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
Y+ +HRD+K NILLD + I DF + +L + + GT Y+A
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYMA 182
Query: 183 PEYVRDGCVT--TKS-DVYAFGVVLMELITGQ 211
PE + + D ++ GV EL+ G+
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-18
Identities = 54/204 (26%), Positives = 84/204 (41%), Gaps = 29/204 (14%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKNT---KSKEFS---SELKILCKV-HSNLIELIG 70
+G GS+G V L K + A+K + K K+ +E +IL V L++L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTR---VQIALDAAKGLEYIHQY 127
+L++V EY G + HL G+ R QI L EY+H
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEP-HARFYAAQIVL----TFEYLHSL 160
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
++RD+K N+L+D ++ DFG K + + GT LAPE +
Sbjct: 161 D---LIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEALAPEIIL 211
Query: 188 DGCVTTKSDVYAFGVVLMELITGQ 211
D +A GV++ E+ G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 54/268 (20%), Positives = 89/268 (33%), Gaps = 83/268 (30%)
Query: 19 KIGQGSYGSVYLGKLRGKN-------AAIKQMKNTKS----KEFSSELKILCKV--HSNL 65
+G+G++G V G + A+K +K + + SELKIL + H N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 66 IELIGY-AAGGDSLFLVYEYAQNGALSDHL--HWPSVKGKKPLAWTTR------------ 110
+ L+G G L ++ E+ + G LS +L K R
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 111 --------------VQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL------------ 144
K L + + P +++D T L+
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 145 ------------------DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL----- 181
KI DFGL + + P+ + L
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLPLKWM 262
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMELIT 209
APE + D T +SDV++FGV+L E+ +
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-18
Identities = 55/204 (26%), Positives = 84/204 (41%), Gaps = 30/204 (14%)
Query: 20 IGQGSYGSVYLG--KLRGKNAAIKQM-KNTKSKE-FSSELKILCKV-HSNLIELIGYAAG 74
IG G++G L KL + A+K + + E E+ + H N++
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGK--KPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
L ++ EYA G L + + G+ + A Q+ G+ Y H
Sbjct: 88 PTHLAIIMEYASGGELYERI---CNAGRFSEDEARFFFQQLLS----GVSYCHSM---QI 137
Query: 133 VHRDVKTSNILLDSNF--RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR--- 187
HRD+K N LLD + R KI DFG K + + VGT Y+APE +
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVLLRQE 193
Query: 188 -DGCVTTKSDVYAFGVVLMELITG 210
DG +DV++ GV L ++ G
Sbjct: 194 YDG---KIADVWSCGVTLYVMLVG 214
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 1e-17
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 29/204 (14%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKNT---KSKEFS---SELKILCKV-HSNLIELIG 70
+G GS+G V+L + R A+K +K + K+ E +L V H +I + G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV---QIALDAAKGLEYIHQY 127
+F++ +Y + G L L + P + ++ L LEY+H
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPNP-VAKFYAAEVCL----ALEYLHSK 125
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
++RD+K NILLD N KI DFG K + + GT Y+APE V
Sbjct: 126 D---IIYRDLKPENILLDKNGHIKITDFGFAK------YVPDVTYTLCGTPDYIAPEVVS 176
Query: 188 DGCVTTKSDVYAFGVVLMELITGQ 211
D ++FG+++ E++ G
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGY 200
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 58/203 (28%), Positives = 85/203 (41%), Gaps = 24/203 (11%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKN---TKSKEFSS---ELKILCKV-HSNLIELIG 70
+G+G++G V L + + A+K ++ E + E ++L H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTT--RVQIALDAAKGLEYIHQYT 128
D L V EYA G L HL + +I LEY+H
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVS----ALEYLHSRD 125
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
V+RD+K N++LD + KI DFGL K E + A GT YLAPE + D
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISD-GATMKTFCGTPEYLAPEVLED 179
Query: 189 GCVTTKSDVYAFGVVLMELITGQ 211
D + GVV+ E++ G+
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-17
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 32/209 (15%)
Query: 20 IGQGSYGSVYLG-KLRGKNA----AIKQMKN----TKSKEFS---SELKILCKV-HSNLI 66
+G+G YG V+ K+ G N A+K +K +K+ + +E IL +V H ++
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 67 ELIGYA-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV---QIALDAAKGLE 122
+LI YA G L+L+ EY G L L + + T +I++ L
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISM----ALG 135
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
++HQ ++RD+K NI+L+ K+ DFGL K E + + GT Y+A
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHT-FCGTIEYMA 189
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
PE + D ++ G ++ +++TG
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKNTKSKEF----------SSELKILCKVHSN--L 65
+G+GS+G V L + +G + A+K +K K+ E ++L L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILK----KDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
+L D L+ V EY G L H+ + K+P A +IA+ GL ++
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIAI----GLFFLQ 459
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
++RD+K N++LDS KIADFG+ K + GT Y+APE
Sbjct: 460 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTFCGTPDYIAPEI 513
Query: 186 VRDGCVTTKSDVYAFGVVLMELITGQ 211
+ D +AFGV+L E++ GQ
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 30/207 (14%)
Query: 20 IGQGSYGSVYL-----GKLRGKNAAIKQMK-----NTKSKEFSSELKILCKV-HSNLIEL 68
+GQGS+G V+L G + A+K +K E IL +V H +++L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 69 IGYA-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV---QIALDAAKGLEYI 124
YA L+L+ ++ + G L L K + ++AL L+++
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELAL----ALDHL 142
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
H ++RD+K NILLD K+ DFGL K E A S GT Y+APE
Sbjct: 143 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYS-FCGTVEYMAPE 196
Query: 185 YVRDGCVTTKSDVYAFGVVLMELITGQ 211
V T +D ++FGV++ E++TG
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 43/219 (19%)
Query: 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS----ELKIL--CKVHSN 64
+ K+G+G+Y +VY GK + A+K+++ + E+ +L K H+N
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HAN 61
Query: 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYI 124
++ L SL LV+EY L +L Q+ +GL Y
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKLFLFQLL----RGLAYC 116
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL-----VKLLEHSPEIAAAASRIVGTFG 179
H+ +HRD+K N+L++ K+ADFGL + + E V T
Sbjct: 117 HR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--------VVTLW 165
Query: 180 YLAPE-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
Y P+ Y +T+ D++ G + E+ TG+
Sbjct: 166 YRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 34/212 (16%)
Query: 20 IGQGSYGSVYLG-KLRGKNA----AIKQMK------NTKSKEFS-SELKILCKVHSN--L 65
+G G+YG V+L K+ G + A+K +K K+ E + +E ++L + + L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 66 IELIGYA-AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV---QIALDAAKGL 121
+ L YA L L+ +Y G L HL S + + ++ +I L L
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHL---SQRERFTEH-EVQIYVGEIVL----AL 172
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
E++H+ ++RD+K NILLDSN + DFGL K E + A GT Y+
Sbjct: 173 EHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYDFCGTIEYM 227
Query: 182 APEYVRDG-CVTTKS-DVYAFGVVLMELITGQ 211
AP+ VR G K+ D ++ GV++ EL+TG
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-17
Identities = 20/211 (9%), Positives = 49/211 (23%), Gaps = 49/211 (23%)
Query: 19 KIGQGSYGSVYLGK--LRGKNAAIKQMK------NTKSKEFSSELKILCKV-HSNLIELI 69
G + + A+ + + +E S L ++ + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
+V E+ + G+L + + ++ A + H+
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVAD-------TSPSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
S + ++ G V L +
Sbjct: 150 --VALSIDHPSRVR--------VSIDGDVVL---------------AYPATMPD------ 178
Query: 190 CVTTKSDVYAFGVVLMELITGQQALSRDANP 220
+ D+ G L L+ + L
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLPEAGVR 208
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 53/229 (23%), Positives = 90/229 (39%), Gaps = 66/229 (28%)
Query: 19 KIGQGSYGSVYLG---KLRGKNAAIKQMKNTKSKE-FSS----ELKIL----CKVHSNLI 66
+IG+G+YG V+ K G+ A+K+++ +E E+ +L H N++
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 67 ELI-----GYAAGGDSLFLVYEYAQNGALSDH-LHWPSVKGKKPLAWTTRVQIALDAAK- 119
L L LV+E+ D L L + + K
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHV------DQDL-------TTYLDKVPEPGVPTETIKD 124
Query: 120 -------GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL----LEHSPEIA 168
GL+++H + VHRD+K NIL+ S+ + K+ADFGL ++ + +
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-- 179
Query: 169 AAASRIVGTFGYLAPE------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
V T Y APE Y T D+++ G + E+ +
Sbjct: 180 ------VVTLWYRAPEVLLQSSY------ATPVDLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 52/231 (22%), Positives = 86/231 (37%), Gaps = 68/231 (29%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS--------ELKIL----CKVHSN 64
+IG G+YG+VY + G A+K ++ E+ +L H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 65 LIELI-----GYAAGGDSLFLVYEYAQNGALSDH-LHWPSVKGKKPLAWTTRVQIALDAA 118
++ L+ + LV+E+ D L + L + +
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHV------DQDL-------RTYLDKAPPPGLPAETI 122
Query: 119 K--------GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL----LEHSPE 166
K GL+++H VHRD+K NIL+ S K+ADFGL ++ + +P
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV 179
Query: 167 IAAAASRIVGTFGYLAPE------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
V T Y APE Y T D+++ G + E+ +
Sbjct: 180 --------VVTLWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRRK 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-17
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKN---TKSKEFSS---ELKILCKVHSN--LIELI 69
+G+GS+G V+L + + N AIK +K + E ++L + L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM- 83
Query: 70 GYAA--GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
+ ++LF V EY G L H+ K A +I L GL+++H
Sbjct: 84 -FCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIIL----GLQFLHSK 137
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
V+RD+K NILLD + KIADFG+ K E+ A + GT Y+APE +
Sbjct: 138 G---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNT-FCGTPDYIAPEILL 191
Query: 188 DGCVTTKSDVYAFGVVLMELITGQ 211
D ++FGV+L E++ GQ
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-17
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKN---TKSKEFSS---ELKILCKVHSN--LIELI 69
IG+GSY V L +L+ + A+K +K ++ E + + ++ L+ L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTT--RVQIALDAAKGLEYIHQY 127
LF V EY G L H+ + K P +I+L L Y+H+
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISL----ALNYLHER 129
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
++RD+K N+LLDS K+ D+G+ K E S GT Y+APE +R
Sbjct: 130 G---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRP-GDTTSTFCGTPNYIAPEILR 183
Query: 188 DGCVTTKSDVYAFGVVLMELITGQ 211
D +A GV++ E++ G+
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-17
Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 43/211 (20%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIK-----------QMKNTKSKEFSSELKILCKV-HSN 64
+G G+ G V L + K AIK + + +E++IL K+ H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 65 LIELIG-YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPL----AWTTRVQIALDAAK 119
+I++ + A + ++V E + G L D V G K L Q+
Sbjct: 77 IIKIKNFFDA--EDYYIVLELMEGGELFDK-----VVGNKRLKEATCKLYFYQM----LL 125
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
++Y+H+ +HRD+K N+LL S + KI DFG K+L + + + G
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM----RTLCG 178
Query: 177 TFGYLAPEYVRDGCV---TTKSDVYAFGVVL 204
T YLAPE + D ++ GV+L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-17
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 37/210 (17%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKNTKSKEF----------SSELKILCKVHSN--L 65
+G+GS+G V L +++ A+K +K K+ +E +IL ++ L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLK----KDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 66 IELIGYAA--GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTT--RVQIALDAAKGL 121
+L + D LF V E+ G L H+ + A +I L
Sbjct: 87 TQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIIS----AL 137
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
++H ++RD+K N+LLD K+ADFG+ K E A+ GT Y+
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTAT-FCGTPDYI 191
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
APE +++ D +A GV+L E++ G
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKNTKSKEF----------SSELKILCKVHSN--L 65
+G+GS+G V L + +G + A+K +K K+ E ++L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILK----KDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTT--RVQIALDAAKGLEY 123
+L D L+ V EY G L H+ G+ +IA+ GL +
Sbjct: 84 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAI----GLFF 136
Query: 124 IHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAP 183
+ ++RD+K N++LDS KIADFG+ K + GT Y+AP
Sbjct: 137 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTFCGTPDYIAP 190
Query: 184 EYVRDGCVTTKSDVYAFGVVLMELITGQ 211
E + D +AFGV+L E++ GQ
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKNTKSKEF----------SSELKILCKVHSN--L 65
IG+GSY V L +L+ + A++ +K KE +E + + ++ L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVK----KELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
+ L LF V EY G L H+ K + A +I+L L Y+H
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISL----ALNYLH 170
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
+ ++RD+K N+LLDS K+ D+G+ K E S GT Y+APE
Sbjct: 171 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRP-GDTTSTFCGTPNYIAPEI 224
Query: 186 VRDGCVTTKSDVYAFGVVLMELITGQ 211
+R D +A GV++ E++ G+
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 62/207 (29%), Positives = 90/207 (43%), Gaps = 31/207 (14%)
Query: 20 IGQGSYGSVYLGKLRGKNA--AIKQMKN---TKSKEFSS---ELKILCKVHSN--LIELI 69
IG+GS+G V L + + + A+K ++ K KE E +L K + L+ L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 104
Query: 70 GYAA--GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTR---VQIALDAAKGLEYI 124
+ + D L+ V +Y G L HL + + L R +IA L Y+
Sbjct: 105 -HFSFQTADKLYFVLDYINGGELFYHLQ----RERCFLEPRARFYAAEIAS----ALGYL 155
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
H V+RD+K NILLDS + DFGL K + E + S GT YLAPE
Sbjct: 156 HSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE---NIEHNSTTSTFCGTPEYLAPE 209
Query: 185 YVRDGCVTTKSDVYAFGVVLMELITGQ 211
+ D + G VL E++ G
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 23/204 (11%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSSELKILC--KVHSNLIEL--IGYA 72
K+G+G Y V+ + +K +K K K+ E+KIL + N+I L I
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD 102
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
+ LV+E+ N + + + +I K L+Y H
Sbjct: 103 PVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY----EIL----KALDYCHSMG---I 151
Query: 133 VHRDVKTSNILLDSNFRA-KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV 191
+HRDVK N+++D R ++ D+GL + E + V + + PE + D +
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLVDYQM 207
Query: 192 TTKS-DVYAFGVVLMELITGQQAL 214
S D+++ G +L +I ++
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 55/250 (22%), Positives = 88/250 (35%), Gaps = 65/250 (26%)
Query: 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS-ELKILCKV-HSNLI 66
+ +S +G GS+G V GK A+K K + + + EL I+ + H N+I
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK--KVLQDPRYKNRELDIMKVLDHVNII 63
Query: 67 EL--IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAW---------------TT 109
+L Y G + + L + + K + T
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 110 RVQIALDAAK-------------------GLEYIHQYTKPYYVHRDVKTSNILLDSN-FR 149
++ + + +IH HRD+K N+L++S
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNT 180
Query: 150 AKIADFGLVK-LLEHSPEIAAAASRIVGTFGYLAPE-------YVRDGCVTTKSDVYAFG 201
K+ DFG K L+ P +A SR Y APE Y T D+++ G
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY------TPSIDLWSIG 229
Query: 202 VVLMELITGQ 211
V ELI G+
Sbjct: 230 CVFGELILGK 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 53/231 (22%), Positives = 78/231 (33%), Gaps = 66/231 (28%)
Query: 19 KIGQGSYGSVYLGK-LRGKNAAIKQMKNTKSKEFSS--------------ELKILCKV-H 62
I GSYG+V G G AIK++ NT S + E+++L H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 63 SNLIELI-----GYAAGGDSLFLVYEY----------AQNGALSDHLHWPSVKGKKPLAW 107
N++ L L+LV E Q +S H + +
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ-H------IQYFMY 141
Query: 108 TTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167
I GL +H+ VHRD+ NILL N I DF L +
Sbjct: 142 ----HIL----LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 168 AAAASRIVGTFGYLAPE-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
+ V Y APE + T D+++ G V+ E+ +
Sbjct: 191 ----THYVTHRWYRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 5e-14
Identities = 49/207 (23%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 20 IGQGSYGSVY--LGKLRGKNAAIKQMKNTKSKEFSS-----ELKILCKV-HSNLIELI-- 69
IG G+ G V + +N AIK++ + + EL ++ V H N+I L+
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 70 ----GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL-DAAKGLEYI 124
++LV E ++ L + L R+ L G++++
Sbjct: 130 FTPQKTLEEFQDVYLVMELMD----AN-LCQVI---QMEL-DHERMSYLLYQMLCGIKHL 180
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
H +HRD+K SNI++ S+ KI DFGL + S + + V T Y APE
Sbjct: 181 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYYRAPE 233
Query: 185 YVRDGCVTTKSDVYAFGVVLMELITGQ 211
+ D+++ G ++ E++ +
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 49/218 (22%)
Query: 20 IGQGSYGSVY--LGKLRGKNAAIKQMKNTKSKEFSS----ELKILCKV-HSNLIEL--IG 70
IG+G+YG V L AIK++ + + + E+KIL + H N+I + I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 71 YAAGGDS---LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV-------QIALDAAKG 120
A + +++V + + +D L+ + + L + QI +G
Sbjct: 95 RAPTIEQMKDVYIVQDLME----TD-LY--KLLKTQHL---SNDHICYFLYQIL----RG 140
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
L+YIH +HRD+K SN+LL++ KI DFGL ++ + + + V T Y
Sbjct: 141 LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 181 LAPE-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
APE Y T D+++ G +L E+++ +
Sbjct: 198 RAPEIMLNSKGY------TKSIDIWSVGCILAEMLSNR 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 7e-14
Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 11 TSNFSTSLKIGQGSYGSVY--LGKLRGKNAAIKQMKNTKSKEFSS-----ELKILCKV-H 62
+ IG G+ G V + +N AIK++ + + EL ++ V H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 63 SNLIELI------GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIAL- 115
N+I L+ +++V E ++ L V + L R+ L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD----AN-LC--QVI-QMEL-DHERMSYLLY 134
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIV 175
G++++H +HRD+K SNI++ S+ KI DFGL + S + + V
Sbjct: 135 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYV 187
Query: 176 GTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
T Y APE + D+++ G ++ E+I G
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-14
Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 44/220 (20%)
Query: 19 KIGQGSYGSVY--LGKLRGKNAAIKQMKNTKSKEFSS----ELKILCKV-HSNLIEL--I 69
+G+G+YG V K G+ AIK+++ F+ E+KIL H N+I + I
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 70 GYAAGGDS---LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQ-IALDAAKGLEYIH 125
++ ++++ E Q +D LH V + L+ +Q + ++ +H
Sbjct: 78 QRPDSFENFNEVYIIQELMQ----TD-LH--RVISTQMLS-DDHIQYFIYQTLRAVKVLH 129
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI-------VGTF 178
+HRD+K SN+L++SN K+ DFGL ++++ S + + V T
Sbjct: 130 GSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 179 GYLAPE-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
Y APE Y + DV++ G +L EL +
Sbjct: 187 WYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRR 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 55/241 (22%), Positives = 98/241 (40%), Gaps = 76/241 (31%)
Query: 19 KIGQGSYGSVY--LGKLRGKNAAIKQMKNTKSKEFSS---------ELKILC--KVHSNL 65
K+G+G+YG V+ + + G+ A+K++ + F + E+ IL H N+
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDA----FQNSTDAQRTFREIMILTELSGHENI 71
Query: 66 IEL--IGYAAGGDSLFLVYEYAQ--------NGALSDHLHWPSVKGKKPLAWTTRVQIAL 115
+ L + A ++LV++Y + L H K+ + + Q+
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV-H------KQYVVY----QLI- 119
Query: 116 DAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI- 174
K ++Y+H +HRD+K SNILL++ K+ADFGL + + +
Sbjct: 120 ---KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 175 -----------------VGTFGYLAPE-------YVRDGCVTTKSDVYAFGVVLMELITG 210
V T Y APE Y T D+++ G +L E++ G
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEILCG 227
Query: 211 Q 211
+
Sbjct: 228 K 228
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 56/233 (24%), Positives = 87/233 (37%), Gaps = 52/233 (22%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSS-----ELKILCKV-HSNLIEL-- 68
IG+GSYG VYL K KN AIK++ E+ IL ++ +I L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 69 IGYAAGGDS---LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQ-IALDAAKGLEYI 124
+ L++V E A SD L K L ++ I + G +I
Sbjct: 93 LIIPDDLLKFDELYIVLEIAD----SD-LK-KLFKTPIFLT-EEHIKTILYNLLLGENFI 145
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAP- 183
H+ +HRD+K +N LL+ + K+ DFGL + + +
Sbjct: 146 HESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 184 -------EYVRDGCVT---------------TKS-DVYAFGVVLMELITGQQA 213
+V VT TKS D+++ G + EL+ Q+
Sbjct: 203 NLKKQLTSHV----VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 49/254 (19%), Positives = 90/254 (35%), Gaps = 73/254 (28%)
Query: 19 KIGQGSYGSVYLG--KLRGKNAAIKQMKNTKSKEFSS-----ELKILCKV-HSNLIELI- 69
IG GSYG V KL + AIK++ E+ IL ++ H ++++++
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 70 ----GYAAGGDSLFLVYEYAQ---------NGALSDHLHWPSVKGKKPLAWTTRVQIALD 116
D L++V E A L++ LH K L + +
Sbjct: 120 IVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTE-LH------IKTLLY----NLL-- 166
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
G++Y+H +HRD+K +N L++ + K+ DFGL + +++ +
Sbjct: 167 --VGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 177 TFGYLAP-------------EYVRDGCVT---------------TKS-DVYAFGVVLMEL 207
+V VT T++ DV++ G + EL
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHV----VTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
Query: 208 ITGQQALSRDANPG 221
+ +
Sbjct: 278 LNMIKENVAYHADR 291
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-13
Identities = 36/202 (17%), Positives = 69/202 (34%), Gaps = 54/202 (26%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGY--- 71
+G G G V + + A+K ++ + E+++ + +++ ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYEN 82
Query: 72 -AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPL-----AWTTRVQIALDAAKGLEYIH 125
AG L +V E G L + +G + + + I + ++Y+H
Sbjct: 83 LYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMK-SIG----EAIQYLH 134
Query: 126 QYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
HRDVK N+L S N K+ DFG A
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFG------------------------FA 167
Query: 183 PEYVRDGCVTTKSDVYAFGVVL 204
E D+++ GV++
Sbjct: 168 KE-TTGEKYDKSCDMWSLGVIM 188
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-13
Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 46/222 (20%)
Query: 19 KIGQGSYGSVY--LGKLRGKNAAIKQM---KNTKSKEFSSELKILCKV-HSNLIELI--- 69
+G G G V+ + K AIK++ K E+KI+ ++ H N++++
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 70 -----------GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQ-IALDA 117
G +S+++V EY + +D L +V + PL +
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LA--NVLEQGPLL-EEHARLFMYQL 129
Query: 118 AKGLEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
+GL+YIH +HRD+K +N+ +++ + KI DFGL ++++ S +
Sbjct: 130 LRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 177 TFGYLAPE-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
T Y +P Y T D++A G + E++TG+
Sbjct: 187 TKWYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 43/213 (20%)
Query: 20 IGQGSYGSVY--LGKLRGKNAAIKQMKNTKSKEFSS-----ELKILCKV-HSNLIEL--I 69
+G G+YG+V + G AIK++ E + EL++L + H N+I L +
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 70 GYAAGGDSLF----LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
F LV + +D L + + L + KGL YIH
Sbjct: 93 FTPDETLDDFTDFYLVMPFMG----TD-LG--KLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE- 184
+HRD+K N+ ++ + KI DFGL + + + V T Y APE
Sbjct: 146 AAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEV 196
Query: 185 ------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
Y T D+++ G ++ E+ITG+
Sbjct: 197 ILNWMRY------TQTVDIWSVGCIMAEMITGK 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 50/225 (22%)
Query: 11 TSNFSTSLKIGQGSYGSVY--LGKLRGKNAAIKQMKNTKSKEFSS-----ELKILCKV-H 62
+ + +G G+YGSV + K G+ AIK++ E + EL +L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 63 SNLIELI------GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRV---QI 113
N+I L+ +LV + Q +D L + G K + Q+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQ--KIMGLKFSEEKIQYLVYQM 135
Query: 114 ALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR 173
KGL+YIH VHRD+K N+ ++ + KI DFGL + A +
Sbjct: 136 L----KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR------HADAEMTG 182
Query: 174 IVGTFGYLAPE-------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
V T Y APE Y D+++ G ++ E++TG+
Sbjct: 183 YVVTRWYRAPEVILSWMHY------NQTVDIWSVGCIMAEMLTGK 221
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 6e-12
Identities = 42/274 (15%), Positives = 65/274 (23%), Gaps = 73/274 (26%)
Query: 10 ATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQM-----------KNTKSKEFSSELKIL 58
T KIG+G +G V+ AIK + +E E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 59 ----------CKVHSNLIELIG------------------------------YAAGGDSL 78
C I L D L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVK 138
F+V E+ G + + K + T I L + HRD+
Sbjct: 138 FIVLEFEFGGIDLEQMR------TKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLH 189
Query: 139 TSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAP--EYVRDGCVTTKSD 196
N+LL K+ K + + G +Y
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSST------------IPSCGLQVSIIDYTLSRLERDGIV 237
Query: 197 VYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230
V+ + +L TG D + +R
Sbjct: 238 VFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRW 271
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 45/214 (21%)
Query: 20 IGQGSYGSVY--LGKLRGKNAAIKQMKNTKSKEFSS-----ELKILCKV-HSNLIEL--I 69
+G G+YGSV G A+K++ + EL++L + H N+I L +
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 70 GYAAGGDSLF----LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQ-IALDAAKGLEYI 124
A F LV +D L+ ++ + L VQ + +GL+YI
Sbjct: 97 FTPARSLEEFNDVYLVTHLMG----AD-LN--NIVKCQKLT-DDHVQFLIYQILRGLKYI 148
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
H +HRD+K SN+ ++ + KI DFGL + A + V T Y APE
Sbjct: 149 HSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------HTADEMTGYVATRWYRAPE 199
Query: 185 -------YVRDGCVTTKSDVYAFGVVLMELITGQ 211
Y D+++ G ++ EL+TG+
Sbjct: 200 IMLNWMHY------NQTVDIWSVGCIMAELLTGR 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 24/167 (14%), Positives = 54/167 (32%), Gaps = 32/167 (19%)
Query: 19 KIGQGSYGSVYLG----------KLRGKNAAIK-QMKNTKSKEFSSELKILCKVHSNLIE 67
+ + G +Y + + ++K K+ + + + K
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 68 LIGYAAGGDSLFLVYEYAQNGA-------------LSDHLHWPSVKGKKPLAWTTRVQIA 114
Y+ ++ + + L L K L+ + +Q+A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV---SPKHVLSERSVLQVA 165
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKI--ADFGLVK 159
LE++H+ YVH +V NI +D ++++ A +G
Sbjct: 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 34/151 (22%), Positives = 62/151 (41%), Gaps = 18/151 (11%)
Query: 19 KIGQGSYGSVYLGK--LRGKNAAIKQMK-NTKSKEFSSELKILCKVH--SNLIELIGYAA 73
+IG+GS+G ++ G L + AIK + + + E + + + + + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
G LV + +L D L G+K + T A ++ IH+ + V
Sbjct: 77 EGLHNVLVIDL-LGPSLEDLLDL---CGRK-FSVKTVAMAAKQMLARVQSIHEKS---LV 128
Query: 134 HRDVKTSNILLDSNFRAK-----IADFGLVK 159
+RD+K N L+ + DFG+VK
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-09
Identities = 39/167 (23%), Positives = 62/167 (37%), Gaps = 35/167 (20%)
Query: 19 KIGQGSYGSVYLGK--LRGKNAAIKQMK--NTKSKEFSSELKIL----------CKVHSN 64
KIG G +G +YL + + A +K ++ SELK +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 65 LIELIG----------YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA 114
++ +G G F+V E L G +T +Q+
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMER-LGIDLQKISGQ---NGTFKK--STVLQLG 157
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKI--ADFGLVK 159
+ LEYIH+ YVH D+K +N+LL ++ AD+GL
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-09
Identities = 46/149 (30%), Positives = 65/149 (43%), Gaps = 16/149 (10%)
Query: 19 KIGQGSYGSVYLGK--LRGKNAAIKQMK-NTKSKEFSSELKILCKVH--SNLIELIGYAA 73
KIG GS+G +YLG G+ AIK TK + E KI + + + A
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
GD +V E +L D ++ S K + T + +A +EYIH ++
Sbjct: 76 EGDYNVMVMEL-LGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSKN---FI 127
Query: 134 HRDVKTSNILLDSNFRAK---IADFGLVK 159
HRDVK N L+ + I DFGL K
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 34/169 (20%), Positives = 58/169 (34%), Gaps = 36/169 (21%)
Query: 19 KIGQGSYGSVYLGKLR-------GKNAAIKQMKNTKSKEFSSELKI---LCKVHSNLIEL 68
IGQG +G +YL + +K + + +ELK K +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEP-SDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 69 IGYAAGGDSLFLVYEYAQNGA----------------LSDHLHWPSVKGKKPLAWTTRVQ 112
+ + + L K+ + T +Q
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA---NAKR-FSRKTVLQ 156
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKI--ADFGLVK 159
++L LEYIH++ YVH D+K SN+LL+ ++ D+GL
Sbjct: 157 LSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 36/213 (16%)
Query: 19 KIGQGSYGSVYLGK--LRGKNAAIKQMK-NTKSKEFSSELKILCKVH--SNLIELIGYAA 73
KIG GS+G +YLG + AIK TK + E KI + + + + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
GD LV + +L D ++ S + L+ T + +A +E++H + ++
Sbjct: 74 EGDYNVLVMDL-LGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS---FL 125
Query: 134 HRDVKTSNILLDSNFRAK---IADFGLVKL------LEHSPEIAAAASRIVGTFGY---- 180
HRD+K N L+ RA I DFGL K +H P + GT Y
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN--LTGTARYASVN 183
Query: 181 --LAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
L E R + D+ + G VLM + G
Sbjct: 184 THLGIEQSR------RDDLESLGYVLMYFLRGS 210
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-08
Identities = 35/151 (23%), Positives = 62/151 (41%), Gaps = 18/151 (11%)
Query: 19 KIGQGSYGSVYLGK--LRGKNAAIK-QMKNTKSKEFSSELKILCKVH--SNLIELIGYAA 73
KIG G++G + LGK + AIK + +++ + E + ++ + ++ +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGP 75
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
G +V E +L D + T + IA+ +EY+H +
Sbjct: 76 CGKYNAMVLEL-LGPSLEDLFDLCDRT----FSLKTVLMIAIQLISRMEYVHSKN---LI 127
Query: 134 HRDVKTSNILL--DSNFRAK---IADFGLVK 159
+RDVK N L+ N + I DF L K
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 57/319 (17%), Positives = 120/319 (37%), Gaps = 68/319 (21%)
Query: 19 KIGQGSYGSVYLGK--LRGKNAAIKQMKNTKS--KEFSSELKILCKV------------H 62
K+G G + +V+L K + + A+K ++ K + E+K+L +V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 63 SNLIELIGY----AAGGDSLFLVYEYAQNGALSDHLH-WPSVKGKKPLAWTTRVQ-IALD 116
+++++L+ + G + +V+E L ++L + + V+ I+
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIP-LIYVKQISKQ 139
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLD------SNFRAKIADFGL--VKLLEHSPEIA 168
GL+Y+H+ +H D+K N+L++ + + KIAD G ++ I
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 169 AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEH 228
+R Y +PE + +D+++ ++ ELITG D + +H
Sbjct: 198 ---TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
Query: 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSN 288
+A++ E L +L+ ++ + R
Sbjct: 250 -----------------IAQIIELLGE-----LPSYLLRNGKYTRTFFNSRGLLRNISKL 287
Query: 289 AAIRLSHILISSKEWEKME 307
L +L ++ K E
Sbjct: 288 KFWPLEDVLTEKYKFSKDE 306
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 34/209 (16%)
Query: 20 IGQGSYGSVY--LGKLRGKNAAIKQMKNTKS--KEFSSELKILCKVH-------SNLIEL 68
IG+GS+G V ++ A+K ++N K ++ + E++IL + N+I +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK-KPLAWTTRVQ-IALDAAKGLEYIHQ 126
+ + + + +E LS +L+ K K + + V+ A + L+ +H+
Sbjct: 165 LENFTFRNHICMTFEL-----LSMNLYELIKKNKFQGFS-LPLVRKFAHSILQCLDALHK 218
Query: 127 YTKPYYVHRDVKTSNILLDSNFRA--KIADFGLVKLL--EHSPEIAAAASRIVGTFGYLA 182
+H D+K NILL R+ K+ DFG I SR F Y A
Sbjct: 219 NR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ---SR----F-YRA 267
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
PE + D+++ G +L EL+TG
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 6e-06
Identities = 46/260 (17%), Positives = 83/260 (31%), Gaps = 80/260 (30%)
Query: 19 KIGQGSYGSVYLGK--LRGKNAAIKQMKNTKS--KEFSSELKILCKVHSNLIELIGYA-- 72
K+G G + +V+L K A+K +K+ + + E+++L V ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 73 -----------AGGDSLFLVYEYAQNGALSDHLHWPSVKG-KKPLAWTTRVQIALDAAKG 120
G + +V+E + L + + +G P Q+ G
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQ----G 158
Query: 121 LEYIHQYTKPYYVHRDVKTSNILL------------------------------------ 144
L+Y+H TK +H D+K NILL
Sbjct: 159 LDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 145 -------------DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV 191
+ KIAD G + + + T Y + E +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF------TEDIQTRQYRSLEVLIGSGY 270
Query: 192 TTKSDVYAFGVVLMELITGQ 211
T +D+++ + EL TG
Sbjct: 271 NTPADIWSTACMAFELATGD 290
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 1e-04
Identities = 63/377 (16%), Positives = 112/377 (29%), Gaps = 106/377 (28%)
Query: 3 SYNEVRDATSN----FS----------TSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNT- 46
Y E RD N F+ L+ L +LR KN I + +
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQA--------LLELRPAKNVLIDGVLGSG 162
Query: 47 KS---KEFSSELKILCKVHSNLIEL-IGYAAGGDSLF-----LVYEYAQNG-ALSDHLHW 96
K+ + K+ CK+ + L + +++ L+Y+ N + SDH
Sbjct: 163 KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN 222
Query: 97 PSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKI---- 152
+ R+ + L Y V +V+ + N KI
Sbjct: 223 IKL----------RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT 272
Query: 153 -----ADFG-------------------------LVKLLEHS----PEIAAAAS-RIVGT 177
DF L+K L+ P + R +
Sbjct: 273 RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI 332
Query: 178 FGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY-ML 236
E +RDG T D + V +L T ++ P E+R + + L
Sbjct: 333 IA----ESIRDGLAT--WDNWKH-VNCDKLTTIIESSLNVLEP-----AEYRKM--FDRL 378
Query: 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296
+VF + L + ++ + ++ L V++ K I + I
Sbjct: 379 SVFPPSAHIPTILLSLIWFDVIKSDVMVVVN-KLHKYSLVEKQPKES------TISIPSI 431
Query: 297 LISSK-EWEKMECCHQM 312
+ K + E H+
Sbjct: 432 YLELKVKLENEYALHRS 448
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 1e-04
Identities = 58/371 (15%), Positives = 104/371 (28%), Gaps = 93/371 (25%)
Query: 17 SLKIGQGSYGSVY---LGKLRGKNAAIKQMKNTKSKEFSSELKILCKVHSNLIELIGYAA 73
S K+ ++ L ++ ++ + SN+ I
Sbjct: 173 SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ-IDPNWTSRSDHSSNIKLRIHSIQ 231
Query: 74 GGDSLFLVYEYAQNGAL-----SDHLHWPSVKGK-KPLAWTTRVQIALDAAKGLEYIHQ- 126
L + +N L + W + K L TTR + D H
Sbjct: 232 AELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILL-TTRFKQVTDFLSAATTTHIS 290
Query: 127 -------YTKPY-------YVH-------RDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165
T Y+ R+V T+N S I D + ++
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG--LATWDNWK 348
Query: 166 EIAAAA-SRIVGTF-GYLAPEYVR-----------DGCVTTK--------SDVYAFGVVL 204
+ + I+ + L P R + T VV+
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVV 408
Query: 205 MELITGQQALSRDANPG---------------NNQYTEHRSLVDYMLAVFNDTKDFMAKL 249
+L + + N+Y HRS+VD+ +N K F
Sbjct: 409 NKLHK-YSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH----YNIPKTF--DS 461
Query: 250 TECLDPNLTRY-------HKDSMLQ---MALLSKDCVDENW---KRRPDMS--NAAIRLS 294
+ + P L +Y H ++ M L +D + K R D + NA+ +
Sbjct: 462 DDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL 521
Query: 295 HILISSKEWEK 305
+ L K ++
Sbjct: 522 NTLQQLKFYKP 532
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 4e-04
Identities = 46/298 (15%), Positives = 88/298 (29%), Gaps = 101/298 (33%)
Query: 45 NTKSKEFSSELKILCKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHL----HWPSVK 100
+ + ++ E+ + + +I ++ D L +W V
Sbjct: 312 DCRPQDLPREV---LTTNPRRLSIIA-----------------ESIRDGLATWDNWKHVN 351
Query: 101 GKKPLAWTTRVQIALDAAKGLEYIHQYTK----PYYVHRDVKTSNILL-----------D 145
K TT ++ +L+ + EY + + P ILL
Sbjct: 352 CDK---LTTIIESSLNVLEPAEYRKMFDRLSVFPP----SAHIPTILLSLIWFDVIKSDV 404
Query: 146 SNFRAKIADFGLVK----------------LLEHSPEIAAAASRIVGTFGYLAPE-YVRD 188
K+ + LV+ L A IV Y P+ + D
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH--YNIPKTFDSD 462
Query: 189 GCVTTKSDVYAF--------GVVLMELITG-----------QQALSRDANPGNNQYTEHR 229
+ D Y + + E +T +Q + D+ N +
Sbjct: 463 DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN 522
Query: 230 SLVD------YML-------AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKD 274
+L Y+ + N DF+ K+ E NL +L++AL+++D
Sbjct: 523 TLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEE----NLICSKYTDLLRIALMAED 576
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 34/211 (16%)
Query: 19 KIGQGSYGSVY--LGKLRGKNAAIKQMKNTKS--KEFSSELKILCKV-------HSNLIE 67
IG+GS+G V ++ + AIK +KN K+ + E+++L + ++
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 68 LIGYAAGGDSLFLVYE-YAQNGALSDHLHWPSVK--GKKPLAWTTRVQIALDAAKGLEYI 124
L + + L LV+E + N L D L + + ++ + A L ++
Sbjct: 121 LKRHFMFRNHLCLVFEMLSYN--LYDLL-----RNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRA--KIADFGLVKLL--EHSPEIAAAASRIVGTFGY 180
+ +H D+K NILL + R+ KI DFG L I SR F Y
Sbjct: 174 AT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI---QSR----F-Y 224
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
+PE + D+++ G +L+E+ TG+
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 313 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.56 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.27 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.94 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.89 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.64 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.62 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.44 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.41 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.29 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.13 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.12 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.09 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.98 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.92 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.9 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.87 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.7 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.66 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.49 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.47 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.39 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.38 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.9 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.83 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.68 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 95.12 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.46 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=397.65 Aligned_cols=247 Identities=24% Similarity=0.399 Sum_probs=201.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.++|+++++||+|+||.||+|+++ ++.||||++.... .+.+.+|+++++.+ |||||++++++.+.+.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999987 8899999986542 34578999999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||++||+|.+++.. .....+++..++.++.|++.||.|||+++ |+||||||+|||++++|.+||+|||++....
T Consensus 103 Ey~~gg~L~~~i~~---~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 103 DYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp ECCTTCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred eCCCCCcHHHHHHH---cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 99999999999952 23356789999999999999999999999 9999999999999999999999999998765
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.... ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+....
T Consensus 177 ~~~~---~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---------------------- 231 (350)
T 4b9d_A 177 STVE---LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---------------------- 231 (350)
T ss_dssp HHHH---HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------------
T ss_pred CCcc---cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----------------------
Confidence 4321 223357999999999999999999999999999999999999999754321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+.. ..........+..+.+||.+||+.||++|||+.|+++.
T Consensus 232 -~~~~~i~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 232 -NLVLKIIS---GSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -HHHHHHHH---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHc---CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112211 11222233456678999999999999999999999863
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-57 Score=389.69 Aligned_cols=262 Identities=25% Similarity=0.407 Sum_probs=214.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|.+.++||+|+||.||+|++. +..||||.++... .+.+.+|+++|+++ |||||++++++.+.+.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 468999999999999999999874 5679999997654 34588999999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCC--------CCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEE
Q 041031 80 LVYEYAQNGALSDHLHWPS--------VKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAK 151 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~--------~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~ 151 (313)
+||||+++|+|.+++.... ......+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999995322 123457999999999999999999999999 99999999999999999999
Q ss_pred EeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchh
Q 041031 152 IADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~ 230 (313)
|+|||++........ ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....
T Consensus 169 i~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---------- 237 (299)
T 4asz_A 169 IGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---------- 237 (299)
T ss_dssp ECCCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----------
T ss_pred ECCcccceecCCCCc-eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----------
Confidence 999999976543221 112223468999999999999999999999999999999999 89999764321
Q ss_pred HHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccc
Q 041031 231 LVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKE 302 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 302 (313)
+....+..... ...+..++..+.+|+.+||+.||++|||+.+|.+.|+.+...++.
T Consensus 238 -------------~~~~~i~~~~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~ 293 (299)
T 4asz_A 238 -------------EVIECITQGRV---LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV 293 (299)
T ss_dssp -------------HHHHHHHHTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred -------------HHHHHHHcCCC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence 22222222211 122345667899999999999999999999999999998876654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=391.09 Aligned_cols=245 Identities=24% Similarity=0.396 Sum_probs=208.2
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEecccc---ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT---KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~---~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
+.|++.++||+|+||.||+|.++ |+.||||++... ..+.+.+|+++|+.+ |||||++++++.+.+.+||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999997 889999998643 355688999999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
+||+|.+++. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.+|.+||+|||++.......
T Consensus 154 ~gg~L~~~l~------~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 154 EGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp TTEEHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCcHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 9999999984 245899999999999999999999999 9999999999999999999999999998765432
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
.......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.... +.
T Consensus 225 ---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-----------------------~~ 278 (346)
T 4fih_A 225 ---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----------------------KA 278 (346)
T ss_dssp ---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----------------------HH
T ss_pred ---CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----------------------HH
Confidence 1233457999999999999999999999999999999999999999754321 22
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...+.....+.+. .....+..+.+||.+||..||++|||+.|+++.
T Consensus 279 ~~~i~~~~~~~~~-~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 279 MKMIRDNLPPRLK-NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHHHHHSSCCCCS-CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHcCCCCCCC-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2233332222222 233456788999999999999999999999874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=389.16 Aligned_cols=263 Identities=24% Similarity=0.437 Sum_probs=209.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|.+.++||+|+||.||+|+++ +..||||.++... .+.+.+|+++|+++ |||||++++++.+.+.++
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 357888999999999999999874 5679999997654 34588999999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCC----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc
Q 041031 80 LVYEYAQNGALSDHLHWPSV----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR 149 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~ 149 (313)
+||||+++|+|.+++..... ....++++..++.++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999864321 12357899999999999999999999999 999999999999999999
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccc
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~ 228 (313)
+||+|||++........ ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 197 ~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-------- 267 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-------- 267 (329)
T ss_dssp EEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--------
T ss_pred EEEcccccceeccCCCc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--------
Confidence 99999999986543322 122234568999999999999999999999999999999999 89999754331
Q ss_pred hhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccc
Q 041031 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW 303 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 303 (313)
+....+....... ....++..+.+|+.+||+.||++|||+.||+++|+.+....+..
T Consensus 268 ---------------~~~~~i~~g~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~~ 324 (329)
T 4aoj_A 268 ---------------EAIDCITQGRELE---RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVY 324 (329)
T ss_dssp ---------------HHHHHHHHTCCCC---CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC--
T ss_pred ---------------HHHHHHHcCCCCC---CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCccc
Confidence 2222232222222 23355678999999999999999999999999999998766544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=383.46 Aligned_cols=258 Identities=30% Similarity=0.522 Sum_probs=207.4
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.+++.+.++||+|+||.||+|++++ .||||+++... .+.+.+|+.+++++ |||||++++++.+ +.+++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 4678889999999999999998875 58999987432 34578999999999 9999999998865 568999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++|+|.+++. .....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++......
T Consensus 113 ~~gGsL~~~l~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 113 CEGSSLYKHLH----VQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CSSCBHHHHHH----TSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred CCCCCHHHHHh----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999995 33457999999999999999999999999 999999999999999999999999999865432
Q ss_pred hhhhhhcccccccccccCCccccC---CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRD---GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.. ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.....
T Consensus 186 ~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-------------------- 244 (307)
T 3omv_A 186 SG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-------------------- 244 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------------------
T ss_pred Cc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--------------------
Confidence 22 122334579999999999964 358999999999999999999999997654310
Q ss_pred cHHHHHHhhh-hcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 242 TKDFMAKLTE-CLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 242 ~~~~~~~l~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
.....+.. ...+.+.....+++..+.+|+.+||+.||++|||+.||++.|+.+...-
T Consensus 245 --~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 245 --QIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp --HHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred --HHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 11111211 2233444455567788999999999999999999999999999887653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=390.74 Aligned_cols=256 Identities=21% Similarity=0.260 Sum_probs=208.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
.+.|.+.++||+|+||.||+|+++ |+.||||+++.... ..+|+.+++.+ |||||++++++.+.+.++|||||++|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 356888899999999999999987 88999999976543 24799999999 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC-cEEEeeccccccccCChh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF-RAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~~~~~~~~ 166 (313)
|+|.+++. ..+.+++..++.++.|++.||+|||+++ |+||||||+|||++.+| .+||+|||++........
T Consensus 135 g~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 135 GSLGQLIK-----QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999994 4467999999999999999999999999 99999999999999887 699999999987654322
Q ss_pred hh--hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 167 IA--AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 167 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
.. .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+..... +
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---------~------------- 264 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---------L------------- 264 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---------C-------------
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---------H-------------
Confidence 11 12233579999999999999999999999999999999999999997654421 0
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
...+... .+.........+..+.+||.+||+.||.+|||+.|+++.|...+.+.
T Consensus 265 -~~~i~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 265 -CLKIASE-PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp -HHHHHHS-CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -HHHHHcC-CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 1111110 01111123445668899999999999999999999999998887653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=385.66 Aligned_cols=246 Identities=23% Similarity=0.379 Sum_probs=207.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|++.+.||+|+||.||+|+++ ++.||||++... ..+.+.+|+++++.+ ||||+++++++.+.+.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 467999999999999999999987 889999998643 345688999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||++||+|.+++. ..+.+++..++.++.|++.||.|||+++ |+||||||+|||++++|.+||+|||++...
T Consensus 111 mEy~~gG~L~~~i~-----~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 111 LSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp ECCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 99999999999994 4467999999999999999999999999 999999999999999999999999999876
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
..... ........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..
T Consensus 183 ~~~~~-~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------------------- 240 (311)
T 4aw0_A 183 SPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--------------------- 240 (311)
T ss_dssp CTTTT-CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------------
T ss_pred CCCCC-cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---------------------
Confidence 54322 12334567999999999999999999999999999999999999999754321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+... ... .....+..+.+||.+||..||++|||++|++..
T Consensus 241 --~~~~~i~~~-~~~---~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 241 --LIFAKIIKL-EYD---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp --HHHHHHHHT-CCC---CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred --HHHHHHHcC-CCC---CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 111222111 111 122345678899999999999999999997543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-56 Score=383.44 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=210.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
.++++..++||+|+||.||+|.+. ++.||||.++... .+.+.+|+.+++++ |||||++++++.+.+.+
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 456788999999999999999874 4679999997543 45688999999999 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCC-----------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC
Q 041031 79 FLVYEYAQNGALSDHLHWPSVK-----------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN 147 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~ 147 (313)
++||||+++|+|.++|...... ....+++..+..++.|++.||+|||+++ |+||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCC
Confidence 9999999999999999543211 1246899999999999999999999999 9999999999999999
Q ss_pred CcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccc
Q 041031 148 FRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYT 226 (313)
Q Consensus 148 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~ 226 (313)
+.+||+|||++........ ........+|+.|+|||++.+..++.++|||||||++|||+| |..||.+....
T Consensus 182 ~~~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~------ 254 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------ 254 (308)
T ss_dssp GCEEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH------
T ss_pred CCEEECCcccceeccCCCc-eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH------
Confidence 9999999999886543221 122334578999999999999999999999999999999999 89999765431
Q ss_pred cchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 227 EHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
+....+.. ........+++..+.+|+.+||+.||++|||+.||+++|+.
T Consensus 255 -----------------~~~~~i~~---~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 255 -----------------DVVEMIRN---RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -----------------HHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -----------------HHHHHHHc---CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 22222222 11222344567789999999999999999999999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=374.68 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=190.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|++.+.||+|+||.||+|+++ ++.||||++.... ...+.+|+++++.+ ||||+++++++.+.+.+++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999987 8899999986432 34588999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+ +|+|.+++. ..+.+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||++...
T Consensus 92 mEy~-~g~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 92 IEYA-GNELFDYIV-----QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EECC-CEEHHHHHH-----HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EeCC-CCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeec
Confidence 9999 679999984 4467999999999999999999999999 999999999999999999999999999865
Q ss_pred cCChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
.... ......||+.|+|||++.+..+ +.++|||||||++|+|+||+.||.+....
T Consensus 163 ~~~~----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-------------------- 218 (275)
T 3hyh_A 163 TDGN----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-------------------- 218 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------------------
T ss_pred CCCC----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--------------------
Confidence 5432 2234579999999999998876 57999999999999999999999653321
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+.... .. .....+..+.+|+.+||+.||++|||++|+++.
T Consensus 219 ---~~~~~i~~~~-~~---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 219 ---VLFKNISNGV-YT---LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---HHHHHHHHTC-CC---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---HHHHHHHcCC-CC---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1112222111 11 122345678899999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=392.51 Aligned_cols=246 Identities=24% Similarity=0.397 Sum_probs=208.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc---ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT---KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~---~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.+.|+++++||+|+||.||+|+++ |+.||||++... ..+.+.+|+.+|+.+ |||||++++++.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999997 889999998643 355688999999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
++||+|.+++. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.+|.+||+|||++......
T Consensus 230 ~~gG~L~~~i~------~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 230 LEGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp CTTEEHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCcHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 99999999984 245899999999999999999999999 999999999999999999999999999876543
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.... +
T Consensus 301 ~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-----------------------~ 354 (423)
T 4fie_A 301 V---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----------------------K 354 (423)
T ss_dssp C---CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----------------------H
T ss_pred C---ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----------------------H
Confidence 2 1233457999999999999999999999999999999999999999754321 2
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
....+.....+.+.. ....+..+.+||.+||..||++|||+.|+++.
T Consensus 355 ~~~~i~~~~~~~~~~-~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 355 AMKMIRDNLPPRLKN-LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHHHHHSCCCCCSC-TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcCCCCCCcc-cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 223333332222222 23445678899999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=371.52 Aligned_cols=241 Identities=25% Similarity=0.417 Sum_probs=194.8
Q ss_pred cccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEe----CCeEEEEE
Q 041031 15 STSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAG----GDSLFLVY 82 (313)
Q Consensus 15 ~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~----~~~~~lv~ 82 (313)
+..++||+|+||.||+|.+. +..||+|.+.... .+.+.+|+++++.+ |||||++++++.+ .+.+++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56778999999999999988 7789999986432 34578999999999 9999999999865 35689999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC-CCCcEEEeeccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD-SNFRAKIADFGLVKLL 161 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~~l~dfg~~~~~ 161 (313)
||+++|+|.+++. ....+++..++.++.|++.||+|||+++. +|+||||||+|||++ ++|.+||+|||++...
T Consensus 109 Ey~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999999999994 44679999999999999999999999863 399999999999997 4799999999999754
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
... ......||+.|+|||++.+ .|+.++|||||||++|+|+||+.||...... .
T Consensus 183 ~~~-----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--------~------------ 236 (290)
T 3fpq_A 183 RAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--------A------------ 236 (290)
T ss_dssp CTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--------H------------
T ss_pred CCC-----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--------H------------
Confidence 332 2334579999999999875 5999999999999999999999999654331 0
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.....+.....+ .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 237 --~~~~~i~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 237 --QIYRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --HHHHHHTTTCCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHcCCCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111222211111 1122233457889999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-55 Score=383.19 Aligned_cols=265 Identities=26% Similarity=0.407 Sum_probs=215.2
Q ss_pred HHhcCccccceeccCCeEEEEEeEECC-------cceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeC
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGG 75 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~ 75 (313)
...++|++.++||+|+||.||+|.+.+ +.||||.+.... ...+.+|+++|.++ |||||++++++...
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 345789999999999999999998763 469999987654 34578899999999 58999999998664
Q ss_pred -CeEEEEEeecCCCChhhhhcCCCC-----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCee
Q 041031 76 -DSLFLVYEYAQNGALSDHLHWPSV-----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNIL 143 (313)
Q Consensus 76 -~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil 143 (313)
+.+++||||+++|+|.++|..... .....+++..+..++.|++.||.|||+++ |+||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCcccee
Confidence 568999999999999999954321 12346899999999999999999999999 999999999999
Q ss_pred eCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCC
Q 041031 144 LDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGN 222 (313)
Q Consensus 144 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~ 222 (313)
+++++.+||+|||++......... .......+|+.|+|||++.+..++.++|||||||++|||+| |..||.+....
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~-- 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-- 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--
T ss_pred eCCCCCEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999866543321 22334568999999999999999999999999999999998 89999765432
Q ss_pred CccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccc
Q 041031 223 NQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKE 302 (313)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 302 (313)
..+...+.....+.. ...++..+.+|+.+||+.||++|||+.+|++.|+.++.++.+
T Consensus 295 --------------------~~~~~~i~~g~~~~~---p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~ 351 (353)
T 4ase_A 295 --------------------EEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 351 (353)
T ss_dssp --------------------HHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC-
T ss_pred --------------------HHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhC
Confidence 122333333333222 234556789999999999999999999999999998876543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=374.05 Aligned_cols=269 Identities=26% Similarity=0.402 Sum_probs=206.6
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHH--Hhc-CCCceeeeeEEEeCC----eEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKIL--CKV-HSNLIELIGYAAGGD----SLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l--~~l-h~~i~~~~~~~~~~~----~~~lv~e 83 (313)
.++|.+.++||+|+||.||+|+++|+.||||+++.........|.+++ ..+ ||||+++++++.+.+ .++||||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 457899999999999999999999999999999877666655555544 556 999999999997654 5899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC--------CCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY--------TKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~--------~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
|+++|+|.+++. ...++++.+..++.|++.||+|||++ + |+||||||+|||+++++.+||+||
T Consensus 82 y~~~gsL~~~l~------~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~---IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 82 YHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp CCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCC
T ss_pred CCCCCcHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---EeeccCCcccEEECCCCCEEEEeC
Confidence 999999999994 24588999999999999999999987 6 999999999999999999999999
Q ss_pred cccccccCChhhh-hhcccccccccccCCccccCC------CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccc--
Q 041031 156 GLVKLLEHSPEIA-AAASRIVGTFGYLAPEYVRDG------CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYT-- 226 (313)
Q Consensus 156 g~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~-- 226 (313)
|++.......... .......||+.|+|||++.+. .++.++|||||||++|||+||..||............
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 9998765432211 122235799999999999764 3678999999999999999999888655432211110
Q ss_pred -cchhHHHHHHHHhcCcHHHHHH-hhhhcCCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 227 -EHRSLVDYMLAVFNDTKDFMAK-LTECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
...... +.... ....+++.+.. ...+....+.+|+.+||+.||++|||+.||+++|+++..+
T Consensus 233 ~~~~~~~-----------~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 233 PSDPSVE-----------EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHH-----------HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccchHH-----------HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 001111 11111 12233344333 2345667899999999999999999999999999988654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=377.29 Aligned_cols=238 Identities=26% Similarity=0.336 Sum_probs=193.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC-----CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|++++.||+|+||.||+|++. ++.||||+++... ...+.+|+++++.+ ||||+++++++.+.+.++
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 478999999999999999999873 5679999986532 33578899999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+||||++||+|.+++. ..+.+++..++.++.|++.||+|||+++ |+||||||+|||++++|.+||+|||++.
T Consensus 103 ivmEy~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLS-----KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEECCCTTCEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEEcCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccce
Confidence 9999999999999994 4467999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...... .......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+..
T Consensus 175 ~~~~~~---~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------------------- 232 (304)
T 3ubd_A 175 ESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------------------- 232 (304)
T ss_dssp C--------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------------
T ss_pred eccCCC---ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-------------------
Confidence 654322 2233457999999999999999999999999999999999999999754321
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM 286 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 286 (313)
+....+... .. ......+..+.+|+++||+.||++|||+
T Consensus 233 ----~~~~~i~~~---~~-~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 233 ----ETMTMILKA---KL-GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ----HHHHHHHHC---CC-CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ----HHHHHHHcC---CC-CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 112222211 11 1223455678899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=364.77 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=186.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC-------
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGD------- 76 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~------- 76 (313)
.++|++++.||+|+||.||+|+++ ++.||||.++... .+.+.+|+++|+.+ |||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 357999999999999999999987 8899999986443 34578899999999 999999999987544
Q ss_pred -----eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEE
Q 041031 77 -----SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAK 151 (313)
Q Consensus 77 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~ 151 (313)
.+++||||+++|+|.+++.... .........++.++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEE
Confidence 3789999999999999995321 1233456678899999999999999999 99999999999999999999
Q ss_pred EeeccccccccCChhhh---------hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCC
Q 041031 152 IADFGLVKLLEHSPEIA---------AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGN 222 (313)
Q Consensus 152 l~dfg~~~~~~~~~~~~---------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~ 222 (313)
|+|||++.......... .......||+.|+|||++.+..|+.++|||||||++|+|++ ||....
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---- 231 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---- 231 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----
Confidence 99999998765432211 11223469999999999999999999999999999999996 764211
Q ss_pred CccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 223 NQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+....+..................+.+|+.+||+.||.+|||+.|+++
T Consensus 232 ---------------------~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ---------------------ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---------------------HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------------------HHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001111111122222222333455778999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=363.56 Aligned_cols=203 Identities=27% Similarity=0.424 Sum_probs=172.9
Q ss_pred HHHHHHhcCccccceeccCCeEEEEEeEEC-----CcceEEEeccccc-cHHHHHHHHHHHhc--CCCceeeeeEEEeCC
Q 041031 5 NEVRDATSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK-SKEFSSELKILCKV--HSNLIELIGYAAGGD 76 (313)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~-~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~ 76 (313)
+.+..+.+.|++.++||+|+||.||+|+++ ++.||||.+.... ...+.+|+++++.+ ||||+++++++.+.+
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 445567789999999999999999999864 5679999886554 55688999999998 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC-CcEEEeec
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN-FRAKIADF 155 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~~l~df 155 (313)
.+++||||+++|+|.+++. .+++..++.++.|++.||+|||++| |+||||||+|||++.+ +.+||+||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcC
Confidence 9999999999999999982 4889999999999999999999999 9999999999999876 89999999
Q ss_pred cccccccCChhhh-------------------------hhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHh
Q 041031 156 GLVKLLEHSPEIA-------------------------AAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELIT 209 (313)
Q Consensus 156 g~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~t 209 (313)
|+|.......... .......||+.|+|||++.+. .++.++||||+||++|+|++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 9997654321110 111234699999999999875 58999999999999999999
Q ss_pred CCCCccCCC
Q 041031 210 GQQALSRDA 218 (313)
Q Consensus 210 g~~p~~~~~ 218 (313)
|+.||....
T Consensus 243 G~~Pf~~~~ 251 (361)
T 4f9c_A 243 GRYPFYKAS 251 (361)
T ss_dssp TCSSSSCCS
T ss_pred CCCCCCCCC
Confidence 999996544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=364.74 Aligned_cols=263 Identities=25% Similarity=0.337 Sum_probs=199.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEe------CC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAG------GD 76 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~------~~ 76 (313)
.++|++++.||+|+||.||+|+++ |+.||||+++... ...+.+|+++|+.+ ||||+++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999987 8899999996532 34477899999999 9999999999753 46
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
.+|+||||++ |+|.+++ ...+.+++..++.++.|++.||.|||+++ |+|+||||+|||++.+|.+|++|||
T Consensus 133 ~~~ivmE~~~-g~L~~~i-----~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQII-----HSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CEEEEEECCS-EEHHHHH-----TSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCC-CCHHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecc
Confidence 7899999995 6799998 34578999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhh-hhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 157 LVKLLEHSPEI-AAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
++......... ........||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+.. .....
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~---------~~l~~ 274 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV---------HQLQL 274 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---------HHHHH
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH---------HHHHH
Confidence 99876543221 1233346899999999998875 4699999999999999999999999765431 11111
Q ss_pred HHHHhcC-cHH---------HHHHhhhhcCCCCCC----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 235 MLAVFND-TKD---------FMAKLTECLDPNLTR----YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 235 ~~~~~~~-~~~---------~~~~l~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+...... ..+ ....+. .+.+.... .....+..+.+||.+||..||.+|||+.|+++.
T Consensus 275 I~~~~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 275 IMMVLGTPSPAVIQAVGAERVRAYIQ-SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHHHCCCCGGGTC-----CHHHHHH-SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHhcCCCChHHhhhhhhhhhhhhhh-cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1111000 000 000000 00000000 112234678899999999999999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=374.55 Aligned_cols=248 Identities=20% Similarity=0.335 Sum_probs=207.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
+.++|++.+.||+|+||.||+|.++ |+.||+|.+.... .+.+.+|+++|+.+ ||||+++++++.+.+.+++|||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4578999999999999999999987 8899999986543 44578999999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC--CCcEEEeeccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS--NFRAKIADFGLVKLL 161 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~--~~~~~l~dfg~~~~~ 161 (313)
|++||+|.+++. .....+++..+..++.|++.||.|||+++ |+|+||||+|||++. .+.+||+|||++...
T Consensus 235 ~~~gg~L~~~i~----~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 235 FMSGGELFEKVA----DEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp CCCCCBHHHHHT----CTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred ecCCCcHHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 999999999984 34467999999999999999999999999 999999999999985 489999999999876
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+....
T Consensus 308 ~~~~----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--------------------- 362 (573)
T 3uto_A 308 DPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------------------- 362 (573)
T ss_dssp CTTS----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---------------------
T ss_pred cCCC----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---------------------
Confidence 5432 223457999999999999999999999999999999999999999765431
Q ss_pred cHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+.... ..... .....+..+.+||++||..||.+|||+.|+++.
T Consensus 363 --~~~~~i~~~~-~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 363 --ETLRNVKSCD-WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp --HHHHHHHTTC-CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --HHHHHHHhCC-CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122222111 11111 223445678899999999999999999999873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=369.50 Aligned_cols=244 Identities=22% Similarity=0.313 Sum_probs=198.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHH---HHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSE---LKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e---~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
.++|+++++||+|+||.||+|+++ |+.||||++.... .....+| +.+++.+ ||||++++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 578999999999999999999987 8899999986432 2234444 4555556 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
|+||||++||+|.+++. ..+.+++..++.++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||++
T Consensus 268 ylVmEy~~GGdL~~~l~-----~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EEEECCCCSCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccccee
Confidence 99999999999999994 4567999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCChhhhhhcccccccccccCCcccc-CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVR-DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
...... ......||+.|+|||++. +..|+.++|+|||||++|+|++|..||.+..... ..
T Consensus 340 ~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---------~~----- 400 (689)
T 3v5w_A 340 CDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---------KH----- 400 (689)
T ss_dssp EECSSC-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---------HH-----
T ss_pred eecCCC-----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---------HH-----
Confidence 876543 233458999999999996 4679999999999999999999999997654321 00
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-----MSNAAI 291 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~ll~ 291 (313)
+....+.. .... .....+..+.+||.+||..||.+|++ ++||++
T Consensus 401 ------~i~~~i~~-~~~~---~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 401 ------EIDRMTLT-MAVE---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------HHHHHHHH-CCCC---CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------HHHHhhcC-CCCC---CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11111111 1111 22345567889999999999999998 677764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=339.71 Aligned_cols=283 Identities=34% Similarity=0.629 Sum_probs=225.5
Q ss_pred cChHHHHHHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeC
Q 041031 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGG 75 (313)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~ 75 (313)
||++++....++|.+.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++.+.
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 789999999999999999999999999999876 8899999987653 33578999999999 99999999999999
Q ss_pred CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC---CCCceEEeccCCCCeeeCCCCcEEE
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY---TKPYYVHRDVKTSNILLDSNFRAKI 152 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~~~~i~h~di~p~nil~~~~~~~~l 152 (313)
+..++||||+.+++|.+++.... .....+++..++.++.|++.||+|||+. + ++|+||||+||+++.++.++|
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEE
T ss_pred CceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999996443 2345689999999999999999999999 8 999999999999999999999
Q ss_pred eeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHH
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLV 232 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~ 232 (313)
+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++|..||......... .....
T Consensus 176 ~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~ 249 (326)
T 3uim_A 176 GDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD----DVMLL 249 (326)
T ss_dssp CCCSSCEECCSSSS--CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS----CSBHH
T ss_pred ccCccccccCcccc--cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc----chhHH
Confidence 99999987653322 2223345899999999999888999999999999999999999999532111100 01111
Q ss_pred HHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 233 DYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 233 ~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
++....... ..+....+..+.. ........+.+++.+||+.||.+|||+.+|+++|++....
T Consensus 250 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 250 DWVKGLLKE-----KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp HHHTTTTSS-----CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HHHHHHhhc-----hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 111111111 0112222232222 5667788999999999999999999999999999865443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=335.59 Aligned_cols=282 Identities=34% Similarity=0.610 Sum_probs=225.4
Q ss_pred ChHHHHHHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 3 SYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
++.++....++|.+.+.||+|+||.||+|.+. ++.||||.+.... .+.+.+|+.+++.+ ||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34455667899999999999999999999987 8899999987654 35578899999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.++||||+++++|.+++.... .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999985432 22346899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+......... .......+++.|+|||++.+..++.++||||||+++|+|++|+.||......... ....+...
T Consensus 186 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~ 258 (321)
T 2qkw_B 186 SKKGTELDQT-HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV------NLAEWAVE 258 (321)
T ss_dssp CEECSSSSCC-CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC------CHHHHTHH
T ss_pred cccccccccc-ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH------HHHHHhhh
Confidence 8764432211 1222345799999999999889999999999999999999999999765543211 11111111
Q ss_pred HhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 238 VFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
... ...+...+++.+.. .....+..+.+++.+||+.||++|||+.++++.|+.++...
T Consensus 259 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 259 SHN-----NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp HHT-----TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ccc-----cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 100 11122233333333 56778889999999999999999999999999999887643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=335.68 Aligned_cols=260 Identities=29% Similarity=0.461 Sum_probs=211.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC-----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
.++|.+.+.||+|+||.||+|.+. +..||||.+.... .+.+.+|+.+++.+ ||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999985 3359999997643 34578899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+++++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 128 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 128 VTEYMENGSLDTFLR----THDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEECCTTCBHHHHHH----TTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EeeCCCCCcHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999995 33457999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------------------- 261 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------------------- 261 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------------------
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-------------------
Confidence 6554332222233345778999999998999999999999999999999 99999654331
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW 303 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 303 (313)
+....+...... ......+..+.+|+.+||+.||.+|||+.+|++.|+.+..+..+.
T Consensus 262 ----~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 262 ----DVISSVEEGYRL---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp ----HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred ----HHHHHHHcCCCC---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 222222222111 123355678899999999999999999999999999998775543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=334.21 Aligned_cols=270 Identities=24% Similarity=0.407 Sum_probs=212.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|++.+.||+|+||.||+|++. +..+|+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999987 7889999885322 34577899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++++|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 90 ~e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE-----SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 99999999999984 3457899999999999999999999999 999999999999999999999999998865
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||.+.... .
T Consensus 162 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------------~-------- 219 (294)
T 4eqm_A 162 SETSL--TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------------S-------- 219 (294)
T ss_dssp ---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------------H--------
T ss_pred ccccc--cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------------H--------
Confidence 53322 2223346899999999999999999999999999999999999999754321 0
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHHHhcccccccccccccC
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-DMSNAAIRLSHILISSKEWEKMECCHQM 312 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~ll~~l~~~~~~~~~~~~~~~~~~~ 312 (313)
.....+...............+..+.+++.+||+.||.+|| +++++.+.|..+..+....++.....+|
T Consensus 220 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~ 289 (294)
T 4eqm_A 220 --IAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKM 289 (294)
T ss_dssp --HHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCCCC----
T ss_pred --HHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcchhhhhcc
Confidence 00111111000000012334556789999999999999999 9999999999998887766666555443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=324.94 Aligned_cols=254 Identities=24% Similarity=0.429 Sum_probs=212.6
Q ss_pred hcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.++|++.+.||+|+||.||+|.+. ++.||+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 478999999999999999999996 7789999997653 56688999999999 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++. .....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~L~~~l~----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 89 HGCLSDYLR----TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TCBHHHHHH----TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCcHHHHHH----hcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999995 33456899999999999999999999999 99999999999999999999999999886554322
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
.......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... +.
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----------------------~~ 216 (269)
T 4hcu_A 162 --TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------------EV 216 (269)
T ss_dssp --HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------------HH
T ss_pred --ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----------------------HH
Confidence 22233456778999999999999999999999999999999 99999654321 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
...+....... .....+..+.+++.+||+.||.+|||+.++++.|+++..+
T Consensus 217 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 217 VEDISTGFRLY---KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhcCccCC---CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 22222221111 2233456788999999999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=330.83 Aligned_cols=262 Identities=29% Similarity=0.449 Sum_probs=205.1
Q ss_pred HHHhcCccccceeccCCeEEEEEeEECCcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
....++|++.+.||+|+||.||+|++.++.||||++.... ...+.+|+.+++++ ||||+++++++.+.+..++|
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456789999999999999999999999999999987543 33577899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+. +++|+||||+||+++.++.++|+|||++...
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999995221 11248999999999999999999999863 3899999999999999999999999998754
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 190 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--------------------- 245 (309)
T 3p86_A 190 ASTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--------------------- 245 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---------------------
T ss_pred cccc---cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------------
Confidence 4321 1223346899999999999999999999999999999999999999754321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+.. ...........+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 246 --~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 246 --QVVAAVGF--KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp --HHHHHHHH--SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred --HHHHHHHh--cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 11111111 11111223445567899999999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=328.79 Aligned_cols=278 Identities=37% Similarity=0.693 Sum_probs=227.2
Q ss_pred cChHHHHHHhcCcccc------ceeccCCeEEEEEeEECCcceEEEeccccc-------cHHHHHHHHHHHhc-CCCcee
Q 041031 2 FSYNEVRDATSNFSTS------LKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-------SKEFSSELKILCKV-HSNLIE 67 (313)
Q Consensus 2 ~~~~~~~~~~~~y~~~------~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-------~~~~~~e~~~l~~l-h~~i~~ 67 (313)
|++.++..+..+|... +.||+|+||.||+|.+.++.+|||.+.... .+.+.+|+.+++.+ ||||++
T Consensus 15 ~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 94 (307)
T 2nru_A 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94 (307)
T ss_dssp CCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEE
Confidence 8899999999999887 999999999999999999999999986431 34578999999999 999999
Q ss_pred eeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC
Q 041031 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN 147 (313)
Q Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~ 147 (313)
+++++.+.+..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++++
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 95 LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEA 169 (307)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT
T ss_pred EEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCC
Confidence 9999999999999999999999999985322 2356899999999999999999999999 9999999999999999
Q ss_pred CcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcccc
Q 041031 148 FRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE 227 (313)
Q Consensus 148 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~ 227 (313)
+.++|+|||++......... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.......
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------ 241 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQT-VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ------ 241 (307)
T ss_dssp CCEEECCCTTCEECCSCSSC-EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS------
T ss_pred CcEEEeeccccccccccccc-ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH------
Confidence 99999999998765432211 12223468999999998875 48899999999999999999999997654431
Q ss_pred chhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 228 HRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
.+..+........ ..+...++..+.......+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 242 --~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 --LLLDIKEEIEDEE----KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp --BTTHHHHHHHTTS----CCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred --HHHHHHHHhhhhh----hhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1112211111111 1223344555555677888899999999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=327.66 Aligned_cols=247 Identities=23% Similarity=0.399 Sum_probs=205.3
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc---ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT---KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~---~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
...+|++.+.||+|+||.||+|.+. ++.||||.+... ..+.+.+|+.+++.+ ||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 4578999999999999999999876 889999998643 345578899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+.+++|.+++. ...+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 98 ~~~~~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 98 YLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp CCTTCBHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCCHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999999984 235889999999999999999999999 99999999999999999999999999876554
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 169 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------------------- 222 (297)
T 3fxz_A 169 EQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----------------------- 222 (297)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----------------------
T ss_pred ccc---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----------------------
Confidence 322 233456899999999999999999999999999999999999999654321
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+.....+... .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 223 RALYLIATNGTPELQ-NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHHHHCSCCCS-CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHhCCCCCCC-CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111111111111 233456678899999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=324.99 Aligned_cols=258 Identities=24% Similarity=0.416 Sum_probs=210.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.++|.+.+.||+|+||.||+|.+. ++.+|+|.+.... .+.+.+|+++++.+ ||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 578999999999999999999987 7889999886543 44578999999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 89 ~~~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIK----SMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHH----HCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999995 33467899999999999999999999999 999999999999999999999999999876543
Q ss_pred hhhhh-----------hcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 165 PEIAA-----------AASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 165 ~~~~~-----------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||...............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~---- 237 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR---- 237 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH----
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh----
Confidence 22111 111346899999999999999999999999999999999999998765443221111110
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
..+.....+ ..+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 238 -------------~~~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 238 -------------GFLDRYCPP-------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp -------------HHHHHTCCT-------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------ccccccCCC-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111111111 2233588899999999999999999999999998865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=335.95 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=204.1
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---------SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
..+.|.+.+.||+|+||.||+|.++ ++.+|+|++.... .+.+.+|+.+++.+ ||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 5678999999999999999999987 7889999987542 35688999999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC----cEEEe
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF----RAKIA 153 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----~~~l~ 153 (313)
+++||||+.+++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++ .++|+
T Consensus 90 ~~lv~e~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHT-----TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEE
Confidence 999999999999999993 4567999999999999999999999999 99999999999998776 79999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.+....
T Consensus 162 DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------------- 224 (361)
T 2yab_A 162 DFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------------- 224 (361)
T ss_dssp CCSSCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------------
T ss_pred ecCCceEcCCCC----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------------
Confidence 999998765432 223356899999999999999999999999999999999999999754321
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+....+...............+..+.+|+.+||..||.+|||+.|+++
T Consensus 225 ----------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 225 ----------ETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----------HHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----------HHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111111000000011223457889999999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=323.50 Aligned_cols=255 Identities=22% Similarity=0.385 Sum_probs=210.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..++|++.+.||+|+||.||+|.+. +..||+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+..++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 4678999999999999999999988 5579999997653 55688999999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++++|.+++. .....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 86 ~~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLR----SHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHH----HHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999985 23346899999999999999999999999 9999999999999999999999999988665432
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... +
T Consensus 159 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------------~ 213 (268)
T 3sxs_A 159 Y--VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----------------------E 213 (268)
T ss_dssp E--EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----------------------H
T ss_pred h--hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----------------------H
Confidence 2 12223345678999999999889999999999999999999 99999654321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
....+...... ......+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 214 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 214 VVLKVSQGHRL---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHHTTCCC---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHHcCCCC---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11111111111 11223345788999999999999999999999999988654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=334.84 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=204.7
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
....++|++.+.||+|+||.||+|.+. ++.||||++.... ...+.+|+++++.+ ||||+++++++...+..+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 345689999999999999999999986 8899999986542 34577899999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+||||+++++|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.
T Consensus 91 lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLV-----AHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSN 162 (328)
T ss_dssp EEECCCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred EEEECCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCce
Confidence 9999999999999984 3456899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCC-CccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVT-TKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
...... ......+|+.|+|||++.+..+. .++|||||||++|+|++|..||.+....
T Consensus 163 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------------------ 220 (328)
T 3fe3_A 163 EFTVGG----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------------------ 220 (328)
T ss_dssp GGSSSC----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------------------
T ss_pred ecCCCC----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------------------
Confidence 655432 22334689999999999988765 7899999999999999999999754321
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+... .. ......+..+.+|+++||..||.+|||+.|+++.
T Consensus 221 -----~~~~~i~~~---~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 221 -----ELRERVLRG---KY-RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----HHHHHHHHC---CC-CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----HHHHHHHhC---CC-CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111112111 11 1122345678889999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=333.31 Aligned_cols=272 Identities=25% Similarity=0.386 Sum_probs=210.3
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEeccccccHH--HHHHHHHHHhc-CCCceeeeeEEEeCC----eEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKE--FSSELKILCKV-HSNLIELIGYAAGGD----SLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~--~~~e~~~l~~l-h~~i~~~~~~~~~~~----~~~lv~e 83 (313)
.++|++.++||+|+||.||+|++.++.||||++....... ...|+.+++.+ ||||+++++++.... .+++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 4689999999999999999999999999999997665333 45677778888 999999999998744 4799999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC----------CCCceEEeccCCCCeeeCCCCcEEEe
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY----------TKPYYVHRDVKTSNILLDSNFRAKIA 153 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~----------~~~~i~h~di~p~nil~~~~~~~~l~ 153 (313)
|+++|+|.+++.. ..+++..++.++.|++.||+|||+. + ++|+||||+||+++.++.+||+
T Consensus 103 ~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 103 FHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp CCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred cCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 9999999999942 3489999999999999999999999 8 9999999999999999999999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCC-----CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccc
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-----CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~ 228 (313)
|||++......... .......+|+.|+|||++.+. .++.++|||||||++|+|+||..||.+........+...
T Consensus 174 DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 174 DFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred cCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999765543221 122234689999999999863 456788999999999999999999987655432222110
Q ss_pred hhHHHHHHHHhcCcHHHHHHh-hhhcCCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 229 RSLVDYMLAVFNDTKDFMAKL-TECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
. ...+...+....+ .....+.+.. .....+..+.+|+.+||+.||++|||+.+++++|+++...
T Consensus 253 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 253 I-------GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp H-------CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred h-------ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0 0001111111111 1112222222 2334567799999999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=323.56 Aligned_cols=255 Identities=22% Similarity=0.395 Sum_probs=209.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-CcceEEEecccc--ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNT--KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~--~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..++|++.+.||+|+||.||+|.+. +..||+|++... ..+.+.+|+.+++.+ ||||+++++++.+.+..++||||+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 4578999999999999999999988 568999999865 356688999999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
.+++|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 102 ~~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 102 ANGCLLNYLR----EMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp TTCBHHHHHH----CGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred CCCcHHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999995 22456899999999999999999999999 9999999999999999999999999988665432
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... +
T Consensus 175 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----------------------~ 229 (283)
T 3gen_A 175 Y--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----------------------E 229 (283)
T ss_dssp H--HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----------------------H
T ss_pred c--ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----------------------H
Confidence 2 22223356788999999998899999999999999999998 99999754321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
....+....... .....+..+.+++.+||+.||.+|||+.++++.|.++..+
T Consensus 230 ~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 230 TAEHIAQGLRLY---RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCC---CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 222222222221 2223346788999999999999999999999999998865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=331.34 Aligned_cols=251 Identities=18% Similarity=0.251 Sum_probs=205.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+.++|.+.+.||+|+||.||+|.+. ++.+|+|.+.... ...+.+|+.+++.+ ||||+++++++.+.+..++||||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4689999999999999999999987 7889999987553 34578999999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC--CCcEEEeecccccccc
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS--NFRAKIADFGLVKLLE 162 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~--~~~~~l~dfg~~~~~~ 162 (313)
+++++|.+++. .....+++..++.++.|++.||.|||+++ ++|+||||+||+++. ++.++|+|||++....
T Consensus 83 ~~g~~L~~~l~----~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 83 ISGLDIFERIN----TSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHT----SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999984 33356899999999999999999999999 999999999999987 7899999999998765
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 156 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------------------- 209 (321)
T 1tki_A 156 PGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---------------------- 209 (321)
T ss_dssp TTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------------
T ss_pred CCC----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH----------------------
Confidence 432 223356899999999999988999999999999999999999999754321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+...............+..+.+|+.+||..||.+|||+.|+++.-+
T Consensus 210 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 210 -QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp -HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -HHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 111111111000000011233567889999999999999999999997543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=335.07 Aligned_cols=262 Identities=24% Similarity=0.413 Sum_probs=212.0
Q ss_pred hcCccccceeccCCeEEEEEeEEC---------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR---------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGG 75 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~ 75 (313)
.++|.+.+.||+|+||.||+|++. +..||||.++... .+.+.+|+.+++.+ ||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999873 3459999997653 34578899999999 99999999999999
Q ss_pred CeEEEEEeecCCCChhhhhcCCCC-----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSV-----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL 144 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 144 (313)
+.+++||||+++|+|.+++..... .....+++..++.++.|++.||.|||+++ ++|+||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999864321 11245889999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCC
Q 041031 145 DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNN 223 (313)
Q Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~ 223 (313)
+.++.+||+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--- 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred CCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999865543221 12222356789999999999999999999999999999999 99999754321
Q ss_pred ccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccc
Q 041031 224 QYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKE 302 (313)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 302 (313)
+....+...... .....++..+.+++.+||+.||.+|||+.++++.|++++....+
T Consensus 313 --------------------~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 313 --------------------ELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp --------------------GHHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred --------------------HHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 112222222111 12334556789999999999999999999999999999875443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=327.98 Aligned_cols=274 Identities=25% Similarity=0.411 Sum_probs=206.4
Q ss_pred HhcCccccceeccCCeEEEEEeEE------CCcceEEEecccccc---HHHHHHHHHHHhc-CCCceeeeeEEEe--CCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKL------RGKNAAIKQMKNTKS---KEFSSELKILCKV-HSNLIELIGYAAG--GDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~------~~~~~aiK~~~~~~~---~~~~~e~~~l~~l-h~~i~~~~~~~~~--~~~ 77 (313)
..++|++.+.||+|+||.||+|++ .++.||||.+..... +.+.+|+.+++.+ ||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 457899999999999999999984 278899999876543 4577899999999 9999999999854 456
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
+++||||+++++|.+++. .....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp CEEEEECCTTCBHHHHHH----HCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred eEEEEEeCCCCCHHHHHH----hcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcc
Confidence 899999999999999995 23345899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+.................++..|+|||++.+..++.++||||||+++|+|++|..||...... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----------~~~~~~~ 230 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----------FMRMIGN 230 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----------HHHHHCT
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----------HHhhhcC
Confidence 987654433222333345677899999999999999999999999999999999998543210 0000000
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
...........................+..+.+++.+||+.||.+|||+.+++++|+++..+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 231 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp TCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 000000001111111111112234455678999999999999999999999999999987653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=324.31 Aligned_cols=258 Identities=23% Similarity=0.384 Sum_probs=213.4
Q ss_pred CcChHHHHHHhcC----------ccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCC
Q 041031 1 MFSYNEVRDATSN----------FSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSN 64 (313)
Q Consensus 1 ~~~~~~~~~~~~~----------y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~ 64 (313)
.||++.++.+.+. |...+.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.+++.+ |||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 3788888888765 788899999999999999987 8899999986543 45578999999999 999
Q ss_pred ceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee
Q 041031 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL 144 (313)
Q Consensus 65 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 144 (313)
|+++++++...+..++||||+++++|.+++. ...+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~------~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999984 246899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCc
Q 041031 145 DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQ 224 (313)
Q Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~ 224 (313)
+.++.++|+|||++........ ......+|+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---- 247 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---- 247 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----
T ss_pred CCCCcEEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 9999999999999876554321 223346899999999999999999999999999999999999999654321
Q ss_pred cccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 225 YTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+.....+.+. .....+..+.+++.+||+.||++|||+.++++.-.
T Consensus 248 -------------------~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 248 -------------------QAMKRLRDSPPPKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp -------------------HHHHHHHHSSCCCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred -------------------HHHHHHhcCCCCCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 112222222222221 12344567889999999999999999999998644
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=327.85 Aligned_cols=247 Identities=23% Similarity=0.366 Sum_probs=203.8
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---------SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
..+.|.+.+.||+|+||.||+|.+. ++.+|+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4567999999999999999999987 7889999986432 45688999999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC----cEEEe
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF----RAKIA 153 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----~~~l~ 153 (313)
.++||||+++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+
T Consensus 89 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHT-----TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHH-----hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 999999999999999993 4567999999999999999999999999 99999999999998877 79999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
|||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.+....
T Consensus 161 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------------- 223 (326)
T 2y0a_A 161 DFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------------- 223 (326)
T ss_dssp CCTTCEECCTTS----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------------
T ss_pred ECCCCeECCCCC----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-------------
Confidence 999998765322 222346899999999999999999999999999999999999999654321
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+.... ..... .....+..+.+|+++||..||.+|||+.++++.
T Consensus 224 ----------~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 224 ----------ETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ----------HHHHHHHHTC-CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----------HHHHHHHhcC-CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111111 11100 112334578899999999999999999999963
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=323.37 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=206.4
Q ss_pred HhcCccccceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHh--c-CCCceeeeeEEEe----CCeEEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK--V-HSNLIELIGYAAG----GDSLFLVY 82 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~--l-h~~i~~~~~~~~~----~~~~~lv~ 82 (313)
..++|++.+.||+|+||.||+|++.++.||||++..........|.+++.. + ||||+++++++.. ....++||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 467999999999999999999999999999999988877778888888887 5 9999999998654 34689999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHh--------cCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH--------QYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--------~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
||+++++|.+++. ...+++..++.++.|++.||+||| +.+ ++|+||||+||+++.++.+||+|
T Consensus 86 e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 86 HYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp CCCTTCBHHHHHT------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred hhccCCCHHHHHh------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 9999999999983 346899999999999999999999 888 99999999999999999999999
Q ss_pred ccccccccCChhhh-hhcccccccccccCCccccCC------CCCCccchhhHHHHHHHHHhC----------CCCccCC
Q 041031 155 FGLVKLLEHSPEIA-AAASRIVGTFGYLAPEYVRDG------CVTTKSDVYAFGVVLMELITG----------QQALSRD 217 (313)
Q Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~~l~~~~tg----------~~p~~~~ 217 (313)
||++.......... .......+|+.|+|||++.+. .++.++||||||+++|+|++| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99987655432211 112234689999999999876 455789999999999999999 7777544
Q ss_pred CCCCCCccccchhHHHHHHHHhcCcHHHHHHhh-hhcCCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 218 ANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLT-ECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.... .... ....... ....+.... .....+..+.+|+.+||+.||++|||+.++++.|+
T Consensus 237 ~~~~-------~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 237 VPND-------PSFE-----------DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp SCSS-------CCHH-----------HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred CCCC-------cchh-----------hhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 3321 0000 1111110 111111111 23456788999999999999999999999999998
Q ss_pred HH
Q 041031 295 HI 296 (313)
Q Consensus 295 ~~ 296 (313)
++
T Consensus 299 ~i 300 (301)
T 3q4u_A 299 KI 300 (301)
T ss_dssp HH
T ss_pred cc
Confidence 75
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=338.38 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=204.8
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
....++|++.+.||+|+||.||+|.+. ++.+|+|++.... .+.+.+|+.+++.+ ||||+++++++.+.+..+
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 356788999999999999999999987 8889999987543 34578999999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC---CCCcEEEeecc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD---SNFRAKIADFG 156 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~---~~~~~~l~dfg 156 (313)
+||||+.+|+|.+.+. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++ .++.+||+|||
T Consensus 87 lv~E~~~gg~L~~~i~-----~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 87 LIFDLVTGGELFEDIV-----AREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEECCCBCCBHHHHHH-----HCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEeCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 9999999999999984 3466999999999999999999999999 99999999999998 46789999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
++........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 159 ~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---------------- 219 (444)
T 3soa_A 159 LAIEVEGEQQ---AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---------------- 219 (444)
T ss_dssp SCBCCCTTCC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------
T ss_pred eeEEecCCCc---eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH----------------
Confidence 9976554321 223356899999999999999999999999999999999999999654321
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+...............+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 220 -------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 220 -------RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -------HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1122222211111111223445678899999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=331.92 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=204.8
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
...++|.+.+.||+|+||.||+|.++ ++.||+|++.... .+.+.+|+.+++.+ ||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45678999999999999999999987 7899999986543 34577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC---CcEEEeeccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN---FRAKIADFGL 157 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~---~~~~l~dfg~ 157 (313)
||||+.+++|.+.+. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.+ +.+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHT-----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 999999999999983 4467899999999999999999999999 9999999999999864 4599999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+....... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 178 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----------------- 236 (362)
T 2bdw_A 178 AIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----------------- 236 (362)
T ss_dssp CBCCTTCC----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------
T ss_pred ceEecCCc----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----------------
Confidence 98665332 222356899999999999999999999999999999999999999654321
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+...............+..+.+|+.+||+.||.+|||+.++++.
T Consensus 237 ------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 237 ------RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ------HHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ------HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1112221111111111223445678999999999999999999999865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=325.72 Aligned_cols=251 Identities=22% Similarity=0.360 Sum_probs=204.1
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
..++|++.+.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.+++.+ ||||+++++++.+.+..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3579999999999999999999987 7889999986443 35588999999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 85 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 85 EYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp ECCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EcCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 9999999999983 4567999999999999999999999999 9999999999999999999999999997654
Q ss_pred CChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.... ........+|+.|+|||++.+..+ +.++||||||+++|+|++|..||....... .
T Consensus 157 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~------------ 216 (323)
T 3tki_A 157 YNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------Q------------ 216 (323)
T ss_dssp ETTE-ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-------H------------
T ss_pred cCCc-ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-------H------------
Confidence 3221 122234578999999999987765 778999999999999999999997654421 0
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
........ ..........+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus 217 --~~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 217 --EYSDWKEK---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp --HHHHHHTT---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred --HHHHHhcc---cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence 00000000 011112234556788999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=334.27 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=198.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC-----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
.++|.+.+.||+|+||.||+|++. +..||||.++... ...+.+|+.+++++ ||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999875 5679999987543 34578899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+++++|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 124 v~e~~~~~sL~~~l~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 124 VTEYMENGSLDSFLR----KHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEECCTTCBHHHHHH----TTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEeCCCCCcHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 999999999999995 33457899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...............+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------------------- 257 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------------------- 257 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-------------------
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------------------
Confidence 6543322222222345678999999999999999999999999999998 99999654321
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+...... ......+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 258 ----~~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 258 ----DVIKAVDEGYRL---PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ----HHHHHHHTTEEC---CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ----HHHHHHHcCCCC---CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 111222111111 122345567899999999999999999999999999997653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=326.23 Aligned_cols=244 Identities=25% Similarity=0.349 Sum_probs=203.6
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|++++.||+|+||.||+|+++ ++.||+|+++.. ....+.+|..+++.+ ||||+++++++.+.+.+++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 578999999999999999999987 888999998643 345678899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++|+|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.+|.+||+|||++...
T Consensus 84 ~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 84 MEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 99999999999984 3456899999999999999999999999 999999999999999999999999998754
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.... .......+|+.|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 156 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------------------- 211 (337)
T 1o6l_A 156 ISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------------------- 211 (337)
T ss_dssp CCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---------------------
T ss_pred ccCC---CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---------------------
Confidence 3221 1233457899999999999999999999999999999999999999654321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
+....+... ... .....+..+.+|+.+||+.||.+|| ++.++++.
T Consensus 212 --~~~~~i~~~-~~~---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 212 --RLFELILME-EIR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --HHHHHHHHC-CCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --HHHHHHHcC-CCC---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 111111110 111 1234456788999999999999999 89998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=333.82 Aligned_cols=270 Identities=25% Similarity=0.391 Sum_probs=215.8
Q ss_pred cChHHHHHHhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceee
Q 041031 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIEL 68 (313)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~ 68 (313)
|+....+...++|++.+.||+|+||.||+|++. ++.||||.+.... .+.+.+|+.++..+ ||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 344555667789999999999999999999853 4689999997643 23478999999999 8999999
Q ss_pred eeEEEeCCe-EEEEEeecCCCChhhhhcCCCCCC----------------------------------------------
Q 041031 69 IGYAAGGDS-LFLVYEYAQNGALSDHLHWPSVKG---------------------------------------------- 101 (313)
Q Consensus 69 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~---------------------------------------------- 101 (313)
++++.+.+. .++||||+++|+|.+++.......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987554 899999999999999996443210
Q ss_pred ---------------CCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 102 ---------------KKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 102 ---------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
...+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999999 99999999999999999999999999986544322
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... ..
T Consensus 249 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------------~~ 305 (359)
T 3vhe_A 249 Y-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----------------------EF 305 (359)
T ss_dssp C-EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----------------------HH
T ss_pred c-hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH----------------------HH
Confidence 1 22233467889999999999999999999999999999998 999997654320 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
...+....... .....+..+.+++.+||+.||.+|||+.++++.|+.++.+.
T Consensus 306 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 306 CRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 22222222222 22334567889999999999999999999999999988653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=317.57 Aligned_cols=251 Identities=28% Similarity=0.441 Sum_probs=197.3
Q ss_pred HhcCccccceeccCCeEEEEEeEECCcceEEEeccccc-------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
..++|++.+.||+|+||.||+|.+.++.+|||++.... .+.+.+|+.+++.+ ||||+++++++.+.+..++|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35789999999999999999999999999999987532 34578899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC--------CCcEEEe
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS--------NFRAKIA 153 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~--------~~~~~l~ 153 (313)
|||+++++|.+++. ...+++..++.++.|++.||+|||+++..+++|+||||+||+++. ++.++|+
T Consensus 85 ~e~~~~~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 85 MEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EECCTTEEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEcCCCCCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 99999999999983 356899999999999999999999998444779999999999985 6789999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
|||.+........ ....+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 159 Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------------- 220 (271)
T 3dtc_A 159 DFGLAREWHRTTK-----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------------- 220 (271)
T ss_dssp CCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------------
T ss_pred cCCcccccccccc-----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------------
Confidence 9999876543221 2346899999999999999999999999999999999999999754321
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
...... .............+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 221 ----------~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 ----------AVAYGV--AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----------HHHHHH--HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----------HHHHhh--hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 000000 011111112344556789999999999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=316.48 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=211.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.++|++.+.||+|+||.||+|.+. ++.+|+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+..+++||+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 578999999999999999999986 7789999998653 46688999999999 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 87 ~~~L~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 87 HGCLSDYLR----TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp TCBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCcHHHHHh----hCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999985 23456899999999999999999999999 99999999999999999999999999886553221
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
.......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... +.
T Consensus 160 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------------~~ 214 (267)
T 3t9t_A 160 --TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------------EV 214 (267)
T ss_dssp --HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------------HH
T ss_pred --cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-----------------------HH
Confidence 22223456788999999998889999999999999999999 89999654321 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
...+....... .....+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 215 ~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 215 VEDISTGFRLY---KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHTTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhcCCcCC---CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 22222211111 2223456788999999999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=322.43 Aligned_cols=269 Identities=24% Similarity=0.381 Sum_probs=209.1
Q ss_pred hcCccccceeccCCeEEEEEeEE------CCcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeC--Ce
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKL------RGKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGG--DS 77 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~------~~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~--~~ 77 (313)
...|++.+.||+|+||.||+|++ .++.||+|.+.... ...+.+|+.+++.+ ||||+++++++.+. +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35689999999999999999984 27889999987543 35688999999999 99999999999876 67
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
+++||||+++++|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||.
T Consensus 100 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLP----KNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEEECCTTCBHHHHHH----HHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHH----hccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccc
Confidence 899999999999999984 23456899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+.................++..|+|||++.+..++.++||||||+++|+|++|..|+..... .......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~ 241 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA-----------LFLKMIG 241 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH-----------HHHHHHC
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh-----------HHhhccC
Confidence 98766543322333345678889999999999999999999999999999999998743211 0000000
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
...........................+..+.+|+.+||+.||.+|||+.+++++|+.++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 242 PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp SCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 001111111112212222222234455678999999999999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=330.00 Aligned_cols=249 Identities=20% Similarity=0.292 Sum_probs=204.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
..++|.+.+.||+|+||.||+|.+. ++.+|+|.+.... ...+.+|+.+++.+ ||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 3578999999999999999999987 7889999987653 34578899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC--CCcEEEeeccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS--NFRAKIADFGLVKLL 161 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~--~~~~~l~dfg~~~~~ 161 (313)
|+.+++|.+++. .....+++..++.++.|++.||.|||+++ ++|+||||+||+++. ++.++|+|||++...
T Consensus 129 ~~~gg~L~~~l~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 129 FLSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp CCCCCBHHHHTT----CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceec
Confidence 999999999984 33457999999999999999999999999 999999999999974 577999999999876
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 202 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------------------- 256 (387)
T 1kob_A 202 NPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------------------- 256 (387)
T ss_dssp CTTS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---------------------
T ss_pred CCCc----ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---------------------
Confidence 5432 222346899999999999999999999999999999999999999754321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+...............+..+.+|+.+||+.||.+|||+.++++.
T Consensus 257 --~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 257 --ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111121111111111223455678999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=334.67 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=208.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++|.+.+.||+|+||.||+|.+. ++.||||.++... ...+.+|+++++.+ ||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 468999999999999999999997 7889999987653 23467899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++++|.+++. .....++...++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 193 ~~~~g~L~~~l~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 193 LVQGGDFLTFLR----TEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp CCTTCBHHHHHH----HHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred cCCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999985 23346899999999999999999999999 99999999999999999999999999876443
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ........++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 266 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---------------------- 322 (377)
T 3cbl_A 266 GVY-AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---------------------- 322 (377)
T ss_dssp SEE-ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----------------------
T ss_pred Cce-eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----------------------
Confidence 211 111112235678999999998899999999999999999998 99999754321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
+....+...... .....++..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 323 -~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 323 -QTREFVEKGGRL---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp -HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 111122111111 1223455678899999999999999999999999998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=330.42 Aligned_cols=263 Identities=25% Similarity=0.407 Sum_probs=214.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC---------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR---------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGG 75 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~ 75 (313)
.++|.+.+.||+|+||.||+|++. +..||||++.... ...+.+|+++++.+ ||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 478999999999999999999874 2469999987654 24577899999998 99999999999999
Q ss_pred CeEEEEEeecCCCChhhhhcCCCC-----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSV-----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL 144 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 144 (313)
+..++||||+.+++|.+++..... .....+++..++.++.|++.||+|||+.+ ++|+||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999864321 11346899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCC
Q 041031 145 DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNN 223 (313)
Q Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~ 223 (313)
++++.+||+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--- 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred cCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999865543221 12223356789999999999999999999999999999999 99999654321
Q ss_pred ccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccc
Q 041031 224 QYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW 303 (313)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 303 (313)
+....+....... .....+..+.+|+.+||+.||++|||+.++++.|+++.......
T Consensus 301 --------------------~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 301 --------------------ELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp --------------------HHHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred --------------------HHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 2222222222221 22345567889999999999999999999999999999865444
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=335.56 Aligned_cols=252 Identities=28% Similarity=0.475 Sum_probs=209.9
Q ss_pred HhcCccccceeccCCeEEEEEeEECCcceEEEeccccc-cHHHHHHHHHHHhc-CCCceeeeeEEEeCC-eEEEEEeecC
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIELIGYAAGGD-SLFLVYEYAQ 86 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~-~~~lv~e~~~ 86 (313)
..++|++.+.||+|+||.||+|.+.++.||||.++... .+.+.+|+.+++++ ||||+++++++.... ..++||||++
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred ChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 35789999999999999999999999999999998654 56688999999999 999999999987665 7999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+|+|.+++... ....++...++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.......
T Consensus 271 ~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 271 KGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp TCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 99999999522 2234789999999999999999999999 9999999999999999999999999987544321
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
....++..|+|||++.+..++.++||||||+++|+|++ |..||...... +.
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----------------------~~ 395 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------------DV 395 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-----------------------TH
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------------HH
Confidence 11246789999999999999999999999999999998 99999765443 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
...+...... .....++..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 396 ~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 396 VPRVEKGYKM---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHcCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 2222221111 12334567899999999999999999999999999998765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=320.42 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=200.6
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
...++|+++++||+|+||.||+|.+. ++.||+|.+.... ...+.+|+.+++.+ ||||+++++++.+.+..++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 45689999999999999999999996 8889999987543 24577899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++ +|.+.+. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 98 ~e~~~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 98 FEFMEK-DLKKVLD----ENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EECCSE-EHHHHHH----TCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EcCCCC-CHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceec
Confidence 999964 7888874 34456899999999999999999999999 999999999999999999999999999865
Q ss_pred cCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .+.........
T Consensus 170 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~ 238 (311)
T 3niz_A 170 GIPVR---SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--------QLPKIFSILGT 238 (311)
T ss_dssp TSCCC------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--------HHHHHHHHHCC
T ss_pred CCCcc---cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHHHCC
Confidence 43221 2223467999999999976 568999999999999999999999997665431 11111110000
Q ss_pred Cc---HHHHHHhhhhcCCCC---CC-----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 241 DT---KDFMAKLTECLDPNL---TR-----YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 241 ~~---~~~~~~l~~~~~~~~---~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.. ......+........ .. .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 000000000000000 00 11223457889999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=319.76 Aligned_cols=264 Identities=17% Similarity=0.208 Sum_probs=211.8
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEee
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
..++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|+.+++.+ |+|++++++++.+....++|||+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 4578999999999999999999975 889999988654 355688999999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc-----EEEeeccccc
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR-----AKIADFGLVK 159 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~-----~~l~dfg~~~ 159 (313)
+ +++|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++. ++|+|||++.
T Consensus 88 ~-~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 88 L-GPSLEDLLD----LCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp C-CCBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred c-CCCHHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 9 999999995 23456999999999999999999999999 999999999999987765 9999999998
Q ss_pred cccCChhhh----hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 160 LLEHSPEIA----AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 160 ~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
......... .......+|+.|+|||++.+..++.++||||||+++|+|++|+.||....... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~ 234 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQKYERIG 234 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc-----cHHHHHHHH
Confidence 765432211 12234568999999999999999999999999999999999999998754421 000000000
Q ss_pred HHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 236 LAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 236 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
... ............+..+.+++.+||+.||.+|||+.+|++.|+++....
T Consensus 235 ~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 235 EKK--------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHH--------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hhc--------------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 000 000000011233467889999999999999999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=317.21 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=210.9
Q ss_pred hcCccccc-eeccCCeEEEEEeEEC----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSL-KIGQGSYGSVYLGKLR----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~-~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
.++|.+.. .||+|+||.||+|.+. +..||||.+.... .+.+.+|+++++.+ ||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 46788877 9999999999999864 6679999997643 34577899999999 99999999999 4556899
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
|||++++++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 87 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 87 VMEMAGGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEECCTTEEHHHHHT----TCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHH----hCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceee
Confidence 999999999999985 34456899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...............+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------------------- 220 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------------------- 220 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------------------
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------------------
Confidence 6543322222233356789999999998889999999999999999998 99999754431
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKE 302 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 302 (313)
+....+.....+ ......+..+.+++.+||+.||.+|||+.++++.|+.+..+...
T Consensus 221 ----~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 221 ----EVMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp ----HHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred ----HHHHHHhcCCcC---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 112222221111 22345567899999999999999999999999999999886443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=328.93 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=202.0
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|++.+.||+|+||.||+|.+. ++.||+|++... ....+.+|+.+++.+ ||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 578999999999999999999987 678999998643 245678899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+.+|+|.+++. ....+++..++.++.|++.||.|||+++ |+|+||||+||+++.+|.++|+|||++...
T Consensus 94 ~e~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ-----QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp ECCCTTEEHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 99999999999994 4567999999999999999999999999 999999999999999999999999999865
Q ss_pred cCChhhhhhcccccccccccCCccccC---CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRD---GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ..
T Consensus 166 ~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---------~~------ 226 (384)
T 4fr4_A 166 PRE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS---------SK------ 226 (384)
T ss_dssp CTT----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC---------HH------
T ss_pred cCC----CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc---------HH------
Confidence 432 22334578999999999974 458999999999999999999999997554321 00
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-HHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-MSNAAI 291 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~ll~ 291 (313)
+....+.... .......+..+.+|+.+||+.||.+||+ ++++++
T Consensus 227 -----~~~~~~~~~~----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 227 -----EIVHTFETTV----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----HHHHHHHHCC----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----HHHHHHhhcc----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1111111111 1122344567889999999999999998 666653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=328.11 Aligned_cols=263 Identities=27% Similarity=0.443 Sum_probs=210.9
Q ss_pred HHhcCccccceeccCCeEEEEEeEECC-------cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGD 76 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~ 76 (313)
...++|.+.+.||+|+||.||+|++.+ +.||||.++... .+.+.+|+.+++.+ ||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 345789999999999999999999864 789999997654 34578899999999 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCCC-------------------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVK-------------------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDV 137 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di 137 (313)
..++||||+++++|.+++...... ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 999999999999999998543211 1257899999999999999999999999 999999
Q ss_pred CCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccC
Q 041031 138 KTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSR 216 (313)
Q Consensus 138 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~ 216 (313)
||+||+++.++.++|+|||++........ ........+++.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999876543211 112223457889999999998899999999999999999999 9999965
Q ss_pred CCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 217 DANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
.... +....+. +..........+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 280 ~~~~-----------------------~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 280 MAHE-----------------------EVIYYVR---DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp SCHH-----------------------HHHHHHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CChH-----------------------HHHHHHh---CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 4321 1111111 1122222334556799999999999999999999999999998
Q ss_pred Hhccc
Q 041031 297 LISSK 301 (313)
Q Consensus 297 ~~~~~ 301 (313)
.....
T Consensus 334 ~~~~~ 338 (343)
T 1luf_A 334 CERAE 338 (343)
T ss_dssp TC---
T ss_pred Hhhhh
Confidence 76543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=323.83 Aligned_cols=261 Identities=28% Similarity=0.461 Sum_probs=204.8
Q ss_pred hcCccccceeccCCeEEEEEeEECC------cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRG------KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~------~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|.+.+.||+|+||.||+|.+.. ..||||.+.... ...+.+|+.+++.+ ||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567889999999999999998762 249999987643 33477899999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+|||++++++|.+++. .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 123 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 123 IITEYMENGALDKFLR----EKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEECCTTEEHHHHHH----HTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEeCCCCCcHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999985 33467899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
................+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------------------ 257 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------------------ 257 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------------------
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------------------
Confidence 76543322222223345788999999999999999999999999999999 99999644321
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccccc
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEWE 304 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 304 (313)
+....+...... ......+..+.+++.+||+.||.+||++.++++.|+++........
T Consensus 258 -----~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~ 315 (333)
T 1mqb_A 258 -----EVMKAINDGFRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 315 (333)
T ss_dssp -----HHHHHHHTTCCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred -----HHHHHHHCCCcC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence 112222221111 1233455678999999999999999999999999999987655443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=325.55 Aligned_cols=245 Identities=23% Similarity=0.324 Sum_probs=203.0
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|.+.+.||+|+||.||+|.+. ++.||||++... ....+.+|+.+++.+ ||||+++++++...+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4578999999999999999999985 789999998643 245688999999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+ +|+|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..
T Consensus 87 v~E~~-~g~l~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 87 VIEYA-GGELFDYIV-----EKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp EECCC-CEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred EEECC-CCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEecccee
Confidence 99999 778988883 3456999999999999999999999999 99999999999999999999999999886
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
..... ......+|+.|+|||++.+..+ +.++||||||+++|+|++|..||..........
T Consensus 158 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------------- 218 (336)
T 3h4j_B 158 MTDGN----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------------- 218 (336)
T ss_dssp TTTSB----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------
T ss_pred ccCCc----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------
Confidence 55432 2233468999999999988776 689999999999999999999997654321110
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.+...........+..+.+|+++||..||.+|||+.|+++.-+
T Consensus 219 ------------~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 219 ------------KVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp ------------CCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred ------------HHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 0011111122334567889999999999999999999987543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=319.19 Aligned_cols=256 Identities=26% Similarity=0.391 Sum_probs=198.2
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC-----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
...++|++.+.||+|+||.||+|.+. +..+|+|...... .+.+.+|+.+++.+ ||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 34678999999999999999999885 3458999987543 34577899999999 999999999985 4568
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++||||+++++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQ----VRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp EEEEECCTTEEHHHHHH----HTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEEecCCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccc
Confidence 99999999999999985 23456899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 164 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----------------- 224 (281)
T 1mp8_A 164 RYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----------------- 224 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------
T ss_pred cccCcccc--cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-----------------
Confidence 86654321 12222346788999999998899999999999999999997 99999754432
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+.... ........+..+.+++.+||+.||.+|||+.++++.|+.+..+.
T Consensus 225 ------~~~~~i~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 225 ------DVIGRIENGE---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ------GHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------HHHHHHHcCC---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111121111 11123345667889999999999999999999999999988654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=325.86 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=191.1
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..++|.+.+.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.+++.+ ||||+++++++.+.+..++||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 4567999999999999999999997 6789999997653 45577899999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcEEEeecccccccc
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLE 162 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~~~~~~ 162 (313)
++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.++|+|||++....
T Consensus 131 ~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 131 TGGELFDRIV-----EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CSCBHHHHHT-----TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred CCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999983 4566899999999999999999999999 999999999999975 8899999999987654
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||...... .
T Consensus 203 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~------------- 257 (349)
T 2w4o_A 203 HQV----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--------Q------------- 257 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--------H-------------
T ss_pred ccc----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--------H-------------
Confidence 321 122346899999999999999999999999999999999999999654331 0
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.....+...............+..+.+|+++||+.||++|||+.++++.
T Consensus 258 -~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 258 -FMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111111111111233456678999999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=323.23 Aligned_cols=264 Identities=24% Similarity=0.387 Sum_probs=218.3
Q ss_pred HHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 5 NEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
+..+...++|++.+.||+|+||.||+|.+. +..+|+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+..+
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 344456789999999999999999999998 7889999987654 45688999999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+|||++.+++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 86 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEECCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEcCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 999999999999998522 3456899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
....... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 160 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~------------------ 219 (288)
T 3kfa_A 160 LMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------------ 219 (288)
T ss_dssp TSCSSSS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------------------
T ss_pred eccCCcc--ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------------------
Confidence 7654322 12223456788999999999999999999999999999999 99999754432
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccc
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKE 302 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 302 (313)
+....+....... .....+..+.+|+.+||+.||.+|||+.++++.|+.+..+...
T Consensus 220 -----~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~ 275 (288)
T 3kfa_A 220 -----QVYELLEKDYRME---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275 (288)
T ss_dssp -----GHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -----HHHHHHhccCCCC---CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 1122222221111 2234456789999999999999999999999999999886543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=321.14 Aligned_cols=266 Identities=27% Similarity=0.424 Sum_probs=208.4
Q ss_pred HHHhcCccccceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc---CCCceeeeeEEEeC----CeEEE
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV---HSNLIELIGYAAGG----DSLFL 80 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l---h~~i~~~~~~~~~~----~~~~l 80 (313)
....++|++.+.||+|+||.||+|++.++.||||++..........|.+++... ||||+++++++... ...++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 345679999999999999999999999999999999877767777777777665 99999999999877 78999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC--------CCCceEEeccCCCCeeeCCCCcEEE
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY--------TKPYYVHRDVKTSNILLDSNFRAKI 152 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~--------~~~~i~h~di~p~nil~~~~~~~~l 152 (313)
||||+++++|.+++. ...+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.+||
T Consensus 113 v~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 113 ITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEE
T ss_pred EEeccCCCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEE
Confidence 999999999999994 23589999999999999999999998 8 999999999999999999999
Q ss_pred eeccccccccCChhhh-hhcccccccccccCCccccCCCCCCc------cchhhHHHHHHHHHhC----------CCCcc
Q 041031 153 ADFGLVKLLEHSPEIA-AAASRIVGTFGYLAPEYVRDGCVTTK------SDVYAFGVVLMELITG----------QQALS 215 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~------~DiwslG~~l~~~~tg----------~~p~~ 215 (313)
+|||++.......... .......+|+.|+|||++.+...+.. +|||||||++|+|++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999997655432211 12223468999999999987766665 9999999999999999 44443
Q ss_pred CCCCCCCCccccchhHHHHHHHHhcCcHHHHHHh-hhhcCCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 216 RDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKL-TECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...... .... .....+ .....+.... ....++..+.+++.+||+.||.+|||+.++++.
T Consensus 264 ~~~~~~-------~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 264 DLVPSD-------PSYE-----------DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTSCSS-------CCHH-----------HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhcCCC-------Cchh-----------hhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 322211 0000 001111 1111222221 233677889999999999999999999999999
Q ss_pred HHHHHhcc
Q 041031 293 LSHILISS 300 (313)
Q Consensus 293 l~~~~~~~ 300 (313)
|+++..+.
T Consensus 326 L~~l~~~~ 333 (337)
T 3mdy_A 326 LAKMSESQ 333 (337)
T ss_dssp HHHHHHTT
T ss_pred HHHHHhhc
Confidence 99988764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=328.53 Aligned_cols=251 Identities=21% Similarity=0.264 Sum_probs=201.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc--------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT--------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~--------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|++.+.||+|+||.||+|.++ ++.||||++... ..+.+.+|+.+++.+ ||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999987 789999998532 345688999999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc---EEEeecc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR---AKIADFG 156 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~---~~l~dfg 156 (313)
+||||+++++|.+.+.... .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999988774221 12345899999999999999999999999 999999999999986554 9999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
++........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 179 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------------- 238 (351)
T 3c0i_A 179 VAIQLGESGL---VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----------------- 238 (351)
T ss_dssp TCEECCTTSC---BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----------------
T ss_pred ceeEecCCCe---eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----------------
Confidence 9987654321 22334689999999999999999999999999999999999999965321
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+...............+..+.+|+.+||..||.+|||+.++++.
T Consensus 239 -------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 239 -------RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -------HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111111100000000011234578899999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=329.15 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=194.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
.++|.+.+.||+|+||.||+|++. ++.||||++.... .+.+.+|+.+++.+ ||||+++++++.+.+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 478999999999999999999997 7889999987543 56688999999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc--EEEeeccccccccC
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR--AKIADFGLVKLLEH 163 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~--~~l~dfg~~~~~~~ 163 (313)
.+++|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++. +||+|||++.....
T Consensus 99 ~~~~L~~~l~-----~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 99 SGGELYERIC-----NAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999983 3456999999999999999999999999 999999999999987665 99999999874332
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCc-cchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTK-SDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
. .......+|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......
T Consensus 171 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------------------- 225 (361)
T 3uc3_A 171 H----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--------------------- 225 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC---------------------
T ss_pred c----CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH---------------------
Confidence 2 12233468999999999988877655 899999999999999999997654421
Q ss_pred HHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.....+.......... .....+..+.+|+.+||..||.+|||+.|+++.-+
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 226 -DYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp -CHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred -HHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 1111111111111111 11234467889999999999999999999997633
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=321.62 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=203.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---------SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
..++|.+.+.||+|+||.||+|.+. ++.+|+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4678999999999999999999987 7889999986532 45688999999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC----cEEEe
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF----RAKIA 153 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----~~~l~ 153 (313)
.++||||+++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+
T Consensus 90 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLA-----QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHH-----TCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEc
Confidence 999999999999999994 4467899999999999999999999999 99999999999999887 79999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+....
T Consensus 162 Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------- 224 (321)
T 2a2a_A 162 DFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------------- 224 (321)
T ss_dssp CCTTCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------------
T ss_pred cCccceecCccc----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------------
Confidence 999998665432 223346899999999999999999999999999999999999999654321
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+...............+..+.+|+.+||+.||.+|||+.++++.
T Consensus 225 ----------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 225 ----------ETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ----------HHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ----------HHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111111000000112234578899999999999999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=329.89 Aligned_cols=247 Identities=24% Similarity=0.351 Sum_probs=198.6
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~l 80 (313)
.++|+++++||+|+||.||+|+++ ++.+|+|+++... ...+..|..++.++ ||||+++++++.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 568999999999999999999987 7789999987542 34477899999887 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+++|+|.+++. ....+++..++.++.|++.||.|||+++ |+|+||||+||+++.+|.+||+|||++..
T Consensus 131 V~E~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence 999999999999984 3457999999999999999999999999 99999999999999999999999999875
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
..... .......+|+.|+|||++.+..++.++|+|||||++|+|++|..||...............
T Consensus 203 ~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~----------- 268 (396)
T 4dc2_A 203 GLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED----------- 268 (396)
T ss_dssp CCCTT---CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHH-----------
T ss_pred cccCC---CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHH-----------
Confidence 33221 2334457899999999999999999999999999999999999999654332111000000
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM 286 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 286 (313)
.....+.. .... .....+..+.+|+++||+.||.+||++
T Consensus 269 ---~~~~~i~~-~~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 269 ---YLFQVILE-KQIR---IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---HHHHHHHH-CCCC---CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---HHHHHHhc-cccC---CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 01111111 0111 223345678899999999999999996
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=317.52 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=195.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----------------------------cHHHHHHHHHH
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----------------------------SKEFSSELKIL 58 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----------------------------~~~~~~e~~~l 58 (313)
..++|++.+.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3578999999999999999999986 7889999986542 24578899999
Q ss_pred Hhc-CCCceeeeeEEEe--CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEe
Q 041031 59 CKV-HSNLIELIGYAAG--GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHR 135 (313)
Q Consensus 59 ~~l-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~ 135 (313)
+.+ ||||+++++++.+ ....++||||+++++|.+++ ....+++..++.++.|++.||+|||+++ ++|+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 161 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP------TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHR 161 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS------CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 999 9999999999986 56899999999999998875 2357999999999999999999999999 9999
Q ss_pred ccCCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCC---CCCccchhhHHHHHHHHHhCCC
Q 041031 136 DVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC---VTTKSDVYAFGVVLMELITGQQ 212 (313)
Q Consensus 136 di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~~~tg~~ 212 (313)
||||+||+++.++.+||+|||++........ ......+|+.|+|||++.+.. ++.++||||||+++|+|++|..
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCHHHEEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999999999999999999887654321 222346899999999998755 3778999999999999999999
Q ss_pred CccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 213 ALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 213 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
||...... .....+.... ... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 239 pf~~~~~~-----------------------~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 239 PFMDERIM-----------------------CLHSKIKSQA-LEF-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSCCSSHH-----------------------HHHHHHHHCC-CCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCccHH-----------------------HHHHHHhccc-CCC-CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 99643210 1111111110 000 012234567889999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=329.42 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=198.3
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV--HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~ 78 (313)
...++|++.+.||+|+||.||+|+++ ++.||||+++.. .......|..+++.+ ||||+++++++.+.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34678999999999999999999987 788999998753 244577899999987 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++||||+++|+|.+++. ....+++..++.++.|++.||.|||+++ |+|+||||+||+++.+|.+||+|||++
T Consensus 100 ~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQ-----KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccce
Confidence 99999999999999984 3466999999999999999999999999 999999999999999999999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
....... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 172 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------------------ 230 (353)
T 3txo_A 172 KEGICNG---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------------------ 230 (353)
T ss_dssp BCSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------------
T ss_pred eecccCC---ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------------------
Confidence 7543322 2233457899999999999988999999999999999999999999754321
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH------HHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM------SNAAI 291 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~------~~ll~ 291 (313)
+....+.. ... ......+..+.+|+++||+.||.+||++ .++++
T Consensus 231 -----~~~~~i~~---~~~-~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 231 -----DLFEAILN---DEV-VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----HHHHHHHH---CCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----HHHHHHHc---CCC-CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11122211 111 1122345678899999999999999998 66664
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=323.98 Aligned_cols=265 Identities=23% Similarity=0.403 Sum_probs=209.2
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-------CcceEEEecccc----ccHHHHHHHHHHHhc--CCCceeeeeEEEeCC
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNT----KSKEFSSELKILCKV--HSNLIELIGYAAGGD 76 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~----~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~ 76 (313)
..++|.+.+.||+|+||.||+|.+. +..||||.+... ..+.+.+|+.+++.+ ||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999972 457999998753 245688999999999 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCCC------------------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccC
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVK------------------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVK 138 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~ 138 (313)
..++||||+++++|.+++...... ....+++..++.++.|++.||.|||+.+ ++|+|||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999643211 1134789999999999999999999999 9999999
Q ss_pred CCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCC
Q 041031 139 TSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRD 217 (313)
Q Consensus 139 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~ 217 (313)
|+||+++.++.++|+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|+| |..||...
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999865433221 12223456789999999999999999999999999999998 99999765
Q ss_pred CCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 218 ANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
.... .+...+....... .....+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 279 ~~~~----------------------~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 279 PVDA----------------------NFYKLIQNGFKMD---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CCSH----------------------HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CcHH----------------------HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 4320 1122222222111 22334567899999999999999999999999999988
Q ss_pred hccccc
Q 041031 298 ISSKEW 303 (313)
Q Consensus 298 ~~~~~~ 303 (313)
...++.
T Consensus 334 ~~~~~~ 339 (344)
T 1rjb_A 334 ADAEEA 339 (344)
T ss_dssp ------
T ss_pred HHHHHH
Confidence 876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=322.97 Aligned_cols=273 Identities=20% Similarity=0.275 Sum_probs=208.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC--eEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGD--SLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~--~~~lv 81 (313)
.++|.+.++||+|+||.||+|.+. ++.||||++.... .+.+.+|+++++.+ ||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999998 8899999987533 45577999999999 999999999998765 78999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee----CCCCcEEEeeccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL----DSNFRAKIADFGL 157 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~----~~~~~~~l~dfg~ 157 (313)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++|+||||+||++ +.++.+||+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EeCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999996332 2234899999999999999999999999 9999999999999 7778899999999
Q ss_pred cccccCChhhhhhcccccccccccCCcccc--------CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccch
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVR--------DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 229 (313)
+....... ......+++.|+|||++. +..++.++|||||||++|+|++|..||........ ...
T Consensus 163 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~ 234 (319)
T 4euu_A 163 ARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR----NKE 234 (319)
T ss_dssp CEECCTTC----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG----CHH
T ss_pred ceecCCCC----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch----hHH
Confidence 98765432 222346899999999986 57789999999999999999999999975543210 001
Q ss_pred hHHHHHHHHhcCcHHHHHHh----hhh--cCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 230 SLVDYMLAVFNDTKDFMAKL----TEC--LDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~l----~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
.................... ..+ .-+............+.+++++||+.||++|||+.|+++...+-
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11111111000000000000 000 00111124567788899999999999999999999999988744
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=319.95 Aligned_cols=240 Identities=25% Similarity=0.395 Sum_probs=202.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|++.+.||+|+||.||+|+++ ++.||+|++... ..+.+.+|..+++.+ ||||+++++++.+.+.+++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 578999999999999999999987 889999998653 345577899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.+|.+||+|||++...
T Consensus 85 ~e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 85 MDYIEGGELFSLLR-----KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp ECCCCSCBHHHHHH-----HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeCCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceec
Confidence 99999999999994 3456899999999999999999999999 999999999999999999999999999865
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
... .....+|+.|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 157 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------------------- 209 (318)
T 1fot_A 157 PDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------------------- 209 (318)
T ss_dssp SSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---------------------
T ss_pred CCc------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---------------------
Confidence 432 22356899999999999999999999999999999999999999654321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAI 291 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~ 291 (313)
+....+.. ... ......+..+.+++.+||..||.+|| +++++++
T Consensus 210 --~~~~~i~~---~~~-~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 210 --KTYEKILN---AEL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --HHHHHHHH---CCC-CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --HHHHHHHh---CCC-CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11111111 111 11223456788999999999999999 8888874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=319.74 Aligned_cols=262 Identities=21% Similarity=0.282 Sum_probs=199.0
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
...++|++.+.||+|+||.||+|.+. ++.||+|++.... .+.+.+|+.+++.+ ||||+++++++.+.+..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 45688999999999999999999987 7889999987542 24577899999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
++||++++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 111 lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~ 182 (309)
T 2h34_A 111 VDMRLINGVDLAAMLR-----RQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS 182 (309)
T ss_dssp EEEECCCCEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred EEEEecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCc
Confidence 9999999999999984 3356899999999999999999999999 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
....... .......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 183 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------------- 241 (309)
T 2h34_A 183 ATTDEKL--TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------------------- 241 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------------------
T ss_pred ccccccc--ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------------------
Confidence 6543221 1222346889999999999999999999999999999999999999643210
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHHHhcccccc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-DMSNAAIRLSHILISSKEWE 304 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~ll~~l~~~~~~~~~~~ 304 (313)
.....+.. ..+.........+..+.+++.+||+.||.+|| |++++++.|+..........
T Consensus 242 ----~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 242 ----VMGAHINQ-AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp ----HHHHHHHS-CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred ----HHHHHhcc-CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 00111111 01111112334455788999999999999999 99999999998877654443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=318.18 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=201.1
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEeccccc-cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (313)
.++|++.+.||+|+||.||+|.+.++.||||.+.... .+.+.+|+++++.+ ||||+++++++.+ ..++||||++++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred HhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 4689999999999999999999999999999997654 45678999999999 9999999998874 478999999999
Q ss_pred ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc---CCCCceEEeccCCCCeeeCCCCc-EEEeeccccccccCC
Q 041031 89 ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ---YTKPYYVHRDVKTSNILLDSNFR-AKIADFGLVKLLEHS 164 (313)
Q Consensus 89 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~~~~i~h~di~p~nil~~~~~~-~~l~dfg~~~~~~~~ 164 (313)
+|.+++.... ....++...++.++.|++.||+|||+ ++ ++|+||||+||+++.++. +||+|||++......
T Consensus 85 ~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 85 SLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp BHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9999995321 12347888999999999999999999 77 999999999999998886 799999998754432
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
.....+++.|+|||++.+..++.++||||||+++|+|++|+.||....... . .
T Consensus 160 ------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------~-----------~ 212 (307)
T 2eva_A 160 ------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----------F-----------R 212 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----------H-----------H
T ss_pred ------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----------H-----------H
Confidence 122358999999999999999999999999999999999999997543310 0 0
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
....... ..........+..+.+++.+||+.||.+|||+.++++.|+.+....+
T Consensus 213 ~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 213 IMWAVHN---GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp HHHHHHT---TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred HHHHHhc---CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0111111 11111233445678899999999999999999999999999886543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=328.64 Aligned_cols=260 Identities=23% Similarity=0.359 Sum_probs=208.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
.++|.+.+.||+|+||.||+|.+. +..||||.++... ...+.+|+.+++.+ ||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999954 4579999986542 33577899999999 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCC--CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC---cEEEe
Q 041031 79 FLVYEYAQNGALSDHLHWPSV--KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF---RAKIA 153 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~---~~~l~ 153 (313)
++||||+.+|+|.+++..... .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999853321 22346899999999999999999999999 99999999999999554 59999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHH
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLV 232 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~ 232 (313)
|||++........ ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 227 DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------------ 293 (367)
T 3l9p_A 227 DFGMARDIYRAGY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------------ 293 (367)
T ss_dssp CCHHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------------
T ss_pred CCccccccccccc-cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 9999875432111 112223457889999999999999999999999999999998 99999754321
Q ss_pred HHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 233 DYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 233 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+...... ......+..+.+|+.+||+.||.+|||+.+|++.|+.+..+.
T Consensus 294 -----------~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 294 -----------EVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp -----------HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -----------HHHHHHHcCCCC---CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 222222221111 123345567889999999999999999999999999887653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=324.05 Aligned_cols=261 Identities=20% Similarity=0.257 Sum_probs=208.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeec
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
.++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|+.+++.+ ||||+++++++.+.+..++|||++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 478999999999999999999975 889999998754 345688999999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc-----EEEeecccccc
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR-----AKIADFGLVKL 160 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~-----~~l~dfg~~~~ 160 (313)
+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++. ++|+|||++..
T Consensus 88 -~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 88 -GPSLEDLFDL----CDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp -CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred -CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999852 2467999999999999999999999999 999999999999998887 99999999987
Q ss_pred ccCChhhhh----hcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 161 LEHSPEIAA----AASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 161 ~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
......... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||.+..... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~---------~~~~~~ 230 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT---------LKERYQ 230 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS---------HHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc---------HHHHHH
Confidence 554322110 1234578999999999999999999999999999999999999998754321 111111
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
..... . ....... .....+ .+.+++..||+.||.+||++.+|.+.|+.+...
T Consensus 231 ~i~~~--~-~~~~~~~-------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 231 KIGDT--K-RATPIEV-------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HHHHH--H-HHSCHHH-------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHhh--h-ccCCHHH-------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 10000 0 0000000 011123 788999999999999999999999999988764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=324.60 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=185.1
Q ss_pred cCcccc---ceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEee
Q 041031 12 SNFSTS---LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 12 ~~y~~~---~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
++|.+. +.||+|+||.||+|.+. ++.||||++.........+|+.+++.+ ||||+++++++.+....++||||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 87 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 87 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence 445554 78999999999999997 788999999888778889999999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC---cEEEeeccccccc
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF---RAKIADFGLVKLL 161 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~---~~~l~dfg~~~~~ 161 (313)
+++++|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++ .++|+|||++...
T Consensus 88 ~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 88 LNGGELFERIK-----KKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp CCSCBHHHHHH-----HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred cCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999984 3467999999999999999999999999 99999999999997665 7999999999865
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||........ .....
T Consensus 160 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~~~--------- 222 (325)
T 3kn6_A 160 PPDNQ---PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-----CTSAV--------- 222 (325)
T ss_dssp CC-------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC------------CCCHH---------
T ss_pred CCCCC---cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-----cccHH---------
Confidence 43322 22234579999999999999999999999999999999999999976543210 00011
Q ss_pred cHHHHHHhhhhcCCCCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTR---YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+ ....... .....+..+.+|+.+||..||.+|||+.++++.
T Consensus 223 --~~~~~i---~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 223 --EIMKKI---KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp --HHHHHH---TTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred --HHHHHH---HcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 111111 1111111 112345678999999999999999999998854
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=318.72 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=208.1
Q ss_pred HhcCccccc-eeccCCeEEEEEeEEC----CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 10 ATSNFSTSL-KIGQGSYGSVYLGKLR----GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 10 ~~~~y~~~~-~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
..++|.+.+ .||+|+||.||+|.+. ++.+|||++.... .+.+.+|+.+++.+ ||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 456788888 9999999999999653 5779999987543 44578899999999 99999999999 56678
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++|||++++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 93 ~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp EEEEECCTTEEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCCHHHHHH-----hCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 99999999999999994 3456899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
.................+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------- 227 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----------------- 227 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------------
Confidence 876543322222222345688999999998889999999999999999999 99999754321
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccc
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW 303 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 303 (313)
+....+...... ......+..+.+++.+||+.||.+|||+.++++.|+.+.......
T Consensus 228 ------~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 228 ------EVTAMLEKGERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp ------HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred ------HHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 112222221111 123345678999999999999999999999999999998865443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=320.45 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=210.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
..++|.+.+.||+|+||.||+|.+. +..||||.+.... .+.+.+|+.+++.+ ||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3578999999999999999999873 3679999997643 34577899999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCC-------------------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccC
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVK-------------------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVK 138 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~ 138 (313)
.++||||+++++|.+++...... ....+++..++.++.|++.||.|||+++ ++|+|||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 99999999999999999643211 1234899999999999999999999999 9999999
Q ss_pred CCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCC
Q 041031 139 TSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRD 217 (313)
Q Consensus 139 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~ 217 (313)
|+||++++++.++|+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccc-eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998765433221 12223356788999999999889999999999999999999 99999754
Q ss_pred CCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 218 ANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
... +....+...... ......+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 257 ~~~-----------------------~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 257 PPE-----------------------RLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp CGG-----------------------GHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHH-----------------------HHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 431 112222221111 123345567899999999999999999999999999887
Q ss_pred hc
Q 041031 298 IS 299 (313)
Q Consensus 298 ~~ 299 (313)
..
T Consensus 311 ~~ 312 (314)
T 2ivs_A 311 VK 312 (314)
T ss_dssp HT
T ss_pred hh
Confidence 53
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=334.99 Aligned_cols=257 Identities=23% Similarity=0.316 Sum_probs=207.1
Q ss_pred hHHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEe
Q 041031 4 YNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAG 74 (313)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~ 74 (313)
+..++...++|++.++||+|+||.||+|+++ ++.||+|++.... ...+.+|..++..+ ||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3445556789999999999999999999988 6789999986532 33478899999999 9999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
.+.+++||||+++|+|.+++. .....+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~----~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLS----KFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHH----TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHH----HccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999995 22467999999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhhhhhcccccccccccCCcccc-----CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccch
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 229 (313)
||++........ .......||+.|+|||++. ...++.++|||||||++|+|++|..||.+....
T Consensus 219 FGla~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--------- 287 (437)
T 4aw2_A 219 FGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--------- 287 (437)
T ss_dssp CTTCEECCTTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---------
T ss_pred hhhhhhcccCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---------
Confidence 999876543322 2223357899999999997 567899999999999999999999999754321
Q ss_pred hHHHHHHHHhcCcHHHHHHhh-hhcCCCCCCCCHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 041031 230 SLVDYMLAVFNDTKDFMAKLT-ECLDPNLTRYHKDSMLQMALLSKDCVDENWKR--RPDMSNAAIR 292 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~ll~~ 292 (313)
+....+. ..............+..+.+||++||..+|.. ||+++|+++.
T Consensus 288 --------------~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 288 --------------ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --------------HHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --------------HHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1111111 11011111112234567889999999998888 9999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=315.31 Aligned_cols=262 Identities=22% Similarity=0.286 Sum_probs=198.0
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
++|++.++||+|+||.||+|.+. ++.||+|.+.... ...+.+|+.+++.+ ||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 68999999999999999999997 7889999986443 24577899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++ ++.+.+. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~-~l~~~~~----~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9975 5555553 33467999999999999999999999999 99999999999999999999999999986543
Q ss_pred ChhhhhhcccccccccccCCccccCCC-CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGC-VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.. .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ...+...........
T Consensus 154 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-------~~~~~~i~~~~~~~~ 223 (292)
T 3o0g_A 154 PV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-------DDQLKRIFRLLGTPT 223 (292)
T ss_dssp CC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-------HHHHHHHHHHHCCCC
T ss_pred cc---ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-------HHHHHHHHHHhCCCC
Confidence 21 1223346799999999998765 799999999999999999988886433221 011111111100000
Q ss_pred HHHHHHhhhhc----------CCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDFMAKLTECL----------DPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~~~~l~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+......... ...+.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000000000 00011122345567889999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=317.75 Aligned_cols=266 Identities=24% Similarity=0.373 Sum_probs=201.3
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|++.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4578999999999999999999986 8899999987422 34577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
|||++.+++|.+++.... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 110 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 999999999999884221 13456899999999999999999999999 99999999999999999999999999876
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.... ..
T Consensus 186 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~-------- 244 (310)
T 2wqm_A 186 FSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------LY-------- 244 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----------HH--------
T ss_pred ecCCCc---cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----------HH--------
Confidence 543221 222346789999999999999999999999999999999999999654321 00
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccccc
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEWEK 305 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 305 (313)
+....+.....+.. .....+..+.+++.+||+.||.+|||+.++++.|+++.+...+-.+
T Consensus 245 ---~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 245 ---SLCKKIEQCDYPPL--PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp ---HHHHHHHTTCSCCC--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred ---HHHHHhhcccCCCC--cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 11111111111111 1234456789999999999999999999999999999987655433
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=311.80 Aligned_cols=249 Identities=30% Similarity=0.522 Sum_probs=201.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----------SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
.++|++.+.||+|+||.||+|.+. ++.||+|.+.... .+.+.+|+.+++.+ ||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999986 8889999986432 15678999999999 999999999987665
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc-----EEE
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR-----AKI 152 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~-----~~l 152 (313)
++||||+++++|.+.+. .....+++..++.++.|++.||+|||+.+. +++|+||||+||+++.++. ++|
T Consensus 97 -~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~-~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLL----DKAHPIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHH----CTTSCCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHh----cccCCccHHHHHHHHHHHHHHHHHHHhCCC-CeecCCCCcceEEEeccCCCCceeEEe
Confidence 69999999999998885 344679999999999999999999999863 3899999999999988776 999
Q ss_pred eeccccccccCChhhhhhcccccccccccCCcccc--CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchh
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR--DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~ 230 (313)
+|||++...... .....+++.|+|||++. ...++.++||||||+++|+|++|..||.......
T Consensus 171 ~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------- 235 (287)
T 4f0f_A 171 ADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK--------- 235 (287)
T ss_dssp CCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH---------
T ss_pred CCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH---------
Confidence 999998754432 22346899999999994 4567899999999999999999999997654320
Q ss_pred HHHHHHHHhcCcHHHHHHhh-hhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 231 LVDYMLAVFNDTKDFMAKLT-ECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
. .....+. ....+ ......+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 236 ~------------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 236 I------------KFINMIREEGLRP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp H------------HHHHHHHHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred H------------HHHHHHhccCCCC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0 0011111 11111 12345567899999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=313.11 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=204.0
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
..++|++.+.||+|+||.||+|.+. ++.+|+|++.... ...+.+|+.+++.+ ||||+++++++.+.+..+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999987 7889999986543 34577899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc---EEEeecccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR---AKIADFGLV 158 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~---~~l~dfg~~ 158 (313)
||++.+++|.+.+. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++. ++|+|||.+
T Consensus 84 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIV-----AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 99999999998884 3456899999999999999999999999 999999999999986554 999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 156 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------------ 213 (284)
T 3kk8_A 156 IEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------------------ 213 (284)
T ss_dssp EECCSSC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------------
T ss_pred EEcccCc----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------------------
Confidence 7655432 122346899999999999999999999999999999999999999654321
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
+....+...............+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus 214 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 214 -----RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp -----HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred -----HHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 11112211111111112234456788999999999999999999999853
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=322.42 Aligned_cols=261 Identities=25% Similarity=0.381 Sum_probs=196.2
Q ss_pred HHhcCccccceeccCCeEEEEEeEECC--c---ceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLRG--K---NAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~~--~---~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
...++|++.+.||+|+||.||+|.+.. . .||||.+... ..+.+.+|+.+++.+ ||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345789999999999999999998872 2 6999998754 245678999999999 9999999999987765
Q ss_pred E------EEEEeecCCCChhhhhcCCCC-CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcE
Q 041031 78 L------FLVYEYAQNGALSDHLHWPSV-KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRA 150 (313)
Q Consensus 78 ~------~lv~e~~~~~~L~~~l~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~ 150 (313)
. +++|||+.+++|.+++..... .....+++..++.++.|++.||+|||+++ ++|+||||+||++++++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 999999999999999843221 12236899999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccch
Q 041031 151 KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~ 229 (313)
+|+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 177 kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------- 246 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--------- 246 (323)
T ss_dssp EECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---------
T ss_pred EEeeccccccccccccc-cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---------
Confidence 99999999865443221 12223356788999999999999999999999999999999 89999765432
Q ss_pred hHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 230 SLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
+....+.... ........+..+.+|+.+||+.||.+|||+.++++.|++++..
T Consensus 247 --------------~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 247 --------------EIYNYLIGGN---RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp --------------GHHHHHHTTC---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------------HHHHHHhcCC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1122221111 1112334556789999999999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=323.43 Aligned_cols=275 Identities=27% Similarity=0.394 Sum_probs=209.9
Q ss_pred hcCccccceeccCCeEEEEEeEE------CCcceEEEecccccc---HHHHHHHHHHHhc-CCCceeeeeEEE--eCCeE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKL------RGKNAAIKQMKNTKS---KEFSSELKILCKV-HSNLIELIGYAA--GGDSL 78 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~------~~~~~aiK~~~~~~~---~~~~~e~~~l~~l-h~~i~~~~~~~~--~~~~~ 78 (313)
.++|++.+.||+|+||.||+|++ .++.||||.+..... +.+.+|+++++.+ ||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 47899999999999999999984 277899999976543 3478999999999 999999999886 55678
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++||||+++++|.+++. .....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 102 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQ----RHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEECCTTCBHHHHHH----HHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEeecCCCCHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccc
Confidence 99999999999999985 22346899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
.................+++.|+|||++.+..++.++||||||+++|+|++|..||...... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-------------~~~~~ 241 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE-------------FLRMM 241 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-------------HHHHC
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch-------------hhhhc
Confidence 87654433222333346788899999999999999999999999999999999998643221 00000
Q ss_pred -h-cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccccc
Q 041031 239 -F-NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEWEK 305 (313)
Q Consensus 239 -~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 305 (313)
. .........................+..+.+|+.+||+.||.+|||+.++++.|+.+......+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp C----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred ccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 0 000011111111111111123445667899999999999999999999999999999876655543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=320.97 Aligned_cols=270 Identities=25% Similarity=0.385 Sum_probs=214.7
Q ss_pred ChHHHHHHhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeee
Q 041031 3 SYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELI 69 (313)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~ 69 (313)
+........++|.+.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 34455556789999999999999999999853 4789999987653 23477899999999 89999999
Q ss_pred eEEEeCC-eEEEEEeecCCCChhhhhcCCCCC-----------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEecc
Q 041031 70 GYAAGGD-SLFLVYEYAQNGALSDHLHWPSVK-----------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDV 137 (313)
Q Consensus 70 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di 137 (313)
+++...+ ..+++|||+++++|.+++...... ....+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987654 589999999999999999643211 0223899999999999999999999999 999999
Q ss_pred CCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccC
Q 041031 138 KTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSR 216 (313)
Q Consensus 138 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~ 216 (313)
||+||+++.++.++|+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccceEEECCCCCEEECCCccccccccCccc-eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999865543221 12233457889999999999999999999999999999998 9999976
Q ss_pred CCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 217 DANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
..... .....+....... .....+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 254 ~~~~~----------------------~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKIDE----------------------EFCRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCSH----------------------HHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhH----------------------HHHHHhccCccCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 54320 1122222221111 1223456788999999999999999999999999999
Q ss_pred Hhccc
Q 041031 297 LISSK 301 (313)
Q Consensus 297 ~~~~~ 301 (313)
..+..
T Consensus 309 ~~~~~ 313 (316)
T 2xir_A 309 LQANA 313 (316)
T ss_dssp HHHHC
T ss_pred Hhhhc
Confidence 87654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=315.53 Aligned_cols=257 Identities=29% Similarity=0.551 Sum_probs=197.6
Q ss_pred HhcCccccceeccCCeEEEEEeEECCcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
..++|++.++||+|+||.||+|++.+ .+|+|.++... .+.+.+|+.+++.+ ||||++++++. .....++|||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 35789999999999999999998875 49999986443 34578899999999 99999999965 5556899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+.+++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 100 ~~~~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHT----TC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999984 34467899999999999999999999999 99999999999999999999999999876543
Q ss_pred ChhhhhhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
... ........+++.|+|||++. +..++.++||||||+++|+|++|..||...... .
T Consensus 173 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~----------- 232 (289)
T 3og7_A 173 WSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--------D----------- 232 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--------H-----------
T ss_pred ccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--------H-----------
Confidence 221 12223346899999999996 566888999999999999999999999765432 0
Q ss_pred CcHHHHHHhhh-hcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 241 DTKDFMAKLTE-CLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 241 ~~~~~~~~l~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
.....+.. ...+........++..+.+|+.+||+.||.+|||+.++++.|+++..
T Consensus 233 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 233 ---QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ---HHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---HHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11111111 22233333445566789999999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=318.13 Aligned_cols=268 Identities=26% Similarity=0.396 Sum_probs=208.5
Q ss_pred cCc-cccceeccCCeEEEEEeEEC------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEe--CCe
Q 041031 12 SNF-STSLKIGQGSYGSVYLGKLR------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAG--GDS 77 (313)
Q Consensus 12 ~~y-~~~~~lg~g~~g~v~~~~~~------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~--~~~ 77 (313)
.+| +++++||+|+||.||++.+. ++.||||++.... ...+.+|+.+++.+ ||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 345 99999999999999988653 6789999998654 34478999999999 9999999999987 467
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
+++||||+++++|.+++. ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~------~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLP------RHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp EEEEECCCTTCBHHHHGG------GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EEEEEecccCCcHHHHHh------hCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccc
Confidence 899999999999999984 234899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+.................++..|+|||++.+..++.++||||||+++|+|++|..||...... ....
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-------------~~~~ 247 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-------------FLEL 247 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-------------HHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-------------hhhh
Confidence 987664432222233345788899999999989999999999999999999999998643210 0000
Q ss_pred H-hcCcHHHHHHhhhhcC-CCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 238 V-FNDTKDFMAKLTECLD-PNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 238 ~-~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
. ..........+...+. ..........+..+.+|+++||+.||.+|||+.++++.|+.+.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 248 IGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 0 0000000111111111 11112344556789999999999999999999999999999876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=333.46 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=204.7
Q ss_pred HHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCC
Q 041031 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGD 76 (313)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~ 76 (313)
.++...++|.+.++||+|+||.||+|+++ ++.||+|++... ....+.+|..+++.+ ||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 44455689999999999999999999997 778999998642 244578899999999 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
.+++||||+++|+|.+++. ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.+|.+||+|||
T Consensus 143 ~~~lV~E~~~gg~L~~~l~------~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp EEEEEECCCTTEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEeCCCCCcHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999984 235899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCC----CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC----VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLV 232 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~ 232 (313)
++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....
T Consensus 214 ~a~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------------ 279 (410)
T 3v8s_A 214 TCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------------ 279 (410)
T ss_dssp TCEECCTTSE--EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------------
T ss_pred eeEeeccCCc--ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------------
Confidence 9976554321 1233457999999999998765 789999999999999999999999754321
Q ss_pred HHHHHHhcCcHHHHHHhhhh-cCCCCCCCCHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 041031 233 DYMLAVFNDTKDFMAKLTEC-LDPNLTRYHKDSMLQMALLSKDCVDENWKR--RPDMSNAAIR 292 (313)
Q Consensus 233 ~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rps~~~ll~~ 292 (313)
+....+... ...... .....+..+.+||.+||..+|.+ ||+++||++.
T Consensus 280 -----------~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 280 -----------GTYSKIMNHKNSLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -----------HHHHHHHTHHHHCCCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -----------hHHHHHHhccccccCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111111110 000111 11234567889999999999988 9999999865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=318.53 Aligned_cols=263 Identities=23% Similarity=0.377 Sum_probs=213.1
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCC
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGD 76 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~ 76 (313)
..++|.+.+.||+|+||.||+|.+. ++.||+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 3578999999999999999999862 5689999997653 34578999999999 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCC-------------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCee
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSV-------------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNIL 143 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil 143 (313)
..++||||+++++|.+++..... .....+++..++.++.|++.||+|||+++ ++|+||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999864321 11235899999999999999999999999 999999999999
Q ss_pred eCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCC
Q 041031 144 LDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGN 222 (313)
Q Consensus 144 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~ 222 (313)
++.++.++|+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 255 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred EcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-
Confidence 999999999999998876543221 12223456788999999999999999999999999999999 999997654320
Q ss_pred CccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 223 NQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
.....+....... .....+..+.+++.+||+.||.+|||+.++++.|+++..+..
T Consensus 256 ---------------------~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 256 ---------------------KFYKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp ---------------------HHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ---------------------HHHHHhccCCCCC---CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 1122222222211 123345678999999999999999999999999999887654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=319.87 Aligned_cols=250 Identities=22% Similarity=0.371 Sum_probs=197.1
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC------
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGD------ 76 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~------ 76 (313)
..++|++.+.||+|+||.||+|++. ++.||||++.... .+.+.+|+.+++.+ ||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4578999999999999999999997 8889999986432 45688999999999 999999999986543
Q ss_pred ---------------------------------------------------eEEEEEeecCCCChhhhhcCCCCCCCCCc
Q 041031 77 ---------------------------------------------------SLFLVYEYAQNGALSDHLHWPSVKGKKPL 105 (313)
Q Consensus 77 ---------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~l 105 (313)
..+++|||+++++|.+++.... .....
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~ 161 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDR 161 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGS
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccch
Confidence 3799999999999999996432 22345
Q ss_pred cHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhh---------hhcccccc
Q 041031 106 AWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIA---------AAASRIVG 176 (313)
Q Consensus 106 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~---------~~~~~~~~ 176 (313)
....++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.......... .......+
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 66678999999999999999999 9999999999999999999999999998766542211 11223468
Q ss_pred cccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCC
Q 041031 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPN 256 (313)
Q Consensus 177 ~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 256 (313)
|+.|+|||++.+..++.++||||||+++|+|++|..|+.. ............
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------------------------~~~~~~~~~~~~ 290 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------------------------RVRIITDVRNLK 290 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------------------------HHHHHHHHHTTC
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------------------------HHHHHHHhhccC
Confidence 9999999999999999999999999999999998776521 111111112222
Q ss_pred CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 257 LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 257 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...........+.+|+.+||+.||.+|||+.|+++.
T Consensus 291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 222233445677899999999999999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=314.74 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=197.4
Q ss_pred cCccccceeccCCeEEEEEeEEC-CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
++|++.+.||+|+||.||+|.+. ++.+|+|.+.... ...+.+|+.+++.+ ||||+++++++.+.+..++|||+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 68999999999999999999987 8899999986443 35678999999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++ +|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 965 8998885 33466899999999999999999999999 999999999999999999999999998765432
Q ss_pred hhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+............
T Consensus 154 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~ 222 (288)
T 1ob3_A 154 VR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--------DQLMRIFRILGTPNS 222 (288)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCCCCT
T ss_pred cc---ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHHCCCCh
Confidence 11 1223467999999999976 45899999999999999999999999754321 111111110000000
Q ss_pred HHHHHhhh--hcCCCCC--------CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 244 DFMAKLTE--CLDPNLT--------RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 244 ~~~~~l~~--~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
........ ..++... ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 0001100 0112345678899999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=323.12 Aligned_cols=276 Identities=25% Similarity=0.386 Sum_probs=206.4
Q ss_pred HhcCccccceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHh--c-CCCceeeeeEEE-----eCCeEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK--V-HSNLIELIGYAA-----GGDSLFLV 81 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~--l-h~~i~~~~~~~~-----~~~~~~lv 81 (313)
..++|++.+.||+|+||.||+|++.++.||||++..........|.+++.. + ||||+++++.+. ....+++|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 467999999999999999999999999999999987777777667666554 5 999999998653 23367899
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC---------CCCceEEeccCCCCeeeCCCCcEEE
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY---------TKPYYVHRDVKTSNILLDSNFRAKI 152 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---------~~~~i~h~di~p~nil~~~~~~~~l 152 (313)
|||+++|+|.+++.. ...++..++.++.|++.||+|||+. + ++|+||||+||+++.++.+||
T Consensus 91 ~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp ECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred EecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence 999999999999842 3347888999999999999999999 8 999999999999999999999
Q ss_pred eeccccccccCChh-----hhhhcccccccccccCCccccC-------CCCCCccchhhHHHHHHHHHhCCCCccCCCCC
Q 041031 153 ADFGLVKLLEHSPE-----IAAAASRIVGTFGYLAPEYVRD-------GCVTTKSDVYAFGVVLMELITGQQALSRDANP 220 (313)
Q Consensus 153 ~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~ 220 (313)
+|||++........ .........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987653221 1112223468999999999986 35667899999999999999998777554432
Q ss_pred CCCccccchhHHHHHHHHhcCcHHHHHHhhh-hcCCCCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 221 GNNQYTEHRSLVDYMLAVFNDTKDFMAKLTE-CLDPNLTR---YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
......... .....+...+....+.. ...+.+.. .....+..+.+|+.+||+.||++|||+.|++++|+++
T Consensus 242 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 242 PEYQMAFQT-----EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCTTHH-----HHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHhhhc-----ccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 211111100 00000111111111111 11222222 2345677899999999999999999999999999999
Q ss_pred Hhc
Q 041031 297 LIS 299 (313)
Q Consensus 297 ~~~ 299 (313)
+..
T Consensus 317 l~~ 319 (336)
T 3g2f_A 317 MMI 319 (336)
T ss_dssp HHC
T ss_pred HHH
Confidence 974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=312.25 Aligned_cols=259 Identities=26% Similarity=0.484 Sum_probs=210.0
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC-CcceEEEecccc--ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNT--KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~--~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
+...++|++.+.||+|+||.||+|.+. +..+|+|.+... ..+.+.+|+++++.+ ||||+++++++.+ +..++|||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 345688999999999999999999988 568999998765 356688999999999 9999999999874 45899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
++++++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 88 ~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 99999999998421 1136899999999999999999999999 99999999999999999999999999987654
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... .......++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 162 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---------------------- 217 (279)
T 1qpc_A 162 NEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---------------------- 217 (279)
T ss_dssp SCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----------------------
T ss_pred ccc--ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH----------------------
Confidence 322 11222346778999999998889999999999999999999 89999654321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
+....+...... ......+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 218 -~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 218 -EVIQNLERGYRM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp -HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -HHHHHHhcccCC---CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 111222211111 1223445678999999999999999999999999999887643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=324.64 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=201.5
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc--CCCceeeeeEEEeCC
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV--HSNLIELIGYAAGGD 76 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~ 76 (313)
.....++|.+.+.||+|+||.||+|+++ ++.||||+++.. .......|..++..+ ||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3456789999999999999999999987 788999998753 345577888888876 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
.+++||||+++|+|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.+|.++|+|||
T Consensus 92 ~~~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp EEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeECh
Confidence 9999999999999999984 3456899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
++....... .......+|+.|+|||++.+..++.++|+|||||++|+|++|..||.+....
T Consensus 164 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---------------- 224 (345)
T 1xjd_A 164 MCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---------------- 224 (345)
T ss_dssp TCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------
T ss_pred hhhhcccCC---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH----------------
Confidence 987543221 1233457899999999999999999999999999999999999999754321
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHH-HHH
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS-NAA 290 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~ll 290 (313)
+....+... .+. .....+..+.+|+.+||..||.+||++. +++
T Consensus 225 -------~~~~~i~~~-~~~---~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 225 -------ELFHSIRMD-NPF---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -------HHHHHHHHC-CCC---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------HHHHHHHhC-CCC---CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111111111 111 1223456788999999999999999997 664
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=339.58 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=213.0
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc--ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT--KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~--~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
..++|.+.++||+|+||.||+|.++ +..||||.++.. ..+.+.+|+.+++.+ ||||+++++++.+....++||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4567899999999999999999998 778999999765 356788999999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+.+|+|.+++... ....++...++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 298 ~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 298 MTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred cCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999522 2356889999999999999999999999 999999999999999999999999999875432
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
.. .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 372 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----------------------- 426 (495)
T 1opk_A 372 TY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------------- 426 (495)
T ss_dssp CE--ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------------
T ss_pred ce--eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----------------------
Confidence 21 11122345678999999998899999999999999999999 99999765431
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+...... .....++..+.+|+.+||+.||.+|||+.+|++.|+.+..+.
T Consensus 427 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 427 QVYELLEKDYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp GHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred HHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 112222221111 123345567899999999999999999999999999987654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=315.18 Aligned_cols=257 Identities=27% Similarity=0.379 Sum_probs=205.8
Q ss_pred HhcCccccceeccCCeEEEEEeEECC-----cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRG-----KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
..++|.+.+.||+|+||.||+|.+.+ ..||+|.+.... .+.+.+|+.+++.+ ||||+++++++.+. ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 46789999999999999999998752 249999987652 45578899999999 99999999998754 568
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+|||++++++|.+++. .....++...++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+.
T Consensus 89 ~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLE----RNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHH----HHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHH----hccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence 9999999999999985 23456899999999999999999999999 9999999999999999999999999988
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
....... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 162 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~------------------ 221 (281)
T 3cc6_A 162 YIEDEDY--YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK------------------ 221 (281)
T ss_dssp CC-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG------------------
T ss_pred ccccccc--cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH------------------
Confidence 6554321 12223456789999999998899999999999999999998 99999654332
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccc
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKE 302 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 302 (313)
+....+....... .....+..+.+++.+||+.||.+|||+.++++.|+.+.....+
T Consensus 222 -----~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 222 -----DVIGVLEKGDRLP---KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp -----GHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -----HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 1112222111111 1223456788999999999999999999999999998876544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=314.13 Aligned_cols=265 Identities=24% Similarity=0.287 Sum_probs=203.8
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-ccHHHHHHHHHHHhc-CCCceeeee-EEEeCCeEEEEEe
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-KSKEFSSELKILCKV-HSNLIELIG-YAAGGDSLFLVYE 83 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-~~~~~~~e~~~l~~l-h~~i~~~~~-~~~~~~~~~lv~e 83 (313)
...++|++.+.||+|+||.||+|.+. ++.||||+.... ....+.+|+.+++.+ |++++..+. ++...+..+++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 45688999999999999999999975 889999986544 345688999999999 666555554 4577888999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee---CCCCcEEEeecccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL---DSNFRAKIADFGLVKL 160 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~---~~~~~~~l~dfg~~~~ 160 (313)
++ +++|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||++ ++++.++|+|||++..
T Consensus 86 ~~-~~~L~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 86 LL-GPSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp CC-CCBHHHHHH----HTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred cc-CCCHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 99 899999985 23456999999999999999999999999 9999999999999 7889999999999987
Q ss_pred ccCChhhh----hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 161 LEHSPEIA----AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 161 ~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
........ .......+++.|+|||++.+..++.++|||||||++|+|++|+.||.......... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~~~ 232 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-----KYERISE 232 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-----HHHHHHH
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh-----hhhhhhc
Confidence 65432211 12234578999999999999999999999999999999999999998655432111 1111111
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
...... .... ....+..+.+++.+||+.||++|||+.++++.|+.+..+.
T Consensus 233 ~~~~~~-------~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 233 KKMSTP-------IEVL-------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHSC-------HHHH-------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccccch-------hhhh-------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 110000 0000 1122457889999999999999999999999999998853
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=320.62 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=202.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--Ccc----eEEEecccc----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKN----AAIKQMKNT----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~----~aiK~~~~~----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|++.++||+|+||.||+|.+. ++. +|+|.+... ....+.+|+.+++.+ ||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 468999999999999999999975 333 588887543 345688999999999 999999999998765 77
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
++++++.+|+|.+++. .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.
T Consensus 93 ~v~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 93 LITQLMPFGCLLDYVR----EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCTTCBHHHHHH----HSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEecCCCcHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence 8999999999999985 33467899999999999999999999999 9999999999999999999999999988
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 166 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------------------ 226 (327)
T 3poz_A 166 LLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------------------ 226 (327)
T ss_dssp HHTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------------------
T ss_pred EccCCccc-ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH------------------
Confidence 65433221 12222356789999999999999999999999999999999 99999754432
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
+....+...... ......+..+.+++.+||+.||.+|||+.++++.|+.+..+
T Consensus 227 -----~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 227 -----EISSILEKGERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----GHHHHHHTTCCC---CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----HHHHHHHcCCCC---CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 112222221111 12334556788999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=335.80 Aligned_cols=257 Identities=24% Similarity=0.446 Sum_probs=210.9
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC-CcceEEEecccc--ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNT--KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~--~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
...++|.+.+.||+|+||.||+|.+. +..||||.++.. ..+.+.+|+.+++.+ ||||+++++++. .+..++||||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 34578999999999999999999997 778999999864 356788999999999 999999999987 5678999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+.+|+|.+++... ....++...++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 264 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 264 MAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CTTCBHHHHHHSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred cCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999522 1235788899999999999999999999 999999999999999999999999999876532
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
.. .......++..|+|||++.+..++.++||||||+++|+|+| |..||.+....
T Consensus 338 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~----------------------- 392 (454)
T 1qcf_A 338 EY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----------------------- 392 (454)
T ss_dssp HH--HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----------------------
T ss_pred ce--eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----------------------
Confidence 21 12222346788999999998899999999999999999999 99999754321
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+....... ....++..+.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus 393 ~~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 393 EVIRALERGYRMP---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HHHHHHHcCCCCC---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 1122222221111 22345667899999999999999999999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=321.52 Aligned_cols=247 Identities=24% Similarity=0.351 Sum_probs=198.0
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~l 80 (313)
.++|++.+.||+|+||.||+|+++ ++.||+|++.... ...+.+|..+++.+ ||||+++++++.+.+.+++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 578999999999999999999987 7889999987542 33467899999887 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.+|.+||+|||++..
T Consensus 88 v~e~~~gg~L~~~l~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQ-----RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEeCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccc
Confidence 999999999999984 3456899999999999999999999999 99999999999999999999999999875
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
..... .......+|+.|+|||++.+..++.++|+|||||++|+|++|..||...............
T Consensus 160 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----------- 225 (345)
T 3a8x_A 160 GLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED----------- 225 (345)
T ss_dssp SCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHH-----------
T ss_pred ccCCC---CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHH-----------
Confidence 33221 2233457899999999999999999999999999999999999999654332110000000
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM 286 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 286 (313)
.....+... ... .....+..+.+|+++||+.||.+||++
T Consensus 226 ---~~~~~i~~~-~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 226 ---YLFQVILEK-QIR---IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---HHHHHHHHC-CCC---CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---HHHHHHHcC-CCC---CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111111111 111 223445678899999999999999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=325.51 Aligned_cols=258 Identities=22% Similarity=0.390 Sum_probs=194.2
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe---
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDS--- 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~--- 77 (313)
..++|++.+.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+ ||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4678999999999999999999986 7889999997642 23467889999888 9999999999876543
Q ss_pred -EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 78 -LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 78 -~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
.++||||+++++|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEECCCEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCS
T ss_pred ccEEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeecc
Confidence 499999999999999984 3456899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
++.................+++.|+|||++.+..++.++||||||+++|+|++|..||.+.... ....
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------------~~~~ 229 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------------SVAY 229 (311)
T ss_dssp CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------------HHHH
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------------HHHH
Confidence 9987654433333333456899999999999999999999999999999999999999754321 0000
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHH-HHHHHHHh
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAA-IRLSHILI 298 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll-~~l~~~~~ 298 (313)
........+ ........+..+.+++.+||+.||.+||+..+++ ..+.++..
T Consensus 230 ----------~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 230 ----------QHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp ----------HHHHCCCCC-HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred ----------HHhcCCCCC-cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 000000000 0001223456788999999999999999665554 55555543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=321.22 Aligned_cols=261 Identities=23% Similarity=0.242 Sum_probs=203.1
Q ss_pred HHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc--------ccHHHHHHHHHHHhc-CCCceeeeeEEEe
Q 041031 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT--------KSKEFSSELKILCKV-HSNLIELIGYAAG 74 (313)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~--------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~ 74 (313)
++....++|++.+.||+|+||.||+|.+. ++.+|+|++... ..+.+.+|+.+++.+ ||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 46778899999999999999999999987 778999988643 245688899999999 9999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCC-----------------------------------CCCCCccHHHHHHHHHHHHH
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSV-----------------------------------KGKKPLAWTTRVQIALDAAK 119 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~-----------------------------------~~~~~l~~~~~~~~~~~i~~ 119 (313)
.+..++||||+++++|.+++..... .....+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999998842100 01223467888999999999
Q ss_pred HHHHHhcCCCCceEEeccCCCCeeeCCCC--cEEEeeccccccccCChh-hhhhcccccccccccCCccccC--CCCCCc
Q 041031 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNF--RAKIADFGLVKLLEHSPE-IAAAASRIVGTFGYLAPEYVRD--GCVTTK 194 (313)
Q Consensus 120 ~l~~lh~~~~~~i~h~di~p~nil~~~~~--~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~--~~~~~~ 194 (313)
||+|||+.+ ++|+||||+||+++.++ .++|+|||++........ .........+++.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999 99999999999998776 899999999986543211 1112234568999999999975 678999
Q ss_pred cchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhh
Q 041031 195 SDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKD 274 (313)
Q Consensus 195 ~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~ 274 (313)
+||||||+++|+|++|..||...... +....+...............+..+.+|+.+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA-----------------------DTISQVLNKKLCFENPNYNVLSPLARDLLSN 313 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH-----------------------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH-----------------------HHHHHHHhcccccCCcccccCCHHHHHHHHH
Confidence 99999999999999999999755431 1111111111111111223356778999999
Q ss_pred ccccCcCCCCCHHHHHHH
Q 041031 275 CVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 275 cl~~~p~~Rps~~~ll~~ 292 (313)
||+.||.+|||+.++++.
T Consensus 314 ~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HSCSCTTTSCCHHHHHHS
T ss_pred HcCCChhHCCCHHHHhcC
Confidence 999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=321.23 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=203.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC--Ccc----eEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKN----AAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~----~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|++.+.||+|+||.||+|.+. ++. +++|.+.... ...+.+|+.+++.+ ||||+++++++.+ +..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence 468999999999999999999986 443 7777765332 34567899999999 9999999999874 5688
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+||||+.+++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 91 ~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVR----QHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEECCTTCBSHHHHH----SSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEeCCCCCHHHHHH----HccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccc
Confidence 9999999999999985 23457889999999999999999999999 9999999999999999999999999998
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------------ 224 (325)
T 3kex_A 164 LLPPDDKQ-LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA------------------ 224 (325)
T ss_dssp GSCCCTTC-CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT------------------
T ss_pred ccCccccc-ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH------------------
Confidence 76543221 12233457789999999999999999999999999999999 99999765442
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+....... .....+..+.+++.+||+.||.+|||+.++++.|+++..+.
T Consensus 225 -----~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 225 -----EVPDLLEKGERLA---QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp -----HHHHHHHTTCBCC---CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred -----HHHHHHHcCCCCC---CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1222222211111 12223445778999999999999999999999999987643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=314.91 Aligned_cols=253 Identities=28% Similarity=0.474 Sum_probs=202.8
Q ss_pred HhcCccccceeccCCeEEEEEeEECCcceEEEeccccc-cHHHHHHHHHHHhc-CCCceeeeeEEEeC-CeEEEEEeecC
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIELIGYAAGG-DSLFLVYEYAQ 86 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h~~i~~~~~~~~~~-~~~~lv~e~~~ 86 (313)
..++|++.+.||+|+||.||+|.+.++.+|||.+.... .+.+.+|+.+++.+ ||||+++++++... +..++|||+++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred ChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 35789999999999999999999999999999998654 55688999999999 99999999997544 47899999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+++|.+++... ....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 99 KGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp TEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999998421 1123788899999999999999999999 9999999999999999999999999987544321
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
....+++.|+|||++.+..++.++||||||+++|+|++ |..||...... +.
T Consensus 172 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----------------------~~ 223 (278)
T 1byg_A 172 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------------DV 223 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----------------------GH
T ss_pred -----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----------------------HH
Confidence 12246789999999998899999999999999999998 99999754321 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
...+...... ......+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 224 ~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 224 VPRVEKGYKM---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHHHTTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHhcCCCC---CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 2222211111 123345567899999999999999999999999999987653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=322.69 Aligned_cols=267 Identities=25% Similarity=0.399 Sum_probs=214.0
Q ss_pred cChHHHHHHhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeee
Q 041031 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELI 69 (313)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~ 69 (313)
|+.++.+...++|++.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 445556667889999999999999999999865 5679999997543 23477899999999 99999999
Q ss_pred eEEEeCCeEEEEEeecCCCChhhhhcCCCC-----CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee
Q 041031 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSV-----KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL 144 (313)
Q Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 144 (313)
+++.+.+..++|||++++++|.+++..... .....+++..++.++.|++.||.|||+++ ++|+||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 999999999999999999999999842210 11245688999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCC
Q 041031 145 DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNN 223 (313)
Q Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~ 223 (313)
+.++.++|+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 247 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--- 247 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---
T ss_pred cCCCeEEECcCcccccccccccc-ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---
Confidence 99999999999998765432211 12223356788999999999899999999999999999999 88998654321
Q ss_pred ccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 224 QYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
+....+ ............+..+.+++.+||+.||.+|||+.++++.|++++.
T Consensus 248 --------------------~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 248 --------------------QVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --------------------HHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --------------------HHHHHH---HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 111111 1112222234455678999999999999999999999999998765
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=322.01 Aligned_cols=241 Identities=23% Similarity=0.346 Sum_probs=202.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|.+++.||+|+||.||+|++. ++.||+|++... ..+.+.+|+.+++.+ ||||+++++++.+.+.+++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 578999999999999999999987 789999998643 245577899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.+|.++|+|||++...
T Consensus 120 ~e~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 120 MEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EECCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EcCCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceec
Confidence 99999999999984 3356899999999999999999999999 999999999999999999999999999865
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 192 ~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------------------- 244 (350)
T 1rdq_E 192 KGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------------------- 244 (350)
T ss_dssp SSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------------
T ss_pred cCC------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---------------------
Confidence 432 22346899999999999999999999999999999999999999754321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-----MSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~ll~~ 292 (313)
+....+... .. ......+..+.+|+.+||+.||.+||+ +++|++.
T Consensus 245 --~~~~~i~~~---~~-~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 245 --QIYEKIVSG---KV-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --HHHHHHHHC---CC-CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --HHHHHHHcC---CC-CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 111112111 11 112334567889999999999999998 7888753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=325.14 Aligned_cols=204 Identities=27% Similarity=0.388 Sum_probs=176.2
Q ss_pred cChHHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc------CCCceeeeeE
Q 041031 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV------HSNLIELIGY 71 (313)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l------h~~i~~~~~~ 71 (313)
|+++.-....++|.+.++||+|+||.||+|++. ++.||||++.... ......|+.+++.+ ||||++++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 444455556789999999999999999999995 7889999997543 44567789999887 8999999999
Q ss_pred EEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-----
Q 041031 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS----- 146 (313)
Q Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~----- 146 (313)
+...+..++|||++ +++|.+++... ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 99999999999999 88999998522 2345899999999999999999999999 999999999999975
Q ss_pred --------------------CCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHH
Q 041031 147 --------------------NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLME 206 (313)
Q Consensus 147 --------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 206 (313)
++.++|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 788999999999764432 223468999999999999999999999999999999
Q ss_pred HHhCCCCccCCC
Q 041031 207 LITGQQALSRDA 218 (313)
Q Consensus 207 ~~tg~~p~~~~~ 218 (313)
|++|..||....
T Consensus 252 ll~g~~pf~~~~ 263 (360)
T 3llt_A 252 LYTGSLLFRTHE 263 (360)
T ss_dssp HHHSSCSCCCSS
T ss_pred HHHCCCCCCCCc
Confidence 999999997644
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=309.17 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=204.3
Q ss_pred HhcCccccceeccCCeEEEEEeEECCcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeC--CeEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGG--DSLFLV 81 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~--~~~~lv 81 (313)
..++|.+.+.||+|+||.||+|.+.++.+|||++.... .+.+.+|+.+++.+ ||||+++++++.+. ...++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35789999999999999999999999999999987543 34578899999999 99999999999877 788999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++++|.+++... ....+++..++.++.|++.||+|||+.+.. ++|+||||+||+++.++.+++.|||.....
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~-i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTTSSSC-CTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCCc-eecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999532 223589999999999999999999997633 899999999999999999999988876543
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCC---ccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTT---KSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
... ...+|+.|+|||++.+..++. ++||||||+++|+|++|..||...... .
T Consensus 164 ~~~--------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------~----- 218 (271)
T 3kmu_A 164 QSP--------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------------E----- 218 (271)
T ss_dssp SCT--------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------------H-----
T ss_pred ccc--------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------------H-----
Confidence 321 235789999999998766555 799999999999999999999654321 0
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
...........+. .....+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 219 -----~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 219 -----IGMKVALEGLRPT---IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -----HHHHHHHSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0011111111121 23345667899999999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=319.30 Aligned_cols=265 Identities=27% Similarity=0.425 Sum_probs=212.9
Q ss_pred HHHhcCccccceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHh--c-CCCceeeeeEEEeCC----eEEE
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCK--V-HSNLIELIGYAAGGD----SLFL 80 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~--l-h~~i~~~~~~~~~~~----~~~l 80 (313)
....++|.+.+.||+|+||.||+|.+.++.||||++.......+.+|.++++. + ||||+++++++.... ..++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 117 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence 44568999999999999999999999999999999988877788899999988 5 999999999998776 7899
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHh--------cCCCCceEEeccCCCCeeeCCCCcEEE
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH--------QYTKPYYVHRDVKTSNILLDSNFRAKI 152 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--------~~~~~~i~h~di~p~nil~~~~~~~~l 152 (313)
||||+++++|.+++. ...+++..++.++.|++.||.||| +.+ ++|+||||+||+++.++.++|
T Consensus 118 v~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp EECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEE
T ss_pred EEeecCCCcHHHHHh------ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEE
Confidence 999999999999994 235899999999999999999999 888 999999999999999999999
Q ss_pred eeccccccccCChhhh-hhcccccccccccCCccccCCC------CCCccchhhHHHHHHHHHhC----------CCCcc
Q 041031 153 ADFGLVKLLEHSPEIA-AAASRIVGTFGYLAPEYVRDGC------VTTKSDVYAFGVVLMELITG----------QQALS 215 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~------~~~~~DiwslG~~l~~~~tg----------~~p~~ 215 (313)
+|||++.......... .......+++.|+|||++.+.. ++.++||||||+++|+|++| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999987655432211 1223346899999999998652 34689999999999999999 66765
Q ss_pred CCCCCCCCccccchhHHHHHHHHhcCcHHHHHHh-hhhcCCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 216 RDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKL-TECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...... .... .....+ .....+.... ........+.+|+.+||+.||.+|||+.+|++.
T Consensus 269 ~~~~~~-------~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 269 DLVPSD-------PSVE-----------EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTSCSS-------CCHH-----------HHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCcCc-------ccHH-----------HHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 443221 0111 111111 1122232222 234667789999999999999999999999999
Q ss_pred HHHHHhc
Q 041031 293 LSHILIS 299 (313)
Q Consensus 293 l~~~~~~ 299 (313)
|+++...
T Consensus 331 L~~i~~~ 337 (342)
T 1b6c_B 331 LSQLSQQ 337 (342)
T ss_dssp HHHHHHT
T ss_pred HHHHHHH
Confidence 9998765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=314.68 Aligned_cols=264 Identities=24% Similarity=0.320 Sum_probs=197.1
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--------cHHHHHHHHHHHhc----CCCceeeeeEEEeC
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--------SKEFSSELKILCKV----HSNLIELIGYAAGG 75 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--------~~~~~~e~~~l~~l----h~~i~~~~~~~~~~ 75 (313)
..++|++.++||+|+||.||+|.+. ++.||||.+.... .....+|+.+++.+ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4689999999999999999999976 7889999986432 34577788887776 99999999999876
Q ss_pred C-----eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcE
Q 041031 76 D-----SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRA 150 (313)
Q Consensus 76 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~ 150 (313)
. ..+++||++. ++|.+++... ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence 5 5899999996 5999998532 2234899999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchh
Q 041031 151 KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~ 230 (313)
+|+|||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ..
T Consensus 160 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~ 227 (308)
T 3g33_A 160 KLADFGLARIYSYQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--------DQ 227 (308)
T ss_dssp EECSCSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--------HH
T ss_pred EEeeCccccccCCCc----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HH
Confidence 999999987654322 223346899999999999999999999999999999999999999765431 11
Q ss_pred HHHHHHHHhcCcH-HHH---HHhhhhcCCCCC----CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 231 LVDYMLAVFNDTK-DFM---AKLTECLDPNLT----RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 231 ~~~~~~~~~~~~~-~~~---~~l~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+............ .+. ........+... ......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1111100000000 000 000000000000 0112345678899999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=313.86 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=204.6
Q ss_pred HhcCccccceeccCCeEEEEEeEECC-----cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEE-EeCCeE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLRG-----KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYA-AGGDSL 78 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~-~~~~~~ 78 (313)
...+|++.+.||+|+||.||+|.+.. ..+|+|.+.... .+.+.+|+.+++.+ ||||+++++++ ...+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34568899999999999999998752 248999887543 34577899999999 99999999985 456678
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
+++|||+++++|.+++. .....++...++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 103 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIR----NETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp EEEEECCTTCBHHHHHH----CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred EEEEeCCCCCCHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccc
Confidence 99999999999999995 34466899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCChhhh-hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHH
Q 041031 159 KLLEHSPEIA-AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 159 ~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
.......... .......+++.|+|||++.+..++.++||||||+++|+|++ |.+||......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---------------- 239 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---------------- 239 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT----------------
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH----------------
Confidence 8665432211 12223456788999999999999999999999999999999 55666544432
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
+....+...... ......+..+.+++.+||+.||.+|||+.++++.|+.+...-.
T Consensus 240 -------~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 240 -------DITVYLLQGRRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp -------THHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred -------HHHHHHhcCCCC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111111111111 1122345678899999999999999999999999999987644
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=323.35 Aligned_cols=254 Identities=17% Similarity=0.253 Sum_probs=195.0
Q ss_pred HhcCcccc-ceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEe----CCeEEE
Q 041031 10 ATSNFSTS-LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAG----GDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~-~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~----~~~~~l 80 (313)
..++|.+. +.||+|+||.||+|.+. ++.||||++.. .....+|+.++.++ ||||+++++++.. ...+++
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 45678776 78999999999999987 78899999864 35677889888665 9999999999875 567899
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcEEEeeccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGL 157 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~ 157 (313)
||||+.+|+|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++. ++.+||+|||+
T Consensus 137 v~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999522 2346899999999999999999999999 999999999999987 78899999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+....... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 211 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------------- 273 (400)
T 1nxk_A 211 AKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------- 273 (400)
T ss_dssp CEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-------------
T ss_pred ccccCCCC----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-------------
Confidence 98655322 2223467999999999999999999999999999999999999997654421100
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.....+...............+..+.+|+++||..||.+|||+.++++.-+
T Consensus 274 ------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 274 ------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp ------SHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ------HHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 001111110000000112334567889999999999999999999997644
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=325.04 Aligned_cols=241 Identities=24% Similarity=0.327 Sum_probs=193.2
Q ss_pred cceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCCCCh
Q 041031 17 SLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (313)
.+.||+|+||.||+|.+. ++.||+|++.... .+.+.+|+.+++.+ ||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 678999999999999986 7899999997643 45688999999999 99999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee--CCCCcEEEeeccccccccCChhhh
Q 041031 91 SDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL--DSNFRAKIADFGLVKLLEHSPEIA 168 (313)
Q Consensus 91 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~--~~~~~~~l~dfg~~~~~~~~~~~~ 168 (313)
.+++. .....+++..++.++.|++.||.|||+.+ ++|+||||+||++ +.++.++|+|||++.......
T Consensus 174 ~~~l~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 174 FDRII----DESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp HHHHH----HTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred HHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 99884 33456899999999999999999999999 9999999999999 567889999999998765432
Q ss_pred hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHH
Q 041031 169 AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAK 248 (313)
Q Consensus 169 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.... +....
T Consensus 244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----------------------~~~~~ 299 (373)
T 2x4f_A 244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-----------------------ETLNN 299 (373)
T ss_dssp -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----------------------HHHHH
T ss_pred -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----------------------HHHHH
Confidence 222346899999999999999999999999999999999999999755421 11111
Q ss_pred hhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 249 LTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 249 l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+...............+..+.+|+.+||+.||.+|||+.|+++
T Consensus 300 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 300 ILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111111011112234567899999999999999999999997
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=312.19 Aligned_cols=245 Identities=24% Similarity=0.402 Sum_probs=201.4
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|++.+.||+|+||.||+|.+. +..+|+|.+.... ...+.+|+.+++.+ ||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4678999999999999999999988 6679999986432 44578899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 87 v~e~~~~~~l~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EECCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEecCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence 999999999999984 3456899999999999999999999999 99999999999999999999999998865
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
.... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 159 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------------- 213 (279)
T 3fdn_A 159 APSS-----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------------------- 213 (279)
T ss_dssp C-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------------------
T ss_pred CCcc-----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--------------------
Confidence 4432 222346899999999999999999999999999999999999999754321
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+... ... .....+..+.+|+.+||+.||.+|||+.|+++.-.
T Consensus 214 ---~~~~~~~~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 214 ---ETYKRISRV-EFT---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp ---HHHHHHHHT-CCC---CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred ---HHHHHHHhC-CCC---CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 111111111 111 12234457889999999999999999999998654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=317.13 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=206.5
Q ss_pred hHHHHHHhcCcccc-ceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc--CCCceeeeeEEE
Q 041031 4 YNEVRDATSNFSTS-LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV--HSNLIELIGYAA 73 (313)
Q Consensus 4 ~~~~~~~~~~y~~~-~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l--h~~i~~~~~~~~ 73 (313)
++..+...+.|.+. +.||+|+||.||+|.+. ++.||+|++.... ...+.+|+.+++.+ ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34566777888888 89999999999999988 8899999987532 45688999999999 799999999999
Q ss_pred eCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcE
Q 041031 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRA 150 (313)
Q Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~ 150 (313)
+.+..++||||+.+++|.+++.. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++. ++.+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred eCCeEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999842 22367899999999999999999999999 999999999999987 7899
Q ss_pred EEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchh
Q 041031 151 KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~ 230 (313)
+|+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 174 kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------- 239 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE----LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---------- 239 (327)
T ss_dssp EECCGGGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------
T ss_pred EEeeCccccccCCccc----cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----------
Confidence 9999999987654322 22346899999999999999999999999999999999999999654321
Q ss_pred HHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 231 LVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+...............+..+.+|+.+||+.||.+|||+.++++.
T Consensus 240 -------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 240 -------------ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -------------HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -------------HHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111122111111112334456678899999999999999999999865
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=311.41 Aligned_cols=247 Identities=22% Similarity=0.329 Sum_probs=201.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc---ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT---KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~---~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
..++|++.+.||+|+||.||+|.+. +..+|+|.+... ..+.+.+|+++++.+ ||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 5678999999999999999999988 567899988653 356688999999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee---CCCCcEEEeecccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL---DSNFRAKIADFGLVKL 160 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~---~~~~~~~l~dfg~~~~ 160 (313)
|+++++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||+|+||++ +.++.++|+|||.+..
T Consensus 87 ~~~~~~L~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 87 LCTGGELFERVV-----HKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp CCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ccCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 999999999884 3456899999999999999999999999 9999999999999 7788999999999886
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
..... ......+++.|+|||++.+. ++.++||||||+++|+|++|..||......
T Consensus 159 ~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------------------- 213 (277)
T 3f3z_A 159 FKPGK----MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------------------- 213 (277)
T ss_dssp CCTTS----CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------------------
T ss_pred ccCcc----chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--------------------
Confidence 55432 22334689999999998765 899999999999999999999999754321
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+...............+..+.+++.+||+.||.+|||+.++++.
T Consensus 214 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 214 ---EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ---HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---HHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111111000000011345678899999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=325.19 Aligned_cols=277 Identities=18% Similarity=0.246 Sum_probs=202.3
Q ss_pred HhcCccccceeccC--CeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 10 ATSNFSTSLKIGQG--SYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 10 ~~~~y~~~~~lg~g--~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
..++|++.++||+| +||.||+|++. ++.||||++.... ...+.+|+.+++.+ ||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 46789999999999 99999999997 8899999987543 34577899999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+||||+++++|.+++... ....+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||.+.
T Consensus 103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence 999999999999998532 2356899999999999999999999999 9999999999999999999999999876
Q ss_pred cccCChhhh----hhcccccccccccCCccccC--CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 160 LLEHSPEIA----AAASRIVGTFGYLAPEYVRD--GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 160 ~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
......... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.................
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 543221111 11222467889999999987 678999999999999999999999997654432110000000000
Q ss_pred HHHHHhcCcHHH-------------HHHhhh------hcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 234 YMLAVFNDTKDF-------------MAKLTE------CLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 234 ~~~~~~~~~~~~-------------~~~l~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
............ ...+.. .............+..+.+|+++||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000000000 000000 00000001223345678999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=311.70 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=202.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---------SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
+.++|++.+.||+|+||.||+|.+. ++.+|+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3468999999999999999999997 7899999886432 45688999999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC----cEEEe
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF----RAKIA 153 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----~~~l~ 153 (313)
.++|||++++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+
T Consensus 83 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLA-----EKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp EEEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEeecCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEE
Confidence 999999999999999984 3456899999999999999999999999 99999999999998876 89999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
|||.+........ .....+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 155 dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------- 217 (283)
T 3bhy_A 155 DFGIAHKIEAGNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------------- 217 (283)
T ss_dssp CCTTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------
T ss_pred ecccceeccCCCc----ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------------
Confidence 9999886654321 22346899999999999999999999999999999999999999654321
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHHHh
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR--LSHILI 298 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~--l~~~~~ 298 (313)
+....+.... ..... .....+..+.+++.+||+.||.+|||+.++++. ++.+..
T Consensus 218 ----------~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 218 ----------ETLTNISAVN-YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp ----------HHHHHHHTTC-CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ----------HHHHHhHhcc-cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 1111111110 00000 112234578899999999999999999999973 444443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=320.51 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=203.7
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEee
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
...++|++.+.||+|+||.||+|.++ ++.||||++..... ...+|++++..+ ||||+++++++.+.+..++||||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 34678999999999999999999987 78899999976543 345688888887 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC----CcEEEeecccccc
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN----FRAKIADFGLVKL 160 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~----~~~~l~dfg~~~~ 160 (313)
+++|+|.+.+. ....+++..++.++.|++.||.|||+++ ++|+||||+||++.++ +.+||+|||++..
T Consensus 98 ~~gg~L~~~i~-----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 98 MKGGELLDKIL-----RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCSCBHHHHHH-----TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999984 4467999999999999999999999999 9999999999998543 3599999999986
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||....... ..
T Consensus 170 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---------~~-------- 229 (342)
T 2qr7_A 170 LRAENG---LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---------PE-------- 229 (342)
T ss_dssp CBCTTC---CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---------HH--------
T ss_pred CcCCCC---ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---------HH--------
Confidence 554321 2233468999999999998889999999999999999999999997543210 00
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
+....+....-..........+..+.+|+++||..||.+|||+.++++.-+-
T Consensus 230 ---~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 230 ---EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp ---HHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ---HHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 1112221111111111223456678899999999999999999999976543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=318.35 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=200.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC--Ccc----eEEEecccc----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKN----AAIKQMKNT----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~----~aiK~~~~~----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.++|++.+.||+|+||.||+|.+. ++. +++|.+... ....+.+|+.+++.+ ||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 478999999999999999999986 444 477766432 355688999999999 999999999998765 78
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
++++++.+++|.+++. .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 93 ~v~~~~~~g~L~~~l~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVR----EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 8999999999999985 33466899999999999999999999999 9999999999999999999999999998
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 166 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------------------ 226 (327)
T 3lzb_A 166 LLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------------------ 226 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------------------
T ss_pred EccCcccc-ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH------------------
Confidence 76543221 12223356788999999999999999999999999999999 99999765432
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+...... ......+..+.+++++||+.||.+|||+.++++.|+++....
T Consensus 227 -----~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 227 -----EISSILEKGERL---PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -----GHHHHHHTTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred -----HHHHHHHcCCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 112222221111 123345567889999999999999999999999999998653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=318.63 Aligned_cols=263 Identities=24% Similarity=0.417 Sum_probs=211.2
Q ss_pred HhcCccccceeccCCeEEEEEeEEC---------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR---------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAG 74 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~---------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~ 74 (313)
..++|.+.+.||+|+||.||+|++. +..||||++.... ...+.+|+.+++.+ ||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999874 4579999997653 34577899999998 9999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCCC-----------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCee
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSVK-----------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNIL 143 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil 143 (313)
.+..++||||+++++|.+++...... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 99999999999999999999643311 1235889999999999999999999999 999999999999
Q ss_pred eCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCC
Q 041031 144 LDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGN 222 (313)
Q Consensus 144 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~ 222 (313)
++.++.+||+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSE-ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EcCCCCEEEccccccccccccccc-cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--
Confidence 999999999999998865543211 11222346788999999998889999999999999999999 99999654321
Q ss_pred CccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccc
Q 041031 223 NQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKE 302 (313)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 302 (313)
+....+....... .....+..+.+++.+||+.||.+|||+.++++.|+++......
T Consensus 267 ---------------------~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 267 ---------------------ELFKLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp ---------------------HHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ---------------------HHHHHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 1122222222111 2234556789999999999999999999999999999876443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=330.13 Aligned_cols=244 Identities=25% Similarity=0.412 Sum_probs=204.3
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|.+.+.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+ ||||+++++++...+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3578999999999999999999987 8899999986532 34688999999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 94 v~E~~~gg~L~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 94 VMEYVSGGELFDYIC-----KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp EEECCSSEEHHHHTT-----SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhh
Confidence 999999999999983 4567999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
..... ......+++.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 166 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------------------- 222 (476)
T 2y94_A 166 MSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------------------- 222 (476)
T ss_dssp CCTTC----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-------------------
T ss_pred ccccc----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-------------------
Confidence 65422 2233468999999999988765 68999999999999999999999754331
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+.... . ......+..+.+|+++||..||.+|||+.++++.
T Consensus 223 ----~~~~~i~~~~---~-~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 223 ----TLFKKICDGI---F-YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ----HHHHHHHTTC---C-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----HHHHHHhcCC---c-CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1112221111 1 1122344578899999999999999999999974
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=307.19 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=204.0
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
...++|++.+.||+|+||.||+|.+. ++.||+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+..++|
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 35688999999999999999999987 7889999986443 35678899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
||++++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 84 ~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 84 LEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EECCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 99999999999983 4467899999999999999999999999 999999999999999999999999998765
Q ss_pred cCChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
..... ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||....... ..
T Consensus 156 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~---------- 217 (276)
T 2yex_A 156 RYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QE---------- 217 (276)
T ss_dssp EETTE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-------HH----------
T ss_pred CCCcc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-------HH----------
Confidence 43221 112233468999999999987665 778999999999999999999997654321 00
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
....... ..........+..+.+|+.+||+.||.+|||+.++++.
T Consensus 218 -----~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 218 -----YSDWKEK--KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -----HHHHHTT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----HHHhhhc--ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0000000 00011123445678899999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=330.21 Aligned_cols=256 Identities=24% Similarity=0.307 Sum_probs=203.8
Q ss_pred hHHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEe
Q 041031 4 YNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAG 74 (313)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~ 74 (313)
+..++...++|++.+.||+|+||.||+|+++ ++.||+|++... ....+.+|..++..+ ||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444556789999999999999999999987 889999998653 233478899999999 9999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
.+.+++||||+++|+|.+++. .....+++..++.++.|++.||.|||+++ |+|+||||+||+++.+|.+||+|
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~----~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLS----KFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHH----HHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999994 22346899999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhhhhhcccccccccccCCcccc-------CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcccc
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR-------DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE 227 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~ 227 (313)
||++........ .......+|+.|+|||++. +..++.++|+|||||++|+|++|+.||.+....
T Consensus 206 FGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------- 276 (412)
T 2vd5_A 206 FGSCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------- 276 (412)
T ss_dssp CTTCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------
T ss_pred chhheeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-------
Confidence 999986554321 1222357899999999997 356899999999999999999999999754321
Q ss_pred chhHHHHHHHHhcCcHHHHHHhhhh-cCCCCCCCCHHHHHHHHHHHhhccccCcCCC---CCHHHHHHH
Q 041031 228 HRSLVDYMLAVFNDTKDFMAKLTEC-LDPNLTRYHKDSMLQMALLSKDCVDENWKRR---PDMSNAAIR 292 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---ps~~~ll~~ 292 (313)
+....+... ............+..+.+||++||. +|.+| |+++|+++.
T Consensus 277 ----------------~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 277 ----------------ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ----------------HHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ----------------HHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111111110 0011111123445678899999999 99998 588888753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=315.88 Aligned_cols=266 Identities=22% Similarity=0.361 Sum_probs=187.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++|++++.||+|+||.||+|.+. ++.||+|.+.... ...+.+|+.+++.+ ||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 578999999999999999999887 7889999986432 45688999999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCC-CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 84 YAQNGALSDHLHWPSV-KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|++ ++|.+++..... .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 599988853221 22346899999999999999999999999 9999999999999999999999999988654
Q ss_pred CChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+......
T Consensus 160 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~i~~~~~~ 227 (317)
T 2pmi_A 160 IPV---NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---------EQLKLIFDIMGT 227 (317)
T ss_dssp SCC---CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---------HHHHHHHHHHCS
T ss_pred CCc---ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHHhCC
Confidence 321 12223467999999999976 46899999999999999999999999765431 111111110000
Q ss_pred -cHHHHHHhhhh--cCCCCCC-------------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 -TKDFMAKLTEC--LDPNLTR-------------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 -~~~~~~~l~~~--~~~~~~~-------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
........... ..+.... .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000000000 0000000 011234578999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=315.35 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=197.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.++|++.++||+|+||.||+|.+. ++.||+|.+.... ...+.+|+.+++.+ ||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 578999999999999999999987 7889999886543 23467899999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+....
T Consensus 82 e~~~~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDR-----YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHh-----hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 9999999998873 4466899999999999999999999999 9999999999999999999999999998765
Q ss_pred CChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.... .............
T Consensus 154 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~ 222 (311)
T 4agu_A 154 GPSD---YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--------DQLYLIRKTLGDL 222 (311)
T ss_dssp ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCSC
T ss_pred Cccc---ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhccc
Confidence 3322 2223467899999999976 66899999999999999999999999765432 0111111110000
Q ss_pred cHHHHHHhh---hhcCCCCCC---------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 TKDFMAKLT---ECLDPNLTR---------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~---~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+....... ......... .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 223 IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000 000000000 112345678899999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=310.86 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=205.8
Q ss_pred CccccceeccCCeEEEEEeEEC--C---cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE-EEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--G---KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSL-FLV 81 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~---~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~-~lv 81 (313)
.|.+.++||+|+||.||+|.+. + ..+|+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566799999999999999864 2 268999987543 34577899999999 99999999999876655 999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
||++.+++|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 102 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 102 LPYMCHGDLLQFIR----SPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp ECCCTTCBHHHHHH----CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EecccCCCHHHHHh----ccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 99999999999995 33567899999999999999999999999 999999999999999999999999999765
Q ss_pred cCChhh-hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 162 EHSPEI-AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 162 ~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
...... ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+...... .
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--------~----------- 235 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--------F----------- 235 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--------G-----------
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--------H-----------
Confidence 432211 11222346788999999999999999999999999999999966554332221 0
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccccc
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEWE 304 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 304 (313)
+....+...... ......+..+.+++.+||+.||.+|||+.++++.|+++.......+
T Consensus 236 ---~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 236 ---DLTHFLAQGRRL---PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp ---GHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred ---HHHHHhhcCCCC---CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 112222221111 1223345678899999999999999999999999999988765443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=312.36 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=197.0
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
..++|.+.++||+|+||.||+|.+. +..+|+|.+.... .+.+.+|+++++.+ ||||+++++++.+.+..++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4578999999999999999999987 7889999986543 46688999999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee---CCCCcEEEeeccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL---DSNFRAKIADFGLVK 159 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~---~~~~~~~l~dfg~~~ 159 (313)
||+++++|.+.+.... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||++.
T Consensus 100 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999884221 12367899999999999999999999999 9999999999999 456789999999997
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...... ......+++.|+|||++. ..++.++||||||+++|+|++|..||.+....
T Consensus 176 ~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------------------- 231 (285)
T 3is5_A 176 LFKSDE----HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------------------- 231 (285)
T ss_dssp C--------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------------
T ss_pred ecCCcc----cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-------------------
Confidence 654332 223346899999999986 46889999999999999999999999754321
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+...... ...+.........+..+.+|+.+||+.||++|||+.|+++
T Consensus 232 ----~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 232 ----EVQQKAT-YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----HHHHHHH-HCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----HHHhhhc-cCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111 1111111112224567889999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=317.18 Aligned_cols=261 Identities=30% Similarity=0.483 Sum_probs=209.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--Ccc--eEEEecccc----ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKN--AAIKQMKNT----KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~--~aiK~~~~~----~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~l 80 (313)
.++|++.+.||+|+||.||+|++. +.. +++|.+... ....+.+|+.+++.+ ||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 478999999999999999999886 443 488888643 244588899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCC-----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc
Q 041031 81 VYEYAQNGALSDHLHWPSV-----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR 149 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~ 149 (313)
||||+++++|.+++..... .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 9999999999999964320 12347899999999999999999999999 999999999999999999
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccc
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~ 228 (313)
++|+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 181 ~kL~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------- 248 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------- 248 (327)
T ss_dssp EEECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------
T ss_pred EEEcccCcCcccccc----ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--------
Confidence 999999998743321 11222346788999999998889999999999999999998 99999654321
Q ss_pred hhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccccc
Q 041031 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEWE 304 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 304 (313)
+....+...... ......+..+.+|+.+||+.||.+|||+.++++.|.++..+.....
T Consensus 249 ---------------~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 249 ---------------ELYEKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp ---------------HHHHHGGGTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred ---------------HHHHHhhcCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 112222222111 1233455678999999999999999999999999999998755443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=308.32 Aligned_cols=248 Identities=25% Similarity=0.432 Sum_probs=184.9
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
-...++|.+.+.||+|+||.||+|.+. ++.||+|.+.... ...+.+|+.+++.+ ||||+++++++.+.+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 345688999999999999999999985 8899999986432 35688999999999 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++||||+++++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 87 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~ 159 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLK----NRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA 159 (278)
T ss_dssp EEEEECCTTEEHHHHHH----TCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecce
Confidence 99999999999999985 33467899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
........ ......+++.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 160 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------- 220 (278)
T 3cok_A 160 TQLKMPHE---KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------------- 220 (278)
T ss_dssp EECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------
T ss_pred eeccCCCC---cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------
Confidence 86553221 12234678999999999998899999999999999999999999976543210
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
... ...... ......+..+.+++.+||+.||++|||+.++++.
T Consensus 221 -------~~~---~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 221 -------LNK---VVLADY-EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -------------CCSSCC-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -------HHH---Hhhccc-CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 000 000000 1122345678899999999999999999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=333.29 Aligned_cols=256 Identities=28% Similarity=0.467 Sum_probs=205.4
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..++|++.++||+|+||.||+|.+. +..||||.++... .+.+.+|+.+++.+ ||||+++++++.+ +..++||||+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 4577999999999999999999998 4679999998643 46788999999999 9999999999876 6789999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++|+|.+++... ....+++..++.++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++.......
T Consensus 261 ~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 261 SKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp TTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999421 2245889999999999999999999999 9999999999999999999999999998654322
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
. .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.... +
T Consensus 335 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----------------------~ 389 (452)
T 1fmk_A 335 Y--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----------------------E 389 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------------H
T ss_pred e--ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----------------------H
Confidence 1 11222346788999999998999999999999999999999 99999754321 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
....+...... .....++..+.+|+.+||+.||.+|||+.+|++.|+.+..+.
T Consensus 390 ~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 390 VLDQVERGYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHcCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 12222211111 123345667899999999999999999999999999987654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=321.09 Aligned_cols=245 Identities=25% Similarity=0.359 Sum_probs=201.2
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV--HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~ 78 (313)
...++|.+.+.||+|+||.||+|+++ ++.||+|+++.. ..+.+..|..++..+ ||+|+++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 35689999999999999999999998 678999998753 344577899999887 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++||||+++|+|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.+|.++|+|||++
T Consensus 97 ~lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 99999999999999984 3356899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
....... .......+|+.|+|||++.+..++.++|+|||||++|+|++|..||.+....
T Consensus 169 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------------------ 227 (353)
T 2i0e_A 169 KENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------------------ 227 (353)
T ss_dssp BCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------------
T ss_pred cccccCC---cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------------------
Confidence 7543221 2233457899999999999999999999999999999999999999754321
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-----MSNAAI 291 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~ll~ 291 (313)
+....+.. ... ......+..+.+|+.+||..||.+||+ +.++++
T Consensus 228 -----~~~~~i~~---~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 228 -----ELFQSIME---HNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -----HHHHHHHH---CCC-CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -----HHHHHHHh---CCC-CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11111111 111 122345567889999999999999995 466654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=313.33 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=203.3
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
...++|.+.+.||+|+||.||+|++. ++.+|+|.+.... ...+.+|+.+++.+ ||||+++++++.+.+..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 45678999999999999999999987 8899999987543 44578999999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee---CCCCcEEEeeccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL---DSNFRAKIADFGLVK 159 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~---~~~~~~~l~dfg~~~ 159 (313)
|++++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++ +.++.++|+|||.+.
T Consensus 86 e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 86 QLVSGGELFDRIL-----ERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp CCCCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EcCCCccHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 9999999999883 3456899999999999999999999999 9999999999999 778899999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 158 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------------- 213 (304)
T 2jam_A 158 MEQNGI-----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------------------- 213 (304)
T ss_dssp CCCCBT-----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-------------------
T ss_pred ecCCCc-----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-------------------
Confidence 544321 12235799999999999999999999999999999999999999654321
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+...............+..+.+++.+||+.||.+|||+.++++.
T Consensus 214 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 214 ----KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ----HHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ----HHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112222111111111223455678999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=313.66 Aligned_cols=264 Identities=25% Similarity=0.374 Sum_probs=201.4
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC-----CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGD 76 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~ 76 (313)
....++|.+.+.||+|+||.||+|.+. +..||+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 344678999999999999999999875 2379999987542 34577899999999 999999999997655
Q ss_pred -----eEEEEEeecCCCChhhhhcCCCC-CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcE
Q 041031 77 -----SLFLVYEYAQNGALSDHLHWPSV-KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRA 150 (313)
Q Consensus 77 -----~~~lv~e~~~~~~L~~~l~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~ 150 (313)
..++||||+++++|.+++..... .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 35999999999999999843321 23467999999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccch
Q 041031 151 KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~ 229 (313)
+|+|||++........ ........+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 187 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------- 256 (313)
T 3brb_A 187 CVADFGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--------- 256 (313)
T ss_dssp EECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---------
T ss_pred EEeecCcceecccccc-cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---------
Confidence 9999999876543321 112223456789999999999999999999999999999999 88999755432
Q ss_pred hHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 230 SLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
+....+.... ........+..+.+++.+||+.||.+|||+.++++.|+.+....+
T Consensus 257 --------------~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 257 --------------EMYDYLLHGH---RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp --------------GHHHHHHTTC---CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --------------HHHHHHHcCC---CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1122221111 112233455678999999999999999999999999999987654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=325.37 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=192.9
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----------cHHHHHHHHHHHhc-CCCceeeeeEEE
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----------SKEFSSELKILCKV-HSNLIELIGYAA 73 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----------~~~~~~e~~~l~~l-h~~i~~~~~~~~ 73 (313)
....++|.+.+.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+ ||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345789999999999999999999987 7899999986532 12478899999999 999999999975
Q ss_pred eCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC---cE
Q 041031 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF---RA 150 (313)
Q Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~---~~ 150 (313)
. +..++||||+++++|.+++ .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++ .+
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l-----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKV-----VGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGT-----SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCE
T ss_pred c-CceEEEEEcCCCCcHHHHH-----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceE
Confidence 4 5689999999999999998 34567999999999999999999999999 99999999999997544 59
Q ss_pred EEeeccccccccCChhhhhhcccccccccccCCccccC---CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcccc
Q 041031 151 KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD---GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE 227 (313)
Q Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~ 227 (313)
||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 282 kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~------ 351 (419)
T 3i6u_A 282 KITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV------ 351 (419)
T ss_dssp EECCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC------
T ss_pred EEeecccceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH------
Confidence 999999998765432 2223468999999999863 567889999999999999999999997644321
Q ss_pred chhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 228 HRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+ ...+...............+..+.+|+.+||+.||.+|||+.++++.
T Consensus 352 --~~--------------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 352 --SL--------------KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --CH--------------HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HH--------------HHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11 11111111000000112234578899999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=319.72 Aligned_cols=238 Identities=21% Similarity=0.327 Sum_probs=200.1
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----------cHHHHHHHHHHHhc-CCCceeeeeEEEeC
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----------SKEFSSELKILCKV-HSNLIELIGYAAGG 75 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~ 75 (313)
..++|++.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999876 7889999987542 23467899999999 99999999999999
Q ss_pred CeEEEEEeecCCC-ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 76 DSLFLVYEYAQNG-ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 76 ~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
+..++|||++.+| +|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID-----RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH-----TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred CEEEEEEEeCCCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEee
Confidence 9999999998766 9999984 4457999999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
||++....... ......+|+.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 174 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------- 236 (335)
T 3dls_A 174 FGSAAYLERGK----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------- 236 (335)
T ss_dssp CTTCEECCTTC----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------
T ss_pred cccceECCCCC----ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------
Confidence 99998765432 2223468999999999988776 78999999999999999999999642210
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...... .....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 237 ---------------~~~~~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ---------------VEAAIH-----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---------------TTTCCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---------------HhhccC-----CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 112234578899999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=331.25 Aligned_cols=248 Identities=24% Similarity=0.355 Sum_probs=202.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccc-----cccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKN-----TKSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~-----~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
..++|.+.++||+|+||.||+|.+. ++.||||++.. .....+.+|+.+++.+ ||||+++++++.+.+.+++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999987 88899999853 2355688999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC---CCCcEEEeecccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD---SNFRAKIADFGLV 158 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~---~~~~~~l~dfg~~ 158 (313)
|||+.+++|.+.+. ....+++..++.++.|++.||.|||+++ |+|+||||+||+++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 99999999999883 3456899999999999999999999999 99999999999995 4567999999999
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
....... ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+....
T Consensus 172 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------------------ 228 (486)
T 3mwu_A 172 TCFQQNT----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------------------ 228 (486)
T ss_dssp TTBCCC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------------------
T ss_pred eECCCCC----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------------------
Confidence 8665432 2223468999999999976 4899999999999999999999999754321
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
+....+...............+..+.+|+++||..||.+|||+.++++.-
T Consensus 229 -----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 229 -----DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp -----HHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred -----HHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 11222222111111112234556788999999999999999999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=318.47 Aligned_cols=262 Identities=21% Similarity=0.326 Sum_probs=193.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccH----HHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK----EFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~----~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++|.+.+.||+|+||.||+|.+. ++.||+|.+...... .+.+|+.+++.+ ||||+++++++.+.+..++|||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 368999999999999999999987 788999998754422 345799999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|++ ++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~-~~l~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 81 YLD-KDLKQYLD----DCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CCS-EEHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ccc-cCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 996 58888885 33456899999999999999999999999 99999999999999999999999999876543
Q ss_pred ChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+.......
T Consensus 153 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~~~~i~~~~~~~ 220 (324)
T 3mtl_A 153 PTK---TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---------EQLHFIFRILGTP 220 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---------HHHHHHHHHHCCC
T ss_pred Ccc---ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHHHhCCC
Confidence 221 2223467999999999976 56899999999999999999999999765431 1111111100000
Q ss_pred H--HHHH-----HhhhhcCCCCCC-----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 K--DFMA-----KLTECLDPNLTR-----YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 ~--~~~~-----~l~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
. .+.. .......+.... .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 221 TEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 0000 000000000000 112334678899999999999999999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=336.28 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=204.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|++.+.||+|+||.||+|.+. ++.||||++... ..+.+.+|+.+++.+ ||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4568999999999999999999987 889999998532 345688999999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee---CCCCcEEEeeccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL---DSNFRAKIADFGL 157 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~---~~~~~~~l~dfg~ 157 (313)
|||++.+++|.+.+. ....+++..++.++.|++.||.|||+++ ++|+||||+||++ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEII-----SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHH-----TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 999999999999984 4467999999999999999999999999 9999999999999 5678999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+........ .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+....
T Consensus 176 a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------- 233 (484)
T 3nyv_A 176 STHFEASKK----MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY----------------- 233 (484)
T ss_dssp HHHBCCCCS----HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------
T ss_pred eEEcccccc----cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-----------------
Confidence 886654322 122368999999999976 6899999999999999999999999754321
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+...............+..+.+|+++||+.||.+|||+.++++.-+
T Consensus 234 ------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 234 ------DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp ------HHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred ------HHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 112222211111111122345667899999999999999999999997543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=316.29 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=193.6
Q ss_pred HhcCccccceeccCCeEEEEEeEE-----CCcceEEEeccccc-------cHHHHHHHHHHHhc-CCCceeeeeEEEeCC
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKL-----RGKNAAIKQMKNTK-------SKEFSSELKILCKV-HSNLIELIGYAAGGD 76 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~aiK~~~~~~-------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~ 76 (313)
..++|++.+.||+|+||.||+|++ .++.+|+|++.... ...+.+|+.+++.+ ||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 357899999999999999999987 37889999987542 33467899999999 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
..++||||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLE-----REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp CEEEEEECCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred EEEEEEeCCCCCcHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCC
Confidence 9999999999999999984 3456889999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
++....... .......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 167 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 227 (327)
T 3a62_A 167 LCKESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---------------- 227 (327)
T ss_dssp CC-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------
T ss_pred cccccccCC---ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH----------------
Confidence 987543221 1223346899999999999989999999999999999999999999754321
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAI 291 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~ 291 (313)
+....+... ... .....+..+.+|+.+||+.||.+|| ++.++++
T Consensus 228 -------~~~~~i~~~-~~~---~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 228 -------KTIDKILKC-KLN---LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -------HHHHHHHHT-CCC---CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -------HHHHHHHhC-CCC---CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 111111111 111 1223456788999999999999999 6777775
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=309.96 Aligned_cols=264 Identities=23% Similarity=0.292 Sum_probs=206.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-ccHHHHHHHHHHHhc-CCCceeeeeE-EEeCCeEEEEEee
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-KSKEFSSELKILCKV-HSNLIELIGY-AAGGDSLFLVYEY 84 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-~~~~~~~e~~~l~~l-h~~i~~~~~~-~~~~~~~~lv~e~ 84 (313)
..++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|+.+++.+ |++++..+.. ....+..++|||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 4578999999999999999999975 889999998654 345688999999999 7665544444 4677888999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC---CCCcEEEeeccccccc
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD---SNFRAKIADFGLVKLL 161 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~---~~~~~~l~dfg~~~~~ 161 (313)
+ +++|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++ .++.++|+|||++...
T Consensus 87 ~-~~~L~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 87 L-GPSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp C-CCBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred c-CCCHHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9 899999985 23456999999999999999999999999 99999999999994 7889999999999876
Q ss_pred cCChhhh----hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 162 EHSPEIA----AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 162 ~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
....... .......+++.|+|||++.+..++.++||||||+++|+|++|+.||......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~ 233 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-----QKYERISEK 233 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-----SHHHHHHHH
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-----hhhhhhccc
Confidence 5432211 1123456899999999999999999999999999999999999999865432211 111111111
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
..... ...+ ....+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 234 ~~~~~-------~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 234 KMSTP-------IEVL-------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHSC-------HHHH-------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccCCc-------hHHH-------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 10000 0000 1123457889999999999999999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=319.54 Aligned_cols=250 Identities=26% Similarity=0.350 Sum_probs=201.5
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----------cHHHHHHHHHHHhc--CCCceeeeeE
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----------SKEFSSELKILCKV--HSNLIELIGY 71 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----------~~~~~~e~~~l~~l--h~~i~~~~~~ 71 (313)
.....++|.+.+.||+|+||.||+|.+. |+.||||++.... .+.+.+|+.+++.+ ||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999986 8899999986543 23467899999998 9999999999
Q ss_pred EEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEE
Q 041031 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAK 151 (313)
Q Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~ 151 (313)
+...+..++||||+++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLT-----EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999984 3456899999999999999999999999 99999999999999999999
Q ss_pred EeeccccccccCChhhhhhcccccccccccCCccccC------CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcc
Q 041031 152 IADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD------GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQY 225 (313)
Q Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~ 225 (313)
|+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 241 l~DfG~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----- 311 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI----- 311 (365)
T ss_dssp ECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----
T ss_pred EEecCcccccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-----
Confidence 99999988665432 2233568999999999863 35888999999999999999999999653221
Q ss_pred ccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 226 TEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.....+...............+..+.+++.+||+.||.+|||+.++++
T Consensus 312 ------------------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 ------------------LMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ------------------HHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------------------HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111000000000123456889999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=322.93 Aligned_cols=265 Identities=18% Similarity=0.263 Sum_probs=201.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccccH--------------HHHHHHHHHHhc-CCCceee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTKSK--------------EFSSELKILCKV-HSNLIEL 68 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~~~--------------~~~~e~~~l~~l-h~~i~~~ 68 (313)
.++|++.++||+|+||.||+|.+. ++.||||++...... ....|+..++.+ ||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 358999999999999999999886 367999998765421 122344455556 9999999
Q ss_pred eeEEEeC----CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee
Q 041031 69 IGYAAGG----DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL 144 (313)
Q Consensus 69 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 144 (313)
++++... ...++||||+ +++|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~----~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYE----ANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHH----HTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 9998764 4589999999 999999995 33467999999999999999999999999 9999999999999
Q ss_pred C--CCCcEEEeeccccccccCChhhhh----hcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCC
Q 041031 145 D--SNFRAKIADFGLVKLLEHSPEIAA----AASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDA 218 (313)
Q Consensus 145 ~--~~~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~ 218 (313)
+ .++.+||+|||++........... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 889999999999976654322111 1123458999999999999999999999999999999999999998543
Q ss_pred CCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 219 NPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
.. ........... .......+..++. ....+..+.+++..||+.||.+||++.+|++.|+.+..
T Consensus 266 ~~--------~~~~~~~~~~~--~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 266 KD--------PKYVRDSKIRY--RENIASLMDKCFP------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp TC--------HHHHHHHHHHH--HHCHHHHHHHHSC------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cC--------HHHHHHHHHHh--hhhHHHHHHHhcc------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 22 11111111100 0111222222221 12334578899999999999999999999999999887
Q ss_pred c
Q 041031 299 S 299 (313)
Q Consensus 299 ~ 299 (313)
.
T Consensus 330 ~ 330 (364)
T 3op5_A 330 A 330 (364)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=323.25 Aligned_cols=272 Identities=21% Similarity=0.297 Sum_probs=211.0
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC--eEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGD--SLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~--~~~lv 81 (313)
.++|.+.++||+|+||.||+|.+. ++.||||++.... .+.+.+|+++++.+ ||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999998 8899999987533 45577899999999 999999999998765 78999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee----CCCCcEEEeeccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL----DSNFRAKIADFGL 157 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~----~~~~~~~l~dfg~ 157 (313)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++|+||||+||++ +.++.+||+|||+
T Consensus 88 ~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp ECCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999985322 2234899999999999999999999999 9999999999999 7777899999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccC--------CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccch
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRD--------GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 229 (313)
+....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 163 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~------ 232 (396)
T 4eut_A 163 ARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN------ 232 (396)
T ss_dssp CEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC------
T ss_pred ceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch------
Confidence 98765432 2223468999999999875 45788999999999999999999999765443211
Q ss_pred hHHHHHHHHhcCcH-HHHHHhhh-------h--cCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 230 SLVDYMLAVFNDTK-DFMAKLTE-------C--LDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 230 ~~~~~~~~~~~~~~-~~~~~l~~-------~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
...+.......+ .....+.. + .-+............+.+++++||+.||++|||+.++++.+..++..
T Consensus 233 --~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 233 --KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp --HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred --HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111111110000 00000000 0 00111124577888899999999999999999999999999998763
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=316.54 Aligned_cols=269 Identities=28% Similarity=0.462 Sum_probs=207.6
Q ss_pred hcCccccceeccCCeEEEEEeEE------CCcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCC--eE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKL------RGKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGD--SL 78 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~------~~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~--~~ 78 (313)
.++|++.+.||+|+||.||+|++ .++.||||.+.... ...+.+|+.+++.+ ||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45699999999999999999984 27889999987654 34578999999999 999999999986544 78
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++|||++++++|.+++. .....+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 120 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQ----KHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp EEEECCCTTCBHHHHHH----HSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence 99999999999999995 23356899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
.................++..|+|||++.+..++.++||||||+++|+|++|..||..... .+....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~-------------~~~~~~ 259 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA-------------EFMRMI 259 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-------------HHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-------------HHHHhh
Confidence 8765443221222234567789999999988899999999999999999999999863311 010000
Q ss_pred hcC--cHHHHHHhhhhcCC-CCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 239 FND--TKDFMAKLTECLDP-NLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 239 ~~~--~~~~~~~l~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
... .......+...+.. .........+..+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 260 GNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp CTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 000 00001111111111 11112334567899999999999999999999999999998753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=331.76 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=198.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
..++|+++++||+|+||.||+|.++ +..+|+|++... ....+.+|+.+++.+ ||||+++++++.+...+++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999997 778999998643 355688999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcEEEeecccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLV 158 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~~ 158 (313)
|||+.+|+|.+.+. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++. ++.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEII-----HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 99999999999883 3456899999999999999999999999 999999999999976 455999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
....... ......+|+.|+|||++. ..++.++||||+||++|+|++|..||.+....
T Consensus 187 ~~~~~~~----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------------------ 243 (494)
T 3lij_A 187 AVFENQK----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------------------ 243 (494)
T ss_dssp EECBTTB----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------------
T ss_pred eECCCCc----cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------------------
Confidence 8765432 223346899999999986 46899999999999999999999999754331
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+...............+..+.+|+++||+.||.+|||+.++++.
T Consensus 244 -----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 244 -----EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -----HHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----HHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1122222211111111123445678899999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=311.30 Aligned_cols=249 Identities=20% Similarity=0.361 Sum_probs=199.0
Q ss_pred hcCccccceeccCCeEEEEEeEEC--C-------cceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--G-------KNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~-------~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
.++|.+.+.||+|+||.||+|.+. + ..+|+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 578999999999999999999877 3 459999986543 45578999999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc--------
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR-------- 149 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~-------- 149 (313)
.++||||+.+++|.+++. .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLK----KNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CEEEEECCTTCBHHHHHH----HTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CEEEEECCCCCCHHHHHH----hCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccce
Confidence 999999999999999995 23345899999999999999999999999 999999999999988876
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccc
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~ 228 (313)
++|+|||.+....... ...+++.|+|||++.+ ..++.++||||||+++|+|++|..|+......
T Consensus 160 ~kl~Dfg~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------- 224 (289)
T 4fvq_A 160 IKLSDPGISITVLPKD-------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------- 224 (289)
T ss_dssp EEECCCCSCTTTSCHH-------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------
T ss_pred eeeccCcccccccCcc-------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--------
Confidence 9999999987554322 1246888999999987 67899999999999999999965444322221
Q ss_pred hhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
. ........ .... ....+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 225 ~--------------~~~~~~~~--~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 225 Q--------------RKLQFYED--RHQL---PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp H--------------HHHHHHHT--TCCC---CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred H--------------HHHHHhhc--cCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 0 00000100 1111 1112345788999999999999999999999999988753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=308.01 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=205.7
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEe-----------
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAG----------- 74 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~----------- 74 (313)
....+|++.+.||+|+||.||+|.+. ++.||+|.+.... +.+.+|+++++.+ ||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 35678999999999999999999997 8899999987654 5677899999999 9999999998864
Q ss_pred -----CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc
Q 041031 75 -----GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR 149 (313)
Q Consensus 75 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~ 149 (313)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 44589999999999999998522 2356889999999999999999999999 999999999999999999
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccch
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 229 (313)
++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..|+....
T Consensus 161 ~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----------- 225 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----------- 225 (284)
T ss_dssp EEECCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----------
T ss_pred EEECcchhheeccccc----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----------
Confidence 9999999988765432 2223468999999999999999999999999999999999998874210
Q ss_pred hHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 230 SLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
.....+. .... ....+..+.+++.+||+.||.+|||+.++++.|+.+..+..
T Consensus 226 --------------~~~~~~~---~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 226 --------------KFFTDLR---DGII---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp --------------HHHHHHH---TTCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred --------------HHHHHhh---cccc---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 0111111 1111 12234568889999999999999999999999998876543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=308.76 Aligned_cols=251 Identities=24% Similarity=0.286 Sum_probs=202.7
Q ss_pred HHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------------cHHHHHHHHHHHhc--CCCceeee
Q 041031 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------------SKEFSSELKILCKV--HSNLIELI 69 (313)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------------~~~~~~e~~~l~~l--h~~i~~~~ 69 (313)
......++|.+.+.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.+++.+ ||||++++
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (298)
T 1phk_A 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90 (298)
T ss_dssp ----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 34566789999999999999999999987 7889999986442 23467899999999 99999999
Q ss_pred eEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc
Q 041031 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR 149 (313)
Q Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~ 149 (313)
+++...+..++|||++++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 91 DTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN 162 (298)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred eeeccCCeEEEEEeccCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCc
Confidence 99999999999999999999999984 3457899999999999999999999999 999999999999999999
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCcccc------CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCC
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR------DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNN 223 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~ 223 (313)
++|+|||.+....... ......+++.|+|||++. ...++.++||||||+++|+|++|..||......
T Consensus 163 ~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--- 235 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--- 235 (298)
T ss_dssp EEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred EEEecccchhhcCCCc----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---
Confidence 9999999988655332 223346899999999985 456889999999999999999999999654321
Q ss_pred ccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 224 QYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+....+...............+..+.+++.+||+.||.+|||+.++++
T Consensus 236 --------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 236 --------------------LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --------------------HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --------------------HHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111111111111111122345678999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=321.16 Aligned_cols=264 Identities=17% Similarity=0.218 Sum_probs=198.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC-----CcceEEEecccccc--------------HHHHHHHHHHHhc-CCCceeeee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTKS--------------KEFSSELKILCKV-HSNLIELIG 70 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~~--------------~~~~~e~~~l~~l-h~~i~~~~~ 70 (313)
.++|.+.+.||+|+||.||+|.+. +..+|+|....... ..+.+|+..++.+ ||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999985 56789999875431 2245677888888 999999999
Q ss_pred EEEe----CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC
Q 041031 71 YAAG----GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS 146 (313)
Q Consensus 71 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~ 146 (313)
++.. ....++|||++ +++|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISG-----QNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCB-----GGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEcc
Confidence 9987 77899999999 999999984 3347999999999999999999999999 999999999999988
Q ss_pred CC--cEEEeeccccccccCChhhh----hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCC
Q 041031 147 NF--RAKIADFGLVKLLEHSPEIA----AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANP 220 (313)
Q Consensus 147 ~~--~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~ 220 (313)
++ .++|+|||++.......... .......+++.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 77 99999999997664322110 1113346899999999999999999999999999999999999999643221
Q ss_pred CCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 221 GNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
...............+ ..+..... ....+..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 267 -------~~~~~~~~~~~~~~~~---~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 267 -------PVAVQTAKTNLLDELP---QSVLKWAP------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp -------HHHHHHHHHHHHHTTT---HHHHHHSC------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred -------cHHHHHHHHhhccccc---HHHHhhcc------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 0111111111111111 11111110 113445789999999999999999999999999987654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=306.75 Aligned_cols=244 Identities=21% Similarity=0.360 Sum_probs=203.1
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|.+.+.||+|+||.||+|.+. +..+|+|++... ....+.+|+.+++.+ ||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3578999999999999999999987 678999998643 235688999999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
|||++++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 92 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 92 MLEFAPRGELYKELQ-----KHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp EECCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 999999999999984 3356899999999999999999999999 99999999999999999999999999876
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
.... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 164 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------------------- 218 (284)
T 2vgo_A 164 APSL-----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------------------- 218 (284)
T ss_dssp CSSS-----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------------------
T ss_pred Cccc-----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------------------
Confidence 5432 122346899999999999999999999999999999999999999654321
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
+....+.. .+.. .....+..+.+++.+||+.||.+|||+.++++.-
T Consensus 219 ---~~~~~~~~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 219 ---ETHRRIVN-VDLK---FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp ---HHHHHHHT-TCCC---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred ---HHHHHHhc-cccC---CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 11111111 1111 1223456788999999999999999999998743
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=337.65 Aligned_cols=254 Identities=26% Similarity=0.440 Sum_probs=202.4
Q ss_pred ccccc-eeccCCeEEEEEeEEC----CcceEEEecccc----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 14 FSTSL-KIGQGSYGSVYLGKLR----GKNAAIKQMKNT----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 14 y~~~~-~lg~g~~g~v~~~~~~----~~~~aiK~~~~~----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
+.+.. .||+|+||.||+|.+. +..||||+++.. ..+.+.+|+++++.+ ||||+++++++.. +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 33444 7999999999999874 456999999764 345688999999999 9999999999976 56899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+.+|+|.+++. .....+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||++.....
T Consensus 416 ~~~~g~L~~~l~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 416 MAGGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp CCTTCBHHHHHT----TCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred eCCCCcHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999985 33466899999999999999999999999 99999999999999999999999999987654
Q ss_pred ChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
............+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---------------------- 546 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---------------------- 546 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----------------------
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----------------------
Confidence 3222222222345688999999999999999999999999999998 99999765442
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
+....+...... .....++..+.+|+.+||+.||.+|||+.+|++.|+.+..+..
T Consensus 547 -~~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 547 -EVMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp -HHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred -HHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 222222222111 1234566789999999999999999999999999999877543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=332.19 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=200.4
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----------------cHHHHHHHHHHHhc-CCCceeee
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----------------SKEFSSELKILCKV-HSNLIELI 69 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----------------~~~~~~e~~~l~~l-h~~i~~~~ 69 (313)
.+.++|.++++||+|+||.||+|.++ ++.+|+|++.... .+.+.+|+.+++.+ ||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35688999999999999999999987 6789999986432 34578899999999 99999999
Q ss_pred eEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC-
Q 041031 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF- 148 (313)
Q Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~- 148 (313)
+++.+...+++||||+++++|.+.+. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQII-----NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence 99999999999999999999999884 3456999999999999999999999999 99999999999998765
Q ss_pred --cEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccc
Q 041031 149 --RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYT 226 (313)
Q Consensus 149 --~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~ 226 (313)
.++|+|||++....... ......+|+.|+|||++.+ .++.++||||+||++|+|++|..||.+....
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------ 253 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------ 253 (504)
T ss_dssp CSSEEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------
T ss_pred CccEEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 69999999998765432 2233468999999999874 6899999999999999999999999764431
Q ss_pred cchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 227 EHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+....-..........+..+.+|+++||..||.+|||+.++++.-+
T Consensus 254 -----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 254 -----------------DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp -----------------HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -----------------HHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 111111111000000011223467889999999999999999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=308.07 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=206.1
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
..+.|.+.+.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.+++.+ ||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3467999999999999999999886 7889999986442 46688999999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 100 e~~~~~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 100 EYLGGGSALDLLE------PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp ECCTTEEHHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EeCCCCcHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecC
Confidence 9999999999983 356899999999999999999999999 9999999999999999999999999987655
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... .......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 171 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------------- 225 (303)
T 3a7i_A 171 DTQ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---------------------- 225 (303)
T ss_dssp TTB---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------------
T ss_pred ccc---cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH----------------------
Confidence 432 1223346889999999999999999999999999999999999999643321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
+....+.....+. .....+..+.+|+.+||+.||.+|||+.++++...-.
T Consensus 226 -~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 226 -KVLFLIPKNNPPT---LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp -HHHHHHHHSCCCC---CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred -HHHHHhhcCCCCC---CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 1111111111111 2233456788999999999999999999999865533
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=312.66 Aligned_cols=248 Identities=27% Similarity=0.365 Sum_probs=196.8
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----------cHHHHHHHHHHHhc-CCCceeeeeEEEe
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----------SKEFSSELKILCKV-HSNLIELIGYAAG 74 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----------~~~~~~e~~~l~~l-h~~i~~~~~~~~~ 74 (313)
...++|.+.+.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+ ||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 45678999999999999999999987 6889999986532 23477899999999 9999999999876
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc---EE
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR---AK 151 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~---~~ 151 (313)
.+ .++||||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++. ++
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHS-----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEE
T ss_pred Cc-eEEEEecCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEE
Confidence 65 899999999999999983 4567999999999999999999999999 999999999999987654 99
Q ss_pred EeeccccccccCChhhhhhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccc
Q 041031 152 IADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~ 228 (313)
|+|||++........ .....+++.|+|||++. ...++.++||||||+++|+|++|..||.......
T Consensus 158 l~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------- 226 (322)
T 2ycf_A 158 ITDFGHSKILGETSL----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV------- 226 (322)
T ss_dssp ECCCTTCEECCCCHH----HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-------
T ss_pred EccCccceecccccc----cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-------
Confidence 999999987654322 12235799999999974 4668899999999999999999999997654321
Q ss_pred hhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+.. .+...............+..+.+|+.+||+.||.+|||+.++++
T Consensus 227 -~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 227 -SLKD--------------QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -CHHH--------------HHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHH--------------HHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111 11111000000011123457889999999999999999999984
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=320.94 Aligned_cols=251 Identities=26% Similarity=0.384 Sum_probs=201.3
Q ss_pred hcCccccceeccCCeEEEEEeEE-----CCcceEEEecccc-------ccHHHHHHHHHHHhc--CCCceeeeeEEEeCC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKL-----RGKNAAIKQMKNT-------KSKEFSSELKILCKV--HSNLIELIGYAAGGD 76 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~aiK~~~~~-------~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~ 76 (313)
.++|.+.+.||+|+||.||+|++ .++.||||+++.. ..+.+.+|+++++.+ ||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 47899999999999999999998 3788999998743 234567899999998 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
..++||||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp EEEEEECCCCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eEEEEeecCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCC
Confidence 9999999999999999984 3356899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccC--CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD--GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .....
T Consensus 205 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~~ 274 (355)
T 1vzo_A 205 LSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--------SQAEI 274 (355)
T ss_dssp EEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--------CHHHH
T ss_pred CCeecccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--------hHHHH
Confidence 9876543222 22334568999999999986 347889999999999999999999997554321 11111
Q ss_pred HHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHHHH
Q 041031 235 MLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIRLS 294 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~l~ 294 (313)
...+... .+ ......+..+.+|+.+||..||.+|| |+.++++...
T Consensus 275 -----------~~~~~~~-~~---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 275 -----------SRRILKS-EP---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp -----------HHHHHHC-CC---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred -----------HHHHhcc-CC---CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 1111111 11 12233456788999999999999999 9999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=317.70 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=194.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc-----cHHHHHHHHHHHhc-C--CCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK-----SKEFSSELKILCKV-H--SNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h--~~i~~~~~~~~~~~~~~l 80 (313)
...+|++.+.||+|+||.||+|.+. ++.||||.+.... .+.+.+|+.+++.+ | |||+++++++.+.+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 3467999999999999999999887 7789999986442 34578899999999 5 999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
|||+ .+++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++ ++.+||+|||++..
T Consensus 87 v~e~-~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EECC-CSEEHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEeC-CCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 9995 5789999994 3467899999999999999999999999 99999999999997 57899999999987
Q ss_pred ccCChhhhhhcccccccccccCCccccC-----------CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccch
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRD-----------GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 229 (313)
....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 157 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------- 226 (343)
T 3dbq_A 157 MQPDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--------- 226 (343)
T ss_dssp C-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---------
T ss_pred cCccccc-ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---------
Confidence 6543221 12233468999999999865 66888999999999999999999999643221
Q ss_pred hHHHHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 230 SLVDYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
...+...+++.... .....+..+.+|+.+||+.||.+|||+.++++.-+
T Consensus 227 ----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 227 ----------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp ----------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ----------------HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 11112222222111 22233456889999999999999999999987644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=311.50 Aligned_cols=238 Identities=23% Similarity=0.290 Sum_probs=188.4
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++|++.++||+|+||.||+|.+. ++.||||++.... ......|+..+..+ ||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999997 8899999876432 22234455555554 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|++ +++|.+++. .....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 137 e~~-~~~L~~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 137 ELC-GPSLQQHCE----AWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp ECC-CCBHHHHHH----HHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred ecc-CCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 999 678988874 33456999999999999999999999999 9999999999999999999999999987654
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ......+|+.|+|||++.+ .++.++||||||+++|+|++|..|+.....
T Consensus 209 ~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------------------- 260 (311)
T 3p1a_A 209 TAG----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------------------- 260 (311)
T ss_dssp ----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------------------
T ss_pred cCC----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------------------
Confidence 332 2223468999999999886 689999999999999999999766542211
Q ss_pred HHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...+. ...... .....+..+.+++.+||+.||++|||+.++++
T Consensus 261 ---~~~~~---~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 261 ---WQQLR---QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHHT---TTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHh---ccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00110 000000 11223467889999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=308.97 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=200.5
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
...++|.+.+.||+|+||.||+|.+. ++.||+|.+.... ...+.+|+.+++.+ ||||+++++++...+..++||||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 45678999999999999999999987 7889999987553 56788999999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 106 ~~~~~L~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 106 CGAGSVSDIIR----LRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CTTEEHHHHHH----HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred CCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999984 23467899999999999999999999999 999999999999999999999999998765432
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
.. ......+++.|+|||++.+..++.++||||||+++|+|++|..||...... .
T Consensus 179 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------------------~ 232 (314)
T 3com_A 179 MA---KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----------------------R 232 (314)
T ss_dssp BS---CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----------------------H
T ss_pred cc---ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----------------------H
Confidence 21 223346889999999999989999999999999999999999999643321 0
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
....+.....+.. ......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 233 AIFMIPTNPPPTF-RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHHHHSCCCCC-SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHhcCCCccc-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111111111111 1223345678999999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=322.85 Aligned_cols=267 Identities=23% Similarity=0.359 Sum_probs=191.5
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc--CCCceeeeeEEEeCC--
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV--HSNLIELIGYAAGGD-- 76 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~-- 76 (313)
....++|++.+.||+|+||.||+|.+. ++.||||.+... ......+|+.+++.+ ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 456789999999999999999999987 889999988543 234467899999998 999999999997544
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
.+++||||++ ++|.+++. ...++...+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIR------ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp CEEEEEECCS-EEHHHHHH------HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecccC-cCHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCc
Confidence 7899999996 58998884 246889999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCh------------------hhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCC
Q 041031 157 LVKLLEHSP------------------EIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRD 217 (313)
Q Consensus 157 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~ 217 (313)
++....... ..........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 997653210 00112223478999999999986 67899999999999999999999999765
Q ss_pred CCCCCCccccchhHHHHHHHHhcCcHH------------HHHHhhhhc---CCCCCCCC-------------HHHHHHHH
Q 041031 218 ANPGNNQYTEHRSLVDYMLAVFNDTKD------------FMAKLTECL---DPNLTRYH-------------KDSMLQMA 269 (313)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~l~~~~---~~~~~~~~-------------~~~~~~l~ 269 (313)
+.. ..+............+ ....+.... ........ ...+..+.
T Consensus 235 ~~~--------~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (388)
T 3oz6_A 235 STM--------NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306 (388)
T ss_dssp SHH--------HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHH
T ss_pred CHH--------HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHH
Confidence 431 1111111111000000 001111100 00000000 13345788
Q ss_pred HHHhhccccCcCCCCCHHHHHHH
Q 041031 270 LLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 270 ~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+|+++||..||.+|||+.|+++.
T Consensus 307 dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 307 DLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHhhccCcccCCCHHHHhCC
Confidence 99999999999999999999976
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=321.53 Aligned_cols=258 Identities=25% Similarity=0.360 Sum_probs=196.5
Q ss_pred CccccceeccCCeEEEEEeEEC-----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEE-eCCeEEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAA-GGDSLFLV 81 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~-~~~~~~lv 81 (313)
.|.+.+.||+|+||.||+|.+. +..+|+|.+.... .+.+.+|+.+++.+ ||||+++++++. ..+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677899999999999999875 1358999886532 34577899999999 999999999865 45678999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++++|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 170 ~e~~~~g~L~~~l~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 170 LPYMKHGDLRNFIR----NETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EECCTTCBHHHHHH----CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EECCCCCCHHHHHh----hcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 99999999999995 34456889999999999999999999999 999999999999999999999999998765
Q ss_pred cCChhh-hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 162 EHSPEI-AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 162 ~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...... ........+++.|+|||++.+..++.++||||||+++|+|++ |.+||......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~------------------- 303 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------------------- 303 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-------------------
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-------------------
Confidence 432211 111223456788999999999999999999999999999999 67777655432
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW 303 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 303 (313)
+....+...... ......+..+.+++.+||+.||.+|||+.++++.|+.+.......
T Consensus 304 ----~~~~~~~~~~~~---~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 304 ----DITVYLLQGRRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp ----CHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ----HHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 111111111111 112334567899999999999999999999999999998765544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=308.61 Aligned_cols=258 Identities=19% Similarity=0.282 Sum_probs=202.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEe--CCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAG--GDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~--~~~~~lv~e~ 84 (313)
.++|++.+.||+|+||.||+|.+. ++.||||++.......+.+|+.+++.+ ||||+++++++.+ ....+++||+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 478999999999999999999886 889999999988888899999999999 9999999999987 6778999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC-cEEEeeccccccccC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF-RAKIADFGLVKLLEH 163 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~~~~~ 163 (313)
+.+++|.+++. .+++..++.++.|++.||+|||+++ ++|+||||+||+++.++ .++|+|||++.....
T Consensus 115 ~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 115 VNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999872 3888999999999999999999999 99999999999999766 899999999986554
Q ss_pred ChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+....... . .
T Consensus 184 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-------~~~l~~~~~~~-~-~ 250 (330)
T 3nsz_A 184 GQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-------YDQLVRIAKVL-G-T 250 (330)
T ss_dssp TC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-------HHHHHHHHHHH-C-H
T ss_pred CC----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-------HHHHHHHHHhc-C-C
Confidence 32 2233468899999999987 67899999999999999999999999544321 01111111100 0 0
Q ss_pred HHHHHHhhh---------------hcCCCCC-----CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 KDFMAKLTE---------------CLDPNLT-----RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 ~~~~~~l~~---------------~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+....+.. ....... ......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 011111110 0000000 0122246788999999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=318.23 Aligned_cols=255 Identities=13% Similarity=0.153 Sum_probs=209.4
Q ss_pred hcCccccceeccCCeEEEEEeE-----EC--CcceEEEeccccccHHHHHHHHHHHhc----CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGK-----LR--GKNAAIKQMKNTKSKEFSSELKILCKV----HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~-----~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l----h~~i~~~~~~~~~~~~~~ 79 (313)
.++|.+.++||+|+||.||+|. .. ++.||||.+.......+..|.++++.+ |+|++++++++...+..+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 4679999999999999999994 22 789999999988888888999988888 899999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-----------CC
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-----------NF 148 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-----------~~ 148 (313)
+||||+++|+|.+++..........+++..++.++.|++.||+|||+++ |+|+||||+||+++. ++
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CT
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccC
Confidence 9999999999999995433224567999999999999999999999999 999999999999988 89
Q ss_pred cEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccc
Q 041031 149 RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~ 228 (313)
.+||+|||++........ ........+|+.|+|||++.+..++.++|||||||++|+|+||+.||.......
T Consensus 221 ~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------- 292 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------- 292 (365)
T ss_dssp TEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------
T ss_pred CEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------
Confidence 999999999975442211 122334568999999999999999999999999999999999999996543310
Q ss_pred hhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCC-CCHHHHHHHHHHHHhcc
Q 041031 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRR-PDMSNAAIRLSHILISS 300 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-ps~~~ll~~l~~~~~~~ 300 (313)
..+....... .....+.+++..||+.+|.+| |+++++.+.|+.+....
T Consensus 293 ----------------------~~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 ----------------------CKPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ----------------------EEECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----------------------eeechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0011111111 224467789999999999998 57888899999887763
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=313.34 Aligned_cols=265 Identities=19% Similarity=0.292 Sum_probs=196.7
Q ss_pred hcCcccc-ceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEE
Q 041031 11 TSNFSTS-LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 11 ~~~y~~~-~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.+.|.+. +.||+|+||.||+|.+. ++.||||++.... ...+.+|+.++.++ ||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678885 78999999999999876 8899999986543 45688999999985 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc---EEEeeccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR---AKIADFGLVK 159 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~---~~l~dfg~~~ 159 (313)
||+++++|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++. ++|+|||++.
T Consensus 91 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 91 EKMRGGSILSHIH-----KRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp ECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EcCCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 9999999999984 3456899999999999999999999999 999999999999988765 9999999987
Q ss_pred cccCChhh----hhhcccccccccccCCccccC-----CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchh
Q 041031 160 LLEHSPEI----AAAASRIVGTFGYLAPEYVRD-----GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 160 ~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~ 230 (313)
........ ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||............. ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-~~ 241 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG-EA 241 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-----C
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc-cc
Confidence 65422111 111122458999999999975 457899999999999999999999998765433111110 00
Q ss_pred HHHHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 231 LVDYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
..... ......+.... ..... .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 242 ~~~~~-------~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 242 CPACQ-------NMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CHHHH-------HHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhHH-------HHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000 00111111110 00000 011234678899999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=314.57 Aligned_cols=266 Identities=22% Similarity=0.317 Sum_probs=197.3
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEe-------
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAG------- 74 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~------- 74 (313)
..++|++.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 3578999999999999999999986 7899999886433 34577899999999 9999999999976
Q ss_pred -CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEe
Q 041031 75 -GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIA 153 (313)
Q Consensus 75 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~ 153 (313)
.+..++||||+++ +|.+.+. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHH----CTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred CCceEEEEEeccCC-CHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEc
Confidence 4568999999965 7777764 33456999999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCChhh-hhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhH
Q 041031 154 DFGLVKLLEHSPEI-AAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 154 dfg~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~ 231 (313)
|||++......... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------~~ 237 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---------HQ 237 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---------HH
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---------HH
Confidence 99998865432211 122233467999999999976 45799999999999999999999999765431 11
Q ss_pred HHHHHHHhcC-cHHHHHHh-----hhhcCCCCCC-CC-H------HHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 232 VDYMLAVFND-TKDFMAKL-----TECLDPNLTR-YH-K------DSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 232 ~~~~~~~~~~-~~~~~~~l-----~~~~~~~~~~-~~-~------~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...+...... ..+..... ...+...... .. . ..+..+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 238 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1111110000 00000000 0000000000 00 0 013458899999999999999999999964
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=312.51 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=196.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC---Cc--ceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR---GK--NAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~---~~--~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
.++|++.+.||+|+||.||+|.+. ++ .||||+++... .+.+.+|+++++.+ ||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 468999999999999999999864 22 58999987532 34577899999999 999999999998765 8
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++|+|++.+++|.+++. .....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 96 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLR----KHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEEECCTTCBHHHHHH----HHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeEecccCCCHHHHHH----hccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccc
Confidence 89999999999999985 22356899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
.................+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----------------- 231 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----------------- 231 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----------------
Confidence 876543322222233456788999999998889999999999999999999 99999654321
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
+....+.... .........+..+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus 232 ------~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 232 ------QILHKIDKEG--ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp ------HHHHHHHTSC--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ------HHHHHHHccC--CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 1111111110 0111233456789999999999999999999999999998876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=315.23 Aligned_cols=266 Identities=20% Similarity=0.266 Sum_probs=204.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEE----eCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAA----GGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~----~~~~~~l 80 (313)
.++|++.+.||+|+||.||+|.+. ++.||||.+.... .+.+.+|+.+++.+ ||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 468999999999999999999985 8899999886443 44578999999999 999999999986 3447899
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+.+++|.+++.... .....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 108 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEECCTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEeCCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999885321 13567899999999999999999999999 99999999999999999999999998776
Q ss_pred ccCChhh------hhhcccccccccccCCccccCCC---CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhH
Q 041031 161 LEHSPEI------AAAASRIVGTFGYLAPEYVRDGC---VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 161 ~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~ 231 (313)
....... ........+++.|+|||++.+.. ++.++||||||+++|+|++|..||....... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~-- 254 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-------D-- 254 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-------S--
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-------c--
Confidence 4321110 01112235689999999997654 6889999999999999999999995321100 0
Q ss_pred HHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccccc
Q 041031 232 VDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEWE 304 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 304 (313)
.....+..... .......+..+.+++.+||+.||.+|||+.++++.|+.+....+..+
T Consensus 255 ------------~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 255 ------------SVALAVQNQLS---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312 (317)
T ss_dssp ------------CHHHHHHCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC--
T ss_pred ------------hhhHHhhccCC---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCC
Confidence 00111111000 01123345678999999999999999999999999999987766543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=329.88 Aligned_cols=244 Identities=25% Similarity=0.342 Sum_probs=194.7
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|+.+++.+ ||||+++++++.+.+.+++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3478999999999999999999987 789999998643 234466788888888 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
||||+++++|.+++. ....+++..++.++.|++.||+|||+ .+ |+|+||||+||+++.++.+||+|||++.
T Consensus 226 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 226 VMEYANGGELFFHLS-----RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EECCCSSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEeeCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence 999999999999984 34578999999999999999999998 89 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 298 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------------------- 355 (446)
T 4ejn_A 298 EGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------------------- 355 (446)
T ss_dssp TTCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------------
T ss_pred eccCCC---cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------------------
Confidence 543322 1233457899999999999999999999999999999999999999654321
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAI 291 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~ 291 (313)
+....+... ... .....+..+.+|+.+||+.||.+|| |+.|+++
T Consensus 356 ----~~~~~i~~~-~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 356 ----KLFELILME-EIR---FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----HHHHHHHHC-CCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----HHHHHHHhC-CCC---CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 111111111 111 1233456788999999999999999 9999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=315.59 Aligned_cols=264 Identities=22% Similarity=0.360 Sum_probs=210.4
Q ss_pred HHHhcCccccceeccCCeEEEEEeEECC-------cceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEe
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAG 74 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~ 74 (313)
+...++|.+.+.||+|+||.||+|.+.+ ..+|+|.+.... .+.+.+|+.+++.+ ||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3345789999999999999999999862 369999987653 34578999999999 9999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCC---------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSV---------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD 145 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~ 145 (313)
.+..++||||+++++|.+++..... .....++...++.++.|++.||.|||+++ ++|+||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 9999999999999999999842210 01346789999999999999999999999 99999999999999
Q ss_pred CCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCc
Q 041031 146 SNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQ 224 (313)
Q Consensus 146 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~ 224 (313)
.++.++|+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|+| |..||.......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--- 274 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--- 274 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---
T ss_pred CCCeEEECccccccccccccce-eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---
Confidence 9999999999998865433221 12223456788999999999899999999999999999998 999997654320
Q ss_pred cccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 225 YTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
.....+....... .....+..+.+++.+||+.||.+|||+.++++.|+.+..+.
T Consensus 275 -------------------~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 275 -------------------KFYKLVKDGYQMA---QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp -------------------HHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------------------HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 1111222211111 12233567889999999999999999999999999887653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=316.40 Aligned_cols=244 Identities=28% Similarity=0.410 Sum_probs=198.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.+.|.+.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 355999999999999999999975 8889999986432 24577899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+. |+|.+++. .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...
T Consensus 133 ~e~~~-g~l~~~l~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 133 MEYCL-GSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EECCS-EEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EecCC-CCHHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 99996 68888774 23467899999999999999999999999 999999999999999999999999998765
Q ss_pred cCChhhhhhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
... ....+|+.|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 205 ~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------------------ 259 (348)
T 1u5q_A 205 APA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------------ 259 (348)
T ss_dssp SSB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------------------
T ss_pred CCC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------------------
Confidence 432 2346899999999985 567899999999999999999999999654321
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+.....+.. .....+..+.+|+.+||+.||++|||+.++++...
T Consensus 260 -----~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 260 -----SALYHIAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp -----HHHHHHHHSCCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred -----HHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 11111111111111 12334567889999999999999999999986544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=332.42 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=204.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|.+.+.||+|+||.||+|.+. ++.||+|++... ....+.+|+++++.+ ||||+++++++.+.+.+++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4577999999999999999999986 889999998643 244577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||++||+|.+++... ....+++..++.++.|++.||.|||+++ |+|+||||+||+++.+|.+||+|||++..
T Consensus 262 VmEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence 99999999999998522 2345899999999999999999999999 99999999999999999999999999987
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||....... ...
T Consensus 336 ~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-----~~~----------- 395 (576)
T 2acx_A 336 VPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KRE----------- 395 (576)
T ss_dssp CCTTC----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-----CHH-----------
T ss_pred cccCc----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-----hHH-----------
Confidence 65332 2223478999999999999999999999999999999999999997654321 000
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
+....+... ... .....+..+.+|+.+||+.||.+|| ++.|+++.
T Consensus 396 ---~i~~~i~~~-~~~---~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 396 ---EVERLVKEV-PEE---YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---HHHHHHHHC-CCC---CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---HHHHHhhcc-ccc---CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111111111 111 1234456788999999999999999 78888753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=322.09 Aligned_cols=246 Identities=26% Similarity=0.364 Sum_probs=193.4
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHH-HHhc-CCCceeeeeEEEeCCeEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKI-LCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~-l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
..++|++++.||+|+||.||+|+++ ++.||+|++.... ...+..|..+ ++.+ ||||+++++++.+.+.++
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3578999999999999999999987 6789999987543 2234556555 3445 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+||||+++|+|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.+|.+||+|||++.
T Consensus 116 lv~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred EEEeCCCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 9999999999999984 3456889999999999999999999999 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...... .......+|+.|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 188 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------------------- 245 (373)
T 2r5t_A 188 ENIEHN---STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------------------- 245 (373)
T ss_dssp GGBCCC---CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-------------------
T ss_pred ccccCC---CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------------------
Confidence 533221 1233457899999999999999999999999999999999999999754321
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
+....+... .+ ......+..+.+|+.+||+.||.+||++.+.++.+
T Consensus 246 ----~~~~~i~~~---~~-~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 246 ----EMYDNILNK---PL-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp ----HHHHHHHHS---CC-CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred ----HHHHHHHhc---cc-CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 111111111 11 11223456788999999999999999986444333
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=320.13 Aligned_cols=246 Identities=24% Similarity=0.353 Sum_probs=193.2
Q ss_pred cCccccceeccCCeEEEEEeEEC-CcceEEEeccccc-----cHHHHHHHHHHHhc---CCCceeeeeEEEeCCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK-----SKEFSSELKILCKV---HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~-----~~~~~~e~~~l~~l---h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.+|.+.+.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.+++.+ ||||+++++++...+.+++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45999999999999999999887 7889999986542 34578999999999 499999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
| +.+++|.+++. ....+++..++.++.|++.||.|||+++ |+|+||||+||+++ ++.+||+|||++....
T Consensus 136 E-~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHH-----HCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 55889999984 3457888899999999999999999999 99999999999995 5789999999998765
Q ss_pred CChhhhhhcccccccccccCCccccC-----------CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhH
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRD-----------GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~ 231 (313)
..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 206 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----------- 273 (390)
T 2zmd_A 206 PDTTS-VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----------- 273 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----------
T ss_pred CCCcc-ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----------
Confidence 33211 12233468999999999975 36888999999999999999999999643221
Q ss_pred HHHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 232 VDYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
...+...+++.... .....+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus 274 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 274 --------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp --------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------------HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 11111222222111 1222245788999999999999999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=326.38 Aligned_cols=260 Identities=22% Similarity=0.287 Sum_probs=194.4
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeC------
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGG------ 75 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~------ 75 (313)
..++|+++++||+|+||.||+|.+. ++.||||++... ....+.+|+.+++.+ ||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999987 788999998643 244577899999999 99999999999654
Q ss_pred CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
..+++||||+++ +|.+.+. ..+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred CeEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEE
Confidence 467999999965 5666662 24889999999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
|++...... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. ..+....
T Consensus 209 G~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~--------~~~~~i~ 276 (464)
T 3ttj_A 209 GLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--------DQWNKVI 276 (464)
T ss_dssp CCC-----C----CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH
T ss_pred EeeeecCCC----cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH
Confidence 999865432 1223346899999999999999999999999999999999999999765431 1111111
Q ss_pred HHHhcCcHHHHHHh----hhhcC--CCCC-----------------CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 236 LAVFNDTKDFMAKL----TECLD--PNLT-----------------RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 236 ~~~~~~~~~~~~~l----~~~~~--~~~~-----------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.......+++...+ ...+. +... ......+..+.+|+.+||..||.+|||+.|+++.
T Consensus 277 ~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 277 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111111111111 00010 0000 0111225678999999999999999999999964
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=314.77 Aligned_cols=265 Identities=20% Similarity=0.304 Sum_probs=192.7
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
-....++|++.++||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+ ||||+++++++.+.+..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 3456789999999999999999999887 8889999997543 23466899999999 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC-----CCCcEEEe
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD-----SNFRAKIA 153 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-----~~~~~~l~ 153 (313)
++||||++ ++|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++ +++.++|+
T Consensus 109 ~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMD-----KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp EEEEECCS-EEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred EEEEecCC-CCHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEEC
Confidence 99999996 59999984 3456899999999999999999999999 99999999999994 45569999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHH
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLV 232 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~ 232 (313)
|||++....... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...... ..+.
T Consensus 180 Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~ 248 (329)
T 3gbz_A 180 DFGLARAFGIPI---RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--------DQLF 248 (329)
T ss_dssp CTTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHH
T ss_pred cCCCccccCCcc---cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--------HHHH
Confidence 999987654321 122234579999999999874 4899999999999999999999999754331 1111
Q ss_pred HHHHHHh-cCcHHH--HHHhhhhcC--CCCCC------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 233 DYMLAVF-NDTKDF--MAKLTECLD--PNLTR------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 233 ~~~~~~~-~~~~~~--~~~l~~~~~--~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
....... +....+ ...+..+.. +.... .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 249 KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 1111000 000000 000000000 00000 01113467889999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=312.87 Aligned_cols=261 Identities=23% Similarity=0.364 Sum_probs=205.3
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
..++|.+.+.||+|+||.||+|.+. +..||||.+.... ...+.+|+.+++.+ ||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 3578999999999999999999843 5679999996442 34577899999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCC--CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcEEE
Q 041031 78 LFLVYEYAQNGALSDHLHWPSV--KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKI 152 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~~l 152 (313)
.++||||+++++|.+++..... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +..++|
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999964331 12245889999999999999999999999 999999999999984 446999
Q ss_pred eeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhH
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~ 231 (313)
+|||++........ ........+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 185 ~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------- 252 (327)
T 2yfx_A 185 GDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----------- 252 (327)
T ss_dssp CCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----------
T ss_pred Cccccccccccccc-cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-----------
Confidence 99999875433221 112223457889999999998899999999999999999998 99999654321
Q ss_pred HHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 232 VDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+...... ......+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 253 ------------~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 253 ------------EVLEFVTSGGRM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp ------------HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ------------HHHHHHhcCCCC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 112222211111 123345567889999999999999999999999999887653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=338.82 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=199.0
Q ss_pred ceeccCCeEEEEEeEEC----CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR----GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
++||+|+||.||+|.+. ++.||||+++... .+.+.+|+++++.+ ||||+++++++... ..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence 47999999999999663 5679999997543 35688999999999 99999999999754 58899999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
|+|.+++. ....+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||++.........
T Consensus 454 g~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999994 3466899999999999999999999999 999999999999999999999999999876543332
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.... +..
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----------------------~~~ 582 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----------------------EVT 582 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------------HHH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------------HHH
Confidence 222233346788999999999999999999999999999998 99999765431 222
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
..+...... .....++..+.+|+.+||+.||++|||+.+|+++|+.+..+
T Consensus 583 ~~i~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 583 AMLEKGERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 222222211 12345567899999999999999999999999999988765
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=314.27 Aligned_cols=269 Identities=24% Similarity=0.304 Sum_probs=195.9
Q ss_pred HHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--------cHHHHHHHHHHHhc-CCCceeeeeEEEe
Q 041031 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--------SKEFSSELKILCKV-HSNLIELIGYAAG 74 (313)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--------~~~~~~e~~~l~~l-h~~i~~~~~~~~~ 74 (313)
++....++|++.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++.+
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 35567789999999999999999999987 7889999987432 23577899999999 9999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
.+..++||||+++ +|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D 155 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLAD 155 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCceEEEEEcCCC-CHHHHHH----hcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEe
Confidence 9999999999975 8888884 33456888999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
||++....... .......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.... ..+..
T Consensus 156 fg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--------~~~~~ 224 (346)
T 1ua2_A 156 FGLAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--------DQLTR 224 (346)
T ss_dssp CGGGSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHH
T ss_pred cccceeccCCc---ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--------HHHHH
Confidence 99988654322 122234679999999999764 5889999999999999999999999765431 11111
Q ss_pred HHHHHhcCcHH-HH--HHhhhhcCC-CCCC-----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 234 YMLAVFNDTKD-FM--AKLTECLDP-NLTR-----YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 234 ~~~~~~~~~~~-~~--~~l~~~~~~-~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
..........+ +. ..+...... .... .....+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus 225 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred HHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 11100000000 00 000000000 0000 0123456789999999999999999999999754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=334.64 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=210.2
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
...++|++.++||+|+||.||+|.+. +..||||+++... .+.+.+|+++|+.+ ||||+++++++.+ +..++||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 34567899999999999999999998 4679999998643 46788999999999 9999999999876 678999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+.+|+|.+++... ....+++..++.++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++......
T Consensus 343 ~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 343 MSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CTTEEHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hcCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999421 2245889999999999999999999999 999999999999999999999999999866532
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
.. .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 417 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~----------------------- 471 (535)
T 2h8h_A 417 EY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----------------------- 471 (535)
T ss_dssp HH--HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----------------------
T ss_pred ce--ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------------
Confidence 21 12222346788999999998899999999999999999999 89999754321
Q ss_pred HHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 244 ~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+...... .....++..+.+|+.+||+.||++|||+.+|++.|+.+..+.
T Consensus 472 ~~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 472 EVLDQVERGYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 112222221111 123345667899999999999999999999999999887653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=307.08 Aligned_cols=247 Identities=20% Similarity=0.320 Sum_probs=203.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|.+.+.||+|+||.||+|.+. ++.+|+|++.... .+.+.+|+.+++.+ ||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 4578999999999999999999998 7789999986442 34577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
+||++++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 93 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 93 VLELCRRRSLLELHK-----RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEECCTTCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 999999999999884 3457899999999999999999999999 99999999999999999999999999886
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 165 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------------------- 221 (294)
T 2rku_A 165 VEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------------------- 221 (294)
T ss_dssp CCSTTC---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------------------
T ss_pred cccCcc---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------------
Confidence 543221 223346899999999999988999999999999999999999999654321
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+. .... ......+..+.+++.+||+.||++|||+.++++.-.
T Consensus 222 ---~~~~~~~---~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 222 ---ETYLRIK---KNEY-SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp ---HHHHHHH---TTCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred ---HHHHHHh---hccC-CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 0011111 1111 112234457889999999999999999999998543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=318.85 Aligned_cols=265 Identities=15% Similarity=0.197 Sum_probs=206.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC----------CcceEEEeccccccHHHHHHHHHHHhc-CCCcee------------
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR----------GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIE------------ 67 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~----------~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~------------ 67 (313)
.++|.+.+.||+|+||.||+|++. ++.||+|.+... ..+.+|+++++.+ |||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 368999999999999999999885 578999998765 4688999999999 998887
Q ss_pred ---eeeEEEe-CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCee
Q 041031 68 ---LIGYAAG-GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNIL 143 (313)
Q Consensus 68 ---~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil 143 (313)
+++++.. .+..++||||+ +++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||||+||+
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6677765 77899999999 99999999522 1367999999999999999999999999 999999999999
Q ss_pred eCCCC--cEEEeeccccccccCChhhh----hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCC
Q 041031 144 LDSNF--RAKIADFGLVKLLEHSPEIA----AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRD 217 (313)
Q Consensus 144 ~~~~~--~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~ 217 (313)
++.++ .++|+|||++.......... .......+++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99988 89999999997655332111 1122347899999999999999999999999999999999999999765
Q ss_pred CCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 041031 218 ANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297 (313)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 297 (313)
.... ..+....... ............ .....+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 272 ~~~~-------~~~~~~~~~~-------~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 272 LPNT-------EDIMKQKQKF-------VDKPGPFVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TTCH-------HHHHHHHHHH-------HHSCCCEECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CcCH-------HHHHHHHHhc-------cCChhhhhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 4210 1111110000 000000111000 11233567899999999999999999999999999998
Q ss_pred hcc
Q 041031 298 ISS 300 (313)
Q Consensus 298 ~~~ 300 (313)
...
T Consensus 336 ~~~ 338 (352)
T 2jii_A 336 QDL 338 (352)
T ss_dssp HHT
T ss_pred Hhc
Confidence 754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=315.72 Aligned_cols=264 Identities=23% Similarity=0.347 Sum_probs=199.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
..++|++.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4678999999999999999999998 7889999886543 23366899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 103 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 103 FEFVDHTILDDLEL-----FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EECCSEEHHHHHHH-----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EecCCcchHHHHHh-----hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 99999998988863 3456999999999999999999999999 999999999999999999999999998765
Q ss_pred cCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
..... ......+++.|+|||++.+. .++.++||||||+++|+|++|..||...... ..+.........
T Consensus 175 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~ 243 (331)
T 4aaa_A 175 AAPGE---VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI--------DQLYHIMMCLGN 243 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCS
T ss_pred cCCcc---ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH--------HHHHHHHHHhCC
Confidence 43221 22234689999999999875 6899999999999999999999999765431 111111111111
Q ss_pred CcHHHHHHhhh------hcCCCCCC------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 241 DTKDFMAKLTE------CLDPNLTR------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 241 ~~~~~~~~l~~------~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
..+........ ...+.... .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11111111000 00011111 112345779999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=312.58 Aligned_cols=262 Identities=19% Similarity=0.281 Sum_probs=202.8
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEecccccc--------------------HHHHHHHHHHHhc-CCCceeee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKS--------------------KEFSSELKILCKV-HSNLIELI 69 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~--------------------~~~~~e~~~l~~l-h~~i~~~~ 69 (313)
.++|++.+.||+|+||.||+|.+.++.||||.+..... +.+.+|+.+++.+ ||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 47899999999999999999999999999999864321 7789999999999 99999999
Q ss_pred eEEEeCCeEEEEEeecCCCChhhhhcCC---CCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeC
Q 041031 70 GYAAGGDSLFLVYEYAQNGALSDHLHWP---SVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLD 145 (313)
Q Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~ 145 (313)
+++.+.+..++||||+++++|.+++... .......+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEc
Confidence 9999999999999999999999983210 11125679999999999999999999999 99 99999999999999
Q ss_pred CCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCC-CCCC-ccchhhHHHHHHHHHhCCCCccCCCCCCCC
Q 041031 146 SNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTT-KSDVYAFGVVLMELITGQQALSRDANPGNN 223 (313)
Q Consensus 146 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~DiwslG~~l~~~~tg~~p~~~~~~~~~~ 223 (313)
.++.++|+|||.+...... ......+++.|+|||++.+. .++. ++||||||+++|+|++|..||.......
T Consensus 187 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 259 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-- 259 (348)
T ss_dssp TTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred CCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence 9999999999998875432 22334689999999999877 5666 9999999999999999999997654410
Q ss_pred ccccchhHHHHHHHHhcCcHHHHH----HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 224 QYTEHRSLVDYMLAVFNDTKDFMA----KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~----~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
............+.. .................+..+.+|+.+||+.||.+|||+.++++
T Consensus 260 ---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ---------ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ---------HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---------HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111000000000 00000000000011345678899999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=303.15 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=194.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|.+.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4578999999999999999999987 8899999986432 34678899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
|||++++++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 89 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 89 VMEYVSGGELFDYIC-----KHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEECCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEeccCCCcHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccc
Confidence 999999999999984 3356899999999999999999999999 99999999999999999999999999886
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
..... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 161 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------------------- 217 (276)
T 2h6d_A 161 MSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------------------- 217 (276)
T ss_dssp CCC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------------
T ss_pred cCCCc----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------------------
Confidence 65432 1223467899999999987765 68999999999999999999999643221
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+..... ......+..+.+++.+||+.||.+|||+.++++.
T Consensus 218 ----~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 218 ----TLFKKIRGGVF----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----HHHHHHHHCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----HHHHHhhcCcc----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111211111 1122334578899999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=309.90 Aligned_cols=257 Identities=22% Similarity=0.340 Sum_probs=202.8
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEE--eCCeE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAA--GGDSL 78 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~--~~~~~ 78 (313)
...++|++.+.||+|+||.||+|.+. ++.+|+|.+.... .+.+.+|+.+++.+ ||||+++++++. .....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 34689999999999999999999987 7889999986542 34577899999999 999999999875 46789
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCC--CCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT--KPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
++||||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ ..+++|+||+|+||+++.++.++|+|||
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEeCCCCCCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999985322 12345899999999999999999999986 2338999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
.+........ ......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 162 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------- 222 (279)
T 2w5a_A 162 LARILNHDTS---FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---------------- 222 (279)
T ss_dssp HHHHC---CH---HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------
T ss_pred hheeeccccc---cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH----------------
Confidence 9876553322 112245789999999999989999999999999999999999999754321
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
+....+.....+ ......+..+.+++.+||+.||.+|||+.+|++.++.
T Consensus 223 -------~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 223 -------ELAGKIREGKFR---RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -------HHHHHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -------HHHHHHhhcccc---cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 112222221111 1223455678999999999999999999999987653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=327.82 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=203.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|.+.+.||+|+||.||+|+++ ++.||+|++.... ...+.+|..+++.+ ||||+++++++.+.+.+++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 478999999999999999999986 8899999986432 34577899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||++||+|.+++.... .....+++..++.++.|++.||.|||+++ |+|+||||+||+++.+|.+||+|||++...
T Consensus 264 mE~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999985332 22457999999999999999999999999 999999999999999999999999999875
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
..... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||....... ...
T Consensus 340 ~~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--------~~~--------- 399 (543)
T 3c4z_A 340 KAGQT---KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--------ENK--------- 399 (543)
T ss_dssp CTTCC---CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--------CHH---------
T ss_pred cCCCc---ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--------hHH---------
Confidence 53321 2233478999999999999999999999999999999999999997654321 000
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH-----HHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM-----SNAAI 291 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~-----~~ll~ 291 (313)
+....+.... . ......+..+.+|+++||+.||.+||++ .+|++
T Consensus 400 --~~~~~i~~~~-~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 400 --ELKQRVLEQA-V---TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --HHHHHHHHCC-C---CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --HHHHHHhhcc-c---CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1111111110 1 1223445678899999999999999975 55653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=317.92 Aligned_cols=268 Identities=21% Similarity=0.320 Sum_probs=202.9
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++|++.+.||+|+||.||+|.+. +..+|+|++.... ...+.+|+.+++.+ ||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999998 8889999987543 34577899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC-CCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY-TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|+++++|.+++. ....+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++....
T Consensus 112 ~~~~~~L~~~l~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 112 HMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999984 345689999999999999999999996 8 9999999999999999999999999986543
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcccc---------------
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE--------------- 227 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~--------------- 227 (313)
. .......+++.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 184 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 184 D-----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp H-----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred c-----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 2 12233468999999999999999999999999999999999999997543210000000
Q ss_pred --chhHHHHH--HHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 228 --HRSLVDYM--LAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 228 --~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
......+. ........+....+.....+.. .....+..+.+|+.+||+.||.+|||+.++++.-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCC--CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCC--CcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 00000000 0000000111111111111111 2223456789999999999999999999999643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=306.40 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=185.5
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccH----H-HHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK----E-FSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~----~-~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
...++|++.+.||+|+||.||+|.+. ++.||+|.+...... . ..++...++.+ ||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 35689999999999999999999985 889999999765322 1 23334445556 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC-CCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY-TKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
||||++ ++|.+++.... .....+++..++.++.|++.||+|||++ + ++|+||||+||+++.++.++|+|||++.
T Consensus 84 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEECCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEehhc-cchHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999996 58877764211 2346799999999999999999999998 9 9999999999999999999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccc----cCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYV----RDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
...... ......+++.|+|||++ .+..++.++||||||+++|+|++|..||...... .
T Consensus 159 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~---- 220 (290)
T 3fme_A 159 YLVDDV----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----------F---- 220 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----------H----
T ss_pred cccccc----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----------H----
Confidence 655432 22223689999999996 4567899999999999999999999999754321 0
Q ss_pred HHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 236 LAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 236 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
........ ...........+..+.+++.+||+.||.+|||+.++++.
T Consensus 221 --------~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 221 --------QQLKQVVE--EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp --------HHHHHHHH--SCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --------HHHHHHhc--cCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 00111111 111111223455678999999999999999999999873
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=311.04 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=199.2
Q ss_pred ChHHHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc--ccHHHHHHHHHHHhc--CCCceeeeeEEEe--
Q 041031 3 SYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT--KSKEFSSELKILCKV--HSNLIELIGYAAG-- 74 (313)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~--~~~~~~~e~~~l~~l--h~~i~~~~~~~~~-- 74 (313)
+...+....++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|+.+++.+ ||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 44556667889999999999999999999995 889999998644 456788999999998 9999999999976
Q ss_pred ----CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcE
Q 041031 75 ----GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRA 150 (313)
Q Consensus 75 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~ 150 (313)
.+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 56899999999999999998532 2356889999999999999999999999 9999999999999999999
Q ss_pred EEeeccccccccCChhhhhhcccccccccccCCcccc-----CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcc
Q 041031 151 KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQY 225 (313)
Q Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~ 225 (313)
+|+|||++........ ......+++.|+|||++. +..++.++||||||+++|+|++|..||......
T Consensus 169 kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----- 240 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----- 240 (326)
T ss_dssp EECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----
T ss_pred EEeeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----
Confidence 9999999876543211 222346899999999997 566889999999999999999999999643321
Q ss_pred ccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 226 TEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+.....+.. .....+..+.+|+.+||..||.+|||+.++++.
T Consensus 241 ------------------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 ------------------RALFLIPRNPAPRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ------------------HHHHHHHHSCCCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ------------------HHHHHhhcCccccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00111111111111 123345678899999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=313.42 Aligned_cols=259 Identities=23% Similarity=0.336 Sum_probs=195.8
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeC------
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGG------ 75 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~------ 75 (313)
+.++|++.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4578999999999999999999986 8899999985432 34577899999999 99999999999765
Q ss_pred CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
..+++|||++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEee
Confidence 3469999999 8899999842 46889999999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
|++...... .....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.. ..+...
T Consensus 173 g~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~l~~i 238 (367)
T 1cm8_A 173 GLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--------DQLKEI 238 (367)
T ss_dssp TTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH
T ss_pred ecccccccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH
Confidence 999865432 223467999999999987 67999999999999999999999999765431 111111
Q ss_pred HHHHhcCcHHHH------------HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 235 MLAVFNDTKDFM------------AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 235 ~~~~~~~~~~~~------------~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.........++. ..+.......+.......+..+.+|+.+||..||.+|||+.++++.
T Consensus 239 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 111111111111 1111111111222233456778999999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=312.78 Aligned_cols=246 Identities=20% Similarity=0.330 Sum_probs=203.3
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
..++|.+.+.||+|+||.||++.+. ++.+|+|++... ..+.+.+|+.+++.+ ||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3568999999999999999999987 678999998654 244577899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+.+++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 119 v~e~~~~~~L~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 119 VLELCRRRSLLELHK-----RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EECCCTTCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 999999999999984 3456899999999999999999999999 99999999999999999999999999886
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 191 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------------------- 247 (335)
T 2owb_A 191 VEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------------------- 247 (335)
T ss_dssp CCSTTC---CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------------------
T ss_pred cccCcc---cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--------------------
Confidence 653221 223346899999999999988999999999999999999999999653321
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
+....+... ... .....+..+.+|+.+||+.||.+|||+.++++.-
T Consensus 248 ---~~~~~~~~~-~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 248 ---ETYLRIKKN-EYS---IPKHINPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp ---HHHHHHHHT-CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ---HHHHHHhcC-CCC---CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 111111111 111 1223345688899999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=323.39 Aligned_cols=197 Identities=28% Similarity=0.412 Sum_probs=164.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeC-----C
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGG-----D 76 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~-----~ 76 (313)
+.++|.+.+.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+ ||||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4678999999999999999999987 7889999987532 34578999999999 99999999999766 5
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
.+++|||+++ ++|.+++. ....+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~-----~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFK-----TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CEEEEEECCS-EEHHHHHH-----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecCC-cCHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCC
Confidence 7999999985 69999984 4466999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhh-------------------hhcccccccccccCCccc-cCCCCCCccchhhHHHHHHHHHhCCCCcc
Q 041031 157 LVKLLEHSPEIA-------------------AAASRIVGTFGYLAPEYV-RDGCVTTKSDVYAFGVVLMELITGQQALS 215 (313)
Q Consensus 157 ~~~~~~~~~~~~-------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~~~tg~~p~~ 215 (313)
++.......... .......+|+.|+|||++ .+..++.++|||||||++|+|++|..||.
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 998765432110 112345789999999986 56679999999999999999998655554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=325.84 Aligned_cols=273 Identities=20% Similarity=0.280 Sum_probs=185.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEe-----CCe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAG-----GDS 77 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~-----~~~ 77 (313)
.++|++.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999887 7899999886532 34577899999999 9999999999843 357
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
+++|||++ +++|.+++. ....+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR-----TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCC-SEEHHHHHH-----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecc-ccchhhhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeeccccc
Confidence 99999998 578999984 4467999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhh------------------------hhhcccccccccccCCccc-cCCCCCCccchhhHHHHHHHHHh---
Q 041031 158 VKLLEHSPEI------------------------AAAASRIVGTFGYLAPEYV-RDGCVTTKSDVYAFGVVLMELIT--- 209 (313)
Q Consensus 158 ~~~~~~~~~~------------------------~~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~~~t--- 209 (313)
+......... ........+|+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 9865432110 0122334679999999986 46679999999999999999999
Q ss_pred --------CCCCccCCCCCCCCcccc-----------chhHHHHHHHHhcC-cHHH---------HHHhhhhc---CCCC
Q 041031 210 --------GQQALSRDANPGNNQYTE-----------HRSLVDYMLAVFND-TKDF---------MAKLTECL---DPNL 257 (313)
Q Consensus 210 --------g~~p~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~-~~~~---------~~~l~~~~---~~~~ 257 (313)
|.+||.+........... .......+...... ..+. ...+.... ...+
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 566665443211000000 00000111111100 0000 00000000 0011
Q ss_pred CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 258 TRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 258 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.......+..+.+|+++||..||.+|||+.|+++.
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11223346678899999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=315.47 Aligned_cols=265 Identities=22% Similarity=0.304 Sum_probs=201.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeC-----Ce
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGG-----DS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~-----~~ 77 (313)
+.++|++.+.||+|+||.||+|.+. +..||||.+.... ...+.+|+.+++.+ ||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4568999999999999999999987 7789999987543 24577899999999 99999999999654 46
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.++|||++. ++|.+++. ...+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 105 ~~iv~e~~~-~~L~~~l~------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLK------TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEEECCS-EEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcccC-cCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcc
Confidence 899999996 58999884 245899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
+.................+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .+.....
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~ 246 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--------QLNHILG 246 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--------HHHHHHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--------HHHHHHH
Confidence 9876543332222334578999999998754 558999999999999999999999997654321 1111111
Q ss_pred HHhcCcHHHH---------HHhhhhcCCCCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 237 AVFNDTKDFM---------AKLTECLDPNLTR---YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 237 ~~~~~~~~~~---------~~l~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.......+.. ............. .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 247 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111100 0011111111000 112345678899999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=301.79 Aligned_cols=244 Identities=25% Similarity=0.412 Sum_probs=194.5
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEe----CCeEEE
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAG----GDSLFL 80 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~----~~~~~l 80 (313)
.|.+.+.||+|+||.||+|.+. +..||+|.+.... ...+.+|+.+++.+ ||||+++++++.. ...+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4888899999999999999987 6778999886432 34577899999999 9999999999865 456899
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC-CCCcEEEeeccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD-SNFRAKIADFGLVK 159 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~~l~dfg~~~ 159 (313)
||||+++++|.+++. ....+++..++.++.|++.||.|||+.+. +++|+||+|+||+++ +++.++|+|||++.
T Consensus 107 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHH-----HccCCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999994 34668999999999999999999999862 289999999999998 78999999999987
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
..... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||.......
T Consensus 181 ~~~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------------------ 236 (290)
T 1t4h_A 181 LKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------------------ 236 (290)
T ss_dssp GCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------------------
T ss_pred ccccc-----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH------------------
Confidence 54432 2223468999999998874 58999999999999999999999996543310
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.....+.....+ .......+..+.+++.+||+.||.+|||+.++++.
T Consensus 237 ----~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 237 ----QIYRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----HHHHHHTTTCCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----HHHHHHhccCCc--cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111111111111 11222334578899999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=310.99 Aligned_cols=262 Identities=23% Similarity=0.274 Sum_probs=192.3
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC-----
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGD----- 76 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~----- 76 (313)
..++|++.+.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+ ||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3578999999999999999999887 7889999986532 34577899999999 999999999997665
Q ss_pred -eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 77 -SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 77 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
..++||||++ ++|.+.+. ..+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+||
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCC
T ss_pred cceEEEEEcCC-CCHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEe
Confidence 7899999996 57888873 34889999999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
|++....... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+....
T Consensus 172 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~ 239 (371)
T 2xrw_A 172 GLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--------DQWNKVI 239 (371)
T ss_dssp CC--------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH
T ss_pred eccccccccc----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH
Confidence 9987654321 122346899999999999999999999999999999999999999765431 0111111
Q ss_pred HHHhcCcHHHHHHh-----------------------hhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 236 LAVFNDTKDFMAKL-----------------------TECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 236 ~~~~~~~~~~~~~l-----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.......+++...+ .....+.........+..+.+|+.+||..||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 240 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp C-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000001111000 0000000000112336778999999999999999999999975
Q ss_pred HH
Q 041031 293 LS 294 (313)
Q Consensus 293 l~ 294 (313)
=.
T Consensus 320 p~ 321 (371)
T 2xrw_A 320 PY 321 (371)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=311.83 Aligned_cols=269 Identities=24% Similarity=0.257 Sum_probs=199.4
Q ss_pred hHHHHHHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--------------cHHHHHHHHHHHhc-CCCcee
Q 041031 4 YNEVRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--------------SKEFSSELKILCKV-HSNLIE 67 (313)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--------------~~~~~~e~~~l~~l-h~~i~~ 67 (313)
.+.+....++|.+.+.||+|+||.||+|.+. ++.||||.+.... .+.+.+|+.+++.+ ||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 5678889999999999999999999999887 8889999886432 15688999999999 999999
Q ss_pred eeeEEEe-----CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCe
Q 041031 68 LIGYAAG-----GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNI 142 (313)
Q Consensus 68 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~ni 142 (313)
+++++.. ....++|||++. ++|.+.+. .....+++..++.++.|++.||.|||+++ ++|+||||+||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH----DQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH----CTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHH----hcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 9999843 346899999996 68888875 34457999999999999999999999999 99999999999
Q ss_pred eeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCC
Q 041031 143 LLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPG 221 (313)
Q Consensus 143 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~ 221 (313)
+++.++.++|+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~- 240 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY- 240 (362)
T ss_dssp EECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred EEcCCCCEEEEecCccccccccc----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-
Confidence 99999999999999987544322 2223467899999999987 67899999999999999999999999764421
Q ss_pred CCccccchhHHHHHHHHhc---------CcHHHHHHhhhhcCCCCCC----CCHHHHHHHHHHHhhccccCcCCCCCHHH
Q 041031 222 NNQYTEHRSLVDYMLAVFN---------DTKDFMAKLTECLDPNLTR----YHKDSMLQMALLSKDCVDENWKRRPDMSN 288 (313)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 288 (313)
..+......... ........+.......... .....+..+.+|+.+||+.||.+|||+.+
T Consensus 241 -------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 313 (362)
T 3pg1_A 241 -------NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313 (362)
T ss_dssp -------HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -------HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 111111111100 0111111111111111111 12233567889999999999999999999
Q ss_pred HHHH
Q 041031 289 AAIR 292 (313)
Q Consensus 289 ll~~ 292 (313)
+++.
T Consensus 314 ll~h 317 (362)
T 3pg1_A 314 ALRH 317 (362)
T ss_dssp HHTS
T ss_pred HHcC
Confidence 9864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=319.03 Aligned_cols=281 Identities=23% Similarity=0.330 Sum_probs=185.7
Q ss_pred HhcCccc-cceeccCCeEEEEEeEEC----CcceEEEeccccc-cHHHHHHHHHHHhc-CCCceeeeeEEEe--CCeEEE
Q 041031 10 ATSNFST-SLKIGQGSYGSVYLGKLR----GKNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIELIGYAAG--GDSLFL 80 (313)
Q Consensus 10 ~~~~y~~-~~~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h~~i~~~~~~~~~--~~~~~l 80 (313)
..+.|.+ .++||+|+||.||+|+++ ++.||||.+.... ...+.+|+.+++.+ ||||+++++++.. ....++
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 4456777 558999999999999965 6789999998654 55688999999999 9999999999954 678999
Q ss_pred EEeecCCCChhhhhcCCC----CCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee----CCCCcEEE
Q 041031 81 VYEYAQNGALSDHLHWPS----VKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL----DSNFRAKI 152 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~----~~~~~~~l 152 (313)
||||+. ++|.+++.... ......+++..++.++.|++.||+|||+++ |+|+||||+||++ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999995 58887773211 112235899999999999999999999999 9999999999999 67789999
Q ss_pred eeccccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhH
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~ 231 (313)
+|||++.................+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...............
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 999999876543222223334578999999999987 4589999999999999999999999976654321111111111
Q ss_pred HHHHHHHhcCc-----------HHHHHHhhhhcCCCCCCC---------CHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 232 VDYMLAVFNDT-----------KDFMAKLTECLDPNLTRY---------HKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 232 ~~~~~~~~~~~-----------~~~~~~l~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...+....... .+................ ....+..+.+|+.+||..||.+|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111110000 000000000000000000 0011346788999999999999999999997
Q ss_pred HHH
Q 041031 292 RLS 294 (313)
Q Consensus 292 ~l~ 294 (313)
.=+
T Consensus 334 hp~ 336 (405)
T 3rgf_A 334 DPY 336 (405)
T ss_dssp SGG
T ss_pred Chh
Confidence 533
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=319.42 Aligned_cols=196 Identities=22% Similarity=0.327 Sum_probs=169.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc-------CCCceeeeeEEEeCCeE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV-------HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l-------h~~i~~~~~~~~~~~~~ 78 (313)
+..+|++.++||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+ |+||+++++++...+..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 3457999999999999999999987 7889999997654 34567788888887 56999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc--EEEeecc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR--AKIADFG 156 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~--~~l~dfg 156 (313)
++|||++. ++|.+++... ....+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++. +||+|||
T Consensus 175 ~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999995 6899988522 2345899999999999999999999999 999999999999999887 9999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCC
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDA 218 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~ 218 (313)
++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 248 ~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 248 SSCYEHQR------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCEETTCC------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceecCCc------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 98754432 223468999999999999999999999999999999999999997654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=304.83 Aligned_cols=248 Identities=21% Similarity=0.344 Sum_probs=197.2
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
..++|++.+.||+|+||.||+|.+. ++.+|+|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4678999999999999999999997 7889999987543 45678899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++++|.+++. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 97 FCPGGAVDAIML----ELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp CCTTEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred eCCCCcHHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999884 23456899999999999999999999999 99999999999999999999999998754221
Q ss_pred ChhhhhhcccccccccccCCcccc-----CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
. ........+++.|+|||++. +..++.++||||||+++|+|++|..||......
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------------ 228 (302)
T 2j7t_A 170 T---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------------------ 228 (302)
T ss_dssp H---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------------------
T ss_pred c---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------------------
Confidence 1 11222346899999999983 667899999999999999999999999754321
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+....+.....+. .......+..+.+++.+||+.||.+|||+.++++
T Consensus 229 -----~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 229 -----RVLLKIAKSDPPT-LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----HHHHHHHHSCCCC-CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----HHHHHHhccCCcc-cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111111111111 1123345567899999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=304.19 Aligned_cols=243 Identities=23% Similarity=0.322 Sum_probs=196.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~l 80 (313)
..++|++.+.||+|+||.||+|.+. ++.||||.+... ....+.+|+..+..+ ||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999997 889999998753 244577888888888 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC-------------
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN------------- 147 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~------------- 147 (313)
||||+++++|.+++.... .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999985221 11256899999999999999999999999 9999999999999844
Q ss_pred ------CcEEEeeccccccccCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCC
Q 041031 148 ------FRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANP 220 (313)
Q Consensus 148 ------~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~ 220 (313)
..++++|||.+....... ...+++.|+|||++.+. .++.++||||||+++|+|++|.+|+....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-- 235 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-- 235 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--
T ss_pred cccCCceEEEEcccccccccCCcc-------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--
Confidence 479999999988655322 23589999999999865 56789999999999999999987764221
Q ss_pred CCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 221 GNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
....+.. ..........+..+.+++.+||+.||.+|||+.++++.
T Consensus 236 ------------------------~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 ------------------------QWHEIRQ---GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ------------------------HHHHHHT---TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ------------------------HHHHHHc---CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0111111 11222233455678999999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=300.89 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=196.4
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
++|.....||+|+||.||+|.+. +..||||.+.... .+.+.+|+.+++.+ ||||+++++++...+..++|||++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555669999999999999986 7789999987543 45578999999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-CCcEEEeeccccccccCC
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~~l~dfg~~~~~~~~ 164 (313)
++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. ++.++|+|||.+......
T Consensus 102 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 102 PGGSLSALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp SEEEHHHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCHHHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 9999999985321 2345678889999999999999999999 999999999999987 899999999998865532
Q ss_pred hhhhhhcccccccccccCCccccCCC--CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGC--VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.. ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||...... ..
T Consensus 177 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------~~----------- 233 (295)
T 2clq_A 177 NP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---------QA----------- 233 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---------HH-----------
T ss_pred CC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---------hH-----------
Confidence 21 223346899999999997643 789999999999999999999999644321 00
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...........+. .....+..+.+++.+||+.||++|||+.++++.
T Consensus 234 -~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 234 -AMFKVGMFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -HHHHHHHHCCCCC---CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -HHHhhcccccccc---ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000001111111 233455678899999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=312.41 Aligned_cols=265 Identities=18% Similarity=0.267 Sum_probs=199.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc---------CCCceeeeeEEE----
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV---------HSNLIELIGYAA---- 73 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l---------h~~i~~~~~~~~---- 73 (313)
.++|++.++||+|+||.||+|++. ++.||||++.... .+.+.+|+.+++.+ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 468999999999999999999887 7889999997653 45678899999988 567999999987
Q ss_pred eCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC-CCCceEEeccCCCCeeeCCCC----
Q 041031 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY-TKPYYVHRDVKTSNILLDSNF---- 148 (313)
Q Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~~~~---- 148 (313)
+....++|||++ +++|.+.+.. .....+++..++.++.|++.||+|||++ + ++|+||||+||+++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIK---SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHH---TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 556899999999 5566665531 2235689999999999999999999998 9 99999999999998775
Q ss_pred ---------------------------------------------cEEEeeccccccccCChhhhhhcccccccccccCC
Q 041031 149 ---------------------------------------------RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAP 183 (313)
Q Consensus 149 ---------------------------------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aP 183 (313)
.++|+|||.+...... .....+|+.|+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aP 262 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCC
Confidence 7999999998865432 2234689999999
Q ss_pred ccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHh----hhhcCC--C-
Q 041031 184 EYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKL----TECLDP--N- 256 (313)
Q Consensus 184 E~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l----~~~~~~--~- 256 (313)
|++.+..++.++|||||||++|+|++|..||.......... .......+.......+.....- ...... .
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR---DEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCH---HHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCc---hHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 99999999999999999999999999999997655432111 1111111111111110000000 000000 0
Q ss_pred -----------------CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 257 -----------------LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 257 -----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...........+.+|+.+||+.||.+|||+.|+++
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00124566788999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=321.52 Aligned_cols=263 Identities=21% Similarity=0.299 Sum_probs=208.8
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEee
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
+.++|.+.++||+|+||.||+|.+. ++.||||++... ....+.+|+++++.+ ++++..+..++...+..++||||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 4578999999999999999999986 889999987644 345688999999999 46677777777888899999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee---CCCCcEEEeeccccccc
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL---DSNFRAKIADFGLVKLL 161 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~---~~~~~~~l~dfg~~~~~ 161 (313)
+ +++|.+++. .....+++..++.++.|++.||.|||+++ |+|+||||+|||+ +.++.+||+|||++...
T Consensus 85 ~-g~sL~~ll~----~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 85 L-GPSLEDLFN----FCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp C-CCBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred C-CCCHHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 9 899999985 23456999999999999999999999999 9999999999999 57889999999999876
Q ss_pred cCChhhh----hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 162 EHSPEIA----AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 162 ~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
....... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-----~~~~~~~i~~~ 231 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-----KKQKYEKISEK 231 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-----HHHHHHHHHHH
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh-----HHHHHHHHhhc
Confidence 5432211 11224578999999999999999999999999999999999999998755421 00111111111
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
... ..+.. .....+..+.+|+..||+.+|.+||++.+|++.|+++...
T Consensus 232 ~~~------~~~~~--------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 232 KVA------TSIEA--------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHH------SCHHH--------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccc------ccHHH--------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 100 00000 0112345788999999999999999999999999999774
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=301.70 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=200.3
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
...++|++.+.||+|+||.||+|.+. ++.||+|++... ....+.+|+++++.+ ||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 45678999999999999999999986 788999998643 345688999999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC---CcEEEeeccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN---FRAKIADFGL 157 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~---~~~~l~dfg~ 157 (313)
++|++.+++|.+.+. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.+ +.++|+|||+
T Consensus 99 v~e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 99 VGELYTGGELFDEII-----KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EECCCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence 999999999998883 3356899999999999999999999999 9999999999999754 4699999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+........ .....+++.|+|||++.+. ++.++||||||+++|+|++|..||......
T Consensus 171 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------- 228 (287)
T 2wei_A 171 STCFQQNTK----MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY----------------- 228 (287)
T ss_dssp GGTBCCCSS----CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------
T ss_pred ceeecCCCc----cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH-----------------
Confidence 876543321 1223578899999998764 899999999999999999999999754321
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+...............+..+.+++.+||+.||.+|||+.++++.
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 229 ------DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ------HHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------HHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 1111111111000001112345678899999999999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=333.41 Aligned_cols=239 Identities=26% Similarity=0.380 Sum_probs=199.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~ 79 (313)
..++|.+++.||+|+||.||+|+++ ++.||||+++.. ..+....|..++..+ ||+|+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4678999999999999999999987 677999998643 345577889999887 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+||||+++|+|.+++. ....+++..++.++.|++.||.|||+++ |+|+||||+|||++.+|.+||+|||++.
T Consensus 419 lV~E~~~gg~L~~~l~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQ-----QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence 9999999999999984 3456999999999999999999999999 9999999999999999999999999988
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..
T Consensus 491 ~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------------------- 548 (674)
T 3pfq_A 491 ENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------------------- 548 (674)
T ss_dssp ECCCTT---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------------
T ss_pred ccccCC---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-------------------
Confidence 543322 2233457899999999999999999999999999999999999999764321
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDM 286 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 286 (313)
+....+ +...+ ......+..+.+|+++||+.||.+||++
T Consensus 549 ----~~~~~i---~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 549 ----ELFQSI---MEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ----HHHHHH---HSSCC-CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ----HHHHHH---HhCCC-CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 111111 11111 1233456678999999999999999997
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=315.47 Aligned_cols=267 Identities=22% Similarity=0.284 Sum_probs=196.6
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEe---------
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAG--------- 74 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~--------- 74 (313)
++...++|++.+.||+|+||.||+|.+. ++.||||.+..+. ....+|+.+++.+ ||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 3456789999999999999999999986 8899999886543 3345799999999 9999999999844
Q ss_pred -----------------------------CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHh
Q 041031 75 -----------------------------GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125 (313)
Q Consensus 75 -----------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh 125 (313)
....++||||++ ++|.+.+.... .....+++..++.++.|++.||+|||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -----------------------------CCEEEEEECCCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334889999997 57777663211 23467899999999999999999999
Q ss_pred cCCCCceEEeccCCCCeeeC-CCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHH
Q 041031 126 QYTKPYYVHRDVKTSNILLD-SNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVV 203 (313)
Q Consensus 126 ~~~~~~i~h~di~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~ 203 (313)
+.+ ++|+||||+||+++ .++.+||+|||++....... ......+++.|+|||++.+. .++.++||||+||+
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE----PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC----CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999 99999999999997 68899999999998654332 22234678999999998875 48999999999999
Q ss_pred HHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhh-hcCCCCC---C------CCHHHHHHHHHHHh
Q 041031 204 LMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTE-CLDPNLT---R------YHKDSMLQMALLSK 273 (313)
Q Consensus 204 l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~---~------~~~~~~~~l~~li~ 273 (313)
+|+|++|+.||.+.... ..+...+........+....... ....... . .....+..+.+|+.
T Consensus 232 l~ell~g~~pf~~~~~~--------~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 303 (383)
T 3eb0_A 232 FGELILGKPLFSGETSI--------DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303 (383)
T ss_dssp HHHHHHSSCSSCCSSHH--------HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred HHHHHhCCCCCCCCChH--------HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence 99999999999765432 11222221111111111111100 0000000 0 12234567899999
Q ss_pred hccccCcCCCCCHHHHHH
Q 041031 274 DCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 274 ~cl~~~p~~Rps~~~ll~ 291 (313)
+||+.||.+|||+.|+++
T Consensus 304 ~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 304 QILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHCCSSGGGSCCHHHHHT
T ss_pred HHccCChhhCCCHHHHhc
Confidence 999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=334.08 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=205.2
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC-----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
+...++|.+.+.||+|+||.||+|.+. +..+|||.+.... .+.+.+|+.+++.+ ||||+++++++.+ +.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc
Confidence 334577999999999999999999885 3458999987543 24577899999999 9999999999854 56
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.++||||+++|+|.+++. .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 465 ~~lv~E~~~~g~L~~~l~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQ----VRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp CEEEEECCTTCBHHHHHH----HTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred eEEEEEcCCCCcHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 899999999999999985 23456899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
+........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 538 a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---------------- 599 (656)
T 2j0j_A 538 SRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---------------- 599 (656)
T ss_dssp CCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------
T ss_pred CeecCCCcc--eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH----------------
Confidence 987654322 12223356789999999998899999999999999999997 99999754321
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+...... ......+..+.+++.+||+.||.+|||+.++++.|+.+..+.
T Consensus 600 -------~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 600 -------DVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp -------HHHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------HHHHHHHcCCCC---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 112222221111 123345568899999999999999999999999999987543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=310.50 Aligned_cols=260 Identities=20% Similarity=0.323 Sum_probs=187.7
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc--CCCceeeeeEEE--------
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV--HSNLIELIGYAA-------- 73 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l--h~~i~~~~~~~~-------- 73 (313)
....+|++.++||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34568999999999999999999985 8899999886543 34577899999998 999999999984
Q ss_pred eCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEe
Q 041031 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIA 153 (313)
Q Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~ 153 (313)
....++++||++. |+|.+++... .....+++..++.++.|++.||+|||+.+. +++|+||||+||+++.++.++|+
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKM--ESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHH--HTTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEEBC
T ss_pred CCceEEEEEEecC-CCHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEEEe
Confidence 3445899999995 6898887421 134569999999999999999999999863 28999999999999999999999
Q ss_pred eccccccccCChhhh---------hhcccccccccccCCccc---cCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCC
Q 041031 154 DFGLVKLLEHSPEIA---------AAASRIVGTFGYLAPEYV---RDGCVTTKSDVYAFGVVLMELITGQQALSRDANPG 221 (313)
Q Consensus 154 dfg~~~~~~~~~~~~---------~~~~~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~ 221 (313)
|||++.......... .......+++.|+|||++ .+..++.++||||||+++|+|++|..||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 999998765432211 111134588999999998 56678999999999999999999999996433210
Q ss_pred CCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 222 NNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
.+....... ........+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus 261 --------------------------~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 --------------------------IVNGKYSIP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -------------------------------CCCC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --------------------------hhcCcccCC---cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 000001100 111222347789999999999999999999999999987543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=309.45 Aligned_cols=260 Identities=22% Similarity=0.340 Sum_probs=200.3
Q ss_pred HHHhcCccccceeccCCeEEEEEeEECCcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
+...++|++.+.||+|+||.||+|.+.+ .+++|.+.... .+.+.+|+.+++.+ ||||+++++++.+.+..+++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 3346889999999999999999999875 59999986432 34567899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++++|.+++. .....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++ ++.++|+|||++...
T Consensus 108 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 108 TSLCKGRTLYSVVR----DAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp CBCCCSEEHHHHTT----SSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred eecccCCcHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999995 23456899999999999999999999999 99999999999998 679999999997754
Q ss_pred cCChh--hhhhcccccccccccCCccccC---------CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchh
Q 041031 162 EHSPE--IAAAASRIVGTFGYLAPEYVRD---------GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230 (313)
Q Consensus 162 ~~~~~--~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~ 230 (313)
..... .........+++.|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------- 249 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---------- 249 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH----------
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------
Confidence 32211 1122223458899999999974 34788999999999999999999999654321
Q ss_pred HHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 231 LVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
+....+.....+... ....+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 250 -------------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 250 -------------AIIWQMGTGMKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp -------------HHHHHHHTTCCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred -------------HHHHHhccCCCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111112222222211 11234568899999999999999999999999999887543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=306.33 Aligned_cols=264 Identities=25% Similarity=0.367 Sum_probs=186.7
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
...++|.+.+.||+|+||.||+|.+. ++.||||.+.... .+.+.+|+.+++.+ ||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34679999999999999999999875 7899999987542 44577889999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCC---CCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 82 YEYAQNGALSDHLHWPS---VKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
|||+++++|.+++.... ......+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 99999999999884211 113456899999999999999999999999 999999999999999999999999998
Q ss_pred ccccCChhh--hhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 159 KLLEHSPEI--AAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 159 ~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
......... ........+++.|+|||++.+ ..++.++||||||+++|+|++|..||....... .. .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~---~ 237 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--------VL---M 237 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HH---H
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--------HH---H
Confidence 765432211 112223468999999999975 568999999999999999999999997644310 00 0
Q ss_pred HHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 236 LAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 236 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
........... ...... ......+..+.+++.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~---~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 238 LTLQNDPPSLE---TGVQDK---EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HHHTSSCCCTT---C--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhccCCCccc---cccccc---hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000000000 000000 0122344578899999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=312.09 Aligned_cols=259 Identities=22% Similarity=0.311 Sum_probs=183.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeC------
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGG------ 75 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~------ 75 (313)
+.++|++.+.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+ ||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3578999999999999999999886 7899999986532 34577899999999 99999999998654
Q ss_pred CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
...++++|++ +++|.+++. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-
T ss_pred CeEEEEeccc-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeec
Confidence 5689999999 789998873 256899999999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
|++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+...
T Consensus 177 G~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~l~~i 242 (367)
T 2fst_X 177 GLARHTADE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--------DQLKLI 242 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHH
T ss_pred ccccccccc------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH
Confidence 998764432 223468999999999987 67899999999999999999999999765431 111111
Q ss_pred HHHHhcCcHHHH--------HHhhhhcCCCCC----CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 235 MLAVFNDTKDFM--------AKLTECLDPNLT----RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 235 ~~~~~~~~~~~~--------~~l~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.........+.. ......+..... ......+..+.+|+.+||..||.+|||+.++++.
T Consensus 243 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 243 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 111111111111 001111110000 0112234678899999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=306.57 Aligned_cols=257 Identities=23% Similarity=0.340 Sum_probs=197.1
Q ss_pred cChHHHHHHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc-----cHHHHHHHHHHHhc---CCCceeeeeEE
Q 041031 2 FSYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK-----SKEFSSELKILCKV---HSNLIELIGYA 72 (313)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~-----~~~~~~e~~~l~~l---h~~i~~~~~~~ 72 (313)
|+++.+....++|++.+.||+|+||.||+|.+. ++.+|||.+.... .+.+.+|+.+++.+ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 344555556788999999999999999999887 7889999986432 34578899999999 49999999999
Q ss_pred EeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEE
Q 041031 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKI 152 (313)
Q Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l 152 (313)
.+.+..+++|| +.+++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||+|+||++++ +.++|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLK-----KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHH-----HCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEE
T ss_pred ecCCEEEEEEe-cCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEE
Confidence 99999999999 45889999984 3457899999999999999999999999 999999999999965 78999
Q ss_pred eeccccccccCChhhhhhcccccccccccCCccccC-----------CCCCCccchhhHHHHHHHHHhCCCCccCCCCCC
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-----------GCVTTKSDVYAFGVVLMELITGQQALSRDANPG 221 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~ 221 (313)
+|||++......... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus 168 ~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~- 245 (313)
T 3cek_A 168 IDFGIANQMQPDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ- 245 (313)
T ss_dssp CCCSSSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-
T ss_pred eeccccccccCcccc-ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-
Confidence 999998865533221 12223468999999999875 46788999999999999999999999643321
Q ss_pred CCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 222 NNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
...+....++.... .....+..+.+++.+||+.||.+|||+.++++.-.
T Consensus 246 ------------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 246 ------------------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp ------------------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ------------------------HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 11111112221111 12223457889999999999999999999997543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=300.13 Aligned_cols=251 Identities=21% Similarity=0.278 Sum_probs=196.3
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-------cHHHHHHHHHHHhc-CCCceeeeeEEE--eCC
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-------SKEFSSELKILCKV-HSNLIELIGYAA--GGD 76 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-------~~~~~~e~~~l~~l-h~~i~~~~~~~~--~~~ 76 (313)
...++|.+.+.||+|+||.||+|.+. ++.+|+|++.... ...+.+|+.+++.+ ||||+++++++. +.+
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 35689999999999999999999986 7789999987532 45688999999999 999999999984 456
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
..++||||+.++ |.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg 154 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALG 154 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred eEEEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccc
Confidence 789999999765 77766422 2457899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCCC--CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC--VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
.+........ ........+++.|+|||++.+.. ++.++||||||+++|+|++|..||......
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------- 219 (305)
T 2wtk_C 155 VAEALHPFAA-DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------------- 219 (305)
T ss_dssp TCEECCTTCS-SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------------
T ss_pred cccccCcccc-ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--------------
Confidence 9886543211 12223446899999999998644 377999999999999999999999754321
Q ss_pred HHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 235 MLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+.... . ......+..+.+++.+||+.||.+|||+.++++.-.
T Consensus 220 ---------~~~~~i~~~~-~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 220 ---------KLFENIGKGS-Y---AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp ---------HHHHHHHHCC-C---CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred ---------HHHHHHhcCC-C---CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 1111111111 1 112234567889999999999999999999997543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=304.12 Aligned_cols=265 Identities=22% Similarity=0.304 Sum_probs=192.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEE----------
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAA---------- 73 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~---------- 73 (313)
..++|.+.+.||+|+||.||+|.+. ++.||+|.+.... .+.+.+|+.+++.+ ||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3578999999999999999999998 7899999887554 34577899999999 999999999873
Q ss_pred ----eCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC-CCC
Q 041031 74 ----GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD-SNF 148 (313)
Q Consensus 74 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~ 148 (313)
+.+..++||||++ ++|.+++. ...+++..++.++.|++.||+|||+++ ++|+||||+||+++ +++
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLE------QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDL 158 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTT
T ss_pred ccccccCceeEEeeccC-CCHHHHhh------cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCC
Confidence 4468899999996 69999983 256889999999999999999999999 99999999999997 567
Q ss_pred cEEEeeccccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcccc
Q 041031 149 RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE 227 (313)
Q Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~ 227 (313)
.++|+|||++.................++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+....
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------- 231 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL------- 231 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-------
Confidence 9999999999876533222222333457899999998875 67899999999999999999999999765421
Q ss_pred chhHHHHHHHHhcCcHHHHHHhhh--------hcC-CC--CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 228 HRSLVDYMLAVFNDTKDFMAKLTE--------CLD-PN--LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~--------~~~-~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...............+....+.. ... +. +.......+..+.+|+++||+.||.+|||+.++++.
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 232 -EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp -HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 11111111111111111111000 000 00 000122345678999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=303.65 Aligned_cols=261 Identities=19% Similarity=0.306 Sum_probs=201.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC---CcceEEEeccccc--cHHHHHHHHHHHhc-CC------CceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR---GKNAAIKQMKNTK--SKEFSSELKILCKV-HS------NLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~------~i~~~~~~~~~~~~ 77 (313)
..++|++.+.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.+++.+ |+ +++++++++...+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 3578999999999999999999873 7789999997643 45678899999988 54 49999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-----------
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS----------- 146 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~----------- 146 (313)
.++|||++ +++|.+++... ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred EEEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999 88999998522 2246889999999999999999999999 999999999999987
Q ss_pred --------CCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCC
Q 041031 147 --------NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDA 218 (313)
Q Consensus 147 --------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~ 218 (313)
++.++|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999998764432 223468999999999999999999999999999999999999997543
Q ss_pred CCCCCccccchhHHHHHHHHhcC-cHHHH-----------------------HHhhhhcCCC--CCCCCHHHHHHHHHHH
Q 041031 219 NPGNNQYTEHRSLVDYMLAVFND-TKDFM-----------------------AKLTECLDPN--LTRYHKDSMLQMALLS 272 (313)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-----------------------~~l~~~~~~~--~~~~~~~~~~~l~~li 272 (313)
.. .....+...... ..... ..+.....+. ........+..+.+|+
T Consensus 239 ~~---------~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 309 (339)
T 1z57_A 239 SK---------EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309 (339)
T ss_dssp HH---------HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred hH---------HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHH
Confidence 31 111111111110 10100 0011111100 0112345567899999
Q ss_pred hhccccCcCCCCCHHHHHHH
Q 041031 273 KDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 273 ~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+||+.||.+|||+.|+++.
T Consensus 310 ~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 310 QKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHTCSSTTTSCCHHHHTTS
T ss_pred HHHhCcCcccccCHHHHhcC
Confidence 99999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=314.76 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=188.8
Q ss_pred cCccccceeccCCeEE-EEEeEECCcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeecCCC
Q 041031 12 SNFSTSLKIGQGSYGS-VYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYAQNG 88 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~-v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (313)
.+|.+.+.||+|+||. ++++...++.||||.+.........+|+.+++.+ ||||+++++++.+.+..++|||++. +
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 4689999999999998 4555666999999999887777788999999998 9999999999999999999999995 6
Q ss_pred ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-----CCcEEEeeccccccccC
Q 041031 89 ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-----NFRAKIADFGLVKLLEH 163 (313)
Q Consensus 89 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-----~~~~~l~dfg~~~~~~~ 163 (313)
+|.+++... ........++.++.|++.||.|||+.+ |+|+||||+||+++. ...++|+|||++.....
T Consensus 103 ~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 103 TLQEYVEQK----DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EHHHHHHSS----SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CHHHHHHhc----CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 999998532 233444456789999999999999999 999999999999953 23578999999987654
Q ss_pred ChhhhhhcccccccccccCCcccc---CCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVR---DGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
............+|+.|+|||++. ...++.++|||||||++|+|++ |..||......
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~------------------- 236 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR------------------- 236 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------------------
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------------------
Confidence 332222333456899999999997 4567889999999999999999 89999643321
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
....+..................+.+|+.+||+.||.+|||+.++++
T Consensus 237 -----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 237 -----QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -----HHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----HHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11111111111111123445566889999999999999999999984
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=301.33 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=191.9
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEe----------
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAG---------- 74 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~---------- 74 (313)
..++|++.+.||+|+||.||+|.+. ++.||||.+.... .+.+.+|+.+++.+ ||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 4678999999999999999999986 8889999986543 45578899999999 9999999998865
Q ss_pred ---CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEE
Q 041031 75 ---GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAK 151 (313)
Q Consensus 75 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~ 151 (313)
.+..++||||+++++|.+++. .....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIH----SENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHH----HSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred cccCCceEEEEecCCCCCHHHhhh----ccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 356899999999999999995 23456788999999999999999999999 99999999999999999999
Q ss_pred EeeccccccccCChhh-----------hhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCC
Q 041031 152 IADFGLVKLLEHSPEI-----------AAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDAN 219 (313)
Q Consensus 152 l~dfg~~~~~~~~~~~-----------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~ 219 (313)
|+|||.+......... ........+++.|+|||++.+. .++.++||||||+++|+|++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 9999998765432110 1122234688999999999864 68999999999999999998 4431110
Q ss_pred CCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 220 PGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.. +....+...............+..+.+++.+||+.||.+|||+.++++.
T Consensus 234 -----------~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 -----------RV-----------NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -----------HH-----------HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----------HH-----------HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00 1111111111111111344555678899999999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=319.49 Aligned_cols=239 Identities=17% Similarity=0.163 Sum_probs=184.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHh---c-CCCceeee-------eE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCK---V-HSNLIELI-------GY 71 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~---l-h~~i~~~~-------~~ 71 (313)
.++|.+.+.||+|+||.||+|.+. ++.||||++... ..+.+.+|+.+++. + ||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467999999999999999999976 889999998632 23567889955444 4 99999998 66
Q ss_pred EEeCC-----------------eEEEEEeecCCCChhhhhcCCCC--CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCce
Q 041031 72 AAGGD-----------------SLFLVYEYAQNGALSDHLHWPSV--KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132 (313)
Q Consensus 72 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i 132 (313)
+.+.+ ..+++|||+ +|+|.+++..... .....+++..++.++.|++.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 278999999 6799999853211 11233455888899999999999999999 9
Q ss_pred EEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCC-----------CCCCccchhhHH
Q 041031 133 VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-----------CVTTKSDVYAFG 201 (313)
Q Consensus 133 ~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~DiwslG 201 (313)
+|+||||+||+++.++.+||+|||++..... ......+ +.|+|||++.+. .++.++||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 9999999999999999999999999885332 2223456 999999999877 899999999999
Q ss_pred HHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcC
Q 041031 202 VVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWK 281 (313)
Q Consensus 202 ~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 281 (313)
|++|+|++|..||......... ..... .....+..+.+|+.+||+.||.
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~--------------------------~~~~~-----~~~~~~~~~~~li~~~L~~dp~ 349 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGS--------------------------EWIFR-----SCKNIPQPVRALLEGFLRYPKE 349 (377)
T ss_dssp HHHHHHHHSSCCC------CCS--------------------------GGGGS-----SCCCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHCCCCCcccccccch--------------------------hhhhh-----hccCCCHHHHHHHHHHcCCCch
Confidence 9999999999999755432100 00000 0112345788999999999999
Q ss_pred CCCCHHHHHH
Q 041031 282 RRPDMSNAAI 291 (313)
Q Consensus 282 ~Rps~~~ll~ 291 (313)
+|||+.++++
T Consensus 350 ~Rpt~~e~l~ 359 (377)
T 3byv_A 350 DRLLPLQAME 359 (377)
T ss_dssp GCCCHHHHHT
T ss_pred hCCCHHHHhh
Confidence 9999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=305.52 Aligned_cols=270 Identities=20% Similarity=0.267 Sum_probs=190.4
Q ss_pred HHHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe---
Q 041031 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDS--- 77 (313)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~--- 77 (313)
......++|++.+.||+|+||.||+|.+. ++.||||.+.... .....++++.+..+ ||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 45677899999999999999999999987 7889999885542 34456777888888 9999999999865433
Q ss_pred ----EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHh--cCCCCceEEeccCCCCeeeCC-CCcE
Q 041031 78 ----LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH--QYTKPYYVHRDVKTSNILLDS-NFRA 150 (313)
Q Consensus 78 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~~~~i~h~di~p~nil~~~-~~~~ 150 (313)
.++||||+++ +|.+.+.... .....+++..++.++.|++.||.||| +.+ ++|+||||+||+++. ++.+
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999976 5544432110 34567889999999999999999999 999 999999999999996 8999
Q ss_pred EEeeccccccccCChhhhhhcccccccccccCCccccCCC-CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccch
Q 041031 151 KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC-VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 229 (313)
+|+|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.... .
T Consensus 172 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--------~ 239 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--------G 239 (360)
T ss_dssp EECCCTTCBCCCTTS----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------H
T ss_pred EEeeCCCceecCCCC----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--------H
Confidence 999999998765432 222346799999999997654 899999999999999999999999765431 1
Q ss_pred hHHHHHHHHhcCcHHHHHHhhhhcC-------CC------CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 230 SLVDYMLAVFNDTKDFMAKLTECLD-------PN------LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~~~~-------~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+............+....+..... .. ........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 2222222221222222211110000 00 001122246789999999999999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=314.12 Aligned_cols=247 Identities=9% Similarity=0.000 Sum_probs=180.5
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc---CCCceeee-------eEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV---HSNLIELI-------GYAA 73 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l---h~~i~~~~-------~~~~ 73 (313)
.+|.+.+.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.+++.+ |||+++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45999999999999999999987 7889999998743 33466787777777 99987755 4444
Q ss_pred eC-----------------CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHH------HHHHHHHHHHHHHHhcCCCC
Q 041031 74 GG-----------------DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTR------VQIALDAAKGLEYIHQYTKP 130 (313)
Q Consensus 74 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~------~~~~~~i~~~l~~lh~~~~~ 130 (313)
.. ..+++||||++ ++|.+++... ...+..... +.++.|++.||+|||+++
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL----DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh----ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 33 34899999997 8999999532 223344444 677799999999999999
Q ss_pred ceEEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccC--CCCCCccchhhHHHHHHHHH
Q 041031 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD--GCVTTKSDVYAFGVVLMELI 208 (313)
Q Consensus 131 ~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~ 208 (313)
|+|+||||+||+++.++.+||+|||++....... ....+++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCCc------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 9999999999999999999999999998654321 12356799999999987 67899999999999999999
Q ss_pred hCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHH
Q 041031 209 TGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMS 287 (313)
Q Consensus 209 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ 287 (313)
+|..||..........+..... .......... .....+..+.+|+.+||+.||++|||+.
T Consensus 288 tg~~Pf~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 348 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGSWKRPSL-------------------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348 (371)
T ss_dssp HSSCSTTBCCTTCTTCCCBCCT-------------------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred hCCCCCCCcCcccccchhhhhh-------------------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 9999998764432111110000 0000000000 1224566889999999999999999999
Q ss_pred HHHH
Q 041031 288 NAAI 291 (313)
Q Consensus 288 ~ll~ 291 (313)
++++
T Consensus 349 e~l~ 352 (371)
T 3q60_A 349 EAME 352 (371)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=305.63 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=178.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccccc----HHHHHHHH-HHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS----KEFSSELK-ILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~----~~~~~e~~-~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.++|.+.+.||+|+||.||+|.+. ++.||||.+..... ..+..|+. +++.+ ||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 578999999999999999999997 88999999876432 23445555 55555 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC-CCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY-TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
||+.+ +|.+++..........+++..++.++.|++.||.|||+. + ++|+||+|+||+++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99965 888877422222356789999999999999999999999 9 999999999999999999999999998765
Q ss_pred cCChhhhhhcccccccccccCCccc----cCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYV----RDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
.... ......+++.|+|||++ .+..++.++||||||+++|+|++|..||.......
T Consensus 177 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------------- 236 (327)
T 3aln_A 177 VDSI----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---------------- 236 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------------
T ss_pred cccc----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----------------
Confidence 4332 12223688999999999 45678999999999999999999999997543210
Q ss_pred HhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
+....+.....+.+.. .....+..+.+|+.+||+.||.+|||+.++++.-.
T Consensus 237 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 237 ------DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp ---------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred ------HHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 0000000001111111 12345567899999999999999999999987433
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=305.69 Aligned_cols=197 Identities=25% Similarity=0.307 Sum_probs=168.6
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc--CC-----CceeeeeEEEeCCe
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV--HS-----NLIELIGYAAGGDS 77 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l--h~-----~i~~~~~~~~~~~~ 77 (313)
...++|++.+.||+|+||.||+|.+. ++.||||++.... ......|+.+++.+ |+ +++++++++...+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 34678999999999999999999987 7789999997653 34567788888888 55 49999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc--CCCCceEEeccCCCCeeeC--CCCcEEEe
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ--YTKPYYVHRDVKTSNILLD--SNFRAKIA 153 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~--~~~~~i~h~di~p~nil~~--~~~~~~l~ 153 (313)
.++|||+++ ++|.+++... ....+++..++.++.|++.||.|||. .+ |+|+||||+||+++ .++.+||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEEC
T ss_pred eEEEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEE
Confidence 999999995 5999998532 22458999999999999999999994 67 99999999999995 47789999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCC
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDA 218 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~ 218 (313)
|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 204 DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999865432 223468999999999999999999999999999999999999997654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=300.05 Aligned_cols=264 Identities=22% Similarity=0.342 Sum_probs=199.0
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC---CcceEEEeccccc-----cHHHHHHHHHHHhc----CCCceeeeeEEE---
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR---GKNAAIKQMKNTK-----SKEFSSELKILCKV----HSNLIELIGYAA--- 73 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~aiK~~~~~~-----~~~~~~e~~~l~~l----h~~i~~~~~~~~--- 73 (313)
...++|++.+.||+|+||.||+|.+. ++.||+|++.... ...+.+|+.+++.+ ||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45689999999999999999999984 6789999986432 33566788777766 999999999987
Q ss_pred --eCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEE
Q 041031 74 --GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAK 151 (313)
Q Consensus 74 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~ 151 (313)
.....++|||++. ++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEE
Confidence 5567899999996 6999998522 2345899999999999999999999999 99999999999999999999
Q ss_pred EeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhH
Q 041031 152 IADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~ 231 (313)
|+|||.+....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.... ..+
T Consensus 161 l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~ 228 (326)
T 1blx_A 161 LADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--------DQL 228 (326)
T ss_dssp ECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHH
T ss_pred EecCcccccccCCC----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--------HHH
Confidence 99999987654321 223356899999999999999999999999999999999999999765431 111
Q ss_pred HHHHHHHh-cCcHHHHHH---hhhhc----CCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 232 VDYMLAVF-NDTKDFMAK---LTECL----DPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 232 ~~~~~~~~-~~~~~~~~~---l~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
........ +...++... ..... ...........+..+.+|+.+||+.||.+|||+.++++
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 229 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11110000 000000000 00000 00011122345567889999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=302.62 Aligned_cols=252 Identities=18% Similarity=0.248 Sum_probs=174.1
Q ss_pred HhcCccccc-eeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHH-HHhc-CCCceeeeeEEEe----CCeEEE
Q 041031 10 ATSNFSTSL-KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKI-LCKV-HSNLIELIGYAAG----GDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~-~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~-l~~l-h~~i~~~~~~~~~----~~~~~l 80 (313)
..++|.+.+ .||+|+||.||+|.+. ++.||||++.... ...+|+.. ++.+ |||++++++++.. ....++
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 567899965 6999999999999998 8899999986542 33344443 4444 9999999999876 455899
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcEEEeeccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGL 157 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~ 157 (313)
||||+.+++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||||+||+++. ++.++|+|||+
T Consensus 104 v~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 104 IMECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999532 2346999999999999999999999999 999999999999976 45599999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+...... ......+++.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 178 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------------- 239 (336)
T 3fhr_A 178 AKETTQN-----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP------------- 239 (336)
T ss_dssp CEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred ceecccc-----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-------------
Confidence 8765432 1223467999999999998889999999999999999999999997654321000
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
.....+...............+..+.+|+.+||+.||.+|||+.++++.-
T Consensus 240 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 240 ------GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred ------hHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00000000000000111234556788999999999999999999999743
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=307.72 Aligned_cols=258 Identities=23% Similarity=0.336 Sum_probs=195.8
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE---
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSL--- 78 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~--- 78 (313)
+.++|.+.+.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+ ||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3578999999999999999999987 8899999987542 34577899999999 99999999999877654
Q ss_pred ---EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 79 ---FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 79 ---~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
++|||++. ++|.+.+. ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECST
T ss_pred eeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEec
Confidence 99999996 68888872 34899999999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
|++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+...
T Consensus 189 g~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i 254 (371)
T 4exu_A 189 GLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--------DQLTQI 254 (371)
T ss_dssp TCC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHH
T ss_pred CcccccccC------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHH
Confidence 998754432 223467999999999987 67899999999999999999999999764421 111111
Q ss_pred HHHHhcCcHHH---------HHHhhhhcCCCCCC---CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 235 MLAVFNDTKDF---------MAKLTECLDPNLTR---YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 235 ~~~~~~~~~~~---------~~~l~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.........++ .............. .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 255 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 11110110010 01111111111000 122345678999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=304.12 Aligned_cols=264 Identities=20% Similarity=0.290 Sum_probs=197.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeC-----Ce
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGG-----DS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~-----~~ 77 (313)
+.++|.+.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4679999999999999999999987 8889999987543 33466899999999 99999999988654 67
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.+++||++. ++|.+++. ...+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 89 ~~lv~e~~~-~~L~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIS------TQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEEEECCCS-EEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeccC-ccHHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccc
Confidence 899999996 68999884 246899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCChhhhh-------hcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccch
Q 041031 158 VKLLEHSPEIAA-------AASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 158 ~~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 229 (313)
+........... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------- 229 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--------- 229 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---------
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---------
Confidence 987653321111 1122467999999998764 67899999999999999999999999765421
Q ss_pred hHHHHHHHHhcC-----------cHHHHHHhhhhcC---CCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 230 SLVDYMLAVFND-----------TKDFMAKLTECLD---PNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 230 ~~~~~~~~~~~~-----------~~~~~~~l~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.....+...... .......+..... ..+.......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 230 HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000 0000111111000 00000112345678899999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=302.43 Aligned_cols=257 Identities=24% Similarity=0.357 Sum_probs=196.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe-----
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDS----- 77 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~----- 77 (313)
.++|.+.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ ||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 578999999999999999999987 8899999986532 34567899999999 9999999999987654
Q ss_pred -EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 78 -LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 78 -~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
.+++||++. ++|.+++. ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecc
Confidence 499999996 68888772 34899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
++...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.... ..+....
T Consensus 172 ~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~~~~~i~ 237 (353)
T 3coi_A 172 LARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--------DQLTQIL 237 (353)
T ss_dssp CTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH--------HHHHHHH
T ss_pred cccCCCCC------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH
Confidence 98764422 223467999999999987 67899999999999999999999999765421 1111111
Q ss_pred HHHhcCcHHHH------------HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 236 LAVFNDTKDFM------------AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 236 ~~~~~~~~~~~------------~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
........++. ..+...............+..+.+|+.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 238 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11000000100 0011111111222334556789999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=301.28 Aligned_cols=261 Identities=18% Similarity=0.282 Sum_probs=198.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--C-cceEEEeccccc--cHHHHHHHHHHHhc-CCC------ceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--G-KNAAIKQMKNTK--SKEFSSELKILCKV-HSN------LIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~-~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~------i~~~~~~~~~~~~ 77 (313)
..++|++.+.||+|+||.||+|.+. + ..||+|+++... .+.+.+|+.+++.+ |++ ++.+++++...+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 3578999999999999999999986 3 679999997643 45577899999998 554 8999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee-------------
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL------------- 144 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~------------- 144 (313)
.++|||++ +++|.+.+.. .....+++..++.++.|++.||+|||+++ ++|+||||+||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred EEEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 99999999 5667666632 22356899999999999999999999999 9999999999999
Q ss_pred ------CCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCC
Q 041031 145 ------DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDA 218 (313)
Q Consensus 145 ------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~ 218 (313)
+.++.++|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 56788999999998764432 223468999999999999999999999999999999999999997544
Q ss_pred CCCCCccccchhHHHHHHHHhcCcH-HHH-----------------------HHhhhhcCCC--CCCCCHHHHHHHHHHH
Q 041031 219 NPGNNQYTEHRSLVDYMLAVFNDTK-DFM-----------------------AKLTECLDPN--LTRYHKDSMLQMALLS 272 (313)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----------------------~~l~~~~~~~--~~~~~~~~~~~l~~li 272 (313)
.. .....+.......+ ... ..+.....+. ........+..+.+|+
T Consensus 244 ~~---------~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 314 (355)
T 2eu9_A 244 NR---------EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 314 (355)
T ss_dssp HH---------HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred HH---------HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHH
Confidence 31 11111111111100 000 0000000000 0012334466889999
Q ss_pred hhccccCcCCCCCHHHHHHH
Q 041031 273 KDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 273 ~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+||+.||.+|||+.|+++.
T Consensus 315 ~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 315 RRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHTCSSTTTSCCHHHHTTS
T ss_pred HHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999853
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=310.44 Aligned_cols=258 Identities=21% Similarity=0.334 Sum_probs=189.3
Q ss_pred HHHHHhcC-ccccceeccCCeEEEEEe-EECCcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEE
Q 041031 6 EVRDATSN-FSTSLKIGQGSYGSVYLG-KLRGKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 6 ~~~~~~~~-y~~~~~lg~g~~g~v~~~-~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv 81 (313)
.++....+ |.+.+.||+|+||+||.+ ...++.||||.+.....+.+.+|+.+++.+ ||||+++++++.+.+..++|
T Consensus 8 ~~~~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 8 NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp CCSCSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred chhhhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 33333444 445688999999999754 444899999999887777788999999876 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCC--CCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC------------
Q 041031 82 YEYAQNGALSDHLHWPSVKGK--KPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN------------ 147 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~------------ 147 (313)
||+++ |+|.+++........ ...++..++.++.|++.||+|||+++ ++|+||||+||+++.+
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCC
Confidence 99995 699999964322111 11133346789999999999999999 9999999999999754
Q ss_pred -CcEEEeeccccccccCChhh-hhhcccccccccccCCccccC-------CCCCCccchhhHHHHHHHHHh-CCCCccCC
Q 041031 148 -FRAKIADFGLVKLLEHSPEI-AAAASRIVGTFGYLAPEYVRD-------GCVTTKSDVYAFGVVLMELIT-GQQALSRD 217 (313)
Q Consensus 148 -~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~~~t-g~~p~~~~ 217 (313)
+.++|+|||++......... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 47999999999876543221 112223468999999999975 568999999999999999999 99999643
Q ss_pred CCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcC-CCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 218 ANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLD-PNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
... ....+..... +.... .....+..+.+|+.+||+.||.+|||+.++++
T Consensus 244 ~~~------------------------~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 244 YSR------------------------ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TTH------------------------HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhh------------------------HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 321 0111111111 11111 34566788999999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=311.60 Aligned_cols=263 Identities=25% Similarity=0.357 Sum_probs=194.1
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEeC------CeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAGG------DSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~------~~~~lv~ 82 (313)
.+|.+.+.||+|+||.||+|++. ++.||||.+.... ....+|+++++.+ ||||+++++++... ..+++||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 36999999999999999999996 8899999986543 3345799999999 99999999998532 2367899
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC-CcEEEeeccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN-FRAKIADFGLVKLL 161 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~~l~dfg~~~~~ 161 (313)
||+++ +|.+.+.... .....+++..++.++.|++.||+|||+++ |+|+||||+||+++.+ +.+||+|||++...
T Consensus 133 e~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp ECCCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hcccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 99965 6666553111 23467899999999999999999999999 9999999999999954 66899999999865
Q ss_pred cCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
.... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... ..+...+...-.
T Consensus 208 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--------~~l~~i~~~lg~ 275 (420)
T 1j1b_A 208 VRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--------DQLVEIIKVLGT 275 (420)
T ss_dssp CTTC----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHHHCS
T ss_pred ccCC----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCC
Confidence 4321 12234679999999999764 7899999999999999999999999765431 122222221111
Q ss_pred CcHHHHHHhhh-hcCCCCCC---------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 241 DTKDFMAKLTE-CLDPNLTR---------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 241 ~~~~~~~~l~~-~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...+....... ..+..+.. .....+..+.+|+.+||..||.+|||+.|+++.
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 11111111100 00111110 112335678999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=301.96 Aligned_cols=267 Identities=18% Similarity=0.298 Sum_probs=196.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc------------CCCceeeeeEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV------------HSNLIELIGYAAG 74 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l------------h~~i~~~~~~~~~ 74 (313)
.++|++.+.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.+++.+ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 468999999999999999999986 8899999998653 44577888888876 5799999999876
Q ss_pred CC----eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC-CCCceEEeccCCCCeeeC----
Q 041031 75 GD----SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY-TKPYYVHRDVKTSNILLD---- 145 (313)
Q Consensus 75 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~---- 145 (313)
.+ ..+++||++ +++|.+++... ....+++..++.++.|++.||+|||++ + ++|+||||+||+++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 54 789999999 88999998532 234589999999999999999999998 9 99999999999994
Q ss_pred --CCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCC
Q 041031 146 --SNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNN 223 (313)
Q Consensus 146 --~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~ 223 (313)
..+.++|+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 3447999999998765432 22346899999999999999999999999999999999999999765432111
Q ss_pred ccccchhHHHHHHHHhcCcHHHHHHh---hhhcCC--------------------CCCCCCHHHHHHHHHHHhhccccCc
Q 041031 224 QYTEHRSLVDYMLAVFNDTKDFMAKL---TECLDP--------------------NLTRYHKDSMLQMALLSKDCVDENW 280 (313)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~--------------------~~~~~~~~~~~~l~~li~~cl~~~p 280 (313)
. ....+.................- ...... .........+..+.+|+.+||+.||
T Consensus 245 ~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 245 K--DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp C--HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred C--hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 0 11111111111111100000000 000000 0001345677889999999999999
Q ss_pred CCCCCHHHHHHH
Q 041031 281 KRRPDMSNAAIR 292 (313)
Q Consensus 281 ~~Rps~~~ll~~ 292 (313)
.+|||+.|+++.
T Consensus 323 ~~Rpt~~ell~h 334 (373)
T 1q8y_A 323 RKRADAGGLVNH 334 (373)
T ss_dssp TTCBCHHHHHTC
T ss_pred cccCCHHHHhhC
Confidence 999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=302.60 Aligned_cols=240 Identities=23% Similarity=0.357 Sum_probs=197.4
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---------cHHHHHHHHHHHhc---CCCceeeeeEE
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---------SKEFSSELKILCKV---HSNLIELIGYA 72 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---------~~~~~~e~~~l~~l---h~~i~~~~~~~ 72 (313)
.....++|++.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+.+++.+ |||++++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3456788999999999999999999886 7889999987543 23466899999999 59999999999
Q ss_pred EeCCeEEEEEeecCC-CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC-CCCcE
Q 041031 73 AGGDSLFLVYEYAQN-GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD-SNFRA 150 (313)
Q Consensus 73 ~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~ 150 (313)
...+..++++|++.+ ++|.+++. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++ +++.+
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCE
Confidence 999999999999976 89999984 3456899999999999999999999999 99999999999999 78899
Q ss_pred EEeeccccccccCChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccch
Q 041031 151 KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHR 229 (313)
Q Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 229 (313)
||+|||++...... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 190 kL~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------- 254 (320)
T 3a99_A 190 KLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------- 254 (320)
T ss_dssp EECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred EEeeCccccccccc-----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------
Confidence 99999998876542 1223468999999999987665 6889999999999999999999953210
Q ss_pred hHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 230 SLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
..... .. .....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 255 ------------------~~~~~--~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 ------------------IIRGQ--VF---FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ------------------HHHCC--CC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------------------hhccc--cc---ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00 112334578899999999999999999999873
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=309.55 Aligned_cols=264 Identities=23% Similarity=0.338 Sum_probs=194.0
Q ss_pred hcCccccceeccCCeEEEEEeEEC-CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEeCCe------EEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAGGDS------LFLVY 82 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~------~~lv~ 82 (313)
..+|++.+.||+|+||.||+|++. +..+|+|.+.... ....+|+++++.+ ||||+++++++..... +++||
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc-chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 357999999999999999999997 5568888876442 2234799999999 9999999999865433 78999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC-CCCcEEEeeccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD-SNFRAKIADFGLVKLL 161 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~~l~dfg~~~~~ 161 (313)
||++++ +.+.+.... .....+++..++.++.|++.||+|||+++ ++|+||||+||+++ .++.+||+|||++...
T Consensus 118 e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 118 EYVPET-VYRASRHYA-KLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp ECCSEE-HHHHHHHHH-HTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eccCcc-HHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999764 433331100 23467899999999999999999999999 99999999999998 7999999999999865
Q ss_pred cCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
.... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.... ..+.......-.
T Consensus 193 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--------~~l~~i~~~~g~ 260 (394)
T 4e7w_A 193 IAGE----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--------DQLVEIIKVLGT 260 (394)
T ss_dssp CTTC----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHHHCC
T ss_pred cCCC----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCC
Confidence 4322 12234679999999999764 5899999999999999999999999765431 112222221111
Q ss_pred CcHHHHHHh-hhhcCCCCCC---------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 241 DTKDFMAKL-TECLDPNLTR---------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 241 ~~~~~~~~l-~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...+..... .......... .....+..+.+|+.+||..||.+|||+.|+++.
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 111111111 1111111111 122345678999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=296.78 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=179.2
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccH----H-HHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK----E-FSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~----~-~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
..++|++.+.||+|+||.||+|.+. ++.||||.+...... . +.++..+++.+ ||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 4578999999999999999999996 889999999765322 2 23334456666 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcC-CCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY-TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
|||+ ++.+..+.. .....+++..++.++.|++.||.|||++ + ++|+||+|+||+++.++.++|+|||++..
T Consensus 103 ~e~~-~~~~~~l~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 103 MELM-GTCAEKLKK----RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp ECCC-SEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred Eecc-CCcHHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 9999 556665553 2245789999999999999999999995 9 99999999999999999999999999876
Q ss_pred ccCChhhhhhcccccccccccCCcccc-----CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
..... ......+++.|+|||++. +..++.++||||||+++|+|++|..||......
T Consensus 175 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------------- 235 (318)
T 2dyl_A 175 LVDDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--------------- 235 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---------------
T ss_pred ccCCc----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------------
Confidence 54322 122346899999999994 456889999999999999999999999753321
Q ss_pred HHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 236 LAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 236 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.+....+.....+... .....+..+.+++.+||+.||.+|||+.++++.
T Consensus 236 -------~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 236 -------FEVLTKVLQEEPPLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -------HHHHHHHHHSCCCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -------HHHHHHHhccCCCCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111111111111111 122345678899999999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.94 Aligned_cols=240 Identities=24% Similarity=0.393 Sum_probs=188.2
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---------cHHHHHHHHHHHhc-----CCCceeeee
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---------SKEFSSELKILCKV-----HSNLIELIG 70 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---------~~~~~~e~~~l~~l-----h~~i~~~~~ 70 (313)
.+...++|++.+.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+ ||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3456788999999999999999999886 7889999997543 22345688888887 999999999
Q ss_pred EEEeCCeEEEEEee-cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC-CCC
Q 041031 71 YAAGGDSLFLVYEY-AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD-SNF 148 (313)
Q Consensus 71 ~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~ 148 (313)
++...+..++|+|+ +.+++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++ .++
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYIT-----EKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTT
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCC
Confidence 99999999999999 78899999984 3456899999999999999999999999 99999999999999 889
Q ss_pred cEEEeeccccccccCChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCcccc
Q 041031 149 RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE 227 (313)
Q Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~ 227 (313)
.++|+|||++....... .....++..|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 178 ~~kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------- 244 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------- 244 (312)
T ss_dssp EEEECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred eEEEEEcchhhhcccCc-----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------
Confidence 99999999988765432 223468999999999987665 4589999999999999999999953210
Q ss_pred chhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 228 HRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.... .. ......+..+.+++.+||+.||++|||+.++++.
T Consensus 245 --------------------~~~~--~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 --------------------ILEA--EL---HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --------------------HHHT--CC---CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------------------Hhhh--cc---CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00 1122345578899999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=285.45 Aligned_cols=229 Identities=10% Similarity=0.068 Sum_probs=182.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccccc------HHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS------KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~------~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|++.+.||+|+||.||+|.+. ++.||||++..... ..+.+|+.++..+ ||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999998 78999999986532 5578899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++++|.+++. . . .....+..++.|++.||+|||+++ ++|+||||+||+++.+|.++|++++.
T Consensus 110 ~e~~~g~~L~~~l~-----~-~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~---- 175 (286)
T 3uqc_A 110 AEWIRGGSLQEVAD-----T-S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT---- 175 (286)
T ss_dssp EECCCEEEHHHHHT-----T-C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC----
T ss_pred EEecCCCCHHHHHh-----c-C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc----
Confidence 99999999999984 1 1 355568889999999999999999 99999999999999999999985432
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
++ .++.++|||||||++|+|++|+.||.+.............
T Consensus 176 -------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~------------ 217 (286)
T 3uqc_A 176 -------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD------------ 217 (286)
T ss_dssp -------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC------------
T ss_pred -------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH------------
Confidence 22 2688999999999999999999999876543211000000
Q ss_pred cHHHHHHhhhhcCCCCC---CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccccc
Q 041031 242 TKDFMAKLTECLDPNLT---RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW 303 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~ 303 (313)
+..... ......+..+.+++.+||+.||.+| |+.++++.|.++.......
T Consensus 218 -----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~ 270 (286)
T 3uqc_A 218 -----------TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRT 270 (286)
T ss_dssp -----------TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-----
T ss_pred -----------hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCcc
Confidence 000000 0112344578899999999999999 9999999999988765543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=282.77 Aligned_cols=228 Identities=16% Similarity=0.291 Sum_probs=180.0
Q ss_pred HhcCcccc-ceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEe----CCeEEE
Q 041031 10 ATSNFSTS-LKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAG----GDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~-~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~----~~~~~l 80 (313)
..++|.+. +.||+|+||.||+|.+. ++.||+|.+.. .....+|+.++.++ ||||+++++++.. ....++
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 46788887 78999999999999986 78899999864 35677889888555 9999999999987 677999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcEEEeeccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGL 157 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~ 157 (313)
||||+++++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||||+||+++. ++.++|+|||+
T Consensus 93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EECCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999998532 2346999999999999999999999999 999999999999997 78899999998
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+.... +..++.++|||||||++|+|++|..||.........
T Consensus 167 a~~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------------- 207 (299)
T 3m2w_A 167 AKETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------- 207 (299)
T ss_dssp CEECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------------
T ss_pred ccccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--------------
Confidence 86433 234678899999999999999999999755432100
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCC----HHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYH----KDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 293 (313)
............... ...+..+.+++.+||+.||.+|||+.|+++.-
T Consensus 208 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 208 ---------PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp ---------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---------HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 000000000000011 23456789999999999999999999999743
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=311.18 Aligned_cols=271 Identities=23% Similarity=0.317 Sum_probs=200.7
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEe------
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAG------ 74 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~------ 74 (313)
-...++|++.+.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.+++.+ ||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 345689999999999999999999986 7899999987542 34577899999999 9999999998765
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc---EE
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR---AK 151 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~---~~ 151 (313)
.+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++. ++
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEE
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEE
Confidence 677899999999999999996432 2346888999999999999999999999 999999999999997665 89
Q ss_pred EeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhH
Q 041031 152 IADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~ 231 (313)
|+|||.+....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.....
T Consensus 165 L~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~---------- 230 (676)
T 3qa8_A 165 IIDLGYAKELDQGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV---------- 230 (676)
T ss_dssp ECSCCCCCBTTSCC----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH----------
T ss_pred Eccccccccccccc----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh----------
Confidence 99999998765432 2233568999999999999999999999999999999999999996542110
Q ss_pred HHHHHHHhcCcHHHHHHhh----hh-----cCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHH-----HHHHHHHHH
Q 041031 232 VDYMLAVFNDTKDFMAKLT----EC-----LDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSN-----AAIRLSHIL 297 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l~----~~-----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~-----ll~~l~~~~ 297 (313)
.|........ ....... .. .-+.........+..+.+++.+||..||++|||+.+ +.+.+..+.
T Consensus 231 -~~~~~i~~~~-~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 231 -QWHGKVREKS-NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp -HSSTTCC-------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred -hhhhhhhccc-chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 0000000000 0000000 00 001111245567888999999999999999999988 556676666
Q ss_pred hc
Q 041031 298 IS 299 (313)
Q Consensus 298 ~~ 299 (313)
..
T Consensus 309 ~~ 310 (676)
T 3qa8_A 309 SL 310 (676)
T ss_dssp CC
T ss_pred hc
Confidence 53
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=308.64 Aligned_cols=236 Identities=23% Similarity=0.361 Sum_probs=190.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC---CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe-----
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR---GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDS----- 77 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~----- 77 (313)
.++|++.+.||+|+||.||+|.+. ++.||||.+.... ...+.+|+++++.+ ||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999985 6889999986543 23467899999999 9999999999987655
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
.++||||+++++|.+++. ..+++..++.++.|++.+|.|||+++ |+|+||||+||+++.+ .+||+|||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence 799999999999998763 26899999999999999999999999 9999999999999886 899999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+...... ....+|+.|+|||++.+. ++.++|||||||++|+|++|..||.+....... .
T Consensus 228 a~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---~---------- 286 (681)
T 2pzi_A 228 VSRINSF-------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---E---------- 286 (681)
T ss_dssp CEETTCC-------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC---T----------
T ss_pred chhcccC-------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc---c----------
Confidence 8865432 234689999999999765 488999999999999999999988653221100 0
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHHHh
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-DMSNAAIRLSHILI 298 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~ll~~l~~~~~ 298 (313)
.......+..+.+++.+||+.||.+|| +++++.+.|..+..
T Consensus 287 --------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 287 --------------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp --------------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred --------------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 000111234678899999999999999 56667777776653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=291.51 Aligned_cols=238 Identities=18% Similarity=0.148 Sum_probs=178.3
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-C-CCc---------eeeeeE-
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-H-SNL---------IELIGY- 71 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h-~~i---------~~~~~~- 71 (313)
.+|...+.||+|+||.||+|.+. ++.||||++.... .+.+.+|+.+++.+ | +|. +.....
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35888899999999999999988 8999999987322 45678899888888 5 321 111111
Q ss_pred -----------EEe-----CCeEEEEEeecCCCChhhhhcCCC--CCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceE
Q 041031 72 -----------AAG-----GDSLFLVYEYAQNGALSDHLHWPS--VKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133 (313)
Q Consensus 72 -----------~~~-----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~ 133 (313)
+.. ...++++|+.. +++|.+++.... ......+++..++.++.|++.||+|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 111 22467777776 679998883110 123456888899999999999999999999 99
Q ss_pred EeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccc----------cCCCCCCccchhhHHHH
Q 041031 134 HRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV----------RDGCVTTKSDVYAFGVV 203 (313)
Q Consensus 134 h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~DiwslG~~ 203 (313)
|+||||+||+++.++.+||+|||++...... .....+ +.|+|||++ .+..++.++|||||||+
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 9999999999999999999999998764432 223456 999999999 55568889999999999
Q ss_pred HHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCC
Q 041031 204 LMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRR 283 (313)
Q Consensus 204 l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 283 (313)
+|+|++|+.||........ ....... ....+..+.+|+.+||+.||.+|
T Consensus 307 l~elltg~~Pf~~~~~~~~--------------------------~~~~~~~-----~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG--------------------------SEWIFRS-----CKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC--------------------------SGGGGSS-----CCCCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHCCCCCCCcchhhh--------------------------HHHHHhh-----cccCCHHHHHHHHHHccCChhhC
Confidence 9999999999975443210 0000110 11233578899999999999999
Q ss_pred CCHHHHHH
Q 041031 284 PDMSNAAI 291 (313)
Q Consensus 284 ps~~~ll~ 291 (313)
||+.++++
T Consensus 356 pt~~~~l~ 363 (413)
T 3dzo_A 356 LLPLQAME 363 (413)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHHh
Confidence 99888754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=281.74 Aligned_cols=235 Identities=18% Similarity=0.202 Sum_probs=182.5
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEecccccc-----------HHHHHHHHHHHhc----------CCCceeee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKS-----------KEFSSELKILCKV----------HSNLIELI 69 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~-----------~~~~~e~~~l~~l----------h~~i~~~~ 69 (313)
.++|++.+.||+|+||.||+|+++++.||||++..... +.+.+|+.+++.+ |||++++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 47899999999999999999999999999999975431 5678888888776 56666666
Q ss_pred eEE-----------------Ee-------------CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHH
Q 041031 70 GYA-----------------AG-------------GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119 (313)
Q Consensus 70 ~~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~ 119 (313)
+++ .+ .+.+++||||+++|++.+.+. ...+++..++.++.|++.
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~------~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR------TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT------TTCCCHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH------hcCCCHHHHHHHHHHHHH
Confidence 654 22 678999999999997766662 155899999999999999
Q ss_pred HHHHHh-cCCCCceEEeccCCCCeeeCCCC--------------------cEEEeeccccccccCChhhhhhcccccccc
Q 041031 120 GLEYIH-QYTKPYYVHRDVKTSNILLDSNF--------------------RAKIADFGLVKLLEHSPEIAAAASRIVGTF 178 (313)
Q Consensus 120 ~l~~lh-~~~~~~i~h~di~p~nil~~~~~--------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 178 (313)
||+||| +++ |+|+||||+|||++.++ .+||+|||++...... ...+|+
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~ 241 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCC
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEee
Confidence 999999 999 99999999999999887 8999999999865532 236899
Q ss_pred cccCCccccCCCCCCccchhhHHHH-HHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCC-
Q 041031 179 GYLAPEYVRDGCVTTKSDVYAFGVV-LMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPN- 256 (313)
Q Consensus 179 ~~~aPE~~~~~~~~~~~DiwslG~~-l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~- 256 (313)
.|+|||++.+.. +.++||||+|++ .+++++|..||... .|.. .....+.......
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------------~~~~-------~~~~~~~~~~~~~~ 298 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------------LWLH-------YLTDKMLKQMTFKT 298 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------------HHHH-------HHHHHHHHTCCCSS
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------------hhhh-------HHHHhhhhhhccCc
Confidence 999999998776 889999998777 67788999998421 0000 0111111111111
Q ss_pred --CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 041031 257 --LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAA 290 (313)
Q Consensus 257 --~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll 290 (313)
........+..+.+|+++||+.| |+.|++
T Consensus 299 ~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 299 KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 11124457788999999999976 899888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-31 Score=248.66 Aligned_cols=180 Identities=17% Similarity=0.154 Sum_probs=126.8
Q ss_pred eccCCeEEEEEeEEC--CcceEEEeccccc-------------cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEE
Q 041031 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTK-------------SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 20 lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-------------~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.+.|++|.+..++.. |+.+++|.+.... .+++.+|+++|+++ |+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 455666665555443 8899999986431 34588999999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||++|++|.+.+. ..++++.. +++.|++.||+|+|++| |+||||||+|||++++|.+||+|||++....
T Consensus 322 Eyv~G~~L~d~i~-----~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 322 EKLPGRLLSDMLA-----AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp ECCCSEEHHHHHH-----TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred ecCCCCcHHHHHH-----hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999994 44556654 47899999999999999 9999999999999999999999999988655
Q ss_pred CChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCc
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQAL 214 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~ 214 (313)
.... ......||+.|+|||++.+. +...+|+||+|++++.+.++..|+
T Consensus 391 ~~~~---~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDCS---WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---C---CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCc---cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 4322 22335799999999999764 677899999999988877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=222.40 Aligned_cols=182 Identities=18% Similarity=0.181 Sum_probs=144.4
Q ss_pred cccceeccCCeEEEEEeEECCcceEEEeccccc-----------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 15 STSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-----------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 15 ~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-----------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
...++||+|+||.||+|...++.+++|...... .+.+.+|+++++++ ||||+++..++.+.+..++||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 446799999999999998889999999864322 22368999999999 999996666666777889999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+++++|.+++.. +..++.|++.+|.|||+++ |+|+||||+||+++. .+||+|||++....
T Consensus 419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 99999999999842 4578999999999999999 999999999999999 99999999999876
Q ss_pred CChhhhh----hcccccccccccCCccccC--CCCCCccchhhHHHHHHHHHhCCCCc
Q 041031 163 HSPEIAA----AASRIVGTFGYLAPEYVRD--GCVTTKSDVYAFGVVLMELITGQQAL 214 (313)
Q Consensus 163 ~~~~~~~----~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~~~tg~~p~ 214 (313)
....... ......+|+.|+|||++.. ..|+..+|+|+..+-..+-..++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 5322111 1234578999999999986 66888899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-24 Score=183.35 Aligned_cols=136 Identities=14% Similarity=0.080 Sum_probs=110.9
Q ss_pred HHHHHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc---------------------cHHHHHHHHHHHhcCC
Q 041031 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK---------------------SKEFSSELKILCKVHS 63 (313)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~---------------------~~~~~~e~~~l~~lh~ 63 (313)
.+......|.+.+.||+|+||.||+|.+. ++.||||.++... ...+.+|+.+++.++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34444556667799999999999999996 7899999986432 234779999999996
Q ss_pred CceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCee
Q 041031 64 NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNIL 143 (313)
Q Consensus 64 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil 143 (313)
| +++.+.+.. +..++||||+++++|.+ +. . .....++.|++.||.|||+.+ ++|+||||+||+
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-----~------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR-----V------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-----C------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cc-----h------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 5 667665544 45699999999999998 52 1 123468999999999999999 999999999999
Q ss_pred eCCCCcEEEeecccccc
Q 041031 144 LDSNFRAKIADFGLVKL 160 (313)
Q Consensus 144 ~~~~~~~~l~dfg~~~~ 160 (313)
++ ++.++|+|||++..
T Consensus 226 l~-~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE 241 (282)
T ss_dssp EE-TTEEEECCCTTCEE
T ss_pred EE-CCcEEEEECCCCeE
Confidence 99 99999999999863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.1e-20 Score=156.07 Aligned_cols=132 Identities=19% Similarity=0.185 Sum_probs=103.7
Q ss_pred ccccceeccCCeEEEEEeEE--CCcc--eEEEecccccc---------------------------HHHHHHHHHHHhc-
Q 041031 14 FSTSLKIGQGSYGSVYLGKL--RGKN--AAIKQMKNTKS---------------------------KEFSSELKILCKV- 61 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~--~~~~--~aiK~~~~~~~---------------------------~~~~~e~~~l~~l- 61 (313)
|.+.+.||+|+||.||+|.+ .|+. ||||+++.... ..+.+|+.+++.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999998 4888 99998654311 2467899999999
Q ss_pred CCCc--eeeeeEEEeCCeEEEEEeecCC-C----ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHh-cCCCCceE
Q 041031 62 HSNL--IELIGYAAGGDSLFLVYEYAQN-G----ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH-QYTKPYYV 133 (313)
Q Consensus 62 h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~~i~ 133 (313)
|+++ ..++.. +..++||||+.+ | +|.+... ..++..+..++.|++.++.+|| +.+ ++
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR--------ELKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG--------GGGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh--------ccChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 7754 344432 356899999942 3 5665542 1234567789999999999999 999 99
Q ss_pred EeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 134 HRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 134 h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
|+||||+||++++ .++|+|||++....
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999999998 89999999987543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=7e-18 Score=148.46 Aligned_cols=135 Identities=13% Similarity=0.149 Sum_probs=99.0
Q ss_pred cCccccceeccCCeEEEEEeEEC-CcceEEEecccccc-----------------HH--------HHHHHHHHHhc-CCC
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKS-----------------KE--------FSSELKILCKV-HSN 64 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~~-----------------~~--------~~~e~~~l~~l-h~~ 64 (313)
.-|.+.+.||.|++|.||+|.+. |+.||||+++.... .. ..+|...|.++ +.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34999999999999999999987 88999998753210 00 23466667777 333
Q ss_pred ceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee
Q 041031 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL 144 (313)
Q Consensus 65 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 144 (313)
+ .+...+... ..++||||++|++|.++.. . .....++.|++.++.+||+.| ++|+||||.|||+
T Consensus 175 v-~vp~p~~~~-~~~LVME~i~G~~L~~l~~---------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl 238 (397)
T 4gyi_A 175 F-PVPEPIAQS-RHTIVMSLVDALPMRQVSS---------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILI 238 (397)
T ss_dssp C-SCCCEEEEE-TTEEEEECCSCEEGGGCCC---------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred C-CCCeeeecc-CceEEEEecCCccHhhhcc---------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence 2 222222112 2379999999988877642 1 123567899999999999999 9999999999999
Q ss_pred CCCC----------cEEEeecccccccc
Q 041031 145 DSNF----------RAKIADFGLVKLLE 162 (313)
Q Consensus 145 ~~~~----------~~~l~dfg~~~~~~ 162 (313)
+++| .+.++||+-+....
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred eCCCCcccccccccceEEEEeCCcccCC
Confidence 8776 38999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=2.3e-14 Score=120.92 Aligned_cols=145 Identities=14% Similarity=0.113 Sum_probs=117.6
Q ss_pred HHHHHhcCccccceeccCCeEEEEEeEECCcceEEEeccc---cccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEE
Q 041031 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKN---TKSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~---~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~l 80 (313)
.+....++|.+...++.|+.+.||++...++.+++|.... .....+.+|..+++.+ +..+.+++++..+....++
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 4567778999999999999999999988888999999875 4456789999999999 5667899999999899999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCC--------------------------------
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT-------------------------------- 128 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-------------------------------- 128 (313)
|||+++|.+|.+.+. +......++.+++.+++.||+..
T Consensus 88 v~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 999999999987641 11122467889999999999811
Q ss_pred ------------------------CCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 129 ------------------------KPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 129 ------------------------~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
...++|+|++|.||++++++.+.++||+.+..
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 12389999999999998765567999997653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=8e-12 Score=104.92 Aligned_cols=141 Identities=13% Similarity=0.078 Sum_probs=104.8
Q ss_pred HHHHhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccccHHHHHHHHHHHhc-CCC--ceeeeeEEEeCCeEEEEE
Q 041031 7 VRDATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKSKEFSSELKILCKV-HSN--LIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~--i~~~~~~~~~~~~~~lv~ 82 (313)
+.....++.+..+.+.|..+.||++... |+.+++|.........+..|+.+++.+ +.+ +.+++++....+..++||
T Consensus 15 l~~~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 15 WVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp GTTTTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred HHHhcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 3444566776555556667999999766 678999998776556788999999999 333 567888888878899999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT---------------------------------- 128 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---------------------------------- 128 (313)
|+++|.+|. .. . .. ...++.+++..++.||+..
T Consensus 95 e~i~G~~l~--~~----~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 95 GEVPGQDLL--SS----H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp ECCSSEETT--TS----C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EecCCcccC--cC----c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 999998884 31 1 11 1246677778888888753
Q ss_pred ---------------------CCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 129 ---------------------KPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 129 ---------------------~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
+..++|+|++|.||++++++.+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11289999999999998776567999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.27 E-value=3e-11 Score=106.52 Aligned_cols=142 Identities=13% Similarity=0.190 Sum_probs=109.3
Q ss_pred ccccceeccCCeEEEEEeEECCcceEEEecc--ccc----cHHHHHHHHHHHhc---CCCceeeeeEEEeC---CeEEEE
Q 041031 14 FSTSLKIGQGSYGSVYLGKLRGKNAAIKQMK--NTK----SKEFSSELKILCKV---HSNLIELIGYAAGG---DSLFLV 81 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~--~~~----~~~~~~e~~~l~~l---h~~i~~~~~~~~~~---~~~~lv 81 (313)
...++.++.|.++.||+....+..+++|... ... ...+.+|..+++.+ +..+.+++.++.+. ...++|
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred CceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3457789999999999998888889999887 432 45688999999999 34578888888766 348999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCC---------------------------------
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT--------------------------------- 128 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--------------------------------- 128 (313)
||+++|.++.+.. ...++......++.+++.+|+.||+..
T Consensus 120 me~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999998775422 134677788889999999999999731
Q ss_pred ----------------------CCceEEeccCCCCeeeCCCCc--EEEeecccccccc
Q 041031 129 ----------------------KPYYVHRDVKTSNILLDSNFR--AKIADFGLVKLLE 162 (313)
Q Consensus 129 ----------------------~~~i~h~di~p~nil~~~~~~--~~l~dfg~~~~~~ 162 (313)
...++|+|++|.||+++.++. +.++||+.+....
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 134999999999999997653 5899999887543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=3.5e-11 Score=103.60 Aligned_cols=185 Identities=19% Similarity=0.225 Sum_probs=122.0
Q ss_pred cceeccCCeEEEEEeEECCcceEEEecccc-ccHHHHHHHHHHHhc--CCC--ceeeeeEEEeCC---eEEEEEeecCCC
Q 041031 17 SLKIGQGSYGSVYLGKLRGKNAAIKQMKNT-KSKEFSSELKILCKV--HSN--LIELIGYAAGGD---SLFLVYEYAQNG 88 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~-~~~~~~~e~~~l~~l--h~~--i~~~~~~~~~~~---~~~lv~e~~~~~ 88 (313)
++.++.|..+.||+.. ..+++|..... ....+.+|..+++.+ +.. +.+++....... ..|+||++++|.
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 5678999999999874 67999987654 345688999999888 322 345554443333 347899999998
Q ss_pred ChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 041031 89 ALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT---------------------------------------- 128 (313)
Q Consensus 89 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---------------------------------------- 128 (313)
+|.+... ..++......++.+++..++.||+..
T Consensus 102 ~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 102 PLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp ECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred ECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 8875331 23566677778888888888888621
Q ss_pred ---------------CCceEEeccCCCCeeeCC--CCcEEEeeccccccccCChhhhhhcccccccccccCCcccc----
Q 041031 129 ---------------KPYYVHRDVKTSNILLDS--NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR---- 187 (313)
Q Consensus 129 ---------------~~~i~h~di~p~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---- 187 (313)
...++|+|++|.||++++ ++.+.++||+.+.......+....... . .-..|+...
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~---~-~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED---D-EEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT---T-TSCCHHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh---c-cccCHHHHHHHHH
Confidence 123799999999999998 455789999987754332221111000 0 001222111
Q ss_pred C-CC---------CCCccchhhHHHHHHHHHhCCCCcc
Q 041031 188 D-GC---------VTTKSDVYAFGVVLMELITGQQALS 215 (313)
Q Consensus 188 ~-~~---------~~~~~DiwslG~~l~~~~tg~~p~~ 215 (313)
. +. .....+.|++|.++|.+.+|..+|.
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0 00 1223588999999999999988763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=1.7e-08 Score=85.08 Aligned_cols=140 Identities=16% Similarity=0.131 Sum_probs=102.3
Q ss_pred hcCccccceeccCCeE-EEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhcCC--CceeeeeEEEeCCeEEEEEeec
Q 041031 11 TSNFSTSLKIGQGSYG-SVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKVHS--NLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g-~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~lh~--~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
...|+.. .+..|..+ .||+.... +..+++|.-.......+.+|..+|+.+.+ -+.+++.++.+.+..++||+++
T Consensus 24 l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 24 LYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp HTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 3444433 33345444 68987665 56799999887777788999999999933 3678889999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCC------------------------------------
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK------------------------------------ 129 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~------------------------------------ 129 (313)
+|.++.+.... .......+..++...++.||+...
T Consensus 103 ~G~~~~~~~~~---------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 103 PGKTAFQVLEE---------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp CSEEHHHHHHH---------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred CCccccccccC---------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 99888776521 112233466677777777776420
Q ss_pred -------------------CceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 130 -------------------PYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 130 -------------------~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
..++|+|+.+.||++++++.+-|+||+.+..
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 0178999999999999877677999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=3.5e-07 Score=78.54 Aligned_cols=134 Identities=18% Similarity=0.251 Sum_probs=93.0
Q ss_pred cceeccCCeEEEEEeEECCcceEEEecccc-ccHHHHHHHHHHHhc-C--C-CceeeeeEEE-eCCeEEEEEeecCCCCh
Q 041031 17 SLKIGQGSYGSVYLGKLRGKNAAIKQMKNT-KSKEFSSELKILCKV-H--S-NLIELIGYAA-GGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~-~~~~~~~e~~~l~~l-h--~-~i~~~~~~~~-~~~~~~lv~e~~~~~~L 90 (313)
++.++.|....||+. +..+++|+.... ....+.+|..+|+.+ + + .+.+++.+.. .....+++|++++|.++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 567888999999988 788999986433 245688999999999 2 1 2556666664 34557899999999888
Q ss_pred hhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 041031 91 SDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT------------------------------------------ 128 (313)
Q Consensus 91 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~------------------------------------------ 128 (313)
.+..- ..++......++.++...|+.||+..
T Consensus 101 ~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 101 GEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp HHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred chhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 76321 12334444455555555555555432
Q ss_pred ---------------CCceEEeccCCCCeeeCC---CCcE-EEeecccccc
Q 041031 129 ---------------KPYYVHRDVKTSNILLDS---NFRA-KIADFGLVKL 160 (313)
Q Consensus 129 ---------------~~~i~h~di~p~nil~~~---~~~~-~l~dfg~~~~ 160 (313)
...++|+|++|.||+++. ++.+ .++||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123799999999999987 4555 7999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.6e-07 Score=81.03 Aligned_cols=77 Identities=9% Similarity=0.170 Sum_probs=58.2
Q ss_pred cccee-ccCCeEEEEEeEEC--------CcceEEEeccccc------cHHHHHHHHHHHhc--C-C-CceeeeeEEEeC-
Q 041031 16 TSLKI-GQGSYGSVYLGKLR--------GKNAAIKQMKNTK------SKEFSSELKILCKV--H-S-NLIELIGYAAGG- 75 (313)
Q Consensus 16 ~~~~l-g~g~~g~v~~~~~~--------~~~~aiK~~~~~~------~~~~~~e~~~l~~l--h-~-~i~~~~~~~~~~- 75 (313)
..+.| +.|....+|+.... ++.+++|...... ...+..|..+++.+ + . .+.+++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34677 88999999988765 6789999876543 35688999999998 4 2 466788777655
Q ss_pred --CeEEEEEeecCCCChhh
Q 041031 76 --DSLFLVYEYAQNGALSD 92 (313)
Q Consensus 76 --~~~~lv~e~~~~~~L~~ 92 (313)
...++|||+++|.++.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.41 E-value=2.8e-06 Score=72.99 Aligned_cols=76 Identities=16% Similarity=0.156 Sum_probs=64.1
Q ss_pred cccceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc--C--CCceeeeeEEEeCCeEEEEEeecCCCCh
Q 041031 15 STSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV--H--SNLIELIGYAAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 15 ~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l--h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (313)
.-.+.|+.|....+|+....+..+++|.........+..|...|+.+ . ..+.+++.+.......++|||++++.++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 34578899999999999887888999998776667788999999998 3 4578888888888889999999998765
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.29 E-value=8.2e-06 Score=70.79 Aligned_cols=73 Identities=15% Similarity=0.214 Sum_probs=46.9
Q ss_pred cceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc--C-CCceeeee------EEEeCCeEEEEEeecCC
Q 041031 17 SLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV--H-SNLIELIG------YAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l--h-~~i~~~~~------~~~~~~~~~lv~e~~~~ 87 (313)
++.|+.|..+.||+....+..+++|..... ...+..|..+++.+ + -.+.+++. +.......+++|+|++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~-~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G 115 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP-EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG 115 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC-HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC-HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence 345666778999999887777999998863 34555677777777 1 12344443 12346678999999998
Q ss_pred CCh
Q 041031 88 GAL 90 (313)
Q Consensus 88 ~~L 90 (313)
.++
T Consensus 116 ~~~ 118 (346)
T 2q83_A 116 RPF 118 (346)
T ss_dssp BCC
T ss_pred ccC
Confidence 655
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.13 E-value=5.5e-06 Score=66.25 Aligned_cols=102 Identities=11% Similarity=0.058 Sum_probs=66.5
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
.||.+.|. ..+.+++++++|.++.|.+.+|.-+-.... -...=+.|..|++..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~----~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILR----LYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHH----HcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc--------
Confidence 46888885 567899999999999999999887632110 01233457899999999987764 1110
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCC
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQ 212 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~ 212 (313)
.....|.|||... ...+.+.=|||||+++|.-+--..
T Consensus 98 -------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 -------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred -------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1233567888763 344677789999999999886443
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=1.3e-05 Score=71.33 Aligned_cols=71 Identities=17% Similarity=0.077 Sum_probs=49.0
Q ss_pred ccceeccCCeEEEEEeEEC--CcceEEEecccc----------ccHHHHHHHHHHHhc---CCC-ceeeeeEEEeCCeEE
Q 041031 16 TSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT----------KSKEFSSELKILCKV---HSN-LIELIGYAAGGDSLF 79 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~----------~~~~~~~e~~~l~~l---h~~-i~~~~~~~~~~~~~~ 79 (313)
..+.+|.|..+.||++... ++.++||...+. ..+....|.++++.+ .+. +.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3668999999999999654 678999976432 234467799999887 233 3455543 344568
Q ss_pred EEEeecCCC
Q 041031 80 LVYEYAQNG 88 (313)
Q Consensus 80 lv~e~~~~~ 88 (313)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.09 E-value=9.4e-05 Score=63.58 Aligned_cols=159 Identities=11% Similarity=0.141 Sum_probs=92.3
Q ss_pred cChHHHHHHhcCccc-----cceeccCCeEEEEEeEECCcceEEEecccc-ccHHHHHHHHHHHhc--CC-CceeeeeE-
Q 041031 2 FSYNEVRDATSNFST-----SLKIGQGSYGSVYLGKLRGKNAAIKQMKNT-KSKEFSSELKILCKV--HS-NLIELIGY- 71 (313)
Q Consensus 2 ~~~~~~~~~~~~y~~-----~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~-~~~~~~~e~~~l~~l--h~-~i~~~~~~- 71 (313)
+|.+.+.....+|.+ .+.++.|....+|+....+..+++|..... ..+.+..|..+++.+ +. .+.+++..
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~ 86 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK 86 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC
Confidence 467788888888865 345667888999999887668999998873 556778889888888 31 12333322
Q ss_pred -----EEeCCeEEEEEeecCCCChhhh--------------hcC---CCCCCC-CCcc---HHHHHH------------H
Q 041031 72 -----AAGGDSLFLVYEYAQNGALSDH--------------LHW---PSVKGK-KPLA---WTTRVQ------------I 113 (313)
Q Consensus 72 -----~~~~~~~~lv~e~~~~~~L~~~--------------l~~---~~~~~~-~~l~---~~~~~~------------~ 113 (313)
.......++++++++|.++... ++. ...... .... +..... +
T Consensus 87 ~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 87 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 1234567899999988654210 000 000000 0001 111000 0
Q ss_pred HHHHHHHHHHHhcC----CCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 114 ALDAAKGLEYIHQY----TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 114 ~~~i~~~l~~lh~~----~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
...+...+..+... .+..++|+|+++.||++++++.+.++||+.+..
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 01133334444421 122389999999999998876557999987763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.98 E-value=3.5e-05 Score=69.10 Aligned_cols=71 Identities=15% Similarity=0.142 Sum_probs=46.4
Q ss_pred cccceeccCCeEEEEEeEECCcceEEEeccc-------c-c--cHHHHHHHHHHHhc----CCCceeeeeEEEeCCeEEE
Q 041031 15 STSLKIGQGSYGSVYLGKLRGKNAAIKQMKN-------T-K--SKEFSSELKILCKV----HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 15 ~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~-------~-~--~~~~~~e~~~l~~l----h~~i~~~~~~~~~~~~~~l 80 (313)
..++.+|.|..+.||++...++.++||...+ . . ......|.+++..+ ...+.+++.+. ....++
T Consensus 37 ~~i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 37 LVIKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp CEEEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred eEEEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 3467889999999999987778899994321 1 1 12333344444333 34566777665 456789
Q ss_pred EEeec-CC
Q 041031 81 VYEYA-QN 87 (313)
Q Consensus 81 v~e~~-~~ 87 (313)
|||++ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.92 E-value=9.1e-05 Score=63.14 Aligned_cols=72 Identities=11% Similarity=0.065 Sum_probs=48.6
Q ss_pred ccccceeccCCeEEEEEeEECCcceEEEeccccc--cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeec-CCC
Q 041031 14 FSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK--SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYA-QNG 88 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~--~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 88 (313)
+.-++.|+.|....+|+. +.+++|+..... ......|..+++.+ +.-..+++.. +...-+++++|+ +|.
T Consensus 20 ~~~i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CCSCEEEESCSSEEEEEE----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred ccceeEcCCcccccccee----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 444788999999999998 679999887542 22346788888888 3222455544 333346899999 665
Q ss_pred Chh
Q 041031 89 ALS 91 (313)
Q Consensus 89 ~L~ 91 (313)
++.
T Consensus 94 ~l~ 96 (301)
T 3dxq_A 94 TMS 96 (301)
T ss_dssp ECC
T ss_pred cCC
Confidence 553
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.90 E-value=0.0002 Score=60.65 Aligned_cols=76 Identities=14% Similarity=0.164 Sum_probs=56.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc---cHHHHHHHHHHHhcCC----CceeeeeEEEeCCeEEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK---SKEFSSELKILCKVHS----NLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~---~~~~~~e~~~l~~lh~----~i~~~~~~~~~~~~~~lv~ 82 (313)
..+..-++.+|.|..+.||+.+.. |+.+++|+..... ...+..|...|+.++. -+.+++++ +. .+++|
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEE
Confidence 456777889999999999999987 7899999876543 3457889999999821 24455544 22 37899
Q ss_pred eecCCCCh
Q 041031 83 EYAQNGAL 90 (313)
Q Consensus 83 e~~~~~~L 90 (313)
|++.++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.87 E-value=5.7e-05 Score=65.36 Aligned_cols=145 Identities=13% Similarity=0.071 Sum_probs=76.9
Q ss_pred cceeccCCeEE-EEEeEEC-CcceEEEeccccccHHHHHHHHHHHhc--CC-CceeeeeEEEeCCeEEEEEeecCCCChh
Q 041031 17 SLKIGQGSYGS-VYLGKLR-GKNAAIKQMKNTKSKEFSSELKILCKV--HS-NLIELIGYAAGGDSLFLVYEYAQNGALS 91 (313)
Q Consensus 17 ~~~lg~g~~g~-v~~~~~~-~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (313)
++.|+.|.... +|+.... ++.+++|...+.....+..|+.+++.+ +. .+.+++.+.... -+++||++++.++.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFT 100 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHH
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchH
Confidence 44566555544 6677664 677888876655435667788888888 32 245666653332 37899999776665
Q ss_pred hhhcCCCC---------------------CCCCCccHHHHH-------HH-------------HHHHHHHHHHHh---cC
Q 041031 92 DHLHWPSV---------------------KGKKPLAWTTRV-------QI-------------ALDAAKGLEYIH---QY 127 (313)
Q Consensus 92 ~~l~~~~~---------------------~~~~~l~~~~~~-------~~-------------~~~i~~~l~~lh---~~ 127 (313)
+.+..... .....+...... .+ ...+...+..+. ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 43321100 000111111100 00 001111122221 11
Q ss_pred CCCceEEeccCCCCeeeCCC----CcEEEeeccccccccC
Q 041031 128 TKPYYVHRDVKTSNILLDSN----FRAKIADFGLVKLLEH 163 (313)
Q Consensus 128 ~~~~i~h~di~p~nil~~~~----~~~~l~dfg~~~~~~~ 163 (313)
....++|+|+.+.||+++.+ +.+.++||+.+.....
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 12339999999999999874 6789999998876444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00069 Score=58.25 Aligned_cols=87 Identities=9% Similarity=0.103 Sum_probs=57.6
Q ss_pred ChHHHHHHhcCccc-----cceeccCCeEEEEEeEEC-CcceEEEecccc--ccHHHHHHHHHHHhc--CC-CceeeeeE
Q 041031 3 SYNEVRDATSNFST-----SLKIGQGSYGSVYLGKLR-GKNAAIKQMKNT--KSKEFSSELKILCKV--HS-NLIELIGY 71 (313)
Q Consensus 3 ~~~~~~~~~~~y~~-----~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~--~~~~~~~e~~~l~~l--h~-~i~~~~~~ 71 (313)
|.+.+......|-+ +..++ |....||+.... |+.+++|...+. ....+..|..+++.+ +. .+.+++..
T Consensus 12 ~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~ 90 (328)
T 1zyl_A 12 HPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF 90 (328)
T ss_dssp CHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB
T ss_pred CHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec
Confidence 44556666665533 34566 888899988765 568999998753 456778899888888 21 13444443
Q ss_pred -----EEeCCeEEEEEeecCCCCh
Q 041031 72 -----AAGGDSLFLVYEYAQNGAL 90 (313)
Q Consensus 72 -----~~~~~~~~lv~e~~~~~~L 90 (313)
....+..++++++++|.++
T Consensus 91 ~g~~~~~~~g~~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 91 NGQTLLNHQGFYFAVFPSVGGRQF 114 (328)
T ss_dssp TTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCcEEEEECCEEEEEEEecCCCCC
Confidence 1234566889999987554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.66 E-value=0.0002 Score=64.25 Aligned_cols=71 Identities=18% Similarity=0.210 Sum_probs=50.8
Q ss_pred ccceeccCCeEEEEEeEEC---------CcceEEEecccccc-HHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEe
Q 041031 16 TSLKIGQGSYGSVYLGKLR---------GKNAAIKQMKNTKS-KEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~---------~~~~aiK~~~~~~~-~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++.|+.|....+|+.... ++.+++|+...... +.+..|..+++.+ +.-..++++.+.+ .+|++
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 3567788889999999865 36789998855333 6667899999998 4333566665542 38999
Q ss_pred ecCCCCh
Q 041031 84 YAQNGAL 90 (313)
Q Consensus 84 ~~~~~~L 90 (313)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00049 Score=60.57 Aligned_cols=140 Identities=15% Similarity=0.142 Sum_probs=81.8
Q ss_pred cceeccCCeEEEEEeEEC---------CcceEEEecccc--ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEe
Q 041031 17 SLKIGQGSYGSVYLGKLR---------GKNAAIKQMKNT--KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~---------~~~~aiK~~~~~--~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e 83 (313)
++.+..|....+|+.... ++.+++|+.... ....+.+|.++++.+ +.-..++++.+.+ .+|+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 456777888999998764 367999986442 345567899999998 4334566666543 28999
Q ss_pred ecCCCChhhh-h----------------cCCCCCCCCCc--cHHHHHHHHHHHHH-------------------HHH---
Q 041031 84 YAQNGALSDH-L----------------HWPSVKGKKPL--AWTTRVQIALDAAK-------------------GLE--- 122 (313)
Q Consensus 84 ~~~~~~L~~~-l----------------~~~~~~~~~~l--~~~~~~~~~~~i~~-------------------~l~--- 122 (313)
|++|.+|..- + ......-.... -...+..++.++-. .+.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665421 1 11110011111 23444445544322 112
Q ss_pred -HHhcC-CCCceEEeccCCCCeeeCCC----CcEEEeecccccc
Q 041031 123 -YIHQY-TKPYYVHRDVKTSNILLDSN----FRAKIADFGLVKL 160 (313)
Q Consensus 123 -~lh~~-~~~~i~h~di~p~nil~~~~----~~~~l~dfg~~~~ 160 (313)
.|... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22222 12238999999999999876 6899999998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0011 Score=59.99 Aligned_cols=71 Identities=17% Similarity=0.102 Sum_probs=48.3
Q ss_pred ccceeccCCeEEEEEeEECC--cceEEEeccccccH--HHHHHHHHHHhc-CCC-ceeeeeEEEeCCeEEEEEeecCCCC
Q 041031 16 TSLKIGQGSYGSVYLGKLRG--KNAAIKQMKNTKSK--EFSSELKILCKV-HSN-LIELIGYAAGGDSLFLVYEYAQNGA 89 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~~--~~~aiK~~~~~~~~--~~~~e~~~l~~l-h~~-i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (313)
.++.|+.|....+|+....+ ..+++|+....... +...|..+++.+ ..+ ..++++.+. + .+|++|++|.+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 35678889999999998876 78999987543322 236899999999 323 356676663 3 25999998755
Q ss_pred h
Q 041031 90 L 90 (313)
Q Consensus 90 L 90 (313)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00082 Score=58.94 Aligned_cols=70 Identities=11% Similarity=0.033 Sum_probs=45.6
Q ss_pred cceeccCCeEEEEEeEECC----------cceEEEecccccc--HHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEE
Q 041031 17 SLKIGQGSYGSVYLGKLRG----------KNAAIKQMKNTKS--KEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~~----------~~~aiK~~~~~~~--~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~ 82 (313)
++.++.|....+|+....+ +.+++|+...... .....|..+++.+ +.-..++++.. . -++++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 5577888889999998763 6789998765432 2346889999988 32244666554 2 26899
Q ss_pred eecCCCCh
Q 041031 83 EYAQNGAL 90 (313)
Q Consensus 83 e~~~~~~L 90 (313)
+|++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0011 Score=57.58 Aligned_cols=71 Identities=14% Similarity=0.067 Sum_probs=47.3
Q ss_pred cceec--cCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc--C--CCceeeeeE------EEeCCeEEEEEee
Q 041031 17 SLKIG--QGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV--H--SNLIELIGY------AAGGDSLFLVYEY 84 (313)
Q Consensus 17 ~~~lg--~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l--h--~~i~~~~~~------~~~~~~~~lv~e~ 84 (313)
++.+. .|....||+....+..+++|+...... ..|+.+++.+ + |.+.+++.. .......+++|+|
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~~g~~vLK~~~~~~~---~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~ 102 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSESKSYFIKLKYGYHD---EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPF 102 (339)
T ss_dssp EEEETTTSCSSCEEEEEECSSCEEEEEEEECSSC---CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEEC
T ss_pred eEEeeccCccccceEEEEeCCCCEEEEEecCccc---hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEec
Confidence 34453 333689999987755999998776542 4677777777 2 224455433 2345678999999
Q ss_pred cCCCCh
Q 041031 85 AQNGAL 90 (313)
Q Consensus 85 ~~~~~L 90 (313)
++|..+
T Consensus 103 i~G~~~ 108 (339)
T 3i1a_A 103 IHAPNG 108 (339)
T ss_dssp CCCCBT
T ss_pred cCCCcC
Confidence 998766
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0049 Score=54.98 Aligned_cols=71 Identities=10% Similarity=0.029 Sum_probs=50.5
Q ss_pred ccceeccCCeEEEEEeEEC---------CcceEEEeccccc--cHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEE
Q 041031 16 TSLKIGQGSYGSVYLGKLR---------GKNAAIKQMKNTK--SKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~---------~~~~aiK~~~~~~--~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.++.+..|....+|+.... ++.+++|+..... .-+..+|..+++.+ +.-..++++.+. -++|+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567777889999999876 5789999876532 22356899999998 333455665432 26899
Q ss_pred eecCCCCh
Q 041031 83 EYAQNGAL 90 (313)
Q Consensus 83 e~~~~~~L 90 (313)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.68 E-value=0.064 Score=47.42 Aligned_cols=29 Identities=28% Similarity=0.515 Sum_probs=24.7
Q ss_pred eEEeccCCCCeee------CCCCcEEEeecccccc
Q 041031 132 YVHRDVKTSNILL------DSNFRAKIADFGLVKL 160 (313)
Q Consensus 132 i~h~di~p~nil~------~~~~~~~l~dfg~~~~ 160 (313)
++|+|+.+.||++ ++++.+.++||.++..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=95.12 E-value=0.052 Score=43.29 Aligned_cols=124 Identities=10% Similarity=0.097 Sum_probs=81.3
Q ss_pred HHHHHHHhcCCCceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCce
Q 041031 53 SELKILCKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132 (313)
Q Consensus 53 ~e~~~l~~lh~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i 132 (313)
.|+.+|...||+++.. ......+.+.+.++.-+ ....+- .-...+....++++.+++....+++ ..
T Consensus 35 ~el~LL~~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~------~ik~~~~~eKlr~l~ni~~l~~~~~-~r---- 100 (215)
T 4ann_A 35 HLMYLLEQHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD------NIKSFTKNEKLRYLLNIKNLEEVNR-TR---- 100 (215)
T ss_dssp GGGGGGGSCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG------GGGGSCHHHHHHHHHHGGGGGGGGG-SS----
T ss_pred HHHHHHhccCCcccce-EEEEcccEEEEEEEcCc--ccCCHH------HHHhcCHHHHHHHHHHHHHHHHHhc-Cc----
Confidence 3555566658988877 45566666666666543 222221 2245788889999999999884443 22
Q ss_pred EEeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCC
Q 041031 133 VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQ 212 (313)
Q Consensus 133 ~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~ 212 (313)
+|.-+.|+|++++.++.++++-.|+-... +|. ..+...=.-..=|++..+++++.
T Consensus 101 ~tf~L~P~NL~f~~~~~p~i~~RGik~~l--------------------~P~-----~~~ee~fL~qyKAliiall~~K~ 155 (215)
T 4ann_A 101 YTFVLAPDELFFTRDGLPIAKTRGLQNVV--------------------DPL-----PVSEAEFLTRYKALVICAFNEKQ 155 (215)
T ss_dssp EECCCSGGGEEECTTSCEEESCCEETTTB--------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTC
T ss_pred eEEEEecceEEEcCCCCEEEEEccCccCC--------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCC
Confidence 78899999999999999999987763322 221 11111222355677888888888
Q ss_pred Ccc
Q 041031 213 ALS 215 (313)
Q Consensus 213 p~~ 215 (313)
.|.
T Consensus 156 ~Fe 158 (215)
T 4ann_A 156 SFD 158 (215)
T ss_dssp CHH
T ss_pred CHH
Confidence 774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.46 E-value=0.14 Score=40.98 Aligned_cols=91 Identities=12% Similarity=0.153 Sum_probs=63.4
Q ss_pred HHHHHHhcCCCceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHH-HHhcCCCCce
Q 041031 54 ELKILCKVHSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLE-YIHQYTKPYY 132 (313)
Q Consensus 54 e~~~l~~lh~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~-~lh~~~~~~i 132 (313)
++.++..-||++ -...-.+++.+.+.++.-+++.-...+ ..++....++++.+++.... +++. -
T Consensus 41 e~~lL~~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--------~~~~~~eKlrll~nl~~L~~~~~~~-----r 105 (219)
T 4ano_A 41 ELEVLKEVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--------RKTTLLSRIRAAIHLVSKVKHHSAR-----R 105 (219)
T ss_dssp GGGGGGGSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--------HTSCHHHHHHHHHHHHHHHSSCCSS-----S
T ss_pred HHHHHhccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--------HhcCHHHHHHHHHHHHHHHHHhhhC-----c
Confidence 344455558888 444556777777777765333222233 34778888998999888766 3332 3
Q ss_pred EEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 133 VHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 133 ~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
++.-+.|+|++++.++.+++.-.|+-.
T Consensus 106 ~tf~l~P~NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 106 LIFIVCPENLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp EECCCCGGGEEECTTCCEEESCCEETT
T ss_pred eeEEEeCceEEEeCCCcEEEEEcCCcc
Confidence 788999999999999999999888643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 313 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-13 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-59
Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTKS-----KEFSSELKILCKV-HSNLIELIGYA 72
+IG GS+G+VY GK G A+K + T + F +E+ +L K H N++ +GY+
Sbjct: 15 RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
L +V ++ + +L HLH + + IA A+G++Y+H
Sbjct: 74 TA-PQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHA---KSI 125
Query: 133 VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR---DG 189
+HRD+K++NI L + KI DFGL + + ++ G+ ++APE +R
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW-SGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 190 CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKL 249
+ +SDVYAFG+VL EL+TGQ Y+ + + V
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP-----------YSNINNRDQIIFMVGRGY------- 226
Query: 250 TECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299
L P+L++ + M L +C+ + RP + + S
Sbjct: 227 ---LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 8e-59
Identities = 74/300 (24%), Positives = 129/300 (43%), Gaps = 34/300 (11%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV---HSNLIELIGYAAGG 75
IG+G +G V+ GK RG+ A+K + + + + E +I V H N++ I
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 76 DS----LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ----- 126
+ L+LV +Y ++G+L D+L+ + + +++AL A GL ++H
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE-IAAAASRIVGTFGYLAPEY 185
KP HRD+K+ NIL+ N IAD GL + + + I A + VGT Y+APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 186 VRDGC------VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
+ D ++D+YA G+V E+ + G D + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARR-------CSIGGIHEDYQLPYYDLVPSDP 236
Query: 240 NDTKDFMAKLTECLDPNL--TRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297
+ + + L PN+ +++ MA + ++C N R LS +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-57
Identities = 66/322 (20%), Positives = 120/322 (37%), Gaps = 39/322 (12%)
Query: 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS----KEFSSELKILCKV-H 62
+F ++G G+ G V+ + G A K + + EL++L +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLE 122
++ G + + E+ G+L L + ++++ KGL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLT 118
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
Y+ + K +HRDVK SNIL++S K+ DFG+ L S A+ VGT Y++
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMS 171
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELITGQ-----------------QALSRDANPGNNQY 225
PE ++ + +SD+++ G+ L+E+ G+ Q A
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 226 TEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD 285
T R L Y + F +P L+ C+ +N R D
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 286 MSNAAIRLSHILISSKEWEKME 307
+ + H I + E+++
Sbjct: 292 LKQL---MVHAFIKRSDAEEVD 310
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-55
Identities = 70/281 (24%), Positives = 127/281 (45%), Gaps = 40/281 (14%)
Query: 19 KIGQGSYGSVYLGKLRGKNAAIKQMKNTKS-KEFSSELKILCKV-HSNLIELIGYAA-GG 75
IG+G +G V LG RG A+K +KN + + F +E ++ ++ HSNL++L+G
Sbjct: 14 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73
Query: 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHR 135
L++V EY G+L D+L +G+ L ++ +LD + +EY+ +VHR
Sbjct: 74 GGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 127
Query: 136 DVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKS 195
D+ N+L+ + AK++DFGL K + + APE +R+ +TKS
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKS 181
Query: 196 DVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDP 255
DV++FG++L E+ + + KD + ++ +
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPL----------------------KDVVPRVEKGYKM 219
Query: 256 NLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296
+ ++ ++ K+C + RP +L HI
Sbjct: 220 DAPDGCPPAVYEVM---KNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 6e-53
Identities = 65/287 (22%), Positives = 117/287 (40%), Gaps = 38/287 (13%)
Query: 19 KIGQGSYGSVYLGKLR-GKNAAIKQMKNTKS--KEFSSELKILCKV-HSNLIELIGYAAG 74
++G G +G V++G A+K +K F +E ++ ++ H L+ L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
+ ++++ EY +NG+L D L P L + +A A+G+ +I + Y+H
Sbjct: 80 -EPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 132
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTK 194
RD++ +NIL+ KIADFGL +L+E + A + APE + G T K
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR--EGAKFPIKWTAPEAINYGTFTIK 190
Query: 195 SDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLD 254
SDV++FG++L E++T + + + L
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTN----------------------PEVIQNLERGYR 228
Query: 255 PNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301
+ + Q+ L C E + RP L +++
Sbjct: 229 MVRPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 3e-52
Identities = 70/317 (22%), Positives = 123/317 (38%), Gaps = 60/317 (18%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTKS----KEFSSELKILCK 60
+N IG+G++G V+ + A+K +K S +F E ++ +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 61 V-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLH-------------------WPSVK 100
+ N+++L+G A G + L++EY G L++ L S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 101 GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160
G PL+ ++ IA A G+ Y+ + +VHRD+ T N L+ N KIADFGL +
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANP 220
+ +S + A ++ PE + TT+SDV+A+GVVL E+ +
Sbjct: 190 I-YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 221 GNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENW 280
+ D N+ ++ L++ L + C +
Sbjct: 249 -------------------------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 283
Query: 281 KRRPDMSNAAIRLSHIL 297
RP + L +
Sbjct: 284 ADRPSFCSIHRILQRMC 300
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 4e-52
Identities = 69/317 (21%), Positives = 126/317 (39%), Gaps = 53/317 (16%)
Query: 2 FSYNEVRDATSNFSTSL---------KIGQGSYGSVYLGKLRGKN-----AAIKQMKNTK 47
F++ + +A F+ + IG G +G V G L+ AIK +K+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 48 S----KEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGK 102
+ ++F SE I+ + H N+I L G + ++ E+ +NG+L L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN----D 122
Query: 103 KPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162
V + A G++Y+ YVHRD+ NIL++SN K++DFGL + LE
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 163 H--SPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANP 220
S +A + APE ++ T+ SDV+++G+V+ E+++ + D
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 221 GNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENW 280
+D + + + ++ Q+ L C ++
Sbjct: 240 ----------------------QDVINAIEQDYRLPPPMDCPSALHQLMLD---CWQKDR 274
Query: 281 KRRPDMSNAAIRLSHIL 297
RP L ++
Sbjct: 275 NHRPKFGQIVNTLDKMI 291
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-51
Identities = 64/291 (21%), Positives = 116/291 (39%), Gaps = 42/291 (14%)
Query: 18 LKIGQGSYGSVYLGKLRGKN----AAIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
+++G G++GSV G R + AIK +K +E E +I+ ++ + ++ L
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
IG ++L LV E A G L L ++ + + ++ + G++Y+ +
Sbjct: 75 IGVCQA-EALMLVMEMAGGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYLEE-- 127
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
+VHRD+ N+LL + AKI+DFGL K L A S + APE +
Sbjct: 128 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186
Query: 189 GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAK 248
+++SDV+++GV + E ++ Q + + MA
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----------------------PEVMAF 224
Query: 249 LTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299
+ + + + C W+ RPD R+ S
Sbjct: 225 IEQGKRMECPPECPPELYALMSD---CWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 3e-51
Identities = 61/290 (21%), Positives = 121/290 (41%), Gaps = 38/290 (13%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKS--KEFSSELKILCKV-HSNLIE 67
S + +IG G +G V+LG AIK ++ ++F E +++ K+ H L++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L G + LV+E+ ++G LSD+L + A T + + LD +G+ Y+ +
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR----TQRGLFAAETLLGMCLDVCEGMAYLEE- 119
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
+HRD+ N L+ N K++DFG+ + + +++ + +PE
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFS 175
Query: 188 DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247
++KSDV++FGV++ E+ + + + + + +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------------------SEVVE 213
Query: 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297
++ R + Q+ C E + RP S +L+ I
Sbjct: 214 DISTGFRLYKPRLASTHVYQIMNH---CWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 5e-51
Identities = 58/290 (20%), Positives = 111/290 (38%), Gaps = 41/290 (14%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTKS--KEFSSELKILCKV-HSNLIE 67
+ + ++G G +G V GK R + AIK +K EF E K++ + H L++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L G +F++ EY NG L ++L + +++ D + +EY+
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES- 118
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
++HRD+ N L++ K++DFGL + + ++ + PE +
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLM 174
Query: 188 DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247
++KSD++AFGV++ E+ + + +
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----------------------SETAE 212
Query: 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297
+ + L + + + C E RP LS+IL
Sbjct: 213 HIAQGLRLYRPHLASEKVYTIMYS---CWHEKADERPTFKIL---LSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 9e-51
Identities = 70/288 (24%), Positives = 119/288 (41%), Gaps = 38/288 (13%)
Query: 19 KIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAG 74
K+GQG +G V++G AIK +K + F E +++ K+ H L++L +
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 83
Query: 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVH 134
+ +++V EY G+L D L + K L V +A A G+ Y+ + YVH
Sbjct: 84 -EPIYIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 136
Query: 135 RDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTK 194
RD++ +NIL+ N K+ADFGL +L+E + A + APE G T K
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTAPEAALYGRFTIK 194
Query: 195 SDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLD 254
SDV++FG++L EL T + ++ + ++
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVN----------------------REVLDQVERGYR 232
Query: 255 PNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKE 302
+S+ + C + + RP L S++
Sbjct: 233 MPCPPECPESLHDLMCQ---CWRKEPEERPTFEYLQAFLEDYFTSTEP 277
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-50
Identities = 76/323 (23%), Positives = 130/323 (40%), Gaps = 53/323 (16%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLRGKN----AAIKQMKNTKS----KEFSSELKILCKV-- 61
++ IG+G++G V +++ AAIK+MK S ++F+ EL++LCK+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 62 HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLH-----------WPSVKGKKPLAWTTR 110
H N+I L+G L+L EYA +G L D L + L+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 111 VQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAA 170
+ A D A+G++Y+ Q ++HRD+ NIL+ N+ AKIADFGL + E
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY----VK 182
Query: 171 ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRS 230
+ ++A E + TT SDV+++GV+L E+++
Sbjct: 183 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------- 232
Query: 231 LVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAA 290
+ KL + D + + C E RP +
Sbjct: 233 ------------AELYEKLPQGYRLEKPLNCDDEVYDLMRQ---CWREKPYERPSFAQIL 277
Query: 291 IRLSHILISSKEWEKMECCHQMS 313
+ L+ +L K + + +
Sbjct: 278 VSLNRMLEERKTYVNTTLYEKFT 300
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-50
Identities = 63/288 (21%), Positives = 118/288 (40%), Gaps = 44/288 (15%)
Query: 19 KIGQGSYGSVYLGKLRGKNA----AIKQMKNTKS-----KEFSSELKILCKV-HSNLIEL 68
++G G++G+V G + K A+K +KN + E +E ++ ++ + ++ +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
IG +S LV E A+ G L+ +L + + +++ + G++Y+ +
Sbjct: 74 IGICEA-ESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
+VHRD+ N+LL + AKI+DFGL K L A + + APE +
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 189 GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAK 248
++KSDV++FGV++ E + Q R + A
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------------------SEVTAM 222
Query: 249 LTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296
L + M + L C + + RP + +RL +
Sbjct: 223 LEKGERMGCPAGCPREMYDLMNL---CWTYDVENRPGFAAVELRLRNY 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-49
Identities = 64/290 (22%), Positives = 113/290 (38%), Gaps = 52/290 (17%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS-----KEFSSELKILCKV-HSNLIELIG 70
+IG+GS+ +VY G A ++++ K + F E ++L + H N++
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 71 Y----AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
G + LV E +G L +L K + KGL+++H
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 127 YTKPYYVHRDVKTSNILLDS-NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
P +HRD+K NI + KI D GL L S A ++GT ++APE
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-----AKAVIGTPEFMAPEM 184
Query: 186 VRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245
+ DVYAFG+ ++E+ T + S N
Sbjct: 185 YEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNA----------------------AQI 221
Query: 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295
++T + P + K ++ ++ + + C+ +N R + + L+H
Sbjct: 222 YRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL---LNH 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-48
Identities = 53/248 (21%), Positives = 108/248 (43%), Gaps = 20/248 (8%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS----KEFSSELKILCKV-HSNLIELIGY 71
+G+G+YG V L R + A+K + ++ + E+ I + H N+++ G+
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPY 131
G+ +L EY G L D + + + G+ Y+H
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG---IG 123
Query: 132 YVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV 191
HRD+K N+LLD KI+DFGL + ++ +++ GT Y+APE ++
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREF 182
Query: 192 -TTKSDVYAFGVVLMELITGQQALSRDANPGN--NQYTEHRSLVDYMLAVFNDTKDFMAK 248
DV++ G+VL ++ G+ + ++ + + E ++ ++ + + + K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 249 LTECLDPN 256
+ +P+
Sbjct: 243 IL-VENPS 249
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-48
Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 43/297 (14%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLRGKNA------AIKQMKNTKS----KEFSSELKILCKV 61
S + IG G +G VY G L+ + AIK +K + +F E I+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 62 -HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
H N+I L G + + ++ EY +NGAL L + + V + A G
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR----EKDGEFSVLQLVGMLRGIAAG 122
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
++Y+ YVHRD+ NIL++SN K++DFGL ++LE PE S +
Sbjct: 123 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240
APE + T+ SDV++FG+V+ E++T + + +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------------------- 219
Query: 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297
+ M + + ++ Q+ + C + RRP ++ L ++
Sbjct: 220 --HEVMKAINDGFRLPTPMDCPSAIYQLMMQ---CWQQERARRPKFADIVSILDKLI 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (409), Expect = 2e-48
Identities = 64/302 (21%), Positives = 124/302 (41%), Gaps = 40/302 (13%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS--KEFSSELKILCKV-HSNLI 66
++ + K+G G YG VY G + A+K +K +EF E ++ ++ H NL+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
+L+G +++ E+ G L D+L ++ ++ + +A + +EY+ +
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
++HRD+ N L+ N K+ADFGL +L+ A + + APE +
Sbjct: 134 ---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESL 188
Query: 187 RDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246
+ KSDV+AFGV+L E+ T + +
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------------------------- 222
Query: 247 AKLTECLDPNLT-RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEWEK 305
+++ E L+ + + ++ L + C N RP + + S ++
Sbjct: 223 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282
Query: 306 ME 307
+E
Sbjct: 283 VE 284
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 2e-48
Identities = 54/250 (21%), Positives = 101/250 (40%), Gaps = 19/250 (7%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-----FSSELKILCKV-HSNLIELIG 70
IG GSYG + + GK K++ E SE+ +L ++ H N++
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 71 Y--AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
+L++V EY + G L+ + + K ++ L +++ L+ H+ +
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 129 KPY--YVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
+HRD+K +N+ LD K+ DFGL ++L H A VGT Y++PE +
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKAFVGTPYYMSPEQM 186
Query: 187 RDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246
KSD+++ G +L EL + + ++ + +
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 246
Query: 247 AKLTECLDPN 256
+ L+
Sbjct: 247 TR---MLNLK 253
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-48
Identities = 58/269 (21%), Positives = 114/269 (42%), Gaps = 25/269 (9%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE---FSSELKILCKV-HSNLIELIGYA 72
++G G++G VY + + AA K + +E + E+ IL H N+++L+
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
++L+++ E+ GA+ + + ++PL + + L Y+H
Sbjct: 79 YYENNLWILIEFCAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 133 VHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV-----R 187
+HRD+K NIL + K+ADFG+ + + +GT ++APE V +
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ---RRDSFIGTPYWMAPEVVMCETSK 188
Query: 188 DGCVTTKSDVYAFGVVLMELITGQQALSRDANPG--NNQYTEHRSLVDYMLAVFNDTKDF 245
D K+DV++ G+ L+E+ + + ++ KDF
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 246 MAKLTECLDPNLTRYHKDSMLQMALLSKD 274
+ K E + + R+ +LQ ++ D
Sbjct: 249 LKKCLE-KNVDA-RWTTSQLLQHPFVTVD 275
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 2e-48
Identities = 72/299 (24%), Positives = 114/299 (38%), Gaps = 55/299 (18%)
Query: 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMK------NTKSKEFSSELKILCK 60
D FS +IG GS+G+VY + + AIK+M N K ++ E++ L K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 61 V-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAK 119
+ H N I+ G + +LV EY A KKPL + A +
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQ 126
Query: 120 GLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFG 179
GL Y+H + +HRDVK NILL K+ DFG ++ + + VGT
Sbjct: 127 GLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPY 176
Query: 180 YLAPEYVR---DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236
++APE + +G K DV++ G+ +EL + L
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------------------- 217
Query: 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295
+ + + + P L H + + C+ + + RP L H
Sbjct: 218 ----NAMSALYHIAQNESPALQSGHWSEYFR-NFVDS-CLQKIPQDRPTSEVL---LKH 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-48
Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS------KEFSSELKILCKV-H 62
+F +G+G +G+VYL + + A+K + + + E++I + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLE 122
N++ L GY ++L+ EYA G + L + A L
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALS 120
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
Y H +HRD+K N+LL S KIADFG S + + GT YL
Sbjct: 121 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RTTLCGTLDYLP 172
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSL-VDYMLAVFND 241
PE + K D+++ GV+ E + G+ +AN Y + + V
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYKRISRVEFTFPDFVTEG 230
Query: 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKD 274
+D +++L +P+ R +L+ ++ +
Sbjct: 231 ARDLISRLL-KHNPSQ-RPMLREVLEHPWITAN 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 8e-48
Identities = 69/291 (23%), Positives = 113/291 (38%), Gaps = 44/291 (15%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
IG+G +G VY G L + A+K + +F +E I+ H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 69 IGYAAGGD-SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
+G + S +V Y ++G L + + + L AKG++++
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLAS- 148
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAA-AASRIVGTFGYLAPEYV 186
+VHRD+ N +LD F K+ADFGL + + + + ++A E +
Sbjct: 149 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 187 RDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246
+ TTKSDV++FGV+L EL+T D N D
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----------------------FDIT 244
Query: 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297
L + Y D + ++ L C + RP S R+S I
Sbjct: 245 VYLLQGRRLLQPEYCPDPLYEVMLK---CWHPKAEMRPSFSELVSRISAIF 292
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 7e-46
Identities = 58/308 (18%), Positives = 103/308 (33%), Gaps = 54/308 (17%)
Query: 19 KIGQGSYGSVYLGKLR-------GKNAAIKQMKNTKS----KEFSSELKILCKV--HSNL 65
+G G++G V A+K +K + + SELK+L + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLH-------------WPSVKGKKPLAWTTRVQ 112
+ L+G G ++ EY G L + L + L +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
+ AKG+ ++ +HRD+ NILL KI DFGL + +++
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-YVVKG 205
Query: 173 RIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLV 232
++APE + + T +SDV+++G+ L EL + +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--------------- 250
Query: 233 DYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292
F + E + M + C D + +RP
Sbjct: 251 ------MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT---CWDADPLKRPTFKQIVQL 301
Query: 293 LSHILISS 300
+ + S
Sbjct: 302 IEKQISES 309
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-45
Identities = 58/300 (19%), Positives = 109/300 (36%), Gaps = 59/300 (19%)
Query: 19 KIGQGSYGSVYLGKLRGKN-------AAIKQMKNTKS----KEFSSELKILCKV--HSNL 65
+G G++G V G + A+K +K + SELK++ ++ H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 66 IELIGYAAGGDSLFLVYEYAQNGALSDHLH------------------WPSVKGKKPLAW 107
+ L+G ++L++EY G L ++L + L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 108 TTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167
+ A AKG+E++ VHRD+ N+L+ KI DFGL + + S
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI-MSDSN 219
Query: 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE 227
++APE + +G T KSDV+++G++L E+ +
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV------- 272
Query: 228 HRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS 287
+F + + Y + + + C + ++RP
Sbjct: 273 --------------DANFYKLIQNGFKMDQPFYATEEIYIIMQS---CWAFDSRKRPSFP 315
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 2e-45
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 3 SYNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMK---NTKSKEFSSELKI 57
S V D ++ KIGQG+ G+VY G+ AI+QM K + +E+ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 58 LCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALD 116
+ + + N++ + GD L++V EY G+L+D + + + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRE 124
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
+ LE++H +HRD+K+ NILL + K+ DFG + S +VG
Sbjct: 125 CLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVG 178
Query: 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ 211
T ++APE V K D+++ G++ +E+I G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-43
Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 20/247 (8%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS------KEFSSELKILCKV-HSNLIELI 69
+G+GS+ +V L + + AIK ++ + E ++ ++ H ++L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
+ L+ YA+NG L ++ T + LEY+H
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---G 126
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
+HRD+K NILL+ + +I DFG K+L + A A+ VGT Y++PE + +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANSFVGTAQYVSPELLTEK 185
Query: 190 CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKL 249
SD++A G ++ +L+ G R N + D+ F +D + KL
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 244
Query: 250 TECLDPN 256
LD
Sbjct: 245 LV-LDAT 250
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 5e-43
Identities = 60/307 (19%), Positives = 113/307 (36%), Gaps = 45/307 (14%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLRGKNA------AIKQMKNTKS----KEFSSELKILCKV 61
+ F +G G++G+VY G + AIK+++ S KE E ++ V
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 62 -HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
+ ++ L+G + L+ + G L D++ + K + + + AKG
Sbjct: 69 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVR----EHKDNIGSQYLLNWCVQIAKG 123
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
+ Y+ VHRD+ N+L+ + KI DFGL KLL + E A +
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-GAEEKEYHAEGGKVPIKW 179
Query: 181 LAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240
+A E + T +SDV+++GV + EL+T
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------------------- 219
Query: 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300
+ + L + + + ++ C + RP I S +
Sbjct: 220 --SEISSILEKGERLP---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
Query: 301 KEWEKME 307
+ + ++
Sbjct: 275 QRYLVIQ 281
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 7e-43
Identities = 63/303 (20%), Positives = 123/303 (40%), Gaps = 46/303 (15%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTKS----KEFSSELKILCK 60
+ S ++GQGS+G VY G + AIK + S EF +E ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 61 V-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWP-----SVKGKKPLAWTTRVQIA 114
+++ L+G + G ++ E G L +L + P + + +Q+A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI 174
+ A G+ Y++ +VHRD+ N ++ +F KI DFG+ + + + + +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKG 195
Query: 175 VGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234
+ +++PE ++DG TT SDV++FGVVL E+ T + + +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------------- 241
Query: 235 MLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294
+ + + E + D + ++ + C N K RP +
Sbjct: 242 --------EQVLRFVMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 290
Query: 295 HIL 297
+
Sbjct: 291 EEM 293
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-42
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 20/214 (9%)
Query: 19 KIGQGSYGSVYLGKLRGKNA-----AIKQMKNTKS------KEFSSELKILCKV-HSNLI 66
K+G GS+G V G+ + A+K +K +F E+ + + H NLI
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
L G + +V E A G+L D L K + T + A+ A+G+ Y+
Sbjct: 75 RLYGVVLTPP-MKMVTELAPLGSLLDRLR----KHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 127 YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYV 186
++HRD+ N+LL + KI DFGL++ L + + F + APE +
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 187 RDGCVTTKSDVYAFGVVLMELITGQQALSRDANP 220
+ + SD + FGV L E+ T Q N
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-42
Identities = 68/305 (22%), Positives = 122/305 (40%), Gaps = 55/305 (18%)
Query: 19 KIGQGSYGSVYLGKLRGKNA---------AIKQMKNTKS----KEFSSELKILCKV--HS 63
+G+G++G V L + G + A+K +K+ + + SE++++ + H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 64 NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHW-----------PSVKGKKPLAWTTRVQ 112
N+I L+G L+++ EYA G L ++L PS ++ L+ V
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAAS 172
A A+G+EY+ +HRD+ N+L+ + KIADFGL + + H +
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 173 RIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLV 232
++APE + D T +SDV++FGV+L E+ T +
Sbjct: 197 GR-LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------------ 243
Query: 233 DYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292
++ L E + + + M +DC +RP
Sbjct: 244 ----------EELFKLLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVED 290
Query: 293 LSHIL 297
L I+
Sbjct: 291 LDRIV 295
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-42
Identities = 71/307 (23%), Positives = 119/307 (38%), Gaps = 53/307 (17%)
Query: 19 KIGQGSYGSVYLGKLR-------GKNAAIKQMK----NTKSKEFSSELKILCKV--HSNL 65
+G+G++G V + A+K +K +++ + SELKIL + H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 66 IELIGYAA-GGDSLFLVYEYAQNGALSDHLH-----------WPSVKGKKPLAWTTRVQI 113
+ L+G G L ++ E+ + G LS +L P K L +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 114 ALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASR 173
+ AKG+E++ +HRD+ NILL KI DFGL + + P+
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK-GD 195
Query: 174 IVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233
++APE + D T +SDV++FGV+L E+ + +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---------------- 239
Query: 234 YMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293
++F +L E Y M Q L C +RP S L
Sbjct: 240 -----VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL 291
Query: 294 SHILISS 300
++L ++
Sbjct: 292 GNLLQAN 298
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 146 bits (369), Expect = 5e-42
Identities = 63/277 (22%), Positives = 109/277 (39%), Gaps = 28/277 (10%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS---KEFSSELKILCKV-HSNLIELIGYA 72
++G G++G V+ R G N A K + + E++ + + H L+ L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
+ + ++YE+ G L + + ++ V+ KGL ++H+ Y
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVA----DEHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 145
Query: 133 VHRDVKTSNILLDS--NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
VH D+K NI+ + + K+ DFGL L+ GT + APE
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEFAAPEVAEGKP 201
Query: 191 VTTKSDVYAFGVVLMELITGQ---QALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247
V +D+++ GV+ L++G + D N + + + D KDF+
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261
Query: 248 KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP 284
KL DPN TR L+ L+ N R
Sbjct: 262 KLLL-ADPN-TRMTIHQALEHPWLTPG----NAPGRD 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-41
Identities = 64/289 (22%), Positives = 110/289 (38%), Gaps = 45/289 (15%)
Query: 19 KIGQGSYGSVYLGKLRGKN-----AAIKQMKNTKS----KEFSSELKILCKV-HSNLIEL 68
IG+G +G V+ G AIK KN S ++F E + + H ++++L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
IG ++++ E G L L K L + + A + L Y+
Sbjct: 74 IGVITENP-VWIIMELCTLGELRSFLQ----VRKYSLDLASLILYAYQLSTALAYLE--- 125
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
+VHRD+ N+L+ SN K+ DFGL + +E S A S+ ++APE +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLPIKWMAPESINF 183
Query: 189 GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAK 248
T+ SDV+ FGV + E++ + D + +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----------------------NDVIGR 221
Query: 249 LTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHIL 297
+ + ++ + C + RRP + +LS IL
Sbjct: 222 IENGERLPMPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 141 bits (357), Expect = 7e-41
Identities = 59/269 (21%), Positives = 111/269 (41%), Gaps = 26/269 (9%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS------KEFSSELKILCKV-HSNLIELI 69
+G G V+L + ++ A+K ++ + F E + + H ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 70 GY----AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIH 125
G ++V EY L D +H P+ +++ DA + L + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH 128
Query: 126 QYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEY 185
Q +HRDVK +NI++ + K+ DFG+ + + S + ++GT YL+PE
Sbjct: 129 Q---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 186 VRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPG---NNQYTEHRSLVDYMLAVFNDT 242
R V +SDVY+ G VL E++TG+ + D+ + + + D
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 243 KDFMAKLTECLDPNLTRYHKDSMLQMALL 271
+ K +P RY + ++ L+
Sbjct: 246 DAVVLKALA-KNPE-NRYQTAAEMRADLV 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 142 bits (359), Expect = 2e-40
Identities = 53/249 (21%), Positives = 94/249 (37%), Gaps = 25/249 (10%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS---KEFSSELKILCKV-HSNLIELIGYA 72
++G G++G V+ + G+ K + +E+ I+ ++ H LI L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
+ L+ E+ G L D + ++ + A +GL+++H+
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMHE---HSI 148
Query: 133 VHRDVKTSNILLDSNF--RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
VH D+K NI+ ++ KI DFGL L T + APE V
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI----VKVTTATAEFAAPEIVDREP 204
Query: 191 VTTKSDVYAFGVVLMELITGQ---QALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMA 247
V +D++A GV+ L++G N + + D +V + KDF+
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264
Query: 248 KLTECLDPN 256
L
Sbjct: 265 N---LLQKE 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 137 bits (346), Expect = 2e-39
Identities = 66/299 (22%), Positives = 111/299 (37%), Gaps = 60/299 (20%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSS------------ELKILCKV--H 62
+G+G V + K A+K + T FS+ E+ IL KV H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLE 122
N+I+L FLV++ + G L D+L K L+ +I + +
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVIC 124
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
+H K VHRD+K NILLD + K+ DFG L+ + + GT YLA
Sbjct: 125 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LREVCGTPSYLA 177
Query: 183 PEYVRDGCV------TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236
PE + + D+++ GV++ L+ G HR + +
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF------------WHRKQMLMLR 225
Query: 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295
+ + F + + + L+S+ + ++R A L+H
Sbjct: 226 MIMSGNYQFGSPEWDDYSDTV----------KDLVSR-FLVVQPQKRYTAEEA---LAH 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-39
Identities = 50/283 (17%), Positives = 104/283 (36%), Gaps = 29/283 (10%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE--FSSELKILCKV-HSNLIELIGYAA 73
+G+G +G V+ K K +K + + E+ IL H N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
+ L +++E+ + + ++ L V + L+++H
Sbjct: 72 SMEELVMIFEFISGLDIFERIN----TSAFELNEREIVSYVHQVCEALQFLHS---HNIG 124
Query: 134 HRDVKTSNILLDS--NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV 191
H D++ NI+ + + KI +FG + L+ + Y APE + V
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEYYAPEVHQHDVV 180
Query: 192 TTKSDVYAFGVVLMELITGQQALSRDANP------GNNQYTEHRSLVDYMLAVFNDTKDF 245
+T +D+++ G ++ L++G + N N +YT + + DF
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE---ISIEAMDF 237
Query: 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSN 288
+ +L + +R LQ L + + K + +
Sbjct: 238 VDRLLV-KERK-SRMTASEALQHPWLKQKIERVSTKVIRTLKH 278
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (344), Expect = 1e-38
Identities = 59/281 (20%), Positives = 106/281 (37%), Gaps = 21/281 (7%)
Query: 4 YNEVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMK----NTKSKEFSSELKI 57
+ + D + +G G++ V L + + K AIK + K +E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 58 LCKV-HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALD 116
L K+ H N++ L G L+L+ + G L D + K ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-----VEKGFYTERDASRLIFQ 115
Query: 117 AAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVG 176
++Y+H + + LD + + I+DFGL K+ + S G
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS----VLSTACG 171
Query: 177 TFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ---QALSRDANPGNNQYTEHRSLVD 233
T GY+APE + + D ++ GV+ L+ G + E+
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231
Query: 234 YMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKD 274
Y + + KDF+ L E DP R+ + LQ ++ D
Sbjct: 232 YWDDISDSAKDFIRHLME-KDPE-KRFTCEQALQHPWIAGD 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-38
Identities = 62/248 (25%), Positives = 101/248 (40%), Gaps = 23/248 (9%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS------KEFSSELKILCKV--HSNLIEL 68
+G+GS+G V+L + + + AIK +K + E ++L H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 69 IGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT 128
++LF V EY G L H+ + A + GL+++H
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLH--- 120
Query: 129 KPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
V+RD+K NILLD + KIADFG+ K + GT Y+APE +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNTFCGTPDYIAPEILLG 177
Query: 189 GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAK 248
D ++FGV+L E++ GQ + ++ Y + + KD + K
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 236
Query: 249 LTECLDPN 256
L +P
Sbjct: 237 LFVR-EPE 243
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-38
Identities = 68/297 (22%), Positives = 118/297 (39%), Gaps = 29/297 (9%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS--------KEFSSELKILCKV-HSNLIE 67
+G+G + +VY + + + AIK++K + E+K+L ++ H N+I
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 68 LIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQY 127
L+ ++ LV+++ + L + L +GLEY+H
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYLH-- 117
Query: 128 TKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVR 187
+ + +HRD+K +N+LLD N K+ADFGL K A + V T Y APE +
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR---AYTHQVVTRWYRAPELLF 173
Query: 188 DGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246
+ D++A G +L EL+ L D + + +L + D
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGD-SDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 247 AKLTECLDPNLTRYHKDSMLQMALLS--KDCVDENWKRRPDMSNAAIRLSHILISSK 301
+T P + +H S LL + N R + A L S++
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA---LKMKYFSNR 286
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 135 bits (341), Expect = 8e-38
Identities = 64/311 (20%), Positives = 110/311 (35%), Gaps = 52/311 (16%)
Query: 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK------EFSSELKILCKV--- 61
+FS IG+G +G VY + GK A+K + + K +E +L V
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 62 -HSNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKG 120
++ + D L + + G L HL + A + G
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILG 119
Query: 121 LEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGY 180
LE++H + V+RD+K +NILLD + +I+D GL VGT GY
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHASVGTHGY 171
Query: 181 LAPEYVRDGC-VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239
+APE ++ G + +D ++ G +L +L+ G + +
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEID 218
Query: 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR--LSHIL 297
T +L + P L +LL + + RR +
Sbjct: 219 RMTLTMAVELPDSFSPEL----------RSLLEG-LLQRDVNRRLGCLGRGAQEVKESPF 267
Query: 298 ISSKEWEKMEC 308
S +W+ +
Sbjct: 268 FRSLDWQMVFL 278
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (335), Expect = 2e-37
Identities = 63/308 (20%), Positives = 95/308 (30%), Gaps = 46/308 (14%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMK-NTKSKEFSSELKILCKV-HSNLIELIGYA-A 73
KIG GS+G +YLG G+ AIK TK + E KI + I I + A
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
GD +V E L + + T + +A +EYIH ++
Sbjct: 74 EGDYNVMVMELLGPS-----LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFI 125
Query: 134 HRDVKTSNIL---LDSNFRAKIADFGLVKLLE----HSPEIAAAASRIVGTFGYLAPEYV 186
HRDVK N L I DFGL K H + GT Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 187 RDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246
+ + D+ + G VLM G + ++ M
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGS------------LPWQGLKAATKRQKYERISEKKM 233
Query: 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK----- 301
+ E L + C + +PD S ++
Sbjct: 234 STPIEVLCKGYPSEFATYLNF-------CRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286
Query: 302 --EWEKME 307
+W ++
Sbjct: 287 VFDWNMLK 294
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 6e-37
Identities = 62/304 (20%), Positives = 114/304 (37%), Gaps = 54/304 (17%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS---------KEFSSELKILCKV-HSNLI 66
++G G + V + + G A K +K ++ ++ E+ IL ++ H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 67 ELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ 126
L + L+ E G L D L K+ L + G+ Y+H
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLH- 130
Query: 127 YTKPYYVHRDVKTSNILLDSN----FRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
H D+K NI+L R KI DFGL ++ E I GT ++A
Sbjct: 131 --SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGTPEFVA 184
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242
PE V + ++D+++ GV+ L++G D + + + V
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------------TKQETLANVSAVN 232
Query: 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKE 302
+F + KD + + + ++ K+R + ++ L H I K+
Sbjct: 233 YEFEDEYFSNTSALA----KD------FIRR-LLVKDPKKRMTIQDS---LQHPWIKPKD 278
Query: 303 WEKM 306
++
Sbjct: 279 TQQA 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-36
Identities = 42/203 (20%), Positives = 79/203 (38%), Gaps = 23/203 (11%)
Query: 20 IGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGY---- 71
+G G G V + + A+K ++ + E+++ + +++ ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYENL 77
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPY 131
AG L +V E G L + +G + +I + ++Y+H
Sbjct: 78 YAGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLH---SIN 131
Query: 132 YVHRDVKTSNILLDS---NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD 188
HRDVK N+L S N K+ DFG K + + T Y+APE +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL----TTPCYTPYYVAPEVLGP 187
Query: 189 GCVTTKSDVYAFGVVLMELITGQ 211
D+++ GV++ L+ G
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-36
Identities = 60/304 (19%), Positives = 114/304 (37%), Gaps = 31/304 (10%)
Query: 19 KIGQGSYGSVYLGKLR---GKNAAIKQMKNTKSKE-----FSSELKILCKV----HSNLI 66
+IG+G+YG V+ + G+ A+K+++ +E E+ +L + H N++
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 67 ELIGYAAGGDS-----LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGL 121
L + L LV+E+ + + + T + +GL
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGL 129
Query: 122 EYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYL 181
+++H + VHRD+K NIL+ S+ + K+ADFGL ++ + + +V T Y
Sbjct: 130 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL----TSVVVTLWYR 182
Query: 182 APEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241
APE + T D+++ G + E+ + ++ + D
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301
+ ++ D L C+ N +R +A LSH
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA---LSHPYFQDL 299
Query: 302 EWEK 305
E K
Sbjct: 300 ERCK 303
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (328), Expect = 3e-36
Identities = 68/307 (22%), Positives = 112/307 (36%), Gaps = 52/307 (16%)
Query: 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS------KEFSSELKILCKV-H 62
+F +G GS+G V+L + R G+ A+K +K + + E +L V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLE 122
+I + G +F++ +Y + G L L + A + LE
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALE 118
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
Y+H ++RD+K NILLD N KI DFG K + + GT Y+A
Sbjct: 119 YLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------YTLCGTPDYIA 169
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242
PE V D ++FG+++ E++ G + + + N
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF------------YDSNTMKTYEKILNAE 217
Query: 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR--LSHILISS 300
F E + KD LLS+ + + +R +H
Sbjct: 218 LRFPPFFNEDV--------KD------LLSR-LITRDLSQRLGNLQNGTEDVKNHPWFKE 262
Query: 301 KEWEKME 307
WEK+
Sbjct: 263 VVWEKLL 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 8e-36
Identities = 53/254 (20%), Positives = 92/254 (36%), Gaps = 38/254 (14%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---------SKEFSSELKILCKV---HSN 64
+G G +GSVY G AIK ++ + E+ +L KV S
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYI 124
+I L+ + DS L+ E + + + L + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDF----ITERGALQEELARSFFWQVLEAVRHC 126
Query: 125 HQYTKPYYVHRDVKTSNILLDSN-FRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAP 183
H +HRD+K NIL+D N K+ DFG LL+ + + GT Y P
Sbjct: 127 HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-----YTDFDGTRVYSPP 178
Query: 184 EYVRDGCVTTKS-DVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242
E++R +S V++ G++L +++ G D Q + + +
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS-------EC 231
Query: 243 KDFMAKLTECLDPN 256
+ + CL
Sbjct: 232 QHLIRW---CLALR 242
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-35
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 32/304 (10%)
Query: 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSN 64
R +++ + IG GS+G VY KL G+ AIK++ K + + EL+I+ K+ H N
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCN 74
Query: 65 LIELIGYAAGGDS------LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAA 118
++ L + L LV +Y H+ + K+ L
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLF 132
Query: 119 KGLEYIHQYTKPYYVHRDVKTSNILLDSN-FRAKIADFGLVKLLEHSPEIAAAASRIVGT 177
+ L YIH + HRD+K N+LLD + K+ DFG K L + +
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN----VSYICS 185
Query: 178 FGYLAPEYVRDGC-VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLV---- 232
Y APE + T+ DV++ G VL EL+ GQ D+ +Q E ++
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPT 243
Query: 233 -DYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291
+ + + + +F + + +AL S+ ++ R A
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR-LLEYTPTARLTPLEA-- 300
Query: 292 RLSH 295
+H
Sbjct: 301 -CAH 303
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 125 bits (314), Expect = 2e-34
Identities = 43/309 (13%), Positives = 87/309 (28%), Gaps = 48/309 (15%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQM-KNTKSKEFSSELKILCKV--HSNLIELIGYAA 73
+IG+GS+G ++ G + AIK + + + + E + + + + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 74 GGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133
G LV + + + T A ++ IH+ + V
Sbjct: 72 EGLHNVLVIDLLGPSLEDLLD-----LCGRKFSVKTVAMAAKQMLARVQSIHEKS---LV 123
Query: 134 HRDVKTSNILLDSNFR-----AKIADFGLVKLL----EHSPEIAAAASRIVGTFGYLAPE 184
+RD+K N L+ + DFG+VK + GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 185 YVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244
+ + D+ A G V M + G + +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGS------------LPWQGLKAATNKQKYERIGEK 231
Query: 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK--- 301
+ L + + + PD S +L
Sbjct: 232 KQSTPLRELCAGFPE-------EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
Query: 302 ----EWEKM 306
+W +
Sbjct: 285 DENFDWNLL 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 3e-34
Identities = 56/294 (19%), Positives = 112/294 (38%), Gaps = 24/294 (8%)
Query: 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-----FSSELKILCKV-HSN 64
NF KIG+G+YG VY + + G+ A+K+++ E E+ +L ++ H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYI 124
+++L+ + L+LV+E+ + +GL +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDA----SALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
H +HRD+K N+L+++ K+ADFGL + + V T Y APE
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPE 172
Query: 185 -YVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPG--NNQYTEHRSLVDYMLAVFND 241
+ +T D+++ G + E++T + D+ + + + +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295
D+ + + ++ L + + +R A L+H
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA---LAH 283
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-34
Identities = 66/308 (21%), Positives = 119/308 (38%), Gaps = 32/308 (10%)
Query: 6 EVRDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS----KEFSSELKILC 59
+V D ++ IG+G+YG V AIK++ + + E+KIL
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 60 KV-HSNLIELIGYAAGGD----SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIA 114
+ H N+I + + + L L + L+
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK------TQHLSNDHICYFL 115
Query: 115 LDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRI 174
+GL+YIH +HRD+K SN+LL++ KI DFGL ++ + + +
Sbjct: 116 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172
Query: 175 VGTFGYLAPEYVRDGCVTTKS-DVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233
V T Y APE + + TKS D+++ G +L E+++ + + + + L
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGS 231
Query: 234 YMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMA------LLSKDCVDENWKRRPDMS 287
N + A+ P+ + + + A LL K + N +R ++
Sbjct: 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK-MLTFNPHKRIEVE 290
Query: 288 NAAIRLSH 295
A L+H
Sbjct: 291 QA---LAH 295
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 121 bits (304), Expect = 3e-33
Identities = 58/286 (20%), Positives = 100/286 (34%), Gaps = 22/286 (7%)
Query: 19 KIGQGSYGSVYLGKLR-GKNAAIKQMKNTKSKE-----FSSELKILCKV-HSNLIELIGY 71
KIG+G+YG VY + G+ A+K+++ K E E+ IL ++ HSN+++L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 72 AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPY 131
L LV+E+ L + L T L G+ Y H
Sbjct: 69 IHTKKRLVLVFEHLDQ-----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 132 YVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV 191
+HRD+K N+L++ KIADFGL + IV + +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKY 178
Query: 192 TTKSDVYAFGVVLMELITGQQALSRDANPG--NNQYTEHRSLVDYMLAVFNDTKDFMAKL 249
+T D+++ G + E++ G + + + + +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 250 TECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295
T + K L + + +R A L H
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA---LEH 281
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-33
Identities = 64/311 (20%), Positives = 121/311 (38%), Gaps = 36/311 (11%)
Query: 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-----FSSELKILCKV 61
D S + KIGQG++G V+ + R G+ A+K++ KE E+KIL +
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 62 -HSNLIELIG--------YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQ 112
H N++ LI Y S++LV+++ ++ + V K L+ RV
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVM 123
Query: 113 IALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE-HSPEIAAAA 171
L L ++ + +HRD+K +N+L+ + K+ADFGL +
Sbjct: 124 QML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 172 SRIVGTFGYLAPEYVRDGC-VTTKSDVYAFGVVLMELITGQQALSRDANPG------NNQ 224
+ V T Y PE + D++ G ++ E+ T + +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 225 YTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP 284
+ + + K + K + + + + + L+ K + + +R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK-LLVLDPAQRI 297
Query: 285 DMSNAAIRLSH 295
D +A L+H
Sbjct: 298 DSDDA---LNH 305
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 6e-33
Identities = 55/202 (27%), Positives = 83/202 (41%), Gaps = 20/202 (9%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS------KEFSSELKILCKV-HSNLIELI 69
+G+G++G V L + + G+ A+K ++ +E ++L H L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
D L V EYA G L HL ++ + LEY+H
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS--- 123
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
V+RD+K N++LD + KI DFGL K GT YLAPE + D
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLEDN 180
Query: 190 CVTTKSDVYAFGVVLMELITGQ 211
D + GVV+ E++ G+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (293), Expect = 3e-31
Identities = 55/306 (17%), Positives = 105/306 (34%), Gaps = 39/306 (12%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKIL--CKVHSNLIELIGY--A 72
K+G+G Y V+ + +K +K K K+ E+KIL + N+I L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD 101
Query: 73 AGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYY 132
+ LV+E+ N + L + K L+Y H
Sbjct: 102 PVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH---SMGI 150
Query: 133 VHRDVKTSNILLDS-NFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GC 190
+HRDVK N+++D + + ++ D+GL + E + V + + PE + D
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY----NVRVASRYFKGPELLVDYQM 206
Query: 191 VTTKSDVYAFGVVLMELITGQQALSRDANP------------GNNQYTEHRSLVDYMLAV 238
D+++ G +L +I ++ + + Y +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298
FND ++ + H S + L K + + + R A + H
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK-LLRYDHQSRLTAREA---MEHPYF 322
Query: 299 SSKEWE 304
+ +
Sbjct: 323 YTVVKD 328
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-31
Identities = 62/293 (21%), Positives = 107/293 (36%), Gaps = 34/293 (11%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-----FSSELKILCKV-HSNLIELIG 70
KIG+G+YG+V+ K R + A+K+++ E E+ +L ++ H N++ L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
L LV+E+ L KGL + H
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSR--- 120
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE-YVRDG 189
+HRD+K N+L++ N K+A+FGL + S V T Y P+
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAK 177
Query: 190 CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKL 249
+T D+++ G + EL + L PGN+ + + + + + M KL
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLF----PGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 250 TECLDPNLTRYHKDSMLQMALLSKDCVD-------ENWKRRPDMSNAAIRLSH 295
+ + + + L+ D N +R A L H
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA---LQH 283
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (287), Expect = 4e-30
Identities = 58/298 (19%), Positives = 104/298 (34%), Gaps = 48/298 (16%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS------KEFSSELKILCKV-HSNLIELI 69
+G GS+G V L K + G + A+K + K + +E +IL V L++L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 70 GYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK 129
+L++V EY G + HL + A EY+H
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHSLD- 161
Query: 130 PYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG 189
++RD+K N+L+D ++ DFG K ++ + GT LAPE +
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT------WTLCGTPEALAPEIILSK 213
Query: 190 CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKL 249
D +A GV++ E+ G + + + F +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF------------FADQPIQIYEKIVSGKVRFPSHF 261
Query: 250 TECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEWEKME 307
+ L L LL D + +++ +H ++ +W +
Sbjct: 262 SSDLKDLLRN----------LLQVDLTKRFGNLKNGVNDI---KNHKWFATTDWIAIY 306
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 3e-28
Identities = 63/304 (20%), Positives = 114/304 (37%), Gaps = 30/304 (9%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKE-----FSSELKILCKV-HSNLIELIG 70
+G G+YG+V G AIK++ E EL++L + H N+I L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
++L ++ +K + L + KGL YIH
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIH---AA 140
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
+HRD+K N+ ++ + KI DFGL + + + V T Y APE + +
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWM 194
Query: 191 -VTTKSDVYAFGVVLMELITGQQALSRDANPG------NNQYTEHRSLVDYMLAVFNDTK 243
T D+++ G ++ E+ITG+ + T V + ++ K
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL--QSDEAK 252
Query: 244 DFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKEW 303
++M L E + ++ L + + + ++R A L+H S
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA---LAHPYFESLHD 309
Query: 304 EKME 307
+ E
Sbjct: 310 TEDE 313
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (263), Expect = 9e-27
Identities = 49/291 (16%), Positives = 108/291 (37%), Gaps = 19/291 (6%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV------------H 62
K+G G + +V+L K + A+K ++ K ++ E+K+L +V
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLE 122
+++++L+ + + + L + + QI+ GL+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 123 YIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLA 182
Y+H+ + +H D+K N+L++ + + L ++ + + T Y +
Sbjct: 140 YMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 183 PEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242
PE + +D+++ ++ ELITG D + +H + + +L
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257
Query: 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRL 293
K T + S L+ L +D + E +K D +
Sbjct: 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPL-EDVLTEKYKFSKDEAKEISDF 307
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 3e-26
Identities = 62/257 (24%), Positives = 99/257 (38%), Gaps = 32/257 (12%)
Query: 19 KIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK-------SKEFSSELKILCKV--HSN 64
+G G+YG V+L + GK A+K +K ++ +E ++L +
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 65 LIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYI 124
L+ L L L+ +Y G L HL ++ + LE++
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHL 145
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
H K ++RD+K NILLDSN + DFGL K A GT Y+AP+
Sbjct: 146 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPD 200
Query: 185 YVRDG--CVTTKSDVYAFGVVLMELITGQ---QALSRDANPGNNQYTEHRSLVDYMLAVF 239
VR G D ++ GV++ EL+TG + +S Y +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 240 NDTKDFMAKLTECLDPN 256
KD + + L +
Sbjct: 261 ALAKDLIQR---LLMKD 274
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 4e-25
Identities = 46/207 (22%), Positives = 77/207 (37%), Gaps = 29/207 (14%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS-----KEFSSELKILCKV-HSNLIELIG 70
IG G+ G V +N AIK++ K EL ++ V H N+I L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 71 Y------AAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYI 124
++LV E + G++++
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--------HERMSYLLYQMLCGIKHL 135
Query: 125 HQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPE 184
H +HRD+K SNI++ S+ KI DFGL + S + V T Y APE
Sbjct: 136 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTRYYRAPE 188
Query: 185 YVRDGCVTTKSDVYAFGVVLMELITGQ 211
+ D+++ G ++ E++ +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 5e-24
Identities = 59/295 (20%), Positives = 109/295 (36%), Gaps = 36/295 (12%)
Query: 19 KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKS-----KEFSSELKILCKV-HSNLIELIG 70
+G G+YGSV G A+K++ K EL++L + H N+I L+
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP 130
SL + L VK + L + +GL+YIH
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHS---A 140
Query: 131 YYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGC 190
+HRD+K SN+ ++ + KI DFGL + + + + +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNWMH 195
Query: 191 VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLV---------DYMLAVFND 241
D+++ G ++ EL+TG+ PG + + + ++
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLF-----PGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 242 TKDFMAKLTECLDPNLTRYHKD-SMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295
++++ LT+ N + L + LL K + + +R + A L+H
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK-MLVLDSDKRITAAQA---LAH 301
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 65.6 bits (159), Expect = 2e-13
Identities = 23/160 (14%), Positives = 47/160 (29%), Gaps = 27/160 (16%)
Query: 19 KIGQGSYGSVYLGKL-RGKNAAIKQMKNTKS-------------KEFSSELKILCKV-HS 63
+G+G +V+ + +K K + FS +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 64 NLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEY 123
L +L G ++ VY + N L + + K + ++ + +
Sbjct: 67 ALQKLQGL-----AVPKVYAWEGNAVLMELIDA---KELYRVRVENPDEVLDMILEEVAK 118
Query: 124 IHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163
+ VH D+ N+L+ I DF +
Sbjct: 119 FYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 313 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.02 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.67 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.06 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.7 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.37 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.18 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 84.78 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=373.86 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=203.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.++|++++.||+|+||.||+|+++ ++.||||++.... .+.+.+|+++++.+ ||||+++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999987 7899999986442 34588999999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+++|+|.+++. ....+++..++.++.|++.||+|||+++ |+|+||||+||++++++.+||+|||++.....
T Consensus 84 y~~gg~L~~~l~-----~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 84 YCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp CCTTEEGGGGSB-----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ccCCCcHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 999999999983 4567999999999999999999999999 99999999999999999999999999987654
Q ss_pred ChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......
T Consensus 156 ~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--------------------- 213 (271)
T d1nvra_ 156 NNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--------------------- 213 (271)
T ss_dssp TTE-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS---------------------
T ss_pred CCc-cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH---------------------
Confidence 322 122334579999999999988776 578999999999999999999997654321
Q ss_pred HHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
........ ...........+..+.+|+.+||+.||++|||++|+++
T Consensus 214 -~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 214 -QEYSDWKE--KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -HHHHHHHT--TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHHHHHhc--CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00011110 11111122344567889999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=371.49 Aligned_cols=241 Identities=24% Similarity=0.409 Sum_probs=204.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|++.+.||+|+||.||+|+++ ++.||+|++... ....+.+|+++++.+ ||||+++++++.+.+..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 368999999999999999999997 788999998643 245578999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++|+|.+++. ....+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||++...
T Consensus 85 mEy~~~g~L~~~l~-----~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 85 LEYAPLGTVYRELQ-----KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EeecCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeec
Confidence 99999999999984 4467999999999999999999999999 999999999999999999999999999765
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 157 ~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------------------- 210 (263)
T d2j4za1 157 PSS-----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------------------- 210 (263)
T ss_dssp CCC-----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---------------------
T ss_pred CCC-----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---------------------
Confidence 542 223457899999999999999999999999999999999999999654321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+....+. .... ......+..+.+|+.+||+.||.+|||++|+++
T Consensus 211 --~~~~~i~---~~~~-~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 211 --ETYKRIS---RVEF-TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --HHHHHHH---TTCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHH---cCCC-CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1111111 1111 122344567889999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=370.22 Aligned_cols=253 Identities=24% Similarity=0.416 Sum_probs=201.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.++|++.++||+|+||.||+|.+. ++.||||.++... .+++.+|+++++.+ ||||+++++++...+..++||||++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 468999999999999999999997 6779999997643 56688999999999 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+|+|.+++. .....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++........
T Consensus 84 ~g~L~~~l~----~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 84 HGCLSDYLR----TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TCBHHHHHH----TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCcHHHHhh----ccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999985 34466889999999999999999999999 99999999999999999999999999987654322
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCC-CCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ-QALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
.......+|+.|+|||++.+..++.++|||||||++|||+|+. +||...... +.
T Consensus 157 --~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----------------------~~ 211 (263)
T d1sm2a_ 157 --TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------------EV 211 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----------------------HH
T ss_pred --eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-----------------------HH
Confidence 1222346889999999999999999999999999999999954 444322210 22
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
...+........ ....+..+.+|+.+||+.||++|||++||+++|+++..
T Consensus 212 ~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 212 VEDISTGFRLYK---PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCC---ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 222332222221 23345678999999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-55 Score=375.45 Aligned_cols=265 Identities=27% Similarity=0.467 Sum_probs=205.4
Q ss_pred cChHHHHHHh---------cCccccceeccCCeEEEEEeEEC--Cc---ceEEEeccccc----cHHHHHHHHHHHhc-C
Q 041031 2 FSYNEVRDAT---------SNFSTSLKIGQGSYGSVYLGKLR--GK---NAAIKQMKNTK----SKEFSSELKILCKV-H 62 (313)
Q Consensus 2 ~~~~~~~~~~---------~~y~~~~~lg~g~~g~v~~~~~~--~~---~~aiK~~~~~~----~~~~~~e~~~l~~l-h 62 (313)
|||+++..++ ++|++.++||+|+||.||+|+++ ++ .||||.+.... .+.+.+|+++|+++ |
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 6777766654 45667899999999999999986 22 48899886543 34578999999999 9
Q ss_pred CCceeeeeEEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCe
Q 041031 63 SNLIELIGYAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNI 142 (313)
Q Consensus 63 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~ni 142 (313)
|||+++++++.+.+.+++||||+++|+|.+++. .....+++..+..++.|++.||+|||+++ ++||||||+||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~----~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NI 159 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR----QNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNI 159 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHH----TTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeec----cccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceE
Confidence 999999999999999999999999999999885 34457999999999999999999999999 99999999999
Q ss_pred eeCCCCcEEEeeccccccccCChhhhhh--cccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCC
Q 041031 143 LLDSNFRAKIADFGLVKLLEHSPEIAAA--ASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDAN 219 (313)
Q Consensus 143 l~~~~~~~~l~dfg~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~ 219 (313)
|++.++.+||+|||++............ .....+|+.|+|||++.+..++.++|||||||++|||+| |..||.+...
T Consensus 160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp EECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999876543322211 112357899999999999999999999999999999998 8999975432
Q ss_pred CCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 220 PGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
. +....+...... ....+.+..+.+|+.+||+.||.+|||+.||++.|++++.+
T Consensus 240 ~-----------------------~~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 240 Q-----------------------DVINAIEQDYRL---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp H-----------------------HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred H-----------------------HHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1 222222221111 13345667899999999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=372.10 Aligned_cols=244 Identities=24% Similarity=0.407 Sum_probs=205.1
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEecccc---ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT---KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~---~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
++|+++++||+|+||.||+|.++ |+.||||++... ..+.+.+|+.+++.+ ||||+++++++.+.+.+++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999987 889999998643 345688999999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++|+|.+++. ...+++..++.++.|++.||+|||+++ |+|+||||+||+++.+|.+||+|||++.......
T Consensus 100 ~gg~L~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp TTCBHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 9999999873 246899999999999999999999999 9999999999999999999999999998765432
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... +.
T Consensus 171 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----------------------~~ 224 (293)
T d1yhwa1 171 ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----------------------RA 224 (293)
T ss_dssp ---CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----------------------HH
T ss_pred ---ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-----------------------HH
Confidence 2333457999999999999999999999999999999999999999654321 11
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
...+...-.+... .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 225 LYLIATNGTPELQ-NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHHCSCCCS-SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHhCCCCCCC-CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111112111 23445678899999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-55 Score=370.03 Aligned_cols=258 Identities=29% Similarity=0.531 Sum_probs=206.3
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.++|++.+.||+|+||.||+|++++ .||||+++... .+.+.+|+.+++++ ||||+++++++.+ +.+++||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 5789999999999999999998765 59999986432 35678999999999 9999999998754 568999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++|+|.+++. .....+++..+..++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||++......
T Consensus 85 ~~~g~L~~~l~----~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 85 CEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCEEEHHHHHH----TSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred CCCCCHHHHHh----hccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999985 33456999999999999999999999999 999999999999999999999999999765532
Q ss_pred hhhhhhcccccccccccCCccccCC---CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDG---CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.. ........+|+.|+|||++.+. .++.++|||||||++|||+||+.||.+.... .
T Consensus 158 ~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--------~------------ 216 (276)
T d1uwha_ 158 SG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--------D------------ 216 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--------H------------
T ss_pred CC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--------H------------
Confidence 22 1233345789999999999643 4789999999999999999999999765431 0
Q ss_pred cHHHHHHhhh-hcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 242 TKDFMAKLTE-CLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 242 ~~~~~~~l~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
.....+.. ...+.+......++..+.+|+.+||+.||.+|||+.+|++.|+.+..+-
T Consensus 217 --~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 217 --QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp --HHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --HHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 11111211 2223333345566778999999999999999999999999999887653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-55 Score=375.33 Aligned_cols=260 Identities=24% Similarity=0.383 Sum_probs=214.8
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
..++|++.++||+|+||.||+|.++ ++.||||.++.+. .+.+.+|+++++.+ ||||+++++++.+.+..++||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 4578999999999999999999987 7789999997553 55688999999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++|+|.+++.. .....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++......
T Consensus 95 ~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 95 MTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp CTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999842 23467899999999999999999999999 999999999999999999999999999876543
Q ss_pred hhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
.. .......+++.|+|||++.+..++.++|||||||++|+|++|..||...... . +
T Consensus 169 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--------~--------------~ 224 (287)
T d1opja_ 169 TY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------S--------------Q 224 (287)
T ss_dssp SS--EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------H--------------H
T ss_pred Cc--eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--------H--------------H
Confidence 22 2222345788999999999999999999999999999999977766433321 0 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcccc
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSKE 302 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 302 (313)
....+.....+. .....+..+.+|+.+||+.||.+|||+.+|++.|+.+..++.-
T Consensus 225 ~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~~ 279 (287)
T d1opja_ 225 VYELLEKDYRME---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 279 (287)
T ss_dssp HHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSCH
T ss_pred HHHHHhcCCCCC---CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCCC
Confidence 122222222222 2334566789999999999999999999999999988766543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=368.12 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=204.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.+.|++++.||+|+||.||+|+++ +..||||++.... .+.+.+|+++++.+ ||||+++++++.+.+.+++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 357999999999999999999987 7789999986543 45688999999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+++|+|.+++. .....+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++......
T Consensus 91 ~~~g~L~~~~~----~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 91 CAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp CTTEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred CCCCcHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 99999999874 33467999999999999999999999999 999999999999999999999999998764432
Q ss_pred hhhhhhcccccccccccCCcccc-----CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVR-----DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
. .......||+.|+|||++. +..++.++|||||||++|+|+||+.||.+....
T Consensus 164 ~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~------------------- 221 (288)
T d2jfla1 164 I---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM------------------- 221 (288)
T ss_dssp H---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-------------------
T ss_pred c---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-------------------
Confidence 1 2333457899999999984 455789999999999999999999999765432
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+....+...-.+.+ ......+..+.+|+++||+.||.+|||+.|+++
T Consensus 222 ----~~~~~i~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 222 ----RVLLKIAKSEPPTL-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----GHHHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----HHHHHHHcCCCCCC-CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111211111111 123455678899999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-55 Score=370.15 Aligned_cols=251 Identities=23% Similarity=0.373 Sum_probs=193.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEe--CCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAG--GDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~--~~~~~l 80 (313)
.++|++++.||+|+||.||+|+++ |+.||||.+.... .+.+.+|+++++.+ ||||+++++++.+ .+.+++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 478999999999999999999987 7889999986543 23477899999999 9999999999865 456899
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCC--CceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTK--PYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~--~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
||||+++|+|.+++.... .....+++..++.++.|++.||.|||+++. .+|+|+||||+||+++.++.+||+|||++
T Consensus 83 vmEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999984221 134679999999999999999999998641 22999999999999999999999999999
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
........ ......+|+.|+|||++.+..++.++|||||||++|+|+||+.||.+....
T Consensus 162 ~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------------------ 220 (269)
T d2java1 162 RILNHDTS---FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------------------ 220 (269)
T ss_dssp HHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------------------
T ss_pred eecccCCC---ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------------------
Confidence 87654322 223457899999999999999999999999999999999999999654321
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+....+... .........+..+.+|+++||+.||.+|||+.|+++
T Consensus 221 -----~~~~~i~~~---~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 221 -----ELAGKIREG---KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----HHHHHHHHT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHHcC---CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112222221 122223345667899999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-54 Score=365.48 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=210.2
Q ss_pred hcCccccc-eeccCCeEEEEEeEEC----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSL-KIGQGSYGSVYLGKLR----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~-~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
.++|.+.. +||+|+||.||+|.++ +..||||.++... .+.+.+|+++++++ ||||+++++++.++ .+++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEE
Confidence 35677777 4999999999999875 3469999987543 34578999999999 99999999998754 5889
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+++|+|.+++. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 86 vmE~~~~g~L~~~l~----~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEECCTTEEHHHHHT----TCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHhh----ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhc
Confidence 999999999999874 34467999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~------------------- 219 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------------------- 219 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------------------
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------------------
Confidence 6654333333344568899999999999999999999999999999998 89999765432
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
+....+.....+ ......+..+.+|+.+||+.||++|||+.+|+++|+....+
T Consensus 220 ----~~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 220 ----EVMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----HHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 222233222222 23345667899999999999999999999999999887664
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-53 Score=373.95 Aligned_cols=249 Identities=20% Similarity=0.313 Sum_probs=207.0
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
+.++|++.+.||+|+||.||+|+++ |+.||||++.... .+.+.+|+.+++.+ ||||+++++++.+.+.+++|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4678999999999999999999987 8899999987654 34577899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC--CCCcEEEeeccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD--SNFRAKIADFGLVKLL 161 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~--~~~~~~l~dfg~~~~~ 161 (313)
|+++|+|.+++. .....+++..++.++.|++.||.|||+++ ++|+||||+||+++ .++.+||+|||++...
T Consensus 104 ~~~gg~L~~~l~----~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 104 FMSGGELFEKVA----DEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CCCSCBHHHHHT----CTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 999999999984 33457999999999999999999999999 99999999999996 4678999999999876
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 177 ~~~~----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------------------- 231 (350)
T d1koaa2 177 DPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------------------- 231 (350)
T ss_dssp CTTS----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------------
T ss_pred cccc----ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---------------------
Confidence 5432 233457899999999999999999999999999999999999999754321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+....-..........+..+.+||++||..||++|||++|+++.
T Consensus 232 --~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 232 --ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --HHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122222111111111223455678999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=365.25 Aligned_cols=257 Identities=25% Similarity=0.459 Sum_probs=209.1
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeec
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..++|++.+.||+|+||.||+|.++ ++.||||.++... .+.+.+|+.+++++ ||||+++++++.+ +..++||||+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3578999999999999999999998 5789999997543 55689999999999 9999999998755 5679999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||++.......
T Consensus 90 ~~g~L~~~~~~~---~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999987421 2235899999999999999999999999 9999999999999999999999999998765432
Q ss_pred hhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 166 EIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
. .......+++.|+|||++.+..++.++|||||||++|||+||..|+...... .+.
T Consensus 164 ~--~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----------------------~~~ 219 (272)
T d1qpca_ 164 Y--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----------------------PEV 219 (272)
T ss_dssp E--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------------HHH
T ss_pred c--ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH----------------------HHH
Confidence 2 2223346889999999999999999999999999999999976555332221 022
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
...+.....+. .....+..+.+|+.+||+.||++|||+.+|++.|+.+..++
T Consensus 220 ~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 220 IQNLERGYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp HHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHhcCCCC---CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 22222222222 23345567899999999999999999999999999887654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-54 Score=372.85 Aligned_cols=250 Identities=22% Similarity=0.354 Sum_probs=193.6
Q ss_pred HHHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 8 RDATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
+++.+.|++.+.||+|+||.||+|+++ ++.||||++.... ...+.+|+.+++.+ ||||+++++++.+.+.+++
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 345678999999999999999999987 7889999987543 33467899999999 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC---CCCcEEEeeccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD---SNFRAKIADFGL 157 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~---~~~~~~l~dfg~ 157 (313)
||||++||+|.+++. ....+++..+..++.|++.||+|||+++ ++|+||||+||++. +++.+||+|||+
T Consensus 85 vmE~~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 85 IMQLVSGGELFDRIV-----EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp EECCCCSCBHHHHHH-----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred EEeccCCCcHHHhhh-----cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccce
Confidence 999999999999994 4567999999999999999999999999 99999999999995 578999999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 157 a~~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----------------- 215 (307)
T d1a06a_ 157 SKMEDPGS----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA----------------- 215 (307)
T ss_dssp --------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------------
T ss_pred eEEccCCC----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-----------------
Confidence 98654332 222356899999999999999999999999999999999999999754321
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+...............+..+.+|+.+||+.||.+|||++|+++.
T Consensus 216 ------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 216 ------KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ------HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------HHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111121111111111233456678999999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=368.94 Aligned_cols=246 Identities=22% Similarity=0.368 Sum_probs=203.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|++.+.||+|+||.||+|+++ ++.||||++... ..+.+.+|+++++++ ||||+++++++.+.+.+++|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 478999999999999999999987 788999998632 345688999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++|+|.+++. ..+.+++..++.++.|++.||+|||+++ |+|+||||+||++++++.+||+|||++...
T Consensus 87 mEy~~gg~L~~~~~-----~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 87 LSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp ECCCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEccCCCCHHHhhh-----ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceec
Confidence 99999999999883 4567999999999999999999999999 999999999999999999999999999876
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 159 ~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------------------- 216 (288)
T d1uu3a_ 159 SPESKQ-ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--------------------- 216 (288)
T ss_dssp C-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------------
T ss_pred ccCCcc-cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---------------------
Confidence 543221 2233456999999999999999999999999999999999999999754321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+.. ... ......+..+.+||++||+.||++|||++|+++.
T Consensus 217 --~~~~~i~~---~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 217 --LIFQKIIK---LEY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --HHHHHHHT---TCC-CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --HHHHHHHc---CCC-CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11111111 111 1223445678899999999999999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=360.88 Aligned_cols=250 Identities=23% Similarity=0.400 Sum_probs=211.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC-CcceEEEecccc--ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNT--KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~--~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.++|++.++||+|+||.||+|+++ +..||||.++.. ..+++.+|+.+++++ ||||+++++++.+.+.+++||||+.
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 478999999999999999999998 568999998764 356789999999999 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+|+|.+++. .....+++..++.++.|+++||+|||+++ ++|+||||+||++++++.+||+|||++........
T Consensus 83 ~g~l~~~~~----~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 83 NGCLLNYLR----EMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TEEHHHHHH----SGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCcHHHhhh----ccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999974 44567889999999999999999999999 99999999999999999999999999976554322
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDF 245 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (313)
.......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... +.
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-----------------------~~ 210 (258)
T d1k2pa_ 156 --TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----------------------ET 210 (258)
T ss_dssp --CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----------------------HH
T ss_pred --eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-----------------------HH
Confidence 22233568899999999999999999999999999999998 89999755431 22
Q ss_pred HHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 041031 246 MAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSH 295 (313)
Q Consensus 246 ~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 295 (313)
...+....... .+...+..+.+|+++||+.||++|||+++|++.|.+
T Consensus 211 ~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 211 AEHIAQGLRLY---RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHhCCCCC---CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 33333322221 233445678999999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=364.21 Aligned_cols=258 Identities=28% Similarity=0.446 Sum_probs=204.0
Q ss_pred hcCccccceeccCCeEEEEEeEECC------cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRG------KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLF 79 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~------~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~ 79 (313)
.+.|+..++||+|+||.||+|.+++ ..||||.+.... ...+.+|+++++.+ ||||+++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 5689999999999999999998762 358999986543 23477899999999 999999999999999999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccc
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVK 159 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~ 159 (313)
+|||++.++++.+.+. .....+++..+..++.|++.|++|||+++ |+|+||||+|||++.++.+||+|||++.
T Consensus 86 ~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 86 IITEYMENGALDKFLR----EKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEECCTTEEHHHHHH----HTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEecccCcchhhhh----cccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999998874 34567999999999999999999999999 9999999999999999999999999998
Q ss_pred cccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 160 LLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
................+|+.|+|||++.+..++.++|||||||++|||++|..|+......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~------------------- 219 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------------------- 219 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------------------
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-------------------
Confidence 7655433333333456899999999999999999999999999999999976665433221
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
.+....+.....+ ....+.+..+.+|+.+||+.||++|||+.||++.|+++....
T Consensus 220 ---~~~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 220 ---HEVMKAINDGFRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp ---HHHHHHHHTTCCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ---HHHHHHHhccCCC---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 0222222222222 233455678999999999999999999999999999988654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-53 Score=372.46 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=207.6
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
..++|++++.||+|+||.||+|.+. ++.||||+++... ...+.+|+.+++++ ||||+++++++.+.+.+++|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3567999999999999999999987 8899999987554 34577899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC--CCCcEEEeeccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD--SNFRAKIADFGLVKLL 161 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~--~~~~~~l~dfg~~~~~ 161 (313)
|++||+|.+.+. .....+++..++.++.|++.||+|||+++ |+|+||||+|||++ .++.+||+|||++...
T Consensus 107 ~~~gg~L~~~~~----~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 107 FLSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp CCCCCBHHHHTT----CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred cCCCChHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceec
Confidence 999999998874 34557999999999999999999999999 99999999999997 6789999999999876
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
... .......+|+.|+|||++.+..++.++|||||||++|+|+||+.||.+....
T Consensus 180 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------------------- 234 (352)
T d1koba_ 180 NPD----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------------------- 234 (352)
T ss_dssp CTT----SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---------------------
T ss_pred CCC----CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---------------------
Confidence 643 2233457899999999999999999999999999999999999999754431
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+....-..........+..+.+||.+||+.||.+|||+.|+++.
T Consensus 235 --~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 235 --ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp --HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122222211111111234456778999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=375.59 Aligned_cols=275 Identities=20% Similarity=0.297 Sum_probs=207.2
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
..++|+++++||+|+||+||+|++. ++.||+|.++... ...+.+|+.+|+.+ ||||+++++++.+.+.+++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999987 7889999986432 34578999999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
||+++|+|.+++. +.+.+++..++.++.|++.||.|||+ ++ |+||||||+|||++++|.+||+|||+|...
T Consensus 84 Ey~~gg~L~~~l~-----~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 84 EHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp ECCTTEEHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EcCCCCcHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 9999999999984 34579999999999999999999997 58 999999999999999999999999998865
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHH---------
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLV--------- 232 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~--------- 232 (313)
.. .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..............
T Consensus 156 ~~-----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 156 ID-----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp HH-----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred CC-----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 32 2233457999999999999999999999999999999999999999765432100000000000
Q ss_pred --------HHHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHHHh
Q 041031 233 --------DYMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR--LSHILI 298 (313)
Q Consensus 233 --------~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~--l~~~~~ 298 (313)
.......+.. .....+.......... .....+..+.+|+.+||..||.+|||++|+++. +++..+
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp ---------------CCC-CHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccccccccccccccch-hHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 0000000000 0011111111111111 122345678899999999999999999999974 444433
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=363.93 Aligned_cols=246 Identities=23% Similarity=0.367 Sum_probs=203.5
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---------SKEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
+.+.|++.+.||+|+||.||+|+++ |+.||||++.... .+.+.+|+.+++.+ ||||+++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3567999999999999999999987 8899999985322 35688999999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC----cEEEe
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF----RAKIA 153 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----~~~l~ 153 (313)
+++||||+++|+|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++ .+|++
T Consensus 88 ~~iv~E~~~gg~L~~~i~-----~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 88 VILILELVAGGELFDFLA-----EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCccccchhc-----cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEec
Confidence 999999999999999984 3457999999999999999999999999 99999999999998766 59999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
|||++....... ......+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+....
T Consensus 160 DfG~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------------- 222 (293)
T d1jksa_ 160 DFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------------- 222 (293)
T ss_dssp CCTTCEECTTSC----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------
T ss_pred chhhhhhcCCCc----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------------
Confidence 999998765432 223346899999999999999999999999999999999999999754321
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+....+.... ..... .....+..+.+||++||+.||.+|||++|+++
T Consensus 223 ----------~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 223 ----------ETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----------HHHHHHHTTC-CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----------HHHHHHHhcC-CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111110 11100 11234467889999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=362.09 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=200.4
Q ss_pred ceeccCCeEEEEEeEEC----CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecCC
Q 041031 18 LKIGQGSYGSVYLGKLR----GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQN 87 (313)
Q Consensus 18 ~~lg~g~~g~v~~~~~~----~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (313)
++||+|+||.||+|.+. ++.||||+++... .+.+.+|+++++++ ||||+++++++.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 47999999999999865 3569999986432 34588999999999 99999999998654 57899999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
|+|.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+|++|||++.........
T Consensus 92 g~L~~~l~-----~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHH-----HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHh-----hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999984 4567999999999999999999999999 999999999999999999999999999876544333
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
........+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... +..
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-----------------------~~~ 220 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----------------------EVT 220 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------------HHH
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-----------------------HHH
Confidence 333334568999999999999999999999999999999998 89999754321 222
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
..+.....+ ......+..+.+|+.+||+.||.+|||+.+|+++|+....+
T Consensus 221 ~~i~~~~~~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 221 AMLEKGERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCC---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 222221111 22345567899999999999999999999999999876543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=355.61 Aligned_cols=241 Identities=25% Similarity=0.417 Sum_probs=194.0
Q ss_pred cccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEe----CCeEEEEE
Q 041031 15 STSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAG----GDSLFLVY 82 (313)
Q Consensus 15 ~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~----~~~~~lv~ 82 (313)
+..++||+|+||+||+|.++ +..||+|.+.... .+.+.+|+++++++ ||||+++++++.+ ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56778999999999999987 6789999886432 34578999999999 9999999999865 45689999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeC-CCCcEEEeeccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLD-SNFRAKIADFGLVKLL 161 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~~l~dfg~~~~~ 161 (313)
||+++|+|.+++. ....+++..++.++.|++.||+|||+++. +|+|+||||+|||++ +++.+||+|||++...
T Consensus 92 E~~~~g~L~~~l~-----~~~~~~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHh-----ccccccHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 9999999999984 44679999999999999999999999862 289999999999996 5789999999999764
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......
T Consensus 166 ~~~-----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--------------------- 218 (270)
T d1t4ha_ 166 RAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--------------------- 218 (270)
T ss_dssp CTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---------------------
T ss_pred cCC-----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH---------------------
Confidence 432 2234579999999999875 5999999999999999999999999654331
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+....+.....+ .......+..+.+|+.+||+.||++|||++|+++
T Consensus 219 -~~~~~~i~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 219 -AQIYRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -HHHHHHHTTTCCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHcCCCC--cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0111222211111 1122334456889999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-53 Score=365.27 Aligned_cols=239 Identities=28% Similarity=0.389 Sum_probs=199.0
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
.|+.+++||+|+||.||+|++. ++.||||++.... .+.+.+|+++++.+ ||||+++++++.+.+.+++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4999999999999999999987 7789999986543 23477899999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
|+.+|+|..++ .....+++..++.++.|++.||.|||+++ |+|+||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~-----~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 96 YCLGSASDLLE-----VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CCSEEHHHHHH-----HHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCCCchHHHH-----HhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999998766 34467999999999999999999999999 99999999999999999999999999986543
Q ss_pred ChhhhhhcccccccccccCCccccC---CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRD---GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
. ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....
T Consensus 168 ~-------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-------------------- 220 (309)
T d1u5ra_ 168 A-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------------------- 220 (309)
T ss_dssp B-------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------------------
T ss_pred C-------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--------------------
Confidence 2 23469999999999964 45889999999999999999999999654321
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+....+.....+.. .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 221 ---~~~~~i~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 221 ---SALYHIAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---HHHHHHHHSCCCCC--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---HHHHHHHhCCCCCC--CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111111111211 22344567899999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-52 Score=358.32 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=200.6
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCC----e
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGD----S 77 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~----~ 77 (313)
.++|++.+.||+|+||.||+|++. ++.||||+++... ...+.+|+++++.+ ||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999987 8899999986542 23478899999999 999999999987654 3
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccc
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGL 157 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~ 157 (313)
+++||||++|++|.+++. ..+.+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++++|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~-----~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhc-----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhh
Confidence 899999999999999883 4467999999999999999999999999 99999999999999999999999998
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+.................||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.... +..
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------------~~~-- 223 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------------SVA-- 223 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------------HHH--
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------------HHH--
Confidence 876654443334444567899999999999999999999999999999999999999754321 000
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-DMSNAAIRLSHIL 297 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~ll~~l~~~~ 297 (313)
...+.....+ ........+..+.+++++||+.||.+|| |++++++.|.++.
T Consensus 224 --------~~~~~~~~~~-~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 224 --------YQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --------HHHHHCCCCC-GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------HHHHhcCCCC-CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111110000 0112334556789999999999999999 8999999998875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=363.79 Aligned_cols=255 Identities=24% Similarity=0.420 Sum_probs=205.8
Q ss_pred hcCccccceeccCCeEEEEEeEECC-------cceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGDS 77 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~ 77 (313)
.++|++.++||+|+||.||+|++.+ ..||+|.+.... ...+.+|+.++.++ ||||+++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4789999999999999999998862 258999886432 44578899999988 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCCC------------------CCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCC
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVK------------------GKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKT 139 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p 139 (313)
+++||||+++|+|.+++...+.. ....+++..++.++.|++.||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 99999999999999999644311 1245889999999999999999999999 99999999
Q ss_pred CCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCC
Q 041031 140 SNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDA 218 (313)
Q Consensus 140 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~ 218 (313)
+||+++.++.+||+|||++......... .......+|+.|+|||++.+..++.++|||||||++|||+| |..||.+..
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999865543221 12223467999999999999999999999999999999998 899997654
Q ss_pred CCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 041031 219 NPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLS 294 (313)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 294 (313)
.. . .+...+....... .....+..+.+|+.+||+.||++|||++||++.|.
T Consensus 272 ~~--------~--------------~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VD--------A--------------NFYKLIQNGFKMD---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CS--------H--------------HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--------H--------------HHHHHHhcCCCCC---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 42 0 1122222222221 23345568999999999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-52 Score=361.63 Aligned_cols=243 Identities=25% Similarity=0.343 Sum_probs=205.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|++++.||+|+||.||+|+++ ++.||||++... ..+.+.+|+.+|+.+ ||||+++++++.+.+.+++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 578999999999999999999987 889999998643 345678999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+++|+|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+||+++++|.+||+|||++...
T Consensus 84 ~ey~~gg~L~~~~~-----~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 84 MEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred eeccCCCchhhhhh-----cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccc
Confidence 99999999999983 4567899999999999999999999999 999999999999999999999999999865
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 156 ~~~~---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--------------------- 211 (337)
T d1o6la_ 156 ISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------------------- 211 (337)
T ss_dssp CCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---------------------
T ss_pred ccCC---cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---------------------
Confidence 4322 2333467999999999999999999999999999999999999999765431
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-----MSNAAI 291 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~ll~ 291 (313)
+....+... ... .....+..+.+||++||+.||.+||+ ++|+++
T Consensus 212 --~~~~~i~~~-~~~---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 212 --RLFELILME-EIR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --HHHHHHHHC-CCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --HHHHHHhcC-CCC---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111111111 111 22344567889999999999999995 788876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=356.48 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=199.1
Q ss_pred hcCccccceeccCCeEEEEEeEEC-----CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
.++|++.+.||+|+||.||+|.+. +..||||.++... .+.+.+|+.+++++ ||||+++++++. ++.+++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 478999999999999999999886 2358888886443 34478899999999 999999999996 467899
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+++|+|.+++. .....+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+|++|||++..
T Consensus 85 v~E~~~~g~l~~~~~----~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQ----VRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEECCTTEEHHHHHH----HTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEeccCCcHHhhhh----ccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999874 34567899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
...... .......+|+.|+|||++.+..++.++|||||||++|||+| |.+||......
T Consensus 158 ~~~~~~--~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~------------------- 216 (273)
T d1mp8a_ 158 MEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------------------- 216 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------------------
T ss_pred ccCCcc--eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-------------------
Confidence 554322 22233467899999999999999999999999999999998 88998765432
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
+....+...... ......+..+.+|+.+||+.||.+|||+.||++.|+.++.+.
T Consensus 217 ----~~~~~i~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 217 ----DVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp ----GHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 222222222111 233455678999999999999999999999999999987653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-53 Score=354.75 Aligned_cols=251 Identities=28% Similarity=0.480 Sum_probs=202.9
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEeccccc-cHHHHHHHHHHHhc-CCCceeeeeEEEe-CCeEEEEEeecCC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK-SKEFSSELKILCKV-HSNLIELIGYAAG-GDSLFLVYEYAQN 87 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~-~~~~~~e~~~l~~l-h~~i~~~~~~~~~-~~~~~lv~e~~~~ 87 (313)
.++|++.+.||+|+||.||+|.++++.||||.++.+. .+.+.+|+.+++++ ||||+++++++.+ .+.+++||||+++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 4679999999999999999999999999999997654 56689999999999 9999999999865 4568999999999
Q ss_pred CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChhh
Q 041031 88 GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEI 167 (313)
Q Consensus 88 ~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 167 (313)
|+|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 86 g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 86 GSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp EEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCHHHHHHhc---CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 9999998421 2235899999999999999999999999 9999999999999999999999999988654322
Q ss_pred hhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 168 AAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 168 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
....+++.|+|||++.+..++.++|||||||++|||+| |++||...... +..
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-----------------------~~~ 210 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------------DVV 210 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----------------------GHH
T ss_pred ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-----------------------HHH
Confidence 22356889999999999999999999999999999998 67777654332 223
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
..+.....+. .....+..+.+|+.+||+.||.+|||+.+|+++|++++..
T Consensus 211 ~~i~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 211 PRVEKGYKMD---APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHTTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCC---CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 3333222222 3334557889999999999999999999999999998653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=361.78 Aligned_cols=249 Identities=18% Similarity=0.281 Sum_probs=205.5
Q ss_pred HHhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccH--HHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 9 DATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSK--EFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 9 ~~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~--~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
++.++|++.+.||+|+||.||+|.++ ++.||||+++....+ .+.+|+.+|+.+ ||||+++++++.+.+.+++|||
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 35689999999999999999999987 788999999876533 477999999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC--CcEEEeeccccccc
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN--FRAKIADFGLVKLL 161 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~--~~~~l~dfg~~~~~ 161 (313)
|++||+|.+++. .....+++..++.++.|++.||.|||+++ |+|+||||+||+++.+ +.++++|||++...
T Consensus 82 ~~~gg~L~~~i~----~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 82 FISGLDIFERIN----TSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCBHHHHHT----SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcc
Confidence 999999999994 33457999999999999999999999999 9999999999999854 57999999998876
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
... .......+++.|+|||.+.+..++.++|||||||++|+|++|..||......
T Consensus 155 ~~~----~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------------------- 209 (321)
T d1tkia_ 155 KPG----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------------------- 209 (321)
T ss_dssp CTT----CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---------------------
T ss_pred ccC----CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---------------------
Confidence 543 2233456899999999999999999999999999999999999999764431
Q ss_pred cHHHHHHhhhhcCCCCCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
+....+.... ..... .....+..+.+|+++||..||.+|||+.|+++.
T Consensus 210 --~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 210 --QIIENIMNAE-YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --HHHHHHHHTC-CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --HHHHHHHhCC-CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112221111 00000 111234568899999999999999999999873
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-51 Score=351.01 Aligned_cols=246 Identities=24% Similarity=0.289 Sum_probs=203.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------------cHHHHHHHHHHHhc--CCCceeeeeEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------------SKEFSSELKILCKV--HSNLIELIGYAAG 74 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------------~~~~~~e~~~l~~l--h~~i~~~~~~~~~ 74 (313)
.++|++.+.||+|+||+||+|++. ++.||||++.... .+.+.+|+.+++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 378999999999999999999986 7899999986532 12467899999999 9999999999999
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
.+.+++||||+++|+|.+++. ..+.+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~-----~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLT-----EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred CcceEEEEEcCCCchHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEcc
Confidence 999999999999999999994 4567999999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccC------CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccc
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD------GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEH 228 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~ 228 (313)
||++....... ......+|+.|.|||++.+ ..++.++||||+||++|+|++|+.||.+....
T Consensus 154 FG~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~-------- 221 (277)
T d1phka_ 154 FGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------- 221 (277)
T ss_dssp CTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------
T ss_pred chheeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--------
Confidence 99998765432 2234578999999999863 45788999999999999999999999754321
Q ss_pred hhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
+....+...-...........+.++.+|+.+||+.||.+|||+.||++
T Consensus 222 ---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 222 ---------------LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ---------------HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---------------HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111112111111111123456678999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=354.15 Aligned_cols=257 Identities=27% Similarity=0.452 Sum_probs=204.8
Q ss_pred hcCccccceeccCCeEEEEEeEEC-CcceEEEeccccc--cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEeecC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK--SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEYAQ 86 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~--~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (313)
.++|++.+.||+|+||.||+|.++ ++.||||.++... .+.+.+|+.+++++ ||||+++++++.+ +..++||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 578999999999999999999998 5679999997654 45689999999999 9999999999865 56789999999
Q ss_pred CCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCChh
Q 041031 87 NGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSPE 166 (313)
Q Consensus 87 ~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (313)
+|+|..++.. .....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 95 ~g~l~~~~~~---~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 95 KGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TCBHHHHHSH---HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCchhhhhhh---cccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999988742 12346899999999999999999999999 99999999999999999999999999986543322
Q ss_pred hhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHHHH
Q 041031 167 IAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFM 246 (313)
Q Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (313)
.......+|+.|+|||++.+..++.++|||||||++|+|++|..||...... .+..
T Consensus 169 --~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----------------------~~~~ 224 (285)
T d1fmka3 169 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------------------REVL 224 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------------HHHH
T ss_pred --eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----------------------HHHH
Confidence 2223346899999999999999999999999999999999976666443321 0222
Q ss_pred HHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 247 AKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 247 ~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
..+...... ......+..+.+|+.+||+.||++|||+++|++.|+....+..
T Consensus 225 ~~i~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 225 DQVERGYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHhcCCC---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 222222222 2334556689999999999999999999999999998776543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-51 Score=355.88 Aligned_cols=241 Identities=24% Similarity=0.385 Sum_probs=203.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|++++.||+|+||.||+|+++ |+.||||+++.. ..+.+.+|+.+++.+ ||||+++++++.+.+.+++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 367999999999999999999987 889999998643 345688999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
|||+.||+|.+++ .....+++..++.++.|++.||+|||+++ |+|+||||+||+++.+|.+||+|||++...
T Consensus 83 mE~~~gg~l~~~~-----~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 83 MDYIEGGELFSLL-----RKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp ECCCCSCBHHHHH-----HHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eeecCCccccccc-----cccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999998 45567888999999999999999999999 999999999999999999999999999876
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 155 ~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------------------- 207 (316)
T d1fota_ 155 PDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------------------- 207 (316)
T ss_dssp SSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---------------------
T ss_pred ccc------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---------------------
Confidence 543 22357999999999999999999999999999999999999999754321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~~ 292 (313)
+....+... ... .....+..+.+++.+||..||.+|+ |++++++.
T Consensus 208 --~~~~~i~~~-~~~---~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 208 --KTYEKILNA-ELR---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --HHHHHHHHC-CCC---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --HHHHHHHcC-CCC---CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 112222111 111 1223456788999999999999996 89999853
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-52 Score=358.51 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=211.9
Q ss_pred HHHHHHhcCccccceeccCCeEEEEEeEECC-------cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEE
Q 041031 5 NEVRDATSNFSTSLKIGQGSYGSVYLGKLRG-------KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYA 72 (313)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~ 72 (313)
++++...++|++.+.||+|+||.||+|++++ +.||||.++... .+.+.+|+.+++.+ ||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3455556899999999999999999999763 579999997653 34588999999999 99999999999
Q ss_pred EeCCeEEEEEeecCCCChhhhhcCCC-------------------CCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceE
Q 041031 73 AGGDSLFLVYEYAQNGALSDHLHWPS-------------------VKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYV 133 (313)
Q Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~ 133 (313)
...+..+++||++.+|+|.+++.... ......+++..++.++.|++.||+|||+++ ++
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999984321 112335889999999999999999999999 99
Q ss_pred EeccCCCCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCC-C
Q 041031 134 HRDVKTSNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ-Q 212 (313)
Q Consensus 134 h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~-~ 212 (313)
|+||||+||+++.++.+||+|||++....+... ........+++.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999876543322 12233456789999999999999999999999999999999986 5
Q ss_pred CccCCCCCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 213 ALSRDANPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 213 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
||...... +....+. +..........+..+.+|+.+||+.||.+|||+.||+++
T Consensus 242 p~~~~~~~-----------------------e~~~~v~---~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~ 295 (301)
T d1lufa_ 242 PYYGMAHE-----------------------EVIYYVR---DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295 (301)
T ss_dssp TTTTSCHH-----------------------HHHHHHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHH-----------------------HHHHHHH---cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 67544321 2222222 222222344556688999999999999999999999999
Q ss_pred HHHHH
Q 041031 293 LSHIL 297 (313)
Q Consensus 293 l~~~~ 297 (313)
|+++.
T Consensus 296 L~~i~ 300 (301)
T d1lufa_ 296 LQRMC 300 (301)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.2e-51 Score=360.09 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=198.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc------cHHHHHH---HHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK------SKEFSSE---LKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~------~~~~~~e---~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
.++|++.++||+|+||.||+|++. |+.||||++.... ...+.+| +.+++.+ ||||+++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 478999999999999999999987 8899999986432 2223444 5556666 99999999999999999
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++||||+++|+|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+|||++.+|.+||+|||++
T Consensus 83 ~ivmE~~~gg~L~~~l~-----~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp EEEECCCCSCBHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHHH-----hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeecee
Confidence 99999999999999984 4467889999999999999999999999 999999999999999999999999999
Q ss_pred ccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||.......
T Consensus 155 ~~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---------------- 213 (364)
T d1omwa3 155 CDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---------------- 213 (364)
T ss_dssp EECSSS-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----------------
T ss_pred eecCCC-----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH----------------
Confidence 876543 2234579999999999974 568999999999999999999999997655431
Q ss_pred HhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-----MSNAAI 291 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~ll~ 291 (313)
........... ........+..+.+||.+||+.||.+||| ++|+++
T Consensus 214 -------~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 214 -------KHEIDRMTLTM-AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -------HHHHHHHSSSC-CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -------HHHHHHhcccC-CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01111111111 11122345567899999999999999999 688875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=354.53 Aligned_cols=248 Identities=17% Similarity=0.274 Sum_probs=200.1
Q ss_pred HhcCccccc-eeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEe----CCeEEE
Q 041031 10 ATSNFSTSL-KIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAG----GDSLFL 80 (313)
Q Consensus 10 ~~~~y~~~~-~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~----~~~~~l 80 (313)
+.++|.++. .||+|+||.||+|++. ++.||||+++. ...+.+|+.++.++ ||||+++++++.+ ++.+++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 467999875 5999999999999987 78999999864 45678899987655 9999999999875 467899
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcEEEeeccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGL 157 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~ 157 (313)
||||++||+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+||++++ ++.+||+|||+
T Consensus 87 vmEy~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 99999999999999522 2357999999999999999999999999 999999999999985 56799999999
Q ss_pred cccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 158 VKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
+....... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.....
T Consensus 161 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~---------------- 220 (335)
T d2ozaa1 161 AKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---------------- 220 (335)
T ss_dssp CEECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred eeeccCCC----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH----------------
Confidence 98765432 2234578999999999999999999999999999999999999998765431
Q ss_pred HhcCcHHHHHHhhhh-cCCC--CCC-CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 238 VFNDTKDFMAKLTEC-LDPN--LTR-YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~-~~~~--~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
....+... .... ... .....+..+.+|+++||+.||++|||+.|+++.
T Consensus 221 -------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 221 -------ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------HHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01111111 1111 111 123445678999999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=351.87 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=197.1
Q ss_pred hcCccccceeccCCeEEEEEeEECC-----cceEEEeccccc------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRG-----KNAAIKQMKNTK------SKEFSSELKILCKV-HSNLIELIGYAAGGDSL 78 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~aiK~~~~~~------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~ 78 (313)
.++|++.+.||+|+||.||+|++.+ ..||||+++... .+.+.+|+.+++++ ||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3679999999999999999998752 258999986432 34578999999999 9999999999976 467
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
++||||+++|++.+.+. .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++
T Consensus 86 ~lv~e~~~~~~l~~~~~----~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLR----KHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp EEEEECCTTCBHHHHHH----HHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred heeeeeecCcchhhhhh----cccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhh
Confidence 89999999999998874 34467999999999999999999999999 999999999999999999999999999
Q ss_pred ccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
.................++..|+|||++.+..++.++||||||+++|||+| |..||.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----------------- 221 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----------------- 221 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-----------------
Confidence 987654433333344567889999999999999999999999999999998 89999754331
Q ss_pred HhcCcHHHHHHhhhhcCCCCC-CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 041031 238 VFNDTKDFMAKLTECLDPNLT-RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHI 296 (313)
Q Consensus 238 ~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 296 (313)
+....+. ..... ......+..+.+|+.+||+.||.+|||+.+|.+.|.+.
T Consensus 222 ------~~~~~i~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 222 ------QILHKID---KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------HHHHHHH---TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHHHH---hCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111111 11111 12344556799999999999999999999999999865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-51 Score=359.57 Aligned_cols=240 Identities=23% Similarity=0.347 Sum_probs=203.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv 81 (313)
.++|++++.||+|+||.||+|+++ |+.||||++... ..+.+.+|+++|+.+ ||||+++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 478999999999999999999987 889999998643 244578999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
||++.+|+|.+.+. ..+.+++..++.++.|++.||.|||+++ |+|+||||+|||++.+|.+||+|||++...
T Consensus 120 ~e~~~~g~l~~~l~-----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EECCTTCBHHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cccccccchhhhHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 99999999999983 4457999999999999999999999999 999999999999999999999999999876
Q ss_pred cCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
... .....||+.|+|||++.+..++.++|||||||++|+|+||..||.+....
T Consensus 192 ~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------------------- 244 (350)
T d1rdqe_ 192 KGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------------------- 244 (350)
T ss_dssp SSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------------
T ss_pred ccc------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---------------------
Confidence 532 22357899999999999999999999999999999999999999754321
Q ss_pred cHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 041031 242 TKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRP-----DMSNAAI 291 (313)
Q Consensus 242 ~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~ 291 (313)
+....+... .. ......+..+.+|+++||..||.+|+ |++++++
T Consensus 245 --~~~~~i~~~---~~-~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 245 --QIYEKIVSG---KV-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --HHHHHHHHC---CC-CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --HHHHHHhcC---CC-CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111111111 11 11234556788999999999999994 8999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-51 Score=353.55 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=203.5
Q ss_pred cCccccceeccCCeEEEEEeEEC--Cc----ceEEEecccc----ccHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GK----NAAIKQMKNT----KSKEFSSELKILCKV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~----~~aiK~~~~~----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~l 80 (313)
++|+++++||+|+||.||+|.+. |+ +||+|.++.. ..+.+.+|+.+++++ ||||+++++++.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 57999999999999999999986 33 5888887643 245688999999999 99999999999875 4677
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
+++++.+++|.+.+. .....+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||++..
T Consensus 88 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVR----EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHH----HTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEeccCCccccccc----ccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccccee
Confidence 889999999998874 44567999999999999999999999999 99999999999999999999999999987
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCCccccchhHHHHHHHHh
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNNQYTEHRSLVDYMLAVF 239 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (313)
....... .......+|+.|+|||++.+..++.++|||||||++|||+| |..||.+....
T Consensus 161 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~------------------- 220 (317)
T d1xkka_ 161 LGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------------------- 220 (317)
T ss_dssp TTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-------------------
T ss_pred ccccccc-ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-------------------
Confidence 6543221 22223457999999999999999999999999999999998 78888654432
Q ss_pred cCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 240 NDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 240 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
+....+....... ....++..+.+|+.+||+.||.+|||+.||++.|.++..+
T Consensus 221 ----~~~~~i~~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 221 ----EISSILEKGERLP---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ----GHHHHHHHTCCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----HHHHHHHcCCCCC---CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 2222332222221 2334556789999999999999999999999999988654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=352.03 Aligned_cols=266 Identities=25% Similarity=0.377 Sum_probs=201.2
Q ss_pred HHHHHHhcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeE
Q 041031 5 NEVRDATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGY 71 (313)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~ 71 (313)
+.-+...++|++.++||+|+||.||+|.+. ++.||||.++... ...+.+|..++.++ |+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 333344588999999999999999999875 2569999987543 33466777777777 8899999998
Q ss_pred EEeC-CeEEEEEeecCCCChhhhhcCCCC-----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCC
Q 041031 72 AAGG-DSLFLVYEYAQNGALSDHLHWPSV-----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKT 139 (313)
Q Consensus 72 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p 139 (313)
+... ..+++||||+++|+|.+++..... .....+++..++.++.|++.||.|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 7654 568999999999999999853321 12345889999999999999999999999 99999999
Q ss_pred CCeeeCCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCC-CCccCCC
Q 041031 140 SNILLDSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ-QALSRDA 218 (313)
Q Consensus 140 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~-~p~~~~~ 218 (313)
+||++++++.+||+|||++......... .......||+.|+|||++.+..++.++||||+||++|+|+||. .||.+..
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceeECCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999865543321 2233457899999999999999999999999999999999975 5776544
Q ss_pred CCCCCccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 219 NPGNNQYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
.. ..+...+.....+.. ....+..+.+|+.+||+.||.+|||+.||+++|+.++.
T Consensus 242 ~~----------------------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 242 ID----------------------EEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CS----------------------HHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----------------------HHHHHHHhcCCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 32 022233333332322 23445678899999999999999999999999999875
Q ss_pred c
Q 041031 299 S 299 (313)
Q Consensus 299 ~ 299 (313)
+
T Consensus 297 ~ 297 (299)
T d1ywna1 297 A 297 (299)
T ss_dssp H
T ss_pred C
Confidence 4
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=354.17 Aligned_cols=243 Identities=26% Similarity=0.373 Sum_probs=201.0
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc------ccHHHHHHHHHHH-hc-CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT------KSKEFSSELKILC-KV-HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~------~~~~~~~e~~~l~-~l-h~~i~~~~~~~~~~~~~~l 80 (313)
.++|.+.+.||+|+||+||+|+++ ++.||||+++.. ..+.+..|..++. .+ ||||+++++++.+++.+++
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 378999999999999999999997 889999998643 2344566776665 56 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 81 VYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
||||+++|+|.+++. ....+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+|++|||++..
T Consensus 81 vmEy~~~g~L~~~i~-----~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEECCTTCBHHHHHH-----HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeecCCCcHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhh
Confidence 999999999999994 4567899999999999999999999999 99999999999999999999999999986
Q ss_pred ccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 161 LEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 153 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-------------------- 209 (320)
T d1xjda_ 153 NMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------------------- 209 (320)
T ss_dssp CCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------------------
T ss_pred ccccc---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--------------------
Confidence 54332 2333457899999999999999999999999999999999999999764431
Q ss_pred CcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHH-HHHH
Q 041031 241 DTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMS-NAAI 291 (313)
Q Consensus 241 ~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~ll~ 291 (313)
+....+.. -.+. .....+..+.+|+.+||..||.+|||+. ++++
T Consensus 210 ---~~~~~i~~-~~~~---~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 210 ---ELFHSIRM-DNPF---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---HHHHHHHH-CCCC---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---HHHHHHHc-CCCC---CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11122211 1121 2233456788999999999999999995 6753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=348.09 Aligned_cols=270 Identities=26% Similarity=0.392 Sum_probs=206.9
Q ss_pred hcCccccceeccCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHH--hc-CCCceeeeeEEEeCC----eEEEEEe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILC--KV-HSNLIELIGYAAGGD----SLFLVYE 83 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~--~l-h~~i~~~~~~~~~~~----~~~lv~e 83 (313)
..+|.+.+.||+|+||.||+|+++|+.||||.++.........|.+++. .+ ||||+++++++.+.+ .+++|||
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4678999999999999999999999999999998777666666665554 45 999999999997654 6899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc--------CCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ--------YTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~--------~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
|+++|+|.+++. ...+++...+.++.|++.|++|+|+ ++ |+|+||||+||++++++.+||+||
T Consensus 82 y~~~g~L~~~l~------~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 82 YHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp CCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEEEec
Confidence 999999999994 2358899999999999999999997 46 999999999999999999999999
Q ss_pred cccccccCChhhh-hhcccccccccccCCccccCCC------CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcccc-
Q 041031 156 GLVKLLEHSPEIA-AAASRIVGTFGYLAPEYVRDGC------VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE- 227 (313)
Q Consensus 156 g~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~------~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~- 227 (313)
|++.......... .......+|+.|+|||++.+.. ++.++|||||||++|||+||..||.............
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 9988765433221 1233457899999999987643 5778999999999999999998886554432211111
Q ss_pred --chhHHHHHHHHhcCcHHHHHHhhhhcCCCCCC--CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 228 --HRSLVDYMLAVFNDTKDFMAKLTECLDPNLTR--YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 228 --~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
........ ........++.+.. ...+....+.+|+.+||+.||++|||+.||++.|+++...
T Consensus 233 ~~~~~~~~~~----------~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSDPSVEEMR----------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHH----------HHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchHHHHH----------HHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 00110000 01111223333323 2344567799999999999999999999999999988754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=347.79 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=206.0
Q ss_pred hcCccccceeccCCeEEEEEeEECC---------cceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLRG---------KNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGG 75 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~~---------~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~ 75 (313)
.++|++.+.||+|+||.||+|++.+ ..||||.++.+. ..++.+|...+.++ ||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4789999999999999999998652 368999997654 24466788888887 99999999999999
Q ss_pred CeEEEEEeecCCCChhhhhcCCCC-----------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSV-----------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL 144 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 144 (313)
...++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+++ ++||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999964431 12356899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHh-CCCCccCCCCCCCC
Q 041031 145 DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELIT-GQQALSRDANPGNN 223 (313)
Q Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~t-g~~p~~~~~~~~~~ 223 (313)
+.++.+||+|||.+......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred cCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence 99999999999999876644322 23334568899999999999999999999999999999998 68888643321
Q ss_pred ccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 224 QYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
+....+.....+. .....+..+.+|+.+||+.||++|||+.||++.|++++.
T Consensus 245 --------------------~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 --------------------ELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp --------------------HHHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------------HHHHHHHcCCCCC---CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1222222222222 233455678999999999999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=346.79 Aligned_cols=257 Identities=24% Similarity=0.273 Sum_probs=193.8
Q ss_pred ccceeccCCeEEEEEeEEC--CcceEEEeccccc--------cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 16 TSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--------SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 16 ~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--------~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
.+++||+|+||+||+|+++ ++.||||+++... ...+.+|+.+++.+ ||||+++++++.+.+.+++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999987 7889999986432 23477899999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+.++++..+. .....+++..+..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||.+......
T Consensus 82 ~~~~~~~~~~-----~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 82 METDLEVIIK-----DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CSEEHHHHHT-----TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hcchHHhhhh-----hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC
Confidence 9887777665 45567899999999999999999999999 999999999999999999999999999765543
Q ss_pred hhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC-c
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND-T 242 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 242 (313)
.. ......+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.... .....+...... .
T Consensus 154 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---------~~l~~i~~~~~~~~ 221 (299)
T d1ua2a_ 154 NR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---------DQLTRIFETLGTPT 221 (299)
T ss_dssp CC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---------HHHHHHHHHHCCCC
T ss_pred cc---cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---------HHHHHHHHhcCCCC
Confidence 21 2223468999999999875 45799999999999999999999999765431 000000000000 0
Q ss_pred H-HHHHHh--hh-hcCCCCCC-----CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 243 K-DFMAKL--TE-CLDPNLTR-----YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 243 ~-~~~~~l--~~-~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
. ...... .. ........ .....+..+.+|+.+||..||++|||++|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 000000 00 00000000 012334678899999999999999999999863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=346.53 Aligned_cols=258 Identities=29% Similarity=0.464 Sum_probs=208.6
Q ss_pred hcCccccceeccCCeEEEEEeEEC--Cc--ceEEEecccc----ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GK--NAAIKQMKNT----KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~--~~aiK~~~~~----~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~l 80 (313)
.++|++.++||+|+||.||+|.++ +. .||||.+... ..+.+.+|+++|..+ ||||+++++++.+.+.+++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 368999999999999999999987 33 4778877543 244588999999998 9999999999999999999
Q ss_pred EEeecCCCChhhhhcCCC-----------CCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCc
Q 041031 81 VYEYAQNGALSDHLHWPS-----------VKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFR 149 (313)
Q Consensus 81 v~e~~~~~~L~~~l~~~~-----------~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~ 149 (313)
||||+++|+|.+++.... ......+++..++.++.|++.||.|+|+++ ++|+||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 999999999999985331 123467899999999999999999999999 999999999999999999
Q ss_pred EEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCC-CCccCCCCCCCCccccc
Q 041031 150 AKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ-QALSRDANPGNNQYTEH 228 (313)
Q Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~-~p~~~~~~~~~~~~~~~ 228 (313)
+||+|||++....... ......+|..|+|||.+.+..++.++|||||||++|+|++|. +||.+....
T Consensus 166 ~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-------- 233 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------- 233 (309)
T ss_dssp EEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------
T ss_pred eEEccccccccccccc----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--------
Confidence 9999999987654322 122345889999999999999999999999999999999976 566543321
Q ss_pred hhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhccc
Q 041031 229 RSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISSK 301 (313)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 301 (313)
++...+.....+ ......+..+.+|+.+||+.||++|||+.+|++.|+++..+.+
T Consensus 234 ---------------~~~~~i~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 234 ---------------ELYEKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp ---------------HHHHHGGGTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ---------------HHHHHHHhcCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 223333332222 2234556789999999999999999999999999999986544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-50 Score=343.65 Aligned_cols=264 Identities=22% Similarity=0.352 Sum_probs=199.0
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEE
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVY 82 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~ 82 (313)
.++|+++++||+|+||.||+|++. ++.||||+++... .+.+.+|+++++++ ||||+++++++.+.+.+++||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 379999999999999999999987 8899999986432 55688999999999 999999999999999999999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLE 162 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~ 162 (313)
||+.++ +.+++. ......+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.+|++|||.+....
T Consensus 81 e~~~~~-~~~~~~---~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 81 EFLHQD-LKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp ECCSEE-HHHHHH---HTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred eecCCc-hhhhhh---hhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceecc
Confidence 999654 444442 134567999999999999999999999999 9999999999999999999999999997655
Q ss_pred CChhhhhhcccccccccccCCccccCCC-CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcC
Q 041031 163 HSPEIAAAASRIVGTFGYLAPEYVRDGC-VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFND 241 (313)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (313)
... .......+|+.|+|||++.... ++.++||||+||++|+|++|+.||.+.+.. ..+..........
T Consensus 154 ~~~---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--------~~~~~i~~~~~~~ 222 (298)
T d1gz8a_ 154 VPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRIFRTLGTP 222 (298)
T ss_dssp CCS---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCCC
T ss_pred CCc---ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--------HHHHHHHHhcCCC
Confidence 332 2233347899999999887655 578999999999999999999999754321 1111111111000
Q ss_pred cHHHHHHhhhhcC--CCCCC--------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 242 TKDFMAKLTECLD--PNLTR--------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 242 ~~~~~~~l~~~~~--~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
............+ ..... .....+..+.+|+++||..||++|||+.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000000000 00000 112334678899999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=346.58 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=211.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC-------CcceEEEeccccc----cHHHHHHHHHHHhc--CCCceeeeeEEEeCCe
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTK----SKEFSSELKILCKV--HSNLIELIGYAAGGDS 77 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~----~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~ 77 (313)
.++|++.++||+|+||.||+|++. ++.||||+++... ...+.+|+.+++.+ ||||+++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 478999999999999999999864 3579999997653 33477899999998 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCCC-------------CCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeee
Q 041031 78 LFLVYEYAQNGALSDHLHWPSV-------------KGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILL 144 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 144 (313)
.+++|||+++|+|.+++..... .....+++..+..++.|++.|++|||+++ ++|+||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999853321 12346899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhC-CCCccCCCCCCCC
Q 041031 145 DSNFRAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITG-QQALSRDANPGNN 223 (313)
Q Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg-~~p~~~~~~~~~~ 223 (313)
+.++.++++|||.+......... .......+|+.|+|||++.+..++.++|||||||++|+|+|+ .+||......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--- 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--- 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred cccCcccccccchheeccCCCcc-eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999876543322 233345789999999999999999999999999999999995 5555443331
Q ss_pred ccccchhHHHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhcc
Q 041031 224 QYTEHRSLVDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILISS 300 (313)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 300 (313)
..+...+.....+.. ....+..+.+|+.+||+.||.+|||+.+|+++|++++.++
T Consensus 255 -------------------~~~~~~i~~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 255 -------------------SKFYKMIKEGFRMLS---PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp -------------------HHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -------------------HHHHHHHhcCCCCCC---cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 122233333332222 2334567899999999999999999999999999887765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=340.90 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=201.2
Q ss_pred cceeccCCeEEEEEeEECC-----cceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEe-CCeEEEEEeec
Q 041031 17 SLKIGQGSYGSVYLGKLRG-----KNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAG-GDSLFLVYEYA 85 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~~-----~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~-~~~~~lv~e~~ 85 (313)
.++||+|+||+||+|.+.. ..||||.++... .+.+.+|+++++++ ||||+++++++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999999862 248999886432 34588999999999 9999999999865 56899999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCCh
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHSP 165 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 165 (313)
++++|.+++. ......+...++.++.|++.||.|+|+.+ |+|+||||+|||+++++.+||+|||++.......
T Consensus 112 ~~g~l~~~~~----~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIR----NETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHH----CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhc----cccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999985 44556788889999999999999999999 9999999999999999999999999998765432
Q ss_pred hhh-hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcHH
Q 041031 166 EIA-AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTKD 244 (313)
Q Consensus 166 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (313)
... .......+|+.|+|||.+.+..++.++||||||+++|||+||..||....... +
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~----------------------~ 242 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----------------------D 242 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------------------------
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH----------------------H
Confidence 211 22223468899999999999999999999999999999999888876433210 1
Q ss_pred HHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 245 FMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 245 ~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
....+.....+. .....+..+.+|+.+||+.||++|||+.||+++|+.++..
T Consensus 243 ~~~~i~~g~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 243 ITVYLLQGRRLL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHcCCCCC---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 112222111121 2234456788999999999999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=341.58 Aligned_cols=236 Identities=23% Similarity=0.368 Sum_probs=194.6
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc---------cHHHHHHHHHHHhc---CCCceeeeeEEEeCC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK---------SKEFSSELKILCKV---HSNLIELIGYAAGGD 76 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~---------~~~~~~e~~~l~~l---h~~i~~~~~~~~~~~ 76 (313)
.++|++.++||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 578999999999999999999987 7899999986432 22356899999998 899999999999999
Q ss_pred eEEEEEeecCC-CChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-CCcEEEee
Q 041031 77 SLFLVYEYAQN-GALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-NFRAKIAD 154 (313)
Q Consensus 77 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~~l~d 154 (313)
..++|||++.+ +++.+++. ....+++..++.++.|++.||+|||+++ ++|+||||+||+++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~-----~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT-----ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH-----HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECc
Confidence 99999999976 57777773 4467999999999999999999999999 999999999999985 57899999
Q ss_pred ccccccccCChhhhhhcccccccccccCCccccCCCC-CCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 155 FGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCV-TTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....
T Consensus 155 FG~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------- 215 (273)
T d1xwsa_ 155 FGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------- 215 (273)
T ss_dssp CTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------
T ss_pred cccceecccc-----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------------
Confidence 9999865432 2234578999999999987665 6778999999999999999999963210
Q ss_pred HHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 234 YMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 234 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.... ... .....+..+.+|+++||+.||++|||++|+++.
T Consensus 216 --------------i~~~--~~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 216 --------------IIRG--QVF---FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --------------HHHC--CCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------------Hhhc--ccC---CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0000 001 122344678899999999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=340.21 Aligned_cols=263 Identities=21% Similarity=0.324 Sum_probs=197.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC---CcceEEEeccccc-----cHHHHHHHHHHHhc----CCCceeeeeEEEe----
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR---GKNAAIKQMKNTK-----SKEFSSELKILCKV----HSNLIELIGYAAG---- 74 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~aiK~~~~~~-----~~~~~~e~~~l~~l----h~~i~~~~~~~~~---- 74 (313)
.++|+++++||+|+||+||+|++. ++.||||+++... .....+|+.+++.+ ||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999985 4568999986432 33467888888776 9999999999853
Q ss_pred -CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEe
Q 041031 75 -GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIA 153 (313)
Q Consensus 75 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~ 153 (313)
....+++||++.++.+..... .....+++..++.++.|++.||+|||+++ |+|+||||+|||+++++.+|++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeec
Confidence 346899999998876655543 44567899999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHH
Q 041031 154 DFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVD 233 (313)
Q Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~ 233 (313)
|||.+...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.... ..+..
T Consensus 159 dfg~~~~~~~~----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--------~~~~~ 226 (305)
T d1blxa_ 159 DFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--------DQLGK 226 (305)
T ss_dssp SCCSCCCCCGG----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHH
T ss_pred chhhhhhhccc----ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--------HHHHH
Confidence 99998765432 2334457999999999999999999999999999999999999999755431 11111
Q ss_pred HHHHHhc-CcHHHHHH---hhhhc----CCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 234 YMLAVFN-DTKDFMAK---LTECL----DPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 234 ~~~~~~~-~~~~~~~~---l~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
....... ...++... ..... ...........+..+.+|+++||+.||++|||+.|+++.
T Consensus 227 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1111000 00000000 00000 000111223345678889999999999999999998763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=340.70 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=209.4
Q ss_pred HhcCccccceeccCCeEEEEEeEEC-------CcceEEEecccccc----HHHHHHHHHHHhc-CCCceeeeeEEEeCCe
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR-------GKNAAIKQMKNTKS----KEFSSELKILCKV-HSNLIELIGYAAGGDS 77 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~aiK~~~~~~~----~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~ 77 (313)
..++|++.++||+|+||.||+|.++ +..||||.++.... ..+.+|+.+++++ ||||+++++++.....
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3578999999999999999999875 36799999975432 2377999999999 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhcCCC-----CCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEE
Q 041031 78 LFLVYEYAQNGALSDHLHWPS-----VKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKI 152 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l 152 (313)
.++||||+++|+|.+++.... ......++...+..++.|++.||.|||+++ |+|+||||+|||+++++.+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 999999999999999874221 112235788899999999999999999999 999999999999999999999
Q ss_pred eeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCC-CCccCCCCCCCCccccchhH
Q 041031 153 ADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQ-QALSRDANPGNNQYTEHRSL 231 (313)
Q Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~-~p~~~~~~~~~~~~~~~~~~ 231 (313)
+|||++......... .......+++.|+|||.+.+..++.++||||||+++|||+||. .||.+....
T Consensus 175 ~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~----------- 242 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----------- 242 (308)
T ss_dssp CCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----------
T ss_pred eecccceeccCCcce-eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-----------
Confidence 999999866543221 2233346899999999999999999999999999999999985 667543321
Q ss_pred HHHHHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 232 VDYMLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 232 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
+....+ .+..........+..+.+++.+||+.||.+|||+.+|+++|++.+.
T Consensus 243 ------------~~~~~i---~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 243 ------------QVLRFV---MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ------------HHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------------HHHHHH---HhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111112 2222222334556789999999999999999999999999987755
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.8e-49 Score=336.56 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=198.4
Q ss_pred cCccccceeccCCeEEEEEeEEC-CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEee
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
++|+++++||+|+||+||+|+++ ++.||||+++... .+.+.+|+.+|+.+ ||||+++++++.+.+..++++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999988 7899999986543 45688999999999 99999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccCC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEHS 164 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 164 (313)
+.++.+..+. .....+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+|++|||.+......
T Consensus 82 ~~~~~~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLD-----VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHH-----TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHH-----hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9877666665 45577999999999999999999999999 999999999999999999999999998876543
Q ss_pred hhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCcH
Q 041031 165 PEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDTK 243 (313)
Q Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
.. ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.... ..+............
T Consensus 154 ~~---~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--------~~~~~i~~~~~~~~~ 222 (286)
T d1ob3a_ 154 VR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--------DQLMRIFRILGTPNS 222 (286)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCCCCT
T ss_pred cc---ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--------HHHHHHHHhhCCCCh
Confidence 22 22334678999999998754 5689999999999999999999999754321 111111111000000
Q ss_pred HHHHHhhhhc--CCCC--------CCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 244 DFMAKLTECL--DPNL--------TRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 244 ~~~~~l~~~~--~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.......... .... .......+..+.+|+++||..||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 0000 0012334567889999999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=332.46 Aligned_cols=264 Identities=21% Similarity=0.295 Sum_probs=193.3
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-----ccHHHHHHHHHHHhc-CCCceeeeeEEEe--------
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-----KSKEFSSELKILCKV-HSNLIELIGYAAG-------- 74 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-----~~~~~~~e~~~l~~l-h~~i~~~~~~~~~-------- 74 (313)
.++|+++++||+|+||+||+|+++ ++.||||++... ....+.+|+++|+.+ |||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 589999999999999999999987 889999998543 245578999999999 9999999999854
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEee
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIAD 154 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~d 154 (313)
....+++||++.++.+.... .....+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+|++|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-----~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-----CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCCCccchhh-----hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeee
Confidence 34689999999777666554 44567899999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCChhh-hhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHH
Q 041031 155 FGLVKLLEHSPEI-AAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLV 232 (313)
Q Consensus 155 fg~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~ 232 (313)
||++......... ........+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.... ...
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~---------~~~ 231 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---------HQL 231 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---------HHH
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH---------HHH
Confidence 9999765533221 1222234689999999999765 6899999999999999999999999654321 111
Q ss_pred HHHHHHhcC-cHH---------HHHHhhhhcCCCCCCC-----CHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 233 DYMLAVFND-TKD---------FMAKLTECLDPNLTRY-----HKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 233 ~~~~~~~~~-~~~---------~~~~l~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
..+...... ..+ ....+.. ........ .......+.+|+.+||..||++|||++|+++.
T Consensus 232 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 232 ALISQLCGSITPEVWPNVDNYELYEKLEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHHHCCCCTTTSTTCCCC-------C-CSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhcCCCChhhccccchhhhhhhhcc-cccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 111111000 000 0000000 00000000 01113456789999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.6e-47 Score=329.93 Aligned_cols=260 Identities=19% Similarity=0.280 Sum_probs=199.5
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc--CCCceeeeeEEEe--CCeEEEEEee
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV--HSNLIELIGYAAG--GDSLFLVYEY 84 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l--h~~i~~~~~~~~~--~~~~~lv~e~ 84 (313)
.++|+++++||+|+||+||+|++. ++.||||+++....+.+.+|+.+|+.+ ||||+++++++.. ...+++||||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 468999999999999999999987 889999999988888899999999998 9999999999974 4568999999
Q ss_pred cCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCC-CcEEEeeccccccccC
Q 041031 85 AQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSN-FRAKIADFGLVKLLEH 163 (313)
Q Consensus 85 ~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~~l~dfg~~~~~~~ 163 (313)
+.+++|.++. ..+++..++.++.|++.||.|||+++ |+|+||||+|||++.+ +.++++|||++.....
T Consensus 114 ~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 114 VNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred cCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999987764 35899999999999999999999999 9999999999999865 4689999999987654
Q ss_pred ChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
.. ......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||....... ............. ..
T Consensus 183 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~----~~~~~i~~~~g~~--~~ 252 (328)
T d3bqca1 183 GQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY----DQLVRIAKVLGTE--DL 252 (328)
T ss_dssp TC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH----HHHHHHHHHHCHH--HH
T ss_pred CC----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH----HHHHHHHHHHCCc--hh
Confidence 32 22344689999999998765 47999999999999999999999997654321 0000010000000 00
Q ss_pred HHHHHHh--------hhhcCCC--------CC-CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDFMAKL--------TECLDPN--------LT-RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~~~~l--------~~~~~~~--------~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
.+..... ....... .. ......+..+.+||++||..||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 0000000 00 012234567889999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=339.46 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=195.7
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC----eE
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK----SKEFSSELKILCKV-HSNLIELIGYAAGGD----SL 78 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~----~~ 78 (313)
+.++|+++++||+|+||+||+|.+. ++.||||++.... .+.+.+|+++|+.+ |||++++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 3568999999999999999999987 8899999997543 33577899999999 999999999987543 23
Q ss_pred EEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecccc
Q 041031 79 FLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLV 158 (313)
Q Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~ 158 (313)
+++++++.+|+|.+++. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 86 ~~l~~~~~~g~L~~~l~------~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLK------TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEEEECCCEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeecCCchhhhhh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCce
Confidence 44455566899999984 236899999999999999999999999 999999999999999999999999999
Q ss_pred ccccCChhhhhhcccccccccccCCcccc-CCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHH
Q 041031 159 KLLEHSPEIAAAASRIVGTFGYLAPEYVR-DGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLA 237 (313)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (313)
.................+++.|+|||++. +..++.++||||+||++|+|++|+.||...... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~---------~~~~~~~~ 227 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---------DQLNHILG 227 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH---------HHHHHHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH---------HHHHHHhh
Confidence 87655433333344457899999999985 456789999999999999999999999654321 11111111
Q ss_pred HhcCcHHH----------HHHhhhhcCCCCC---CCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 238 VFNDTKDF----------MAKLTECLDPNLT---RYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 238 ~~~~~~~~----------~~~l~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
........ ............. ......+..+.+|+.+||..||.+|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110000 0000000000000 0112233568899999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=333.21 Aligned_cols=248 Identities=26% Similarity=0.373 Sum_probs=200.2
Q ss_pred hcCccccceeccCCeEEEEEeEEC-----CcceEEEecccc-------ccHHHHHHHHHHHhc-C-CCceeeeeEEEeCC
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR-----GKNAAIKQMKNT-------KSKEFSSELKILCKV-H-SNLIELIGYAAGGD 76 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~aiK~~~~~-------~~~~~~~e~~~l~~l-h-~~i~~~~~~~~~~~ 76 (313)
.++|+++++||+|+||.||+|++. |+.||||+++.. ..+.+.+|+++++++ | |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 478999999999999999999863 678999998643 244577899999999 6 89999999999999
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
..+++|||+.+|+|.+++. ....+++..++.++.|++.||.|+|+++ ++|+||||+||+++.++.++|+|||
T Consensus 103 ~~~~v~e~~~~~~L~~~i~-----~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp EEEEEECCCCSCBHHHHHH-----HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred ceeeeeecccccHHHHHHH-----hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeecc
Confidence 9999999999999999983 4456788999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCC--CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG--CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
++........ .......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+..... .....
T Consensus 175 ~a~~~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--------~~~~i 244 (322)
T d1vzoa_ 175 LSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--------SQAEI 244 (322)
T ss_dssp EEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--------CHHHH
T ss_pred chhhhccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHH
Confidence 9986654332 233345789999999999754 46889999999999999999999997765432 10000
Q ss_pred HHHHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 041031 235 MLAVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPD-----MSNAAI 291 (313)
Q Consensus 235 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-----~~~ll~ 291 (313)
... ...... ......+..+.+|+++||+.||.+||| ++|+++
T Consensus 245 -----------~~~---~~~~~~-~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 245 -----------SRR---ILKSEP-PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----------HHH---HHHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----------HHh---cccCCC-CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111 111111 122345678899999999999999994 788875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-47 Score=328.00 Aligned_cols=261 Identities=23% Similarity=0.271 Sum_probs=200.4
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-ccHHHHHHHHHHHhc-CCC-ceeeeeEEEeCCeEEEEEeec
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-KSKEFSSELKILCKV-HSN-LIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-~~~~~~~e~~~l~~l-h~~-i~~~~~~~~~~~~~~lv~e~~ 85 (313)
.++|++.+.||+|+||.||+|++. ++.||||++... ....+..|+++++.+ |++ |+.+..++.+.+..++|||++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 467999999999999999999987 789999987654 345688999999999 555 556666678888999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC---CCcEEEeecccccccc
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS---NFRAKIADFGLVKLLE 162 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~~l~dfg~~~~~~ 162 (313)
+++|.+.+. .....+++..+..++.|++.||+|||+++ |+|+||||+||+++. +..++++|||++....
T Consensus 86 -~~~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 86 -GPSLEDLFN----FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp -CCBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred -CCchhhhhh----hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 556766653 34567999999999999999999999999 999999999999863 5579999999998766
Q ss_pred CChhhh----hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHH
Q 041031 163 HSPEIA----AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAV 238 (313)
Q Consensus 163 ~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (313)
...... .......||+.|+|||++.+..++.++|||||||++|+|+||..||........... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-----~~~~~~~~ 232 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-----YERISEKK 232 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------------HHHHHHHH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-----HHHhhccc
Confidence 433211 122345799999999999999999999999999999999999999976554321110 00000000
Q ss_pred hcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHh
Q 041031 239 FNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILI 298 (313)
Q Consensus 239 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 298 (313)
+ ...........+..+.+++..||+.+|.+||++.++.+.|+.+..
T Consensus 233 ----------~----~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 233 ----------M----STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----------H----HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ----------C----CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0 000000112334578899999999999999999999998887754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=332.15 Aligned_cols=259 Identities=22% Similarity=0.329 Sum_probs=194.0
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCC-----
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGD----- 76 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~----- 76 (313)
..++|+++++||+|+||+||+|.++ ++.||||+++... .+.+.+|+++|+.+ ||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4578999999999999999999987 8899999997532 33577899999999 999999999997654
Q ss_pred -eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 77 -SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 77 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
.+++||||+ +.+|..++. ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++++||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK------HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecc-cccHHHHHH------hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccc
Confidence 579999999 667877763 356999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDY 234 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (313)
|.+...... .....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.... ..+...
T Consensus 166 g~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~--------~~~~~~ 231 (346)
T d1cm8a_ 166 GLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--------DQLKEI 231 (346)
T ss_dssp TTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH
T ss_pred cceeccCCc------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH--------HHHHHH
Confidence 999876532 233568999999999876 45689999999999999999999999765431 111111
Q ss_pred HHHHhcCcH--------HHHHHhhhhc----CCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 235 MLAVFNDTK--------DFMAKLTECL----DPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 235 ~~~~~~~~~--------~~~~~l~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
......... .........+ ...+.......+..+.+|+++||..||.+|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111100000 0011111111 111111223345678899999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=324.68 Aligned_cols=262 Identities=22% Similarity=0.283 Sum_probs=201.3
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeCCeEEEEEe
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGGDSLFLVYE 83 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~~~~~lv~e 83 (313)
++|+++++||+|+||+||+|++. ++.||||+++... ...+.+|+.+++.+ ||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999987 7789999986432 35578999999999 9999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeeccccccccC
Q 041031 84 YAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFGLVKLLEH 163 (313)
Q Consensus 84 ~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~~~~ 163 (313)
++.+++|..++ ...+.+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.+|++|||.+.....
T Consensus 82 ~~~~~~l~~~~-----~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFD-----SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHH-----HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecccccccccc-----ccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999888887 35567899999999999999999999999 99999999999999999999999999987654
Q ss_pred ChhhhhhcccccccccccCCccccCCC-CCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhcCc
Q 041031 164 SPEIAAAASRIVGTFGYLAPEYVRDGC-VTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFNDT 242 (313)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (313)
... ......+++.|+|||++.+.. ++.++||||+||++|+|++|+.||....+. ...............
T Consensus 154 ~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~-------~~~~~~~~~~~~~~~ 223 (292)
T d1unla_ 154 PVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-------DDQLKRIFRLLGTPT 223 (292)
T ss_dssp CCS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-------HHHHHHHHHHHCCCC
T ss_pred CCc---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH-------HHHHHHHHhhcCCCC
Confidence 322 222345778999999987665 689999999999999999999997543321 011111111110000
Q ss_pred HHH---HHHhhhh-------cCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 041031 243 KDF---MAKLTEC-------LDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAI 291 (313)
Q Consensus 243 ~~~---~~~l~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 291 (313)
... ....... ............+..+.+|+++||+.||.+|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000 001111123344567889999999999999999999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-46 Score=323.11 Aligned_cols=262 Identities=18% Similarity=0.215 Sum_probs=207.7
Q ss_pred hcCccccceeccCCeEEEEEeEEC--CcceEEEecccc-ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEeec
Q 041031 11 TSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT-KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEYA 85 (313)
Q Consensus 11 ~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~-~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~~ 85 (313)
..+|++.++||+|+||.||+|++. ++.||||+++.. ....+.+|++.++.+ |+|++.+++++......++|||++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 468999999999999999999987 788999988544 355688899999999 689999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCC-----CCcEEEeecccccc
Q 041031 86 QNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDS-----NFRAKIADFGLVKL 160 (313)
Q Consensus 86 ~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~-----~~~~~l~dfg~~~~ 160 (313)
+++|.+++. .....++...+..++.|++.+|.|||+++ ++|+||||+||+++. ++.++++|||++..
T Consensus 84 -~~~l~~~~~----~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 84 -GPSLEDLLD----LCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp -CCBHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred -CCCHHHHHH----hhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 789999884 33457899999999999999999999999 999999999999964 57899999999987
Q ss_pred ccCChhhh----hhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHH
Q 041031 161 LEHSPEIA----AAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYML 236 (313)
Q Consensus 161 ~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (313)
........ .......||+.|+|||++.+..++.++||||||+++|+|+||..||.+...... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~-----~~~~~~i~~ 230 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-----KQKYERIGE 230 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-----HHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH-----HHHHHHHHh
Confidence 65432211 123345799999999999999999999999999999999999999976554310 000000000
Q ss_pred HHhcCcHHHHHHhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHhc
Q 041031 237 AVFNDTKDFMAKLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIRLSHILIS 299 (313)
Q Consensus 237 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 299 (313)
... . ..........+..+.+++..|++.+|.+||+.+.+.+.|++++..
T Consensus 231 ~~~-------~-------~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 231 KKQ-------S-------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHH-------H-------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccC-------C-------CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 000 0 000001122345788899999999999999999999988887653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=329.11 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=194.2
Q ss_pred cCccccceeccCCeEEEEEeEEC--CcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEEEe------CCeEEEEE
Q 041031 12 SNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYAAG------GDSLFLVY 82 (313)
Q Consensus 12 ~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~~~------~~~~~lv~ 82 (313)
.+|..+++||+|+||+||+|++. ++.||||++..+. ....+|+++|+++ ||||+++++++.. ...+++||
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 36999999999999999999997 8889999997653 3345799999999 9999999999853 33578999
Q ss_pred eecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCC-cEEEeeccccccc
Q 041031 83 EYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNF-RAKIADFGLVKLL 161 (313)
Q Consensus 83 e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~~l~dfg~~~~~ 161 (313)
||++++.+..+.. . ......+++..++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 99 Ey~~~~~~~~l~~-~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 99 DYVPETVYRVARH-Y-SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp ECCSEEHHHHHHH-H-HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred eccCCccHHHHHh-h-hhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9997654333321 1 124567999999999999999999999999 99999999999999765 8999999998866
Q ss_pred cCChhhhhhcccccccccccCCccccC-CCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHHHHHhc
Q 041031 162 EHSPEIAAAASRIVGTFGYLAPEYVRD-GCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYMLAVFN 240 (313)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (313)
.... ......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...... ..+.......-.
T Consensus 174 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--------~~l~~i~~~~g~ 241 (350)
T d1q5ka_ 174 VRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--------DQLVEIIKVLGT 241 (350)
T ss_dssp CTTS----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--------HHHHHHHHHHCC
T ss_pred cCCc----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--------HHHHHHHHHhCC
Confidence 5432 2233468999999998875 56899999999999999999999999755431 111111111111
Q ss_pred CcHHHHHHh-hhhcCCCCCC---------CCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 241 DTKDFMAKL-TECLDPNLTR---------YHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 241 ~~~~~~~~l-~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
...+..... ....+..... .....+..+.+|+.+||..||.+|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111111 1111111110 123345678899999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=328.99 Aligned_cols=260 Identities=22% Similarity=0.251 Sum_probs=190.3
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEe------C
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAG------G 75 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~------~ 75 (313)
+.++|+++++||+|+||+||+|.++ |+.||||++.... ...+.+|+.+++.+ ||||+++++++.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3468999999999999999999987 8899999987432 33577999999999 9999999999963 4
Q ss_pred CeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeec
Q 041031 76 DSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADF 155 (313)
Q Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 155 (313)
+.+|+||||+.++.+ +.+. ..+++..++.++.|++.||.|||++| |+|+||||+||+++.++.++++||
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp CEEEEEEECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred ceeEEEEeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeech
Confidence 689999999976544 4441 45889999999999999999999999 999999999999999999999999
Q ss_pred cccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 156 GLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
|.+...... .......+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.. .......
T Consensus 164 ~~~~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~--------~~~~~i~ 231 (355)
T d2b1pa1 164 GLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--------DQWNKVI 231 (355)
T ss_dssp CC-------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH
T ss_pred hhhhccccc----cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH--------HHHHHHH
Confidence 987765543 2233446899999999999999999999999999999999999999765421 1111111
Q ss_pred HHHhcCcHHHHH-----------------------HhhhhcCCCCCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 236 LAVFNDTKDFMA-----------------------KLTECLDPNLTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 236 ~~~~~~~~~~~~-----------------------~l~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
.......++... .......+.........+..+.+|+++||..||++|||++|+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111111111110 001111111111233456778999999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=329.04 Aligned_cols=259 Identities=20% Similarity=0.292 Sum_probs=193.0
Q ss_pred HhcCccccceeccCCeEEEEEeEEC--CcceEEEeccccc-----cHHHHHHHHHHHhc-CCCceeeeeEEEeC-----C
Q 041031 10 ATSNFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK-----SKEFSSELKILCKV-HSNLIELIGYAAGG-----D 76 (313)
Q Consensus 10 ~~~~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~-----~~~~~~e~~~l~~l-h~~i~~~~~~~~~~-----~ 76 (313)
+.++|+++++||+|+||+||+|++. ++.||||++.... .+.+.+|+++|+.+ |||++++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3578999999999999999999987 8899999997543 33577899999999 99999999998643 3
Q ss_pred eEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcEEEeecc
Q 041031 77 SLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRAKIADFG 156 (313)
Q Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~dfg 156 (313)
..+++++++.+|+|.+++. ...+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.++++|||
T Consensus 96 ~~~~i~~~~~gg~L~~~~~------~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK------CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC-
T ss_pred ceEEEEEeecCCchhhhcc------cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccc
Confidence 3456677778999999983 246999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCChhhhhhcccccccccccCCccccCC-CCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCccccchhHHHHH
Q 041031 157 LVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDG-CVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTEHRSLVDYM 235 (313)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (313)
.+..... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.. .....+
T Consensus 167 ~a~~~~~------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~---------~~~~~i 231 (348)
T d2gfsa1 167 LARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---------DQLKLI 231 (348)
T ss_dssp ---CCTG------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---------HHHHHH
T ss_pred hhcccCc------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH---------HHHHHH
Confidence 9875442 22334688999999987765 4688999999999999999999999765431 111111
Q ss_pred HHH-hcCcHHH--------HHHhhhhcCCC----CCCCCHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 041031 236 LAV-FNDTKDF--------MAKLTECLDPN----LTRYHKDSMLQMALLSKDCVDENWKRRPDMSNAAIR 292 (313)
Q Consensus 236 ~~~-~~~~~~~--------~~~l~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 292 (313)
... .....+. .......+... +.......+..+.+||++||..||.+|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 111 1110000 00000000000 000112334678899999999999999999999973
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-40 Score=294.51 Aligned_cols=267 Identities=18% Similarity=0.271 Sum_probs=188.4
Q ss_pred CccccceeccCCeEEEEEeEEC--CcceEEEeccccc--cHHHHHHHHHHHhc------------CCCceeeeeEEEe--
Q 041031 13 NFSTSLKIGQGSYGSVYLGKLR--GKNAAIKQMKNTK--SKEFSSELKILCKV------------HSNLIELIGYAAG-- 74 (313)
Q Consensus 13 ~y~~~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~~--~~~~~~e~~~l~~l------------h~~i~~~~~~~~~-- 74 (313)
+|+++++||+|+||+||+|++. |+.||||+++.+. .+...+|+.+++.+ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 5999999999999999999986 8899999998664 45577888888776 4789999988754
Q ss_pred CCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhc-CCCCceEEeccCCCCeeeCCCC-----
Q 041031 75 GDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQ-YTKPYYVHRDVKTSNILLDSNF----- 148 (313)
Q Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~----- 148 (313)
....++++.+...+....... .......+++..++.++.|++.||.|||+ .+ |+|+||||+||+++.++
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALI--KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHH--HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccceeeeeeeccccccccccc--ccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 455666666665443322221 11345678999999999999999999997 88 99999999999998654
Q ss_pred -cEEEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHHHHHHhCCCCccCCCCCCCCcccc
Q 041031 149 -RAKIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVLMELITGQQALSRDANPGNNQYTE 227 (313)
Q Consensus 149 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~~~tg~~p~~~~~~~~~~~~~~ 227 (313)
.++++|||.+...... .....+|+.|+|||++.+..++.++||||+||++++|++|+.||............
T Consensus 169 ~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~- 241 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD- 241 (362)
T ss_dssp EEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH-
T ss_pred ceeeEeecccccccccc------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh-
Confidence 3899999998765432 23356899999999999999999999999999999999999999765442211111
Q ss_pred chhHHHHHHHHhcCcHHHHHHh---hhhcC---------C-----------CCCCCCHHHHHHHHHHHhhccccCcCCCC
Q 041031 228 HRSLVDYMLAVFNDTKDFMAKL---TECLD---------P-----------NLTRYHKDSMLQMALLSKDCVDENWKRRP 284 (313)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l---~~~~~---------~-----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 284 (313)
..+.......-....+..... ....+ . .........+..+.+|+.+||.+||.+||
T Consensus 242 -~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 242 -DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp -HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred -HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 111111111101000110000 00000 0 00112456678899999999999999999
Q ss_pred CHHHHHHH
Q 041031 285 DMSNAAIR 292 (313)
Q Consensus 285 s~~~ll~~ 292 (313)
|++|+|+.
T Consensus 321 ta~e~L~H 328 (362)
T d1q8ya_ 321 DAGGLVNH 328 (362)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhcC
Confidence 99999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2e-24 Score=172.37 Aligned_cols=165 Identities=12% Similarity=0.043 Sum_probs=116.4
Q ss_pred ccccceeccCCeEEEEEeEEC-CcceEEEeccccc---------------------cHHHHHHHHHHHhc-CCCceeeee
Q 041031 14 FSTSLKIGQGSYGSVYLGKLR-GKNAAIKQMKNTK---------------------SKEFSSELKILCKV-HSNLIELIG 70 (313)
Q Consensus 14 y~~~~~lg~g~~g~v~~~~~~-~~~~aiK~~~~~~---------------------~~~~~~e~~~l~~l-h~~i~~~~~ 70 (313)
+.+.++||+|+||.||+|.+. |+.||||+++... ......|...+.++ |.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 457899999999999999976 8899999875321 11134577888888 888888776
Q ss_pred EEEeCCeEEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEeccCCCCeeeCCCCcE
Q 041031 71 YAAGGDSLFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDVKTSNILLDSNFRA 150 (313)
Q Consensus 71 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~ 150 (313)
+.. .+++||++++..+.++ +......++.|++.+++|||+++ ++|+||||+||++++++ +
T Consensus 82 ~~~----~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~ 141 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-I 141 (191)
T ss_dssp EET----TEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-E
T ss_pred ecC----CEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-E
Confidence 532 3789999987655432 23335678999999999999999 99999999999999765 8
Q ss_pred EEeeccccccccCChhhhhhcccccccccccCCccccCCCCCCccchhhHHHHH
Q 041031 151 KIADFGLVKLLEHSPEIAAAASRIVGTFGYLAPEYVRDGCVTTKSDVYAFGVVL 204 (313)
Q Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l 204 (313)
+++|||.+.................... + +....|+.++|+||+.--+
T Consensus 142 ~liDFG~a~~~~~~~~~~~l~rd~~~~~-----~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWREILERDVRNII-----T-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTHHHHHHHHHHHHH-----H-HHHHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCcHHHHHHHHHHHH-----H-HHcCCCCCcccHHHHHHHH
Confidence 9999999876543221110000000000 1 1135578899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.02 E-value=1.6e-09 Score=88.89 Aligned_cols=146 Identities=14% Similarity=0.120 Sum_probs=108.7
Q ss_pred HHHHHHhcCccccceeccCCeEEEEEeEECCcceEEEeccccc---cHHHHHHHHHHHhcCC--CceeeeeEEEeCCeEE
Q 041031 5 NEVRDATSNFSTSLKIGQGSYGSVYLGKLRGKNAAIKQMKNTK---SKEFSSELKILCKVHS--NLIELIGYAAGGDSLF 79 (313)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~aiK~~~~~~---~~~~~~e~~~l~~lh~--~i~~~~~~~~~~~~~~ 79 (313)
.++....++|++.+..+.++.+.||+....+..+++|...... ...+.+|..+++.++. -+.+++.+..+.+..+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3677888999999887766678999998888889999886543 4457889999988833 3578888888889999
Q ss_pred EEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCC-----------------------------
Q 041031 80 LVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKP----------------------------- 130 (313)
Q Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~----------------------------- 130 (313)
+||++++|.++.+... .. .. ...++.++...++.||+....
T Consensus 87 lv~~~l~G~~~~~~~~-----~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYE-----DE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHTT-----TC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEeccccccccccc-----cc--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 9999999988876542 10 11 223455666666677754310
Q ss_pred ---------------------------ceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 131 ---------------------------YYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 131 ---------------------------~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
.++|+|+.|.||++++++.+.++||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 168999999999999876667999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.67 E-value=6.2e-08 Score=78.79 Aligned_cols=140 Identities=13% Similarity=0.075 Sum_probs=95.6
Q ss_pred HHHHhcCccccceeccCC-eEEEEEeEEC-CcceEEEeccccccHHHHHHHHHHHhc-C--CCceeeeeEEEeCCeEEEE
Q 041031 7 VRDATSNFSTSLKIGQGS-YGSVYLGKLR-GKNAAIKQMKNTKSKEFSSELKILCKV-H--SNLIELIGYAAGGDSLFLV 81 (313)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~-~g~v~~~~~~-~~~~aiK~~~~~~~~~~~~e~~~l~~l-h--~~i~~~~~~~~~~~~~~lv 81 (313)
+......+.... +..|. .+.||+.... +..+++|.........+..|...++.+ . -.+.+++.+..+.+..+++
T Consensus 6 ~~~~l~g~~~~~-~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 6 WVERLFGYDWAQ-QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp GTTTTTTCEEEE-CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred HHHhccCCceEE-cCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 333444454443 34444 4688999887 556899998888777899999999988 2 2356778888888889999
Q ss_pred EeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCC---------------------------------
Q 041031 82 YEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYT--------------------------------- 128 (313)
Q Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--------------------------------- 128 (313)
|++++|.++.+.. ... ...+.++...++.||+..
T Consensus 85 ~~~i~G~~~~~~~----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (255)
T d1nd4a_ 85 LGEVPGQDLLSSH----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 151 (255)
T ss_dssp EECCSSEETTTSC----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred EEeeecccccccc----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccc
Confidence 9999887664421 111 112334455555555422
Q ss_pred ----------------------CCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 129 ----------------------KPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 129 ----------------------~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
...++|+|+.|.||+++++..+-++||+.+..
T Consensus 152 ~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 152 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11169999999999999876667999997653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.06 E-value=8.8e-06 Score=70.18 Aligned_cols=72 Identities=17% Similarity=0.091 Sum_probs=48.9
Q ss_pred cceeccCCeEEEEEeEEC--CcceEEEecccc----------ccHHHHHHHHHHHhc--C--CCceeeeeEEEeCCeEEE
Q 041031 17 SLKIGQGSYGSVYLGKLR--GKNAAIKQMKNT----------KSKEFSSELKILCKV--H--SNLIELIGYAAGGDSLFL 80 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~--~~~~aiK~~~~~----------~~~~~~~e~~~l~~l--h--~~i~~~~~~~~~~~~~~l 80 (313)
.+.+|.|....||+.... ++.++||.-.+. ..++...|.+.|+.+ + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 557899999999999765 567888875431 234466788888877 2 235555544 4455678
Q ss_pred EEeecCCCCh
Q 041031 81 VYEYAQNGAL 90 (313)
Q Consensus 81 v~e~~~~~~L 90 (313)
+||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.70 E-value=0.00068 Score=55.98 Aligned_cols=158 Identities=8% Similarity=-0.011 Sum_probs=89.3
Q ss_pred ChHHHHHHhcCcccccee-----ccCCeEEEEEeEECCcceEEEecccc-ccHHHHHHHHHHHhc-CCC--ceeeeeE--
Q 041031 3 SYNEVRDATSNFSTSLKI-----GQGSYGSVYLGKLRGKNAAIKQMKNT-KSKEFSSELKILCKV-HSN--LIELIGY-- 71 (313)
Q Consensus 3 ~~~~~~~~~~~y~~~~~l-----g~g~~g~v~~~~~~~~~~aiK~~~~~-~~~~~~~e~~~l~~l-h~~--i~~~~~~-- 71 (313)
|-++++...++|-+.+.. ..|---+.|+....+..+++|+.... ..+++..|++++..+ ..+ +...+..
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~ 83 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKD 83 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecC
Confidence 568899999999775444 35666888999888778999998764 566778888888888 211 1111111
Q ss_pred ----EEeCCeEEEEEeecCCCChhhhh-----------------cCCC--CCCCC-----------------CccHHHHH
Q 041031 72 ----AAGGDSLFLVYEYAQNGALSDHL-----------------HWPS--VKGKK-----------------PLAWTTRV 111 (313)
Q Consensus 72 ----~~~~~~~~lv~e~~~~~~L~~~l-----------------~~~~--~~~~~-----------------~l~~~~~~ 111 (313)
.........++.+..+......- .... ..... ........
T Consensus 84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (316)
T d2ppqa1 84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 163 (316)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence 22334556666666653332100 0000 00000 00011112
Q ss_pred HHHHHHHHHHHHHhcCC-CCceEEeccCCCCeeeCCCCcEEEeecccccc
Q 041031 112 QIALDAAKGLEYIHQYT-KPYYVHRDVKTSNILLDSNFRAKIADFGLVKL 160 (313)
Q Consensus 112 ~~~~~i~~~l~~lh~~~-~~~i~h~di~p~nil~~~~~~~~l~dfg~~~~ 160 (313)
..+......+......+ +.+++|+|+.++|++++.+...-++||+.+..
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 22333333333333221 23389999999999999887678999998763
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.37 E-value=0.00097 Score=55.38 Aligned_cols=135 Identities=10% Similarity=0.072 Sum_probs=78.5
Q ss_pred eEEEEEeEEC-CcceEEEecccc--ccHHHHHHHHHHHhc-CCC--ceeeee-----EEEeCCeEEEEEeecCCCChhh-
Q 041031 25 YGSVYLGKLR-GKNAAIKQMKNT--KSKEFSSELKILCKV-HSN--LIELIG-----YAAGGDSLFLVYEYAQNGALSD- 92 (313)
Q Consensus 25 ~g~v~~~~~~-~~~~aiK~~~~~--~~~~~~~e~~~l~~l-h~~--i~~~~~-----~~~~~~~~~lv~e~~~~~~L~~- 92 (313)
--.||++... |+.+++|+.++. +.+++..|...+..| ..+ ++..+. .+......+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4689999876 788999998775 467788899998888 211 121211 2345567888999997744321
Q ss_pred ----------hh-------cCCCCCCCCC-------------------cc---HHHHHHHHHHHHHHHHHHh-cCCCCce
Q 041031 93 ----------HL-------HWPSVKGKKP-------------------LA---WTTRVQIALDAAKGLEYIH-QYTKPYY 132 (313)
Q Consensus 93 ----------~l-------~~~~~~~~~~-------------------l~---~~~~~~~~~~i~~~l~~lh-~~~~~~i 132 (313)
.+ .......... ++ .......+..+...+...- +..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 0000000001 11 1122233344444433322 2223348
Q ss_pred EEeccCCCCeeeCCCCcEEEeeccccccc
Q 041031 133 VHRDVKTSNILLDSNFRAKIADFGLVKLL 161 (313)
Q Consensus 133 ~h~di~p~nil~~~~~~~~l~dfg~~~~~ 161 (313)
+|+|+.+.||+++++ ..++||+-+...
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred ecCCCCcccEEEeCC--ceEEechhcccC
Confidence 999999999999754 458999987753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.18 E-value=0.00096 Score=56.99 Aligned_cols=71 Identities=20% Similarity=0.210 Sum_probs=49.8
Q ss_pred cceeccCCeEEEEEeEEC---------CcceEEEecccc-ccHHHHHHHHHHHhc--CCCceeeeeEEEeCCeEEEEEee
Q 041031 17 SLKIGQGSYGSVYLGKLR---------GKNAAIKQMKNT-KSKEFSSELKILCKV--HSNLIELIGYAAGGDSLFLVYEY 84 (313)
Q Consensus 17 ~~~lg~g~~g~v~~~~~~---------~~~~aiK~~~~~-~~~~~~~e~~~l~~l--h~~i~~~~~~~~~~~~~~lv~e~ 84 (313)
++.|+.|-.-.+|++... .+.+++++.... ......+|..+++.+ +.-..++++++.+ .+|++|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 457888999999999865 245777776532 234567899999998 5444577777653 579999
Q ss_pred cCCCChh
Q 041031 85 AQNGALS 91 (313)
Q Consensus 85 ~~~~~L~ 91 (313)
++|.++.
T Consensus 123 i~g~~l~ 129 (395)
T d1nw1a_ 123 IPSRPLS 129 (395)
T ss_dssp CCEEECC
T ss_pred eccccCC
Confidence 9875443
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=84.78 E-value=0.94 Score=36.07 Aligned_cols=133 Identities=12% Similarity=0.053 Sum_probs=73.0
Q ss_pred cCCeEEEEEeEECCcceEEEeccccccHHHHHHHHHHHhc-CCCceeeeeEE-----------------------EeCCe
Q 041031 22 QGSYGSVYLGKLRGKNAAIKQMKNTKSKEFSSELKILCKV-HSNLIELIGYA-----------------------AGGDS 77 (313)
Q Consensus 22 ~g~~g~v~~~~~~~~~~aiK~~~~~~~~~~~~e~~~l~~l-h~~i~~~~~~~-----------------------~~~~~ 77 (313)
.+|.+.|+-+...+..++||.-.....+.+-.++...-.+ .|...-+- .+ .....
T Consensus 78 ~~Gs~Gv~FV~~e~gaiVlK~s~tta~E~y~~eLAr~LGvpvPqmRvI~-~~~~E~~~~~~~~l~~~e~d~~I~sel~~A 156 (342)
T d1cjaa_ 78 EKGTEGLFFVETESGVFIVKRSTNIESETFCSLLCMRLGLHAPKVRVVS-SNSEEGTNMLECLAAIDKSFRVITTLANQA 156 (342)
T ss_dssp CSTTSCEEEEEESSCEEEEECCTTHHHHHHHHHHHHHHTCCCCCEEEEE-SSSHHHHHHHHHHHHHCSSSCHHHHHTTCS
T ss_pred ecCCceEEEEEcCCceEEEecCCchHHHHHHHHHHHHhCCCCCceEEec-CCCHHHHHHHHHHhcCCChhHHHHHHHhcc
Confidence 3444445556777778889886544444444454444444 55433322 10 11245
Q ss_pred EEEEEeecCCCChhhhhcCCCCCCCCCccHHHHHHHHHHHHHHHHHHhcCCCCceEEecc-CCCCeeeCCCC-cEEEeec
Q 041031 78 LFLVYEYAQNGALSDHLHWPSVKGKKPLAWTTRVQIALDAAKGLEYIHQYTKPYYVHRDV-KTSNILLDSNF-RAKIADF 155 (313)
Q Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di-~p~nil~~~~~-~~~l~df 155 (313)
.+++|||.+|.+|.+.-... ......... ..-+..++..=.+++...+-|+.+++- +++|+++++++ .+..+|=
T Consensus 157 ~~liMeYvpG~~l~e~~~~~---a~~~fs~~~-l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~~~~~IDs 232 (342)
T d1cjaa_ 157 NILLMELVRGITLNKLTTTS---APEVLTKST-MQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVPIDS 232 (342)
T ss_dssp EEEEEECCCEEESTTCCSSS---HHHHSCHHH-HHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEECSC
T ss_pred cceeeeccCCcccccccccc---chhhhcHHH-HHHhhhHHHHHHHHcCCccccccccCCCCccceEEecCCcEEEEecC
Confidence 78999999998876653100 001122222 222333444444566666655666532 79999998877 6778886
Q ss_pred cccc
Q 041031 156 GLVK 159 (313)
Q Consensus 156 g~~~ 159 (313)
+...
T Consensus 233 ~i~~ 236 (342)
T d1cjaa_ 233 KIIP 236 (342)
T ss_dssp CCCC
T ss_pred Cccc
Confidence 5543
|